Citrus Sinensis ID: 006031
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 664 | 2.2.26 [Sep-21-2011] | |||||||
| Q93Y06 | 669 | Probable inactive recepto | no | no | 0.945 | 0.938 | 0.553 | 0.0 | |
| Q84MA9 | 652 | Inactive leucine-rich rep | no | no | 0.884 | 0.900 | 0.438 | 1e-132 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.873 | 0.865 | 0.399 | 3e-99 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.879 | 0.887 | 0.367 | 2e-93 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.878 | 0.891 | 0.349 | 9e-86 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.862 | 0.895 | 0.352 | 7e-81 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.868 | 0.880 | 0.334 | 5e-80 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.882 | 0.915 | 0.343 | 7e-79 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.875 | 0.897 | 0.342 | 2e-76 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.862 | 0.913 | 0.321 | 2e-73 |
| >sp|Q93Y06|Y5720_ARATH Probable inactive receptor kinase At5g67200 OS=Arabidopsis thaliana GN=At5g67200 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/656 (55%), Positives = 465/656 (70%), Gaps = 28/656 (4%)
Query: 27 SASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVV 86
SA + NSLLPSDA LL+FK+ ADL N L +S + +CQW+GV C Q ++VR+V
Sbjct: 19 SAGAEPNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLV 78
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPP 146
L G+ L G F+ +L++LDQLRVL L+NNSL GPIPDLS LVNLKSLFL N F+G+FPP
Sbjct: 79 LSGVGLRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGAFPP 138
Query: 147 SLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVS 206
S+LSLHRL L +S+NN SG +P E+ + RL SL LD NRFNG++P LNQS L FNVS
Sbjct: 139 SILSLHRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNGTLPSLNQSFLTSFNVS 198
Query: 207 GNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVL 266
GNN TG I VT TLSRF SSF NP LCGEII++ C R PFFG + ++ P L
Sbjct: 199 GNNLTGVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFFGSTNKTTSSEAP---L 255
Query: 267 GQQSAQMHGVELTQP---SPKSHKKTAVIIGFSSG---VLVLICSLVLFAMAVKKQKQ-- 318
GQ + +G + P + K K++ +++GF++G ++VL LV+F++ +KK+
Sbjct: 256 GQSAQAQNGGAVVIPPVVTKKKGKESGLVLGFTAGLASLIVLGLCLVVFSLVIKKRNDDG 315
Query: 319 ------RKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQ--VAKSGNLV 370
+ + S +A+ ++ + E++ +EK + Q + + SGNLV
Sbjct: 316 IYEPNPKGEASLSQQQQSQNQTPRTRAVPVLNSDTESQKREKEVQFQETEQRIPNSGNLV 375
Query: 371 FCAGEAQ---LYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
FC GE++ +YT++QLMRASAELLG+GS+G TYKAVLDN+LIV VKRLDA+K A TS E
Sbjct: 376 FC-GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEE 434
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 487
+E HME VGGLRH NLVP+R+YFQ+ ERL+IYDY PNGSLF+LIHGS+S+RAKPLHWT
Sbjct: 435 AFENHMEIVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWT 494
Query: 488 SCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFEACLADYCLTALT-ADSLQDD 545
SCLKIAEDVAQGL YIHQ + LVHGNLKS+N+LLG DFEACL DYCL+ LT + S D
Sbjct: 495 SCLKIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPD 554
Query: 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
DPD+ YKAPE R +S + TSK DVYSFGVL+ ELLTGK S+H F+ P++M++WVR+ R
Sbjct: 555 DPDSSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMR 614
Query: 606 -EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELDPL 660
E++G ED RLGM+ E A C SPEQRPTM QV+KM+QEIK +V+ E E DP
Sbjct: 615 EEEEGTEDNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAE--ENDPF 668
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1215), Expect = e-132, Method: Compositional matrix adjust.
Identities = 290/662 (43%), Positives = 393/662 (59%), Gaps = 75/662 (11%)
Query: 13 LFFLSNTFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQW 72
+FFL F LI+ +S D + LL+ K+ D N + + + C W
Sbjct: 8 MFFLVFAFFLISPVRSS------------DVEALLSLKSSIDPSNSIPW---RGTDPCNW 52
Query: 73 QGVI-CYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLK 131
+GV C + +V ++VL+ L+L G SL +LDQLRVL + NSL+G IP+LSGLVNLK
Sbjct: 53 EGVKKCMKGRVSKLVLENLNLSGSLNGKSLNQLDQLRVLSFKGNSLSGSIPNLSGLVNLK 112
Query: 132 SLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
SL+L+ N F+G FP SL SLHRLKT+ LS N SG +P L RLY+ + N F+GS
Sbjct: 113 SLYLNDNNFSGEFPESLTSLHRLKTVVLSRNRFSGKIPSSLLRLSRLYTFYVQDNLFSGS 172
Query: 192 IPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFG 251
IPPLNQ++L+ FNVS N +G I T L+RF SSF N +LCG+ I CN G
Sbjct: 173 IPPLNQATLRFFNVSNNQLSGHIPPTQALNRFNESSFTDNIALCGDQIQNSCNDTT---G 229
Query: 252 PSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLV-------LIC 304
++T +A P P K+ +T +IG SG + L
Sbjct: 230 ITSTPSAKP------------------AIPVAKTRSRTK-LIGIISGSICGGILILLLTF 270
Query: 305 SLVLFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKR---AQGI 361
L+ K+ K +++++ +A + A TA+ +E +K KR +
Sbjct: 271 LLICLLWRRKRSKSKREERRSKRVAESKEAKTAET-------EEGTSDQKNKRFSWEKES 323
Query: 362 QVAKSGNLVFCAGEAQL--YTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDAS 419
+ G LVF + + YT+D L++ASAE LG+G+LG+TYKAV+++ I+ VKRL
Sbjct: 324 EEGSVGTLVFLGRDITVVRYTMDDLLKASAETLGRGTLGSTYKAVMESGFIITVKRL--- 380
Query: 420 KLAGTSN-EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK- 477
K AG + +++H+E +G L+HPNLVPLRAYFQAKEE LL+YDY PNGSLFSLIHGSK
Sbjct: 381 KDAGFPRMDEFKRHIEILGRLKHPNLVPLRAYFQAKEECLLVYDYFPNGSLFSLIHGSKV 440
Query: 478 STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537
S KPLHWTSCLKIAED+A GL YIHQ L HGNLKSSNVLLGPDFE+CL DY L+ L
Sbjct: 441 SGSGKPLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYGLSDL 500
Query: 538 -TADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ---HSFLV 593
S++D +L YKAPE R+ +T +DVYSFGVLLLELLTG+ + H +
Sbjct: 501 HDPYSIEDTSAASLFYKAPECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVHKY-- 558
Query: 594 PNEMMNWVRSAREDD-------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+++ WVR+ RE++ A +E+L LL +A AC + PE RP M +VLKM+++
Sbjct: 559 GSDISTWVRAVREEETEVSEELNASEEKLQALLTIATACVAVKPENRPAMREVLKMVKDA 618
Query: 647 KG 648
+
Sbjct: 619 RA 620
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 255/639 (39%), Positives = 367/639 (57%), Gaps = 59/639 (9%)
Query: 41 SDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNS 100
+D++ LL FK AD L S N + + CQW GV C + +V R+VL+ ++L G + S
Sbjct: 30 TDSETLLNFKLTADSTGKLN-SWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSIS--S 86
Query: 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
LT L LRVL L++N+L+GPIP+LS L LK LFL +N F+G+FP S+ SL RL LDLS
Sbjct: 87 LTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLS 146
Query: 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTL 220
+NN SG +P +L L +LRL+ NRF+G IP +N S L+ FNVSGNNF G I ++L
Sbjct: 147 FNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQI--PNSL 204
Query: 221 SRFGISSFLFNPSLCGEIIHK----ECNPRPPFFGPSATAAAAPPPVTVLGQQSAQMHGV 276
S+F S F NPSLCG + K +P P A A+ P TV ++ +HG
Sbjct: 205 SQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTS-IHGG 263
Query: 277 ELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLF-----AMAVKKQKQRKDKKSKAMIASD 331
+ + + + + + I +++ SL+L+ AV K+K K + + ++ S
Sbjct: 264 DKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSS 323
Query: 332 EAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLDQLMRASAEL 391
T+ Q + QV G +VF G + + L+ L+RASAE+
Sbjct: 324 NPYPTSTQNNNNQNQ---------------QVGDKGKMVFFEG-TRRFELEDLLRASAEM 367
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRL-DASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
LGKG GT YKAVL++ V VKRL DA +AG + +EQ ME +G LRH NLV L+AY
Sbjct: 368 LGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAG--KKEFEQQMEVLGRLRHTNLVSLKAY 425
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH---QAW 507
+ A+EE+LL+YDY PNGSLF L+HG++ PL WT+ LKIA A+GL++IH +
Sbjct: 426 YFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTL 485
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
+L HG++KS+NVLL A ++D+ L+ Y+APE + + T K
Sbjct: 486 KLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSNG---YRAPELIDG-RKHTQK 541
Query: 568 SDVYSFGVLLLELLTGKPPSQ----HSFLVPNEMMNWVRS-AREDDGAE----------- 611
SDVYSFGVLLLE+LTGK P+ HS ++ WV+S RE+ AE
Sbjct: 542 SDVYSFGVLLLEILTGKCPNMVETGHSGGAV-DLPRWVQSVVREEWTAEVFDLELMRYKD 600
Query: 612 -DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+E + LL++A+AC + + + RP M V+K++++I+G
Sbjct: 601 IEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGG 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 237/645 (36%), Positives = 348/645 (53%), Gaps = 61/645 (9%)
Query: 35 VNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICY--QQKVVRVVLQGLDL 92
VNS ++ Q LL F + N L ++++ S C W GV C Q + + L G L
Sbjct: 21 VNSESTAEKQALLTFLQQIPHENRLQWNESDSA--CNWVGVECNSNQSSIHSLRLPGTGL 78
Query: 93 GGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSL 151
G SL +L +LRVL L++N L+G IP D S L +L+SL+L HN F+G FP S L
Sbjct: 79 VGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQL 138
Query: 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
+ L LD+S NN +G +P + + L L L N F+G++P ++ L FNVS NN
Sbjct: 139 NNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLN 197
Query: 212 GAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSA 271
G+I S+LSRF SF N LCG + K C FF + +P P
Sbjct: 198 GSIP--SSLSRFSAESFTGNVDLCGGPL-KPCKS---FF-----VSPSPSP--------- 237
Query: 272 QMHGVELTQPSPKSHKKT-----AVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDKKSKA 326
L PS + K A I+ ++ L+ + + +K+R +++
Sbjct: 238 -----SLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEART 292
Query: 327 MIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLDQLMR 386
AT E G + ++ LVF G + L+ L+R
Sbjct: 293 KQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERN-KLVFTEGGVYSFDLEDLLR 351
Query: 387 ASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
ASAE+LGKGS+GT+YKAVL+ V VKRL K S + +E ME VG ++HPN++P
Sbjct: 352 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRL---KDVMASKKEFETQMEVVGKIKHPNVIP 408
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
LRAY+ +K+E+LL++D+ P GSL +L+HGS+ + PL W + ++IA A+GL+++H +
Sbjct: 409 LRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS 468
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--YKAPETRNASHQA 564
+LVHGN+K+SN+LL P+ + C++DY L L ++S P N L Y APE + +
Sbjct: 469 AKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNS----SPPNRLAGYHAPEVL-ETRKV 523
Query: 565 TSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRS-AREDDGAE----------- 611
T KSDVYSFGVLLLELLTGK P+Q S ++ WV S RE+ AE
Sbjct: 524 TFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHN 583
Query: 612 -DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDG 655
+E + LL++A+AC S P+QRP M +VL+M++++ + +DG
Sbjct: 584 IEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDDG 628
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 9e-86, Method: Compositional matrix adjust.
Identities = 230/659 (34%), Positives = 352/659 (53%), Gaps = 76/659 (11%)
Query: 15 FLSN---TFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ 71
FLS +FL +T+ S + + +NS D Q LLAF A L + N + H C+
Sbjct: 22 FLSTCLVSFLFVTTTFCSYAIADLNS----DRQALLAFAASVPHLRRL--NWNSTNHICK 75
Query: 72 -WQGVICYQQ--KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGL 127
W GV C V + L G+ L G PN+L KL+ LR+L L++N L+G +P D+ L
Sbjct: 76 SWVGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSL 135
Query: 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
+L ++L HN F+G P S +S +L LDLS+N+ +G +P + +L L L N+
Sbjct: 136 PSLDYIYLQHNNFSGEVP-SFVS-RQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNK 193
Query: 188 FNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRP 247
+G +P L+ SL+ N+S N+ G+I S L F SSF N LCG + P
Sbjct: 194 LSGPVPNLDTVSLRRLNLSNNHLNGSIP--SALGGFPSSSFSGNTLLCGLPLQPCATSSP 251
Query: 248 PFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV 307
P PS T + PP+ + K H T + I L+L+ +++
Sbjct: 252 P---PSLTPHISTPPLPPFPHKEGSKR---------KLHVSTIIPIAAGGAALLLLITVI 299
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSG 367
+ +KK+ +R+D K +++A K + G+Q +
Sbjct: 300 ILCCCIKKKDKREDSIVKVKTLTEKA--------------------KQEFGSGVQEPEKN 339
Query: 368 NLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
LVF G + + L+ L+RASAE+LGKGS GT YKAVL+ V VKRL K
Sbjct: 340 KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL---KEVAAGKR 396
Query: 428 MYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHW 486
+EQ ME + + HP++VPLRAY+ +K+E+L++ DY P G+L SL+HG++ + PL W
Sbjct: 397 EFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDW 456
Query: 487 TSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544
S +KI A+G++++H A + HGN+KSSNV++ + +AC++D+ LT L A +
Sbjct: 457 DSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAP 516
Query: 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN---WV 601
Y+APE + + T KSDVYSFGVL+LE+LTGK P Q ++M++ WV
Sbjct: 517 MRGAG--YRAPEVME-TRKHTHKSDVYSFGVLILEMLTGKSPVQSPSR--DDMVDLPRWV 571
Query: 602 RS-AREDDGAE------------DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+S RE+ +E +E + +L++A+AC + PE RPTM V++M++EI+
Sbjct: 572 QSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 232/658 (35%), Positives = 342/658 (51%), Gaps = 85/658 (12%)
Query: 20 FLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ-WQGVICY 78
FLL+ + +A V++ L SD Q LL F A L + NK+L C W G+ C
Sbjct: 15 FLLLAA-----TAVLVSADLASDEQALLNFAASVPHPPKL--NWNKNLSLCSSWIGITCD 67
Query: 79 QQ----KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSL 133
+ +VV V L G+ L G P +L KLD L+VL L++NSL G +P D+ L +L+ L
Sbjct: 68 ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127
Query: 134 FLDHNFFTGSFPP-SLLSLHR-LKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
+L HN F+G SL S+ + L LDLSYN+LSG +P L + ++ L L N F+G
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187
Query: 192 IPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFG 251
I L+ S+K+ N+S NN +G I L + SF+ N LCG PP
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIP--EHLKKSPEYSFIGNSLLCG----------PPLNA 235
Query: 252 PSATAAAA----PPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV 307
S A + P P+T +H V Q A+++G S V VL +V
Sbjct: 236 CSGGAISPSSNLPRPLT------ENLHPVRRRQ---SKAYIIAIVVGCS--VAVLFLGIV 284
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSG 367
VKK K+ + E T + Q+ G+Q +
Sbjct: 285 FLVCLVKKTKKEE--------GGGEGVRTQMGGVNSKKPQD--------FGSGVQDPEKN 328
Query: 368 NLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
L F + L+ L++ASAE+LGKGS GT YKAVL++ V VKRL + S +
Sbjct: 329 KLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRL---REVVASKK 385
Query: 428 MYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHW 486
+EQ ME VG + +H N VPL AY+ +K+E+LL+Y Y GSLF ++HG++ R + W
Sbjct: 386 EFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRG--VDW 443
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546
+ +KIA ++ +SY+H + + VHG++KSSN+LL D E CL+D L L +L
Sbjct: 444 ETRMKIATGTSKAISYLH-SLKFVHGDIKSSNILLTEDLEPCLSDTSLVTLF--NLPTHT 500
Query: 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL----VPNEMMNWVR 602
P + Y APE + + + +SDVYSFGV++LE+LTGK P L V ++ WVR
Sbjct: 501 PRTIGYNAPEVIE-TRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVR 559
Query: 603 S-AREDDGAE------------DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
S RE+ AE +E + +L++A+AC + +PE RP M +V +M+++++
Sbjct: 560 SVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVR 617
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 5e-80, Method: Compositional matrix adjust.
Identities = 215/643 (33%), Positives = 328/643 (51%), Gaps = 66/643 (10%)
Query: 39 LPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAP 98
L +D LL+ ++ R F K C W GV C +V + L G+ L G
Sbjct: 33 LNADRTALLSLRSAVGGRT--FRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPE 90
Query: 99 NSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
L QLR L L+ N+L+G +P DLS NL+ L+L N F+G P L SL L L
Sbjct: 91 GIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRL 150
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVT 217
+L+ N+ +G + + +L +L L+ N+ +GSIP L+ ++ FNVS N+ G+I
Sbjct: 151 NLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLVQ-FNVSNNSLNGSIP-- 207
Query: 218 STLSRFGISSFLFNPSLCGEIIH----KECNPRPPFFGPSATAAAAPPPVTVLGQQSAQM 273
L RF SFL SLCG+ + +E P P G + T PP V
Sbjct: 208 KNLQRFESDSFL-QTSLCGKPLKLCPDEETVPSQPTSGGNRT----PPSV---------- 252
Query: 274 HGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKD---------KKS 324
G E + K+ I G G +V +VL M + ++K K K+
Sbjct: 253 EGSE--EKKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQ 310
Query: 325 KAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLDQL 384
+ I D+ A + + + K ++G A + LVF +++ L+ L
Sbjct: 311 EPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPA-TKKLVFFGNATKVFDLEDL 369
Query: 385 MRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
+RASAE+LGKG+ GT YKAVLD +V VKRL +A ++ +++ +E VG + H NL
Sbjct: 370 LRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMA---DKEFKEKIELVGAMDHENL 426
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
VPLRAY+ +++E+LL+YD+ P GSL +L+HG++ PL+W +IA A+GL Y+H
Sbjct: 427 VPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLH 486
Query: 505 -QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-YKAPETRNASH 562
Q HGN+KSSN+LL +A ++D+ L L S +P+ Y+APE +
Sbjct: 487 SQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSAT--NPNRATGYRAPEVTDP-K 543
Query: 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE----MMNWVRSAREDD---------- 608
+ + K DVYSFGV+LLEL+TGK PS V NE + WV+S D+
Sbjct: 544 RVSQKGDVYSFGVVLLELITGKAPSNS---VMNEEGVDLPRWVKSVARDEWRREVFDSEL 600
Query: 609 ----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
E+E + ++++ + C S P+QRP M +V++ ++ ++
Sbjct: 601 LSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 7e-79, Method: Compositional matrix adjust.
Identities = 229/666 (34%), Positives = 334/666 (50%), Gaps = 80/666 (12%)
Query: 8 LLPQLLFFLSNTFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSL 67
++ LF L TF+ SR SA + SD Q LL F + L + N ++
Sbjct: 4 IIAAFLFLLVTTFV-------SRCLSAD---IESDKQALLEFASLVPHSRKLNW--NSTI 51
Query: 68 HFC-QWQGVICYQQ--KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD- 123
C W G+ C + +V + L G L G + KLD LR++ L++N L G IP
Sbjct: 52 PICASWTGITCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSV 111
Query: 124 LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRL 183
+ L ++SL+ N F+G+ PP L HRL LDLS N+LSG +P L + +L L L
Sbjct: 112 ILSLPFIRSLYFHENNFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSL 169
Query: 184 DVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKEC 243
N +G IP L LK N+S NN G +V S++ F SSF N LCG
Sbjct: 170 QNNSLSGPIPNL-PPRLKYLNLSFNNLNG--SVPSSVKSFPASSFQGNSLLCGA------ 220
Query: 244 NPRPPFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSG--VLV 301
P P P T A +P P T G + + K T I+G + G VL+
Sbjct: 221 -PLTPC--PENTTAPSPSPTTPTEGPGTTNIG----RGTAKKVLSTGAIVGIAVGGSVLL 273
Query: 302 LICSLVLFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGI 361
I ++ KK+ +D + + A+ G+
Sbjct: 274 FIILAIITLCCAKKRDGGQDSTAVPKAKPGRSDNKAEEFG-----------------SGV 316
Query: 362 QVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKL 421
Q A+ LVF G + + L+ L+RASAE+LGKGS GTTYKA+L+ V VKRL K
Sbjct: 317 QEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRL---KE 373
Query: 422 AGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR 480
+EQ ME+VG + H N+ PLRAY+ +K+E+LL+YDY G+ L+HG+
Sbjct: 374 VAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGG 433
Query: 481 AKPLHWTSCLKIAEDVAQGLSYIHQA--WRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538
L W + L+I + A+G+S+IH A +L+HGN+KS NVLL + C++D+ + L
Sbjct: 434 RAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLM 493
Query: 539 ADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ---HSFLVPN 595
+ +L Y+APE + + T KSDVYSFGVLLLE+LTGK + H +V
Sbjct: 494 SHHTLIPS-RSLGYRAPEAIE-TRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVV-- 549
Query: 596 EMMNWVRS-AREDDGAE-------------DERLGMLLEVAIACNSASPEQRPTMWQVLK 641
++ WV+S RE+ E +E + +L++A+AC S P+ RP+M +V+
Sbjct: 550 DLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVN 609
Query: 642 MLQEIK 647
M++EI+
Sbjct: 610 MMEEIR 615
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 218/637 (34%), Positives = 326/637 (51%), Gaps = 56/637 (8%)
Query: 39 LPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAP 98
L +D LL+F++ R L+ + S C W GV+C +V + L G L G
Sbjct: 31 LAADKSALLSFRSAVGGRTLLWDVKQTSP--CNWTGVLCDGGRVTALRLPGETLSGHIPE 88
Query: 99 NSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
L QLR L L+ N LTG +P DL +L+ L+L N F+G P L SL L L
Sbjct: 89 GIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRL 148
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVT 217
+L+ N SG + + RL +L L+ N+ +GS+ L+ S + FNVS N G+I
Sbjct: 149 NLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQ-FNVSNNLLNGSIP-- 205
Query: 218 STLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSAQMHGVE 277
+L +F SF+ SLCG+ P S P++V G + G E
Sbjct: 206 KSLQKFDSDSFV-GTSLCGK----------PLVVCSNEGTVPSQPISV-GNIPGTVEGSE 253
Query: 278 LTQPSPK--SHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDKKSKAMIASDEAAA 335
+ K ++IG G+ +++ ++L + KK +R A I E
Sbjct: 254 EKKKRKKLSGGAIAGIVIGCVVGLSLIV--MILMVLFRKKGNERTRAIDLATIKHHEVEI 311
Query: 336 TAQALAMIQIEQENELQEKVKRA-QGIQVAKSG--NLVFCAGEAQLYTLDQLMRASAELL 392
+ A+ E + + E A + ++V SG LVF +++ L+ L+RASAE+L
Sbjct: 312 PGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVL 371
Query: 393 GKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ 452
GKG+ GT YKAVLD +V VKRL +A + +++ +E VG + H NLVPLRAY+
Sbjct: 372 GKGTFGTAYKAVLDAVTLVAVKRLKDVTMA---DREFKEKIEVVGAMDHENLVPLRAYYY 428
Query: 453 AKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL-VH 511
+ +E+LL+YD+ P GSL +L+HG+K PL+W IA A+GL Y+H L H
Sbjct: 429 SGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSH 488
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-YKAPETRNASHQATSKSDV 570
GN+KSSN+LL +A ++D+ L L + S P+ Y+APE + + + K+DV
Sbjct: 489 GNVKSSNILLTNSHDARVSDFGLAQLVSAS--STTPNRATGYRAPEVTDP-RRVSQKADV 545
Query: 571 YSFGVLLLELLTGKPPSQHSFLVPNE----MMNWVRS-AREDDGAE-------------- 611
YSFGV+LLELLTGK PS V NE + WV S ARE+ E
Sbjct: 546 YSFGVVLLELLTGKAPSNS---VMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVS 602
Query: 612 -DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+E + +L++ I C P++RP M +V++ +QE++
Sbjct: 603 VEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 205/637 (32%), Positives = 328/637 (51%), Gaps = 64/637 (10%)
Query: 33 SAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDL 92
+AV S L SD + LLA + R L+ S C W GV C +V + L G L
Sbjct: 20 AAVTSDLESDRRALLAVRNSVRGRPLLWNMSASSP--CNWHGVHCDAGRVTALRLPGSGL 77
Query: 93 GGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSL 151
G + L QL+ L L+ NSL+GPIP D S LV L+ L+L N F+G P L +L
Sbjct: 78 FGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLFTL 137
Query: 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
+ ++L N SG +P + S RL +L L+ N+ +G IP + L+ FNVS N
Sbjct: 138 PSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLP-LQQFNVSSNQLN 196
Query: 212 GAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSA 271
G+I S+LS + ++F N +LCG+ + C P G +
Sbjct: 197 GSIP--SSLSSWPRTAFEGN-TLCGKPLDT-CEAESPNGGDA------------------ 234
Query: 272 QMHGVELTQPSPKSHKK--TAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDKKSKAMIA 329
G T P K K I+G G +V + L+L + +++++++ +
Sbjct: 235 ---GGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCRKRKKEENVPSRNVE 291
Query: 330 SDEAAATAQALAMIQIEQENELQEKVKRAQGIQV-AKSGNLVFCAGEAQLYTLDQLMRAS 388
+ AAAT+ A I +E + +A G + A + +L F + LD L++AS
Sbjct: 292 APVAAATSSA----AIPKETVVVVPPAKATGSESGAVNKDLTFFVKSFGEFDLDGLLKAS 347
Query: 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
AE+LGKG++G++YKA ++ L+V VKRL + + + + + +G + H NLV L
Sbjct: 348 AEVLGKGTVGSSYKASFEHGLVVAVKRL---RDVVVPEKEFRERLHVLGSMSHANLVTLI 404
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-QAW 507
AY+ +++E+LL+++Y GSL +++HG+K PL+W + IA A+ +SY+H +
Sbjct: 405 AYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDG 464
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
HGN+KSSN+LL +EA ++DY L + + + + D Y+APE +A + + K
Sbjct: 465 TTSHGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDG--YRAPEITDA-RKISQK 521
Query: 568 SDVYSFGVLLLELLTGKPPSQHSFLVPNE----MMNWVRSAREDDGAED----------- 612
+DVYSFGVL+LELLTGK P+ NE + WV+S E D
Sbjct: 522 ADVYSFGVLILELLTGKSPTHQQL---NEEGVDLPRWVQSVTEQQTPSDVLDPELTRYQP 578
Query: 613 ---ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
E + LL++ ++C + P+ RP+M +V ++++E+
Sbjct: 579 EGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEV 615
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 664 | ||||||
| 255538220 | 649 | ATP binding protein, putative [Ricinus c | 0.959 | 0.981 | 0.725 | 0.0 | |
| 147790678 | 662 | hypothetical protein VITISV_001142 [Viti | 0.972 | 0.975 | 0.706 | 0.0 | |
| 359492580 | 687 | PREDICTED: probable inactive receptor ki | 0.972 | 0.940 | 0.706 | 0.0 | |
| 302142279 | 675 | unnamed protein product [Vitis vinifera] | 0.971 | 0.955 | 0.705 | 0.0 | |
| 224137624 | 646 | predicted protein [Populus trichocarpa] | 0.954 | 0.981 | 0.685 | 0.0 | |
| 77417498 | 665 | putative receptor kinase [Malus x domest | 0.917 | 0.915 | 0.670 | 0.0 | |
| 356509745 | 652 | PREDICTED: probable inactive receptor ki | 0.936 | 0.953 | 0.661 | 0.0 | |
| 225438793 | 671 | PREDICTED: probable inactive receptor ki | 0.926 | 0.916 | 0.656 | 0.0 | |
| 357465601 | 655 | Disease resistance protein [Medicago tru | 0.942 | 0.955 | 0.637 | 0.0 | |
| 297791631 | 669 | hypothetical protein ARALYDRAFT_494701 [ | 0.956 | 0.949 | 0.601 | 0.0 |
| >gi|255538220|ref|XP_002510175.1| ATP binding protein, putative [Ricinus communis] gi|223550876|gb|EEF52362.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/652 (72%), Positives = 544/652 (83%), Gaps = 15/652 (2%)
Query: 12 LLFFLSNTFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ 71
L SN FLL++ + +AS SDA LLAFK+ DL ++L +SQN + HFC+
Sbjct: 2 LRLLFSNAFLLLSFSTIFTAASTT-----SDATALLAFKSTVDLNSNLPYSQNTTSHFCE 56
Query: 72 WQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLK 131
W GV C+Q+KVVR+VL LDLGG FAP++LT LDQLRVL LQNNS+TGPIPDLS LVNLK
Sbjct: 57 WVGVKCFQRKVVRLVLHNLDLGGTFAPDTLTLLDQLRVLSLQNNSITGPIPDLSKLVNLK 116
Query: 132 SLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
SLFLDHN FT SFPPSL SLHRL+TLDLS+NNLSGP+P L+S RLYS RLD NRFNGS
Sbjct: 117 SLFLDHNSFTASFPPSLRSLHRLRTLDLSHNNLSGPIPTWLSSLDRLYSFRLDSNRFNGS 176
Query: 192 IPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFG 251
IPPLNQSSLK FNVS NNFTGA+ VT TL RF +SSFL NP+LCGEIIHKEC+P PP
Sbjct: 177 IPPLNQSSLKTFNVSYNNFTGAVPVTPTLLRFDLSSFLSNPNLCGEIIHKECHPSPP--F 234
Query: 252 PSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKS-HKKTAVIIGFSSGVLVLICSLVLFA 310
++ ++PPP LGQ SA++HGV+L+QPS K+ HK+TA+IIGF+SGV + I SL+ FA
Sbjct: 235 FGSSPPSSPPPAVTLGQ-SAELHGVDLSQPSSKTKHKRTALIIGFASGVFIFIGSLLCFA 293
Query: 311 MAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQ-ENELQEKVKRAQGIQVAKSGNL 369
MAV+KQ R KKSK + S+ A A++QI+Q ENEL+EKVKR QG+ V KSG L
Sbjct: 294 MAVRKQ--RNQKKSKETVTSEGCGGVAAVAAVMQIDQQENELEEKVKRVQGMHVGKSGCL 351
Query: 370 VFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMY 429
+FCAGEAQLYTLDQLMRASAELLG+G++GTTYKAVLDNRLIVCVKRLDASKL G S + +
Sbjct: 352 LFCAGEAQLYTLDQLMRASAELLGRGTIGTTYKAVLDNRLIVCVKRLDASKLQGNSKDDF 411
Query: 430 EQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC 489
E+HMESVGGLRHPNLVPLRAYFQA+EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC
Sbjct: 412 ERHMESVGGLRHPNLVPLRAYFQAREERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC 471
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL-TADSLQDD--D 546
LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP+FEAC+ADYCL L T+ SLQDD +
Sbjct: 472 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPEFEACIADYCLAVLATSQSLQDDNNN 531
Query: 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE 606
PD YKAPETRN++HQ+TSKSDV+SFG+LLLELLTGKPPSQ FLVP++MM+WVRSARE
Sbjct: 532 PDATAYKAPETRNSTHQSTSKSDVFSFGILLLELLTGKPPSQLPFLVPDDMMDWVRSARE 591
Query: 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELD 658
DDG+ED RL MLLEVA+AC+S SPEQRPTMWQVLKMLQEIK VL+ED E+D
Sbjct: 592 DDGSEDSRLEMLLEVALACSSTSPEQRPTMWQVLKMLQEIKETVLLEDSEVD 643
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147790678|emb|CAN61022.1| hypothetical protein VITISV_001142 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/657 (70%), Positives = 538/657 (81%), Gaps = 11/657 (1%)
Query: 13 LFFLSNTFLLITSCSASRSASAVNSLLPS-----DAQVLLAFKAKADLRNHLFFSQNKSL 67
LF LS FL +S +A+ AV+ DA L+ FK+KADL N L F+ + SL
Sbjct: 12 LFILSVAFLTASSTAATHPPHAVSPSPSPTLPPSDAIALVMFKSKADLGNKLRFTASTSL 71
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL 127
++C WQGV C + KVVR+VL+GLDLGG+F P++L++LDQLRVL LQNNSL GPIPDLS
Sbjct: 72 NYCYWQGVTCLRGKVVRLVLEGLDLGGVFGPDTLSRLDQLRVLSLQNNSLVGPIPDLSKF 131
Query: 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
NLK+LFLDHN FTGSFPPS+ SLHRL+TLD SYNNL+GPLP L RLY LRL+ NR
Sbjct: 132 FNLKALFLDHNSFTGSFPPSISSLHRLRTLDFSYNNLTGPLPIWLTKLDRLYYLRLESNR 191
Query: 188 FNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRP 247
FNG+IPPLNQS+L+ FNVS NN GAI VT TL F S+F NP LCGEI+HKEC+P
Sbjct: 192 FNGTIPPLNQSTLQTFNVSRNNLFGAIPVTPTLLHFEASAFALNPGLCGEILHKECHPSQ 251
Query: 248 PFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV 307
PFF PSA A PPPV LGQ Q+HGVEL QP PK+HK+T VI+GFSSGV VLI SL+
Sbjct: 252 PFFSPSAPVATPPPPVG-LGQNE-QVHGVELAQPCPKNHKRTVVILGFSSGVFVLISSLL 309
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSG 367
F +A+K+Q+ ++++ A + ++AATAQA A+++IE+ENEL+EKVK+ QG+QVAKSG
Sbjct: 310 CFVIAMKRQR---NQRNTAPTMASDSAATAQAAAVMRIEEENELEEKVKKVQGMQVAKSG 366
Query: 368 NLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
+LVFCAGEAQLYTL+QLMRASAELLG+GS+GTTYKAVLDNRLIV VKRLDA K A T E
Sbjct: 367 SLVFCAGEAQLYTLEQLMRASAELLGRGSIGTTYKAVLDNRLIVSVKRLDAGKTAITDKE 426
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 487
YE+HMESVGGLRHPNLVPLRAYFQA+EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT
Sbjct: 427 TYERHMESVGGLRHPNLVPLRAYFQAQEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 486
Query: 488 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547
SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL DYCL L + S+ DDD
Sbjct: 487 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLTDYCLAVLASPSV-DDDL 545
Query: 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED 607
D+ YKAPETRN S QATSK+DVY+FG+LLLELLTGKPPSQH L+P++MMNWVRS R+D
Sbjct: 546 DSASYKAPETRNPSGQATSKADVYAFGILLLELLTGKPPSQHPVLMPDDMMNWVRSTRDD 605
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELDPLSGIS 664
D ED R+GMLLEVAIAC+ SPEQRPTMWQVLKM+QEIK +VLMED ELDPL+G+S
Sbjct: 606 DDGEDNRMGMLLEVAIACSVTSPEQRPTMWQVLKMIQEIKESVLMEDNELDPLTGLS 662
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492580|ref|XP_003634438.1| PREDICTED: probable inactive receptor kinase At5g67200-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2295), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/657 (70%), Positives = 538/657 (81%), Gaps = 11/657 (1%)
Query: 13 LFFLSNTFLLITSCSASRSASAVNSLLPS-----DAQVLLAFKAKADLRNHLFFSQNKSL 67
LF LS FL +S +A+ AV+ DA L+ FK+KADL N L F+ + SL
Sbjct: 37 LFILSVAFLTASSTAATHPPHAVSPSPSPTLPPSDAIALVMFKSKADLGNKLRFTASTSL 96
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL 127
++C WQGV C + KVVR+VL+GLDLGG+F P++L++LDQLRVL LQNNSL GPIPDLS
Sbjct: 97 NYCYWQGVTCLRGKVVRLVLEGLDLGGVFGPDTLSRLDQLRVLSLQNNSLVGPIPDLSKF 156
Query: 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
NLK+LFLDHN FTGSFPPS+ SLHRL+TLD SYNNL+GPLP L RLY LRL+ NR
Sbjct: 157 FNLKALFLDHNSFTGSFPPSISSLHRLRTLDFSYNNLTGPLPIWLTKLDRLYYLRLESNR 216
Query: 188 FNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRP 247
FNG+IPPLNQS+L+ FNVS NN GAI VT TL F S+F NP LCGEI+HKEC+P
Sbjct: 217 FNGTIPPLNQSTLQTFNVSRNNLFGAIPVTPTLLHFEASAFALNPGLCGEILHKECHPSQ 276
Query: 248 PFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV 307
PFF PSA A PPPV LGQ Q+HGVEL QP PK+HK+T VI+GFSSGV VLI SL+
Sbjct: 277 PFFSPSAPVATPPPPVG-LGQNE-QVHGVELAQPCPKNHKRTVVILGFSSGVFVLISSLL 334
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSG 367
F +A+K+Q+ ++++ A + ++AATAQA A+++IE+ENEL+EKVK+ QG+QVAKSG
Sbjct: 335 CFVIAMKRQR---NQRNTAPTMASDSAATAQAAAVMRIEEENELEEKVKKVQGMQVAKSG 391
Query: 368 NLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
+LVFCAGEAQLYTL+QLMRASAELLG+GS+GTTYKAVLDNRLIV VKRLDA K A T E
Sbjct: 392 SLVFCAGEAQLYTLEQLMRASAELLGRGSIGTTYKAVLDNRLIVSVKRLDAGKTAITDKE 451
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 487
YE+HMESVGGLRHPNLVPLRAYFQA+EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT
Sbjct: 452 TYERHMESVGGLRHPNLVPLRAYFQAQEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 511
Query: 488 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547
SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL DYCL L + S+ DDD
Sbjct: 512 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLTDYCLAVLASPSV-DDDL 570
Query: 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED 607
D+ YKAPETRN S QATSK+DVY+FG+LLLELLTGKPPSQH L+P++MMNWVRS R+D
Sbjct: 571 DSASYKAPETRNPSGQATSKADVYAFGILLLELLTGKPPSQHPVLMPDDMMNWVRSTRDD 630
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELDPLSGIS 664
D ED R+GMLLEVAIAC+ SPEQRPTMWQVLKM+QEIK +VLMED ELDPL+G+S
Sbjct: 631 DDGEDNRMGMLLEVAIACSVTSPEQRPTMWQVLKMIQEIKESVLMEDNELDPLTGLS 687
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142279|emb|CBI19482.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/656 (70%), Positives = 537/656 (81%), Gaps = 11/656 (1%)
Query: 13 LFFLSNTFLLITSCSASRSASAVNSLLPS-----DAQVLLAFKAKADLRNHLFFSQNKSL 67
LF LS FL +S +A+ AV+ DA L+ FK+KADL N L F+ + SL
Sbjct: 12 LFILSVAFLTASSTAATHPPHAVSPSPSPTLPPSDAIALVMFKSKADLGNKLRFTASTSL 71
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL 127
++C WQGV C + KVVR+VL+GLDLGG+F P++L++LDQLRVL LQNNSL GPIPDLS
Sbjct: 72 NYCYWQGVTCLRGKVVRLVLEGLDLGGVFGPDTLSRLDQLRVLSLQNNSLVGPIPDLSKF 131
Query: 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
NLK+LFLDHN FTGSFPPS+ SLHRL+TLD SYNNL+GPLP L RLY LRL+ NR
Sbjct: 132 FNLKALFLDHNSFTGSFPPSISSLHRLRTLDFSYNNLTGPLPIWLTKLDRLYYLRLESNR 191
Query: 188 FNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRP 247
FNG+IPPLNQS+L+ FNVS NN GAI VT TL F S+F NP LCGEI+HKEC+P
Sbjct: 192 FNGTIPPLNQSTLQTFNVSRNNLFGAIPVTPTLLHFEASAFALNPGLCGEILHKECHPSQ 251
Query: 248 PFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV 307
PFF PSA A PPPV LGQ Q+HGVEL QP PK+HK+T VI+GFSSGV VLI SL+
Sbjct: 252 PFFSPSAPVATPPPPVG-LGQNE-QVHGVELAQPCPKNHKRTVVILGFSSGVFVLISSLL 309
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSG 367
F +A+K+Q+ ++++ A + ++AATAQA A+++IE+ENEL+EKVK+ QG+QVAKSG
Sbjct: 310 CFVIAMKRQR---NQRNTAPTMASDSAATAQAAAVMRIEEENELEEKVKKVQGMQVAKSG 366
Query: 368 NLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNE 427
+LVFCAGEAQLYTL+QLMRASAELLG+GS+GTTYKAVLDNRLIV VKRLDA K A T E
Sbjct: 367 SLVFCAGEAQLYTLEQLMRASAELLGRGSIGTTYKAVLDNRLIVSVKRLDAGKTAITDKE 426
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 487
YE+HMESVGGLRHPNLVPLRAYFQA+EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT
Sbjct: 427 TYERHMESVGGLRHPNLVPLRAYFQAQEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 486
Query: 488 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547
SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL DYCL L + S+ DDD
Sbjct: 487 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLTDYCLAVLASPSV-DDDL 545
Query: 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED 607
D+ YKAPETRN S QATSK+DVY+FG+LLLELLTGKPPSQH L+P++MMNWVRS R+D
Sbjct: 546 DSASYKAPETRNPSGQATSKADVYAFGILLLELLTGKPPSQHPVLMPDDMMNWVRSTRDD 605
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELDPLSGI 663
D ED R+GMLLEVAIAC+ SPEQRPTMWQVLKM+QEIK +VLMED ELDPL+G+
Sbjct: 606 DDGEDNRMGMLLEVAIACSVTSPEQRPTMWQVLKMIQEIKESVLMEDNELDPLTGL 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137624|ref|XP_002327172.1| predicted protein [Populus trichocarpa] gi|222835487|gb|EEE73922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2229), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/662 (68%), Positives = 519/662 (78%), Gaps = 28/662 (4%)
Query: 12 LLFFLSNTFLLIT--SCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHF 69
LL LS + L+ AS +A A N P DA LLAFK KADL +L FSQN + HF
Sbjct: 2 LLVLLSTSHFLLCFFITVASSTAPASNLPAPPDATALLAFKYKADLNKNLPFSQNTTFHF 61
Query: 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLV 128
CQW GV C+QQK++R+VL+ DLGGIFAP +LT LDQLRVLGLQNNSLTGPIP DLS L
Sbjct: 62 CQWPGVKCFQQKIIRLVLRDSDLGGIFAPKTLTFLDQLRVLGLQNNSLTGPIPYDLSKLT 121
Query: 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188
NLKSLFLDHN F+GSFPP LLSLHRL+TLDLS+NNLSGP+P L S RLY LRLD N F
Sbjct: 122 NLKSLFLDHNSFSGSFPPPLLSLHRLRTLDLSHNNLSGPIPSALISLDRLYYLRLDRNLF 181
Query: 189 NGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPP 248
NGSIPPLNQSSL NVS NN +GAI VT TL RF +SSF NPSLCG+IIHKEC+P P
Sbjct: 182 NGSIPPLNQSSLLTLNVSFNNLSGAIPVTPTLLRFDLSSFSSNPSLCGKIIHKECHPASP 241
Query: 249 FFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKS-HKKTAVIIGFSSGVLVLICSLV 307
FFGPS AA + GV+L Q K+ HKK +IIGFSSG VL+ S++
Sbjct: 242 FFGPSPAAA---------------LQGVDLAQSGQKTKHKKNVLIIGFSSGAFVLLGSVI 286
Query: 308 LFAMAVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIE-QENELQEKVKRAQGIQVAKS 366
F +A KKQK +K + A ++ TA+++A++QI+ QENEL+EKVKR QG+ V KS
Sbjct: 287 CFVIAAKKQKTQKKSTA-ATASAGIIGPTAESVAVMQIDRQENELEEKVKRVQGLHVGKS 345
Query: 367 GNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSN 426
G+L FCAGEA LY+LDQLMRASAELLG+G++GTTYKAVLDNRLIVCVKRLDASKL+ S
Sbjct: 346 GSLAFCAGEAHLYSLDQLMRASAELLGRGTMGTTYKAVLDNRLIVCVKRLDASKLSDGSK 405
Query: 427 EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHW 486
E++E HMESVGGLRHPNLVPLRAYFQA+EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHW
Sbjct: 406 EVFEPHMESVGGLRHPNLVPLRAYFQAREERLLIYDYQPNGSLFSLIHGSKSTRAKPLHW 465
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD-D 545
TSCLKIAEDVA+GLSYIHQAWRLVHGNLKSSNVLLGPDFEAC++DYCL L + D D
Sbjct: 466 TSCLKIAEDVARGLSYIHQAWRLVHGNLKSSNVLLGPDFEACVSDYCLAVLANSPIDDED 525
Query: 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
DPD YKAPETR++S QATSKSDVY+FGVLLLEL+TGKPPS +P +++NWVRS R
Sbjct: 526 DPDASAYKAPETRSSSQQATSKSDVYAFGVLLLELITGKPPSL--LPLPQDVVNWVRSTR 583
Query: 606 ---EDDGA-EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELDPLS 661
+DDGA ED RL MLLEVAIAC+ SPEQRPTMWQVLKMLQEIK VL+ED ELD +
Sbjct: 584 GNHQDDGAGEDNRLEMLLEVAIACSLTSPEQRPTMWQVLKMLQEIKETVLLEDSELDLQT 643
Query: 662 GI 663
G+
Sbjct: 644 GM 645
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|77417498|gb|ABA82080.1| putative receptor kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/640 (67%), Positives = 505/640 (78%), Gaps = 31/640 (4%)
Query: 39 LPSDAQVLLAFKAKADLRNHLFFSQNKSL--HFCQWQGVICYQQ-KVVRVVLQGLDLGGI 95
LP DA LLAFK+KADL + L FS N + C+W GV C + K+VR+V++ +LGGI
Sbjct: 31 LPPDALALLAFKSKADLHDALPFSSNATAVQSICRWTGVQCAARYKIVRLVIKSQNLGGI 90
Query: 96 FAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK 155
FAP++LT+LDQLRVL LQNNSLTGP+PDL+G NLK+LFLDHN F+GSFPPSL SL+ L+
Sbjct: 91 FAPDTLTRLDQLRVLSLQNNSLTGPVPDLAGFTNLKTLFLDHNSFSGSFPPSLSSLYLLR 150
Query: 156 TLDLSYNNLSGPLPKELASQ-GRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAI 214
TLDLSYNNL+G LP L + RLY LRL+ NRF G +P LNQS+L+ FNVSGNN TGAI
Sbjct: 151 TLDLSYNNLTGSLPAFLITDLDRLYYLRLEWNRFTGPVPALNQSNLQTFNVSGNNLTGAI 210
Query: 215 TVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSAQ-M 273
VT TL RFG SSF +NP LCGEI++KECN PFFG + A APPP LGQ SA+ +
Sbjct: 211 PVTPTLLRFGASSFSWNPFLCGEIVNKECNDTTPFFG-TTEAHGAPPPAKALGQSSAEDI 269
Query: 274 HGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQ---RKDKKSKAMIAS 330
GVELTQPS K H++TAVIIGFSSGV LICSL+ FAMAVKKQ+ RK S +
Sbjct: 270 QGVELTQPSHKKHRRTAVIIGFSSGVFFLICSLLCFAMAVKKQRTPQTRKTVNSAGPTVT 329
Query: 331 DEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLDQLMRASAE 390
+E AA A+++IE+E L++KVKRAQGIQV KSG+L+FCAGE+QLY+LDQLMRASAE
Sbjct: 330 EETAA-----AVVEIEEE--LEQKVKRAQGIQVVKSGSLMFCAGESQLYSLDQLMRASAE 382
Query: 391 LLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
LLGKG++GTTYKAVLDNRLIV VKRLDA KL+GTS E++E+H+ESVG LRHPNLVPLRAY
Sbjct: 383 LLGKGTIGTTYKAVLDNRLIVSVKRLDAGKLSGTSREVFERHLESVGALRHPNLVPLRAY 442
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLV 510
FQAK+ERLL+YDYQPNGS+FSL+HG KSTRAKPLHWTSCLKIAED+AQGLSYIHQAWRLV
Sbjct: 443 FQAKDERLLVYDYQPNGSVFSLVHG-KSTRAKPLHWTSCLKIAEDIAQGLSYIHQAWRLV 501
Query: 511 HGNLKSSNVLLGPDFEACLADYCLTAL-TADSLQDDDPDNLLYKAPETRNASHQA----- 564
HGNLKS+NVLLG DFEACL DYCL+ L T ++DPD+ YKAPETR S
Sbjct: 502 HGNLKSTNVLLGSDFEACLTDYCLSVLATTTPTSEEDPDSAAYKAPETRTNSSNDHDHHD 561
Query: 565 -----TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-DERLGML 618
TSKSDVY+FG+LL+ELLTGKPPSQH L PN+ M WVRS RED+ + +++ ML
Sbjct: 562 QQQQPTSKSDVYAFGILLVELLTGKPPSQHLVLPPNDTMKWVRSLREDEQNDGHDKMAML 621
Query: 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL--MEDGE 656
LEVAIAC+S SPEQRPTMWQVLKMLQEIK + ME+ E
Sbjct: 622 LEVAIACSSTSPEQRPTMWQVLKMLQEIKDETISSMEEVE 661
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509745|ref|XP_003523606.1| PREDICTED: probable inactive receptor kinase At5g67200-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2129), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/638 (66%), Positives = 509/638 (79%), Gaps = 16/638 (2%)
Query: 27 SASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQ-NKSLHFCQWQGVICYQQKVVRV 85
S++ S + +L+ +DA LLAFK KAD+ +HL FS + L FC WQGV C KVVR+
Sbjct: 17 SSNAHCSKLPTLVFTDATALLAFKLKADVNDHLHFSPLTRGLRFCAWQGVECNGPKVVRL 76
Query: 86 VLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145
VLQ LDLGG +APN+L++LDQLRVL LQNNSLTGP+PDL+GL NLKSLFLD+N+FTGS P
Sbjct: 77 VLQNLDLGGAWAPNTLSRLDQLRVLSLQNNSLTGPLPDLTGLFNLKSLFLDNNYFTGSLP 136
Query: 146 PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNV 205
PSL SLHRL+ LD S+NN SGP+ S RL+SLRL N FNGSIPP NQSSLK+F V
Sbjct: 137 PSLFSLHRLRNLDFSHNNFSGPISAAFTSLDRLHSLRLSFNSFNGSIPPFNQSSLKVFEV 196
Query: 206 SGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTV 265
SGNN +GA+ VT TL RF SSF FNPSLCGEII +C P PFFGP+A PP
Sbjct: 197 SGNNLSGAVPVTPTLFRFPPSSFAFNPSLCGEIIRVQCRPAQPFFGPAA------PPTAA 250
Query: 266 LGQQSAQMHGVE--LTQP-SPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDK 322
LGQ SAQ+HGV + QP K H + A+IIGFS+G+ VL+CSLV FA AV+KQ+ R K
Sbjct: 251 LGQ-SAQVHGVNGIIRQPYEKKRHDRRALIIGFSAGIFVLVCSLVCFAAAVRKQRSRSKK 309
Query: 323 KSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLD 382
++ I + + AATA+A A++++E E EL+EKVKRA+ VAKSG+LVFCAGEAQ+YTLD
Sbjct: 310 DGRSGIMAADEAATAEAAAVMRMEMERELEEKVKRAE---VAKSGSLVFCAGEAQVYTLD 366
Query: 383 QLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRH 441
QLM+ SAELLG+G LGTTYKAVLD+RL+V VKRLDA K+A + E++E+HMESVGGLRH
Sbjct: 367 QLMKGSAELLGRGCLGTTYKAVLDSRLMVTVKRLDAGKMASHATKEVFERHMESVGGLRH 426
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
PNLVPLRAYFQAK ERL+IYD+QPNGSLFSLIHGS+S+RA+PLHWTSCLKIAEDVAQGL+
Sbjct: 427 PNLVPLRAYFQAKHERLIIYDFQPNGSLFSLIHGSRSSRARPLHWTSCLKIAEDVAQGLA 486
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNAS 561
+IHQAWRLVHGNLKSSNVLLGPDFEAC+ DYCL+ LT S+ D+D D+ Y+APETRN +
Sbjct: 487 FIHQAWRLVHGNLKSSNVLLGPDFEACITDYCLSVLTHPSIFDEDGDSAAYRAPETRNPN 546
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621
H T KSDVY++G+LLLELLTGK PS+ F+VP +M +WVRS R+D+G+ED ++ MLL+V
Sbjct: 547 HHPTHKSDVYAYGILLLELLTGKFPSELPFMVPGDMSSWVRSIRDDNGSEDNQMDMLLQV 606
Query: 622 AIACNSASPEQRPTMWQVLKMLQEIKGAVLMED-GELD 658
A C+ SPEQRPTMWQVLKMLQEIK VL+ED ELD
Sbjct: 607 ATTCSLTSPEQRPTMWQVLKMLQEIKEIVLLEDSSELD 644
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438793|ref|XP_002283167.1| PREDICTED: probable inactive receptor kinase At5g67200 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/634 (65%), Positives = 490/634 (77%), Gaps = 19/634 (2%)
Query: 34 AVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLG 93
+V+SLLPSDA LL+FKAKADL N L ++ N+ +CQW+GV C Q +VVR QG L
Sbjct: 34 SVSSLLPSDAVSLLSFKAKADLDNKLLYTLNERFDYCQWRGVKCVQGRVVRFDTQGFGLR 93
Query: 94 GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHR 153
G FAPN+LT+LDQLRVL L NNSL+GPIPDL+ LVNLKSLFLDHN F+G FPPS+LSLHR
Sbjct: 94 GYFAPNTLTRLDQLRVLSLHNNSLSGPIPDLAALVNLKSLFLDHNSFSGYFPPSILSLHR 153
Query: 154 LKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGA 213
L+ LDLS+NNL+G +P EL+ RL SLRL+ N+FNG++PPLNQSSL IFNVSGNN TG
Sbjct: 154 LRILDLSHNNLTGLIPVELSGLDRLSSLRLEWNQFNGTVPPLNQSSLLIFNVSGNNLTGP 213
Query: 214 ITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFF-GPSATAAAAPPPVTVLGQQSAQ 272
I VT TLSRFG+SSF +NP+LCGEII+K+C PFF P A AAP P + QS Q
Sbjct: 214 IPVTPTLSRFGVSSFSWNPNLCGEIINKQCRSSSPFFESPGVRAGAAPSPTPLW--QSTQ 271
Query: 273 MHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLV-LFAMAVKKQKQRKDKKSKAMI--- 328
GV L+ PS K H T +I+GF G+ VLI SLV LFA+ K RK KS M
Sbjct: 272 AQGVVLSTPSSKKHVGTPLILGFVIGMGVLIVSLVCLFALVCK--HSRKTPKSNPMPEPK 329
Query: 329 --ASDEAAATAQALAMIQI------EQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYT 380
A E AL M +QENE++ + KR Q + V KSGNLVFC GE QLY
Sbjct: 330 AEAEAEPEPVMAALDMCNTNTAEMRQQENEMEGEAKRVQQV-VGKSGNLVFCVGEPQLYN 388
Query: 381 LDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR 440
LDQLMRASAE+LG+GS+GTTYKAVLDN+LIV VKRLDASK A TS E++E+HMESVGGLR
Sbjct: 389 LDQLMRASAEMLGRGSIGTTYKAVLDNQLIVSVKRLDASKTAITSGEVFERHMESVGGLR 448
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HPNLVP+RAYFQAKEERL+IYDYQPNGSLFSLIHGS+STRAKPLHWTSCLKIAEDVAQGL
Sbjct: 449 HPNLVPIRAYFQAKEERLVIYDYQPNGSLFSLIHGSRSTRAKPLHWTSCLKIAEDVAQGL 508
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA 560
+YIHQA +LVHGNLKSSNVLLG DFEAC+ DYCL AL AD +++PD+ Y+APETR +
Sbjct: 509 AYIHQASKLVHGNLKSSNVLLGADFEACITDYCLAAL-ADLPANENPDSAGYRAPETRKS 567
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620
S +AT+KSDVY+FGVLLLELL+GKPPSQH FL P +M WVR+ R+DDG ED RL +L+E
Sbjct: 568 SRRATAKSDVYAFGVLLLELLSGKPPSQHPFLAPTDMSGWVRAMRDDDGGEDNRLALLVE 627
Query: 621 VAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654
VA C+ SPEQRP MWQV KM+QEIK ++++ED
Sbjct: 628 VASVCSLTSPEQRPAMWQVSKMIQEIKNSIMVED 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465601|ref|XP_003603085.1| Disease resistance protein [Medicago truncatula] gi|355492133|gb|AES73336.1| Disease resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/645 (63%), Positives = 502/645 (77%), Gaps = 19/645 (2%)
Query: 20 FLLITSCSASRSASAVNSLLPS--DAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVIC 77
FLL+T+ + S S N PS D LLAFK+KADL NHL F+ FC WQGV C
Sbjct: 14 FLLLTTTTFSNSTKLNNKTKPSLSDPTSLLAFKSKADLNNHLNFTTKTP--FCNWQGVEC 71
Query: 78 Y-QQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLD 136
+ KV+R++L+ LDLGG F +L+ LDQLRVL LQNNSLTG IP+LSGL NLKSLFLD
Sbjct: 72 NNEHKVIRLILRNLDLGGFFPSRTLSNLDQLRVLSLQNNSLTGTIPNLSGLFNLKSLFLD 131
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLN 196
+N+FTGS P S+ SLHRLKTLD S+NNLSG +P + RLY LRL N FNG+IPP N
Sbjct: 132 NNYFTGSIPFSIFSLHRLKTLDFSHNNLSGNIPTHFINVDRLYYLRLSFNSFNGTIPPFN 191
Query: 197 QSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATA 256
QSSLK F+VSGNN +GA+ +T+ LSRF SSF NP+LCGEII +EC P PFF P
Sbjct: 192 QSSLKTFDVSGNNLSGAVPLTTALSRFQPSSFALNPNLCGEIIRRECRPSTPFFSP---- 247
Query: 257 AAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQ 316
A PP V + QSA++HG+ + QP K H + AVIIGFS+G++ L+ SL FA+ +KKQ
Sbjct: 248 -ATPPTVGL--NQSAKVHGL-IRQPYGKKHDRRAVIIGFSTGIVFLLLSLACFAVVIKKQ 303
Query: 317 KQRKDKKSK--AMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAG 374
+++K K + +++ASD AAAT + ++Q+EQE EL++KVKRAQ VAKSG+L+FCAG
Sbjct: 304 RKKKGKGTSGSSVMASDTAAATVEEAVVMQMEQERELEQKVKRAQ---VAKSGSLIFCAG 360
Query: 375 EAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG-TSNEMYEQHM 433
E+Q+YTLDQLM+ SAELLG+G LGTTYKAVLDNRLIV VKRLD +K+ G S +++E+HM
Sbjct: 361 ESQVYTLDQLMKGSAELLGRGCLGTTYKAVLDNRLIVTVKRLDCAKMGGYVSKDVFERHM 420
Query: 434 ESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA 493
ESVGGLRHPNLV +RAYFQA +ERL+IYDYQPNGSLFSLIHGS+S+RA+PLHWTSCLKIA
Sbjct: 421 ESVGGLRHPNLVAVRAYFQANQERLIIYDYQPNGSLFSLIHGSRSSRARPLHWTSCLKIA 480
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK 553
ED+AQGLSYIHQAWRLVHGNLKS+NVLLGPDFEAC+ DYCL+ LT S D+ D+ Y+
Sbjct: 481 EDLAQGLSYIHQAWRLVHGNLKSTNVLLGPDFEACVTDYCLSVLTNPSTFDEVGDSAPYR 540
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613
APETRN +HQ T KSDVY++G+LLLELLTGK S+ F+VP +M WVRS R+D+G+ED
Sbjct: 541 APETRNPNHQPTPKSDVYAYGILLLELLTGKYASELPFMVPGDMSKWVRSIRDDNGSEDN 600
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELD 658
R+ MLL+VA C+ SPEQRPTMWQVLKMLQEIK VL+ED ELD
Sbjct: 601 RMDMLLQVATTCSLISPEQRPTMWQVLKMLQEIKEIVLLEDSELD 645
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297791631|ref|XP_002863700.1| hypothetical protein ARALYDRAFT_494701 [Arabidopsis lyrata subsp. lyrata] gi|297309535|gb|EFH39959.1| hypothetical protein ARALYDRAFT_494701 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/668 (60%), Positives = 489/668 (73%), Gaps = 33/668 (4%)
Query: 7 PLLPQLLFFLSNTFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKS 66
P+ LLF T + +S S +R+ + D LL FK+KADL N + N S
Sbjct: 8 PISGFLLFCFFFTIVASSSSSLNRTKHVFH--YHRDVSALLRFKSKADLWNKI----NTS 61
Query: 67 LHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSG 126
HFCQW GV CY +VVR+V++ L LGG P+S+ KLDQLRVL L+N SLTGP+PD SG
Sbjct: 62 SHFCQWWGVTCYGNRVVRLVIEDLYLGGRLVPDSVNKLDQLRVLSLKNTSLTGPLPDFSG 121
Query: 127 LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
LVNLKSLFLDHN F+GSFP S+L+LHRL+TLD S+NNL+GP+P L RL LRLD N
Sbjct: 122 LVNLKSLFLDHNSFSGSFPFSVLALHRLRTLDFSFNNLTGPIPPGLVLSDRLIYLRLDSN 181
Query: 187 RFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPR 246
RFNG++P LNQSSL FNVS NN TG++ VT+ L RFGISSFL NP+LCGEI+HKECNPR
Sbjct: 182 RFNGAVPALNQSSLHTFNVSVNNLTGSVPVTTVLLRFGISSFLKNPNLCGEIVHKECNPR 241
Query: 247 PPFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSL 306
P FF P AAPPP VLGQ AQ+ G L++P+ H + VI+GF SG +L S+
Sbjct: 242 PKFFTP---VTAAPPPKMVLGQ-IAQIGGARLSRPNQNKHSRFFVILGFISGAFILFISV 297
Query: 307 VLFAMAVKKQK----QRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQ 362
AVK+++ ++K K+S A+++ D A A A+ EQE+E++EKVK+ +Q
Sbjct: 298 ACLIGAVKRRRSKNEKQKGKESTAVVSFDAAETAEVAAAI---EQESEIEEKVKK---LQ 351
Query: 363 VAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA 422
KSG+LVFCAGEA +YT+DQLM ASAELLG+G++GTTYKA+LD+RLIV VKRLDA +LA
Sbjct: 352 ATKSGSLVFCAGEAHVYTMDQLMTASAELLGRGTVGTTYKALLDSRLIVTVKRLDAIRLA 411
Query: 423 GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAK 482
G + +E+HMESVG L HPNLVPLRAYFQAKEERLLIYDY PNGSL SL+HG+KS+RA
Sbjct: 412 GVGRDKFERHMESVGALGHPNLVPLRAYFQAKEERLLIYDYLPNGSLSSLVHGTKSSRAT 471
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-- 540
PLHWTSCLKIAEDVAQGLSYIHQAW+LVHGNLKSSNVLLGPDFEAC+ADYCL AL +
Sbjct: 472 PLHWTSCLKIAEDVAQGLSYIHQAWQLVHGNLKSSNVLLGPDFEACIADYCLVALATNPP 531
Query: 541 ---SLQDDDPDNLLYKAPETRNASHQATS-KSDVYSFGVLLLELLTGKPPSQHSFLVPNE 596
+ +D D YKAPE R+ S S K+DVYSFG+LLLELLTGK PS+ L +E
Sbjct: 532 LTSNDGQEDADAAAYKAPEARHKSLNYQSVKADVYSFGILLLELLTGKQPSKIPVLPLDE 591
Query: 597 MMNWVRSARED------DGAED-ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
M+ WVR RE+ + ED ++ GML EVA+AC+ SPEQRPTMWQVLKMLQEIK A
Sbjct: 592 MIEWVRKVREEGEKKNGNWREDRDKFGMLTEVAVACSLTSPEQRPTMWQVLKMLQEIKEA 651
Query: 650 VLMEDGEL 657
+ME+ EL
Sbjct: 652 AVMEECEL 659
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 664 | ||||||
| TAIR|locus:2167781 | 669 | AT5G43020 [Arabidopsis thalian | 0.951 | 0.944 | 0.587 | 5.4e-189 | |
| TAIR|locus:2074830 | 660 | AT3G50230 [Arabidopsis thalian | 0.948 | 0.954 | 0.485 | 2.2e-153 | |
| TAIR|locus:2155508 | 669 | AT5G67200 [Arabidopsis thalian | 0.799 | 0.793 | 0.530 | 5.1e-138 | |
| TAIR|locus:2036499 | 652 | AT1G60630 [Arabidopsis thalian | 0.438 | 0.446 | 0.528 | 1.2e-121 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.424 | 0.420 | 0.446 | 2.5e-100 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.420 | 0.424 | 0.445 | 3.4e-92 | |
| TAIR|locus:2196464 | 663 | AT1G10850 [Arabidopsis thalian | 0.784 | 0.785 | 0.400 | 3.8e-85 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.438 | 0.444 | 0.408 | 3.1e-83 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.420 | 0.435 | 0.392 | 8.4e-79 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.423 | 0.439 | 0.405 | 1.4e-78 |
| TAIR|locus:2167781 AT5G43020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1832 (650.0 bits), Expect = 5.4e-189, P = 5.4e-189
Identities = 387/659 (58%), Positives = 460/659 (69%)
Query: 15 FLSNTFLLITSCSASRSASAVNSLLPS--DAQVLLAFKAKADLRNHLFFSQNKSLHFCQW 72
FL FL S+S S++ + S D LL FK+KADL N + N S HFCQW
Sbjct: 12 FLLFCFLFTIVASSSSSSNHTKRVFHSHRDVSALLRFKSKADLWNKI----NTSSHFCQW 67
Query: 73 QGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKS 132
GV CY +VVR+V++ L LGG P+S+ KLDQLRVL L+N SLTGP+PD SGLVNLKS
Sbjct: 68 WGVTCYGNRVVRLVIEDLYLGGRLIPDSVNKLDQLRVLSLKNTSLTGPLPDFSGLVNLKS 127
Query: 133 LFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSI 192
LFLDHN F+GSFP S+L+ HRL+TLD S+NNL+GP+P L RL LRLD NRFNG +
Sbjct: 128 LFLDHNSFSGSFPLSVLAFHRLRTLDFSFNNLTGPIPSGLVLSDRLIYLRLDSNRFNGPV 187
Query: 193 PPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRXXXXXX 252
PPLNQS+L FNVS NN TGA+ VT+ L RFGISSFL NP+LCGEI+HKECNPR
Sbjct: 188 PPLNQSTLHTFNVSVNNLTGAVPVTTVLLRFGISSFLKNPNLCGEIVHKECNPRAKFFTP 247
Query: 253 XXXXXXXXXXVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMA 312
VLGQ AQ+ G L++PS H + VI+GF SG +L S+ A
Sbjct: 248 VTAAPSPKM---VLGQ-IAQIGGARLSRPSQNKHSRFFVILGFISGAFILFISVACLIGA 303
Query: 313 VXXXXXXXXXXXXAMIXXXXXXXXXXXXXMIQ-IEQENELQEKVKRAQGIQVAKSGNLVF 371
V + IEQE+E++EKVK+ +Q KSG+LVF
Sbjct: 304 VKRRRSKTEKQKGKESTAVVTFDAAETAEVAAAIEQESEIEEKVKK---LQATKSGSLVF 360
Query: 372 CAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQ 431
CAGEA +YT+DQLM ASAELLG+G++GTTYKA+LD+RLIV VKRLDA +LAG + +E
Sbjct: 361 CAGEAHVYTMDQLMTASAELLGRGTVGTTYKALLDSRLIVTVKRLDAIRLAGVGRDKFEH 420
Query: 432 HMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK 491
HMESVG L HPNLVPLRAYFQAKEERLLIYDY PNGSL SL+HG+KS+RA PLHWTSCLK
Sbjct: 421 HMESVGALGHPNLVPLRAYFQAKEERLLIYDYLPNGSLSSLVHGTKSSRATPLHWTSCLK 480
Query: 492 IAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD---SLQD--DD 546
IAEDVAQGLSYIHQAW+LVHGNLKSSNVLLG DFEAC+ADYCL AL + + D +D
Sbjct: 481 IAEDVAQGLSYIHQAWQLVHGNLKSSNVLLGQDFEACIADYCLVALATNPPLTSNDGQED 540
Query: 547 PDNLLYKAPETRNASHQATS-KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
D YK PE R+ S S K+DVYSFG+LLLELLTGK PS+ L +EM+ WVR R
Sbjct: 541 ADAAAYKPPEARHKSLNYQSVKADVYSFGILLLELLTGKQPSKIPVLPLDEMIEWVRKVR 600
Query: 606 ED----DG--AED-ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGEL 657
E+ +G ED ++ GML EVA+AC+ ASPEQRPTMWQVLKMLQEIK A +ME+ EL
Sbjct: 601 EEGEKKNGNWREDRDKFGMLTEVAVACSLASPEQRPTMWQVLKMLQEIKEAAVMEECEL 659
|
|
| TAIR|locus:2074830 AT3G50230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1496 (531.7 bits), Expect = 2.2e-153, P = 2.2e-153
Identities = 325/670 (48%), Positives = 434/670 (64%)
Query: 12 LLFFLSNTFLLITSCSASRSASAVN---SLLPSDAQVLLAFKAKADLRNHLFFSQNKSLH 68
L FF S FLL+ ++ S A N S LPSDA LL+FK+ ADL N L +S +
Sbjct: 3 LFFFYSLLFLLLLLRISTASLPATNYFDSFLPSDAVALLSFKSTADLDNKLLYSLTEPYD 62
Query: 69 FCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLV 128
+CQW+GV C Q +VVR++L G+ L G F+P +L++LDQLRVL L+NNS++G IPDLS LV
Sbjct: 63 YCQWRGVDCSQDRVVRLILDGVGLRGSFSPETLSRLDQLRVLSLENNSISGSIPDLSPLV 122
Query: 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188
NLK+L L N F+G+ S+LSL RL LDLS+NN SG +P + + RL SL L+ NR
Sbjct: 123 NLKTLTLSKNGFSGTLSSSILSLRRLTELDLSFNNFSGEIPSGINALSRLSSLNLEFNRL 182
Query: 189 NGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKEC----- 243
NG++PPLN SSL FNVS NN TG + +T TL RF SSF NP LCGEII++ C
Sbjct: 183 NGTLPPLNLSSLISFNVSSNNLTGLVPLTKTLLRFNASSFSSNPGLCGEIINRSCGLHSS 242
Query: 244 -----NPRXXXXXXXXXXXXXXXXVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSG 298
+P+ V + +Q+ + + P K K +++GF+ G
Sbjct: 243 SPFFGSPKPNTTSSTSSASSSEAPV-IQSEQNGE--AAMIVPPVVKKVKNGWLVLGFTIG 299
Query: 299 V---LVLICSLVLFAMAVXXXXXXXXXXXXAMIXXXXXXXXXXXXXMIQIEQENELQEKV 355
+ +VL LV+F++ + +I IQ + +K
Sbjct: 300 LASLIVLGLCLVVFSLFIKNRREDYDD----VIITQPKREEENKEIKIQFQTTAPSSKK- 354
Query: 356 KRAQGIQVAKSGNLVFCA-----GEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLI 410
++ ++G+L+FC GEA +YT+DQLMRASAELLG+GS+GTTYKAV+ N++I
Sbjct: 355 ------RIPRNGDLIFCGEGGGGGEA-MYTVDQLMRASAELLGRGSVGTTYKAVMVNQMI 407
Query: 411 VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLF 470
V VKR SK A TS+ +E ME VGGL+HPNLVP++AYFQ+ ERL+IY+YQPNGSLF
Sbjct: 408 VTVKRFAPSKTAITSDLEFENQMEIVGGLKHPNLVPVKAYFQSNGERLVIYEYQPNGSLF 467
Query: 471 SLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLA 530
+LIHGS++++AKPLHWTSCLKIAEDVAQ L YIHQ+ HGNLKS+N+LLG DFEAC+
Sbjct: 468 NLIHGSRTSKAKPLHWTSCLKIAEDVAQALHYIHQSSAKFHGNLKSTNILLGHDFEACVT 527
Query: 531 DYCLTALTADSLQDDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQH 589
DYCL+ LT S+ +DPD YKAPE R ++ + TSK DVYSFGV LLELLTGK S+
Sbjct: 528 DYCLSVLTDSSVPPNDPDISSYKAPEIRKSTDSRPTSKCDVYSFGVFLLELLTGKTASRQ 587
Query: 590 SFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ PN+M++WVR+ R+++ E+ L M+ + A C SPEQRPTM +V+KM+QEIK
Sbjct: 588 PIMEPNDMLDWVRAMRQEEERSKEENGLEMMTQTACLCRVTSPEQRPTMKEVIKMIQEIK 647
Query: 648 GAVLM-EDGE 656
G+V+M E+ E
Sbjct: 648 GSVVMTEENE 657
|
|
| TAIR|locus:2155508 AT5G67200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1351 (480.6 bits), Expect = 5.1e-138, P = 5.1e-138
Identities = 295/556 (53%), Positives = 370/556 (66%)
Query: 12 LLFFLSNTFLLIT-SCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFC 70
L FFL F I SA + NSLLPSDA LL+FK+ ADL N L +S + +C
Sbjct: 3 LNFFLPFFFFFILLRVSAGAEPNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYC 62
Query: 71 QWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNL 130
QW+GV C Q ++VR+VL G+ L G F+ +L++LDQLRVL L+NNSL GPIPDLS LVNL
Sbjct: 63 QWRGVKCAQGRIVRLVLSGVGLRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNL 122
Query: 131 KSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG 190
KSLFL N F+G+FPPS+LSLHRL L +S+NN SG +P E+ + RL SL LD NRFNG
Sbjct: 123 KSLFLSRNQFSGAFPPSILSLHRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNG 182
Query: 191 SIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRXXXX 250
++P LNQS L FNVSGNN TG I VT TLSRF SSF NP LCGEII++ C R
Sbjct: 183 TLPSLNQSFLTSFNVSGNNLTGVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFF 242
Query: 251 XXXXXXXXXXXXVTVLGQQS-AQMHGVELTQP--SPKSHKKTAVIIGFSSGV---LVLIC 304
LGQ + AQ G + P + K K++ +++GF++G+ +VL
Sbjct: 243 GSTNKTTSSEAP---LGQSAQAQNGGAVVIPPVVTKKKGKESGLVLGFTAGLASLIVLGL 299
Query: 305 SLVLFAMAVXXXXXXXXXX----XXAMIXXXXXXXXXXXXX----MIQIEQENELQEKVK 356
LV+F++ + A + ++ + E++ +EK
Sbjct: 300 CLVVFSLVIKKRNDDGIYEPNPKGEASLSQQQQSQNQTPRTRAVPVLNSDTESQKREKEV 359
Query: 357 RAQGIQ--VAKSGNLVFCAGEAQ---LYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIV 411
+ Q + + SGNLVFC GE++ +YT++QLMRASAELLG+GS+G TYKAVLDN+LIV
Sbjct: 360 QFQETEQRIPNSGNLVFC-GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIV 418
Query: 412 CVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFS 471
VKRLDA+K A TS E +E HME VGGLRH NLVP+R+YFQ+ ERL+IYDY PNGSLF+
Sbjct: 419 TVKRLDAAKTAVTSEEAFENHMEIVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFN 478
Query: 472 LIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFEACLA 530
LIHGS+S+RAKPLHWTSCLKIAEDVAQGL YIHQ + LVHGNLKS+N+LLG DFEACL
Sbjct: 479 LIHGSRSSRAKPLHWTSCLKIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLT 538
Query: 531 DYCLTALTADSLQDDD 546
DYCL+ LT S D
Sbjct: 539 DYCLSVLTDSSSASPD 554
|
|
| TAIR|locus:2036499 AT1G60630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 165/312 (52%), Positives = 212/312 (67%)
Query: 367 GNLVFCAGEAQL--YTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT 424
G LVF + + YT+D L++ASAE LG+G+LG+TYKAV+++ I+ VKRL K AG
Sbjct: 329 GTLVFLGRDITVVRYTMDDLLKASAETLGRGTLGSTYKAVMESGFIITVKRL---KDAGF 385
Query: 425 SN-EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK-STRAK 482
+ +++H+E +G L+HPNLVPLRAYFQAKEE LL+YDY PNGSLFSLIHGSK S K
Sbjct: 386 PRMDEFKRHIEILGRLKHPNLVPLRAYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGK 445
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-S 541
PLHWTSCLKIAED+A GL YIHQ L HGNLKSSNVLLGPDFE+CL DY L+ L S
Sbjct: 446 PLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYGLSDLHDPYS 505
Query: 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ---HSFLVPNEMM 598
++D +L YKAPE R+ +T +DVYSFGVLLLELLTG+ + H + +++
Sbjct: 506 IEDTSAASLFYKAPECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVHKY--GSDIS 563
Query: 599 NWVRSAREDD-------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG-AV 650
WVR+ RE++ A +E+L LL +A AC + PE RP M +VLKM+++ + A
Sbjct: 564 TWVRAVREEETEVSEELNASEEKLQALLTIATACVAVKPENRPAMREVLKMVKDARAEAA 623
Query: 651 LMEDGELDPLSG 662
L D G
Sbjct: 624 LFSFNSSDHSPG 635
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 2.5e-100, Sum P(2) = 2.5e-100
Identities = 139/311 (44%), Positives = 195/311 (62%)
Query: 359 QGIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRL-D 417
Q QV G +VF G + + L+ L+RASAE+LGKG GT YKAVL++ V VKRL D
Sbjct: 336 QNQQVGDKGKMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKD 394
Query: 418 ASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK 477
A +AG +EQ ME +G LRH NLV L+AY+ A+EE+LL+YDY PNGSLF L+HG++
Sbjct: 395 AVTVAGKKE--FEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNR 452
Query: 478 STRAKPLHWTSCLKIAEDVAQGLSYIH---QAWRLVHGNLKSSNVLLGPDFEACLADYCL 534
PL WT+ LKIA A+GL++IH + +L HG++KS+NVLL A ++D+ L
Sbjct: 453 GPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGL 512
Query: 535 TALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ----HS 590
+ + A S Q N Y+APE + + T KSDVYSFGVLLLE+LTGK P+ HS
Sbjct: 513 S-IFAPS-QTVAKSNG-YRAPELIDG-RKHTQKSDVYSFGVLLLEILTGKCPNMVETGHS 568
Query: 591 FLVPNEMMNWVRSA-REDDGAE------------DERLGMLLEVAIACNSASPEQRPTMW 637
++ WV+S RE+ AE +E + LL++A+AC + + + RP M
Sbjct: 569 GGAV-DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMG 627
Query: 638 QVLKMLQEIKG 648
V+K++++I+G
Sbjct: 628 HVVKLIEDIRG 638
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 3.4e-92, Sum P(2) = 3.4e-92
Identities = 135/303 (44%), Positives = 197/303 (65%)
Query: 369 LVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEM 428
LVF G + L+ L+RASAE+LGKGS+GT+YKAVL+ V VKRL K S +
Sbjct: 334 LVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL---KDVMASKKE 390
Query: 429 YEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTS 488
+E ME VG ++HPN++PLRAY+ +K+E+LL++D+ P GSL +L+HGS+ + PL W +
Sbjct: 391 FETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDN 450
Query: 489 CLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548
++IA A+GL+++H + +LVHGN+K+SN+LL P+ + C++DY L L ++S P
Sbjct: 451 RMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNS----SPP 506
Query: 549 NLL--YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSA- 604
N L Y APE + + T KSDVYSFGVLLLELLTGK P+Q S ++ WV S
Sbjct: 507 NRLAGYHAPEVLE-TRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVV 565
Query: 605 REDDGAE------------DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLM 652
RE+ AE +E + LL++A+AC S P+QRP M +VL+M++++ +
Sbjct: 566 REEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETT 625
Query: 653 EDG 655
+DG
Sbjct: 626 DDG 628
|
|
| TAIR|locus:2196464 AT1G10850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
Identities = 230/574 (40%), Positives = 317/574 (55%)
Query: 110 LGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGP 167
L L+ +LTG + + L+ L L+ L N +GS P +L L LK++ L+ NN SG
Sbjct: 75 LVLEYLNLTGSLNEKSLNQLDQLRVLSFKANSLSGSIP-NLSGLVNLKSVYLNDNNFSGD 133
Query: 168 LPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITVTS--TLSRF 223
P+ L S RL ++ L NR +G IP L S L NV N FTG+I + +L F
Sbjct: 134 FPESLTSLHRLKTIFLSGNRLSGRIPSSLLRLSRLYTLNVEDNLFTGSIPPLNQTSLRYF 193
Query: 224 GISSFLFNPSLCGEIIHKECNPRXXXXXXXXXXXXXXXXVTVLGQQSAQMHGVELTQ--- 280
+S N L G+I P V + G Q G+
Sbjct: 194 NVS----NNKLSGQI------P-LTRALKQFDESSFTGNVALCGDQIGSPCGISPAPSAK 242
Query: 281 --PSPKSHKKTAVIIGF-----SSGVLVLICSLVLFAMAVXXXXXXXXXXXXAMIXXXXX 333
P PKS K A +IG + GVLVLI L L +
Sbjct: 243 PTPIPKSKKSKAKLIGIIAGSVAGGVLVLILLLTLLIVCWRRKRRNQAPREDRK---GKG 299
Query: 334 XXXXXXXXMIQIEQENELQEKVKRAQGIQVAKSGNLVFC----AGEAQL-YTLDQLMRAS 388
+ E++ E +++ + + G LVF +GE + YT++ L++AS
Sbjct: 300 IAEAEGATTAETERDIERKDRGFSWERGEEGAVGTLVFLGTSDSGETVVRYTMEDLLKAS 359
Query: 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
AE LG+G+LG+TYKAV+++ IV VKRL ++ E +++H+E +G L+HPNLVPLR
Sbjct: 360 AETLGRGTLGSTYKAVMESGFIVTVKRLKNARYPRM--EEFKRHVEILGQLKHPNLVPLR 417
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRA-KPLHWTSCLKIAEDVAQGLSYIHQAW 507
AYFQAKEERLL+YDY PNGSLF+LIHG++++ + KPLHWTSCLKIAED+A L YIHQ
Sbjct: 418 AYFQAKEERLLVYDYFPNGSLFTLIHGTRASGSGKPLHWTSCLKIAEDLASALLYIHQNP 477
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTAL-TADSLQDDDPDNLLYKAPETRNASHQATS 566
L HGNLKSSNVLLGPDFE+CL DY L+ L DS+++ +L YKAPE R+ +T
Sbjct: 478 GLTHGNLKSSNVLLGPDFESCLTDYGLSTLHDPDSVEETSAVSLFYKAPECRDPRKASTQ 537
Query: 567 KSDVYSFGVLLLELLTGKPPSQHSFL-VPNEMMNWVRSAREDD---GAE---------DE 613
+DVYSFGVLLLELLTG+ P Q +++ WVR+ RE++ G E +E
Sbjct: 538 PADVYSFGVLLLELLTGRTPFQDLVQEYGSDISRWVRAVREEETESGEEPTSSGNEASEE 597
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+L LL +A C + P+ RP M +VLKM+++ +
Sbjct: 598 KLQALLSIATVCVTIQPDNRPVMREVLKMVRDAR 631
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 129/316 (40%), Positives = 194/316 (61%)
Query: 351 LQEKVKR--AQGIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNR 408
L EK K+ G+Q + LVF G + + L+ L+RASAE+LGKGS GT YKAVL+
Sbjct: 321 LTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES 380
Query: 409 LIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467
V VKRL ++A E +EQ ME + + HP++VPLRAY+ +K+E+L++ DY P G
Sbjct: 381 TTVVVKRL--KEVAAGKRE-FEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAG 437
Query: 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDF 525
+L SL+HG++ + PL W S +KI A+G++++H A + HGN+KSSNV++ +
Sbjct: 438 NLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQES 497
Query: 526 EACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
+AC++D+ LT L A + Y+APE + + T KSDVYSFGVL+LE+LTGK
Sbjct: 498 DACISDFGLTPLMAVPIAPMRGAG--YRAPEVME-TRKHTHKSDVYSFGVLILEMLTGKS 554
Query: 586 PSQHSFLVPN-EMMNWVRSA-REDDGAE------------DERLGMLLEVAIACNSASPE 631
P Q ++ WV+S RE+ +E +E + +L++A+AC + PE
Sbjct: 555 PVQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPE 614
Query: 632 QRPTMWQVLKMLQEIK 647
RPTM V++M++EI+
Sbjct: 615 VRPTMDDVVRMIEEIR 630
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
Identities = 120/306 (39%), Positives = 183/306 (59%)
Query: 360 GIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDAS 419
G+Q + L F + L+ L++ASAE+LGKGS GT YKAVL++ V VKRL
Sbjct: 321 GVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRL--R 378
Query: 420 KLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS 478
++ + E +EQ ME VG + +H N VPL AY+ +K+E+LL+Y Y GSLF ++HG++
Sbjct: 379 EVVASKKE-FEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRG 437
Query: 479 TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538
R + W + +KIA ++ +SY+H + VHG++KSSN+LL D E CL+D L L
Sbjct: 438 DRG--VDWETRMKIATGTSKAISYLHSL-KFVHGDIKSSNILLTEDLEPCLSDTSLVTLF 494
Query: 539 ADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL----VP 594
+L P + Y APE + + + +SDVYSFGV++LE+LTGK P L V
Sbjct: 495 --NLPTHTPRTIGYNAPEVIE-TRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVV 551
Query: 595 NEMMNWVRSA-REDDGAE------------DERLGMLLEVAIACNSASPEQRPTMWQVLK 641
++ WVRS RE+ AE +E + +L++A+AC + +PE RP M +V +
Sbjct: 552 IDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVAR 611
Query: 642 MLQEIK 647
M+++++
Sbjct: 612 MIEDVR 617
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
Identities = 125/308 (40%), Positives = 187/308 (60%)
Query: 360 GIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDAS 419
G+Q A+ LVF G + + L+ L+RASAE+LGKGS GTTYKA+L+ V VKRL
Sbjct: 315 GVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRL--K 372
Query: 420 KLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS 478
++A E +EQ ME+VG + H N+ PLRAY+ +K+E+LL+YDY G+ L+HG+
Sbjct: 373 EVAAGKRE-FEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNE 431
Query: 479 TRAKPLHWTSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDFEACLADYCLTA 536
L W + L+I + A+G+S+IH A +L+HGN+KS NVLL + C++D+ +
Sbjct: 432 GGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAP 491
Query: 537 LTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ---HSFLV 593
L + +L Y+APE + + T KSDVYSFGVLLLE+LTGK + H +V
Sbjct: 492 LMSHHTLIPSR-SLGYRAPEAIE-TRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVV 549
Query: 594 PNEMMNWVRSA-REDDGAE-------------DERLGMLLEVAIACNSASPEQRPTMWQV 639
++ WV+S RE+ E +E + +L++A+AC S P+ RP+M +V
Sbjct: 550 --DLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEV 607
Query: 640 LKMLQEIK 647
+ M++EI+
Sbjct: 608 VNMMEEIR 615
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 664 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.001 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.004 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 77/266 (28%), Positives = 112/266 (42%), Gaps = 28/266 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHME--SVGGLRHPNLVP 446
LG GS GT YKA IV VK L S + E + L HPN+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE--KSKKDQTARREIRILRRLSHPNIVR 62
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L F+ K+ L+ +Y G LF + +R PL KIA + +GL Y+H
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD---DPDNLLYKAPETRNAS 561
++H +LK N+LL + +AD+ L + S P Y APE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPW---YMAPEVLLGG 173
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHS------FLVPNEMMNWVRSAREDDGAEDERL 615
+ K DV+S GV+L ELLTGKPP L+ + + + E
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 616 GMLLEVAIACNSASPEQRPTMWQVLK 641
L++ + + P +RPT ++L+
Sbjct: 234 KDLIKKCLNKD---PSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 14/195 (7%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVPLR 448
LG+G GT Y A V +K + + E+ + ++ L HPN+V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKK---LNHPNIVKLY 57
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F+ + L+ +Y GSL L+ L L+I + +GL Y+H
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSN-G 112
Query: 509 LVHGNLKSSNVLLG-PDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQAT 565
++H +LK N+LL + + LAD+ L+ L Y APE +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 566 SKSDVYSFGVLLLEL 580
KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 390 ELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
+ LG+G+ G YK L + V VK L E + M L HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRK---LDHP 61
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N+V L +E +++ +Y P G L + + R K L + L A +A+G+ Y
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEY 118
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK--APETRN 559
+ +H +L + N L+G + ++D+ L+ L D L + APE+
Sbjct: 119 LESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 560 ASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM- 617
+ TSKSDV+SFGVLL E+ T G+ P + + E++ +++ + RL
Sbjct: 178 -EGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEVLEYLK--------KGYRLPKP 226
Query: 618 ------LLEVAIACNSASPEQRPTMWQVLKML 643
L ++ + C + PE RPT +++++L
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
+ LG+G+ G YK L ++ V VK L E + M L HP
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRK---LDHP 61
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N+V L +E ++ +Y G L S + ++ L + L A +A+G+ Y
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEY 117
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK--APETRN 559
+ +H +L + N L+G + ++D+ L+ L D L + APE+
Sbjct: 118 LESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 560 ASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM- 617
+ TSKSDV+SFGVLL E+ T G+ P + + E++ +++ RL
Sbjct: 177 -EGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEVLEYLK--------NGYRLPQP 225
Query: 618 ------LLEVAIACNSASPEQRPTMWQVLKML 643
L ++ + C + PE RPT +++++L
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-28
Identities = 134/567 (23%), Positives = 211/567 (37%), Gaps = 129/567 (22%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
P L L +L L L N L+G IPD LS L SL L HN +G P S + L
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITV 216
LDLS N LSG +PK L N SL N+S N+ G++
Sbjct: 552 LDLSQNQLSGEIPKNLG----------------------NVESLVQVNISHNHLHGSLPS 589
Query: 217 TSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSAQMHGV 276
T S+ N LC + PP +
Sbjct: 590 TGAFLAINASAVAGNIDLC-----------------GGDTTSGLPPCKRV---------- 622
Query: 277 ELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDKKSKAMIASDEAAAT 336
+KT + + L L L A + R + + K
Sbjct: 623 ----------RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK----------- 661
Query: 337 AQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVFCAGEAQLYTLDQLMRASAE--LLGK 394
++E E+ E F + ++ T++ ++ + E ++ +
Sbjct: 662 -------RVENEDGTWEL--------------QFFDSKVSKSITINDILSSLKEENVISR 700
Query: 395 GSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA 453
G G +YK + N + VK ++ N + + +G L+HPN+V L ++
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEIN------DVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754
Query: 454 KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ--AWRLVH 511
++ LI++Y +L ++ L W KIA +A+ L ++H + +V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVY 571
GNL +++ E L L+ + Y APETR + T KSD+Y
Sbjct: 807 GNLSPEKIIIDGKDEPHL---RLSLPGLLCTDTKCFISSAYVAPETRE-TKDITEKSDIY 862
Query: 572 SFGVLLLELLTGKPPSQHSFLVPNEMMNWVR--------------SAREDDGAEDERLGM 617
FG++L+ELLTGK P+ F V ++ W R S R D +
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQ 644
++ +A+ C + P RP VLK L+
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 35/276 (12%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+ LG+G+ G YK L V VK L + + + L HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF-LKEARVMKKLGHPNVV 59
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC----LKIAEDVAQGLS 501
L +E L+ +Y G L + S+ P T L A +A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----QDDDPDNLLYKAPET 557
Y+ + VH +L + N L+G D ++D+ L+ D + + + APE+
Sbjct: 120 YLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 558 RNASHQA-TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615
TSKSDV+SFGVLL E+ T G P + L E++ ++R + RL
Sbjct: 179 --LKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYLR--------KGYRL 226
Query: 616 GM-------LLEVAIACNSASPEQRPTMWQVLKMLQ 644
L E+ ++C PE RPT ++++ L+
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/265 (24%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVP 446
E LG+GS G Y A +V +K + K+ + + ++ L+HPN+V
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKK---LKHPNIVR 61
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L F+ +++ L+ +Y G LF L+ + L + L Y+H
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLK-----KRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD----PDNLLYKAPET-RNAS 561
+VH +LK N+LL D LAD+ L + P+ Y APE
Sbjct: 117 G-IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKG 172
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621
+ D++S GV+L ELLTGKPP F ++++ + + +
Sbjct: 173 Y--GKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPE 226
Query: 622 AI----ACNSASPEQRPTMWQVLKM 642
A PE+R T + L+
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 50/279 (17%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
+ LG+G+ G YK L V VK L + E + + + L HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNI 63
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
V L E ++ +Y P G L + K L L++A +A+G+ Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDL--LQMALQIAKGMEYLE 119
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK----------- 553
+ VH +L + N L+ + ++D+ L + + +DD Y+
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGL----SRDIYEDD----YYRKRGGGKLPIKW 170
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
APE+ TSKSDV+SFGVLL E+ T G+ P + E++ + +
Sbjct: 171 MAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPYPG--MSNEEVLELLE--------D 219
Query: 612 DERLGM-------LLEVAIACNSASPEQRPTMWQVLKML 643
RL L E+ + C + PE RPT ++++ L
Sbjct: 220 GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG---GLRHPNLV 445
ELLG+GS G+ Y A+ D ++ VK ++ L+G S E E + L+HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 446 PLRAYFQAKEER----LLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
Y+ ++ + L I+ +Y GSL SL+ + L K + +GL
Sbjct: 63 ---RYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGL 114
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAP 555
+Y+H +VH ++K +N+L+ D LAD+ A ++ + + + AP
Sbjct: 115 AYLHSN-GIVHRDIKGANILVDSDGVVKLADFG-CAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E + +D++S G ++E+ TGKPP
Sbjct: 173 EVIRGE-EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+L+G+G+ G YK + L+ V +K++ K+ + + Q ++ + L+HPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + +I +Y NGSL +I + P + V QGL+Y+H+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHEQ-G 119
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNLLY-KAPETRNASHQATS 566
++H ++K++N+L D LAD+ + T L S D Y APE S A++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GAST 178
Query: 567 KSDVYSFGVLLLELLTGKPP 586
SD++S G ++ELLTG PP
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.7 bits (231), Expect = 2e-20
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASK-LAGTSNEMYEQHMESVGGLRHP-NLVPL 447
LG+GS G Y A +R +V +K L E + + ++ + L HP N+V L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+FQ + L+ +Y GSL L+ K R PL + L I + L Y+H
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 508 RLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSLQDDDPDNLL--------YKAPE-- 556
++H ++K N+LL D L D+ L L D L Y APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 557 TRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588
+ A+S SD++S G+ L ELLTG PP +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 390 ELLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLV 445
E +GKG G YKA V +K + E E+ + + L+ HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIV 60
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ K+E ++ ++ GSL L+ + + L + + +++ +GL Y+H
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS 116
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPETRNAS 561
++H ++K++N+LL D E L D+ L+A +D+ + ++ + APE N
Sbjct: 117 N-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
K+D++S G+ +EL GKPP
Sbjct: 173 PY-DYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 25/267 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEM-YEQHMESVGGLRHPNLVPL 447
E++G G+ Y A+ L N V +KR+D K + +E+ E S HPN+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS--QCNHPNVVKY 64
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F +E L+ Y GSL ++ S + + ++V +GL Y+H
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--VLKEVLKGLEYLHSN- 121
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDNLLYKAPETR 558
+H ++K+ N+LLG D +AD+ ++A AD P + APE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP---CWMAPEVM 178
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE-MMNWVRSA--REDDGAEDERL 615
H K+D++SFG+ +EL TG P +S P + +M +++ + GA+ ++
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP--YSKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 616 GMLLEVAIA-CNSASPEQRPTMWQVLK 641
I+ C P +RPT ++LK
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 74/256 (28%), Positives = 118/256 (46%), Gaps = 31/256 (12%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G G + + V VK L K S E + Q + + LRH LV L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+E ++ +Y GSL + KS K L + +A +A+G++Y+ +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIH 126
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDNLLYKAPETRNASH 562
+L + N+L+G + +AD+ L L ++DD+ P + + APE N
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL----IEDDEYTAREGAKFP--IKWTAPEAANYG- 179
Query: 563 QATSKSDVYSFGVLLLELLT-GK-P-PSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
+ T KSDV+SFG+LL E++T G+ P P + V ++ R R +E ++L
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP-PNCPEELYDLML 238
Query: 620 EVAIACNSASPEQRPT 635
+ C PE+RPT
Sbjct: 239 Q----CWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 29/255 (11%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G G ++ + NR+ V +K L + L + +++ ++++ LRH +L+ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
E +I + GSL + + +S + L S + +A VA+G++Y+ + +H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYL-EEQNSIH 127
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--APETRNASHQATS-KS 568
+L + N+L+G D +AD+ L L + + + YK APE ASH S KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA--ASHGTFSTKS 185
Query: 569 DVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL-------GMLLE 620
DV+SFG+LL E+ T G+ VP MN + R+ + +
Sbjct: 186 DVWSFGILLYEMFTYGQ--------VPYPGMNNHEVYDQIT--AGYRMPCPAKCPQEIYK 235
Query: 621 VAIACNSASPEQRPT 635
+ + C +A PE RP+
Sbjct: 236 IMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 45/274 (16%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+ +GKGS G Y D +L +K +D S ++ E ++ + L HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKL-YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKP------LHWTS--CLKIAEDVAQG 499
F+ K + ++ +Y G L I + KP L W CL
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCL--------A 115
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDNL 550
L Y+H +++H ++K N+ L + L D+ + + L P
Sbjct: 116 LKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGI----SKVLSSTVDLAKTVVGTP--- 167
Query: 551 LYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG 609
Y +PE +N + KSD++S G +L EL T K P + L + ++
Sbjct: 168 YYLSPELCQNKPY--NYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKILKGQYPPIP 224
Query: 610 AE-DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642
++ L L+ + PE+RP++ Q+L+
Sbjct: 225 SQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 41/273 (15%)
Query: 392 LGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
LG+G G D V VK L+ S ++ +E+ +E + L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENIVK 70
Query: 447 LR--AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ LI +Y P+GSL + + L + + +G+ Y+
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----LLLFSSQICKGMDYLG 126
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADS----LQDDDPDNLLYKAPETRN 559
+ R +H +L + N+L+ + ++D+ L L D +++ + + APE
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
S + +S SDV+SFGV L EL T PSQ M+ + RL LL
Sbjct: 186 TS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-----IVTRLLELL 239
Query: 620 E-----------------VAIACNSASPEQRPT 635
+ + C A P+ RP+
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 63/184 (34%), Positives = 88/184 (47%), Gaps = 33/184 (17%)
Query: 87 LQGLDLGGIF----APNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFT 141
L+ LDLGG PNSLT L L L L +N L G IP +L + +LK ++L +N +
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP------- 194
G P + L L LDL YNNL+GP+P L + L L L N+ +G IPP
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK 285
Query: 195 -------------------LNQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNPSL 234
+ +L+I ++ NNFTG I V ++L R + L++
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ-LWSNKF 344
Query: 235 CGEI 238
GEI
Sbjct: 345 SGEI 348
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 48/230 (20%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESV-------GGL-R 440
+++G+GS T A + +K LD +L + E+ ++ V L
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL------IKEKKVKYVKIEKEVLTRLNG 60
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIH--GSKSTRAKPLHWTSCLKIAEDVAQ 498
HP ++ L FQ +E + +Y PNG L I GS + A ++
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-------CTRFYAAEILL 113
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY----------CLTALTADSLQDDDPD 548
L Y+H ++H +LK N+LL D + D+ + D+ D
Sbjct: 114 ALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 549 NLLYK------------APETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ +PE N A SD+++ G ++ ++LTGKPP
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 71/252 (28%), Positives = 114/252 (45%), Gaps = 20/252 (7%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ LG G G + + V +K L K S E + + L+HP LV L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E +I +Y NGSL + K+ L + +A +A+G+++I +
Sbjct: 69 VV-TQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERK-NY 123
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDPDNLLYKAPETRNASHQATS 566
+H +L+++N+L+ +AD+ L L D+ ++ + + APE N T
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTI 182
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAR--EDDGAEDERLGMLLEVAI 623
KSDV+SFG+LL E++T G+ P P + N R R D +E L E+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYRMPRPDNCPEE----LYELMR 237
Query: 624 ACNSASPEQRPT 635
C PE+RPT
Sbjct: 238 LCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-16
Identities = 55/144 (38%), Positives = 74/144 (51%), Gaps = 3/144 (2%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
P+SL L L+ L L N L+GPIP + L L SL L N +G P ++ L L+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214
L L NN +G +P L S RL L+L N+F+G IP ++L + ++S NN TG I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 215 TVTSTLSRFGISSFLFNPSLCGEI 238
S LF+ SL GEI
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEI 396
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 18/259 (6%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG+G G + + V +K L K S E + Q + + LRH LV L A
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
++E ++ +Y GSL + G L + +A +A G++Y+ + VH
Sbjct: 71 -SEEPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERM-NYVH 125
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTAD---SLQDDDPDNLLYKAPETRNASHQATSKS 568
+L+++N+L+G + +AD+ L L D + + + + APE + T KS
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 184
Query: 569 DVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV-RSAREDDGAEDERLGMLLEVAIACN 626
DV+SFG+LL EL T G+ P + +V E+++ V R R E L ++ C
Sbjct: 185 DVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP--CPPECPESLHDLMCQCW 240
Query: 627 SASPEQRPTMWQVLKMLQE 645
PE+RPT + L++
Sbjct: 241 RKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 64/198 (32%), Positives = 88/198 (44%), Gaps = 28/198 (14%)
Query: 44 QVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQ-QKVVRVVLQGLDLGGIFAP---- 98
++LL+FK+ + + N S C WQG+ C +VV + L G ++ G +
Sbjct: 32 ELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR 91
Query: 99 -----------NSL---------TKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHN 138
N L T LR L L NN+ TG IP S + NL++L L +N
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS-IPNLETLDLSNN 150
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP-PLNQ 197
+G P + S LK LDL N L G +P L + L L L N+ G IP L Q
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 198 -SSLKIFNVSGNNFTGAI 214
SLK + NN +G I
Sbjct: 211 MKSLKWIYLGYNNLSGEI 228
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 53/158 (33%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165
L++L L N G +PD G L++L L N F+G+ P L SL L L LS N LS
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 166 GPLPKELASQGRLYSLRLDVNRFNGSIP------PL--------NQSSLKI--------- 202
G +P EL+S +L SL L N+ +G IP P+ NQ S +I
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572
Query: 203 ---FNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGE 237
N+S N+ G++ T S+ N LCG
Sbjct: 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 30/266 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+GKG G + V VK L K T+ + + + LRHPNLV L
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK-VAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKI-AEDVAQGLSYIHQAWR 508
++ +Y GSL + +R + + + A DV +G+ Y+ +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYL-EEKN 122
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--APET-RNASHQAT 565
VH +L + NVL+ D A ++D+ L ++ Q D L K APE R + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDF---GLAKEASQGQDSGKLPVKWTAPEALREK--KFS 177
Query: 566 SKSDVYSFGVLLLELLT-GKPPSQHSFLVP-NEMMNWVRSA-RED--DGAEDERLGMLLE 620
+KSDV+SFG+LL E+ + G+ P +P +++ V R + +G E + +
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPHVEKGYRMEAPEGCPPE----VYK 230
Query: 621 VAIACNSASPEQRPTMWQVLKMLQEI 646
V C P +RPT Q+ + L I
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/252 (26%), Positives = 117/252 (46%), Gaps = 23/252 (9%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G G + +N V VK L K S + + + + L+H LV L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+E +I +Y GSL + KS + + + +A+G++YI + +H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIH 126
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTAD---SLQDDDPDNLLYKAPETRNASHQATSKS 568
+L+++NVL+ +AD+ L + D + ++ + + APE N T KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKS 185
Query: 569 DVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV----RSAREDDGAEDERLGMLLEVAI 623
DV+SFG+LL E++T GK P + + +++M+ + R R ++ ++ L ++
Sbjct: 186 DVWSFGILLYEIVTYGKIP--YPGMSNSDVMSALQRGYRMPRMENCPDE-----LYDIMK 238
Query: 624 ACNSASPEQRPT 635
C E+RPT
Sbjct: 239 TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 383 QLMRASAEL---LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL 439
++ R S +L LG G G + A + V VK + K S E + + L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTL 58
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+H LV L A KE +I ++ GSL + KS + + +A+G
Sbjct: 59 QHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEG 114
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDPDNLLYKAPE 556
+++I Q +H +L+++N+L+ +AD+ L + D+ ++ + + APE
Sbjct: 115 MAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 557 TRNASHQATSKSDVYSFGVLLLELLT-GKP--PSQHSFLVPNEMMNWVRSAREDDGAEDE 613
N T KSDV+SFG+LL+E++T G+ P + V + R R ++ E+
Sbjct: 174 AINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE- 231
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
L + + C PE+RPT + +L +
Sbjct: 232 ----LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 22/261 (8%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG+G G + + V +K L K E + Q + + LRH LVPL A
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
++E ++ ++ GSL + K K L + +A +A G++YI + +H
Sbjct: 71 -SEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIH 125
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTAD---SLQDDDPDNLLYKAPETRNASHQATSKS 568
+L+++N+L+G + +AD+ L L D + + + + APE + T KS
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 184
Query: 569 DVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV-RSARE--DDGAEDERLGMLLEVAIA 624
DV+SFG+LL EL+T G+ P + +V E++ V R R G + L E+
Sbjct: 185 DVWSFGILLTELVTKGRVP--YPGMVNREVLEQVERGYRMPCPQGCPES----LHELMKL 238
Query: 625 CNSASPEQRPTMWQVLKMLQE 645
C P++RPT + L++
Sbjct: 239 CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 70/256 (27%), Positives = 116/256 (45%), Gaps = 17/256 (6%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +GKGS G +K + DNR +V +K +D + A E +Q + + P +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + +I +Y GS L+ PL T I ++ +GL Y+H
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE- 120
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDPDNLLYKAPETRNASHQAT 565
+ +H ++K++NVLL E LAD+ + D+ ++ + APE S
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYD 179
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625
SK+D++S G+ +EL G+PP HS L P +++ ++ E L E AC
Sbjct: 180 SKADIWSLGITAIELAKGEPP--HSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEAC 236
Query: 626 NSASPEQRPTMWQVLK 641
+ P RPT ++LK
Sbjct: 237 LNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
+ HP +V L FQ +E+ L+ +Y P G LFS + S + + AE +
Sbjct: 50 INHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAE-IVL 104
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNL 550
L Y+H +++ +LK N+LL D L D+ L + + P+
Sbjct: 105 ALEYLHSL-GIIYRDLKPENILLDADGHIKLTDF---GLAKELSSEGSRTNTFCGTPE-- 158
Query: 551 LYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPPSQHSFLVPNEMM 598
Y APE + K+ D +S GVLL E+LTGKPP F +
Sbjct: 159 -YLAPEVLLGKGY---GKAVDWWSLGVLLYEMLTGKPP----FYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 386 RASAEL---LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP 442
R S +L LG G G ++ + +N V VK L + Q M+ LRHP
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKK---LRHP 61
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
L+ L A +E ++ + GSL + G L + +A VA G++Y
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAY 118
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAPETRN 559
+ +A +H +L + NVL+G + +AD+ L + + + + + APE
Sbjct: 119 L-EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 560 ASHQATSKSDVYSFGVLLLELLT-GKPP 586
++ + KSDV+SFG+LL E++T G+ P
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 19/270 (7%)
Query: 383 QLMRASAEL---LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL 439
++ R S +L LG G G + + V VK L K S E + + + + L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKL 58
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
RH LV L A ++E ++ +Y GSL + K + L + + +A VA G
Sbjct: 59 RHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAG 114
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD---SLQDDDPDNLLYKAPE 556
++YI + +H +L+S+N+L+G +AD+ L L D + + + + APE
Sbjct: 115 MAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 557 TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615
+ T KSDV+SFG+LL EL+T G+ P + + E++ V +D +
Sbjct: 174 AA-LYGRFTIKSDVWSFGILLTELVTKGRVP--YPGMNNREVLEQVERGYRMPCPQDCPI 230
Query: 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
L E+ + C PE+RPT + L++
Sbjct: 231 S-LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 392 LGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
LG G+ GT YK V ++ V +K L + E+ + + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEIL-DEAYVMASVDHPHVVR 73
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L + LI P G L + K + L +A+G+SY+ +
Sbjct: 74 LLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDN----IGSQYLLNWCVQIAKGMSYLEEK 128
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK---------APET 557
RLVH +L + NVL+ + D+ L L D D + A E+
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----DVDEKEYHAEGGKVPIKWMALES 182
Query: 558 ---RNASHQATSKSDVYSFGVLLLELLT-GKPP 586
R +H+ SDV+S+GV + EL+T G P
Sbjct: 183 ILHRIYTHK----SDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 30/269 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKR--LDASKLAGTSNEMYEQHMESVG---GLRHPNL 444
E+LGKG+ GT Y + + ++ VK+ LD S + E YE+ E V L+H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE-YEKLQEEVDLLKSLKHVNI 64
Query: 445 VPLRAYFQA--KEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
V Y + + I+ ++ P GS+ S+++ R PL K + + G++
Sbjct: 65 V---QYLGTCLDDNTISIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVA 116
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY-CLTALTADSLQDDDPDNL-------LYK 553
Y+H +VH ++K +NV+L P+ L D+ C L L + L +
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613
APE N S KSD++S G + E+ TGKPP + + M ++ + R +
Sbjct: 176 APEVINESGYG-RKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLPD 232
Query: 614 RL-GMLLEVAIACNSASPEQRPTMWQVLK 641
++ +C + +RP+ Q+L+
Sbjct: 233 SFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRL---------DASKLAGTSNEMYEQHMESVGGL 439
EL+GKG+ G Y A+ + ++ VK++ S+ + +E++ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL-RSEIETLKDL 65
Query: 440 RHPNLVPLRAY--FQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV 496
H N+V Y F+ EE L I+ +Y P GS+ S + E V
Sbjct: 66 DHLNIV---QYLGFETTEEYLSIFLEYVPGGSIGSCLR-----TYGRFEEQLVRFFTEQV 117
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL----LY 552
+GL+Y+H ++H +LK+ N+L+ D ++D+ ++ + D +D ++ +
Sbjct: 118 LEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 553 KAPETRNASHQATS-KSDVYSFGVLLLELLTGKPP 586
APE ++ Q S K D++S G ++LE+ G+ P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKR---LDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
ELLG GS G+ Y+ + LD+ VK D + + + EQ + + L+HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 446 PLRAYFQAKEE-RLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+ +EE L I+ + P GSL L+ + + GL Y+
Sbjct: 66 --QYLGTEREEDNLYIFLELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYL 118
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDPDNLLYKAPETRNASH 562
H VH ++K +N+L+ + LAD+ + + S + + APE
Sbjct: 119 H-DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 563 QATSKSDVYSFGVLLLELLTGKPP-SQHSFLVPNEMMNWVRS----AREDDGAEDERLGM 617
+D++S G +LE+ TGKPP SQ + + RS D +++ + +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 618 LLEVAIACNSASPEQRPTMWQVLK 641
L C P RPT ++L+
Sbjct: 236 LK-----CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 392 LGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGTSNEMYEQ----HMESVGGLRHPNLV 445
LG+GS G YK + I +K K+ +E + + ++++ P +V
Sbjct: 9 LGQGSSGVVYKVRHKPTGK-IYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
F + E ++ +Y GSL L+ + + IA + +GL Y+H
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETRNA 560
++H ++K SN+L+ E +AD+ ++ + ++L D N + Y +PE R
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---DQCNTFVGTVTYMSPE-RIQ 173
Query: 561 SHQATSKSDVYSFGVLLLELLTGK----PPSQHSFLVPNEMM 598
+ +D++S G+ LLE GK PP Q SF E+M
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---ELM 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGL---RHPNLVPL 447
LG G+ G YKA A+K+ S E E M + L +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKET-----GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 448 -RAYFQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
AYF E +L I ++ G+L S++ + + L + + + L+++H
Sbjct: 68 YEAYFY--ENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH- 120
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKAPE---T 557
+ +++H +LK+ N+LL D + LAD+ ++A +LQ D P + APE
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP---YWMAPEVVAC 177
Query: 558 RNASHQA-TSKSDVYSFGVLLLELLTGKPPSQHSFLVP 594
K+D++S G+ L+EL +PP H L P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP--HHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 53/142 (37%), Positives = 69/142 (48%), Gaps = 27/142 (19%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK- 155
P S+ L +L L L +NSL+G IP+L L NL+ L L N FTG P +L SL RL+
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 156 -----------------------TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSI 192
LDLS NNL+G +P+ L S G L+ L L N G I
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 193 PP-LNQ-SSLKIFNVSGNNFTG 212
P L SL+ + N+F+G
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSG 418
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 66/268 (24%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
E LG+G+ G YK L + V +K L + E + Q E + L+HPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPN 69
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKS---------TRAKPLHWTSCLKI 492
+V L ++ ++++Y +G L F + + S T L + L I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL--TAD--SLQDDDPD 548
A +A G+ Y+ + VH +L + N L+G ++D+ L+ +AD +Q
Sbjct: 130 AIQIAAGMEYL-SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED 607
+ + PE + T++SD++SFGV+L E+ + G P + E++ +RS R+
Sbjct: 189 PVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQP--YYGFSNQEVIEMIRS-RQL 244
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPT 635
++ + + I C + P +RP
Sbjct: 245 LPCPEDCPARVYALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH---PNLVPLR 448
LG G+ G+ K V K+ G + + +Q + + + P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F + + ++ GSL + + P+ KIA V +GL+Y++ R
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRI-----YKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKS 568
++H ++K SN+L+ + L D+ ++ +S+ D Y +PE R + T KS
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE-RIQGGKYTVKS 183
Query: 569 DVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618
DV+S G+ ++EL GK P F N DD +D+ +G+L
Sbjct: 184 DVWSLGISIIELALGKFP----FAFSN----------IDDDGQDDPMGIL 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 49/277 (17%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +GKG+ G YK VL V VK S L + Q E + HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
K+ ++ + P GSL + + K+ L L+++ D A G+ Y+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESK-NC 114
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----------YKAPETRN 559
+H +L + N L+G + ++D+ + S +++ + + APE N
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGM------SREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 560 ASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE--DDG------- 609
+ TS+SDV+S+G+LL E + G P P M N + RE + G
Sbjct: 169 YG-RYTSESDVWSYGILLWETFSLGDTP------YPG-MSN--QQTRERIESGYRMPAPQ 218
Query: 610 --AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
E+ ML C + PE RP+ ++ LQ
Sbjct: 219 LCPEEIYRLMLQ-----CWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 65/285 (22%), Positives = 120/285 (42%), Gaps = 51/285 (17%)
Query: 391 LLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
LG+G G + A +V VK L +K +E + + ++ L H N+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSHKNV 70
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKSTRAKPLHWTS--CLKIAEDVAQGL 500
V L + E +I +Y G L F SK + KP ++ + + +A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLA-----------DYC--------LTALTADS 541
++ A R VH +L + N L+ E ++ +Y L L ++
Sbjct: 131 DHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600
+Q+DD ++KSDV+SFGVL+ E+ T G+ P L E++N
Sbjct: 190 VQEDD-----------------FSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLNR 230
Query: 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+++ + + + L ++ C + +P+ RP+ +++ L E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 29/262 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +GKGS G YK + DNR +V +K +D + A E +Q + + P +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + +I +Y GS L+ + PL T I ++ +GL Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHSE- 120
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDPDNLLYKAPETRNASHQAT 565
R +H ++K++NVLL + LAD+ + D+ ++ + APE S
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYD 179
Query: 566 SKSDVYSFGVLLLELLTGKPPSQ--HS----FLVPNEMMNWVRSAREDDGAEDERLGMLL 619
K+D++S G+ +EL G+PP+ H FL+P S +G + +
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------SPPTLEGQYSKPFKEFV 233
Query: 620 EVAIACNSASPEQRPTMWQVLK 641
E AC + P RPT ++LK
Sbjct: 234 E---ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 23/274 (8%)
Query: 390 ELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
++LG+G G+ + L ++L V VK + + E + + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 446 PLRAY-FQAKEER-----LLIYDYQPNGSLFSLIHGSKSTRAKPLHWT--SCLKIAEDVA 497
L F+A + ++I + +G L S + S+ P + LK D+A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-LGGLPEKLPLQTLLKFMVDIA 123
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL--TALTADSLQDDDPDNLLYK-- 553
G+ Y+ +H +L + N +L D C+AD+ L + D + + K
Sbjct: 124 LGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612
A E+ A TSKSDV++FGV + E+ T G+ P + + +E+ +++R ED
Sbjct: 183 AIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHGNRLKQPED 239
Query: 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L L ++ +C A P+ RPT ++ ++L+ I
Sbjct: 240 -CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 48/139 (34%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 110 LGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPL 168
LGL N L G IP D+S L +L+S+ L N G+ PPSL S+ L+ LDLSYN+ +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 169 PKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAI--TVTSTLSRFGIS 226
P S G+L +SL+I N++GN+ +G + + L
Sbjct: 483 P---ESLGQL-------------------TSLRILNLNGNSLSGRVPAALGGRLLHRASF 520
Query: 227 SFLFNPSLCGEIIHKECNP 245
+F N LCG + C P
Sbjct: 521 NFTDNAGLCGIPGLRACGP 539
|
Length = 623 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 75/293 (25%), Positives = 129/293 (44%), Gaps = 49/293 (16%)
Query: 390 ELLGKGSLGTTYKAVLDN---RLIVCVKRLD--ASKLAGTSNEMYEQHMESVGGLR---- 440
+++G+G+ G KA + R+ +KR+ ASK + H + G L
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---------DDHRDFAGELEVLCK 63
Query: 441 ---HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKP-----------LHW 486
HPN++ L + + L +Y P+G+L + S+ P L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT---ALTADSLQ 543
L A DVA+G+ Y+ Q + +H +L + N+L+G ++ A +AD+ L+ +
Sbjct: 124 QQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLEL--LTGKPPSQHSFLVPNEMMNWV 601
P + + A E+ N S T+ SDV+S+GVLL E+ L G P + E +
Sbjct: 183 GRLP--VRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVL----KMLQEIKGAV 650
+ +DE + ++ C P +RP+ Q+L +ML+E K V
Sbjct: 240 YRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 62/291 (21%), Positives = 122/291 (41%), Gaps = 56/291 (19%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
LG+G+ G + +++ +V VK L + + + +E+ E + +H N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHEN 69
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAK-------PLHWTSCLKIAE 494
+V + +++++Y +G L + HG + K L + L+IA
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--------- 545
+A G+ Y+ + VH +L + N L+G D + D+ ++ D D
Sbjct: 130 QIASGMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDF---GMSRDVYTTDYYRVGGHTM 185
Query: 546 ------DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPP-SQHSFLVPNEM 597
P++++Y+ + T++SDV+SFGV+L E+ T GK P S E+
Sbjct: 186 LPIRWMPPESIMYR---------KFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEV 233
Query: 598 MNWVRSARE---DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ + R E + ++ + C P+QR + + + LQ+
Sbjct: 234 IECITQGRLLQRPRTCPSE----VYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 438 GLRHPNLVP-LRAYFQAKEERLLIYDYQPNGSLFSLIHGSK---STRAKPLHWTSCLKIA 493
GL H N++P L + E ++Y Y G+L + + + + L + +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD-----DPD 548
+A G+SY+H+ ++H ++ + N ++ + + + D AL+ D D D +
Sbjct: 124 IQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNE 179
Query: 549 N--LLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAR 605
N + + A E+ +++ SDV+SFGVLL EL+T G+ P + + P EM +++
Sbjct: 180 NRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTP--YVEIDPFEMAAYLKDGY 236
Query: 606 ---EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ DE L V C + PE+RP+ Q+++ L +
Sbjct: 237 RLAQPINCPDE----LFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-12
Identities = 43/113 (38%), Positives = 61/113 (53%), Gaps = 8/113 (7%)
Query: 72 WQGVIC-YQQKVVRVVLQGLDLG--GI--FAPNSLTKLDQLRVLGLQNNSLTGPIP-DLS 125
W G C + + + GL L G+ F PN ++KL L+ + L NS+ G IP L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 126 GLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRL 178
+ +L+ L L +N F GS P SL L L+ L+L+ N+LSG +P L GRL
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG--GRL 514
|
Length = 623 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLV 445
E +GKGS G YKA+ D R +V +K +D L +E+ + Q ++ + R P +
Sbjct: 7 ECIGKGSFGEVYKAI-DKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 446 PLRAYFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
F K +L +I +Y GS L+ + L T I +V GL Y+H
Sbjct: 63 KYYGSF-LKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLH 115
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDD----PDNLLYKAPET-R 558
+ +H ++K++N+LL + + LAD+ ++ LT+ + + P + APE +
Sbjct: 116 EE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWMAPEVIK 171
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQH 589
+ + K+D++S G+ +EL G+PP
Sbjct: 172 QSGYD--EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
+LLG G GT +K + ++ V +K + T E+ + HM ++G L H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD-HMLAMGSLDHAYI 71
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
V L +L + P GSL + + + C++IA +G+ Y+
Sbjct: 72 VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA----KGMYYLE 126
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPET------- 557
+ R+VH NL + N+LL D +AD+ + AD L DD Y +T
Sbjct: 127 EH-RMVHRNLAARNILLKSDSIVQIADFGV----ADLLYPDD-KKYFYSEHKTPIKWMAL 180
Query: 558 -----RNASHQATSKSDVYSFGVLLLELLT 582
+HQ SDV+S+GV + E+++
Sbjct: 181 ESILFGRYTHQ----SDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 441 HPNLVPLRAYFQAKEERLL--IYDYQPNGSLFSLIHGSKS----TRAKPLHWTSCLKIAE 494
P +V F + + +Y GSL S+ K K L KIAE
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAE 112
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKA 554
V +GLSY+H +++H ++K SN+LL + L D+ ++ +SL Y A
Sbjct: 113 SVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMA 171
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGK---PPSQHSFLVPNEMMNWVRSAREDDGAE 611
PE R + SDV+S G+ LLE+ + PP L P E+++++ + + +
Sbjct: 172 PE-RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 612 DERLGMLLEVAI-----ACNSASPEQRPTMWQVLK---MLQEIKGAVLME 653
+ G+ C P +RPT W +L+ + ++K V M
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIH----------GSKSTR---------A 481
HP+++ L LLI +Y GSL S + GS R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 482 KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541
+ L + A +++G+ Y+ + +LVH +L + NVL+ + ++D+ L+ D
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLVAEGRKMKISDF---GLSRDV 177
Query: 542 LQDD-------DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLV 593
++D + + A E+ H T++SDV+SFGVLL E++T G P + +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIA 234
Query: 594 PNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648
P + N +++ + E+ M + + C P++RPT + K L+++
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEM-YNLMLTCWKQEPDKRPTFADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 51/280 (18%)
Query: 390 ELLGKGSLGTT----YKAVLDNR-LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
+ LGKG+ G+ Y + DN +V VK+L S +E+ +E + L+H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNI 67
Query: 445 VPLRA--YFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGL 500
V + Y + L+ +Y P GSL + H + K L + S + +G+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS------QICKGM 121
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD------PDN--LLY 552
Y+ + R VH +L + N+L+ + + D+ LT + QD + P + +
Sbjct: 122 EYL-GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP---QDKEYYKVREPGESPIFW 177
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLT-----GKPPSQHSFLVPNE---------MM 598
APE+ S + + SDV+SFGV+L EL T PP++ ++ N+ ++
Sbjct: 178 YAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236
Query: 599 NWVRSAR---EDDGAEDERLGMLLEVAIACNSASPEQRPT 635
+++ G E ++ E C + P QRP+
Sbjct: 237 ELLKNNGRLPAPPGCPAEIYAIMKE----CWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCL-KIAEDV 496
LRH NLV L ++ L I +Y GSL + +R + + CL K + DV
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDV 111
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPE 556
+ + Y+ +A VH +L + NVL+ D A ++D+ LT A S QD + + APE
Sbjct: 112 CEAMEYL-EANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTAPE 169
Query: 557 TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615
+T KSDV+SFG+LL E+ + G+ P L +++ V + D A D
Sbjct: 170 ALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMD-APDGCP 225
Query: 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
++ +V C RP+ Q+ + L+ I
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 39/267 (14%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +GKGS G +K + DNR +V +K +D + A E +Q + + P +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + +I +Y GS L+ RA P + +++ +GL Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHSE- 120
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDPDNLLYKAPETRNASHQAT 565
+ +H ++K++NVLL + LAD+ + D+ ++ + APE S
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYD 179
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHS------FLVPNE-----MMNWVRSAREDDGAEDER 614
SK+D++S G+ +EL G+PP+ FL+P + + +
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK--------- 230
Query: 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641
E AC + P RPT ++LK
Sbjct: 231 -----EFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 392 LGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+G+G+ G YKA L IV +K++ + + + ++ + L HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGE-IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
F+ K + L++++ + L+ LI R + L + + QGL++ H +
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLI----KDRQRGLPESLIKSYLYQLLQGLAFCHSHG-I 119
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---DDPDNLLYKAPETRNASHQATS 566
+H +LK N+L+ + LAD+ L A + S Y+APE ++
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGL-ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 567 KSDVYSFGVLLLELLTGKP 585
D++S G + ELL+ +P
Sbjct: 179 PVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 52/242 (21%), Positives = 100/242 (41%), Gaps = 34/242 (14%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
+G G G + + V +K + + S E + + + + L HP LV L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+ L++++ +G L + + ++ CL DV +G++Y+ + ++H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL----DVCEGMAYLESS-NVIH 123
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN---LLYKAPETRNASHQATSKS 568
+L + N L+G + ++D+ +T D + + +PE + S + +SKS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKS 182
Query: 569 DVYSFGVLLLELLT-GKPPSQ--------------HSFLVPN-------EMMNWVRSARE 606
DV+SFGVL+ E+ + GK P + P E+M R
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERP 242
Query: 607 DD 608
+D
Sbjct: 243 ED 244
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 391 LLGKGSLGTTYKAVLDNRLIVCVKRLD-----ASKLAGTSNEMYEQHMESVGGLR----- 440
LGKGS G+ YK VKRL A K + ++ ++V +R
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 441 -HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
HPN++ + F + ++ +Y P G L I K R K + +I + +G
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRG 115
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRN 559
L +H +++H +LKS+N+LL + + D ++ + ++ Y APE
Sbjct: 116 LQALH-EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWK 174
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPP 586
+ KSD++S G LL E+ T PP
Sbjct: 175 -GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 393 GKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYE-------QHMESVGGLRHPNLV 445
G+G+ G YKA N + A K E Y + + + L+H N+V
Sbjct: 9 GRGTYGRVYKAKRKNGK---DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 446 PLRAYFQAKEERL--LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK-IAEDVAQGLSY 502
L F ++ L++DY + L+ +I + + + S +K + + G+ Y
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNGVHY 123
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEAC----LADYCLTALTADSLQ---DDDPD--NLLYK 553
+H W L H +LK +N+L+ + + D L L L+ D DP + Y+
Sbjct: 124 LHSNWVL-HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE + T D+++ G + ELLT +P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 390 ELLGKGSLGTTYKAVL---DNRLIVC-VKRLDASKLAGTSNEMYEQHMES---VGGLRHP 442
++GKG G Y L D + I C VK L +++ T E EQ ++ + HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRI--TDLEEVEQFLKEGIIMKDFSHP 56
Query: 443 NLVPLRAYFQAKE-ERLLIYDYQPNGSLFSLIHG-SKSTRAKPLHWTSCLKIAEDVAQGL 500
N++ L E L++ Y +G L + I + + K L + VA+G+
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA 560
Y+ + VH +L + N +L F +AD+ L D D Y A
Sbjct: 112 EYLASK-KFVHRDLAARNCMLDESFTVKVADF--------GLARDIYDKEYYSVHNHTGA 162
Query: 561 -------------SHQATSKSDVYSFGVLLLELLT-GKPPSQH--SFLVPNEMMNWVRSA 604
+ + T+KSDV+SFGVLL EL+T G PP SF + ++ R
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRL 221
Query: 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+ + D L EV ++C PE RPT +++ +++I
Sbjct: 222 LQPEYCPDP----LYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 390 ELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL------- 439
+++G+G+ G +A++ ++ +K L K + N+ H + G L
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKML---KEFASEND----HRDFAGELEVLCKLG 60
Query: 440 RHPNLVPLRAYFQAKEERLLIY---DYQPNGSLFSLIHGSKSTRAKPL----HWTSC--- 489
HPN++ L A E R +Y +Y P G+L + S+ P H T+
Sbjct: 61 HHPNIINL---LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 490 ----LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT---ALTADSL 542
L+ A DVA G+ Y+ + + +H +L + NVL+G + + +AD+ L+ +
Sbjct: 118 SQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLEL--LTGKPPSQHSFLVPNEMMNW 600
P + + A E+ N S T+KSDV+SFGVLL E+ L G P + E +
Sbjct: 177 MGRLP--VRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQV---LKMLQEIKGA 649
+ +DE + E+ C P +RP Q+ L + E + A
Sbjct: 234 GYRMEKPRNCDDE----VYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 36/273 (13%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASK-LAGTSNEMYEQHMESV---GGLRHPN 443
+ LG G+ + Y+A V L+ VK++ + + E+ E + + L HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMA-VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ + L ++ GS+ L+ + + E + +GLSY+
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYL 119
Query: 504 HQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTA-----LT-ADSLQDDDPDNLLYKA 554
H+ +++H ++K +N+L+ G +AD+ A T A Q + + A
Sbjct: 120 HEN-QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP------SQHSFLVPNEMMNWVRSAREDD 608
PE S DV+S G +++E+ T KPP S H L+ + SA
Sbjct: 177 PEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-----IASATTAP 230
Query: 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ L +V + C PE RP ++LK
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 27/263 (10%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEM----YEQHMESVGGLRHPNLVPL 447
LG G+ G YKA N+ L A+K+ T +E Y +E + HP +V L
Sbjct: 20 LGDGAFGKVYKA--KNKE---TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F + ++ ++ P G++ +++ +P C ++ E L Y+H
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE----ALQYLHSM- 129
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPETRNASHQAT 565
+++H +LK+ NVLL D + LAD+ ++A +LQ D + APE
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 566 S----KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621
+ K+D++S G+ L+E+ +PP H N M ++ A+ + + +E
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPP-HHEL---NPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 622 AIACNSA---SPEQRPTMWQVLK 641
+A PE RP+ Q+L+
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+GKGS G +K V ++ + +K++D SK+ E + L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F K + ++ +Y NG L L+ K R +PL + + GL+++H +
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLGLAHLHSK-K 121
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDDDPDNLLYKAPETRNASHQATS 566
++H ++KS N+ L + D + L +D+ + Y +PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL-CEDKPYNE 180
Query: 567 KSDVYSFGVLLLELLTGKPP 586
KSDV++ GV+L E TGK P
Sbjct: 181 KSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 376 AQLYTLDQLMRASAEL--LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQH 432
A+L+ D + ++L +G GS G Y A + N +V +K++ S SNE ++
Sbjct: 5 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDI 62
Query: 433 MESVG---GLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC 489
++ V LRHPN + R + + L+ +Y GS L+ K KPL
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEI 117
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN 549
+ QGL+Y+H ++H ++K+ N+LL L D+ ++ A P N
Sbjct: 118 AAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PAN 169
Query: 550 LL-----YKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPP 586
+ APE A Q K DV+S G+ +EL KPP
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 72/272 (26%), Positives = 115/272 (42%), Gaps = 34/272 (12%)
Query: 393 GKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEM-YEQHMESVGGLRHPNLVPLRAYF 451
GK LG ++ + R++V K L AS A ++ + Q ++ L HPN++
Sbjct: 9 GKVLLGEAHRGMSKARVVV--KELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
LL+ ++ P G L + + ++ A+ ++A +VA GL ++HQA +H
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIH 123
Query: 512 GNLKSSNVLLGPDFEACLADYCL--TALTADSLQDDD----PDNLLYKAPETRNASHQ-- 563
+L N L D + DY L D D P L + APE Q
Sbjct: 124 SDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP--LRWLAPELVEIRGQDL 181
Query: 564 ----ATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMNWVRSAREDDGAEDE-RLG 616
T KS+++S GV + EL T +P S +++ V RE D + +L
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQV--VREQDIKLPKPQLD 236
Query: 617 MLL-----EVAIACNSASPEQRPTMWQVLKML 643
+ EV C PE RPT +V ++L
Sbjct: 237 LKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 42/217 (19%)
Query: 390 ELLGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGTSN--------E---MYEQHMESV 436
+ LG+G+ YKA R IV +K++ + + E + E
Sbjct: 6 KKLGEGTYAVVYKARDKETGR-IVAIKKIKLGERKEAKDGINFTALREIKLLQE------ 58
Query: 437 GGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV 496
L+HPN++ L F K L++++ L +I KS P S + +
Sbjct: 59 --LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMT--- 111
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------- 549
+GL Y+H W L H +LK +N+L+ D LAD+ L P+
Sbjct: 112 LRGLEYLHSNWIL-HRDLKPNNLLIASDGVLKLADFGLARSFGS------PNRKMTHQVV 164
Query: 550 -LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE + D++S G + ELL P
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 51/203 (25%), Positives = 79/203 (38%), Gaps = 22/203 (10%)
Query: 393 GKGSLGTTYKAVL-DNRLIVCVK---RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
GKG+ G D + + +K + + N + E+ + L HP LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ--ELNHPFLVNLW 66
Query: 449 AYFQAKEERLLIYDYQPNGSL-FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
FQ +E L+ D G L + L K + + W + L Y+H
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI------VLALEYLHSK- 119
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNLLYKAPE---TRNASHQ 563
++H ++K N+LL + D+ + T +T D+L Y APE + S
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV- 178
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
D +S GV E L GK P
Sbjct: 179 ---AVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
+G G+ G Y AV LD ++ VK + + + M+ + L+HPNLV Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KY 64
Query: 451 F--QAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKI-AEDVAQGLSYIHQA 506
+ + E++ I+ +Y G+L L+ R H +++ + +GL+Y+H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEH---VIRVYTLQLLEGLAYLHSH 118
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADY-CLTALTADSLQDDDPDNLL-----YKAPE--TR 558
+VH ++K +N+ L + L D+ C L ++ + L Y APE T
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP 586
+D++S G ++LE+ TGK P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 45/284 (15%)
Query: 391 LLGKGSLGTTYKAVLDNRLI-------VCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
LG G+ G Y+ + L V VK L + T E E + + H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKP--LHWTSCLKIAEDVAQG 499
PN+V L E + +I + G L S + ++ R P L L I DVA+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEAC-----LADYCLTALTADSLQDD----DPDNL 550
Y+ Q +H +L + N L+ + D+ L D + D + + L
Sbjct: 119 CVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDF---GLARDIYKSDYYRKEGEGL 174
Query: 551 L---YKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMNWVRSA- 604
L + APE+ + T++SDV+SFGVL+ E+LT +P + E++ V +
Sbjct: 175 LPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVTAGG 230
Query: 605 ---REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ ++ + M C + P +RPT ++ ++LQ
Sbjct: 231 RLQKPENCPDKIYQLMTN-----CWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVPL 447
+G GS G Y A + +V +K++ S SNE ++ ++ V L RHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + + L+ +Y GS ++ K KPL I QGL+Y+H
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPETRNA-- 560
R +H ++K+ N+LL LAD+ +L P N + APE A
Sbjct: 136 R-IHRDIKAGNILLTEPGTVKLADFGSASLV-------SPANSFVGTPYWMAPEVILAMD 187
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
Q K DV+S G+ +EL KPP
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 50/142 (35%), Positives = 69/142 (48%), Gaps = 18/142 (12%)
Query: 87 LQGLDLGGIFA-------PNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHN 138
LQ L++ +F+ P +LT L +L+VL L +N +G IP +L NL L L N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP----- 193
TG P L S L L L N+L G +PK L + L +RL N F+G +P
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 194 -PLNQSSLKIFNVSGNNFTGAI 214
PL + ++S NN G I
Sbjct: 427 LPL----VYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 64/265 (24%), Positives = 115/265 (43%), Gaps = 31/265 (11%)
Query: 392 LGKGSLG--TTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
LGKG+ G T Y+ D+ L+V K ++ ++L+ + + L+HPN++ A
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNII---A 63
Query: 450 YFQA--KEERLLI-YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA--EDVAQGLSYIH 504
Y+ + LLI +Y G+L+ I R K + + + + +SYIH
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQDDDPDNLLYKAPETRNASH 562
+A ++H ++K+ N+ L L D+ ++ + S+ + Y +PE
Sbjct: 119 KA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV- 176
Query: 563 QATSKSDVYSFGVLLLELLTGK---PPSQHSFLVPNEMM-NWVRSAREDDGAEDERLGML 618
+ KSD+++ G +L ELLT K + LV + N+ E L
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY---TPVVSVYSSE----L 229
Query: 619 LEVAIACNSASPEQRPTMWQVLKML 643
+ + + PE+RPT +VL
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 67/299 (22%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRL--DASK--LAGTSNEMYEQHMESVGGL 439
+ LG+G+ G KA + V VK L DA++ L+ +EM + M+ +G
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEM--EMMKMIG-- 73
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKSTRAKPL------------H 485
+H N++ L + ++ +Y +G+L F A P
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545
S A VA+G+ ++ + +H +L + NVL+ D +AD+ L A +
Sbjct: 134 LVSF---AYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHI 185
Query: 546 D------PDNLLYK--APET---RNASHQATSKSDVYSFGVLLLELLT--GKP-PSQHSF 591
D L K APE R +HQ SDV+SFGVLL E+ T G P P
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQ----SDVWSFGVLLWEIFTLGGSPYPG---- 237
Query: 592 LVP-NEMMNWVRSAREDD---GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+P E+ ++ + E ++ + C P QRPT Q+++ L +
Sbjct: 238 -IPVEELFKLLKEGYRMEKPQNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
ELLGKG+ G +K L ++ V VK L + + HPN+V L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
++ ++ + P G S + K L +K A D A G++Y+ ++
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYL-ESKNC 114
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----------PDNLLYKAPETR 558
+H +L + N L+G + ++D+ + S Q+DD P + + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGM------SRQEDDGIYSSSGLKQIP--IKWTAPEAL 166
Query: 559 NASHQATSKSDVYSFGVLLLELLT 582
N + +S+SDV+S+G+LL E +
Sbjct: 167 NYG-RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-------HP 442
+++G+G+ G KA + + + K + ++ H + G L HP
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHP 56
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL----HWTSC-------LK 491
N++ L + + L +Y P+G+L + S+ P + T+ L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 492 IAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT---ALTADSLQDDDPD 548
A DVA+G+ Y+ Q + +H +L + N+L+G ++ A +AD+ L+ + P
Sbjct: 117 FAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP- 174
Query: 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLEL--LTGKPPSQHSFLVPNEMMNWVRSARE 606
+ + A E+ N S T+ SDV+S+GVLL E+ L G P + E + +
Sbjct: 175 -VRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQV 639
+DE + ++ C P +RP+ Q+
Sbjct: 233 PLNCDDE----VYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 55/223 (24%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRL--------DASKLAGTSNE-MYEQHMESVGGLRH 441
LGKG+ G +KA+ + +V +K++ DA + T E M+ Q + H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR---TFREIMFLQELGD-----H 66
Query: 442 PNLVPLRAYFQAKEER--LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV--- 496
PN+V L +A+ ++ L+++Y L ++I RA I EDV
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI------RAN---------ILEDVHKR 110
Query: 497 ------AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
+ L YIH ++H +LK SN+LL D LAD+ L A + L+++ + +
Sbjct: 111 YIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGL-ARSLSELEENPENPV 168
Query: 551 L--------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
L Y+APE S + T D++S G +L E+L GKP
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 70/282 (24%), Positives = 112/282 (39%), Gaps = 51/282 (18%)
Query: 390 ELLGKGSLGT----TYKAVLDNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPN 443
+ LG GS G + + V VK L + KL+ ++ + M S L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHS---LDHEN 57
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLH--WTSCLKIAEDVAQGLS 501
L+ L +++ + P GSL + + ++IA G+
Sbjct: 58 LIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDA-LGHFLISTLCDYAVQIAN----GMR 111
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDD----------PDNL 550
Y+ R +H +L + N+LL D + + D+ L AL Q++D P
Sbjct: 112 YLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRAL----PQNEDHYVMEEHLKVP--F 164
Query: 551 LYKAPE---TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQH---SFLVPNEMMNWVRS 603
+ APE TR SH SDV+ FGV L E+ T G+ P S ++ R
Sbjct: 165 AWCAPESLRTRTFSH----ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220
Query: 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
R + +D + V + C + +P RPT + + L E
Sbjct: 221 ERPEACPQD-----IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 55/293 (18%)
Query: 392 LGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
LG+G+ G + A N +++V VK L LA + +++ E + L+H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 446 PLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKS---TRAKPLH------WTSCLKIAE 494
+ +++++Y +G L F HG + +P + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--------- 545
+A G+ Y+ + VH +L + N L+G + + D+ ++ D D
Sbjct: 131 QIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDF---GMSRDVYSTDYYRVGGHTM 186
Query: 546 ------DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMM 598
P++++Y+ + T++SDV+SFGV+L E+ T GK P L E++
Sbjct: 187 LPIRWMPPESIMYR---------KFTTESDVWSFGVILWEIFTYGKQPWFQ--LSNTEVI 235
Query: 599 NWVRSAREDDGAEDERL--GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+ R E R+ + ++ + C P+QR + ++ K+L + A
Sbjct: 236 ECITQGRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDAS--------KLAGTSNEMYE-QHMESVGGLRHP 442
+G+G+ G YKA KR D ++ GT M + + + L+HP
Sbjct: 9 VGRGTYGHVYKA----------KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 443 NLVPLRAYFQAKEER--LLIYDYQPNGSLFSLIHGSKSTRA--KPLHWTSCL--KIAEDV 496
N++ L+ F + +R L++DY + L+ +I ++++A KP+ + + +
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLL---GPDF-EACLADYCLTALTADSLQ---DDDPD- 548
G+ Y+H W ++H +LK +N+L+ GP+ +AD L L+ D DP
Sbjct: 118 LDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 549 -NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE + T D+++ G + ELLT +P
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVK--RLDASKLAGTSNE---MYEQHMESVGGLRHP 442
E +G+G+ G YKA + V +K RL NE M + +HP
Sbjct: 25 EKIGEGASGEVYKATDRATGKE-VAIKKMRLRKQNKELIINEILIMKD--------CKHP 75
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA---EDVAQG 499
N+V + +E ++ +Y GSL +I + +P +IA +V QG
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVLQG 128
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD--YCLTALTADSLQDDDPDNLL-----Y 552
L Y+H ++H ++KS N+LL D LAD + LT + + N + +
Sbjct: 129 LEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSK----RNSVVGTPYW 182
Query: 553 KAPE--TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE R K D++S G++ +E+ G+PP
Sbjct: 183 MAPEVIKR---KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG+GS G+ YKA+ + +V +K + + + + + P +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + ++ +Y GS+ ++ K T K L I +GL Y+H +
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM---KITN-KTLTEEEIAAILYQTLKGLEYLHSN-K 119
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKAPETRNASHQ 563
+H ++K+ N+LL + +A LAD+ ++ D++ + P + APE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP---FWMAPEVIQEI-G 175
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQH------SFLVPN 595
+K+D++S G+ +E+ GKPP F++PN
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDAS--------KLAGTSNEMYE-QHMESVGGLRHP 442
+G+G+ G YKA KR D ++ GT M + + + L+HP
Sbjct: 9 VGRGTYGHVYKA----------KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHP 58
Query: 443 NLVPLRAYFQAKEER--LLIYDYQPNGSLFSLIHGSKSTRA--KPLHWTSCL--KIAEDV 496
N++ L+ F + +R L++DY + L+ +I ++++A KP+ + + +
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLL---GPDF-EACLADYCLTALTADSLQ---DDDPD- 548
G+ Y+H W ++H +LK +N+L+ GP+ +AD L L+ D DP
Sbjct: 118 LDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 549 -NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE + T D+++ G + ELLT +P
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 28/148 (18%)
Query: 93 GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSL--- 148
G I P +L K + L VL L N+LTG IP+ L NL L L N G P SL
Sbjct: 346 GEI--PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 149 LSLHRLKT---------------------LDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
SL R++ LD+S NNL G + L L L N+
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 188 FNGSIPPLNQSS-LKIFNVSGNNFTGAI 214
F G +P S L+ ++S N F+GA+
Sbjct: 464 FFGGLPDSFGSKRLENLDLSRNQFSGAV 491
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 392 LGKGSLGTTYKAVLDNR-LIVCVKRL--DASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G G Y+ V L V VK L D ++ E + + + ++HPNLV L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-----EEFLKEAAVMKEIKHPNLVQLL 68
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +I ++ G+L + + + ++ L +A ++ + Y+ +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL-EKKN 124
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTAD---SLQDDDPDNLLYKAPETRNASHQAT 565
+H +L + N L+G + +AD+ L+ L + + + APE+ A ++ +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFS 183
Query: 566 SKSDVYSFGVLLLELLT 582
KSDV++FGVLL E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR----HPNLV 445
EL+G G+ G YK V +L A K+ + + E+ + + L+ H N+
Sbjct: 12 ELVGNGTYGQVYKGRH-----VKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 446 PLRAYFQAK------EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
F K ++ L+ ++ GS+ LI +K K W + I ++ +G
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA--YICREILRG 123
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPET 557
LS++HQ +++H ++K NVLL + E L D+ ++A ++ + + APE
Sbjct: 124 LSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182
Query: 558 ----RNASHQATSKSDVYSFGVLLLELLTGKPP--SQHS----FLVPNEMMNWVRSARED 607
N KSD++S G+ +E+ G PP H FL+P ++S +
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK-- 240
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
++ +E +C + QRPT Q++K
Sbjct: 241 ---WSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 20/205 (9%)
Query: 391 LLGKGSLGTTYKAVLDNR----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+LGKGS G A L I +K+ + M E+ + ++ HP L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L FQ KE + +Y G L I S + + ++ GL ++H+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAA-----EIICGLQFLHKK 115
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD---DPDNLLYKAPETRNAS 561
+++ +LK NVLL D +AD+ C + + PD Y APE
Sbjct: 116 G-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD---YIAPEILKGQ 171
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
S D +SFGVLL E+L G+ P
Sbjct: 172 KYNES-VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P + L FQ+K+ L+ +Y G SLI K+ P W + IAE V G+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIAE-VVLGVE 111
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD----PDNLLYKAPET 557
+HQ ++H ++K N+L+ L D+ L+ + L++ PD Y APET
Sbjct: 112 DLHQR-GIIHRDIKPENLLIDQTGHLKLTDF---GLSRNGLENKKFVGTPD---YLAPET 164
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP 586
SD +S G ++ E L G PP
Sbjct: 165 ILGVGD-DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 61/262 (23%), Positives = 118/262 (45%), Gaps = 22/262 (8%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYE-QHMESV-GGLRH---P 442
EL+G+G+ G Y+ V R +V +K ++ L +++ + Q ++ LR P
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGR-VVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N+ + +I +Y GS+ +L+ +A P+ I +V L Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREVLVALKY 116
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDPDNLLY-KAPETRNA 560
IH+ ++H ++K++N+L+ L D+ + A L +S + Y APE
Sbjct: 117 IHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620
+K+D++S G+ + E+ TG PP +S + M + ++ ++ +L E
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233
Query: 621 VAIACNSASPEQRPTMWQVLKM 642
AC P++R + ++LK
Sbjct: 234 FVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
++LG G+ GT YK + ++ V +K L+ + + E ++ + + + HP+L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMASMDHPHL 71
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
V L + +L + P+G L +H K L C++IA +G+ Y+
Sbjct: 72 VRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE 126
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-------LLYKAPET 557
+ RLVH +L + NVL+ + D+ L L ++ + D + +
Sbjct: 127 ER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 558 RNASHQATSKSDVYSFGVLLLELLT--GKP 585
R +HQ SDV+S+GV + EL+T GKP
Sbjct: 186 RKFTHQ----SDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 52/280 (18%)
Query: 392 LGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
LG G+ G+ K V + V VK L +A E + + L HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLRE-ASVMAQLDHPCIVRL 61
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ E +L+ + P G L + + L ++A VA G++Y+
Sbjct: 62 IGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK- 114
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK------------A 554
VH +L + NVLL +A ++D+ ++ AL A S Y+ A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--------YRATTAGRWPLKWYA 166
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613
PE N + +SKSDV+S+GV L E + G P EM A + G E
Sbjct: 167 PECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-------EMKGAEVIAMLESG---E 215
Query: 614 RLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL + + ++C PE RPT ++ +
Sbjct: 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPL 447
LG G+ G K + I+ VK + + + +Q + + L P +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F + + +Y GSL ++ + P KIA V +GL+Y+H+
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILG--KIAVAVLKGLTYLHEKH 120
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
+++H ++K SN+L+ + L D+ ++ +SL Y APE R + + K
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE-RIQGNDYSVK 179
Query: 568 SDVYSFGVLLLELLTGKPP 586
SD++S G+ L+EL TG+ P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 37/279 (13%)
Query: 392 LGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVP 446
+G GS G Y A D R +V +K++ S SNE ++ ++ V L +HPN +
Sbjct: 33 IGHGSFGAVYFA-RDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ + + L+ +Y GS L+ K KPL I QGL+Y+H +
Sbjct: 90 YKGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH-S 143
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPETRNA- 560
++H ++K+ N+LL + LAD+ ++ + P N + APE A
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-------PANSFVGTPYWMAPEVILAM 196
Query: 561 -SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA--EDERLGM 617
Q K DV+S G+ +EL KPP N M A+ + +E
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPTLQSNEWSDY 252
Query: 618 LLEVAIACNSASPEQRPTMWQVLK---MLQEIKGAVLME 653
+C P+ RPT ++LK +L+E VL++
Sbjct: 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 49/228 (21%)
Query: 392 LGKGSLGTTYKAVLDN------RLIVCVKRL-DASKLAGTSNEMYEQHMESVGGLRHPNL 444
LG+G+ G + A N +++V VK L +AS+ ++ + +++ E + L+H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHI 69
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSL--FSLIHG--------SKSTRAKPLHWTSCLKIAE 494
V L++++Y +G L F HG + L L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--------- 545
+A G+ Y+ + VH +L + N L+G + D+ ++ D D
Sbjct: 130 QIASGMVYL-ASLHFVHRDLATRNCLVGQGLVVKIGDF---GMSRDIYSTDYYRVGGRTM 185
Query: 546 ------DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPP 586
P+++LY+ + T++SD++SFGV+L E+ T GK P
Sbjct: 186 LPIRWMPPESILYR---------KFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 439 LRHPNLVPLRAYFQAKEER--LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK-IAED 495
LRHPN+V L+ +K + ++++Y + L L+ S + +K +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD-SPEVKFTESQ----IKCYMKQ 108
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LL 551
+ +GL Y+H ++H ++K SN+L+ D LAD+ L A D N L
Sbjct: 109 LLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLW 166
Query: 552 YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588
Y+ PE + + + D++S G +L EL GKP Q
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+G+ G Y+A + IV +K R+D + + + E + + LRHPN+V L+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITL--LLNLRHPNIVELK 72
Query: 449 AYFQAK--EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
K + L+ +Y L SL+ + P + + + +GL Y+H+
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT----PFSESQVKCLMLQLLRGLQYLHEN 127
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQA 564
+ ++H +LK SN+LL +AD+ L + P L Y+APE
Sbjct: 128 F-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 565 TSKSDVYSFGVLLLELLTGKP 585
T+ D+++ G +L ELL KP
Sbjct: 187 TTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLR---HPNLVPL 447
LG G+ G YKA N+ L A+K+ T S E E +M + L HPN+V L
Sbjct: 13 LGDGAFGKVYKA--QNKE---TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F + ++ ++ G++ +++ +PL + + + L+Y+H+
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVM----LELERPLTEPQIRVVCKQTLEALNYLHEN- 122
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPET----RNAS 561
+++H +LK+ N+L D + LAD+ ++A ++Q D + APE +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
K+DV+S G+ L+E+ +PP
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 392 LGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
+G+G+ G +KA + V +K++ +L G + ++++ +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLV 510
F +L+ +Y P L ++ +PL + +G++Y+H ++
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR----DEERPLPEAQVKSYMRMLLKGVAYMHAN-GIM 121
Query: 511 HGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAPETRNASH 562
H +LK +N+L+ D +AD+ L L ++ L Y+APE +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLA-----RLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 563 QATSKSDVYSFGVLLLELLTGKP 585
+ D+++ G + ELL G P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 391 LLGKGSLGTT----YKAVLDNRLIVCVKRLDASKLAGTSNEMY---EQHMESVGGLRHPN 443
L+GK K N L+ VK+++ L S E +Q + + L+HPN
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVA-VKKIN---LDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++P F E ++ GS L+ K+ + L + I +DV L YI
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLL---KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLAD--YCLTALTADSLQ---DDDP----DNLLYKA 554
H +H ++K+S++LL D + L+ Y ++ + Q D P NL + +
Sbjct: 118 HSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 555 PET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE + KSD+YS G+ EL G P
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAG-TSNEM--YEQHMESVGGLRHPNLV 445
+LLG+G+ G Y +D + VK++ + T E+ E ++ + L+H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 446 PLRAYFQAKEERLLIY---DYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGL 500
Y+ + + +Y P GS+ + +G L T K + +G+
Sbjct: 68 ---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGV 117
Query: 501 SYIHQAWRLVHGNLKSSNVL--------LGPDFEAC--LADYCLTALTADSLQDDDPDNL 550
Y+H +VH ++K +N+L LG DF A L C + T P
Sbjct: 118 EYLHSN-MIVHRDIKGANILRDSAGNVKLG-DFGASKRLQTICSSG-TGMKSVTGTPY-- 172
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ +PE + K+DV+S G ++E+LT KPP
Sbjct: 173 -WMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 52/212 (24%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL-HWTSCLKIAEDVA 497
L H NLV L ++ + G+L + + TR + L L+ + DVA
Sbjct: 56 LHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVA 110
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPET 557
+G+ Y+ ++ +LVH +L + N+L+ D A ++D+ L + + + D+ + + APE
Sbjct: 111 EGMEYL-ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSKLPVKWTAPEA 168
Query: 558 RNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDD---GAEDE 613
+ +SKSDV+S+GVLL E+ + G+ P P + V+ E +
Sbjct: 169 LK-HKKFSSKSDVWSYGVLLWEVFSYGRAP------YPKMSLKEVKECVEKGYRMEPPEG 221
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ + +C P++RP+ ++ + L++
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMES--VGGLRHPN 443
+++G G G + L + V +K L K + + + E+ +G HPN
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ L ++I +Y NGSL + + K + + +A G+ Y+
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGK-FTVGQLVGMLRGIASGMKYL 122
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLYKAPET 557
+ VH +L + N+L+ + ++D+ L+ DS + + + APE
Sbjct: 123 SEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEA 179
Query: 558 RNASHQA-TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW-VRSAREDDGAEDER 614
+++ TS SDV+SFG+++ E+++ G+ P +M N V A ED R
Sbjct: 180 --IAYRKFTSASDVWSFGIVMWEVMSYGERPYW-------DMSNQDVIKAVED----GYR 226
Query: 615 L-------GMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
L L ++ + C +RPT Q++ L
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPL 447
+G GS G Y A +V VK++ S +NE ++ ++ V L+ HPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYS--GKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + + L+ +Y GS L+ K KPL I QGL+Y+H +
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH-SH 140
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPETRNA-- 560
++H ++K+ N+LL + LAD+ + ++ P N + APE A
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------PANSFVGTPYWMAPEVILAMD 193
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
Q K DV+S G+ +EL KPP
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR----HPNLVP 446
LG G+ G+ Y A + +V +K++ K S E E V LR HPN+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLRE-VKSLRKLNEHPNIVK 62
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L+ F+ +E +++Y G+L+ L+ K + KP + I + QGL++IH+
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAHIHK- 117
Query: 507 WRLVHG----NLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP-----DNLLYKAPET 557
HG +LK N+L+ +AD+ L A ++ P Y+APE
Sbjct: 118 ----HGFFHRDLKPENLLVSGPEVVKIADFGL----AREIRSRPPYTDYVSTRWYRAPEI 169
Query: 558 --RNASHQATSKSDVYSFGVLLLELLTGKP 585
R+ S+ +S D+++ G ++ EL T +P
Sbjct: 170 LLRSTSY--SSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G G+ G YKA + +V +K +L+ G E+ +Q + + RHPN+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIV--- 63
Query: 449 AYFQA--KEERLLI-YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA---EDVAQGLSY 502
AYF + + ++L I +Y GSL + TR PL S L+IA + +GL+Y
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRG-PL---SELQIAYVCRETLKGLAY 116
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPETRNA 560
+H+ +H ++K +N+LL D + LAD+ ++A ++ + APE
Sbjct: 117 LHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 561 SHQA--TSKSDVYSFGVLLLELLTGKPP 586
+ K D+++ G+ +EL +PP
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT Y A+ + V +K+++ + E+ + + +HPN+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYL 82
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +E ++ +Y GSL ++ + + + + Q L ++H + +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLH-SNQ 135
Query: 509 LVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPE--TRNASHQA 564
++H ++KS N+LLG D L D+ C S + + APE TR
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK---AY 192
Query: 565 TSKSDVYSFGVLLLELLTGKPP 586
K D++S G++ +E++ G+PP
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 434 ESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA 493
E+ RHP LV L A FQ ++ + +Y G L IH + + + + +C
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC---- 109
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD------- 546
V GL Y+H+ ++V+ +LK N+LL + +AD+ L + + D
Sbjct: 110 --VVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADF---GLCKEGMGFGDRTSTFCG 163
Query: 547 -PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
P+ L APE T D + GVL+ E+L G+ P
Sbjct: 164 TPEFL---APEVL-TETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 24/260 (9%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G G + ++ V +K ++ + S E + + + + L HP LV L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
++ ++ ++ NG L + + + +K + + C +DV +G+ Y+ + +H
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC----QDVCEGMEYLERN-SFIH 123
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTAD-----SLQDDDPDNLLYKAPETRNASHQATS 566
+L + N L+ ++D+ +T D S P + + PE N S + +S
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFS-KYSS 180
Query: 567 KSDVYSFGVLLLELLT-GKPP--SQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623
KSDV+SFGVL+ E+ T GK P + ++ V + R R + + EV
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASM-----TVYEVMY 235
Query: 624 ACNSASPEQRPTMWQVLKML 643
+C PE RPT ++L+ +
Sbjct: 236 SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR----HPNL 444
E++G+G+ G YKA +V +K +D + + E+ E LR HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNI 65
Query: 445 VPLR-AYFQA----KEERL-LIYDYQPNGSLFSLIHGS-KSTRAKPLHWTSCLKIAEDVA 497
A+ + +++L L+ + GS+ L+ G K + W + I +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETL 123
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK---- 553
+GL+Y+H+ +++H ++K N+LL + E L D+ ++A D+ L +
Sbjct: 124 RGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSA---------QLDSTLGRRNTF 173
Query: 554 -------APETRNASHQAT----SKSDVYSFGVLLLELLTGKPP 586
APE Q ++SDV+S G+ +EL GKPP
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 38/283 (13%)
Query: 392 LGKGSLGTTYKA----VLDNR--LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+G+G+ G ++A +L +V VK L A + +++ + HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHPNIV 71
Query: 446 PLRAYFQAKEERLLIYDYQPNGSL------------FSLIHGSKSTRAK-----PLHWTS 488
L + L+++Y G L SL H + S R PL T
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 489 CLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT--ALTADSLQDDD 546
L IA+ VA G++Y+ + + VH +L + N L+G + +AD+ L+ +AD + +
Sbjct: 132 QLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 547 PDNLLYK-APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSA 604
D + + P ++ T++SDV+++GV+L E+ + G P + + E++ +VR
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP--YYGMAHEEVIYYVRDG 248
Query: 605 RE---DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
D E L + C S P RP+ + ++LQ
Sbjct: 249 NVLSCPDNCPLE----LYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 74/288 (25%), Positives = 114/288 (39%), Gaps = 39/288 (13%)
Query: 383 QLMRASAEL---LGKGSLGTTYKAVLDNRLIVCVKRLDASKLA---GTSNEMYEQHMES- 435
++ R S L LG G+ G Y+ + R DA +L T E + ES
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGR------DGDAVELQVAVKTLPESCSEQDESD 55
Query: 436 -------VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKST--RAKPLHW 486
+ H N+V L + R ++ + G L S + ++ R L
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTA--LTADS 541
L A DVA+G Y+ + +H ++ + N LL GP A +AD+ + A
Sbjct: 116 KDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 542 LQDDDPDNLLYK-APETRNASHQATSKSDVYSFGVLLLEL--LTGKP-PSQHSFLVPNEM 597
+ L K P TSK+DV+SFGVLL E+ L P P + + E+
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEV 230
Query: 598 MNWV-RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
M +V R D G + + C +PE RP +L+ +Q
Sbjct: 231 MEFVTGGGRLDPPKGCP--GPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIY----DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAE 494
LRHPN+V F + +RL I + P G F+ + K + W I
Sbjct: 66 LRHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFV 120
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA-DSLQDDDPDNLLYK 553
+ L Y+H+ R+VH +L +N++LG D + + D+ L +S +LY
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE--DDGAE 611
PE + K+DV++FG +L ++ T +PP +S + + V + E +G
Sbjct: 181 CPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKML 643
E + ++ +C + E RP + QV M+
Sbjct: 239 SEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 67/276 (24%), Positives = 107/276 (38%), Gaps = 38/276 (13%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +GKGS GT K D +++V K +D + + + + L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVW-KEIDYGNMTEKEKQQLVSEVNILRELKHPNIV-- 62
Query: 448 RAYFQ----AKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
Y+ + L I +Y G L LI K R K + +I + L
Sbjct: 63 -RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYE 120
Query: 503 IHQAW----RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDN 549
H ++H +LK +N+ L + L D+ L A L D P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL----AKILGHDSSFAKTYVGTP-- 174
Query: 550 LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ-HSFLVPNEMMNWVRSAREDD 608
Y +PE N KSD++S G L+ EL PP + L + + R
Sbjct: 175 -YYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY 232
Query: 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
E L EV + + P++RP+ ++L++
Sbjct: 233 RYSSE----LNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +G+G+ GT + A+ D V +K+++ K E+ + + L++PN+V
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNF 81
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F +E ++ +Y GSL ++ + A+ + + Q L ++H A
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ------IAAVCRECLQALEFLH-AN 134
Query: 508 RLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPE--TRNASHQ 563
+++H ++KS NVLLG D L D+ C S + + APE TR A
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-- 192
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
K D++S G++ +E++ G+PP
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 392 LGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+G+GS G KA+L D + V +K ++ SK++ E + + + ++HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHW--TSCLKIAEDVAQGLS 501
+ F+ ++ DY G L+ I+ + + L W CL L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL--------ALK 115
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-----DDDPDNLLYKAPE 556
++H +++H ++KS N+ L D L D+ + + +++ P Y +PE
Sbjct: 116 HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP---YYLSPE 171
Query: 557 T-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601
N + +KSD+++ G +L E+ T K H+F N M N V
Sbjct: 172 ICENRPYN--NKSDIWALGCVLYEMCTLK----HAFEAGN-MKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 34/276 (12%)
Query: 381 LDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR 440
+D + LG G G + ++ V +K + + S + + + + + L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLS 57
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HPNLV L + ++ +Y NG L + + R L L + DV + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR----ERKGKLGTEWLLDMCSDVCEAM 113
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-----SLQDDDPDNLLYKAP 555
Y+ +H +L + N L+G D ++D+ L D S P + + P
Sbjct: 114 EYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPP 170
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614
E + S + +SKSDV+SFGVL+ E+ + GK P + + S + + R
Sbjct: 171 EVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYE----------RFSNSEVVESVSAGYR 219
Query: 615 LGM-------LLEVAIACNSASPEQRPTMWQVLKML 643
L + + +C PE RP ++L L
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 66/292 (22%), Positives = 126/292 (43%), Gaps = 56/292 (19%)
Query: 392 LGKGSLGTTYKAVLDN------RLIVCVKRL-DASKLAGTSNEMYEQHMESVGGLRHPNL 444
LG+G+ G + A N +++V VK L DAS + + + + E + L+H ++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHI 69
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSL--FSLIHG------SKSTRAKPLHWTSCLKIAEDV 496
V + +++++Y +G L F HG ++ R L + L IA+ +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD----------- 545
A G+ Y+ + VH +L + N L+G + + D+ ++ D D
Sbjct: 130 AAGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDF---GMSRDVYSTDYYRVGGHTMLP 185
Query: 546 ----DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600
P++++Y+ + T++SDV+S GV+L E+ T GK P L NE++
Sbjct: 186 IRWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQPWYQ--LSNNEVIEC 234
Query: 601 VRSAR---EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+ R E + ++ + C P R + ++ +LQ + A
Sbjct: 235 ITQGRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 42/226 (18%)
Query: 392 LGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHMESVG------------ 437
LG+G+ G KA D IV +K++ +++ + Q + G
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKD-RQLVGMCGIHFTTLRELKIM 74
Query: 438 -GLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK-IAED 495
++H N++ L + + L+ D L K K S +K I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDL------KKVVDRKIRLTESQVKCILLQ 127
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA-----DSLQDDDPD-- 548
+ GL+ +H W +H +L +N+ + +AD+ L D+L D+
Sbjct: 128 ILNGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 549 ---------NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
L Y+APE + + D++S G + ELLTGKP
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
+ P +V L FQ K+ L+ +Y P G L SL+ + + + IAE +
Sbjct: 50 AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVAR-IYIAE-IVL 104
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN--------- 549
L Y+H ++H +LK N+L+ + L D+ L+ + Q + D+
Sbjct: 105 ALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 550 -LLYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE H + D +S G +L E L G PP
Sbjct: 164 TPDYIAPEVILGQGH--SKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 30/171 (17%)
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGS---KSTRAKPL 484
M E+ + ++ G +HP L L + FQ K+ + +Y G L I S RA+
Sbjct: 43 MTEKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR-- 99
Query: 485 HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544
A ++ GL ++H+ +++ +LK NVLL + +AD+ + + +
Sbjct: 100 ------FYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADF---GMCKEGILG 149
Query: 545 DD--------PDNLLYKAPETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
PD Y APE S+Q + D ++ GVLL E+L G+ P
Sbjct: 150 GVTTSTFCGTPD---YIAPEI--LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 390 ELLGKGSLGTTY--KAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+ +G+GS G Y KA D+ V +K +D +K+ E ++ + + ++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLI---HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
A FQ ++ +Y G L I G + + L W ++ GL +IH
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QISLGLKHIH 118
Query: 505 QAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSLQ--DDDPDNLLYKAPET-RNA 560
+++H ++KS N+ L + A L D+ + DS++ Y +PE +N
Sbjct: 119 DR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
+ +K+D++S G +L EL T K P
Sbjct: 178 PYN--NKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 62/214 (28%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSN---EMYEQHMESVGGLRHPNLV 445
++LGKGS G + A L +K L + + M E+ + S+ HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 59
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKI--------AEDVA 497
L FQ KE + +Y G L H SC K A ++
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLM-------------FHIQSCHKFDLPRATFYAAEII 106
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD---DPDNLLY 552
GL ++H +V+ +LK N+LL D +AD+ C + D+ PD Y
Sbjct: 107 CGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD---Y 162
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE TS D +SFGVLL E+L G+ P
Sbjct: 163 IAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 20/275 (7%)
Query: 387 ASAELLGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
A + LG+G G+ + L D+ L V VK + + + E + + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 444 LVPLRAY-FQAKEER-----LLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDV 496
++ L Q E ++I + +G L S L++ + L +K D+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA--LTADSLQDDDPDNLLYK- 553
A G+ Y+ +H +L + N +L + C+AD+ L+ D + + K
Sbjct: 122 ASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
A E+ A T+KSDV+SFGV + E+ T G+ P + + +E+ +++R
Sbjct: 181 IAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSEIYDYLRQGNRLKQPP 237
Query: 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
D L L + +C +P+ RP+ + L++
Sbjct: 238 D-CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEM-YEQHMES----VGGLRHPN 443
+ LG GS G + +K L +K+ ++ +H+ + + +RHP
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV----KLKQVEHVLNEKRILQSIRHPF 62
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
LV L FQ L+ +Y P G LFS + + + P A+ V L Y+
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVA-RFYAAQ-VVLALEYL 117
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADY-------------CLTALTADSLQDDDPDNL 550
H +V+ +LK N+LL D + D+ C T P+
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGT-----------PE-- 163
Query: 551 LYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE + + D ++ G+L+ E+L G PP
Sbjct: 164 -YLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 64/277 (23%), Positives = 126/277 (45%), Gaps = 36/277 (12%)
Query: 392 LGKGSLGTTYKAV--------LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
LG+GS G Y+ + R V VK ++ S E + G H +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH-H 70
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHG----SKSTRAKPL-HWTSCLKIAEDVAQ 498
+V L + L++ + +G L S + +++ +P +++A ++A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD----DPDNLL--- 551
G++Y++ A + VH +L + N ++ DF + D+ +T D + D LL
Sbjct: 131 GMAYLN-AKKFVHRDLAARNCMVAHDFTVKIGDF---GMTRDIYETDYYRKGGKGLLPVR 186
Query: 552 YKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGA 610
+ APE+ T+ SD++SFGV+L E+ + + P Q L +++ +V D
Sbjct: 187 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQG--LSNEQVLKFVMDGGYLDQP 243
Query: 611 ED--ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
++ ER+ L+ + C +P+ RPT +++ +L++
Sbjct: 244 DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 34/259 (13%)
Query: 410 IVCVKRLDASKLAGTSNEM-YEQHMESVGGLRHPNLVPLRAYFQAKEER--LLIYDYQPN 466
+V VK L G N +++ + + L H N+V + + + LI +Y P
Sbjct: 35 MVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE 526
GSL + K L+ L A+ + +G++Y+H + +H +L + NVLL D
Sbjct: 93 GSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDNDRL 145
Query: 527 ACLADYCLTALTADS-----LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELL 581
+ D+ L + +++D + + A E ++ + SDV+SFGV L ELL
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELL 204
Query: 582 TGKPPSQH---SFL----VPNEMMNWVRSAREDDGAEDERL----GMLLEVAI---ACNS 627
T Q F M VR + RL EV I C
Sbjct: 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLI--ELLERGMRLPCPKNCPQEVYILMKNCWE 262
Query: 628 ASPEQRPTMWQVLKMLQEI 646
+ RPT ++ +L+E+
Sbjct: 263 TEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 69/275 (25%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 391 LLGKGSLGTTYKAVL---DNRLI-VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-- 444
+LGKG G+ +A L D V VK L A + + E + + + HPN+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 445 ---VPLRAYFQAKEE-RLLIYDYQPNGSLFSLIHGSK-STRAKPLHWTSCLKIAEDVAQG 499
V LR+ + + ++I + +G L + + S+ L + ++ D+A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA--LTADSLQDDDPDNLLYK--AP 555
+ Y+ +H +L + N +L + C+AD+ L+ + D + L K A
Sbjct: 126 MEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV----RSAREDDGA 610
E+ A + T+ SDV++FGV + E++T G+ P ++ + +E+ N++ R + D
Sbjct: 185 ESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSEIYNYLIKGNRLKQPPDCL 241
Query: 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
ED + E+ C S P+ RP+ +Q L+ E
Sbjct: 242 ED-----VYELMCQCWSPEPKCRPS-FQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 390 ELLGKGSLGTTYKAVLDNRL---IVCVK--RLDASKLAGT-SNEMYEQHMESVGGLRHPN 443
E LG+G+ T YK NR IV +K LDA + GT S + E + + L+H N
Sbjct: 6 EKLGEGTYATVYKGR--NRTTGEIVALKEIHLDAEE--GTPSTAIRE--ISLMKELKHEN 59
Query: 444 LVPLRAYFQAKEERLLIYDYQPNG-SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+V L + + +L+++Y + HG + L + + +G+++
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAF 115
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDDPDNLLYKAPETRNA 560
H+ R++H +LK N+L+ E LAD+ L + ++ L Y+AP+
Sbjct: 116 CHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 561 SHQATSKSDVYSFGVLLLELLTGKP 585
S ++ D++S G ++ E++TG+P
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/195 (22%), Positives = 90/195 (46%), Gaps = 6/195 (3%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G+ G K ++ ++L ++ + ++ + P +V F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+ E + ++ GSL ++ +K + L K++ V +GL+Y+ + +++H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKHQIMH 127
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVY 571
++K SN+L+ E L D+ ++ DS+ + Y +PE +H + +SD++
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV-QSDIW 186
Query: 572 SFGVLLLELLTGKPP 586
S G+ L+EL G+ P
Sbjct: 187 SMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDDPDN 549
KIA + + L Y+H ++H ++K SNVL+ + + L D+ ++ DS+ + D
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166
Query: 550 LLYKAPETRNASHQATS---KSDVYSFGVLLLELLTGKPP 586
Y APE N KSDV+S G+ ++EL TG+ P
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 33/212 (15%)
Query: 392 LGKGSLGTTYKA------------VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL 439
+GKG+ G Y+ VL + IV K + + G N + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK--EVAHTIGERNILVRTLLDES--- 55
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLF-SLIHGSK--STRAKPLHWTSCLKIAEDV 496
P +V L+ FQ + L+ DY G LF L + RAK IAE V
Sbjct: 56 --PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAK-------FYIAELV 106
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA--LTADSLQDDDPDNLLYKA 554
L ++H+ + +V+ +LK N+LL L D+ L+ LT + + Y A
Sbjct: 107 L-ALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE T D +S GVL+ E+ G P
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 392 LGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESV-GGLRHPNLVPLRA 449
+GKGS G + D + I +K + + + S + +V + P +VPL+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGS---KSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
FQ+ E+ L+ + G LF + +RA+ +T+ L A L +H+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRAR--FYTAELLCA------LENLHK- 111
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPETRNAS 561
+ +++ +LK N+LL L D+ L L +++DDD N Y APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELL-LG 167
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
H T D ++ GVLL E+LTG PP
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 392 LGKGSLGTTYKAV--LDNRLI-VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ G K V + + I V +K L +EM + E + L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE-AEIMHQLDNPYIVRMI 61
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+A E +L+ + G L + G K + ++ +++ V+ G+ Y+
Sbjct: 62 GVCEA-EALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEGK-N 115
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDN-----------LLYKAPE 556
VH +L + NVLL A ++D+ L+ AL AD D+ L + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-------DSYYKARSAGKWPLKWYAPE 168
Query: 557 TRNASHQATSKSDVYSFGVLLLELLT--GKP------PSQHSFLVPNEMMN 599
N + +S+SDV+S+G+ + E + KP P SF+ + ++
Sbjct: 169 CINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG+GS T YK N +V +K + + GT + + GL+H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIRE-ASLLKGLKHANIVLLH 69
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
KE L+++Y + + + LH + + +GLSYIHQ +
Sbjct: 70 DIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPETRNASHQA 564
++H +LK N+L+ E LAD+ L A S+ N L Y+ P+ S +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLA--RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 565 TSKSDVYSFGVLLLELLTG 583
++ D++ G + +E++ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 392 LGKGSLGTTYKAVL--------DNRLIVCVKRL--DASK--LAGTSNEMYEQHMESVGGL 439
LG+G G +A D + V VK L +A+ LA +EM + M+ +G
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIG-- 75
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK-----------STRAKPLHWTS 488
+H N++ L + +I +Y G+L + + + L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 489 CLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548
+ A VA+G+ Y+ ++ R +H +L + NVL+ D +AD+ L A + D D
Sbjct: 136 LVSCAYQVARGMEYL-ESRRCIHRDLAARNVLVTEDNVMKIADFGL----ARGVHDID-- 188
Query: 549 NLLYK------------APET---RNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSF 591
YK APE R +HQ SDV+SFG+L+ E+ T G P +
Sbjct: 189 --YYKKTSNGRLPVKWMAPEALFDRVYTHQ----SDVWSFGILMWEIFTLGGSP---YPG 239
Query: 592 LVPNEMMNWVRSAREDDGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+ E+ +R D + L ML+ C A P QRPT Q+++ L ++ A
Sbjct: 240 IPVEELFKLLREGHRMDKPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAA 296
Query: 650 VLME 653
V E
Sbjct: 297 VSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+LGKG+ G Y A L ++ + +K + E + S L+H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY--LKHRNIVQYLG 72
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL--HWTSCLKIAEDVAQGLSYIHQAW 507
+ + P GSL +L+ ++ PL + + + + + +GL Y+H
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLR----SKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 508 RLVHGNLKSSNVLLG--------PDFEAC--LA--DYCLTALTADSLQDDDPDNLLYKAP 555
++VH ++K NVL+ DF LA + C T +LQ Y AP
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG-TLQ--------YMAP 178
Query: 556 ETRNASHQATSK-SDVYSFGVLLLELLTGKPP 586
E + + +D++S G ++E+ TGKPP
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKR-----LDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
LGKG+ G+ YK + + + LD SK E+ H ++V P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH-KAVS----PYIVD 63
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
F + + +Y GSL L G +T P +I V +GL ++ +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR--RITYAVVKGLKFLKEE 121
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPE-----TRNAS 561
++H ++K +NVL+ + + L D+ ++ SL + Y APE N +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
T +SDV+S G+ +LE+ G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 34/260 (13%)
Query: 390 ELLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQ---HMESVGGLRHPNLV 445
E+LG G+ GT YKA L R I+ VK + + E+ +Q +E + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVI----PLDITVELQKQIMSELEILYKCDSPYII 62
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
F + + ++ GSL R P H +IA V +GL+Y+
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLG--RIAVAVVKGLTYL-- 111
Query: 506 AW--RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQ 563
W +++H ++K SN+L+ + L D+ ++ +S+ Y APE R + Q
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE-RISGEQ 169
Query: 564 ATSKSDVYSFGVLLLELLTGKPP-----SQHSFLVPNEMMNWV---RSAREDDGAEDERL 615
SDV+S G+ +EL G+ P L+P +++ + G E+
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK- 228
Query: 616 GMLLEVAIACNSASPEQRPT 635
+ C P++RP
Sbjct: 229 --FVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 58/261 (22%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
LG G G + V +K + K S + + + + + L H LV L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+ ++ +Y NG L + + + K + L++ +DV +G++Y+ ++ + +H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL---REHG-KRFQPSQLLEMCKDVCEGMAYL-ESKQFIH 123
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTAD-----SLQDDDPDNLLYKAPETRNASHQATS 566
+L + N L+ ++D+ L+ D S+ P + + PE S + +S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYS-KFSS 180
Query: 567 KSDVYSFGVLLLELLT-GKPPSQ--HSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623
KSDV++FGVL+ E+ + GK P + ++ ++ +R R +E + +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK-----VYAIMY 235
Query: 624 ACNSASPEQRPTMWQVLKMLQ 644
+C E+RPT Q+L ++
Sbjct: 236 SCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 14/190 (7%)
Query: 459 LIYDYQPNGSLFSLIHG-SKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSS 517
L+ DY G L I +K+ R H L I V + ++H ++H ++KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI--QVLLAVHHVHSK-HMIHRDIKSA 172
Query: 518 NVLLGPDFEACLADYCLTALTADSLQDDDPDNL----LYKAPET-RNASHQATSKSDVYS 572
N+LL + L D+ + + A ++ DD Y APE R + + K+D++S
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY--SKKADMFS 230
Query: 573 FGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQ 632
GVLL ELLT K P + E+M+ + R D + E+ A S+ P++
Sbjct: 231 LGVLLYELLTLKRPFDGENM--EEVMHKTLAGRYDP-LPPSISPEMQEIVTALLSSDPKR 287
Query: 633 RPTMWQVLKM 642
RP+ ++L M
Sbjct: 288 RPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 29/96 (30%), Positives = 55/96 (57%), Gaps = 1/96 (1%)
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
KI+ V +GL+Y+ + +++H ++K SN+L+ E L D+ ++ DS+ +
Sbjct: 103 KISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 162
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y +PE +H T +SD++S G+ L+E+ G+ P
Sbjct: 163 SYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR-AKPLHWTSCLKIAEDV--- 496
HP +V L FQ + + LI D+ G LF TR +K + +T EDV
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLF--------TRLSKEVMFTE-----EDVKFY 103
Query: 497 ----AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNL 550
A L ++H + +++ +LK N+LL + L D+ L+ + D + +
Sbjct: 104 LAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
Y APE N S +D +SFGVL+ E+LTG P Q E M + A+
Sbjct: 163 EYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGK--DRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDAS-------KLAGTSNEMYEQHMESVGGLRHPN 443
+G+GS G +K + IV +K+ S K+A M +Q L+HPN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQ-------LKHPN 61
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
LV L F+ K + L+++Y + L L K+ R P H KI Q +++
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEH--LIKKIIWQTLQAVNFC 116
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPETRN 559
H+ +H ++K N+L+ + L D+ + + DD + + Y+APE
Sbjct: 117 HKH-NCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLV 173
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKP 585
Q DV++ G + ELLTG+P
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT Y A+ + V +++++ + E+ + + ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 83
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +E ++ +Y GSL ++ + + + + Q L ++H +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSN-Q 136
Query: 509 LVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPE--TRNASHQA 564
++H ++KS N+LLG D L D+ C S + + APE TR A
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY--- 193
Query: 565 TSKSDVYSFGVLLLELLTGKPP 586
K D++S G++ +E++ G+PP
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 27/96 (28%), Positives = 55/96 (57%), Gaps = 1/96 (1%)
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
K++ V +GL+Y+ + +++H ++K SN+L+ E L D+ ++ DS+ +
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y +PE +H + +SD++S G+ L+E+ G+ P
Sbjct: 167 SYMSPERLQGTHYSV-QSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT Y A+ + V +K+++ + E+ + + ++PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 82
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +E ++ +Y GSL ++ + + + + Q L ++H +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALDFLHSN-Q 135
Query: 509 LVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPE--TRNASHQA 564
++H ++KS N+LLG D L D+ C S + + APE TR A
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY--- 192
Query: 565 TSKSDVYSFGVLLLELLTGKPP 586
K D++S G++ +E++ G+PP
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 6e-07
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
E LG+G+ G YKA D + IV +K RLD + S + E + + L+HPN+V
Sbjct: 5 EKLGEGTYGVVYKAR-DKKTGEIVALKKIRLDNEEEGIPSTALRE--ISLLKELKHPNIV 61
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK-IAEDVAQGLSYIH 504
L + + L+++Y L + R PL + +K I + +GL+Y H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLD----KRPGPLS-PNLIKSIMYQLLRGLAYCH 115
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASH 562
R++H +LK N+L+ D LAD+ L L+ + L Y+APE S
Sbjct: 116 SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 563 QATSKSDVYSFGVLLLELLTGKP 585
++ D++S G + E++TGKP
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTS-NEMYEQHMESVGGLRHPNLVPL 447
E LG+GS T YK + N +V +K + G + E + + GL+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASL--LKGLKHANIVLL 68
Query: 448 RAYFQAKEERLLIYDY-QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
KE +++Y + + + + H LH + + +GL+YIH
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGG------LHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQA 564
++H +LK N+L+ E LAD+ L + Q + L Y+ P+ +
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 565 TSKSDVYSFGVLLLELLTGKP 585
+S D++ G + +E+L G+P
Sbjct: 182 SSALDIWGAGCIFIEMLQGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 35/153 (22%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+H N+V + + EE ++ ++ G+L ++ ++ + + E V Q
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQ------IATVCESVLQA 129
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL------LYK 553
L Y+H + ++H ++KS ++LL D L+D+ A + D P +
Sbjct: 130 LCYLH-SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA----QISKDVPKRKSLVGTPYWM 184
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE + + T + D++S G++++E++ G+PP
Sbjct: 185 APEVISRTPYGT-EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 46/282 (16%)
Query: 392 LGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHME-SV-GGLRHPN 443
LG+GS G Y+ + V +K ++ + E E E SV +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLNEASVMKEFNCHH 70
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAK--------PLHWTSCLKIAED 495
+V L + L++ + G L S + +S R + P +++A +
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYL---RSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD----DPDNLL 551
+A G++Y+ A + VH +L + N ++ D + D+ +T D + D LL
Sbjct: 128 IADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDF---GMTRDIYETDYYRKGGKGLL 183
Query: 552 ---YKAPET-RNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSA-- 604
+ APE+ ++ T+KSDV+SFGV+L E+ T + P Q L E++ +V
Sbjct: 184 PVRWMAPESLKDGVF--TTKSDVWSFGVVLWEMATLAEQPYQG--LSNEEVLKFVIDGGH 239
Query: 605 -REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ D LLE+ C +P+ RPT +++ L++
Sbjct: 240 LDLPENCPD----KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 46/212 (21%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 390 ELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+++G G G ++ +L + V +K L + + +G H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSE-ASIMGQFSHHNII 69
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L + ++I +Y NG+L + L+ +A G+ Y+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR-DHDGEFSSYQLVGMLR---GIAAGMKYLSD 125
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----------LLYKAP 555
VH +L + N+L+ + E ++D+ L+ + +DDP+ + + AP
Sbjct: 126 M-NYVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWTAP 179
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPP 586
E A + TS SDV+SFG+++ E+++ G+ P
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR----HPNLV 445
E++G G+ G YK V +L A K+ + + E+ + L+ H N+
Sbjct: 22 EVVGNGTYGQVYKGRH-----VKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 446 PLRAYFQAK------EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
F K ++ L+ ++ GS+ L+ K+T+ L I ++ +G
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDWIAYICREILRG 133
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPET 557
L+++H A +++H ++K NVLL + E L D+ ++A ++ + + APE
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 558 ----RNASHQATSKSDVYSFGVLLLELLTGKPP--SQHS----FLVP 594
N +SD++S G+ +E+ G PP H FL+P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 391 LLGKGSLGTTYKAVLDNRLIVCVKRLDAS------KLAGTSNEMYEQHMESV--GGLRHP 442
++G+GS G L+V D +L +S+ + + E+V ++HP
Sbjct: 7 VVGEGSFGRA--------LLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N+V + F+A ++ +Y G L I K R K + L+ + G+ +
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQDDDPDNLLYKAPET-RN 559
IH+ R++H ++KS N+ L + + L D+ L + Y PE N
Sbjct: 116 IHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQ 588
+ +KSD++S G +L EL T K P Q
Sbjct: 175 MPYN--NKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 392 LGKGSLGTTYKA------------VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL 439
+GKGS G A VL + I+ K+ + + N + + +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVL-------LKNV 53
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDV 496
+HP LV L FQ ++ + DY G LF + +S RA+ A ++
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEI 105
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----- 551
A L Y+H +++ +LK N+LL L D+ L + ++ +
Sbjct: 106 ASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDF---GLCKEGIEHSKTTSTFCGTPE 161
Query: 552 YKAPETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE Q ++ D + G +L E+L G PP
Sbjct: 162 YLAPEV--LRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 32/275 (11%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPN---LVP 446
LG+GS G Y+ + + + A K + M E + + ++ N +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS-TRAKPLHWTSCLK----IAEDVAQGLS 501
L + L+I + G L S + + P+ LK +A ++A G++
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD----DPDNLL---YKA 554
Y++ A + VH +L + N ++ DF + D+ +T D + D LL + +
Sbjct: 134 YLN-ANKFVHRDLAARNCMVAEDFTVKIGDF---GMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSA---REDDGA 610
PE+ T+ SDV+SFGV+L E+ T + P Q + +++ +V + D
Sbjct: 190 PESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQG--MSNEQVLRFVMEGGLLDKPDNC 246
Query: 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
D ML E+ C +P+ RP+ +++ ++E
Sbjct: 247 PD----MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 430 EQHMES----VGGLRHPNLVPLRAYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKP 483
EQH+ + + + HP ++ R ++ ++R L + +Y P G LFS + S
Sbjct: 45 EQHVHNEKRVLKEVSHPFII--RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-- 100
Query: 484 LHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543
++ L A ++ L Y+H +V+ +LK N+LL + L D+ A L+
Sbjct: 101 ---STGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGF----AKKLR 152
Query: 544 D------DDPDNLLYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
D P+ Y APE ++ H D ++ G+L+ E+L G PP
Sbjct: 153 DRTWTLCGTPE---YLAPEVIQSKGHN--KAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 44/148 (29%), Positives = 61/148 (41%), Gaps = 8/148 (5%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
+SL+ L L L L NN L + L NL++L L +N S SL SL L+ L
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLREL 282
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS-LKIFNVSGNNFTG---A 213
DLS N+LS LP L + L L L +S L N+ N T A
Sbjct: 283 DLSGNSLSNALP--LIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340
Query: 214 ITVTSTLSRFGISSFLFNPSLCGEIIHK 241
+++ +L+ + S I K
Sbjct: 341 LSILESLNNLWTLDNALDESNLNRYIVK 368
|
Length = 394 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 64/236 (27%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 447 LRAYFQAKEERLLIYDYQPNGS---LFSLIHGSKSTRAKPLH-----WTSCLKIAE---- 494
R F+A E+ + G LFS S S P W S L + +
Sbjct: 120 QRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICY 179
Query: 495 --DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD------ 546
VA+G+ ++ + + +H +L + N+LL E + C L D +D D
Sbjct: 180 SFQVARGMEFL-ASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 547 ---PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVR 602
P L + APE+ T++SDV+SFGVLL E+ + G P P +N
Sbjct: 236 ARLP--LKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASP------YPGVQINEEF 286
Query: 603 SAREDDG----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654
R DG A + + + +AC P++RPT L EI G +L E+
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----FSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 392 LGKGSLGTT----YKAVLDNR-LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
LG+G G Y DN V VK L ++ ++ +E + L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE-IEILRNLYHENIVK 70
Query: 447 LRAYFQAKEER--LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ LI ++ P+GSL + +K+ ++ LK A + +G+ Y+
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYL- 125
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTAD----SLQDDDPDNLLYKAPETRN 559
+ + VH +L + NVL+ + + + D+ LT A+ D +++DD + + APE
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 560 ASHQATSKSDVYSFGVLLLELLT 582
S + SDV+SFGV L ELLT
Sbjct: 186 QS-KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 392 LGKGSLGTTYKAVLDNRL---IVCVKRL-DASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
LG G+ GT K + + V VK L + + +E+ + + L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLRE-ANVMQQLDNPYIVRM 61
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+A E +L+ + G L + +K K + ++ V+ G+ Y+ +
Sbjct: 62 IGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEET- 114
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADS----LQDDDPDNLLYKAPETRNASH 562
VH +L + NVLL A ++D+ L+ AL AD + + + APE N +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YY 173
Query: 563 QATSKSDVYSFGVLLLELLT-GKPP 586
+ +SKSDV+SFGVL+ E + G+ P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 392 LGKGSLGTTY-----KAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMES--VGGLRHPNL 444
LGKGS GT Y KAV + RL V +K + +L NE + + E+ + L HP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ---GLS 501
V A F ++ +I +Y L + K T S ++ E Q G+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQVCEWFIQLLLGVH 120
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDDDPDNLLYKAPETRN 559
Y+HQ R++H +LK+ N+ L + + D+ ++ L S L Y +PE
Sbjct: 121 YMHQR-RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-- 176
Query: 560 ASHQA-TSKSDVYSFGVLLLEL 580
HQ SKSD++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 29/61 (47%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 106 QLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
L+ L L NN LT IPD GL NLK L L N T P + L L++LDLS NN
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 164 L 164
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 59/269 (21%), Positives = 113/269 (42%), Gaps = 27/269 (10%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+GKG YKA+ L + +V +K++ ++ + + + ++ + L HPN++ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
F E ++ + G L +I K + + + + K + L ++H R+
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSALEHMHSK-RI 127
Query: 510 VHGNLKSSNVLLGPDFEACLADYCL------TALTADSLQDDDPDNLLYKAPETRNASHQ 563
+H ++K +NV + L D L A SL Y +PE R +
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP----YYMSPE-RIHENG 182
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE------DERLGM 617
KSD++S G LL E+ + P + MN ++ + + D
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ++ C + PE+RP + VL++ +E+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ--- 498
PN+V L Y +++ L+ + G L+S H + L I E+ +
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWS-------------HISKFLNIPEECVKRWA 91
Query: 499 -----GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK 553
L +H+ +V +L +N+LL L + + DS + +N+ Y
Sbjct: 92 AEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-YC 149
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588
APE S + T D +S G +L ELLTGK +
Sbjct: 150 APEVGGISEE-TEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 30/268 (11%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
E LG+ + G YK L D+ +V +K L E ++Q + L HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNI 69
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKS----------TRAKPLHWTSCLKI 492
V L ++ ++++Y G L F ++ S T L L I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLL 551
A +A G+ Y+ + VH +L + N+L+G ++D L+ + + P +LL
Sbjct: 130 AIQIAAGMEYLSSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 552 ---YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD 608
+ PE + +S SD++SFGV+L E+ + + F E++ VR +
Sbjct: 189 PIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF-SNQEVIEMVRKRQLLP 246
Query: 609 GAED--ERLGMLLEVAIACNSASPEQRP 634
+ED R+ L+ C P +RP
Sbjct: 247 CSEDCPPRMYSLM---TECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
R P LV L FQ + LI DY G LF+ ++ + + + IAE V
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVR----VYIAEIVL-A 117
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQ--DDDPDNLLYKAPE 556
L ++HQ +++ ++K N+LL + L D+ L+ A+ + + Y APE
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 557 TRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
K+ D +S GVL ELLTG P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 28/193 (14%)
Query: 411 VCVKRLDASKLAGTSNEMY-----EQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465
V V+R++ L +NEM E H+ + HPN+VP RA F A E ++ +
Sbjct: 28 VTVRRIN---LEACTNEMVTFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 466 NGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523
GS LI H + + I + V + L YIH VH ++K+S++L+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHHM-GYVHRSVKASHILISV 136
Query: 524 DFEACLADY--CLTALTADSLQ---DDDPDN----LLYKAPETRNASHQA-TSKSDVYSF 573
D + L+ L+ + D P L + +PE + Q +KSD+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 574 GVLLLELLTGKPP 586
G+ EL G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 17/154 (11%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
L+HP LV L FQ E+ + DY G LF + + + A +VA
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVAS 107
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YK 553
+ Y+H + +++ +LK N+LL L D+ L + ++ ++ + Y
Sbjct: 108 AIGYLH-SLNIIYRDLKPENILLDSQGHVVLTDF---GLCKEGVEPEETTSTFCGTPEYL 163
Query: 554 APET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE R + T D + G +L E+L G PP
Sbjct: 164 APEVLRKEPYDRT--VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 391 LLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA----GTSNEMYEQH-MESVGGLRH 441
+LGKG G ++ D I +K L + + T++ E++ +E+V +H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV---KH 59
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P +V L FQ + LI +Y G LF +H + + T+C ++E ++ L
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLER--EGIFMEDTACFYLSE-ISLALE 114
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPE--T 557
++HQ +++ +LK N+LL L D+ C ++ ++ + Y APE
Sbjct: 115 HLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP 586
R+ +A D +S G L+ ++LTG PP
Sbjct: 174 RSGHGKAV---DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 51/233 (21%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT--SCLKIA 493
+G HPN++ L + +++ +Y NGSL + + R +T + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGML 112
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN---- 549
+A G+ Y+ VH +L + N+L+ + ++D+ L+ + +DDP+
Sbjct: 113 RGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEAAYTT 166
Query: 550 ------LLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVR 602
+ + APE A + TS SDV+S+G+++ E+++ G+ P W
Sbjct: 167 RGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPY------------WEM 213
Query: 603 SAREDDGAEDE--RL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
S ++ A +E RL L ++ + C +RP Q++ +L ++
Sbjct: 214 SNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 15/152 (9%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+HP L L FQ K+ + +Y G L I R++ A +V
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-----RSRKFDEPRSRFYAAEVTLA 108
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD---DPDNLLYKA 554
L ++H+ +++ +LK N+LL + LAD+ C + PD Y A
Sbjct: 109 LMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD---YIA 164
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE S D ++ GVL+ E++ G+PP
Sbjct: 165 PEILQELEYGPS-VDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 391 LLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA---------GTSNEMYEQHMESVGGLRH 441
+LGKGS G K +L R L A K+ M E+ + ++ G +
Sbjct: 7 VLGKGSFG---KVMLAER--KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KP 60
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P L L + FQ + + +Y G L + H + + K H + A ++A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPH---AVFYAAEIAIGLF 115
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLLYK 553
++H +++ +LK NV+L + +AD+ + +++ PD Y
Sbjct: 116 FLHSK-GIIYRDLKLDNVMLDAEGHIKIADF---GMCKENIFGGKTTRTFCGTPD---YI 168
Query: 554 APETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
APE ++Q KS D ++FGVLL E+L G+PP
Sbjct: 169 APEI--IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 391 LLGKGSLGTTYKAVLDNRL----IVCVKRLDASKLAGTSN---EMYEQHMESVGGLRHPN 443
+LGKGS G K +L R + +K L + + M E+ + ++ G + P
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPF 62
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
L L + FQ + + +Y G L + + R K H + A ++A GL ++
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPH---AVFYAAEIAIGLFFL 117
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--------DPDNLLYKAP 555
H +++ +LK NV+L + +AD+ + +++ D PD Y AP
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGHIKIADF---GMCKENMWDGVTTKTFCGTPD---YIAP 170
Query: 556 ETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
E ++Q KS D ++FGVLL E+L G+ P
Sbjct: 171 EI--IAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
LR Y +A+ + Y Y P + L + + A VA+G+ Y+
Sbjct: 111 LREYLRARRPPGMEYCYNPT-----------QVPEEQLSFKDLVSCAYQVARGMEYLASK 159
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSLQDDDPDNLLYK--APET---RN 559
+ +H +L + NVL+ D +AD+ L D + L K APE R
Sbjct: 160 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218
Query: 560 ASHQATSKSDVYSFGVLLLELLT--GKP-PSQHSFLVP-NEMMNWVRSAREDDGAED--E 613
+HQ SDV+SFGVLL E+ T G P P VP E+ ++ D +
Sbjct: 219 YTHQ----SDVWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPSNCTN 269
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L M++ C A P QRPT Q+++ L I
Sbjct: 270 ELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 49/202 (24%), Positives = 76/202 (37%), Gaps = 52/202 (25%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR-----AKPLH-WTSC--- 489
L HP +VP+ + + +Y P ++L KS +K L TS
Sbjct: 59 LIHPGIVPV---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--- 546
L I + + Y+H L H +LK N+LLG E + D+ A+ ++D
Sbjct: 116 LSIFHKICATIEYVHSKGVL-HRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDI 173
Query: 547 ---------------------PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--- 582
PD Y APE R A+ +D+Y+ GV+L ++LT
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPD---YMAPE-RLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 583 -------GKPPSQHSFLVPNEM 597
K + L P E+
Sbjct: 230 PYRRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 390 ELLGKGSLGTTYKAVLDNR-LIVCVKRLDASKLAGTSN---EMYEQHMESVGGLRHPNLV 445
++LGKGS G A L + VK L + + M E+ + ++ +P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLT 59
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L FQ KE + ++ G L + H R T A ++ GL ++H
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATF---YAAEIVCGLQFLHS 114
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD---DPDNLLYKAPETRNA 560
+++ +LK NV+L D +AD+ C + D+ PD Y APE
Sbjct: 115 KG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD---YIAPEILQG 170
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
+ T D +SFGVLL E+L G+ P
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 390 ELLGKGSLGTTYKAVLDNRL---IVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
E +G+G+ G YKA N+L +V +K RLD S + E + + L HPN+
Sbjct: 6 EKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIRE--ISLLKELNHPNI 61
Query: 445 VPLRAYFQAKEERLLIYDY------------QPNGSLFSLIHGSKSTRAKPLHWTSCLKI 492
V L + + L++++ +G LI KS + L
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLI---KSYLFQLL-------- 110
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NL 550
QGL++ H + R++H +LK N+L+ + LAD+ L ++ + L
Sbjct: 111 -----QGLAFCH-SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 164
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGK 584
Y+APE ++ D++S G + E++T +
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 34/271 (12%)
Query: 392 LGKGSLGTTYKAVLDNR--LIVCVKRLDAS---KLAGTSNEMYEQHMESVGGLR---HPN 443
LG+G+ YK VL + L + + S K+ G+ + E+ + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
LV L +E +++ +Y G L +H + LHW L +A+ +A L Y+
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH--REKNNVSLHWK--LDVAKQLASALHYL 117
Query: 504 HQAWRLVHGNLKSSNVLL-------GPDFEACLAD--YCLTALTADSLQDDDPDNLLYKA 554
+LVHGN+ N+L+ G L+D +T L+ + + P + A
Sbjct: 118 EDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIA 172
Query: 555 PE-TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612
PE RN T +D +SFG LLE+ + G+ P S L +E + + +
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEP--LSTLSSSEKERFYQDQHRLPMPDC 230
Query: 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKML 643
L L+ C + P +RP+ +L+ L
Sbjct: 231 AELANLIN---QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
L+G+GS G K + IV +K+ S+ ++ + + + LRH NLV L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 449 AYFQAKEERLLIYDYQPNGSLFSL---IHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
F+ K+ L++++ + L L +G +R + + + +G+ + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHS 118
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAPETRNASH 562
++H ++K N+L+ L D+ A T + + D + Y+APE
Sbjct: 119 H-NIIHRDIKPENILVSQSGVVKLCDFGF-ARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 563 QATSKSDVYSFGVLLLELLTGKP----------------------PSQHSFLVPNEMMNW 600
+ D+++ G L+ E+LTG+P P N +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 601 VR--SAREDDGAEDERL----GMLLEVAIACNSASPEQRPTMWQVLK 641
+R +E + E +R G++L++A C P+ RP+ Q+L
Sbjct: 237 MRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P LV L FQ + LI DY G LF+ H S+ R K + E + L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQ--IYSGE-IVLALE 119
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP------DNLLYKAP 555
++H+ +++ ++K N+LL + L D+ L+ + +D+ + Y AP
Sbjct: 120 HLHKL-GIIYRDIKLENILLDSNGHVVLTDF---GLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 556 ETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
+ K+ D +S GVL+ ELLTG P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 13/112 (11%)
Query: 489 CLKIAEDVAQ--------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540
C K+ +D Q GL YIH A ++H +LK SN+ + D E + D+ L T D
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK---PPSQH 589
+ Y+APE D++S G ++ ELLTG+ P + H
Sbjct: 173 EMTGYVATR-WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 44/203 (21%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKL----AGTSNEMYEQHMESVGGLRHPNLVPL 447
+G G+ G YKA V L A K+ G + +Q + + +H N+V
Sbjct: 17 IGSGTYGDVYKA-----RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ +++ + ++ GSL + H + PL + ++ + QGL Y+H
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG 126
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPETRNASHQA- 564
++ H ++K +N+LL + LAD+ ++A ++ + APE +
Sbjct: 127 KM-HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 565 -TSKSDVYSFGVLLLELLTGKPP 586
D+++ G+ +EL +PP
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 390 ELLGKGSLGTTY--KAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMES-----VGGLRHP 442
+++GKGS G K LD + VK L + N ++H+ + + ++HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYA-VKVLQKKIVL---NRKEQKHIMAERNVLLKNVKHP 56
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDVAQG 499
LV L FQ E+ + D+ G LF + +S RA+ AE +A
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRAR-------FYAAE-IASA 108
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKA 554
L Y+H + +V+ +LK N+LL L D+ L + + D Y A
Sbjct: 109 LGYLH-SINIVYRDLKPENILLDSQGHVVLTDF---GLCKEGIAQSDTTTTFCGTPEYLA 164
Query: 555 PET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE R + T D + G +L E+L G PP
Sbjct: 165 PEVIRKQPYDNT--VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 34/149 (22%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
+ HP+++ ++ + ++ + + L++ + + R++PL L I + + +
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYL----TKRSRPLPIDQALIIEKQILE 168
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL------LY 552
GL Y+H R++H ++K+ N+ + + C+ D L A P L
Sbjct: 169 GLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGD-----LGAAQFPVVAPAFLGLAGTVET 222
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELL 581
APE A + SK+D++S G++L E+L
Sbjct: 223 NAPEVL-ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG-------LRHP 442
L+G GS G+ Y + + ++ VK+++ ++ +S + ++++ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 443 NLVPLRAYF--QAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
N+V Y + L I+ +Y P GS+ +L+ T + +G
Sbjct: 67 NIV---QYLGSSLDADHLNIFLEYVPGGSVAALL-----NNYGAFEETLVRNFVRQILKG 118
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDPDN-------LL 551
L+Y+H ++H ++K +N+L+ ++D+ ++ L A+SL +
Sbjct: 119 LNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 552 YKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ APE + S+ T K+D++S G L++E+LTGK P
Sbjct: 178 WMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 491 KIAEDVAQ--------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
K++ED Q GL YIH A ++H +LK N+ + D E + D+ L A DS
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGL-ARQTDSE 171
Query: 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE T D++S G ++ E+LTGKP
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 49/205 (23%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 392 LGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPL 447
+G+GS G A V VK++D K + E V +R HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + +E ++ ++ G+L ++ TR ++ + V + LS++H A
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIV---THTR---MNEEQIATVCLAVLKALSFLH-AQ 134
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLL----YKAPETRNAS 561
++H ++KS ++LL D L+D+ A + + P +L+ + APE +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCA----QVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
T + D++S G++++E++ G+PP
Sbjct: 191 PYGT-EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 63/262 (24%), Positives = 116/262 (44%), Gaps = 28/262 (10%)
Query: 392 LGKGSLG--TTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+GKGS G + + D + V +K+L+ + + EQ + + L+HPN+V R
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 450 YFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
++ ++ L ++ + G L+ H K + K L ++ +A L Y+H+
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-H 122
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPETRNASHQA 564
++H +LK+ NV L + D + + + Q D L+ Y +PE ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELF-SNKPY 179
Query: 565 TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-----DERLGMLL 619
KSDV++ G + E+ T K H+F +M + V E LG L+
Sbjct: 180 NYKSDVWALGCCVYEMATLK----HAFNA-KDMNSLVYRIIEGKLPPMPKDYSPELGELI 234
Query: 620 EVAIACNSASPEQRPTMWQVLK 641
+ S PE+RP++ +L+
Sbjct: 235 ATML---SKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLV--NLKSLFLDHNFFTGSFPPSLLSLHRLK 155
+ L +L L L L NN++T IP L GL+ NLK L L N S P L +L LK
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ--SSLKIFNVSGNN---F 210
LDLS+N+LS LPK L++ L +L L N+ + +PP + S+L+ ++S N+
Sbjct: 167 NLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL 224
Query: 211 TGAITVTSTLSRFGISSFLFNPSLCGE 237
+++ LS +S+
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPESI 251
|
Length = 394 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 390 ELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMES---VGGLRHP 442
E++G G G + L + V +K L + G + + + +G HP
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHP 65
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N++ L ++I ++ NG+L S + + + L+ +A G+ Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLR---GIAAGMKY 121
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-------YKAP 555
+ + VH +L + N+L+ + ++D+ L+ D D + L + AP
Sbjct: 122 LSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPP 586
E A + TS SDV+S+G+++ E+++ G+ P
Sbjct: 181 EAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGP--DFEACLADYCLTALTADSLQDDDPDNLL----- 551
GL YIH A ++H +LK SN+LL D + C D+ L + + D L
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNTNCDLKIC--DFGLARIAD---PEHDHTGFLTEYVA 171
Query: 552 ---YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP--PSQH 589
Y+APE S T D++S G +L E+L+ +P P +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
+G G+ G YKA L + VK + G + +Q + V +H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLV 510
+ ++E+ + +Y GSL + H + PL + + QGL+Y+H ++
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKM- 128
Query: 511 HGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDPDNLLY-KAPET----RNASHQA 564
H ++K +N+LL + + LAD+ + A +TA + Y APE +N +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 565 TSKSDVYSFGVLLLELLTGKPP 586
D+++ G+ +EL +PP
Sbjct: 189 L--CDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT--ALTADSLQDDDPDNL 550
A VA+G+ Y+ + + +H +L + NVL+ D +AD+ L D + L
Sbjct: 140 AYQVARGMEYL-ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 551 LYK--APET---RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
K APE R +HQ SDV+SFGVLL E+ T S + + E+ ++
Sbjct: 199 PVKWMAPEALFDRVYTHQ----SDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLKEGH 253
Query: 606 EDDGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
D + L M++ C A P QRPT Q+++ L +
Sbjct: 254 RMDKPANCTHELYMIMR---ECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 15/151 (9%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HP LV L + FQ + + +Y G L + H + + H + +++ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEH---ARFYSAEISLAL 109
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAP 555
+Y+H+ +++ +LK NVLL + L DY + + L+ D + Y AP
Sbjct: 110 NYLHER-GIIYRDLKLDNVLLDSEGHIKLTDY---GMCKEGLRPGDTTSTFCGTPNYIAP 165
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E S D ++ GVL+ E++ G+ P
Sbjct: 166 EILRGEDYGFS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 390 ELLGKGSLGTTYKAVLDNR--LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +GKG+ G YK V + + + VK LD E ++S+ HPN+V
Sbjct: 28 ETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN--HPNVVKF 84
Query: 448 RAYFQAKEERL-----LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
F ++ + L+ + GS+ L+ G + L I GL +
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQH 143
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDP-DNLLYKAPETRNA 560
+H R++H ++K +N+LL + L D+ ++A LT+ L+ + + APE
Sbjct: 144 LHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 561 SHQATS----KSDVYSFGVLLLELLTGKPP 586
Q + DV+S G+ +EL G PP
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+G+ G YKA D +V +K RLD K + E ++ + L H N+V L+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE--IKILRQLNHRNIVNLK 72
Query: 449 AYFQAKEERL----------LIYDYQPN---GSLFS-LIHGSKSTRAKPLHWTSCLKIAE 494
K++ L L+++Y + G L S L+H S+ H S +K
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED------HIKSFMK--- 123
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL-TADS--LQDDDPDNLL 551
+ +GL+Y H+ +H ++K SN+LL + LAD+ L L ++ + L
Sbjct: 124 QLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 552 YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+ PE + DV+S G +L EL T KP
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAP 555
GL YIH A ++H +LK SN+LL + + + D+ L A T D + ++ Y+AP
Sbjct: 120 GLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSEKGDFMTEYVVTRWYRAP 177
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKP 585
E + T+ DV+S G + ELL KP
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 41/270 (15%)
Query: 403 AVLDNRLIVCVKRL--DASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLI 460
D ++V VK L DAS + E + + ++ + L PN+ L +I
Sbjct: 41 DNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMI 97
Query: 461 YDYQPNGSL--FSLIH----GSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNL 514
+Y NG L F H + +K L +++ L +A +A G+ Y+ VH +L
Sbjct: 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDL 156
Query: 515 KSSNVLLGPDFEACLADY--CLTALTAD--SLQDDDPDNLLYKAPE----TRNASHQATS 566
+ N L+G ++ +AD+ ++D +Q P + + A E + T+
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-----FTT 211
Query: 567 KSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMM--NWVRSAREDDGAEDERLGM----- 617
KSDV++FGV L E+LT + P +H + ++ + N R+D L
Sbjct: 212 KSDVWAFGVTLWEILTLCREQPYEH---LTDQQVIENAGHFFRDDGR--QIYLPRPPNCP 266
Query: 618 --LLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ E+ + C E RPT ++ LQ
Sbjct: 267 KDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 48/221 (21%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 369 LVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNR-LIVCVKRLDASKLAGTSNE 427
+V G+ + Y LD ++ +G+GS G A + + +V VK++D K E
Sbjct: 11 MVVDPGDPRTY-LDNFIK-----IGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRE 62
Query: 428 MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT 487
+ + + +H N+V + + +E ++ ++ G+L ++ ++ +
Sbjct: 63 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--A 120
Query: 488 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547
CL V + LS +H A ++H ++KS ++LL D L+D+ A + +
Sbjct: 121 VCLA----VLKALSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 548 --DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ APE + + D++S G++++E++ G+PP
Sbjct: 176 LVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 40/178 (22%), Positives = 83/178 (46%), Gaps = 12/178 (6%)
Query: 411 VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLF 470
V VK++D K E+ + + H N+V + + +E ++ ++ G+L
Sbjct: 50 VAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 471 SLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLA 530
++ ++ + T CL V + LSY+H ++H ++KS ++LL D L+
Sbjct: 108 DIVTHTRMNEEQIA--TVCLS----VLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLS 160
Query: 531 DYCLTALTADSLQDDDP--DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
D+ A + + + APE + T + D++S G++++E++ G+PP
Sbjct: 161 DFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLV 510
F++ ++ LLI +Y G L I P + + L +H +++
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL-PFQEYEVGLLFYQIVLALDEVHSR-KMM 191
Query: 511 HGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL----LYKAPETRNASHQATS 566
H +LKS+N+ L P L D+ + +DS+ D + Y APE + +
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE-RKRYSK 250
Query: 567 KSDVYSFGVLLLELLT----GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM--LLE 620
K+D++S GV+L ELLT K PSQ E+M V + D GM LL+
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYDPFPCPVSSGMKALLD 304
Query: 621 VAIACNSASPEQRPTMWQVL 640
+ S +P RPT Q+L
Sbjct: 305 PLL---SKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 35/162 (21%)
Query: 439 LRHPNLVPLRAYFQAKEERL----LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAE 494
+H N++ +R + ++ D + L +IH + PL E
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PL--------TE 106
Query: 495 DVAQ--------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546
+ + GL YIH A ++H +LK SN+L+ D E + D+ + A S +
Sbjct: 107 EHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGM-ARGLSSSPTEH 164
Query: 547 PD-------NLLYKAPETRNASHQATSKSDVYSFGVLLLELL 581
Y+APE + + T+ D++S G + E+L
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPNLVP 446
+++GKGS G A VK L + E + +V ++HP LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSK---STRAKPLHWTSCLKIAEDVAQGLSYI 503
L FQ ++ + DY G LF + + RA+ A ++A L Y+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR--------FYAAEIASALGYL 112
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPETRNAS 561
H + +V+ +LK N+LL L D+ C + + Y APE +
Sbjct: 113 H-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-- 169
Query: 562 HQATSKS-DVYSFGVLLLELLTGKPP 586
Q ++ D + G +L E+L G PP
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETR 558
GL YIH A ++H +LK SN+ + D E + D+ L A D Y+APE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGL-ARHTDDEMTGYVATRWYRAPEIM 187
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKP 585
D++S G ++ ELLTGK
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 38/194 (19%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P +V L FQ +E L+ +Y P G L +L+ + P IAE V L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVF-PEETARFY-IAELVL-ALD 115
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA----------LTADSLQDDDPDNLL 551
+H+ +H ++K N+L+ D LAD+ L DS DN+L
Sbjct: 116 SVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 552 YKAPETRNASHQATS--------------------KSDVYSFGVLLLELLTGKPP--SQH 589
+ + + +A S + D +S GV+L E+L G PP S
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 590 SFLVPNEMMNWVRS 603
N+++NW S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQH--MESVGGLRHP 442
++LG G+ GT YK + ++ V +K L + + E+ ++ M SV +P
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV---DNP 69
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKP--LHWTSCLKIAEDVAQGL 500
++ L +L I P G L + K L+W C++IA +G+
Sbjct: 70 HVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----KGM 122
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL-TADSLQ---DDDPDNLLYKAPE 556
+Y+ + RLVH +L + NVL+ + D+ L L AD + + + + A E
Sbjct: 123 NYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 557 T---RNASHQATSKSDVYSFGVLLLELLT-GKPP 586
+ R +HQ SDV+S+GV + EL+T G P
Sbjct: 182 SILHRIYTHQ----SDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 62/242 (25%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEM----YEQHMESVGGLRHPNL 444
+LLGKG +G + L + +K LD ++ N++ EQ + + L HP L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILAT--LDHPFL 63
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ------ 498
L A FQ + L+ DY P G LF L+ + +P CL E+VA+
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLL------QRQP---GKCLS--EEVARFYAAEV 112
Query: 499 --GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL-------TALTADSLQDDDPDN 549
L Y+H +V+ +LK N+LL L+D+ L + +L+ +
Sbjct: 113 LLALEYLH-LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 550 LL------------------------YKAPET-RNASHQATSKSDVYSFGVLLLELLTGK 584
+ Y APE H S D ++ G+LL E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEMLYGT 229
Query: 585 PP 586
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN--------- 549
GL YIH A ++H +LK N+L+ D E + D+ L A ++ +N
Sbjct: 117 GLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGL----ARGFSENPGENAGFMTEYVA 171
Query: 550 -LLYKAPETRNASHQATSKS-DVYSFGVLLLELLTGKP 585
Y+APE S Q+ +K+ DV+S G +L ELL KP
Sbjct: 172 TRWYRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 42/277 (15%)
Query: 392 LGKGSLGTTYKAVL------DNRLIVCVKRLDAS-KLAGTSNEMYEQHMESVGGLRHPNL 444
LG G+ G +A D + V VK L + + M E + S G H N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHENI 101
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
V L L+I +Y G L + + R L L + VA+G++++
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK----------A 554
+ +H +L + NVLL + C L D + D N + K A
Sbjct: 158 ASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS---NYVVKGNARLPVKWMA 211
Query: 555 PETRNASHQATSKSDVYSFGVLLLEL--LTGKP----PSQHSFLVPNEMMNWVRSAREDD 608
PE+ + T +SDV+S+G+LL E+ L P P F + R A+ +
Sbjct: 212 PESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--KLIKEGYRMAQPEH 268
Query: 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ + ++ C A P +RPT Q+++++ +
Sbjct: 269 APAE-----IYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 35/149 (23%), Positives = 63/149 (42%), Gaps = 9/149 (6%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
RHP L L+ FQ K+ + +Y G LF + +R + ++
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSA 107
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDDPDNLLYKAPET 557
L Y+H ++V+ +LK N++L D + D+ C +T + Y APE
Sbjct: 108 LDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ + D + GV++ E++ G+ P
Sbjct: 167 LEDNDYGRA-VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 60/292 (20%), Positives = 104/292 (35%), Gaps = 52/292 (17%)
Query: 390 ELLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG---GLRHPNLV 445
++G+G+ G K IV +K+ K + ++ + + V LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF---KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L+ F+ K L+++Y L L S P + Q ++Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVR--SYIWQLLQAIAYCHS 118
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-------YKAPETR 558
++H ++K N+L+ L D+ A +L+ L Y+APE
Sbjct: 119 H-NIIHRDIKPENILVSESGVLKLCDFGF----ARALRARPASPLTDYVATRWYRAPELL 173
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKP----------------------PSQHSFLVPNE 596
DV++ G ++ ELL G+P PS N
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233
Query: 597 MMNWVR--SAREDDGAEDERLGMLLEVAI----ACNSASPEQRPTMWQVLKM 642
V + + E G + A+ AC P++R T ++L+
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 47/265 (17%)
Query: 411 VCVKRL--DASK--LAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466
V VK L DA++ L+ +EM + M+ +G +H N++ L +I +Y
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEM--EMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 467 GSLFSLIHGSKS---------TRA--KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLK 515
G+L + + R + + + + VA+G+ Y+ + + +H +L
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL-ASQKCIHRDLA 164
Query: 516 SSNVLLGPDFEACLADYCLT--ALTADSLQDDDPDNLLYK--APET---RNASHQATSKS 568
+ NVL+ + +AD+ L D + L K APE R +HQ S
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ----S 220
Query: 569 DVYSFGVLLLELLT--GKP----PSQHSFLVPNEMMNWVRSAREDDGAE-DERLGMLLEV 621
DV+SFGVL+ E+ T G P P + F + E R D A L M++
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE------GHRMDKPANCTNELYMMMR- 273
Query: 622 AIACNSASPEQRPTMWQVLKMLQEI 646
C A P RPT Q+++ L I
Sbjct: 274 --DCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 3/113 (2%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
P+ L L L+ L L N L+ LS L NL +L L N + PP + L L+ L
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNN 209
DLS N++ L L++ L L L N+ + N S+L+ ++S N
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 44/194 (22%), Positives = 80/194 (41%), Gaps = 9/194 (4%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
+G L + + L + + K + + Y + ++ + LRH N++ L F
Sbjct: 20 MGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLRHENIISLSDIF 78
Query: 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVH 511
+ E + L L+ ++PL + +GL Y+H A +VH
Sbjct: 79 ISPLEDIYFVTELLGTDLHRLL------TSRPLEKQFIQYFLYQILRGLKYVHSA-GVVH 131
Query: 512 GNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVY 571
+LK SN+L+ + + + D+ L A D Y+APE + + D++
Sbjct: 132 RDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190
Query: 572 SFGVLLLELLTGKP 585
S G + E+L GKP
Sbjct: 191 SAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 15/151 (9%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P LV L FQ + + LI DY G +F+ ++ + + + S ++ L
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS-----GEIILALE 119
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP------DNLLYKAP 555
++H+ +V+ ++K N+LL + L D+ L+ + L ++ + Y AP
Sbjct: 120 HLHKL-GIVYRDIKLENILLDSEGHVVLTDF---GLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E D +S G+L+ ELLTG P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 28/220 (12%)
Query: 392 LGKGSLGTTY--KAVLDNRLIV--CVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
LG G G K NR CVK+ + E E + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F+ K+ ++ +Y G L++++ R +T+ IA V Y+H
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIAC-VVLAFEYLHNR- 112
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLLYKAPETRN 559
+++ +LK N+LL + L D+ A L+ P+ Y APE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFG----FAKKLKSGQKTWTFCGTPE---YVAPEIIL 165
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599
S D +S G+LL ELLTG+PP P E+ N
Sbjct: 166 NKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYN 204
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
PL L+ + VAQG+ ++ + +H ++ + NVLL A + D+ L D +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDF---GLARDIM 263
Query: 543 QDDDPDNLLYK----------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSF 591
D N + K APE+ T +SDV+S+G+LL E+ + GK P
Sbjct: 264 NDS---NYVVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYP-GI 318
Query: 592 LVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648
LV ++ V+ + + + + C + P +RPT Q+ +++Q G
Sbjct: 319 LVNSKFYKMVKRGYQMSRPDFAPPEI-YSIMKMCWNLEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC--LADYCLTALTADSL-QDDDP 547
KIA + L+Y+ + +++H ++K SN+LL D L D+ ++ DS+ + D
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAKTRDA 168
Query: 548 DNLLYKAPETRNASHQATS--KSDVYSFGVLLLELLTGKPP 586
Y APE + S + +SDV+S G+ L E+ TGK P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 60/269 (22%), Positives = 105/269 (39%), Gaps = 32/269 (11%)
Query: 390 ELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
E +G+G+ G + L DN V VK + L + Q + HPN+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTP-VAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
K+ ++ + G + + T L +++ E+ A G+ Y+ ++
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYL-ESK 113
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD----NLLYKAPETRNASHQ 563
+H +L + N L+ ++D+ ++ D + + + APE N +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-R 172
Query: 564 ATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED-------DGAEDERL 615
+S+SDV+SFG+LL E + G P N R A E + D
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP------YANLSNQQTREAIEQGVRLPCPELCPDAVY 226
Query: 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
++ C P QRP+ V + LQ
Sbjct: 227 RLMER----CWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 391 LLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+LG G+ GT YK + + ++ V +K L + + E+ ++ + G+ P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY-VMAGVGSPYVC 72
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKP--LHWTSCLKIAEDVAQGLSYI 503
L +L + P G L + +K L+W C++IA +G+SY+
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW--CVQIA----KGMSYL 125
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPET-- 557
+ RLVH +L + NVL+ + D+ L L + D + + A E+
Sbjct: 126 EEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 558 -RNASHQATSKSDVYSFGVLLLELLT-GKPP 586
R +HQ SDV+S+GV + EL+T G P
Sbjct: 185 HRRFTHQ----SDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESV-----------GGLR 440
+G G+ GT YK + RL A K+ +Y H ++V +
Sbjct: 82 IGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHEDTVRRQICREIEILRDVN 130
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HPN+V F E ++ ++ GSL + T + + +A + G+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLA--DVARQILSGI 181
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAP 555
+Y+H+ +VH ++K SN+L+ +AD+ ++ + A Q DP N + Y +P
Sbjct: 182 AYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPCNSSVGTIAYMSP 237
Query: 556 ETRNA--SHQATS--KSDVYSFGVLLLELLTGKPP 586
E N +H A D++S GV +LE G+ P
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 390 ELLGKGSLGTTYKAVLD--NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVP 446
E +GKG+ G +K VL+ N VK LD +E E + L HPN+V
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVK 79
Query: 447 LRAYFQAKEER-----LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+ K+ + L+ + GS+ L+ G R + + I + GL
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQ 138
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDDP-DNLLYKAPETRN 559
++H + +H ++K +N+LL + L D+ ++A LT+ L+ + + APE
Sbjct: 139 HLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 560 ASHQATS----KSDVYSFGVLLLELLTGKPP 586
Q S + DV+S G+ +EL G PP
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
+P LV L + FQ L+ +Y G L + H + + H A ++ L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEH---ARFYAAEICIAL 109
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAP 555
+++H+ +++ +LK NVLL D L DY + + L D + Y AP
Sbjct: 110 NFLHER-GIIYRDLKLDNVLLDADGHIKLTDY---GMCKEGLGPGDTTSTFCGTPNYIAP 165
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E S D ++ GVL+ E++ G+ P
Sbjct: 166 EILRGEEYGFS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 489 CLKIAEDVAQ--------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540
C K++++ Q GL YIH A ++H +LK SNV + D E + D+ L A AD
Sbjct: 112 CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGL-ARQAD 169
Query: 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK 584
Y+APE D++S G ++ ELL GK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
++G GS G Y+A+ +D V +K++ + ++ L H N++ L+
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN------LNHINIIFLKD 126
Query: 450 Y-----FQAKEERL---LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
Y F+ E+ + ++ ++ P + H +++ A PL + + + L+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY--SYQLCRALA 184
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEAC-LADY-CLTALTADSLQDDDPDNLLYKAPETRN 559
YIH + + H +LK N+L+ P+ L D+ L A + Y+APE
Sbjct: 185 YIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKP 585
+ T+ D++S G ++ E++ G P
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 49/292 (16%)
Query: 379 YTLDQLMRASAELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHME 434
Y + + +G+G G Y+ V + ++ V VK + + E + Q
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAY 59
Query: 435 SVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAE 494
+ HP++V L + ++ + P G L S + L S + +
Sbjct: 60 IMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSY 114
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKA 554
++ L+Y+ R VH ++ + NVL+ L D+ L+ L+D+ YKA
Sbjct: 115 QLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRY----LEDES----YYKA 165
Query: 555 -----------PETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVR 602
PE+ N + TS SDV+ FGV + E+L G P Q V N +
Sbjct: 166 SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQG---VKNNDV---- 217
Query: 603 SAREDDGAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
R ++G ERL M L + C + P +RP ++ L +I
Sbjct: 218 IGRIENG---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 23/154 (14%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P L L + FQ + + +Y G L I + + A +++ GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLF 115
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--------DPDNLLYK 553
++H+ +++ +LK NV+L + +AD+ + + + D PD Y
Sbjct: 116 FLHRR-GIIYRDLKLDNVMLDSEGHIKIADF---GMCKEHMVDGVTTRTFCGTPD---YI 168
Query: 554 APETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
APE ++Q KS D +++GVLL E+L G+PP
Sbjct: 169 APEI--IAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 30/160 (18%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPN---------GSLFSLIHGSKSTRAKPLHWTSC 489
L+H N+V L + L+++Y + G+L S+ H K + L
Sbjct: 60 LKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM-HNVKIFMFQLL----- 113
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN 549
+GLSY H+ +++H +LK N+L+ E LAD+ L A S+ N
Sbjct: 114 --------RGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLA--RAKSVPTKTYSN 162
Query: 550 ----LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
L Y+ P+ S + ++ D++ G +L E+ TG+P
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRL----DASKLAGTSNEMYEQHMESVGGLRHPN 443
+LLG+G+ G Y D + VK++ D+ + + N + E ++ + LRH
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNAL-ECEIQLLKNLRHDR 65
Query: 444 LVPLRAYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+V + EE+ L +Y P GS+ + + + + QG+S
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-----RYTRQILQGVS 120
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY---------CLTALTADSLQDDDPDNLLY 552
Y+H +VH ++K +N+L L D+ C++ S+ +
Sbjct: 121 YLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP----YW 175
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+PE + K+DV+S ++E+LT KPP
Sbjct: 176 MSPEVISGEGYG-RKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 16/193 (8%)
Query: 411 VCVKRLDASKLAGTSNEM-YEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469
V VK L S A +M + + + L+H NL+ LL+ ++ P G L
Sbjct: 25 VVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL 82
Query: 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL 529
+ + T+ ++A ++A GL ++H+ +H +L N LL D +
Sbjct: 83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKI 141
Query: 530 ADYCLTALTADSLQDDDPDNLL----YKAPETRNASH------QATSKSDVYSFGVLLLE 579
DY L+ PD L + APE + H T +S+V+S GV + E
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
Query: 580 L--LTGKPPSQHS 590
L L +P S
Sbjct: 202 LFELGSQPYRHLS 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL------- 551
GL Y+H A ++H +LK SN+L+ + + + D+ L A D +D+ L
Sbjct: 115 GLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDP-DEDEKGFLTEYVVTRW 171
Query: 552 YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE +S + T D++S G + ELLT KP
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/168 (30%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+ L FQ + L+ DY G L +L+ SK P + IAE V + I
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPED-MARFYIAEMVL-AIHSI 118
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD----DPDNLLYKAPET 557
HQ VH ++K NVLL + LAD+ CL ++Q PD Y +PE
Sbjct: 119 HQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD---YISPEI 174
Query: 558 RNASHQATSK----SDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMN 599
A K D +S GV + E+L G+ P LV ++MN
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 24/60 (40%), Positives = 29/60 (48%)
Query: 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188
NLKSL L +N T + L LK LDLS NNL+ P+ + L SL L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 17/266 (6%)
Query: 392 LGKGSLGTTYKA--VLDNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+G Y+A +LD + V +K++ L + + ++ + L HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI-HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
A F E ++ + G L +I H K R P + K + L ++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK--TVWKYFVQLCSALEHMHSR- 125
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCL-----TALTADSLQDDDPDNLLYKAPETRNASH 562
R++H ++K +NV + L D L + TA P Y +PE R +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPE-RIHEN 181
Query: 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
KSD++S G LL E+ + P + + + D L ++
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 623 IACNSASPEQRPTMWQVLKMLQEIKG 648
C + PE+RP + V + + +
Sbjct: 242 NMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLA-GTSNEM--YEQHMESVGGLRHPNL 444
+LLG+G+ G Y +D + K++ + TS E+ E ++ + L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 445 VPLRAYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
V + + E+ L +Y P GS+ + + L + K + +G+SY
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSY 121
Query: 503 IHQAWRLVHGNLKSSNVL--------LGPDFEAC--LADYCLTALTADSLQDDDPDNLLY 552
+H +VH ++K +N+L LG DF A L C++ S+ +
Sbjct: 122 LHSN-MIVHRDIKGANILRDSAGNVKLG-DFGASKRLQTICMSGTGIRSVTGTP----YW 175
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+PE + K+DV+S G ++E+LT KPP
Sbjct: 176 MSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 390 ELLGKGSLGTTYKA----VLDNRLI----VCVKRLDASKLAGTSNEMYEQHMESVGGLRH 441
E LG+G+ +K V D + V +K LD S + + M S L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMS--QLSH 58
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+LV +E +++ +Y GSL + + +K+ + W L++A+ +A L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWK--LEVAKQLAWALH 114
Query: 502 YIHQAWRLVHGNLKSSNVLL---------GPDFEACLAD--YCLTALTADSLQDDDPDNL 550
++ L HGN+ + NVLL P F L+D +T L + L + P
Sbjct: 115 FLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLERIP--- 169
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTG 583
+ PE + +D +SFG L E+ +G
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 12/148 (8%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
+PN + L + +LI DY +G LF L+ + L KI + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEAL 122
Query: 501 SYIHQAWRLVHGNLKSSNVLL-GPDFEACLADYCLTALT-ADSLQDDDPDNLLYKAPETR 558
+ +H+ ++H ++K NVL L DY L + S D D Y +PE
Sbjct: 123 NDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD---YFSPEKI 178
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP 586
+ S D ++ GVL ELLTGK P
Sbjct: 179 KGHNYDVS-FDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 35/151 (23%), Positives = 67/151 (44%), Gaps = 15/151 (9%)
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HP LV L + FQ + + ++ G L + H + + H + +++ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEH---ARFYSAEISLAL 109
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAP 555
+++H+ +++ +LK NVLL + L DY + + ++ D + Y AP
Sbjct: 110 NFLHER-GIIYRDLKLDNVLLDAEGHIKLTDY---GMCKEGIRPGDTTSTFCGTPNYIAP 165
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E S D ++ GVL+ E++ G+ P
Sbjct: 166 EILRGEDYGFS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 39/194 (20%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 401 YKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERL-- 458
YK + +N+ ++ K ++ E ++++ + N++ + + + L
Sbjct: 37 YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96
Query: 459 --LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKS 516
LI +Y G L ++ K L + + L +A D +GL +++ + NL S
Sbjct: 97 LSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151
Query: 517 SNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPET-RNASHQATSKSDVYSFGV 575
+ L+ +++ + + L + + S + + ++Y + + + + T K D+YS GV
Sbjct: 152 VSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 576 LLLELLTGKPPSQH 589
+L E+ TGK P ++
Sbjct: 211 VLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 392 LGKGSLGTTYKA---VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG+G+ T YK + DN + + RL+ + A + + + + L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI---REVSLLKDLKHANIVTLH 70
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
++ L+++Y L + ++ + + +GL+Y H+ +
Sbjct: 71 DIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-K 124
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPETRNASHQA 564
++H +LK N+L+ E LAD+ L A S+ N L Y+ P+ S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA--RAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 565 TSKSDVYSFGVLLLELLTGKP 585
+++ D++ G + E+ TG+P
Sbjct: 183 STQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETR 558
GL YIH A ++H +LK N+ + D E + D+ L A AD+ Y+APE
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGL-ARHADAEMTGYVVTRWYRAPEVI 186
Query: 559 NASHQATSKSDVYSFGVLLLELLTGK 584
D++S G ++ E+LTGK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 409 LIVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466
++V VK R DA+K A + + ++ + L+ PN++ L A + +I +Y N
Sbjct: 47 VLVAVKMLREDANKNARND---FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 467 GSLFSLI------HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVL 520
G L + ++ + +++ + +A +A G+ Y+ + VH +L + N L
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL-SSLNFVHRDLATRNCL 162
Query: 521 LGPDFEACLADYCLTALTADSLQDDDPDNLLYKAP-ETRNASHQA------TSKSDVYSF 573
+G ++ +AD+ ++ +L D + +A R S ++ T+ SDV++F
Sbjct: 163 VGKNYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218
Query: 574 GVLLLELLT---GKPPSQHS 590
GV L E+LT +P SQ S
Sbjct: 219 GVTLWEILTLCKEQPYSQLS 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 390 ELLGKGSLGTTYKA---VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
E LG+G+ T +K + +N + + RL+ + A + + + + L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKDLKHANIVT 68
Query: 447 LRAYFQAKEERLLIYDYQPN---------GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVA 497
L + L+++Y G++ S +H K +
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKI-------------FLYQIL 114
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYK 553
+GL+Y H+ +++H +LK N+L+ E LAD+ L A S+ N L Y+
Sbjct: 115 RGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLA--RAKSVPTKTYSNEVVTLWYR 171
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKP 585
P+ S + +++ D++ G + E+ +G+P
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 374 GEAQLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHM 433
GE L + L AE LG+G+ + VL V VK L A N+ ++ +
Sbjct: 19 GEVHLCEAEGL----AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKE-I 68
Query: 434 ESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHG-------SKSTRAKPLHW 486
+ + L++PN++ L + + +I +Y NG L + + + +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA--LTAD--SL 542
+ L +A +A G+ Y+ + VH +L + N L+G + +AD+ ++ + D +
Sbjct: 129 ANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT 582
Q + + A E+ + T+ SDV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 34/154 (22%)
Query: 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ--------GLSY 502
FQ + L+ DY G L +L+ SK ++ ED+A+ +
Sbjct: 70 FQDENNLYLVMDYYVGGDLLTLL--SKFED----------RLPEDMARFYLAEMVLAIDS 117
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD----DPDNLLYKAPE 556
+HQ VH ++K NVLL + LAD+ CL L ++Q + PD Y +PE
Sbjct: 118 VHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD---YISPE 173
Query: 557 TRNASHQATSK----SDVYSFGVLLLELLTGKPP 586
A + D +S GV + E+L G+ P
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 13/151 (8%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P +V L FQ + ++ +Y P G L +L+ S P W +V L
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFY--TAEVVLALD 156
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDD----PDNLLYKAP 555
IH + L+H ++K N+LL LAD+ C+ ++ D PD + +
Sbjct: 157 AIH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+++ + D +S GV L E+L G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 34/260 (13%)
Query: 391 LLGKGSLGTTY---KAVLDNRLIVCVKRLDASKLA---GTSNEMYEQHMES-VGGLRHPN 443
++G+G G Y KA D + +K LD ++ G + + E+ M S V P
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+V + F ++ I D G L + HG S + + A ++ GL
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-------ATEIILGLE 111
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNAS 561
++H + +V+ +LK +N+LL ++D L + Y APE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621
S +D +S G +L +LL G P R + D E +R+ + + V
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP--------------FRQHKTKDKHEIDRMTLTVNV 216
Query: 622 AIACNSASPEQRPTMWQVLK 641
+ +S SPE + + +L+
Sbjct: 217 ELP-DSFSPELKSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 32/212 (15%)
Query: 390 ELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSN---EMYEQHMESVGGLRHPNL 444
+LGKGS G A L RL VK L + + M E+ + S+ HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYA-VKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFL 58
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
L FQ + + ++ G L + H KS R + AE + L ++H
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEAR--ARFYAAE-ITSALMFLH 113
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADY----------CLTALTADSLQDDDPDNLLYKA 554
+++ +LK NVLL + LAD+ T+ + PD Y A
Sbjct: 114 DK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT-----PD---YIA 164
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE S D ++ GVLL E+L G P
Sbjct: 165 PEILQEMLYGPS-VDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 21/155 (13%)
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+V L FQ + ++ +Y P G L +L+ S P W AE V L
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWAR-FYTAE-VVLALD 156
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDD-----PDNLLYKA 554
IH + +H ++K N+LL LAD+ C+ + A+ + D PD Y +
Sbjct: 157 AIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MDANGMVRCDTAVGTPD---YIS 211
Query: 555 PET-RNASHQAT--SKSDVYSFGVLLLELLTGKPP 586
PE ++ + D +S GV L E+L G P
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 17/174 (9%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
RHP L L+ FQ + + +Y G LF H S R + ++
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLS---RERVFSEDRARFYGAEIVSA 107
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKA 554
L Y+H +V+ +LK N++L D + D+ L + ++D Y A
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF---GLCKEGIKDGATMKTFCGTPEYLA 164
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP---SQHSFLVPNEMMNWVRSAR 605
PE + + D + GV++ E++ G+ P H L +M +R R
Sbjct: 165 PEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 16/36 (44%), Positives = 20/36 (55%), Gaps = 1/36 (2%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L L L NN +T +P LS L NL++L L N T
Sbjct: 2 NLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
K+ + + L Y+ + ++H ++K SN+LL L D+ ++ DS
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 551 -LYKAPETRNASHQATS---KSDVYSFGVLLLELLTGKPP 586
Y APE + ++DV+S G+ L+EL TG+ P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 40/168 (23%), Positives = 62/168 (36%), Gaps = 36/168 (21%)
Query: 439 LRHPNLVPLRAYFQAKEERLL-IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVA 497
L HPN+V L +A L +++Y P +L ++ L ++ V
Sbjct: 35 LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADG-----ALPAGETGRLMLQVL 89
Query: 498 QGLSYIHQAWRLVHGNLKSSNVL-------------------LGPDFEACLADYCLTALT 538
L+ H +VH +LK N++ L P LT
Sbjct: 90 DALACAHNQ-GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV----ATLT 144
Query: 539 ADSLQDDDPDNLLYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKP 585
+ P Y APE R T SD+Y++G++ LE LTG+
Sbjct: 145 RTTEVLGTPT---YCAPEQLRGEP--VTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDAS-KLAGTSNEM--YEQHMESVGGLRHPNL 444
+LLG+G+ G Y D + VK++ + TS E+ E ++ + L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 445 VPLRAYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
V + ER L ++ P GS+ + KS A + T K + +G+SY
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTR--KYTRQILEGVSY 121
Query: 503 IHQAWRLVHGNLKSSNVL--------LGPDFEAC--LADYCLTALTADSLQDDDPDNLLY 552
+H +VH ++K +N+L LG DF A L CL+ S+ +
Sbjct: 122 LHSN-MIVHRDIKGANILRDSVGNVKLG-DFGASKRLQTICLSGTGMKSVTGTP----YW 175
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+PE + K+D++S G ++E+LT KPP
Sbjct: 176 MSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 392 LGKGSLGTTYKA-VLDNRLIVCVKRLDAS---KLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+G+G G + A D IV +KR+ S KL + + E+ + + + LV L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT--KSEWLVKL 66
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGS---KSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
FQ E L +Y P G +L++ A+ +AE + +H
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-------FYMAEMFE-AVDALH 118
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT---ADSLQDDDPDNLLYKAPETRNAS 561
+ +H +LK N L+ L D+ L+ A+S+ PD Y APE
Sbjct: 119 EL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGS-PD---YMAPEVLRGK 173
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE 606
D +S G +L E L G PP S PNE ++ +E
Sbjct: 174 -GYDFTVDYWSLGCMLYEFLCGFPPFSGS--TPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 22/155 (14%)
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL--HWTSCLKIAEDVAQGLS 501
+ L FQ + L+ DY G L +L+ + + + + + + IA D L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDD----DPDNLLYKAP 555
Y+H+ ++K N+L+ + LAD+ CL + ++Q PD Y +P
Sbjct: 123 YVHR-------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD---YISP 172
Query: 556 ETRNASHQATSK----SDVYSFGVLLLELLTGKPP 586
E A K D +S GV + E+L G+ P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 33/272 (12%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451
GK L Y R++V K L A+ + NE +Q + L+HPN+ L+
Sbjct: 8 FGKVLLSEIYTDTGVARVVV--KELKANASSKEQNEFLQQG-DPYRILQHPNI--LQCLG 62
Query: 452 QAKEE--RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
Q E LL+++Y G L S + + R ++A ++A G++++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS-QLLLLQRMACEIAAGVTHMHKH-NF 120
Query: 510 VHGNLKSSNVLLGPDFEACLADYCL--TALTADSLQDDDPD--NLLYKAPETRNASH--- 562
+H +L N L D + DY + + D ++ +D L + APE H
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180
Query: 563 ---QATSKSDVYSFGVLLLELL-TGKPPSQHSFLVPNEMMNWVRSARED-------DGAE 611
+ T S+V++ GV L EL P H L E++N V ++ +
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSH--LSDREVLNHVIKDQQVKLFKPQLELPY 238
Query: 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKML 643
ER EV C SPE+R T +V ++L
Sbjct: 239 SERW---YEVLQFC-WLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 37/168 (22%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN 549
L VA+G+ ++ VH +L + NVLL + + C L D + D + +
Sbjct: 240 LSFTYQVARGMEFLASK-NCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVS 295
Query: 550 -------LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR 602
+ + APE+ + T+ SDV+S+G+LL E+ + +V + N ++
Sbjct: 296 KGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354
Query: 603 S----AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
S A+ D ++ + ++ + C ++ PE+RP+ + +++ +
Sbjct: 355 SGYRMAKPDHATQE-----VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA-DSLQDDDPDNLLYKAPE 556
+GL ++H + R+VH +LK N+L+ + LAD+ L + + L Y+APE
Sbjct: 121 RGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 557 TRNASHQATSKSDVYSFGVLLLELLTGKP 585
S AT D++S G + E+ KP
Sbjct: 180 VLLQSSYATP-VDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
PL + + VA+G+ ++ + + +H +L + N+LL E + C L D
Sbjct: 169 PLTLEDLISYSFQVARGMEFL-ASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIY 224
Query: 543 QDDD---------PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFL 592
+D D P L + APE+ T++SDV+SFGVLL E+ + G P
Sbjct: 225 KDPDYVRKGDARLP--LKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASP------ 275
Query: 593 VPNEMMNWVRSAREDDG----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643
P ++ R +G A + + + + C +PE RPT +++++L
Sbjct: 276 YPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------- 546
VA+G+ ++ + + +H +L + N+LL E + C L D +D D
Sbjct: 188 VAKGMEFL-ASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAR 605
P L + APET T +SDV+SFGVLL E+ + G P P ++ R
Sbjct: 244 P--LKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASP------YPGVKIDEEFCRR 294
Query: 606 EDDG----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643
+G A D + + + C P QRPT ++++ L
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 14/95 (14%)
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL------ 551
+GL Y+H A ++H ++K N+L+ + C+ C L +++ D +
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSN---CVLKICDFGLA--RVEEPDESKHMTQEVVT 167
Query: 552 --YKAPETRNASHQATSKSDVYSFGVLLLELLTGK 584
Y+APE S TS D++S G + ELL +
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 664 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.48 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.37 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.34 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.33 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.3 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.29 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.09 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.06 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.76 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.72 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.71 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.67 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.64 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.27 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.24 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.17 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.08 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.07 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.99 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-61 Score=581.64 Aligned_cols=460 Identities=27% Similarity=0.434 Sum_probs=314.8
Q ss_pred CCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeee
Q 006031 104 LDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182 (664)
Q Consensus 104 l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 182 (664)
+++|+.|+|++|+++|.+| .+.++++|+.|+|++|+++|.+|..+.++++|++|+|++|+++|.+|..+..+++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 3555666666666666665 356667777777777777777777777777777777777777777777777777777777
Q ss_pred CcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCccCcCCCCCCCCCCCCCCCCCCCC
Q 006031 183 LDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSATAAAAP 260 (664)
Q Consensus 183 l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~~~~~~c~~~~~~~~~~~~~~~~~ 260 (664)
|++|+++|.+|.. .+++|+.|++++|+++|.+|..+.+..+....+.+|+.+||...... . +
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~-----------~-----~ 617 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG-----------L-----P 617 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC-----------C-----C
Confidence 7777777777753 56677777777777777777666666677777777777776421100 0 0
Q ss_pred CCccccCCCCcccCCCccCCCCCCCCccceeeehhhHHHHHHHHHHHHHHHHHHHHhccccccchhhhhhhHHHHHHHHH
Q 006031 261 PPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQKQRKDKKSKAMIASDEAAATAQAL 340 (664)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~i~vg~~vl~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (664)
+. .........++++++++++++++++++++++++++|++.+.++... ....
T Consensus 618 ----------~c--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------- 669 (968)
T PLN00113 618 ----------PC--------KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN---EDGT------- 669 (968)
T ss_pred ----------CC--------ccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccc---cccc-------
Confidence 00 0000111233444444454444444333333333222111110000 0000
Q ss_pred HHHHHHHhHHHHHHHHhhhccccccCCceeEec-CCccccCHHHHHHHH--hccccccCceeEEEEEE-cCCeEEEEEEc
Q 006031 341 AMIQIEQENELQEKVKRAQGIQVAKSGNLVFCA-GEAQLYTLDQLMRAS--AELLGKGSLGTTYKAVL-DNRLIVCVKRL 416 (664)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l 416 (664)
+ ...++. .....++++++.... .++||+|+||.||+|.. .++..||||++
T Consensus 670 ------------~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~ 723 (968)
T PLN00113 670 ------------W--------------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723 (968)
T ss_pred ------------c--------------cccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence 0 000000 001123444443332 35799999999999996 57899999998
Q ss_pred cCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHH
Q 006031 417 DASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV 496 (664)
Q Consensus 417 ~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 496 (664)
+.... ....|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++ .++|..+.+|+.|+
T Consensus 724 ~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~i 789 (968)
T PLN00113 724 NDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGI 789 (968)
T ss_pred cCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHH
Confidence 64322 12345888999999999999999999999999999999999999994 28999999999999
Q ss_pred HHHHHHHHhc--CCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHH
Q 006031 497 AQGLSYIHQA--WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFG 574 (664)
Q Consensus 497 a~~L~yLH~~--~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfG 574 (664)
|+||+|||+. ++|+||||||+||+++.++.+++. ||.+...... ....++..|+|||++. ...++.|+||||||
T Consensus 790 a~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--~~~~~t~~y~aPE~~~-~~~~~~~sDv~S~G 865 (968)
T PLN00113 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--TKCFISSAYVAPETRE-TKDITEKSDIYGFG 865 (968)
T ss_pred HHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--CCccccccccCccccc-CCCCCcccchhhHH
Confidence 9999999942 389999999999999999998876 6665443222 2235788999999987 67789999999999
Q ss_pred HHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006031 575 VLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 575 vvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 640 (664)
|++|||+||+.||+........+.+|++...... ....+...++.+++.+||+.+|++||||+||+
T Consensus 866 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 9999999999999765444455666655332111 12234566788999999999999999999999
Q ss_pred HHHHhhhcccc
Q 006031 641 KMLQEIKGAVL 651 (664)
Q Consensus 641 ~~L~~i~~~~~ 651 (664)
++|+++.....
T Consensus 946 ~~L~~~~~~~~ 956 (968)
T PLN00113 946 KTLESASRSSS 956 (968)
T ss_pred HHHHHhhcccc
Confidence 99999876443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=438.09 Aligned_cols=269 Identities=39% Similarity=0.652 Sum_probs=227.1
Q ss_pred CccccCHHHHHHHHh-----ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceE
Q 006031 375 EAQLYTLDQLMRASA-----ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449 (664)
Q Consensus 375 ~~~~~~~~~l~~~~~-----~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g 449 (664)
....|+++++..||. ++||+|+||.||+|.+++++.||||++....... ..+|..|++++++++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 455789999999983 6899999999999999999999999887654421 566999999999999999999999
Q ss_pred EEecCC-ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCCCeEeCCCCC
Q 006031 450 YFQAKE-ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 450 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~ivHrDlk~~NILl~~~~~ 526 (664)
||.+.+ +++||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.. +||||||||+|||||++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999 499999999999999999864322 8999999999999999999999953 6999999999999999999
Q ss_pred eEEeeccccccccC-CCCC-CC-CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-ChhhHHHHHH
Q 006031 527 ACLADYCLTALTAD-SLQD-DD-PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL-VPNEMMNWVR 602 (664)
Q Consensus 527 ~ki~DfGla~~~~~-~~~~-~~-~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~-~~~~~~~~~~ 602 (664)
+||+|||+++.... .... .. .||.+|+|||++. .+..+.|+|||||||+|+|++||+.|.+.... ....+..|+.
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999987764 3222 22 7999999999997 68899999999999999999999998876432 2334777754
Q ss_pred hhccCC-------------Cchh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 603 SAREDD-------------GAED-ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 603 ~~~~~~-------------~~~~-~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
...... .... +....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 333321 1122 5677799999999999999999999999999776544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=419.56 Aligned_cols=265 Identities=29% Similarity=0.422 Sum_probs=223.6
Q ss_pred cCHHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-ce
Q 006031 379 YTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-ER 457 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~ 457 (664)
+..+++. ..+.||+|+||+||+|.+++...||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..
T Consensus 38 i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 3344443 34569999999999999988877999999876654444779999999999999999999999999887 79
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-cccCCCCCCCeEeCCCC-CeEEeecccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR-LVHGNLKSSNVLLGPDF-EACLADYCLT 535 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-ivHrDlk~~NILl~~~~-~~ki~DfGla 535 (664)
++|||||++|+|.++++.. ....+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 9999999999999999752 357899999999999999999999998 7 99999999999999997 9999999999
Q ss_pred ccccCC--CCCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 536 ALTADS--LQDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 536 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
+..... ..+...||+.|||||++.+ ...++.|+|||||||+||||+||+.||..... ..+...+.........+.
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPPIPK 269 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCCCCc
Confidence 877653 3334679999999999974 35799999999999999999999999987532 444444443333333344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
..+..+..++.+||+.||+.||++.|++..|+.+.....
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 467779999999999999999999999999999876554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=409.18 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=220.6
Q ss_pred CHHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEE
Q 006031 380 TLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 380 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 459 (664)
.++.-.....+.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++..||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 33333445678899999999999999999999999997654 367889999999999999999999999999899999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
|||||+.|+|.++|+. ..+..+.-.+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccC
Confidence 9999999999999974 3456788999999999999999999999 99999999999999999999999999999665
Q ss_pred CCCCCCC---CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 540 DSLQDDD---PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 540 ~~~~~~~---~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
++..... .-+..|.|||.+. ...++.|||||||||+||||+| |+.||... ...++.+.+....+- +.++.++
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~le~GyRl-p~P~~CP 430 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELLERGYRL-PRPEGCP 430 (468)
T ss_pred CCceeecCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHHhccCcC-CCCCCCC
Confidence 5543322 2357899999998 7889999999999999999999 99998764 234555544433332 2345567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..++++|..||..+|++||||+.+...|+++....
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 77999999999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=428.72 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=221.6
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|... +.+.||||.+++... .+..++|++|+++++.++|||||+|+|.|.+++..++|+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 467999999999999843 457899999987654 2357899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 463 YQPNGSLFSLIHGSKSTR---------AKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
||..|||.++|+...... ..+|+..+.+.||.|||.||+||-++ .+|||||.++|+||+++..+||+|||
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecccc
Confidence 999999999997533211 34489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCC----CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCC
Q 006031 534 LTALTADSLQDD----DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDD 608 (664)
Q Consensus 534 la~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 608 (664)
+++......... ..-+++|||||.+. .+++|++||||||||||||++| |+.||.+. ..+++.+.++.... .
T Consensus 649 LsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--Sn~EVIe~i~~g~l-L 724 (774)
T KOG1026|consen 649 LSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--SNQEVIECIRAGQL-L 724 (774)
T ss_pred cchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCccccc--chHHHHHHHHcCCc-c
Confidence 998765543222 22467999999998 7899999999999999999999 99998764 45677777776666 5
Q ss_pred CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 609 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..++.++.++++||..||+..|++||+++||-..|+......
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 677788889999999999999999999999999999876554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=382.98 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=216.9
Q ss_pred ccCHHHHHHHHhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-
Q 006031 378 LYTLDQLMRASAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE- 455 (664)
Q Consensus 378 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~- 455 (664)
.++.+|++. ...||+|..|+|||+.++ +++.+|+|.+.. .......+++.+|++++++.+|||||.+||.|..+.
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 355666643 578999999999999965 688999999943 333345688999999999999999999999999988
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
+..++||||++|+|.+++.. .+.+++...-+|+.+|++||.|||+..+||||||||+|||++..|++||||||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 59999999999999999953 3568999999999999999999997449999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---ChhhHHHHHHhhccCCCchh
Q 006031 536 ALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL---VPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 536 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~ 612 (664)
+.+.++......||..|||||.+. +..|+.++||||||++++|+.+|+.||..... ...++..++-....+.-+..
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred HHhhhhhcccccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 998888777889999999999998 67899999999999999999999999986522 23355555443333332333
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+..++..++..|+++||.+||++.|+++.
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 477889999999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=364.27 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=195.4
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||.|+||+||+|+++ ++..||||.+.+.....+..+.+..|+++++.++|||||.+++++..++..++|||||.+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 44999999999999964 58999999998877655677889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC------CCeEEeeccccccccCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD------FEACLADYCLTALTADSL 542 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~------~~~ki~DfGla~~~~~~~ 542 (664)
|.++++. .+.+++.+...+..|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.+..
T Consensus 96 Ls~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 96 LSDYIRR-----RGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 9999963 45799999999999999999999999 99999999999999765 458999999999877543
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-chhHHHHHHHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG-AEDERLGMLLE 620 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 620 (664)
....+|++.|||||++. ..+|+.|+|+||.|+++||+++|++||+.. ...++...++....... .+........+
T Consensus 170 ~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~--t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAE--TPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred HHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCcccc--CHHHHHHHHhccccccCchhhhccCchhh
Confidence 34568999999999997 789999999999999999999999999853 34455554444333322 12222222345
Q ss_pred HHHHcccCCCCCCCCHHH
Q 006031 621 VAIACNSASPEQRPTMWQ 638 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~e 638 (664)
+...-++.+|.+|-++.+
T Consensus 247 Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFED 264 (429)
T ss_pred hhhHHHhcCccccCchHH
Confidence 555555555555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=366.64 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=204.9
Q ss_pred HhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCc-----HHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTS-----NEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~-----~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
..+.||+|+||.|-+|. .++|+.||||.+++....... ....++|+++|++|+|||||++++++...+..|||+
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 35789999999999998 567999999999876654422 233579999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~ 538 (664)
|||+||+|.+.+- ..+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 256 E~v~GGeLfd~vv-----~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 256 EYVEGGELFDKVV-----ANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEecCccHHHHHH-----hccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999999994 456788888899999999999999999 99999999999999765 88999999999987
Q ss_pred cCC-CCCCCCCCCcccCccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhH
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQ--ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDE 613 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 613 (664)
... .....+||+.|.|||++...+. +..|.|+||+||+||-+++|.+||.+...... +.+-+....-.. ..+.+
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHHHhcCcccccChhhhh
Confidence 644 3346789999999999874322 34489999999999999999999987544332 222222222221 34566
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..++..+++.+++..||++|||+.|+++
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 7788999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=375.51 Aligned_cols=259 Identities=23% Similarity=0.386 Sum_probs=212.1
Q ss_pred cCHHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceE
Q 006031 379 YTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 458 (664)
+.++++ ...+.||+|.||+||+|.|.+ .||||.++.........+.|+.|+.++++-||.||+-+.|||..... .
T Consensus 389 Ip~~ev--~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEV--LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHh--hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 344444 346889999999999999977 49999999887766777899999999999999999999999988776 9
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
||+.+|+|-+|+.+||. ....++..+...||+|||.||.|||.+ +|||||||+.||+|.+++.+||+|||++..-
T Consensus 464 IiTqwCeGsSLY~hlHv----~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHV----QETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccc----hhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999994 346799999999999999999999999 9999999999999999999999999998543
Q ss_pred cC----CCCCCCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---C
Q 006031 539 AD----SLQDDDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---G 609 (664)
Q Consensus 539 ~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~ 609 (664)
.. .......+...|||||++.. ...|++.+||||||||+|||+||..||... ....+.-.+....... .
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEecccccCccchh
Confidence 22 22233457788999998763 345899999999999999999999999832 2222221122221111 1
Q ss_pred chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 610 AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 610 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
......+++.+|+..||..++++||.+.+|+..|+++...
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2345567799999999999999999999999988888663
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.79 Aligned_cols=249 Identities=20% Similarity=0.382 Sum_probs=215.0
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.++||.|.||.||+|+++- ...||||.++.... ++...+|..|..+|++..||||++|.|+.......+||+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 5799999999999999753 56899999986543 456778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
+||+|..+|+. ...++++.+...+.++||.||.||.++ ++|||||.++|||++.+..+||+|||+++...++...
T Consensus 713 ENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 713 ENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999984 345699999999999999999999999 9999999999999999999999999999987665421
Q ss_pred C---CC--CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 545 D---DP--DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 545 ~---~~--~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
. .. -+++|.|||.+. .++++.+||||||||||||.++ |..||.+. ..+++...+....+-+ .+.+++..+
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVIkaIe~gyRLP-pPmDCP~aL 863 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIKAIEQGYRLP-PPMDCPAAL 863 (996)
T ss_pred cccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCccccc--chHHHHHHHHhccCCC-CCCCCcHHH
Confidence 1 11 257899999997 7899999999999999999998 99999864 3456666555443332 345677789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
++||+.||++|-.+||.|.+|+..|+++.
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 99999999999999999999999998874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=400.42 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=215.5
Q ss_pred hccccccCceeEEEEEEcC--C----eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDN--R----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|...+ + ..||||.++.... .++..+|.+|..+|++++|||||+++|.|.+....+|++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 5789999999999999654 3 3489999875432 3456889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 463 YQPNGSLFSLIHGSKST--RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
||++|||..+|++.+.. ....|+..+.+.|+.|||+|+.||+++ ++|||||.++|+||++...+||+|||+|+...+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~ 854 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDIYD 854 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence 99999999999865322 245689999999999999999999999 999999999999999999999999999995444
Q ss_pred CCCCC----CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHH-HHHhhccCCCchhHH
Q 006031 541 SLQDD----DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMN-WVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~~~~----~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 614 (664)
..... ..-..+|||||.+. .+.++.|+|||||||++||++| |..||.+. ...++.. +.... ..+.+..+
T Consensus 855 ~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~~~~~gg--RL~~P~~C 929 (1025)
T KOG1095|consen 855 KDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLLDVLEGG--RLDPPSYC 929 (1025)
T ss_pred chheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHHHHHhCC--ccCCCCCC
Confidence 32211 12357899999998 6899999999999999999999 99999864 3445555 44444 33456677
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
+..++++|..||+.+|++||++..+++++..+.....
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 8889999999999999999999999999999877664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=369.05 Aligned_cols=243 Identities=23% Similarity=0.391 Sum_probs=207.1
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+++||+|||+.||+++. ..|..||+|++.+.... ....+...+||++-+.|+|||||+++++|++.+..|||.|+|.
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 467899999999999996 88999999999765432 2346788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+++|.+++. ..+++++.++..+.+||+.||.|||+. +|+|||||..|++|+++.++||+|||+|..... ...
T Consensus 102 ~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 102 RGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred CccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999994 567899999999999999999999999 999999999999999999999999999987653 344
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~ 622 (664)
...+||+-|+|||++. ....+..+||||+|||||-|++|++||+.. .+.+-.+...... ..+.....+..+++
T Consensus 176 ~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~Y~~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNEYSMPSHLSAEAKDLI 249 (592)
T ss_pred ceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcCcccccccCHHHHHHH
Confidence 5678999999999997 556788999999999999999999999863 2222222222222 12234445688999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+.++.+|.+|||+.+|+..
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=342.33 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=210.1
Q ss_pred HhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceE-EEecCCc-eEEEEecC
Q 006031 388 SAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA-YFQAKEE-RLLIYDYQ 464 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~e~~ 464 (664)
..++||.|.||+|||+. +.+|..||.|.+.-........+....|+.++++|+|||||++++ .+.++.+ .+|||||+
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 45789999999999998 788999999999866665566788999999999999999999999 4555555 89999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CC--cccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-WR--LVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~--ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
..|||...++..+ ...+.+++...++++.|+++||..+|.+ ++ |+||||||.||+|+.+|.+|++|||+++.+...
T Consensus 103 ~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 9999999997544 3456799999999999999999999993 24 999999999999999999999999999988765
Q ss_pred CC--CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 542 LQ--DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 542 ~~--~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
.. ...+||+.||+||.+. ...|+.||||||+||++|||..-++||.+. .--++..-+...--+....+.....+.
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred hHHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 43 3467999999999997 778999999999999999999999999764 122333333333222223366788899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.++..|+..||+.||+...++..++
T Consensus 259 ~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHccCCcccCCCcchHHHHHH
Confidence 9999999999999998655555543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=372.68 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=212.7
Q ss_pred hccccccCceeEEEEEEcCC-----eEEEEEEccCcc-ccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNR-----LIVCVKRLDASK-LAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.++||+|+||.||+|.+..+ ..||||..+... .......+|.+|.++|++++|||||+++|++..+.+.|+|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 37899999999999996542 238999987532 434556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
+|.||+|.++|+.. ...++..+++.++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++......
T Consensus 242 l~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred ecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999642 23699999999999999999999999 99999999999999999999999999988654211
Q ss_pred C-C-CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 543 Q-D-DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 543 ~-~-~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
. . ...-+.+|+|||.+. ...++.++|||||||++||+++ |..||.+. ...++..++....-....+...+..+.
T Consensus 317 ~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--KNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCC--CHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 1 1 122467899999998 6689999999999999999999 88998764 344666666333333333345566788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhccccC
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGAVLM 652 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~ 652 (664)
.++.+||..+|++||+|.++.+.|+.+......
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 899999999999999999999999999776543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=352.90 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=211.1
Q ss_pred cccCHHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCc-HHHHHHHHHHHcCCCCCCcccceEEEec--
Q 006031 377 QLYTLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS-NEMYEQHMESVGGLRHPNLVPLRAYFQA-- 453 (664)
Q Consensus 377 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~-- 453 (664)
..++.+++.......||+|++|.||+|.+ +|+.||||+++........ .+.|.+|+++|++++||||++++|++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 35566677555567899999999999998 6789999999765432211 4678899999999999999999999876
Q ss_pred --CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 454 --KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 454 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
....++||||+++|+|.++++. ...++|.....++.+++.||+|||+..+++||||||+||++++++.+||+|
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcc
Confidence 3467899999999999999953 346899999999999999999999844889999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 532 YCLTALTADSLQDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
||+++...... ....++..|+|||.+.. ...++.++|||||||++|||++|+.||... ...++...+.........
T Consensus 167 fg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 167 HGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNNSLKL 243 (283)
T ss_pred cchHhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcCCCCCC
Confidence 99998654332 23457889999999863 257899999999999999999999999754 223333333222112222
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
+...+..+.+++.+||+.||++||||.|+++.|+++.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2234567999999999999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.49 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..++|+|+||+|||++.+ .|+.||||++..+.......+-..+|++++++++|+|+|.++.+|..+...+||+||++..
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 357999999999999965 5999999999877665556677889999999999999999999999999999999999884
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~~ 545 (664)
-| +-|. .....++.....+++.|+++|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.... +..+.
T Consensus 87 vL-~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 87 VL-HELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred HH-HHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 44 4443 2334578888999999999999999999 999999999999999999999999999998762 33455
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc----------cCC-------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR----------EDD------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~----------~~~------- 608 (664)
...|.+|+|||.+.+..+|...+||||.||++.||+||.+-|.+... -..+........ ...
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 67899999999998878999999999999999999999998876422 112221111111 000
Q ss_pred ---C----c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---G----A----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---~----~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. . .......+.++++.|++.||.+|++-+|++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 0 1122235789999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.35 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=198.0
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCC-cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..++||+|+||+||+++. +.++.+|+|++++...... +.+....|..+|.+++||.||+++..|++.+..|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 357899999999999985 5588999999988765443 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 543 (664)
||.|+.+|+ +...+++.....++.+|+.||.|||++ +||||||||+|||||.+|+++++|||+++..-.. ..
T Consensus 109 GGeLf~hL~-----~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 109 GGELFYHLQ-----REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred CccHHHHHH-----hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 999999994 456799999999999999999999999 9999999999999999999999999999854332 34
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...+||+.|||||++. ...++..+|.||+||++|||++|.+||... +...+.+-+...... ..+.-......+++.
T Consensus 183 ~tfcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~--~~~~~~~~I~~~k~~-~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAE--DVKKMYDKILKGKLP-LPPGYLSEEARDLLK 258 (357)
T ss_pred ccccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCc--cHHHHHHHHhcCcCC-CCCccCCHHHHHHHH
Confidence 4568999999999998 668899999999999999999999999763 222333322222211 112223455889999
Q ss_pred HcccCCCCCCC
Q 006031 624 ACNSASPEQRP 634 (664)
Q Consensus 624 ~Cl~~~P~~RP 634 (664)
+.++.+|++|-
T Consensus 259 ~LL~rdp~~RL 269 (357)
T KOG0598|consen 259 KLLKRDPRQRL 269 (357)
T ss_pred HHhccCHHHhc
Confidence 99999999995
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=360.11 Aligned_cols=243 Identities=24% Similarity=0.424 Sum_probs=203.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+-||.|+.|.||+|++++. .||||+++. .-+.+|+.|++|+||||+.+.|+|.....++||||||..|-
T Consensus 129 LeWlGSGaQGAVF~Grl~ne-tVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNE-TVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeeccCc-eehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 46799999999999999775 799998743 33567899999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DDDP 547 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~~ 547 (664)
|.+.|+ ....++......|..+||.||.|||.+ +|||||||+-||||..+..+||+|||-++...+... ...+
T Consensus 199 L~~VLk-----a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLK-----AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHh-----ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 999995 345678888899999999999999999 999999999999999999999999999987765432 3467
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH-HHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW-VRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
||..|||||++. ....++|+||||||||||||+||..||.+.... ..-| |.........+..+++.+.-|++.||
T Consensus 273 GTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 273 GTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence 999999999998 778899999999999999999999999764211 1111 11111122345667777889999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 627 SASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
+..|..||+|++++..|+-..+...
T Consensus 349 ~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred hcCCCCCccHHHHHHHHhhcCHHHh
Confidence 9999999999999999987665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=349.94 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=199.1
Q ss_pred HhccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--ceEEEEecC
Q 006031 388 SAELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--ERLLIYDYQ 464 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~ 464 (664)
..+.||+|+||+||++...+ |...|||....... ...+.+++|+.+|.+++|||||+++|.....+ ..++.|||+
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 45789999999999999654 88999999876532 12667899999999999999999999865555 589999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccC---
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTAD--- 540 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~--- 540 (664)
++|+|.+++... .. .|++....+++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999632 22 699999999999999999999999 9999999999999999 79999999999987663
Q ss_pred --CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 541 --SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 541 --~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
.......||+.|||||++..+.....++|||||||++.||+||++||.........+....... ..+..+...+...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEA 252 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccCHHH
Confidence 1122456899999999997422334589999999999999999999976311111111111111 1123344456678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.+++.+|+..+|++|||+.++++.--
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChh
Confidence 99999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=349.91 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=203.3
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 465 (664)
.++||+|+||.||||+ ..+|+.||+|++..............+||.+|++|+||||++|.+...+. ...|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4679999999999998 67899999999987766555667788999999999999999999998876 68999999998
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
. ||..++. .....++..++..++.|++.||+|+|+. +|+|||||.+|||||.+|.+||+|||+|++.....
T Consensus 202 h-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 202 H-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred c-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 7 9999885 3456799999999999999999999999 99999999999999999999999999999765543
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-------------
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG------------- 609 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 609 (664)
.+..+-|++|+|||.+.+...|+...|+||.||||.||++|++.|.+... .+++....+....+.+
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhccccccCCcccc
Confidence 23455689999999999999999999999999999999999999987422 1222222221111110
Q ss_pred -------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 -------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 -------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.....+...++|+..+|..||.+|.|+.++++
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01112345788999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=351.01 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=206.8
Q ss_pred HHHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCC-ceEEEEe
Q 006031 386 RASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKE-ERLLIYD 462 (664)
Q Consensus 386 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~e 462 (664)
+...++||.|+||.||+|+ ...+..||||+++..... .++-.-.+|++.|++++ |||||++.+.+.+.+ ..++|||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 4456789999999999998 667889999999865542 34455679999999998 999999999998888 9999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
||+. +|++++.. +...+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+||......
T Consensus 91 ~Md~-NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 91 FMDC-NLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred hhhh-hHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCC
Confidence 9976 99999964 367899999999999999999999999 99999999999999999999999999999876543
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC------------
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG------------ 609 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------------ 609 (664)
.+..+.|.+|+|||++.....|+.+.|+||+|||++|+.+-++-|.+... ..++.+...-...+..
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 35677899999999998889999999999999999999999999876422 1233222221111110
Q ss_pred ---------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 610 ---------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 610 ---------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.......+..+++.+|++.||.+|||+.|+++.
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 112245678999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=343.30 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred HHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 387 ASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...++||.|.-++||+|+ .+.+..||||++...+... ..+.+++|+..|+.++||||++++..|..++..++||.||.
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 345789999999999998 5678999999998776633 36889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
+|++.+++... -...+++..+..|.+++++||.|||++ |.||||||+.|||||++|.+||+|||.+..+.+...
T Consensus 108 ~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 108 GGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 99999999643 234489999999999999999999999 999999999999999999999999999876544321
Q ss_pred ----CCCCCCCcccCccc-cccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc------CCCchh
Q 006031 544 ----DDDPDNLLYKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE------DDGAED 612 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~-~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~------~~~~~~ 612 (664)
....|++.|||||+ .....-|+.|+|||||||+..|+.+|..||........-++........ +.+...
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 23478999999999 4444568999999999999999999999998642221122222111110 111222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.....+.+++..|+++||++|||++++++
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 34457899999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.44 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=205.8
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||+|+.|.||.|. ...++.||||++..... ...+...+|+.+|+..+|+|||.++..|...++.++|||||++|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 3579999999999998 56788999999986654 45677889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+.+.. ..+++.++..|+++++.||+|||.+ +|+|||||++|||++.+|.+||+|||++....... ...
T Consensus 356 sLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 356 SLTDVVTK------TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred chhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 99999843 4489999999999999999999999 99999999999999999999999999998765543 345
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..||++|||||+.. .+.|++|.||||||++++||+.|.+||-.. .+- .+.............++.....+.+|+.+
T Consensus 429 mVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCC--ChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67999999999997 788999999999999999999999998642 222 22222222223333456667789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
|++.|+++||++.|+++
T Consensus 506 cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLE 522 (550)
T ss_pred HhhcchhcCCCHHHHhc
Confidence 99999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=355.83 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=200.2
Q ss_pred HhccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCC-ceEE
Q 006031 388 SAELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKE-ERLL 459 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~-~~~l 459 (664)
..++||+|+||.||+|.. .++..||+|+++.... ....+.+.+|++++.++ +||||++++++|...+ ..++
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV 89 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence 457899999999999974 2356899999864322 22346788999999999 8999999999987644 5889
Q ss_pred EEecCCCCCHHHHhccCCCC---------------------------------------------------------CCC
Q 006031 460 IYDYQPNGSLFSLIHGSKST---------------------------------------------------------RAK 482 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~ 482 (664)
||||+++|+|.++++..... ...
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 99999999999999743210 023
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----CCCCCCCcccCcccc
Q 006031 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ----DDDPDNLLYKAPETR 558 (664)
Q Consensus 483 ~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~ 558 (664)
.+++.....++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....++..|+|||++
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 588899999999999999999998 999999999999999999999999999986533211 122346789999998
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHH
Q 006031 559 NASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMW 637 (664)
Q Consensus 559 ~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 637 (664)
. ...++.++|||||||++|||++ |+.||...... ..+......... ...+...+..+.+++.+||+.+|++|||+.
T Consensus 249 ~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 249 F-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTR-MRAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred h-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 6 5678999999999999999997 99999764322 222222221111 111223445689999999999999999999
Q ss_pred HHHHHHHhhhc
Q 006031 638 QVLKMLQEIKG 648 (664)
Q Consensus 638 ev~~~L~~i~~ 648 (664)
|+++.|+++..
T Consensus 326 el~~~l~~~~~ 336 (338)
T cd05102 326 ALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.33 Aligned_cols=263 Identities=21% Similarity=0.357 Sum_probs=220.6
Q ss_pred cccCHHHHHHHHhccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC
Q 006031 377 QLYTLDQLMRASAELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE 455 (664)
Q Consensus 377 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 455 (664)
..++++.-.....++||-|.||.||.|.|+. ...||||.++... ...++|.+|..+|+.++|||+|+|+|+|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3445544444456899999999999999876 5679999997654 46789999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..|||+|||..|+|.++|+++. ...++-...+.++.||+.||+||..+ ++|||||.++|+|+.++-.+||+|||++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999998754 34566677889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCC---CCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 536 ALTADSLQDDDPD---NLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 536 ~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
+++..+..+...| .+.|.|||.+. ...++.|+|||+|||+||||.| |-.||.+.. ..++........+ -+.+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--lSqVY~LLEkgyR-M~~P 488 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYGLLEKGYR-MDGP 488 (1157)
T ss_pred hhhcCCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHhcccc-ccCC
Confidence 9998887666665 56899999986 7789999999999999999999 999987642 1222222221111 1345
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.++..++++|+.||+.+|.+||+++|+-+.++.+-...
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 567778999999999999999999999999999886554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=315.03 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=206.6
Q ss_pred HHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 387 ASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...+++|+|.||.||+|+ ...|+.||||+++..+..+.......+||+.++.++|+||+.++++|...+..-||+|||+
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence 345789999999999999 5679999999998877655667788899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
. +|...++. ....++..+...++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+++.......
T Consensus 85 t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 85 T-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred c-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 6 99999963 456799999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--------------
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG-------------- 609 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 609 (664)
....-|.+|+|||.+.+.++|+...|+||.||++.||+-|.+-|.+. .+-+++....+....+.+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 23367899999999998999999999999999999999988877653 222233333222222110
Q ss_pred -----------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 610 -----------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 610 -----------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.........++++..++..+|.+|+|+.|++++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011223456999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.47 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=208.7
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..++||+|-||.|.++...++..||||.++.... .....+|.+|+++|.+++|||||.++|+|..++..++|+|||++|
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 4689999999999999999999999999986543 234689999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.+++.+... ..+.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++-+......
T Consensus 621 DLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 621 DLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred cHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999975321 2245556778999999999999998 9999999999999999999999999999965443322
Q ss_pred -CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCChhhHHHHHHhhccCCC------chhHHH
Q 006031 545 -DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMNWVRSAREDDG------AEDERL 615 (664)
Q Consensus 545 -~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 615 (664)
...-+++|||||.+. -++++.+||||+|||+|||+++ ...||... ..+++.+-......... .+.-++
T Consensus 697 gr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred cceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 233468999999998 6889999999999999999987 77888754 23344443333333321 344566
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..++++|.+||..+.++||+++++...|++.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 7799999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=345.52 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=202.1
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCC-cHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+++||+|+|++||+|+ ...++.+|||++.+.....+ ..+....|-+.|.+| .||.|++|+..|++...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 5789999999999999 55689999999976654322 235567788888888 89999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
+|+|.++|+ +.+.+++.....++.+|+.||+|||+. |||||||||+|||||+|+++||.|||.|+.+.....
T Consensus 158 nGdll~~i~-----K~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 158 NGDLLDLIK-----KYGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred CCcHHHHHH-----HhCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999999995 457799999999999999999999999 999999999999999999999999999987654321
Q ss_pred -------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 544 -------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 544 -------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
...+||..|.+||++. ....+..+|+|+|||++|+|+.|++||.+.. +..-+.+-...+-+.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQKIQALDYEF 306 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHHHHHHhcccC
Confidence 1246899999999997 7788999999999999999999999998642 222222222222233
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
++..+..+.+|+.+.+..||.+|+|..+|-+.
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 44445668999999999999999999877653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.63 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred HHhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 387 ASAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...+.||+|.||.||||+.+ +.+.||+|.+.+.....++.+.+.+|++++++++|||||.++++|+...+.++|+||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 34567999999999999954 57899999998877766667889999999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--C
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--Q 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~ 543 (664)
+ +|+.+|. ..+.+++.....|+.++..||.|||+. +|.|||+||.|||++..+.+|+||||+++-+.... .
T Consensus 85 g-~L~~il~-----~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 85 G-DLFTILE-----QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred h-hHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 7 9999994 456799999999999999999999999 99999999999999999999999999999876543 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-chhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG-AEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~ 622 (664)
....||+.|||||... +..|+..+|.||+||++||+++|++||.. ..+.+.++....++. .+......+.+++
T Consensus 158 tsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPVKPPSTASSSFVNFL 231 (808)
T ss_pred eeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCCCCcccccHHHHHHH
Confidence 3457999999999987 78899999999999999999999999864 456666666665553 3445667799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+.+||.+|.|-.+++.
T Consensus 232 ~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHhhcChhhcccHHHHhc
Confidence 9999999999999998875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.74 Aligned_cols=246 Identities=32% Similarity=0.505 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEEc-----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||.|.||.||+|.+. .+..|+||.++.... ....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeecccccccccccccccccccccccccccccccc
Confidence 357999999999999987 367899999954322 12367899999999999999999999999988889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL- 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 542 (664)
+++|+|.++|+.. ....+++..+..|+.||++||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 9999999999753 245799999999999999999999999 99999999999999999999999999998763211
Q ss_pred ---CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 543 ---QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 543 ---~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
.........|+|||.+. ...++.++||||||+++||++| |+.||... ...++...+....... .+...+..+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQRLP-IPDNCPKDI 234 (259)
T ss_dssp EEESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEETT-SBTTSBHHH
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccc--ccccccccccccccce-eccchhHHH
Confidence 12234667899999987 5668999999999999999999 78888654 3444444443333322 233345568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
.+++..||+.+|++||||.++++.|
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.00 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=203.7
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCcccc---CCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLA---GTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||.|. ...+..||+|.++..... ....+.+.+|+.++++++ ||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 5679999999999997 456899999977654221 123556778999999999 99999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeecccccccc--C
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTA--D 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~--~ 540 (664)
+.+|+|++++.. ...+.+....+++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++.... .
T Consensus 102 ~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 102 CSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred cCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 999999999952 46788899999999999999999999 99999999999999999 999999999999873 3
Q ss_pred CCCCCCCCCCcccCccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH-HHHH
Q 006031 541 SLQDDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER-LGML 618 (664)
Q Consensus 541 ~~~~~~~~~~~y~aPE~~~~~~-~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 618 (664)
......+|++.|+|||++.+.. ....++||||+||+||.|++|+.||++. ....+..-+. ......+... ...+
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~~~~l~~ki~--~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--NVPNLYRKIR--KGEFKIPSYLLSPEA 251 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--cHHHHHHHHh--cCCccCCCCcCCHHH
Confidence 4556788999999999998555 3458899999999999999999999873 1112211111 1111223333 6678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
..++.+|+..+|.+|+|+.|++ .-.-++.
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 9999999999999999999998 5444443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.82 Aligned_cols=249 Identities=21% Similarity=0.363 Sum_probs=201.4
Q ss_pred HhccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||.||+|++. .+..||+|.++.... ......|.+|+..+++++||||+++++++...+..++||||
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 3568999999999999853 367899999875432 22346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....++|..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 88 ~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 88 MSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred CCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999963 234689999999999999999999998 999999999999999999999999998765432211
Q ss_pred ---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....++..|+|||.+. ...++.++|||||||++||+++ |+.||... ...++.+.+...... ..+...+..+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDGFRL-PAPRNCPNLLH 238 (266)
T ss_pred hcccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 1123457899999886 5778999999999999999886 99998753 223333433322211 12334556789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+++.+||+.+|++||++.|+.+.|+++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.79 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred hccccccCceeEEEEEEcC-----------------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEE
Q 006031 389 AELLGKGSLGTTYKAVLDN-----------------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 451 (664)
.+.||+|+||.||++.+++ +..||+|.+..... ......|.+|++++.+++||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 4679999999999998542 34799999865322 12346789999999999999999999999
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCC
Q 006031 452 QAKEERLLIYDYQPNGSLFSLIHGSK--------------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSS 517 (664)
Q Consensus 452 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~ 517 (664)
.+.+..++||||+++|+|.+++.... ......++|....+++.|++.||+|||+. +|+||||||+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~dlkp~ 167 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRDLATR 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccCcchh
Confidence 99999999999999999999985321 11123578999999999999999999998 9999999999
Q ss_pred CeEeCCCCCeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 006031 518 NVLLGPDFEACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSF 591 (664)
Q Consensus 518 NILl~~~~~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt--G~~P~~~~~ 591 (664)
|||+++++.+||+|||+++...... .....++..|+|||++. ...++.++||||||+++|||++ +..||...
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~- 245 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYGEL- 245 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCCCcC-
Confidence 9999999999999999997653321 11233577899999986 5678999999999999999987 55666543
Q ss_pred CChhhHHHHHHhhccCC------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 592 LVPNEMMNWVRSAREDD------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 592 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
...++...+....... ..+...+..+.+++.+||+.+|++||||.||.+.|++
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 -TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred -CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 2223332222111110 1122334568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.53 Aligned_cols=247 Identities=18% Similarity=0.230 Sum_probs=198.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++|+||+++++++.+.+..++|+||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999985 578999999986543321 2345678999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ...
T Consensus 85 g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 85 GDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred CcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999888532 234689999999999999999999998 99999999999999999999999999998654322 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..|+..|+|||++. ...++.++|||||||++|||++|+.||....... ..+...+... ...........+.+++.
T Consensus 161 ~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 161 RVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKSICR 237 (285)
T ss_pred CCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHHHHH
Confidence 56899999999987 6678999999999999999999999997643211 1222212111 11223334556899999
Q ss_pred HcccCCCCCCCC-----HHHHHHH
Q 006031 624 ACNSASPEQRPT-----MWQVLKM 642 (664)
Q Consensus 624 ~Cl~~~P~~RPt-----~~ev~~~ 642 (664)
+||+.+|++||+ ++|+++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.15 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=215.0
Q ss_pred ccccCHHHHHHHHhccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEE
Q 006031 376 AQLYTLDQLMRASAELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450 (664)
Q Consensus 376 ~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~ 450 (664)
.+.|.++.-.....++||+|-||.||+|...+ ...||||..+.... ....+.|.+|..+|++++|||||+++|.
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 33455554444567899999999999998533 34688998876443 3457889999999999999999999999
Q ss_pred EecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEe
Q 006031 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLA 530 (664)
Q Consensus 451 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~ 530 (664)
|.+ ...+||||.++-|.|..+|+. ....|+..+...++.||..||+|||+. ++|||||.++|||+....-+|++
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeec
Confidence 975 578999999999999999974 345789999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCC---CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 531 DYCLTALTADSLQD---DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 531 DfGla~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
|||+++.+.++... ...-++.|||||.+. .++++.+||||.|||.|||++. |..||.+....+. +.. .....
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-I~~--iEnGe 609 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-IGH--IENGE 609 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccce-EEE--ecCCC
Confidence 99999998776432 122367899999997 7899999999999999999998 9999986432211 111 11122
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
..+.++.++..++.+|.+||+.+|.+||++.|+...|.++..
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 224567778889999999999999999999999999988866
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=346.11 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=201.7
Q ss_pred HHhccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEE
Q 006031 387 ASAELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 459 (664)
...+.||+|+||.||+|.. ..+..||||+++.... ....+.+.+|++++..+ +||||++++++|.+.+..++
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 3468899999999999973 3466899999864332 23456788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-------------------------------------------------------------
Q 006031 460 IYDYQPNGSLFSLIHGSKS------------------------------------------------------------- 478 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 478 (664)
||||+++|+|.++++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 9999999999999964221
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC----C
Q 006031 479 ---------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD----D 545 (664)
Q Consensus 479 ---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~----~ 545 (664)
.....++|..+.+|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 0123588999999999999999999998 9999999999999999999999999999765433211 1
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|||||||++|||++ |..||.... ......+++....... .+...+.++.+++.+
T Consensus 276 ~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 352 (375)
T cd05104 276 ARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMP-VDSKFYKMIKEGYRML-SPECAPSEMYDIMKS 352 (375)
T ss_pred CCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC-chHHHHHHHHhCccCC-CCCCCCHHHHHHHHH
Confidence 22456799999986 5678999999999999999998 888886532 2223333333322111 112234568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
||+.+|++||+|.||++.|++.
T Consensus 353 cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 353 CWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.00 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=214.1
Q ss_pred HHHHHHHHhccccccCceeEEEEEE-cC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC
Q 006031 381 LDQLMRASAELLGKGSLGTTYKAVL-DN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE 455 (664)
Q Consensus 381 ~~~l~~~~~~~lG~G~fg~Vy~~~~-~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 455 (664)
++|.+.....+||+|+||+||||.+ ++ ..+||+|++..... .+..+++..|+-+|.+++|||+++++|+|....
T Consensus 693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 4455555678999999999999984 44 35789998865443 345678999999999999999999999998765
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..||++||+.|+|.++++. .+..+.-+..+.|..|||+||.|||++ ++|||||.++|||+.+-..+||.|||++
T Consensus 772 -~qlvtq~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchh
Confidence 8899999999999999984 445688888999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCC----CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 536 ALTADSLQDD----DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 536 ~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
+....+..+. ..-.+.|||-|.+. .+.++.++|||||||++||++| |..||+.. ...++.+..+...+ ...
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~dlle~geR-Lsq 921 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPDLLEKGER-LSQ 921 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhHHHhcccc-CCC
Confidence 9877654332 22357799999987 7889999999999999999999 99999875 33466665554444 334
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
++.....++.++.+||..|++.||+|+++..++.++..
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 55566678999999999999999999999999987644
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.14 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=201.7
Q ss_pred HHHhccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceE
Q 006031 386 RASAELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 386 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 458 (664)
+...+.||+|+||.||+|... ++..||+|+++.... ....+.+.+|+++++.+ +|+|||+++++|...+..+
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 345688999999999998742 345799999975432 12345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCC------------------------------------------------------------
Q 006031 459 LIYDYQPNGSLFSLIHGSKS------------------------------------------------------------ 478 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 478 (664)
+||||+++|+|.++++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999999864210
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC----CCCCC
Q 006031 479 -----TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD----DDPDN 549 (664)
Q Consensus 479 -----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~----~~~~~ 549 (664)
.....+++....+|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ ...++
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 0123578899999999999999999998 9999999999999999999999999999765432211 12245
Q ss_pred CcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccC
Q 006031 550 LLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSA 628 (664)
Q Consensus 550 ~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 628 (664)
..|+|||++. ...++.++|||||||++|||++ |+.||...... ..+.......... ..+...+..+.+++.+||+.
T Consensus 278 ~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 278 VKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRGYQM-SRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred cceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcccCc-cCCCCCCHHHHHHHHHHcCC
Confidence 6799999986 5678999999999999999997 99998764221 2222222221111 11222345689999999999
Q ss_pred CCCCCCCHHHHHHHHHhhh
Q 006031 629 SPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 629 ~P~~RPt~~ev~~~L~~i~ 647 (664)
+|++|||+.||+++|+++.
T Consensus 355 dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 355 EPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=306.25 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=216.1
Q ss_pred cccCHHHHHHHHhccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecC
Q 006031 377 QLYTLDQLMRASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAK 454 (664)
Q Consensus 377 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 454 (664)
..++++++ ..++.||+|-||.||.|+. +++..||+|++.+..... ....++++|+++.+.|+||||+++|+||.+.
T Consensus 17 ~~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 45677776 3578999999999999995 567889999997765432 3457899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 455 EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 455 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
...||++||...|.+...|++. ....++......++.|+|.||.|+|.. +|+||||||+|+|++.++..|++|||-
T Consensus 95 ~riyLilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999999999742 345688888899999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 535 TALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 535 a~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
+...+.......+||.-|.+||+.. +...+.+.|+|++||+.||++.|.+||.... ..+..+.++..... .+...
T Consensus 171 sV~~p~~kR~tlcgt~dyl~pEmv~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~--~p~~i 245 (281)
T KOG0580|consen 171 SVHAPSNKRKTLCGTLDYLPPEMVE-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLK--FPSTI 245 (281)
T ss_pred eeecCCCCceeeecccccCCHhhcC-CCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHcccc--CCccc
Confidence 9887766667788999999999987 6778999999999999999999999998643 33433333333222 22344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.....+++.+|+..+|.+|.+..|++..
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhh
Confidence 5568999999999999999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.30 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=208.8
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCc-cccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDAS-KLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++.||+|+.|.|..|+ ...|+.+|||.+.+. .........+++|+-+|+-+.||||+++++++.++.++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 4679999999999998 467999999999765 33334456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC-CCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-SLQDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-~~~~~ 545 (664)
|-|++++ ...++++..+..+++.||..|+.|+|.. +|+||||||+|+|||.++++||+|||+|.+... ..-+.
T Consensus 97 GELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 97 GELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred chhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 9999999 4567899999999999999999999998 999999999999999999999999999987544 44567
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
.+|.+.|.+||++.+..+...++||||+|||||.|+||+.||++. .-..+..-++.. ..+.+...+.+..+|+.++
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV~~G--~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKVQRG--VFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHHHcC--cccCCCcCCHHHHHHHHHH
Confidence 899999999999997667789999999999999999999999853 122222222222 2234456667789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
++.||++|.|+.||.+.
T Consensus 247 l~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKH 263 (786)
T ss_pred hccCccccccHHHHhhC
Confidence 99999999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.16 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=198.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 35799999999999999888899999886433 245678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.++++.. ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||.++........ .
T Consensus 86 L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 86 LLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 99999632 23589999999999999999999998 9999999999999999999999999998765332211 2
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||++. ...++.++||||||+++|||++ |+.||... ...+....+...... ..+......+.+++.+
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~ 236 (256)
T cd05114 161 AKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRL-YRPKLASMTVYEVMYS 236 (256)
T ss_pred CCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHH
Confidence 23456899999986 5678899999999999999999 89998653 222333333322111 1122234568999999
Q ss_pred cccCCCCCCCCHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L 643 (664)
||+.+|++||+|.|+++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 9999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.37 Aligned_cols=256 Identities=18% Similarity=0.280 Sum_probs=207.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|.+..... .......+.+|++++++++||||+++++++.+.+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999995 4788999998764332 122345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
|+|.+++.... .....+++.....++.|++.||+|||+. +++|+||||+||+++.++.++++|||++........ .
T Consensus 87 ~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 164 (267)
T cd08228 87 GDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHh
Confidence 99999885322 1234578899999999999999999998 999999999999999999999999999876543321 1
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++||||||+++|||++|+.||........++...+................+.+++.+
T Consensus 165 ~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08228 165 SLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243 (267)
T ss_pred cCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHH
Confidence 245778999999886 5667899999999999999999999986543333344443333222222333455679999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
||+.+|++||++.||++.|++++
T Consensus 244 cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 244 CIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HCCCCcccCcCHHHHHHHHHHhc
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.96 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=196.2
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
++||+|+||.||++.. .+++.||+|+++..... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 56889999998754321 123456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99999952 35689999999999999999999999 9999999999999999999999999998753222 1223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..|++.|+|||.+. ...++.++|||||||++|||+||+.||... ....+...+... ....+......+.+++.+|
T Consensus 155 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 155 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILME--EIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred eecCccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCC--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence 45899999999987 567899999999999999999999999653 222332322211 1122233455689999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~ 641 (664)
|+.||++|| ++.++++
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHc
Confidence 999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.71 Aligned_cols=245 Identities=20% Similarity=0.258 Sum_probs=198.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... ++..||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 467999999999999965 578899998864321 123467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.+++.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++.+||+|||+++...........
T Consensus 89 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (331)
T cd06649 89 SLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163 (331)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCC
Confidence 99999953 3458899999999999999999998646999999999999999999999999999866554444556
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH-------------------------
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR------------------------- 602 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~------------------------- 602 (664)
++..|+|||.+. ...++.++|||||||++|||+||+.||..... .++.....
T Consensus 164 g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 164 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcccccccccc
Confidence 899999999987 56789999999999999999999999964321 11111111
Q ss_pred ---------------------hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 603 ---------------------SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 603 ---------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
...............+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000111234568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.96 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=203.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 46899999999999998888899999986433 245788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........ ..
T Consensus 88 L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 88 LLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 99999642 235688999999999999999999998 999999999999999999999999999987644321 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||++. ...++.++|||||||++|||+| |+.||... ........+....... .....+..+.+++.+
T Consensus 164 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 239 (261)
T cd05072 164 AKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGYRMP-RMENCPDELYDIMKT 239 (261)
T ss_pred CccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHH
Confidence 23466899999986 5678899999999999999999 99998653 2233333333222211 122344568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
||+.+|++||++.++.+.|+++
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.73 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=203.6
Q ss_pred hccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|.... ...||+|.+..... ......|.+|++.+.+++||||+++++++...+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 4679999999999998643 25799999864332 2234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 463 YQPNGSLFSLIHGSKSTR-----------AKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
|+++|+|.+++....... ...+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcEEECC
Confidence 999999999996432111 15688999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 532 YCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 532 fGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
||+++...... .....++..|+|||.+. ...++.++|||||||++|||++ |..||... ...++...+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~--~~~~~~~~i~~~~~ 244 (283)
T cd05048 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--SNQEVIEMIRSRQL 244 (283)
T ss_pred CcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCc
Confidence 99997653321 12234577899999886 5678999999999999999998 99998753 23445444433222
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
. ..+...+..+.+++.+||+.+|.+||++.||++.|+.+
T Consensus 245 ~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 245 L-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred C-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2 22344567799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.83 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=198.8
Q ss_pred cccccCceeEEEEEE---cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|.+ .++..+|+|+++.........+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 35788999998754433334577899999999999999999999885 45678999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999952 34689999999999999999999998 999999999999999999999999999976543321
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++.+.+..... .+.+...+..+.++
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~l 230 (257)
T cd05116 155 KTHGKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGER-MECPQRCPPEMYDL 230 (257)
T ss_pred cCCCCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCC-CCCCCCCCHHHHHH
Confidence 1122357899999886 5667889999999999999998 99998753 23344444443222 12233345668999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+.+||+.+|++||++.+|++.|++.
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.53 Aligned_cols=247 Identities=25% Similarity=0.432 Sum_probs=203.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 46899999999999998888899999986543 245778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 548 (664)
|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...........+
T Consensus 88 L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 88 LLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 99999642 234689999999999999999999998 99999999999999999999999999998765433222222
Q ss_pred ---CCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 549 ---NLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 549 ---~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
+..|+|||++. ...++.++||||||+++|||+| |+.||... ....+...+..... .......+..+.+++.+
T Consensus 164 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 164 AKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--TNAEVLQQVDQGYR-MPCPPGCPKELYDIMLD 239 (261)
T ss_pred CcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC-CCCCCcCCHHHHHHHHH
Confidence 35799999886 5678999999999999999999 99998653 22233333322211 11223345678999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
||+.+|++||++.++.+.|+++
T Consensus 240 ~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 240 CWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.71 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=192.7
Q ss_pred ccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||+|... +++.||+|.+..... .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 578999999865332 123346678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDP 547 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~~ 547 (664)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999953 34689999999999999999999998 99999999999999999999999999997543221 22345
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHccc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 627 (664)
|++.|+|||.+. ...++.++|||||||++|||+||+.||.... ..++..... ......+......+.+++.+||+
T Consensus 155 gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 155 GTPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred CCcccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCC--HHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcC
Confidence 899999999987 5678999999999999999999999997531 222222111 11112233345568899999999
Q ss_pred CCCCCCCC---HHHHHH
Q 006031 628 ASPEQRPT---MWQVLK 641 (664)
Q Consensus 628 ~~P~~RPt---~~ev~~ 641 (664)
.+|++||+ +.|++.
T Consensus 230 ~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 230 RDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHcCCCCCHHHHHc
Confidence 99999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=336.46 Aligned_cols=241 Identities=18% Similarity=0.240 Sum_probs=194.9
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
++||+|+||.||++.. .++..||+|.+...... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999998754321 123456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99999852 34689999999999999999999999 99999999999999999999999999987532221 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..|++.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.. .....+......+.+++.+|
T Consensus 155 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 155 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM--EEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ccCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHH
Confidence 45889999999986 5678999999999999999999999987532 2222222211 11112233445688999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~ 641 (664)
|+.+|++|| ++.++++
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHc
Confidence 999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=333.29 Aligned_cols=241 Identities=24% Similarity=0.410 Sum_probs=200.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|.||.||||.. ..++.||+|.+..... ..+.++.++|+.++..++++||.++||.+..+..++++||||.+|+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 6799999999999994 5688999999976543 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
+.+.+.. ...+++....-|.+++..||.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+..... ...
T Consensus 98 v~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 98 VLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred hhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 9999953 34457777778999999999999999 999999999999999999999999999987765433 456
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|||||++. ...|+.|+||||+|++.+||.+|.+|+........ ...+ ....++.........+.+++..|+
T Consensus 172 vGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflI-pk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 172 VGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLI-PKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred cccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEec-cCCCCCccccccCHHHHHHHHHHh
Confidence 7999999999998 67899999999999999999999999976533111 0001 111111222355666999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 006031 627 SASPEQRPTMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~ 641 (664)
+++|+.||+++++++
T Consensus 248 ~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLK 262 (467)
T ss_pred hcCcccCcCHHHHhh
Confidence 999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.49 Aligned_cols=242 Identities=21% Similarity=0.331 Sum_probs=191.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 468999999999999854 688999999854322 123467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.... ...+.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence 986432 345677889999999999999999 999999999999999999999999999987543321 23
Q ss_pred CCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
..|+..|+|||++.. ....+.++|||||||++|||++|+.||....... ..+...+. ..............+.+
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREFRH 306 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHHHH
Confidence 468999999998742 2234568999999999999999999997432111 11211111 11111222334566899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
++.+||+.+|++||++.|+++.
T Consensus 307 li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.67 Aligned_cols=246 Identities=21% Similarity=0.344 Sum_probs=197.9
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||.||+|.. .+++.||+|...... .......+.+|++++++++||||++++++|...+..++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999986 468899999875432 12335678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC---
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD--- 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~--- 545 (664)
|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++..........
T Consensus 80 L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 80 FLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999953 234689999999999999999999998 99999999999999999999999999987654322111
Q ss_pred -CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 -DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 -~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...+..|+|||.+. ...++.++|||||||++||+++ |..||... ........+..... ...+...+..+.+++.
T Consensus 155 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 230 (252)
T cd05084 155 MKQIPVKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANL--SNQQTREAIEQGVR-LPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCceeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccc--CHHHHHHHHHcCCC-CCCcccCCHHHHHHHH
Confidence 12245699999986 5668999999999999999998 88888643 22233332222111 1223344567899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
+||+.+|++|||+.|+.++|++
T Consensus 231 ~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHcCCChhhCcCHHHHHHHHhC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.21 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEEc-CCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.+. ++. .||+|.++.... ....+.+.+|+.+++.++||||++++|+|... ..++|+||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 467999999999999853 333 489999864322 23456788999999999999999999999764 57899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 90 MPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred CCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999963 234588999999999999999999998 999999999999999999999999999987643321
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
.....+..|+|||++. ...++.++|||||||++|||+| |+.||... ...++.......... ..+......+
T Consensus 165 ~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (316)
T cd05108 165 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERL-PQPPICTIDV 240 (316)
T ss_pred ceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhCCCCC-CCCCCCCHHH
Confidence 1122456899999986 5678999999999999999998 99998753 222333333322111 1122234568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+++.+||+.+|++||++.+++..|.++....
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 89999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.02 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=206.4
Q ss_pred HHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 387 ASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
...++||+|+||.||+|...++..+++|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 44578999999999999988899999999865432 3456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
|+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+........ .
T Consensus 87 ~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 87 GSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred CCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 9999999642 335689999999999999999999998 999999999999999999999999999976644322 1
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||.+. ...++.++||||||+++|||++ |+.||... ...+..+.+...... ..+...+..+.+++.
T Consensus 163 ~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 238 (261)
T cd05148 163 DKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--NNHEVYDQITAGYRM-PCPAKCPQEIYKIML 238 (261)
T ss_pred CCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHHhCCcC-CCCCCCCHHHHHHHH
Confidence 233567899999886 5678899999999999999999 89998653 223333333322221 122344566899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+||+.+|++|||+.++++.|+.+
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.34 Aligned_cols=245 Identities=19% Similarity=0.261 Sum_probs=195.7
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|++++++++|+||++++++|.+.+..++||||+++
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 3568999999999999965 578889998764321 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++.....++.+++.||+|||+..+|+||||||+|||++.++.+||+|||++...........
T Consensus 88 ~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 88 GSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999999953 345889999999999999999999854799999999999999999999999999976554443445
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-------------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV------------------------- 601 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~------------------------- 601 (664)
.++..|+|||.+. +..++.++|||||||++|||++|+.||..... .++....
T Consensus 163 ~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 163 VGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred CCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 6889999999986 56788999999999999999999999875321 1111110
Q ss_pred -------------------HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 602 -------------------RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 602 -------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...............++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000001112345889999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.77 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=202.6
Q ss_pred HHhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEE
Q 006031 387 ASAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~l 459 (664)
...+.||+|+||.||+|.... +..||||+++.... ....+.+.+|++++++++ ||||++++++|.+.+..++
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 446789999999999998532 34799999965332 233567899999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCC------------------------------------------------------------
Q 006031 460 IYDYQPNGSLFSLIHGSKST------------------------------------------------------------ 479 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~------------------------------------------------------------ 479 (664)
||||+++|+|.++++.....
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999998643210
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 480 -------------------------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 480 -------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEEE
Confidence 123588899999999999999999998 999999999999999999999
Q ss_pred EeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+++....... ....++..|+|||.+. ...++.++|||||||++|||++ |..||...... ..+...+..
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-~~~~~~~~~ 355 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-STFYNKIKS 355 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-HHHHHHHhc
Confidence 999999976533221 1233567899999886 5678999999999999999997 99998753221 222222222
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.... ......+..+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 356 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 356 GYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2111 1223345668999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=321.19 Aligned_cols=247 Identities=22% Similarity=0.378 Sum_probs=201.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... .+..||+|.+.... ...+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 467999999999999964 58889999986432 24567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 88 ~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 88 NLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred cHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 999999642 234689999999999999999999998 9999999999999999999999999998765443221
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....+..|+|||.+. ...++.++|||||||++|||+| |..||... ...+.......... ...+...+..+.+++.
T Consensus 164 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 239 (263)
T cd05052 164 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGYR-MERPEGCPPKVYELMR 239 (263)
T ss_pred CCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCC-CCCCCCCCHHHHHHHH
Confidence 122356799999886 5678899999999999999998 99998753 22233232222111 1222334566899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+||+.+|++||++.|++++|+++
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.78 Aligned_cols=245 Identities=20% Similarity=0.209 Sum_probs=194.7
Q ss_pred ccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||+||++.. .+++.||+|.+....... ...+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 468899999986543321 1235677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDP 547 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~~ 547 (664)
.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 98885322 2345689999999999999999999999 99999999999999999999999999987654332 12346
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
+++.|+|||++. ...++.++|||||||++|||++|+.||....... ..+..... ......+...+..+.+++.+|
T Consensus 159 g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--ccCCCCcccCCHHHHHHHHHH
Confidence 789999999987 5678899999999999999999999997532211 12221111 111122233456689999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~ 641 (664)
|+.+|++|| +++++++
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhc
Confidence 999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=319.10 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=199.1
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||.||+|..+++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++|+||++++
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 356799999999999998887889999986433 24567888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC--
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD-- 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~-- 545 (664)
+|.++++.. ...++|..+..|+.|++.||+|||+. +++||||||+||++++++.+||+|||+++...+.....
T Consensus 85 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 85 CLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999632 23689999999999999999999998 99999999999999999999999999987654332211
Q ss_pred -CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 -DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 -~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||.+. ...++.++||||||+++||++| |+.||... ...+....+...... ..+...+..+.+++.
T Consensus 160 ~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 235 (256)
T cd05059 160 GTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSAGYRL-YRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHH
Confidence 22345799999987 5678899999999999999999 89998653 223333333222111 112234567999999
Q ss_pred HcccCCCCCCCCHHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L 643 (664)
+||..+|++||||.|+++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.91 Aligned_cols=242 Identities=18% Similarity=0.222 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 467999999999999965 6889999998654321 12346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.++++. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 86 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (291)
T cd05612 86 GELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-WTL 158 (291)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-ccc
Confidence 999999953 34689999999999999999999998 99999999999999999999999999998664432 234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.|++.|+|||.+. ...++.++|||||||++|||++|+.||... ...++.+.+..... ..+......+.+++.+||
T Consensus 159 ~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 159 CGTPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDD--NPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred cCChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHc
Confidence 6889999999986 566789999999999999999999999753 22233332222211 122223456889999999
Q ss_pred cCCCCCCCC-----HHHHHHH
Q 006031 627 SASPEQRPT-----MWQVLKM 642 (664)
Q Consensus 627 ~~~P~~RPt-----~~ev~~~ 642 (664)
+.||.+||+ +.|+++.
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCHHHccCCccCCHHHHhcC
Confidence 999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.21 Aligned_cols=242 Identities=19% Similarity=0.263 Sum_probs=196.3
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
++||+|+||.||++.. .+++.||+|.+...... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999999754321 223467888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9999984 234689999999999999999999999 9999999999999999999999999998753322 1223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..|++.|+|||++. ...++.++|||||||++|||++|+.||... ...++...+.. .....+......+.+++.+|
T Consensus 155 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~--~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 155 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILM--EDIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred ccCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCC--CHHHHHHHhcc--CCccCCCCCCHHHHHHHHHH
Confidence 45899999999986 567899999999999999999999999753 22222222211 11122233445688999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~~ 642 (664)
|+.+|++|| ++.|+++.
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcC
Confidence 999999997 88988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.86 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=195.8
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHH--cCCCCCCcccceEEEecCC----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPNLVPLRAYFQAKE----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l--~~l~H~niv~l~g~~~~~~----~~~lV~e 462 (664)
.++||+|+||.||||.+.+ +.||||++.. .+.+.|..|-++. -.++|+||++++++-.... +..||++
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3579999999999999976 6999999864 3456677666654 4568999999999865544 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA--------WRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
|.++|+|.++|. ...++|....+|+..+++||+|||+. ++|+|||||++|||+..|+++.|+|||+
T Consensus 289 fh~kGsL~dyL~------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLK------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHH------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999995 35699999999999999999999973 4799999999999999999999999999
Q ss_pred cccccCCCCC----CCCCCCcccCccccccCCCCC-----chhhHHHHHHHHHHHHcCCCCC--------CCCCC-----
Q 006031 535 TALTADSLQD----DDPDNLLYKAPETRNASHQAT-----SKSDVYSFGVLLLELLTGKPPS--------QHSFL----- 592 (664)
Q Consensus 535 a~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~-----~ksDVwSfGvvl~elltG~~P~--------~~~~~----- 592 (664)
|..+...... ..+||.+|||||++.+.-.+. .+.||||+|.|||||++...-+ .-++.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9876544322 356999999999997554444 4689999999999999854432 21221
Q ss_pred --ChhhHHHHHHhhccCCCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 593 --VPNEMMNWVRSAREDDGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 593 --~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.-+++...+...+..+.. ....+..+.+.+..||+.||+.|-|+.=|-+++.++....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 112444444433333321 1244567899999999999999999998888888876544
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.12 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=206.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999976 78899999886433222 3356789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
|+|.+++.... .....+++..+..++.+++.||+|||+. +++||||+|+||+++.++.++++|||++........ .
T Consensus 87 ~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 164 (267)
T cd08224 87 GDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccc
Confidence 99999986432 2345689999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++|||||||++|||++|+.||........++.+..................+.+++.+
T Consensus 165 ~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 243 (267)
T cd08224 165 SLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243 (267)
T ss_pred eecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHH
Confidence 235778899999886 5668899999999999999999999986533222223222222111111222445678999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
||..+|++|||+.+|+++|+++.
T Consensus 244 cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 244 CINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.91 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=194.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+++.+ +++.||+|+++.........+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999975 5789999999765444445677889999999999999999999999999999999999987
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~ 544 (664)
.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 86 MLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred HHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 7765542 234689999999999999999999998 999999999999999999999999999987543221 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc------------c------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR------------E------ 606 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~------------~------ 606 (664)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ............ .
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 160 EYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESE-IDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345788999999987 56688999999999999999999999975321 111111100000 0
Q ss_pred --CC----C-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 --DD----G-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 --~~----~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. . .....+..+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0 00113456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=320.70 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=198.0
Q ss_pred hccccccCceeEEEEEEcCC---eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEE
Q 006031 389 AELLGKGSLGTTYKAVLDNR---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~l 459 (664)
.+.||+|+||.||+|...+. ..||+|.++.........+.+.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 46899999999999997543 2689998875433333456788999999999999999999987432 24689
Q ss_pred EEecCCCCCHHHHhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSK-STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
|+||+++|+|.+++.... ......+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCccccc
Confidence 999999999999874221 12234589999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhH
Q 006031 539 ADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613 (664)
Q Consensus 539 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (664)
..... .....+..|+|||+.. ...++.++||||||+++|||++ |+.||... ...++.+.+...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~ 238 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNRL-KQPPD 238 (272)
T ss_pred CcccceecCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCC
Confidence 43221 1223566899999986 5678999999999999999999 88898653 223333333322111 11223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 445689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.35 Aligned_cols=244 Identities=20% Similarity=0.223 Sum_probs=198.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|+++...... ...+.+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999965 58899999997543221 2345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 86 ~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~ 158 (333)
T cd05600 86 GDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSV 158 (333)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCc
Confidence 999999952 34688999999999999999999999 999999999999999999999999999986544 22345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHh----hccCCC--chhHHHHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRS----AREDDG--AEDERLGMLLE 620 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~l~~ 620 (664)
.|++.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+.. ...... ........+.+
T Consensus 159 ~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 159 VGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred ccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 6899999999987 5678999999999999999999999997542 2222221111 111111 01123556889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
++.+||..+|++||++.|+++.
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.79 Aligned_cols=241 Identities=20% Similarity=0.273 Sum_probs=193.6
Q ss_pred ccccccCceeEEEEEE----cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
+.||+|+||.||++.. ..++.||+|.++..... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999985 35789999998754321 12345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-- 541 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 541 (664)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999952 34678888899999999999999998 9999999999999999999999999998753222
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
......|++.|+|||++. ...++.++|||||||++|||++|+.||.... .......+... ....+......+.++
T Consensus 156 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~l 230 (323)
T cd05584 156 VTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--RKKTIDKILKG--KLNLPPYLTPEARDL 230 (323)
T ss_pred cccccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCC--HHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 222346899999999987 5667899999999999999999999997532 12222222111 111222334568899
Q ss_pred HHHcccCCCCCCC-----CHHHHHH
Q 006031 622 AIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
+.+||+.+|++|| ++.++++
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhc
Confidence 9999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.24 Aligned_cols=242 Identities=20% Similarity=0.245 Sum_probs=197.1
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 3578999999999999965 5889999998754321 1234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
+|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 102 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 174 (329)
T PTZ00263 102 GGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-FT 174 (329)
T ss_pred CChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-ce
Confidence 9999999953 34688889999999999999999999 99999999999999999999999999998664432 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..|++.|+|||.+. ...++.++|||||||++|||+||+.||... ...+....+..... ..+......+.+++.+|
T Consensus 175 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 175 LCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAGRL--KFPNWFDGRARDLVKGL 249 (329)
T ss_pred ecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHH
Confidence 46889999999987 566789999999999999999999999653 22222222222211 12222345588999999
Q ss_pred ccCCCCCCCC-----HHHHHH
Q 006031 626 NSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt-----~~ev~~ 641 (664)
|+.||++||+ +.|+++
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhc
Confidence 9999999996 677663
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=319.79 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=189.3
Q ss_pred ccccccCceeEEEEEEcC-------------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc
Q 006031 390 ELLGKGSLGTTYKAVLDN-------------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE 456 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 456 (664)
+.||+|+||.||+|.+.+ ...|++|.+..... .....|.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998532 23588888765332 334578889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC-------eEE
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE-------ACL 529 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~-------~ki 529 (664)
.++||||+++|+|..+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999999863 234689999999999999999999998 9999999999999987664 899
Q ss_pred eeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCChhhHHHHHHhhccCC
Q 006031 530 ADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELL-TGKPPSQHSFLVPNEMMNWVRSAREDD 608 (664)
Q Consensus 530 ~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~ 608 (664)
+|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|+.|+..... .+..........
T Consensus 154 ~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~-- 227 (262)
T cd05077 154 SDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEKERFYEGQCM-- 227 (262)
T ss_pred CCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHhcCcc--
Confidence 999998654322 22456788999998864567889999999999999997 58888764321 122111111111
Q ss_pred CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 609 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
........+.+++.+||+.+|++||++.++++.|
T Consensus 228 -~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 -LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111234588999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.29 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=203.1
Q ss_pred HhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
..+.||+|+||.||+|...+ +..||+|.++.... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEE
Confidence 34679999999999998643 47899999865432 124578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 462 DYQPNGSLFSLIHGSK---------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
||+++++|.++++... ......+++.....++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEECCc
Confidence 9999999999997532 12234589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC
Q 006031 533 CLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED 607 (664)
Q Consensus 533 Gla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 607 (664)
|+++...... .....++..|+|||++. ...++.++|||||||++|||++ |+.||... ...+..+.+......
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--~~~~~~~~~~~~~~~ 243 (280)
T cd05049 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--SNEEVIECITQGRLL 243 (280)
T ss_pred ccceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCcC
Confidence 9987543221 11223467899999987 6678999999999999999999 99998653 233444443322221
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
. .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 244 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 244 Q-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred C-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 223345668999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=318.31 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=199.1
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|...++..||+|.+..... ..+.|.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 457999999999999988877899999864432 45678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.++++.. ...+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++........ .
T Consensus 86 l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 86 LLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 99999632 23689999999999999999999998 9999999999999999999999999998765433211 1
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|||||||++|||+| |+.||.... ..++...+...... .........+.+++.+
T Consensus 161 ~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 236 (256)
T cd05113 161 SKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLRL-YRPHLASEKVYAIMYS 236 (256)
T ss_pred CccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHH
Confidence 23456799999986 5668899999999999999999 999986532 22333333222111 1122234668999999
Q ss_pred cccCCCCCCCCHHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~ 644 (664)
||+.+|++||++.++++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=322.96 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=188.4
Q ss_pred cccccCceeEEEEEEcC-------------------------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcc
Q 006031 391 LLGKGSLGTTYKAVLDN-------------------------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv 445 (664)
.||+|+||.||+|.+.. ...|++|.+..... .....|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999998521 24588898864322 2345688889999999999999
Q ss_pred cceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 446 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
+++++|.+....++||||+++|+|..+++. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccC
Confidence 999999999999999999999999999863 234688999999999999999999998 999999999999997644
Q ss_pred -------CeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCChhhH
Q 006031 526 -------EACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELL-TGKPPSQHSFLVPNEM 597 (664)
Q Consensus 526 -------~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ell-tG~~P~~~~~~~~~~~ 597 (664)
.+|++|||.+...... ....++..|+|||.+.....++.++|||||||++||++ +|+.||.... ..+.
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~ 230 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT--PSEK 230 (274)
T ss_pred cccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC--hHHH
Confidence 3799999987643222 22356788999998864566899999999999999994 7999987532 2222
Q ss_pred HHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 598 MNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
.......... +......+.+++.+||+.+|++||||.+|++.|
T Consensus 231 ~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEKKHRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhccCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2222221111 111224588999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=318.04 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=205.0
Q ss_pred HhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCc-HHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTS-NEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|.||.|-+|. ...|+.||||.+++.+..... .-.+++||++|+.|+||||+.++.+|.+++...|||||..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 34679999999999998 578999999999887763322 3468899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QD 544 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~ 544 (664)
+|.|++++. ....|++.....|++||..|+.|+|.. +++|||||.+|||||.++++||+|||++-++.+.. -+
T Consensus 137 ~GeLYDYiS-----er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 137 GGELYDYIS-----ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred CccHHHHHH-----HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999994 456799999999999999999999998 99999999999999999999999999998776543 35
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..+|++.|.+||...+..+-.+..|-||+||+||-++.|..||++. +....++......-...+.+....-++..
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaYrEP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGAYREPETPSDASGLIRW 285 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhcccccCCCCCchHHHHHHH
Confidence 6789999999999986666688999999999999999999999864 22333332222211111222335678899
Q ss_pred cccCCCCCCCCHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L 643 (664)
++..+|++|.|..||....
T Consensus 286 mLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHhcCcccchhHHHHhhhh
Confidence 9999999999999998654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=319.75 Aligned_cols=256 Identities=19% Similarity=0.288 Sum_probs=206.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .++..+|||.+...... ....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 46799999999999995 57889999988653321 12345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
++|.+++.... .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++........ .
T Consensus 87 ~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd08229 87 GDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccc
Confidence 99999986322 2335689999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||++. ...++.++||||||+++|||++|..||...........+.+................+.+++.+
T Consensus 165 ~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08229 165 SLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243 (267)
T ss_pred cccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHH
Confidence 345788999999986 5668899999999999999999999986532222233333322222222233456679999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
||+.+|++||||.+|++.++++.
T Consensus 244 ~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 244 CINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.19 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=203.7
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... ++..+++|.++.... ...+.+.+|++.+++++|+||+++++++...+..++|||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 367999999999999742 356789998864432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 463 YQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
|+++++|.++++.... .....++|..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEECC
Confidence 9999999999964321 1224589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 532 YCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 532 fGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
||++....... .....++..|+|||++. ...++.++|||||||++|||+| |+.||.... ..+..+.......
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~ 243 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--NTEVIECITQGRV 243 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhCCCC
Confidence 99987553321 11234567899999886 5678999999999999999999 999986532 2233333322221
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
. ......+..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 244 ~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 244 L-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred C-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11223455689999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.88 Aligned_cols=248 Identities=21% Similarity=0.388 Sum_probs=202.0
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||+||+|.+.. ...||+|.++.... ......|.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 5689999999999998742 46899998865432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||+++.......
T Consensus 88 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 88 ENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 999999999632 24689999999999999999999998 999999999999999999999999999987642111
Q ss_pred ---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....++..|+|||.+. ...++.++||||||+++||+++ |..||... ...++.+.+...... ..+...+..+.
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~ 238 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAVEDGYRL-PPPMDCPSALY 238 (266)
T ss_pred eeccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 1123457899999986 5678999999999999999998 99998653 233444444322111 12223456689
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+++.+||+.+|++||++.||++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.66 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=209.4
Q ss_pred HHhccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 387 ASAELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
...++||+|.||+|++|.|.. ...||||.+....... ...+|.+|+.+|-+|+|+|+++|||...+ ...++|+|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 357899999999999999753 3578999998766532 67899999999999999999999999887 78899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
.++.|+|.+.|++ .....|-......++.|||.||.||..+ ++|||||.++|+||-..-.+||+|||+.+-+....
T Consensus 191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999985 3456788888899999999999999999 99999999999999999999999999998765543
Q ss_pred CC-----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 543 QD-----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 543 ~~-----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
.. ...-.+.|-|||.+. .+.++.++|||+|||++||||| |..||.+- ...++.+.+. ..+....+..+++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD-~~erLpRPk~cse 342 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNID-AGERLPRPKYCSE 342 (1039)
T ss_pred cceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhcc-ccccCCCCCCChH
Confidence 22 122356799999997 8899999999999999999999 88998763 3446666665 3334445667788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
.++++|+.||+.+|++||||..+++.+
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhH
Confidence 899999999999999999999998555
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.52 Aligned_cols=255 Identities=22% Similarity=0.390 Sum_probs=203.5
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||++.. .++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 46799999999999974 2346689998865432 345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 463 YQPNGSLFSLIHGSKS--------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
|+++++|.++++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccCCc
Confidence 9999999999964321 1234589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCC
Q 006031 535 TALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDG 609 (664)
Q Consensus 535 a~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 609 (664)
++....... ....++..|+|||.+. ...++.++|||||||++|||+| |+.||.... ..+....+...... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~~~~~~~i~~~~~~-~ 242 (288)
T cd05093 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECITQGRVL-Q 242 (288)
T ss_pred cccccCCceeecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCcC-C
Confidence 975533211 1233467899999886 5678999999999999999999 899986542 22333333222111 1
Q ss_pred chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 610 AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 610 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.....+..+.+++.+||+.+|.+|||+.|+.+.|+++....
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 12223456899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.84 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=202.1
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc------eE
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE------RL 458 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~ 458 (664)
.+.||+|+||.||+|.... +..||+|+++.........+.+.+|++.++.++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999998643 3679999987544433345678999999999999999999999866554 78
Q ss_pred EEEecCCCCCHHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKS-TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
+|+||+++|+|..++..... .....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccceee
Confidence 99999999999999854321 1234689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... .....+..|+|||++. ...++.++|||||||++|||++ |..||... ...++.+++...... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~ 238 (273)
T cd05035 163 IYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--ENHEIYDYLRHGNRL-KQPE 238 (273)
T ss_pred ccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCc
Confidence 543321 1123456899999886 5678999999999999999999 88988653 233444444332222 1233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.30 Aligned_cols=243 Identities=19% Similarity=0.190 Sum_probs=196.5
Q ss_pred HhccccccCceeEEEEEEcC--CeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 388 SAELLGKGSLGTTYKAVLDN--RLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
..+.||+|+||.||+|...+ +..||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 35789999999999998543 368999998654321 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 114 ~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-~ 186 (340)
T PTZ00426 114 IGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-Y 186 (340)
T ss_pred CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-c
Confidence 99999999953 34689999999999999999999999 99999999999999999999999999998754332 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...||+.|+|||++. ...++.++|||||||++|||+||+.||... ....+...+.... ...+......+.+++.+
T Consensus 187 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 187 TLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYAN--EPLLIYQKILEGI--IYFPKFLDNNCKHLMKK 261 (340)
T ss_pred eecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCC--CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHH
Confidence 356899999999987 566789999999999999999999999753 2222222222111 11222334457899999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 006031 625 CNSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RP-----t~~ev~~~ 642 (664)
|++.+|++|+ +++|+.+.
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999995 78887654
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.51 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=200.2
Q ss_pred ccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
++||+|++|.||+|.+.+ ...||+|.+...... ...+.+.+|++.+++++||||+++++++.+ ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 236899999765543 345689999999999999999999999988 88999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
+|+|.+++.... ...++|.....++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999996422 15689999999999999999999998 999999999999999999999999999986544211
Q ss_pred ---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....++..|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+.........+...+..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ecccCCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 1234667899999886 5678999999999999999999 99998643 223333333322222222334456799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+++.+||+.+|++||++.|+++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.43 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=202.1
Q ss_pred HHHhccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceE
Q 006031 386 RASAELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 386 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~ 458 (664)
....++||+|+||.||+|.+. .+..||+|+++.... ....+.+.+|++++.++. |||||+++++|...+..+
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 345789999999999999864 346899999975432 223457889999999997 999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCC------------------------------------------------------------
Q 006031 459 LIYDYQPNGSLFSLIHGSKS------------------------------------------------------------ 478 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 478 (664)
+|+||+++|+|.++++..+.
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999975321
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 479 ---------------------------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 479 ---------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
.....++|...+.|+.|++.||+|||+. +++||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCC
Confidence 0113478888999999999999999998 999999999999999999
Q ss_pred CeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHH
Q 006031 526 EACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 526 ~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 600 (664)
.+|++|||+++....... ....++..|+|||.+. ...++.++|||||||++|||++ |+.||..... .......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~~~~~ 354 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQFYNA 354 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHH
Confidence 999999999976432211 1234567899999986 5668899999999999999998 8899865321 1222222
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
+...... ..+......+.+++.+||..+|++||+++||++.|+++.
T Consensus 355 ~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 355 IKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2211111 112223456899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.47 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=196.9
Q ss_pred cccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|.+. ++..||+|.+..... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999863 456799999865432 233567999999999999999999999885 45789999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+++.. ....+++..+.+++.|++.||+|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 80 ~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999963 234689999999999999999999998 999999999999999999999999999975433221
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....++..|+|||.+. ...++.++|||||||++||+++ |+.||... ...++...+...... +.+...+..+.++
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 155 RSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred cCCCCCCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1122356899999886 5668899999999999999997 99998753 233444443332221 2223345668899
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+.+||+.+|++||++.+|.+.|+++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.50 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=198.9
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
++||+|+||.||+|...++..||+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999988899999999865332 22345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---CC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---DD 546 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~~ 546 (664)
.+++... ...+++..+..++.+++.||.|||+. +++||||||+||++++++.+|++|||++......... ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9998632 34588999999999999999999998 9999999999999999999999999998754433211 12
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
.++..|+|||++. ...++.++||||||+++||+++ |..||... ........+...... ..+...+..+.+++.+|
T Consensus 155 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 155 QIPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCcccccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHH
Confidence 3456799999986 6678999999999999999999 99998653 222222222222111 12223456789999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~L~ 644 (664)
|+.+|++||++.|++++|.
T Consensus 231 l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 231 WDYKPENRPKFSELQKELA 249 (250)
T ss_pred cccCcccCCCHHHHHHHhc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.37 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=191.6
Q ss_pred cccccCceeEEEEEEcC---CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLDN---RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|...+ +..+|+|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 45789998865432 223457888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.++++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999999753322334577888889999999999999998 999999999999999999999999999875433211
Q ss_pred CCCCCCCcccCccccccC------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHH-HHhhcc---CCCchh
Q 006031 544 DDDPDNLLYKAPETRNAS------HQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW-VRSARE---DDGAED 612 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~------~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~-~~~~~~---~~~~~~ 612 (664)
....++..|+|||++... ..++.++||||||+++|||++ |+.||..... .+.... +..... ......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcccCCCCCCccCC
Confidence 123457789999987522 135789999999999999996 9999975422 222221 111111 111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.....+.+++..|| .+|++|||+.||++.|.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22345788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=323.48 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=192.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... ++..||+|.++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 467999999999999864 688999999865432 23345678899999999999999999999999999999999975
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 88 ~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 88 DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 99998853 234578899999999999999999998 99999999999999999999999999987543222 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||.+.+...++.++||||+||++|||+||+.||..... ...+...........
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 45788999999887556789999999999999999999999975421 111111111100000
Q ss_pred ---C-------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---G-------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---~-------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ..........+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.55 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=192.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 467999999999999965 688999999875432 2234567789999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 88 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 88 DLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 88888853 234588899999999999999999999 9999999999999999999999999998754322 1223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..+++.|+|||.+.+...++.++|||||||++|||+||+.||.........+...........
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 457889999998865566889999999999999999999999764221112211111100000
Q ss_pred ------Cchh------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ------GAED------ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ------~~~~------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... .....+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 01235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.17 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=200.9
Q ss_pred cCHHHHHHHHhccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCc
Q 006031 379 YTLDQLMRASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE 456 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 456 (664)
+.++|.. ....||.|+||.|.+++. .+|..+|+|++++.+.-. ...+....|..+++.+.||+++++++.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 5666653 457899999999999995 468899999998765422 234567789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.||||||++||.|+.+++. .+.++......+|.||+.||+|||+. +|++|||||+|||+|.+|.+||.|||+|+
T Consensus 119 lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceE
Confidence 9999999999999999963 45689999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 537 LTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 537 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
..... ....+||+.|+|||.+. .+.+...+|.|||||++|||+.|.+||.... +..+.+-+ .......+.....
T Consensus 193 ~v~~r-T~TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI--~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 193 RVSGR-TWTLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKI--LEGKVKFPSYFSS 266 (355)
T ss_pred EecCc-EEEecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHH--HhCcccCCcccCH
Confidence 87665 45578999999999997 7888999999999999999999999997642 22222222 1222223444455
Q ss_pred HHHHHHHHcccCCCCCC
Q 006031 617 MLLEVAIACNSASPEQR 633 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~R 633 (664)
.+.+++.+.++.|-.+|
T Consensus 267 ~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHHhhhhHhh
Confidence 68889999999998888
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.10 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=200.6
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 3567999999999999988888999999875433 4567999999999999999999999875 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.++++.. ....+++.++..++.+++.||+|||+. +++||||||+||++++++.++++|||++.........
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 86 SLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999999642 234589999999999999999999998 9999999999999999999999999999765433211
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||++. ...++.++||||||+++|||++ |+.||... ...+..+...... ..+.+...+..+.+++.
T Consensus 162 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQVERGY-RMPCPQDCPISLHELML 237 (260)
T ss_pred CCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-CCCCCCcCCHHHHHHHH
Confidence 123456799999886 5678899999999999999999 89998653 2233333332221 11223344566999999
Q ss_pred HcccCCCCCCCCHHHHHHHHHh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
+||+.+|++|||+.++.+.|++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.07 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEc-CCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|.+. ++. .|++|.+..... ......+..|+..+++++||||+++++++. ....++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 468999999999999863 343 477777753221 123456788888999999999999999885 4567899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....++|.....|+.||+.||+|||+. +++||||||+||++++++.+|++|||+++.......
T Consensus 90 ~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 90 SPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999963 234689999999999999999999998 999999999999999999999999999976543221
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....++..|+|||.+. ...++.++|||||||++||++| |+.||.+. ....+.+.+....... .+......+
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (279)
T cd05111 165 KYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM--RPHEVPDLLEKGERLA-QPQICTIDV 240 (279)
T ss_pred ccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcCC-CCCCCCHHH
Confidence 1234567899999986 5678999999999999999998 99998753 2334444443322221 112233457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 8899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=306.32 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=202.5
Q ss_pred CHHHHHHHHhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCc
Q 006031 380 TLDQLMRASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEE 456 (664)
Q Consensus 380 ~~~~l~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~ 456 (664)
++++. ...+.|++|+||.||+|+. +++..||+|+++.......---...+||.++.+++|||||.+..+... -+.
T Consensus 74 sv~ef--e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEF--EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHH--HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 34444 3357899999999999994 568899999998765433334456799999999999999999988754 457
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.|+|||||+. ||..+++.. ..++...+...+..|+++|++|||+. -|+|||||++|+|+..+|.+||+|||+|+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhh
Confidence 9999999987 999999743 36788899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCC--CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-----
Q 006031 537 LTADSLQ--DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG----- 609 (664)
Q Consensus 537 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 609 (664)
....... +...-|.+|+|||.+.+...|++..|+||+|||+.|++++++-|.+.. ...++....+....+.+
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCccccCCC
Confidence 8876643 234568999999999989999999999999999999999999887642 22233333332222110
Q ss_pred -----------------------ch-hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 -----------------------AE-DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 -----------------------~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. ......-++++...+..||.+|.|+.|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 002245678999999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.36 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=207.0
Q ss_pred ccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
-+||+|.||+||-|+ ..+...+|||.+..... ...+-+.+||.+-++++|.|||+++|.|.+++..-|.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 479999999999999 45677899999876544 445678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccCC--CC
Q 006031 469 LFSLIHGSKSTRAKPL--HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~--~~ 543 (664)
|.++|+. .-+++ .+.+.-.+.+||++||.|||+. .|||||||-.|||++. .|.+||+|||-++.+..- ..
T Consensus 659 LSsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 659 LSSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9999973 44566 6778888999999999999999 9999999999999975 689999999999876543 34
Q ss_pred CCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
....||..|||||++..+ +.|..++|||||||++.||.||++||-... .+.-.+--+......+..+++...+...++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg-spqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG-SPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC-ChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 456799999999999744 347899999999999999999999997532 233333344555555567788888899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+|+.++|.+||+++++++.
T Consensus 813 lrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHcCCCcccCccHHHhccC
Confidence 99999999999999998753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.32 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=193.8
Q ss_pred ccccccCceeEEEEEE----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+.||+|+||.||++.. .+++.||+|++............+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357899999997654433344567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--C
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--Q 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~ 543 (664)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999952 34689999999999999999999998 99999999999999999999999999987654332 1
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....|+..|+|||.+. ...++.++|||||||++|||+||+.||... ...+....+.... ...+......+.+++.
T Consensus 156 ~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~--~~~~~~~~i~~~~--~~~p~~~~~~~~~li~ 230 (318)
T cd05582 156 YSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGK--DRKETMTMILKAK--LGMPQFLSPEAQSLLR 230 (318)
T ss_pred ecccCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCC--CHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 2345889999999986 566789999999999999999999999753 2223322222111 1122233456889999
Q ss_pred HcccCCCCCCCCHHH
Q 006031 624 ACNSASPEQRPTMWQ 638 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~e 638 (664)
+||+.+|++||++.+
T Consensus 231 ~~l~~~P~~R~~a~~ 245 (318)
T cd05582 231 ALFKRNPANRLGAGP 245 (318)
T ss_pred HHhhcCHhHcCCCCC
Confidence 999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.31 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=199.3
Q ss_pred ccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
++||+|+||.||+|.... +..+|+|.+...... ...+.+.+|++++++++|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999997432 268999998755432 34567899999999999999999999876 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC-
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD- 544 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~- 544 (664)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++........
T Consensus 79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999953 23689999999999999999999998 9999999999999999999999999999765433211
Q ss_pred ----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 545 ----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 545 ----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
...++..|+|||.+. ...++.++|||||||++||+++ |+.||... ...++..++...... ..+...+..+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~ 228 (257)
T cd05060 153 RATTAGRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESGERL-PRPEECPQEIY 228 (257)
T ss_pred ccccCccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCcC-CCCCCCCHHHH
Confidence 112346799999886 5678999999999999999998 99998753 233444444333221 22333456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
+++.+||..+|++||++.++++.|+++.
T Consensus 229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 229 SIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.86 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=203.3
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... ....+++|.+..... ....+.+.+|+.+++.++||||++++++|...+..++|+|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 467999999999999853 235788888764322 1234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 463 YQPNGSLFSLIHGSKS-------------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
|+.+|+|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||++++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill~~ 162 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLVAE 162 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEEcC
Confidence 9999999999864211 1124588999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHH
Q 006031 524 DFEACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMM 598 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~ 598 (664)
++.+||+|||+++....... ....++..|+|||++. ...++.++||||||+++|||+| |+.||... ....+.
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~ 239 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--APERLF 239 (290)
T ss_pred CCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCC--CHHHHH
Confidence 99999999999875432211 1223467899999876 5678999999999999999999 99998653 334444
Q ss_pred HHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 599 NWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
......... ..+......+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 240 NLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 544432222 12233445689999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.88 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=197.3
Q ss_pred HhccccccCceeEEEEEEc-C-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-N-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||.||+|... + +..||+|.+..... .....+.+|+++++.++|||||++++++...+..++||||++
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 3578999999999999843 3 57788887643322 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
+|+|.++++... ....++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999886322 2235688999999999999999999998 99999999999999999999999999998754432
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||... ...++...+...... ..+......+.++
T Consensus 227 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--~~~~~~~~~~~~~~~-~~~~~~s~~~~~l 302 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGP--SQREIMQQVLYGKYD-PFPCPVSSGMKAL 302 (478)
T ss_pred cccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-CCCccCCHHHHHH
Confidence 22345899999999987 567899999999999999999999998753 222333332221111 1122334568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.+|++||++.+++.
T Consensus 303 i~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhccChhhCcCHHHHHh
Confidence 99999999999999999864
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.63 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=204.9
Q ss_pred hccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 462 (664)
.++||+|+||.||+|...+ +..|++|++.... .....+.+.+|+.++++++|+||+++++++.. ....++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 5789999999999999766 7889999886432 22335678899999999999999999998776 567899999
Q ss_pred cCCCCCHHHHhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 463 YQPNGSLFSLIHGSKST---RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
|+++|+|.+++...... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.+.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~ 168 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRDLF 168 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence 99999999999643211 125689999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 540 DSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 540 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
.... ....++..|+|||++. ...++.++||||||+++||+++ |+.||... ...++..+........ .....
T Consensus 169 ~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~ 244 (280)
T cd05043 169 PMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDGYRLA-QPINC 244 (280)
T ss_pred CCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcCCCCC-CCCcC
Confidence 3211 1234567899999986 5668999999999999999999 99998753 2334444443332211 12233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+..+.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 45689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.12 Aligned_cols=246 Identities=20% Similarity=0.239 Sum_probs=193.9
Q ss_pred ccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||++.. .+|+.||+|.+....... .....+..|++++++++||||+++.+++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 458899999986543322 2234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DDDPD 548 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~~~ 548 (664)
.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........ ....+
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence 9988532 234589999999999999999999998 999999999999999999999999999876543322 23467
Q ss_pred CCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHHHHHcc
Q 006031 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVAIACN 626 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl 626 (664)
+..|+|||++. ...++.++|||||||++|||++|+.||...... .............. .........+.+++.+||
T Consensus 157 ~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 234 (277)
T cd05607 157 TNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL 234 (277)
T ss_pred CCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence 88999999987 556899999999999999999999998753221 11111111111111 111233456899999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 006031 627 SASPEQRPTMWQVLKML 643 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L 643 (664)
+.+|++||+++|+++.+
T Consensus 235 ~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 235 AKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCHhhCCCCccchhhh
Confidence 99999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.81 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=197.3
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-----CCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-----KEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e~ 463 (664)
+.||+|+||.|+.|.. .+|..||||++...-......+.-.+|+++++.++|+||+.+.+.+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5699999999999984 568999999997443333455677899999999999999999998754 4478999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC---
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--- 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 540 (664)
|+ -+|...++ ....|+......+..|+++||.|+|+. +|+||||||+|++++.+...||+|||+|+....
T Consensus 108 Me-tDL~~iik-----~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 108 ME-TDLHQIIK-----SQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred Hh-hHHHHHHH-----cCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 94 59999995 344599999999999999999999999 999999999999999999999999999998753
Q ss_pred -CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-------------h---------H
Q 006031 541 -SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-------------E---------M 597 (664)
Q Consensus 541 -~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-------------~---------~ 597 (664)
..-+....|.+|+|||.+.....|+...||||.||++.||++|++-|.+.....+ + .
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 2234567899999999988788899999999999999999999999876532111 0 1
Q ss_pred HHHHHhhccCCCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 598 MNWVRSAREDDGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 598 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+++........ .........+++.+++..||.+|+|++|.++.
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111110 11223457899999999999999999998763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.57 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=192.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+.||+|+||.||+|.. .++..||+|++............+.+|++++++++||||+++++++...+ ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46799999999999995 46889999998643322233456889999999999999999999885432 4799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 85 LME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred cCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 995 69999984 234689999999999999999999999 99999999999999999999999999997543221
Q ss_pred C-----CCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH--------------
Q 006031 543 Q-----DDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR-------------- 602 (664)
Q Consensus 543 ~-----~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~-------------- 602 (664)
. ....++..|+|||++.. ...++.++|||||||++|||+||+.||..... ......+.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHh
Confidence 1 23458899999998753 25678999999999999999999999965321 11111100
Q ss_pred ----------hhccCCCc--h---hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhc
Q 006031 603 ----------SAREDDGA--E---DERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKG 648 (664)
Q Consensus 603 ----------~~~~~~~~--~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~ 648 (664)
........ . ......+.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000 0 0123457899999999999999999999864 444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.15 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=198.3
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... .+..||+|++..... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 467999999999999753 256799998854322 1234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSKST-----RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
|+++|+|.++++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 168 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCccc
Confidence 99999999999642211 123578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... ....++..|+|||++. ...++.++|||||||++|||++ |..||... ...+..+.+..... ...+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~-~~~~~ 244 (277)
T cd05062 169 IYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRFVMEGGL-LDKPD 244 (277)
T ss_pred cCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCc-CCCCC
Confidence 433221 1123467899999986 5678999999999999999999 78888653 22333333322211 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
..+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 344568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.02 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=200.5
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|.. .++..|++|.+..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence 46799999999999984 3467899999874332 12346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 464 QPNGSLFSLIHGSKS------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
+++++|.+++..... .....+++.+...++.|++.||+|||+. +++||||||+||++++++.+|++|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCcEEecc
Confidence 999999999853210 1124588999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 532 YCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 532 fGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
||+++...... .....++..|+|||++. ...++.++|||||||++|||++ |..||... ...++.+.+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~ 244 (283)
T cd05090 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVIEMVRKRQL 244 (283)
T ss_pred ccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCc
Confidence 99997653321 12233567799999986 5678999999999999999999 99998653 23344444433222
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
. ..+...+..+.+++.+||+.+|++||++.++.++|+.
T Consensus 245 ~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 245 L-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred C-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1223344568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.85 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=199.4
Q ss_pred HHhccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC-CceE
Q 006031 387 ASAELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK-EERL 458 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~ 458 (664)
...+.||+|+||.||+|... .++.||+|+++.... ....+.+.+|++++.++ +|+||++++++|... ...+
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 34578999999999999742 246899999864322 12345677899999999 899999999988654 5688
Q ss_pred EEEecCCCCCHHHHhccCCCC--------------------------------------------------------CCC
Q 006031 459 LIYDYQPNGSLFSLIHGSKST--------------------------------------------------------RAK 482 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~ 482 (664)
+++||+++|+|.+++...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998632110 023
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----CCCCCCCcccCcccc
Q 006031 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ----DDDPDNLLYKAPETR 558 (664)
Q Consensus 483 ~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~ 558 (664)
.++|..+.+++.||+.||+|||+. +|+||||||+|||+++++.++|+|||+++....... ....++..|+|||++
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 689999999999999999999998 999999999999999999999999999986533221 122346789999988
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHH
Q 006031 559 NASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMW 637 (664)
Q Consensus 559 ~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 637 (664)
. ...++.++|||||||++|||++ |+.||...... ..+.......... ..+......+.+++.+||+.+|++||++.
T Consensus 248 ~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 248 F-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred c-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 6 5778999999999999999998 99998753221 2222222211111 11223345689999999999999999999
Q ss_pred HHHHHHHhhhc
Q 006031 638 QVLKMLQEIKG 648 (664)
Q Consensus 638 ev~~~L~~i~~ 648 (664)
|+++.|+++..
T Consensus 325 ell~~l~~~~~ 335 (337)
T cd05054 325 ELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHh
Confidence 99999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=331.41 Aligned_cols=245 Identities=20% Similarity=0.240 Sum_probs=194.3
Q ss_pred hccccccCceeEEEEEE----cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||++.. .+++.||+|++...... ....+.+.+|++++.++ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46799999999999875 35789999998654321 12345678899999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 85 DYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999953 34689999999999999999999998 9999999999999999999999999998764322
Q ss_pred C---CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHHH
Q 006031 542 L---QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 542 ~---~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
. .....|+..|+|||.+.+...++.++|||||||++|||+||+.||...... ...+...+.. .....+.....
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCH
Confidence 1 123458999999999874445788999999999999999999999643211 1222222211 11122233445
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
.+.+++.+||+.||++|| ++.++++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 688999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.91 Aligned_cols=246 Identities=19% Similarity=0.267 Sum_probs=188.2
Q ss_pred hccccccCceeEEEEEE--cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC---CCCCcccceEEEec-----CCceE
Q 006031 389 AELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVPLRAYFQA-----KEERL 458 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~-----~~~~~ 458 (664)
.+.||+|+||+||+|.. .++..||+|+++...........+.+|+.+++.+ +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 46799999999999985 3478899999875443333344566677666554 79999999999852 34689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
+||||++ ++|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred EEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 9999996 6999998632 234589999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---------
Q 006031 539 ADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--------- 608 (664)
Q Consensus 539 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--------- 608 (664)
.... .....++..|+|||.+. ...++.++|||||||++|||++|++||..... ...+...+.......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred cCCcccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhchhhhc
Confidence 4332 22345789999999986 56788999999999999999999999976421 111211111110000
Q ss_pred -----------Cc----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -----------GA----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -----------~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. .......+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0112345789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.18 Aligned_cols=247 Identities=18% Similarity=0.233 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||++.. .+++.||+|.+....... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46799999999999985 468899999986543321 2235677899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........ ..
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 85 GDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred CcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999988532 234689999999999999999999998 999999999999999999999999999976543222 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||.+. ...++.++|||||||++||+++|+.||....... .++...+... ....+......+.+++.
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 161 RVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARSICR 237 (285)
T ss_pred ccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHHHHH
Confidence 46789999999987 5678899999999999999999999997532211 1222222211 11223345566899999
Q ss_pred HcccCCCCCCC-----CHHHHHHH
Q 006031 624 ACNSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 624 ~Cl~~~P~~RP-----t~~ev~~~ 642 (664)
+||+.||++|| +++++++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.44 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=201.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..|++|.+..........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 367999999999999964 6889999998755444445678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++++.. ....+++..+..++.+++.||.|||+. +++|+||||+||++++++.++++|||+++....... ..
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 85 DLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred cHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 999999742 235689999999999999999999998 999999999999999999999999999876544322 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||+.. ...++.++|||||||++|||+||+.||.... .......+...... .........+.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 161 IVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGVFP-PVSQMYSQQLAQLIDQC 236 (256)
T ss_pred cccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCC-CCccccCHHHHHHHHHH
Confidence 35778899999987 5668899999999999999999999997542 23333332221111 12224456689999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.++++.
T Consensus 237 l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 237 LTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCCcccCcCHHHHhhC
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.82 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=193.2
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||+|... +++.||+|+++..... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 5789999998754321 22345677888888765 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999999853 34689999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|+..|+|||++. ...++.++|||||||++|||+||+.||... ...+....+... ....+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 155 TFCGTPDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEAD--NEDDLFESILHD--DVLYPVWLSKEAVSILKA 229 (321)
T ss_pred ccccCccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCC--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 345889999999986 567899999999999999999999999753 223333322211 111222234568899999
Q ss_pred cccCCCCCCC-------CHHHHHHH
Q 006031 625 CNSASPEQRP-------TMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RP-------t~~ev~~~ 642 (664)
|++.+|++|| ++.++++.
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.14 Aligned_cols=238 Identities=22% Similarity=0.304 Sum_probs=197.3
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+..+||+|+||.||.|+- ..|..+|+|++++..... .+.+..+.|-.+|...++|.||+|+..|++.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 357899999999999995 569999999998765422 344678888999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC-----
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD----- 540 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----- 540 (664)
|||+..+| .....|+......++.+++.|++-||+. |+|||||||+|+|||..|++|++|||++.-...
T Consensus 225 GGD~mTLL-----~~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 225 GGDMMTLL-----MRKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred CccHHHHH-----HhcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999999 4567899999999999999999999999 999999999999999999999999999842110
Q ss_pred ------------------C-C-----C--------------------CCCCCCCcccCccccccCCCCCchhhHHHHHHH
Q 006031 541 ------------------S-L-----Q--------------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVL 576 (664)
Q Consensus 541 ------------------~-~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvv 576 (664)
. . . ....||+-|||||++. +..|+..+|.||+|||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHHHHH
Confidence 0 0 0 0124789999999998 5668999999999999
Q ss_pred HHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCC
Q 006031 577 LLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPT 635 (664)
Q Consensus 577 l~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 635 (664)
||||+.|.+||......+ ..+..|......+.+.. ...+..++|.+|+. ||++|--
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--ccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999998754332 36777776555544322 22568899999998 9999986
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=313.03 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=193.8
Q ss_pred ccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~ 464 (664)
+.||+|+||.||+|... +...||+|++..... ....+.+.+|+.+++.++||||+++++++.. ++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999853 246799998854221 1234678899999999999999999998764 55689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-- 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 542 (664)
.+|+|.++++.. ...+.+..+..++.|++.||+|||+. +++||||||+|||+++++.+|++|||+++......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999632 23467888899999999999999998 99999999999999999999999999987543321
Q ss_pred ----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 543 ----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTG-KPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 543 ----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
.....++..|+|||++. ...++.++|||||||++|||++| .+||... ...++...+...... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRRL-LQPEYCPDP 230 (262)
T ss_pred eecccccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCCC-CCCCcCCHH
Confidence 11223466899999886 56788999999999999999995 5565532 223333333222111 112223456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.62 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=195.2
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.||+|+||.||++.. .++..||+|.++..... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 56889999998754321 123456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|..++. ....+++..+..++.|++.||+|||+..+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9999984 23468999999999999999999997339999999999999999999999999998753222 2223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..|++.|+|||++. ...++.++|||||||++|||+||+.||... ........+.... ...+......+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~ 230 (325)
T cd05594 156 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEE--IRFPRTLSPEAKSLLSGL 230 (325)
T ss_pred ccCCcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCC--CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHH
Confidence 45899999999986 567899999999999999999999999753 2223333222111 112223345688999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~~ 642 (664)
|+.||++|+ ++.++++.
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcC
Confidence 999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=329.38 Aligned_cols=236 Identities=21% Similarity=0.256 Sum_probs=190.3
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||+||+|..+ +++.||+|.+..... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 578999999875432 123345677888888766 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999999853 34689999999999999999999998 999999999999999999999999999875322 2222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|++.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+.... ...+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~ 229 (320)
T cd05590 155 TFCGTPDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDE--VVYPTWLSQDAVDILKA 229 (320)
T ss_pred ccccCccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHH
Confidence 346899999999986 567889999999999999999999999753 2223333322211 11222344568899999
Q ss_pred cccCCCCCCCCH
Q 006031 625 CNSASPEQRPTM 636 (664)
Q Consensus 625 Cl~~~P~~RPt~ 636 (664)
|++.||++||++
T Consensus 230 ~L~~dP~~R~~~ 241 (320)
T cd05590 230 FMTKNPTMRLGS 241 (320)
T ss_pred HcccCHHHCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.06 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=204.3
Q ss_pred HHhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCce
Q 006031 387 ASAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEER 457 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 457 (664)
...+.||+|+||.||++... +...+|+|.++.... ......+.+|++++.++ +|+||++++++|...+..
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34678999999999999752 235699999875321 23345688899999999 799999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC
Q 006031 458 LLIYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~ 526 (664)
++||||+++|+|.++++.... .....++|.+++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNV 178 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCCc
Confidence 999999999999999975321 1124589999999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHH
Q 006031 527 ACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 601 (664)
+|++|||.++...... .....++..|+|||.+. ...++.++|||||||++|||++ |+.||... ...++...+
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~~~~~~~ 255 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLL 255 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHH
Confidence 9999999987554321 11122346899999886 5678999999999999999998 88888642 223333333
Q ss_pred HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 602 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
...... +.+......+.+++.+||..+|++||+|.||++.|+++.....
T Consensus 256 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 256 KEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 322211 2223345668899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.34 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=191.6
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcC-CCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGG-LRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||+||+|... +++.||+|.++..... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 4788999998754321 1234456667777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999999952 34688999999999999999999999 999999999999999999999999999875321 2222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|+..|+|||++. ...++.++|||||||++|||++|+.||... ...++.+.+...... .+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~ 229 (316)
T cd05619 155 TFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIRMDNPC--YPRWLTREAKDILVK 229 (316)
T ss_pred eecCCccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC--CCccCCHHHHHHHHH
Confidence 345889999999987 567899999999999999999999999753 233343333322211 122334568899999
Q ss_pred cccCCCCCCCCHH-HHH
Q 006031 625 CNSASPEQRPTMW-QVL 640 (664)
Q Consensus 625 Cl~~~P~~RPt~~-ev~ 640 (664)
||+.+|++||++. ++.
T Consensus 230 ~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 230 LFVREPERRLGVKGDIR 246 (316)
T ss_pred HhccCHhhcCCChHHHH
Confidence 9999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.06 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=201.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+++|.|+||.||+|... .+..||||+.-.. .+.-.+|+++|++++|||||++.-+|.... ...+|||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 478999999999999954 4689999987432 223457889999999999999999886432 2358999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADS 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~ 541 (664)
||+. +|.+.++.. ......++.....-+..|+.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus 103 ymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 9987 999998631 12245577777888999999999999997 99999999999999977 99999999999987655
Q ss_pred CCC-CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-----------
Q 006031 542 LQD-DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG----------- 609 (664)
Q Consensus 542 ~~~-~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 609 (664)
... ...-+..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.+... ..++...++....+..
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 433 234578899999999889999999999999999999999999987422 2233333332222220
Q ss_pred ---------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhccccCCCCCC
Q 006031 610 ---------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKGAVLMEDGEL 657 (664)
Q Consensus 610 ---------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~~~~~~~~~~ 657 (664)
.......+..+++.++++.+|.+|.++.|++. .++++++.....+...
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR 323 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence 11223356899999999999999999999885 4688877765555554
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.94 Aligned_cols=240 Identities=18% Similarity=0.246 Sum_probs=188.8
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||+|... +++.||+|.++...... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57899999997543321 2345577888888766 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|..++.. ...+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999998842 34689999999999999999999999 999999999999999999999999999875322 1222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---hhhHHHHHHh--hccCCCchhHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV---PNEMMNWVRS--AREDDGAEDERLGMLL 619 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~l~ 619 (664)
...|+..|+|||++. +..++.++|||||||++|||+||+.||...... ......+... .......+......+.
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 233 (329)
T cd05618 155 TFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233 (329)
T ss_pred cccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 346899999999987 567889999999999999999999999632111 1111111111 1111122333445688
Q ss_pred HHHHHcccCCCCCCCCH
Q 006031 620 EVAIACNSASPEQRPTM 636 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~ 636 (664)
+++.+||+.||++||++
T Consensus 234 ~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 234 SVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHhcCCHHHcCCC
Confidence 99999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=329.85 Aligned_cols=243 Identities=17% Similarity=0.250 Sum_probs=192.7
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||++... +++.||+|.++...... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999864 68899999997543322 2345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc--CCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA--DSLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~--~~~~~ 544 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++... .....
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999998842 35699999999999999999999999 99999999999999999999999999987432 12222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---hh----hHHHHHHhhccCCCchhHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV---PN----EMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
...|+..|+|||++. ...++.++|||||||++|||+||+.||+..... .. .+.+.+.... ...+......
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~ 231 (329)
T cd05588 155 TFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVK 231 (329)
T ss_pred cccCCccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHH
Confidence 346899999999987 567889999999999999999999999642111 11 1111111111 1122233456
Q ss_pred HHHHHHHcccCCCCCCCC------HHHHHH
Q 006031 618 LLEVAIACNSASPEQRPT------MWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt------~~ev~~ 641 (664)
+.+++.+|++.+|++||+ +.|+++
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 889999999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.06 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=199.4
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++. .+..++||||+++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 346799999999999998777789999987533 24567899999999999999999999874 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 86 SLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred cHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 999999632 234579999999999999999999998 9999999999999999999999999999765433211
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||+.. ...++.++||||||+++||++| |+.||.... ..+.......... .....+.+..+.+++.
T Consensus 162 ~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 237 (262)
T cd05071 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYR-MPCPPECPESLHDLMC 237 (262)
T ss_pred CCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCCC-CCCccccCHHHHHHHH
Confidence 233566799999886 5678999999999999999999 888886532 2222222211111 1123345667899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+||+.+|++||++.++.+.|++.
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.77 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=193.7
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccC------------CcHHHHHHHHHHHcCCCCCCcccceEEEecC-
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAG------------TSNEMYEQHMESVGGLRHPNLVPLRAYFQAK- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~- 454 (664)
...||+|.||.|-+|+ ..+++.||||++.+..... ...+...+||.+|++++|||||+|+.+..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 4579999999999999 5678999999997543221 1235789999999999999999999998764
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 455 -EERLLIYDYQPNGSLFSLIHGSKSTRAKP-LHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 455 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
+..|||+|||..|.+...= ..++ ++..+..++++++..||+|||.+ +||||||||+|+||+++|++||+||
T Consensus 182 s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEeecc
Confidence 5789999999988775432 2334 99999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-------CCCCCCCcccCccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH
Q 006031 533 CLTALTADSLQ-------DDDPDNLLYKAPETRNASH---QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR 602 (664)
Q Consensus 533 Gla~~~~~~~~-------~~~~~~~~y~aPE~~~~~~---~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~ 602 (664)
|.+........ ....||+.|+|||....+. ..+.+.||||+||+||.|+.|+.||-+.+ ..++.+-+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~l~~KIv 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELELFDKIV 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HHHHHHHHh
Confidence 99986633211 2357999999999876422 34678999999999999999999997532 223322222
Q ss_pred hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 603 SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 603 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
..........+....+.+++++++.+||++|.+..+|....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 22222122234566789999999999999999999886544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.20 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=200.1
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++|+||+++++
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGS 86 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCC
Confidence 468999999999999998999999999875432 4578899999999999999999999874 567899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.++++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++......... .
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 87 LVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99998642 235689999999999999999999998 9999999999999999999999999999765522211 2
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||++. ...++.++||||||+++||+++ |+.||.... ..++.......... ......+..+.+++.+
T Consensus 163 ~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 238 (260)
T cd05067 163 AKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGYRM-PRPDNCPEELYELMRL 238 (260)
T ss_pred CcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 23467899999886 5667899999999999999999 999997532 22333333222111 1222334569999999
Q ss_pred cccCCCCCCCCHHHHHHHHHh
Q 006031 625 CNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
||+.+|++||+++++.+.|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=318.65 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=189.0
Q ss_pred ccccccCceeEEEEEEcC--------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 390 ELLGKGSLGTTYKAVLDN--------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
+.||+|+||.||+|.... ...|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH--HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999998542 23477887754321 33467888999999999999999999999989999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--------eEEeecc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE--------ACLADYC 533 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~--------~ki~DfG 533 (664)
||+++|+|.++++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999642 23689999999999999999999998 9999999999999988765 5899999
Q ss_pred ccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 534 LTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK-PPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 534 la~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
++...... ....++..|+|||++.....++.++|||||||++|||++|. .|+.... .......... ....+.
T Consensus 154 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~---~~~~~~ 226 (258)
T cd05078 154 ISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--SQKKLQFYED---RHQLPA 226 (258)
T ss_pred cccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--HHHHHHHHHc---cccCCC
Confidence 88654332 22457788999999874456789999999999999999985 5554321 1111111111 111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.....+.+++.+||+.+|++|||++++++.|+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 23355899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=311.94 Aligned_cols=245 Identities=27% Similarity=0.447 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+++|+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 46799999999999998887789999876433 24567889999999999999999999875 456899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.++++.. ....++|..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......... .
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 87 LLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 99999642 234589999999999999999999998 9999999999999999999999999999765432211 2
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||+.. ...++.++|||||||++|||+| |+.||... ...+...+....... ..+...+..+.+++.+
T Consensus 163 ~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 238 (260)
T cd05069 163 AKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM--VNREVLEQVERGYRM-PCPQGCPESLHELMKL 238 (260)
T ss_pred CccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHHHHHHHH
Confidence 23567899999886 5678999999999999999999 89998753 223333333322111 1223455678999999
Q ss_pred cccCCCCCCCCHHHHHHHHHh
Q 006031 625 CNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
||+.+|++||++.+|++.|++
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.15 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=189.1
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcC-CCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGG-LRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||+|... +++.||+|.++..... ....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 5788999998754321 1233445556666654 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999999953 34688999999999999999999998 9999999999999999999999999999754322 222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|++.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+.... ...+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 155 TFCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGE--DEDELFDSILNDR--PHFPRWISKEAKDCLSK 229 (316)
T ss_pred cccCCccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 346899999999987 567899999999999999999999999753 2223322222111 11222334568899999
Q ss_pred cccCCCCCCCCHH-HHH
Q 006031 625 CNSASPEQRPTMW-QVL 640 (664)
Q Consensus 625 Cl~~~P~~RPt~~-ev~ 640 (664)
||+.+|++||++. ++.
T Consensus 230 ~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 230 LFERDPTKRLGVDGDIR 246 (316)
T ss_pred HccCCHHHcCCChHHHH
Confidence 9999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.87 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=196.1
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 461 (664)
.+.||+|+||+||++.. .++..||+|.++.... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 46799999999988653 4577899999865422 23456788999999999999999999998654 3578999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||+++.....
T Consensus 88 e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 88 EYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred cCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999953 3489999999999999999999999 9999999999999999999999999999865443
Q ss_pred CC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH----------HHHhh--
Q 006031 542 LQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN----------WVRSA-- 604 (664)
Q Consensus 542 ~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~----------~~~~~-- 604 (664)
.. ....++..|+|||.+. ...++.++||||||+++|||+||+.|+........+... +....
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 21 1223456799999886 567889999999999999999999998643211111110 00000
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
......+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000112234567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.56 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=204.4
Q ss_pred HHHhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCc
Q 006031 386 RASAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEE 456 (664)
Q Consensus 386 ~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 456 (664)
+...+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 345678999999999999741 345799998864321 23456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKST-----------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
.++||||+++|+|.+++...... ....++|.++..++.||+.||+|||+. +++||||||+||++++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~ 174 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENN 174 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCC
Confidence 99999999999999999643211 124688999999999999999999998 999999999999999999
Q ss_pred CeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHH
Q 006031 526 EACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 526 ~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 600 (664)
.+||+|||+++....... ....++..|+|||.+. ...++.++||||||+++||+++ |..||... ...++...
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~ 251 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKL 251 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHHHH
Confidence 999999999986543221 1223457899999886 5678899999999999999999 78887643 23333333
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+...... ..+...+..+.+++.+||+.+|++||+|.|+++.|+++...
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 252 LKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 3322211 12233456689999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.01 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=189.9
Q ss_pred cccccCceeEEEEEEcC---CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLDN---RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||+||+|...+ ...+++|.+.... .......|.+|++.++.++|+||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3467888775432 1233457889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~ 543 (664)
+|.+++...........++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999754433334467888899999999999999999 99999999999999999999999999986532221 1
Q ss_pred CCCCCCCcccCcccccc------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhH-HHHHHhhccC---CCchh
Q 006031 544 DDDPDNLLYKAPETRNA------SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEM-MNWVRSARED---DGAED 612 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~------~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~-~~~~~~~~~~---~~~~~ 612 (664)
....++..|+|||+... ...++.++|||||||++|||++ |+.||... ...+. .......... .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL--SDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC--CHHHHHHHHhhccCccCCCCcccc
Confidence 22335677999998642 2356889999999999999999 78888653 12222 2222211111 11122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
.....+.+++..|| .+|++|||++||++.|
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 34456778899999 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.48 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=201.9
Q ss_pred HhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
..+.||+|+||.||+|...+ +..||+|.+..... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 35789999999999998643 46899999864322 123457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 462 DYQPNGSLFSLIHGSKST-----RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
||+++|+|.+++...... ....++|..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcccch
Confidence 999999999999643211 223578999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 537 LTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 537 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
....... ....++..|+|||.+. ...++.++|||||||++||++| |+.||... ...+.......... ...+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~~ 243 (277)
T cd05032 168 DIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVIDGGH-LDLP 243 (277)
T ss_pred hhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHhcCCC-CCCC
Confidence 6543221 1234567899999886 5678999999999999999998 99998653 23344444442211 1223
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 3345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.43 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=193.6
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||+||+|... ++..||+|.++..... ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 4789999998754321 12345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999999853 34689999999999999999999998 9999999999999999999999999998753221 122
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||++. ...++.++|||||||++|||++|+.||... ....+...+..... ..+......+.+++.+
T Consensus 155 ~~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~--~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (318)
T cd05570 155 TFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGD--DEDELFQSILEDEV--RYPRWLSKEAKSILKS 229 (318)
T ss_pred ceecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCC--CCCCcCCHHHHHHHHH
Confidence 345789999999987 567899999999999999999999999753 22233322221111 1222344568999999
Q ss_pred cccCCCCCCCCH-----HHHHH
Q 006031 625 CNSASPEQRPTM-----WQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~-----~ev~~ 641 (664)
||+.||++||++ .++++
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhc
Confidence 999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.57 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=200.9
Q ss_pred HhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
..+.||+|+||.||+|...+ +..||+|+++.... ....+.+.+|+.++++++||||+++++++...+..++++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 35679999999999998643 57899999975432 123467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEe
Q 006031 462 DYQPNGSLFSLIHGSK-----------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLA 530 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~ 530 (664)
||+++++|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCceEec
Confidence 9999999999985211 11234588999999999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhc
Q 006031 531 DYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAR 605 (664)
Q Consensus 531 DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 605 (664)
|||+++....... ....+++.|+|||.+. ...++.++|||||||++|||+| |..||... ...++.+.+....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~ 243 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIEMIRNRQ 243 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCC
Confidence 9999876533221 1233567899999986 5668899999999999999998 88888653 2334444433322
Q ss_pred cCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 606 EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 606 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
.. ..+...+..+.+++.+||+.+|++||++++|+..|+.
T Consensus 244 ~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 244 VL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 21 1233455668999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=312.03 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=204.4
Q ss_pred ccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+.||+|+||.||+|.... +..|++|.+....... ..+.+.+|++.+..++|+||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999654 7889999987654322 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 466 NGSLFSLIHGSKST----RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
+++|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999643110 136799999999999999999999998 9999999999999999999999999999876553
Q ss_pred C----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 542 L----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 542 ~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
. .....++..|+|||.+. ...++.++||||+|+++|||++ |+.||... ...++.+.+.... ....+...+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~ 234 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGY-RLPKPEYCPD 234 (262)
T ss_pred cccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-CCCCCccCCh
Confidence 2 22345678899999887 4578999999999999999999 69998764 2334444443311 1122333456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.+.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.06 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=196.5
Q ss_pred ccccccCceeEEEEEEcC-Ce--EEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVLDN-RL--IVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
++||+|+||.||+|...+ +. .+++|.++.... ....+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 468999999999999754 33 568888764321 23346788999999999 89999999999999999999999999
Q ss_pred CCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 466 NGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 466 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
+|+|.++++.... .....+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999964321 1123588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCC-CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 535 TALTADSLQD-DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 535 a~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
+......... ....+..|+|||++. ...++.++|||||||++|||++ |+.||... ...+....+..... .+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~~-~~~~~ 234 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYR-LEKPL 234 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccc--CHHHHHHHHhCCCC-CCCCC
Confidence 8633221111 122356799999886 5678899999999999999997 99998653 12222222221111 11222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
.....+.+++.+||+.+|.+|||+.|+++.|+++-
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 33456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=343.20 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--------ceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--------ERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~~l 459 (664)
.+.||+|+||+||+|.. .+++.||||.+............+.+|+..+..++|+||+++.+.+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 46899999999999984 57899999998765543344567889999999999999999888765433 3679
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++|+|.++++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 V~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~ 194 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194 (496)
T ss_pred EEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence 999999999999996432 2345689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 540 DSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 540 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||... ...++.......... ..+...+
T Consensus 195 ~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--~~~~~~~~~~~~~~~-~~~~~~~ 270 (496)
T PTZ00283 195 ATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGE--NMEEVMHKTLAGRYD-PLPPSIS 270 (496)
T ss_pred ccccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCCCC-CCCCCCC
Confidence 321 22346899999999987 567899999999999999999999999753 222232222211111 1223345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+.+++.+||+.+|++||++.++++.
T Consensus 271 ~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 271 PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 668999999999999999999999763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.07 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEc-----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 461 (664)
.+.||+|+||.||++..+ ++..||+|++..... ...+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 467999999999999753 578899999865432 335678999999999999999999998754 34688999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 87 EYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999999632 34589999999999999999999999 9999999999999999999999999999865443
Q ss_pred CC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--------------hhHHHHHH
Q 006031 542 LQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--------------NEMMNWVR 602 (664)
Q Consensus 542 ~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--------------~~~~~~~~ 602 (664)
.. ....++..|+|||++. ...++.++|||||||++|||++|..|+....... ..+.+...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 21 1122345699999986 5678999999999999999999887754321100 00111111
Q ss_pred hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 603 SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 603 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
..... ......+..+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 241 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11110 112233456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.91 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=200.8
Q ss_pred hccccccCceeEEEEEE-cCCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|+||+||+|.+ .++. .||+|.++.... ....+.+.+|+.++..++|+||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 46899999999999985 3443 489998864322 2235678899999999999999999999975 457899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 90 MPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999963 234689999999999999999999999 999999999999999999999999999986643221
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....++..|+|||... ...++.++|||||||++|||+| |..||... ....+..++...... ..+...+..+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (279)
T cd05109 165 EYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGERL-PQPPICTIDV 240 (279)
T ss_pred eeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcC-CCCccCCHHH
Confidence 1123456899999986 5678999999999999999999 89998653 233444444433222 1223345568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+++.+||+.+|++||++.|+++.|+++....
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 99999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.41 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=200.1
Q ss_pred hccccccCceeEEEEEEcC-C--eEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN-R--LIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~--~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.++||+|+||.||+|...+ + ..+++|.++.... ....+.+.+|++++.++ +||||+++++++...+..++|+||+
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 4579999999999998654 3 3478888764221 12346788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 465 PNGSLFSLIHGSKST-----------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
++|+|.++++..... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEECCcC
Confidence 999999999643211 123589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCC-CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 534 LTALTADSLQDD-DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 534 la~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
++.......... ...+..|+|||++. ...++.++|||||||++|||+| |+.||.... ..++......... ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~~~~~~~~~~~~~-~~~~ 240 (297)
T cd05089 165 LSRGEEVYVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGYR-MEKP 240 (297)
T ss_pred CCccccceeccCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCC-CCCC
Confidence 986433221111 22345799999886 5668999999999999999998 999987532 2232222221111 1122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 241 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 241 RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 234456899999999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.86 Aligned_cols=248 Identities=20% Similarity=0.397 Sum_probs=200.1
Q ss_pred hccccccCceeEEEEEEcC-C---eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN-R---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.... + ..+|+|.++.... ....+.+..|++++++++|+||+++.+++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4789999999999999642 2 3789998864322 223567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
++++|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||++.........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 89 ENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999963 234689999999999999999999998 9999999999999999999999999998765432211
Q ss_pred -----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 545 -----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 545 -----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....+..|+|||++. ...++.++|||||||++||++| |+.||.... ..++...+.... ........+..+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~~~~-~~~~~~~~~~~~ 239 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDGF-RLPAPMDCPSAV 239 (268)
T ss_pred ceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhcCC-CCCCCCCCCHHH
Confidence 112345799999986 5678999999999999999998 999986532 233333333221 112223345668
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.+++.+||+.+|++||++.+|++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.50 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=191.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 36799999999999985 56789999999754332 12346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----- 541 (664)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 86 GDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999953 34588899999999999999999998 9999999999999999999999999997532100
Q ss_pred --------------------------------------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHH
Q 006031 542 --------------------------------------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLL 577 (664)
Q Consensus 542 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl 577 (664)
......||+.|+|||.+. ...++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHH
Confidence 001235889999999986 56688999999999999
Q ss_pred HHHHcCCCCCCCCCCChhhHHHHHHhhc-cCCCchhHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 006031 578 LELLTGKPPSQHSFLVPNEMMNWVRSAR-EDDGAEDERLGMLLEVAIA--CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 578 ~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPt~~ev~~~ 642 (664)
|||+||+.||...... ........... ...........++.+++.+ |+..+|..||++.|+++.
T Consensus 239 ~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPT-ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHH-HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999764321 11111111000 0111111223456778776 667777789999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.56 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=202.2
Q ss_pred HhccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
..+.||+|+||.||++... ....+|+|.+..... ......+.+|++++.++ +|+||+++++++...+..++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 4568999999999999864 246899999865322 12345688999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEE
Q 006031 461 YDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL 529 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki 529 (664)
|||+++|+|.++++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEEe
Confidence 999999999999964210 2345689999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhh
Q 006031 530 ADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 530 ~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 604 (664)
+|||+++....... ....++..|+|||.+. ...++.++|||||||++||+++ |..||... ...++.+.....
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~ 250 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEG 250 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCC--CHHHHHHHHHcC
Confidence 99999986543221 1122456799999876 5678899999999999999998 99998653 222333333222
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
... ..+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 251 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 251 YRM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 211 122233456899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.25 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=202.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 568999999999999875 67899999865432 45778999999999999999999999998899999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 548 (664)
|.++++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++....... ....
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 161 (256)
T cd05039 87 LVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKL 161 (256)
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccc-cCCC
Confidence 99999642 223689999999999999999999998 999999999999999999999999999987643322 2334
Q ss_pred CCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHccc
Q 006031 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 627 (664)
+..|+|||++. ...++.++||||||+++||+++ |+.||... ...++...+...... ..+...+..+.+++.+||.
T Consensus 162 ~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 162 PVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEKGYRM-EAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred cccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCC-CCccCCCHHHHHHHHHHhc
Confidence 56799999886 5678899999999999999997 99998653 233343333322121 1122345668999999999
Q ss_pred CCCCCCCCHHHHHHHHHhh
Q 006031 628 ASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 628 ~~P~~RPt~~ev~~~L~~i 646 (664)
.+|++||++.|++++|+.+
T Consensus 238 ~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 238 LDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cChhhCcCHHHHHHHHhcC
Confidence 9999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.63 Aligned_cols=237 Identities=21% Similarity=0.267 Sum_probs=187.6
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHH-HHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHME-SVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||+||+|... +++.||+|.+....... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999964 68899999986543211 12233444444 56889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999999952 34688999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|++.|+|||++. ...++.++|||||||++|||++|+.||... ...++.+.+... ...........+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 229 (323)
T cd05575 155 TFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DTAEMYDNILNK--PLRLKPNISVSARHLLEG 229 (323)
T ss_pred cccCChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCC--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 345899999999987 567899999999999999999999999753 222222222111 111122235568999999
Q ss_pred cccCCCCCCCCHH
Q 006031 625 CNSASPEQRPTMW 637 (664)
Q Consensus 625 Cl~~~P~~RPt~~ 637 (664)
|++.+|++||++.
T Consensus 230 ~l~~~p~~R~~~~ 242 (323)
T cd05575 230 LLQKDRTKRLGAK 242 (323)
T ss_pred HhhcCHHhCCCCC
Confidence 9999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=334.10 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=197.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||+|+++...... .....+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 467999999999999965 68899999997554322 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 86 GDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999953 25689999999999999999999998 99999999999999999999999999997654332
Q ss_pred ---------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh
Q 006031 543 ---------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN 595 (664)
Q Consensus 543 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~ 595 (664)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~ 236 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDT--LQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCC--HH
Confidence 12345889999999987 5678999999999999999999999997643 11
Q ss_pred hHHHHHHhhccCC--CchhHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 006031 596 EMMNWVRSAREDD--GAEDERLGMLLEVAIACNSASPEQRPT-MWQVLKM 642 (664)
Q Consensus 596 ~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~ev~~~ 642 (664)
+....+....... ......+..+.+++.+|+. +|++||+ +.|+++.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111100111 1111135568899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.20 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=206.8
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+.||+|||+.||.+. ..++..+|+|++..... ++.+..++|++.-++++||||+++++++..+. +.||+++
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 4679999999999998 77888999999976653 56778899999999999999999999875433 5899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
|...|+|.+.+...+ .++..+++.+++.|+.+|.+||++||+. ++++||||||.|||+.+++.+++.|||.+....-.
T Consensus 104 yy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 999999999997654 3455799999999999999999999995 46999999999999999999999999998764322
Q ss_pred CCC-----------CCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC
Q 006031 542 LQD-----------DDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD 608 (664)
Q Consensus 542 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 608 (664)
... ...-|..|+|||.+.- ....++++|||||||++|+|+.|..||+......+.+.-.+.......
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~ 262 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI 262 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc
Confidence 211 1224788999998752 234689999999999999999999999865543333333333222222
Q ss_pred CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 609 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
+.....++.+.++++.|++.||.+||+..+++..++.+.
T Consensus 263 P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 263 PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 223336677999999999999999999999999998753
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.52 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=190.1
Q ss_pred ccccccCceeEEEEEEcCCe-----------EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceE
Q 006031 390 ELLGKGSLGTTYKAVLDNRL-----------IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 458 (664)
+.||+|+||.||+|...+.. .|++|.+..... ....|.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999976433 577787654332 26788999999999999999999999988 7889
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-------CeEEee
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-------EACLAD 531 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-------~~ki~D 531 (664)
+|+||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 77 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999999632 22689999999999999999999998 999999999999999887 799999
Q ss_pred ccccccccCCCCCCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCC
Q 006031 532 YCLTALTADSLQDDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDG 609 (664)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 609 (664)
||++..... .....++..|+|||++... ..++.++|||||||++||+++ |..|+.... ..+...+.......
T Consensus 152 fg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~~~~~~-- 225 (259)
T cd05037 152 PGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQDQHRL-- 225 (259)
T ss_pred CCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHhcCCCC--
Confidence 999886544 2224466789999998743 368899999999999999999 577776542 22222222211111
Q ss_pred chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 610 AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 610 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 -PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111256889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.29 Aligned_cols=240 Identities=23% Similarity=0.279 Sum_probs=190.9
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcC-CCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGG-LRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||+|... ++..||+|.++..... ....+.+..|.+++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 5789999998754321 1234556677777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc--CCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA--DSLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~--~~~~~ 544 (664)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++... .....
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999999853 34688999999999999999999999 99999999999999999999999999987432 12223
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|+..|+|||++. ...++.++|||||||++|||++|+.||... ....+.+.+..... ..+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 229 (316)
T cd05620 155 TFCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVDTP--HYPRWITKESKDILEK 229 (316)
T ss_pred ccCCCcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCC--CCCCCCCHHHHHHHHH
Confidence 356899999999987 567899999999999999999999999753 22333333322211 1222234568899999
Q ss_pred cccCCCCCCCCHH-HHH
Q 006031 625 CNSASPEQRPTMW-QVL 640 (664)
Q Consensus 625 Cl~~~P~~RPt~~-ev~ 640 (664)
||+.||++||++. ++.
T Consensus 230 ~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 230 LFERDPTRRLGVVGNIR 246 (316)
T ss_pred HccCCHHHcCCChHHHH
Confidence 9999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.36 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=197.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe-cCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ-AKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+..++|+||++++
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 468999999999999875 667899988543 23567889999999999999999999764 456789999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++...... ....
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 160 (256)
T cd05082 86 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGK 160 (256)
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccC-CCCc
Confidence 999999642 234589999999999999999999998 99999999999999999999999999987544322 2233
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.+..|+|||++. ...++.++|||||||++|||++ |+.||... ...++...+...... ......+..+.+++.+||
T Consensus 161 ~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 161 LPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM-DAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred cceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHh
Confidence 456899999886 5678899999999999999998 99998643 223333333222111 222334566899999999
Q ss_pred cCCCCCCCCHHHHHHHHHhh
Q 006031 627 SASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i 646 (664)
+.+|++|||+.++++.|+++
T Consensus 237 ~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 237 HLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=302.01 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=203.4
Q ss_pred HHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 387 ASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...++||+|.|+.||+.. ...|+..|+|.+..........+++++|+.+.+.|+|||||++...+.+....|+|+|+|.
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence 345789999999999987 5678899999998777766788999999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccccCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALTADSL 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~~ 542 (664)
|++|..-+- ....+++...-..++||++||.|+|.. +|||||+||+|+++... --+|++|||++....+..
T Consensus 94 G~dl~~eIV-----~R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 94 GGELFEDIV-----AREFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred chHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 999987773 234567788889999999999999999 99999999999999543 447999999998877433
Q ss_pred C-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHH
Q 006031 543 Q-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLL 619 (664)
Q Consensus 543 ~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 619 (664)
. ....||++|||||+.. ...++..+|||+.||+||-++.|++||.+. +..++.+.+....-.. ...+...++..
T Consensus 168 ~~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 2 3467999999999997 678899999999999999999999999863 2223333333222211 23444556689
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++.+|+..||.+|.|+.|.++
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHhccChhhhccHHHHhC
Confidence 9999999999999999998764
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.94 Aligned_cols=246 Identities=27% Similarity=0.457 Sum_probs=201.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 46799999999999998888899999987543 245779999999999999999999999998899999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.++++.. ....+++..+..++.+++.|++|||+. +++|+||||+||++++++.+|++|||.+........ ..
T Consensus 88 L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 88 LLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 99999642 234689999999999999999999999 999999999999999999999999999876543211 11
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+..|+|||.+. ...++.++||||||+++||++| |+.||... ......+.+...... ..+...+..+.+++.+
T Consensus 164 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 164 AKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQVERGYRM-PRPPNCPEELYDLMLQ 239 (261)
T ss_pred cCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 22456799999887 5678999999999999999999 99998653 223333333222111 1122235568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHh
Q 006031 625 CNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
|++.+|++||+++++.+.|+.
T Consensus 240 ~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 240 CWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.27 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=198.4
Q ss_pred hccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|...+ +..|++|.+..... ......|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 4679999999999999753 57889998764322 1234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSKS--TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~ 537 (664)
|+++++|.++++.... .....++|..+.+++.||+.||+|||+. +++||||||+||+++.++ .+|++|||+++.
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~ 168 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccccc
Confidence 9999999999964321 1223689999999999999999999998 999999999999998754 589999999986
Q ss_pred ccCCCCC----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQD----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
....... ....+..|+|||++. ...++.++|||||||++|||++ |+.||... ....+.+.+...... ..+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~~~-~~~~ 244 (277)
T cd05036 169 IYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--TNQEVMEFVTGGGRL-DPPK 244 (277)
T ss_pred cCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCcC-CCCC
Confidence 5332211 122346799999986 5678999999999999999997 99998753 223333333322111 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
..+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 245 ~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 245 GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 345668999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=312.53 Aligned_cols=248 Identities=20% Similarity=0.391 Sum_probs=199.8
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... .+..+|+|.++.... ....+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 468999999999999863 234799998865322 223567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
++++|.+++.. ....+++.++..|+.|++.||+|||+. +++||||||+||+++.++.++++|||++.........
T Consensus 88 ~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 88 ENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999963 234689999999999999999999998 9999999999999999999999999999865443211
Q ss_pred -----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 545 -----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 545 -----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
...++..|+|||++. ...++.++||||||+++||+++ |+.||.... ..+....+...... ......+..+
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIEEGYRL-PAPMDCPAAL 238 (267)
T ss_pred eeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHhCCCcC-CCCCCCCHHH
Confidence 112346799999986 5678999999999999999887 999986532 22333333322111 1122334568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.+++.+||+.+|++||+|.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.79 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=198.4
Q ss_pred hccccccCceeEEEEEEcC-----------------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEE
Q 006031 389 AELLGKGSLGTTYKAVLDN-----------------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 451 (664)
.+.||+|+||.||+|...+ +..||+|.+..... ....+.+.+|++++++++||||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 4679999999999988542 35689999865432 13456789999999999999999999999
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 452 QAKEERLLIYDYQPNGSLFSLIHGSKST------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 452 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
..++..++|+||+++++|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLVGKNY 167 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccccchhceeecCCC
Confidence 9999999999999999999999754321 123689999999999999999999998 999999999999999999
Q ss_pred CeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCChhhHHH
Q 006031 526 EACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 526 ~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt--G~~P~~~~~~~~~~~~~ 599 (664)
.++++|||+++...... .....++..|+|||++. ...++.++|||||||++|||++ |..||... ...++..
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~~~~~~~ 244 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TDQQVIE 244 (296)
T ss_pred ceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--ChHHHHH
Confidence 99999999987643322 11233567899999986 5678999999999999999998 67777543 2223333
Q ss_pred HHHhhccC------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 600 WVRSARED------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 600 ~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
........ .......+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 32222110 11122234569999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.77 Aligned_cols=242 Identities=21% Similarity=0.257 Sum_probs=189.1
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHH-HHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQH-MESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e-~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||+||+|... +++.||+|++....... .....+..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 57789999986543211 122333344 3457889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|.+++.. ...+.+.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999999953 34577888889999999999999999 9999999999999999999999999998753221 222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|++.|+|||++. ...++.++|||||||++|||++|+.||... ...+..+.+... ...........+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 155 TFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNK--PLQLKPNITNSARHLLEG 229 (325)
T ss_pred cccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCC--CHHHHHHHHHhC--CcCCCCCCCHHHHHHHHH
Confidence 346899999999987 567889999999999999999999999753 222333322221 111222344568899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
|++.+|++||++.+.+.+
T Consensus 230 ~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 230 LLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HcccCHHHCCCCCCCHHH
Confidence 999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.67 Aligned_cols=241 Identities=23% Similarity=0.274 Sum_probs=190.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHH---HcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMES---VGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~---l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|... +++.||||+++..... ....+.+.+|+++ +++++||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 357999999999999854 6889999999754321 1233456666554 4677899999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-- 541 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 541 (664)
+++|+|..+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999998852 3589999999999999999999998 9999999999999999999999999998753221
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
......|++.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+.... ...+......+.++
T Consensus 157 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~--~~~p~~~~~~~~~l 231 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSIVNDE--VRYPRFLSREAISI 231 (324)
T ss_pred cccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCC--CCCCCCCCHHHHHH
Confidence 122345889999999987 567899999999999999999999999753 2223322222111 11222334568899
Q ss_pred HHHcccCCCCCCCC-----HHHHHH
Q 006031 622 AIACNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt-----~~ev~~ 641 (664)
+.+||+.+|++||+ +.++++
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 99999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.16 Aligned_cols=245 Identities=17% Similarity=0.245 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46799999999999995 57899999998654332234467889999999999999999999998776 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 85 LMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred ccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 996 58888884 235689999999999999999999999 99999999999999999999999999997654322
Q ss_pred C---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh---------------
Q 006031 543 Q---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA--------------- 604 (664)
Q Consensus 543 ~---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~--------------- 604 (664)
. ....++..|+|||.+.+...++.++|||||||++|||++|+.||..... .+....+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 1 2235688999999987556689999999999999999999999975421 1111111000
Q ss_pred --------ccCCC-------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 605 --------REDDG-------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 605 --------~~~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..... ........+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 011123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=324.72 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=210.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc-eEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE-RLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~~~~ 466 (664)
.+++|+|+||.++..+. .++..+++|.+..........+...+|+.++++++|||||.+.+.|.+++. .+|||+|++|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 46899999999998874 356789999998777766667788999999999999999999999999988 9999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|++.+.+... +...+++....+++.|++.|+.|||+. +|+|||||+.||+++.+..+|++|||+|+.+... ...
T Consensus 89 g~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~ 164 (426)
T KOG0589|consen 89 GDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAS 164 (426)
T ss_pred CCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhh
Confidence 9999999653 356789999999999999999999988 9999999999999999999999999999998776 345
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...||+.||.||.+. +..|..|+||||+||++|||.+-+++|.... ...-+.+..+.... +.+..+..++..++..
T Consensus 165 tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li~ki~~~~~~--Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELILKINRGLYS--PLPSMYSSELRSLVKS 240 (426)
T ss_pred eecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccc-hHHHHHHHhhccCC--CCCccccHHHHHHHHH
Confidence 678999999999987 7899999999999999999999999998642 12222233332211 2344556679999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
|++.+|+.||++.+++.+
T Consensus 241 ~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhhcCCccCCCHHHHhhC
Confidence 999999999999999987
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.42 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=200.1
Q ss_pred HhccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
..+.||+|+||.||+|.. ..+..||+|.++.... ....+.+.+|+++++++ +|+||+++++++...+..++|
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 457899999999999974 2345799998865432 23346789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||+++|+|.++++.. ....+++.++..++.|++.||+|||+. +|+|+||||+||++++++.++++|||+++....
T Consensus 118 ~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 118 TEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999642 223489999999999999999999998 999999999999999999999999999976543
Q ss_pred CCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 541 SLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 541 ~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
... ....++..|+|||.+. ...++.++|||||||++|||+| |+.||..... ...+.......... ..+....
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 270 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEGYRM-AQPEHAP 270 (302)
T ss_pred CCceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHcCCcC-CCCCCCC
Confidence 221 1123467899999886 5668999999999999999998 9999875422 22333333222111 1122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 5689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=311.34 Aligned_cols=245 Identities=19% Similarity=0.272 Sum_probs=197.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC---CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG---TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||++.. .++..||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 56899999999999985 468899999886443211 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++++|.+++.. ...+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 87 ~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 87 PGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999953 34588899999999999999999999 999999999999999999999999999875433211
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....++..|+|||.+. +..++.++||||||+++||+++|+.||.... .................+......+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCCCCCCCccCCHHHH
Confidence 1234678899999987 5668899999999999999999999986532 11111122211122222334456689
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+++.+||..+|++|||+.|+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.42 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .+++.||+|++..... .....+++|+.++++++||||+++++++...+..++|+||++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 46799999999999995 5688999999864432 34467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ..
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 92 SLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 99999852 34689999999999999999999998 999999999999999999999999999986543321 23
Q ss_pred CCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEV 621 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 621 (664)
..++..|+|||.+.. ...++.++|||||||++|||++|+.||....... ....+......... .....+..+.++
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hheeeecCCCCCCCCccccccCHHHHHH
Confidence 457789999998742 3446789999999999999999999986432111 11111111111111 112334678999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.+|++||+++++++.
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.62 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=196.3
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4467999999999999965 477889998864332 3356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
++|..+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....... ..
T Consensus 87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999998853 234689999999999999999999998 99999999999999999999999999987543322 12
Q ss_pred CCCCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
...++..|+|||++. ....++.++|||||||++|||++|++||.... ....+.............+......+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 345788999999874 23456789999999999999999999987532 1122223222222121222334566899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.69 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 36799999999999984 5688999998864321 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|..+. .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++............
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 997553 367888899999999999999998 9999999999999999999999999999876555444567
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-----hHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-----EMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
++..|+|||++. ...++.++||||||+++|||++|+.||........ ......................+.+++
T Consensus 155 ~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 889999999987 56788999999999999999999999865332111 111111111111111222345689999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+||+.+|++||++.|+++.
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhhCChhhCCCHHHHhcC
Confidence 99999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.64 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=205.0
Q ss_pred HHhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCce
Q 006031 387 ASAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEER 457 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 457 (664)
...+.||+|+||.||++... ....||+|.++.... ......+..|+++++++ +||||++++++|...+..
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 34678999999999999742 245789998864322 22345688999999999 699999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC
Q 006031 458 LLIYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~ 526 (664)
++|+||+++|+|.+++..... .....++|.++..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCCc
Confidence 999999999999999964321 1234689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHH
Q 006031 527 ACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 601 (664)
+|++|||+++....... ....++..|+|||.+. ...++.++|||||||++|||++ |+.||... ...++....
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~~~~~~ 249 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEELFKLL 249 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH
Confidence 99999999986543211 1122345799999886 5678999999999999999999 88998653 223333333
Q ss_pred HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCC
Q 006031 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLME 653 (664)
Q Consensus 602 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~ 653 (664)
...... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++......+
T Consensus 250 ~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 300 (314)
T cd05099 250 REGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300 (314)
T ss_pred HcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCC
Confidence 322111 122333456889999999999999999999999999997655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.34 Aligned_cols=242 Identities=21% Similarity=0.243 Sum_probs=189.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHH-HHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHME-SVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||+||+|.. .+++.||+|++...... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999985 46889999998654321 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99999985 335689999999999999999999998 999999999999999999999999999875322 1222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|+..|+|||++. ...++.++|||||||++|||++|+.||... ...++.+.+... ...........+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 155 TFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEMYDNILHK--PLVLRPGASLTAWSILEE 229 (325)
T ss_pred cccCChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCC--CHHHHHHHHHcC--CccCCCCCCHHHHHHHHH
Confidence 345899999999987 567889999999999999999999999753 222222222211 111112234557899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
|++.+|++||++++.+++
T Consensus 230 ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HhccCHHhcCCCCCCHHH
Confidence 999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.98 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=199.4
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
++||+|+||.||++...+++.||+|.+...... ...+.+.+|++++++++|+||+++++++.+.+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877999999988754432 3456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC----C
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD----D 545 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~----~ 545 (664)
.++++.. ...+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9999632 23588999999999999999999998 9999999999999999999999999998765422211 1
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+..|+|||.+. ...++.++|||||||++|||+| |..||.... .......+.... ....+...+..+.+++.+
T Consensus 155 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 155 KQIPIKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESGY-RMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred CcceeccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcCC-CCCCCccCCHHHHHHHHH
Confidence 12355799999886 5678999999999999999999 888886532 223333332211 111223345679999999
Q ss_pred cccCCCCCCCCHHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~ 644 (664)
||..+|++|||+.|+++.|+
T Consensus 231 ~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 231 CWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HhccChhhCcCHHHHHHHhh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.97 Aligned_cols=248 Identities=20% Similarity=0.387 Sum_probs=200.4
Q ss_pred hccccccCceeEEEEEEcC-C---eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN-R---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.... + ..||+|.++.... ....+.|..|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 5689999999999999643 2 4699999865321 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
++|+|.++++. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++.........
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 88 ENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999963 234689999999999999999999998 9999999999999999999999999998765432211
Q ss_pred -----CCC--CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 545 -----DDP--DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 545 -----~~~--~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
... .+..|+|||++. ...++.++|||||||++||+++ |..||... ...++..++...... ..+.+.+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~ 238 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIEQDYRL-PPPMDCPT 238 (269)
T ss_pred cccccccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCCcC-CCcccCCH
Confidence 111 235799999986 6678999999999999999997 99998653 233444444322111 12233456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.+.+++.+||+.+|++||++.+++..|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.32 Aligned_cols=244 Identities=22% Similarity=0.387 Sum_probs=198.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..+|+|.+..... ....|.+|++++++++|||++++++++......++|+||+++++
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 467999999999999987788899998864432 45678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.++++.. ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||.++........ .
T Consensus 86 L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 99999632 24588999999999999999999998 9999999999999999999999999998765433211 2
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+.+|+|||.+. ...++.++||||||+++||+++ |+.||.... ..++.+........ ..+...+..+.+++.+
T Consensus 161 ~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 161 TKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGFRL-YKPRLASQSVYELMQH 236 (256)
T ss_pred CccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHhCCCCC-CCCCCCCHHHHHHHHH
Confidence 23456899999886 5678899999999999999998 999986532 22333332221111 1112234568999999
Q ss_pred cccCCCCCCCCHHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~ 644 (664)
||+.+|++|||+.|++++|+
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HcccChhhCCCHHHHHHhhC
Confidence 99999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=318.90 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=198.3
Q ss_pred hccccccCceeEEEEEEc-CCe--EEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRL--IVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... ++. .+++|.++... .......+.+|++++.++ +|+||+++++++...+..++|+||+
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 467999999999999964 343 46777765322 123446788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 465 PNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 465 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
++|+|.++++.... .....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEEeCccc
Confidence 99999999974321 1123689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCC-CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 534 LTALTADSLQD-DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 534 la~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
++......... ....+..|+|||++. ...++.++|||||||++|||+| |..||.... ..+..+........ ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~-~~~ 245 (303)
T cd05088 170 LSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGYRL-EKP 245 (303)
T ss_pred cCcccchhhhcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcCCcC-CCC
Confidence 98643221111 122356799999886 5668899999999999999998 999986432 22222222221111 112
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.+|++||++.++++.|+++....
T Consensus 246 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 223456889999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=304.91 Aligned_cols=257 Identities=19% Similarity=0.256 Sum_probs=202.6
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC-cccceEEEecCC------ceEEE
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN-LVPLRAYFQAKE------ERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~------~~~lV 460 (664)
-++||+|+||+||+|+ ..+|+.||+|++......+.......+|+.++++++|+| ||.+++++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 3569999999999999 567899999999765443334456689999999999999 999999998877 78899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+||++. +|..++....... ..++-..+..+..|+++||+|||++ +|+||||||.|||++++|.+||+|||+|+...-
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 999976 9999996432111 3566688999999999999999999 999999999999999999999999999986542
Q ss_pred CC--CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC---------
Q 006031 541 SL--QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--------- 609 (664)
Q Consensus 541 ~~--~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 609 (664)
.. ......|.+|+|||++.+...|+...||||+||++.||+++++-|.+... ..++....+....+..
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCCCCcccc
Confidence 22 23456789999999999888899999999999999999999998876422 2233333222222110
Q ss_pred ---------------chhH---HHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhcc
Q 006031 610 ---------------AEDE---RLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGA 649 (664)
Q Consensus 610 ---------------~~~~---~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~ 649 (664)
.... ......+++.+|++.+|.+|.|++.++++ +.++...
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 0011 11357899999999999999999999986 6665433
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.24 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEcC---------------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN---------------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 453 (664)
.+.||+|+||.||++...+ ...||+|.+..... ....+.|.+|++++++++|+||+++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 4679999999999987542 23589999864322 2335678999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC
Q 006031 454 KEERLLIYDYQPNGSLFSLIHGSKS-------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 454 ~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~ 526 (664)
.+..++||||+++++|.+++..... .....++|..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGNHYT 167 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcCCCc
Confidence 9999999999999999999964211 0113478999999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCChhhHHHH
Q 006031 527 ACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt--G~~P~~~~~~~~~~~~~~ 600 (664)
+|++|||++........ ....++..|+|||+.. ...++.++|||||||++|||++ |..||.... ..++...
T Consensus 168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~~~~~~ 244 (295)
T cd05097 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DEQVIEN 244 (295)
T ss_pred EEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hHHHHHH
Confidence 99999999876433221 1123467899999886 5678999999999999999998 556765432 2222222
Q ss_pred HHhhccC------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 601 VRSARED------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 601 ~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
....... .......+..+.+++.+||+.+|++||+|.+|++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111110 01122234569999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.30 Aligned_cols=245 Identities=19% Similarity=0.227 Sum_probs=189.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||++... +++.||+|++...... ......+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 467999999999999854 5889999999754321 12345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 86 GDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999953 35689999999999999999999998 99999999999999999999999999987542210
Q ss_pred ---------------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006031 543 ---------------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589 (664)
Q Consensus 543 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~ 589 (664)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01235899999999987 56788999999999999999999999975
Q ss_pred CCCChhhHHHHHHhhccCC--CchhHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 006031 590 SFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVAIA--CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~--Cl~~~P~~RPt~~ev~~~ 642 (664)
.. ..+....+....... .........+.+++.+ |...++..||++.|+++.
T Consensus 239 ~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ET--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CC--HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 32 222222222111111 0001122345566655 333344567999999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.35 Aligned_cols=238 Identities=19% Similarity=0.244 Sum_probs=189.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||.||++.. .+++.||+|+++...... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999996 457899999997543321 2345678899988888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|..++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99999884 234699999999999999999999999 999999999999999999999999999875322 2222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----hhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-----PNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
...|++.|+|||++. ...++.++|||||||++|||+||+.||...... ...+...+.. .....+......+.
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~ 231 (327)
T cd05617 155 TFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPRFLSVKAS 231 (327)
T ss_pred cccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCCCCCCCCCHHHH
Confidence 356899999999987 567899999999999999999999999643211 1112221111 11112223345688
Q ss_pred HHHHHcccCCCCCCCCH
Q 006031 620 EVAIACNSASPEQRPTM 636 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~ 636 (664)
+++.+||+.||++||++
T Consensus 232 ~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 232 HVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHhccCHHHcCCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.97 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=198.9
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.++||+|+||.||++... ++..+++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 467999999999999642 356889998865432 345689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 463 YQPNGSLFSLIHGSKS----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
|+++|+|.++++.... .....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEECCC
Confidence 9999999999964321 1123589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC
Q 006031 533 CLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED 607 (664)
Q Consensus 533 Gla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 607 (664)
|++........ ....+++.|+|||.+. ...++.++|||||||++|||++ |++||.... ..+...........
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~~ 243 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEAIECITQGREL 243 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--HHHHHHHHHcCccC
Confidence 99875533221 1223467899999886 5678999999999999999999 899986432 22333332222111
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
..+...+..+.+++.+||+.+|++||++.||.+.|++
T Consensus 244 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 244 -ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1222344568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=346.67 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=211.7
Q ss_pred HHhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCce
Q 006031 387 ASAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEER 457 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 457 (664)
+..+.||+|.||.|++|... ....||||.++..... .+.+.+..|+++|+.+ +|+||+.++|+|..++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 34559999999999999843 1567999999876553 5678999999999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC
Q 006031 458 LLIYDYQPNGSLFSLIHGSK---------STRA--KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~ 526 (664)
++|.||++.|+|.++++..+ .... ..++..+.+.++.|||.||+||++. ++|||||.++|||+.++..
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCE
Confidence 99999999999999998655 1111 2389999999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccccCCCCC---CCC--CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHH
Q 006031 527 ACLADYCLTALTADSLQD---DDP--DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~~~---~~~--~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 600 (664)
+||+|||+++...+.... ... -+..|||||.+. ...++.|+|||||||+||||+| |..||.+. ....++.++
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-PPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCC-CcHHHHHHH
Confidence 999999999965443222 122 245699999998 5889999999999999999999 99999762 224455665
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
++...+.. .+..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 535 l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 535 LKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 55554433 3444467799999999999999999999999999884
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.03 Aligned_cols=243 Identities=19% Similarity=0.341 Sum_probs=197.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 36799999999999985 5688999999875443 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 103 ~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 103 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred CHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99999852 3478999999999999999999999 99999999999999999999999999987644322 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++|||||||++|||++|+.||...... .....+..........+......+.+++.+|
T Consensus 176 ~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred ccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 45788999999886 566789999999999999999999999754221 1122222111111112334456688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|..+|++||++.|+++.
T Consensus 254 l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 254 LDMDVEKRGSAKELLQH 270 (296)
T ss_pred CcCCcccCcCHHHHhhC
Confidence 99999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.96 Aligned_cols=248 Identities=19% Similarity=0.213 Sum_probs=196.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|++++++++|+||+.+.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 36799999999999985 468899999986543322 2235678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....... ...
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 85 GDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred ccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999988632 234699999999999999999999998 99999999999999999999999999987653322 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-CCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED-DGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||++. ...++.++|+|||||++||+++|+.||...... ............. ..........+.+++.+
T Consensus 161 ~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 161 RVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 46889999999986 567899999999999999999999999753211 1111111111111 11223344568899999
Q ss_pred cccCCCCCCCC-----HHHHHHH
Q 006031 625 CNSASPEQRPT-----MWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt-----~~ev~~~ 642 (664)
||+.+|++||+ +.++++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 6676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=331.17 Aligned_cols=243 Identities=21% Similarity=0.317 Sum_probs=206.0
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCc--HHHHHHHHHHHcCCCCCCcccceEEEecCCc--eEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTS--NEMYEQHMESVGGLRHPNLVPLRAYFQAKEE--RLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~lV~e~~ 464 (664)
++||+|+|-+||||.. ..|.+||--.++..+..... .+.|..|+.+|+.|+|||||+++.+|.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 5699999999999985 45777875444433333333 4789999999999999999999999987665 67899999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCeEeCC-CCCeEEeeccccccccCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-WRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADSL 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~ 542 (664)
..|+|..|+. +.+.++......|++||++||.|||++ |+|||||||-.||+|+. .|.+||+|.|+|..+..+.
T Consensus 126 TSGtLr~Y~k-----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRK-----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHH-----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999995 345688889999999999999999996 78999999999999975 5999999999999998887
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
.....||+.|||||++. ..|++..||||||+.|+||+|+..||.. ....+++.+-+.+...+.....-...++.++|
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhh-hCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 77788999999999985 6799999999999999999999999964 45567888877777766543333345689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+|+.. .++|||+.|++.
T Consensus 278 ekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhcC-chhccCHHHHhh
Confidence 999999 999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.05 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=198.3
Q ss_pred HHhccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC-CceE
Q 006031 387 ASAELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK-EERL 458 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~ 458 (664)
...+.||+|+||.||+|.. .+++.||||+++.... ......+.+|+.++.++ +|+||++++++|... ...+
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 4467899999999999973 3578899999965332 12345688999999999 689999999988654 4678
Q ss_pred EEEecCCCCCHHHHhccCCCC-----------------------------------------------------------
Q 006031 459 LIYDYQPNGSLFSLIHGSKST----------------------------------------------------------- 479 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~----------------------------------------------------------- 479 (664)
+||||+++|+|.++++.....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998642210
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----CCCCCCCcc
Q 006031 480 ---RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ----DDDPDNLLY 552 (664)
Q Consensus 480 ---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y 552 (664)
....++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........ ....++..|
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 013478899999999999999999998 999999999999999999999999999876433211 112345679
Q ss_pred cCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCC
Q 006031 553 KAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPE 631 (664)
Q Consensus 553 ~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~ 631 (664)
+|||.+. ...++.++||||||+++|||++ |..||...... ..+...+...... ..+......+.+++.+||+.+|+
T Consensus 248 ~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 248 MAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred ECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChh
Confidence 9999886 5678999999999999999997 99998754222 2222222211111 11122334689999999999999
Q ss_pred CCCCHHHHHHHHHhhhc
Q 006031 632 QRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 632 ~RPt~~ev~~~L~~i~~ 648 (664)
+|||+.||++.|+.+..
T Consensus 325 ~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 325 QRPTFSELVEHLGNLLQ 341 (343)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.50 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=198.1
Q ss_pred HHhccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEE
Q 006031 387 ASAELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLL 459 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 459 (664)
...+.||+|+||.||++.. .++..||+|.++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 4557899999999999974 3578899999864432 23456799999999999999999999998775 56889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++++|.+++.. ....++|..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 86 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 86 IMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999953 224589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----------hhhHHHHHHhh
Q 006031 540 DSLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV----------PNEMMNWVRSA 604 (664)
Q Consensus 540 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~----------~~~~~~~~~~~ 604 (664)
.... ....++..|+|||++. ...++.++|||||||++||++|++.|....... ......++...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 3221 1234566799999886 567889999999999999999988765332110 00111111111
Q ss_pred cc--CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 605 RE--DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 605 ~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.. ..+.....+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 1111223456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.75 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=202.4
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||+||++... +++.||+|.+..... ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence 4568999999999999854 688899998764322 23457789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.++++. ...+++..+..++.+++.||.|||+..+++||||||+||++++++.++|+|||++...........
T Consensus 88 ~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 88 GSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred CCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence 999999853 346899999999999999999999844899999999999999999999999999876544333345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------hhhHHHHHHhhccCC---CchhHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV------PNEMMNWVRSAREDD---GAEDERLGM 617 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~ 617 (664)
.++..|+|||++. ...++.++|||||||++||++||+.||...... ...+..+........ ......+..
T Consensus 163 ~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd06620 163 VGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241 (284)
T ss_pred ccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHH
Confidence 6889999999986 567889999999999999999999999754321 112223333222211 112235567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+.+++.+||+.+|++|||+.|++++.-
T Consensus 242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 242 LRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.14 Aligned_cols=237 Identities=21% Similarity=0.274 Sum_probs=186.9
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHH-HHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHM-ESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||.||+|+.. ++..||+|++....... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57899999986543211 2233444454 467889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|..++.. ...+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999998842 34678888899999999999999998 999999999999999999999999999875322 1222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+++.|+|||.+. ...++.++|||||||++|||++|+.||... ....+.+.+... ....+......+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 155 TFCGTPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHK--PLQLPGGKTVAACDLLVG 229 (321)
T ss_pred cccCCcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCC--CHHHHHHHHhcC--CCCCCCCCCHHHHHHHHH
Confidence 345889999999986 567899999999999999999999999753 222222222211 111222334568899999
Q ss_pred cccCCCCCCCCHH
Q 006031 625 CNSASPEQRPTMW 637 (664)
Q Consensus 625 Cl~~~P~~RPt~~ 637 (664)
|++.+|++||++.
T Consensus 230 ~l~~~p~~R~~~~ 242 (321)
T cd05603 230 LLHKDQRRRLGAK 242 (321)
T ss_pred HccCCHhhcCCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.24 Aligned_cols=237 Identities=17% Similarity=0.241 Sum_probs=187.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++.. ..++.||+|... ...+.+|++++++++||||+++++++...+..++|+||+. +
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 46799999999999985 568899999653 2346789999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC---CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~~~ 544 (664)
+|..++.. ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 168 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 168 DLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 89888842 34689999999999999999999999 9999999999999999999999999999754322 122
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------hhhHHHHHHhh--------------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV------PNEMMNWVRSA-------------- 604 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~------~~~~~~~~~~~-------------- 604 (664)
...||+.|+|||++. ...++.++|||||||++|||+||+.|+...... ...+...+...
T Consensus 242 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 346899999999987 567899999999999999999999886432110 01111111000
Q ss_pred ------------cc-CCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 605 ------------RE-DDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 605 ------------~~-~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. ... .....+..+.+++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000 01123456889999999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.30 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=200.4
Q ss_pred hccccccCceeEEEEEEc-----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 461 (664)
.+.||+|+||.||+|.+. .+..||+|.+...... ...+.|.+|++.+++++|+||+++++++.. ....++||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 367999999999999854 3688999999754432 246789999999999999999999999877 55789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 88 e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 88 EYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred ecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999642 23599999999999999999999998 9999999999999999999999999999876532
Q ss_pred CC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-------------hhHHHHHHh
Q 006031 542 LQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-------------NEMMNWVRS 603 (664)
Q Consensus 542 ~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-------------~~~~~~~~~ 603 (664)
.. ....++..|+|||+.. ...++.++||||||+++|||+||+.|+....... ..+..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 21 1123456799999886 5678899999999999999999999976532211 111122221
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
.... ..+...+..+.+++.+||+.+|++||||.||+++|++++
T Consensus 242 ~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 242 GERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred CCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111 112233466899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.07 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=204.1
Q ss_pred HHHHhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCC
Q 006031 385 MRASAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKE 455 (664)
Q Consensus 385 ~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 455 (664)
.+...+.||+|+||.||+|... ....||+|.++.... ....+.+.+|+++++++ +||||++++++|...+
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3345678999999999999742 134689998864321 23356788999999999 7999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD 524 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~ 524 (664)
..++|+||+++|+|.+++..... .....++|.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~ 170 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTED 170 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCC
Confidence 99999999999999999964221 1234689999999999999999999998 99999999999999999
Q ss_pred CCeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHH
Q 006031 525 FEACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 525 ~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~ 599 (664)
+.+||+|||+++....... ....++..|+|||.+. ...++.++|||||||++|||++ |..||... ...++..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~ 247 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFK 247 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHH
Confidence 9999999999976543221 1122356799999986 5678899999999999999999 88888653 2233333
Q ss_pred HHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 600 WVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+...... +.+......+.+++.+||+.+|++||+|.|+++.|+++....
T Consensus 248 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 248 LLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 33222111 122233456889999999999999999999999999997443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.70 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||||++...... ......+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 467999999999999964 6889999999754321 12345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 86 GDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred cHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999953 34689999999999999999999999 999999999999999999999999999865322110
Q ss_pred -------------------------------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 006031 544 -------------------------------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586 (664)
Q Consensus 544 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P 586 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCCC
Confidence 0134889999999986 56789999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 006031 587 SQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVAIACNSASPEQRPT---MWQVLK 641 (664)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~ev~~ 641 (664)
|.... ..+....+........ ........+.+++.+|+. +|.+|++ +.|+++
T Consensus 239 f~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDN--PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCC--HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 97542 2222222211111111 111224457889999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.07 Aligned_cols=242 Identities=21% Similarity=0.364 Sum_probs=205.8
Q ss_pred HHhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 387 ASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...++||+|+||.||||.+ ..|..||||.+... ...+++.+|+.+|++++.|++|++||.|......++|||||.
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3457899999999999985 56999999998543 356889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
-|++.+.++ .+.++|++..+..|++..++||+|||.. +-+|||||+.||||+.+|.+|++|||.+..+.+...
T Consensus 112 AGSiSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999997 3567899999999999999999999998 889999999999999999999999999987766433
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|||||++. .-.|+.++||||+|++..||..|++||.+......-+ ......+. ..+++...++.++
T Consensus 187 NTVIGTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred CccccCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCCCCCCCChHhhhhHHHHH
Confidence 3456999999999997 6678899999999999999999999998754322111 00111111 2467788889999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++|+-+.|++|-|+.++++
T Consensus 263 i~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhh
Confidence 99999999999999988765
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.52 Aligned_cols=237 Identities=21% Similarity=0.265 Sum_probs=189.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCC-CcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHP-NLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... +++.||+|++...... ....+.+..|.+++..++|+ +|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 467999999999999865 5778999998754321 23345678889999988765 68889999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 85 ~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 85 GGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 9999999952 34688999999999999999999998 999999999999999999999999999864321 222
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....|+..|+|||++. ...++.++|||||||++|||+||+.||... ...++...+..... ..+......+.+++.
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~--~~~~~~~~~~~~li~ 233 (324)
T cd05587 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (324)
T ss_pred eeecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 2345899999999987 567889999999999999999999999753 22333333322211 122233456889999
Q ss_pred HcccCCCCCCCCH
Q 006031 624 ACNSASPEQRPTM 636 (664)
Q Consensus 624 ~Cl~~~P~~RPt~ 636 (664)
+||+.+|++|++.
T Consensus 234 ~~l~~~P~~R~~~ 246 (324)
T cd05587 234 GLLTKHPAKRLGC 246 (324)
T ss_pred HHhhcCHHHcCCC
Confidence 9999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.79 Aligned_cols=237 Identities=23% Similarity=0.294 Sum_probs=197.9
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
...+||+|.||+|+++.++ +++.+|||.+++...-. .+.+..+.|-+++... +||.++.++++|+.+++.|.||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 3578999999999999965 47799999998876533 3456666776666555 6999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc--cCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSL 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~ 542 (664)
.||++..+.+ ...+++.....++..|+.||.|||++ +||+||||-+|||||.+|.+||+|||+++.. ....
T Consensus 452 ~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 452 AGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred CCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 9999555443 35699999999999999999999999 9999999999999999999999999999863 3345
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
....+||+.|||||++. +..|+..+|.|||||+||||+.|..||.+. +++++-+.+. .++...+.....+..+++
T Consensus 525 TsTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~--~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIV--NDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred cccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHh--cCCCCCCCcccHHHHHHH
Confidence 55688999999999998 788999999999999999999999999863 3445544332 223334555667789999
Q ss_pred HHcccCCCCCCCCH
Q 006031 623 IACNSASPEQRPTM 636 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~ 636 (664)
.+.++++|++|--+
T Consensus 600 ~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhccCcccccCC
Confidence 99999999999865
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.07 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=199.1
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 467999999999999864 467899999864322 1234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 463 YQPNGSLFSLIHGSKS-----------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
|+++|+|.++++.... .....+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVGENM 167 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheEecCCC
Confidence 9999999999964211 1123578999999999999999999998 999999999999999999
Q ss_pred CeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHH
Q 006031 526 EACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 526 ~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 600 (664)
.++++|||++....... ......+..|+|||.+. ...++.++|||||||++|||++ |..||... ...+....
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--~~~~~~~~ 244 (288)
T cd05050 168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--AHEEVIYY 244 (288)
T ss_pred ceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHH
Confidence 99999999987543221 11223456799999886 5678999999999999999998 88888643 22333333
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
+...... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 245 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 245 VRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3322211 1122345668999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.17 Aligned_cols=251 Identities=18% Similarity=0.283 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|+.. ++..||+|.++.... ......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 467999999999999854 578899999865432 23345677899999999999999999999999999999999975
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 89 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 89 DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 88888853 234588999999999999999999998 99999999999999999999999999987643322 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||.+.+...++.++|||||||++|||+||+.||...... ..+...........
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 456889999998865567889999999999999999999999754221 11111111000000
Q ss_pred --C--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 006031 609 --G--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIK 647 (664)
Q Consensus 609 --~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~ 647 (664)
. ........+.+++.+|++.||++|||+.|+++ .++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0 00112345789999999999999999999987 344443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.94 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+..+++++||||+++++++.+.+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 468999999999999754 245899998764322 1234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSKS-----TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
|+++|+|.++++.... .....+++.....++.|++.||.|||+. +|+||||||+||++++++.++++|||+++.
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~~~~ 168 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCcccc
Confidence 9999999999964221 1124567788899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... ....++..|+|||.+. ...++.++|||||||++|||++ |+.||... ...++.+.+...... ..+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~~-~~~~ 244 (288)
T cd05061 169 IYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMDGGYL-DQPD 244 (288)
T ss_pred ccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCC
Confidence 433211 1123456799999986 5678999999999999999999 78888653 223343333221111 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
..+..+.+++.+||+.+|++|||+.|+++.|++..
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 33456999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.71 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||++.. .+++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 46799999999999985 4688999999975433 123456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 86 GDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 9999999632 24689999999999999999999999 999999999999999999999999999976543321
Q ss_pred CCCCCCCcccCcccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHHH
Q 006031 544 DDDPDNLLYKAPETRNA-----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLGM 617 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~-----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 617 (664)
....+++.|+|||++.. ...++.++|||||||++|||++|+.||..... ............. ...........
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-AKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-HHHHHHHHcCCCccCCCCCCCCCHH
Confidence 22358899999998752 34567899999999999999999999975321 1111111111110 00111123455
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++..|++ +|++||++.++++
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhC
Confidence 8899999997 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.05 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=194.0
Q ss_pred cccccc--CceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKG--SLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+| +|++||++.. .+++.||+|+++.........+.+.+|+++++.++||||++++++|..++..++|+||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 579999 7889999985 5789999999976543333456788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----- 541 (664)
|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+........
T Consensus 84 ~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 84 GSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999532 223589999999999999999999998 9999999999999999999999999865332111
Q ss_pred ----CCCCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc----------
Q 006031 542 ----LQDDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE---------- 606 (664)
Q Consensus 542 ----~~~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~---------- 606 (664)
......++..|+|||++... ..++.++|||||||++|||++|+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh-HHHHHHhcCCccccccccchhh
Confidence 01122456779999998633 35789999999999999999999999753211 111111100000
Q ss_pred -------------------------CC--------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 006031 607 -------------------------DD--------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIK 647 (664)
Q Consensus 607 -------------------------~~--------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~ 647 (664)
.. .........+.+++.+||+.||++|||+.|+++ .+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00 001123356889999999999999999999987 355544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.04 Aligned_cols=247 Identities=19% Similarity=0.296 Sum_probs=186.0
Q ss_pred hccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~ 463 (664)
+.+||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 467999999999999864 46789999986432 23457789999999999999999998854 4467899999
Q ss_pred CCCCCHHHHhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe----CCCCCeEEeecccc
Q 006031 464 QPNGSLFSLIHGSKS----TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLT 535 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla 535 (664)
+. ++|.+++..... .....+++.....++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 86 488888753211 1223588999999999999999999999 99999999999999 45688999999999
Q ss_pred ccccCCCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--------hhHHHHHH
Q 006031 536 ALTADSLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--------NEMMNWVR 602 (664)
Q Consensus 536 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--------~~~~~~~~ 602 (664)
+....... ....+|+.|+|||++.+...++.++||||+||++|||++|++||....... ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 87543321 234578899999998755668999999999999999999999996432110 01111110
Q ss_pred hhccCCC---------------------------c--------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 603 SAREDDG---------------------------A--------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 603 ~~~~~~~---------------------------~--------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....+.. . .......+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0 0001134778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.48 Aligned_cols=252 Identities=20% Similarity=0.330 Sum_probs=195.6
Q ss_pred hccccccCceeEEEEEEc-----------------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-----------------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 451 (664)
.+.||+|+||.||++... ++..||+|.+..... ....+.+.+|++++++++|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 467999999999998532 245689999864321 23356789999999999999999999999
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 452 QAKEERLLIYDYQPNGSLFSLIHGSKST------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 452 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
...+..++||||+++|+|.+++...... ....+++.+...++.|++.||+|||+. +++||||||+||++++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVGKNY 167 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEcCCC
Confidence 9999999999999999999999753211 123578899999999999999999999 999999999999999999
Q ss_pred CeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCChhhHHH
Q 006031 526 EACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT--GKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 526 ~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt--G~~P~~~~~~~~~~~~~ 599 (664)
.++++|||+++....... .....+..|+|||... ...++.++|||||||++|||+| |..||.... ..+...
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~--~~~~~~ 244 (296)
T cd05095 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS--DEQVIE 244 (296)
T ss_pred CEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccC--hHHHHH
Confidence 999999999976533221 1122356899999876 5678999999999999999998 677876432 122221
Q ss_pred HH----Hhhcc--CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 600 WV----RSARE--DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 600 ~~----~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
.. ..... ....+...+..+.+++.+||+.+|++||++.||.+.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11100 011122344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.34 Aligned_cols=246 Identities=17% Similarity=0.211 Sum_probs=194.7
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||.||++... ++..||+|.+...... ....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 3578999999999999864 5889999998653321 1234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
+|+|.++++. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 127 gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 127 GGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 9999999953 2477888889999999999999998 99999999999999999999999999997654321
Q ss_pred CCCCCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGM 617 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 617 (664)
.....|++.|+|||.+... ..++.++|||||||++|||++|+.||.... .......+........ .....+..
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 1234689999999987532 247889999999999999999999997532 1122222211111111 11123466
Q ss_pred HHHHHHHcccCCCCC--CCCHHHHHHH
Q 006031 618 LLEVAIACNSASPEQ--RPTMWQVLKM 642 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~--RPt~~ev~~~ 642 (664)
+.+++.+|++.+|++ ||++.|+++.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcC
Confidence 889999999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.17 Aligned_cols=246 Identities=20% Similarity=0.256 Sum_probs=196.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||++.. .+++.||+|.+....... ...+.+.+|+.++++++|+||+.+++.+.+.+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 36799999999999985 468899999986543322 2235677899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++++|||++........ ..
T Consensus 85 ~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 85 GDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred CcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9999998532 234589999999999999999999998 999999999999999999999999999876543222 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||++. ...++.++|||||||++|||++|+.||....... ............ .........+.+++.
T Consensus 161 ~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 237 (285)
T cd05630 161 RVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--EYSEKFSPDARSLCK 237 (285)
T ss_pred CCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--hcCccCCHHHHHHHH
Confidence 46889999999987 5678999999999999999999999997542211 111111111111 112233455889999
Q ss_pred HcccCCCCCCCC-----HHHHHH
Q 006031 624 ACNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt-----~~ev~~ 641 (664)
+||+.+|++||| +.|+++
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHc
Confidence 999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=322.92 Aligned_cols=237 Identities=20% Similarity=0.257 Sum_probs=189.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... ++..||+|.+...... ....+.+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 467999999999999865 5779999998754321 12234566777777766 58999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.... ...
T Consensus 85 ~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 85 GGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 9999999852 34688999999999999999999998 999999999999999999999999999875432 122
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....|++.|+|||++. ...++.++|||||||++|||+||+.||... ...++...+..... ..+......+.+++.
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (323)
T cd05616 159 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNV--AYPKSMSKEAVAICK 233 (323)
T ss_pred ccCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCC--CCCCcCCHHHHHHHH
Confidence 2356899999999987 567899999999999999999999999753 22333333322211 122334556889999
Q ss_pred HcccCCCCCCCCH
Q 006031 624 ACNSASPEQRPTM 636 (664)
Q Consensus 624 ~Cl~~~P~~RPt~ 636 (664)
+|++.+|++|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05616 234 GLMTKHPGKRLGC 246 (323)
T ss_pred HHcccCHHhcCCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.63 Aligned_cols=251 Identities=17% Similarity=0.284 Sum_probs=189.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--------CceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--------EERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~~~~l 459 (664)
.++||+|+||.||+|.. ..++.||||++... .....+|+.++++++|||||++++++... ...++
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 46899999999999996 46889999988532 22345799999999999999999886432 13668
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALT 538 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~ 538 (664)
||||+++ +|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 145 vmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 9999975 7777664221 2345689999999999999999999999 999999999999999665 6999999999865
Q ss_pred cCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---------
Q 006031 539 ADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--------- 608 (664)
Q Consensus 539 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--------- 608 (664)
.... .....+++.|+|||++.+...++.++|||||||++|||+||++||.+... ...+...+.....+.
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhch
Confidence 4322 22346789999999987556789999999999999999999999975421 122222221111000
Q ss_pred -------------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhcc
Q 006031 609 -------------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKGA 649 (664)
Q Consensus 609 -------------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~~ 649 (664)
+ .+...+.++.+++.+||+.+|++|||+.|+++ .++++++.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 0 01112356889999999999999999999984 35655543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.35 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=199.6
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||++... .+..||+|.+.... .......+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 3467999999999999965 68899999886431 122346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|..+++.. .....+++..+..++.+++.||.|||+..+|+||||||+||+++.++.++|+|||++...........
T Consensus 84 ~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 84 GSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred CCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 9999998642 12347899999999999999999999754899999999999999999999999999976655544455
Q ss_pred CCCCcccCccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc--cCCCchhHHHHHHH
Q 006031 547 PDNLLYKAPETRNAS-----HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR--EDDGAEDERLGMLL 619 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~-----~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 619 (664)
.++..|+|||.+... ..++.++|||||||++|||++|+.||..... ........... .....+......+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGDPPTLPSGYSDDAQ 239 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence 678899999987522 2357899999999999999999999965321 11111111111 11122334566789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+++.+||+.+|++||++.+++..
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhcC
Confidence 99999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.38 Aligned_cols=244 Identities=18% Similarity=0.207 Sum_probs=190.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||++.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 46799999999999985 5688999999865332 122346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 86 GDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999952 34688889999999999999999999 99999999999999999999999999986321100
Q ss_pred ---------------------------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHH
Q 006031 543 ---------------------------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLL 577 (664)
Q Consensus 543 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl 577 (664)
.....||+.|+|||++. ...++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchhh
Confidence 00135889999999986 56789999999999999
Q ss_pred HHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 006031 578 LELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVAIACNSASPEQR---PTMWQVLKM 642 (664)
Q Consensus 578 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~ev~~~ 642 (664)
|||+||+.||.... ..+....+........ ........+.+++.+|+. +|.+| +++.|+++.
T Consensus 239 ~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSEN--SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCC--HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999997532 2222111111111111 111233557899999997 67665 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.33 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=200.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++.+++.+ ...+++|||+++|+
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 46799999999999998888889999886432 235678899999999999999999999887 77899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---C
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD---D 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~ 545 (664)
|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||.+......... .
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 87 LLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99999642 234688999999999999999999998 9999999999999999999999999998765432211 1
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||++. ...++.++|||||||++||++| |+.||... ....+..+....... ......+..+.+++.+
T Consensus 163 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 163 AKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYRM-PRPENCPEELYNIMMR 238 (260)
T ss_pred CcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCCC-CCcccCCHHHHHHHHH
Confidence 23456799999986 5678899999999999999999 99998753 223334433322211 1223445668999999
Q ss_pred cccCCCCCCCCHHHHHHHHHh
Q 006031 625 CNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
||+.+|++||++.++.+.|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 239 CWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.68 Aligned_cols=245 Identities=20% Similarity=0.270 Sum_probs=195.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... ++..+|+|.+..... ......+.+|++++.+++||||+++++++.+++..++||||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 467999999999999854 577888888764321 123456889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++. ...+++..+..++.|+++||+|||+..+++||||||+||++++++.+||+|||++............
T Consensus 85 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 85 SLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999953 3568899999999999999999998448999999999999999999999999998766544444456
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-----------------------
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA----------------------- 604 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~----------------------- 604 (664)
++..|+|||.+. +..++.++|||||||++|||++|+.||.... ......+....
T Consensus 160 ~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 160 GTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 788999999886 5668899999999999999999999986432 11111111100
Q ss_pred ----------ccCC---CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 605 ----------REDD---GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 605 ----------~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.... .........+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0011134468899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.90 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=198.0
Q ss_pred ccccccCceeEEEEEEcC-------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 390 ELLGKGSLGTTYKAVLDN-------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
+.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998643 25789998764322 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-----CeEEeecccc
Q 006031 463 YQPNGSLFSLIHGSKST--RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-----EACLADYCLT 535 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-----~~ki~DfGla 535 (664)
|+++++|.++++..... ....++|.+++.++.|++.||+|||+. +++|+||||+||+++.+. .++++|||++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999643211 234588999999999999999999998 999999999999999887 8999999998
Q ss_pred ccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 536 ALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 536 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
+....... .....+..|+|||++. ...++.++|||||||++|||+| |+.||... ...+....+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~-~~ 234 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQHVTAGGRL-QK 234 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCccc--CHHHHHHHHhcCCcc-CC
Confidence 75433211 1223467899999987 5678999999999999999998 99998643 222333333221111 12
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
....+..+.+++.+||+.+|++||++.++.+.|++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 23345678999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.72 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC------CceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK------EERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~------~~~~lV 460 (664)
.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... +..++|
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 467999999999999864 57889999986432 3456788999999988 799999999998753 357899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 9999999999999642 234689999999999999999999998 999999999999999999999999999876543
Q ss_pred CC--CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 541 SL--QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~--~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
.. .....++..|+|||++.. ...++.++|||||||++|||++|+.||..... ....................
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhcCCCCCCCCCCc
Confidence 22 123457889999998752 23577899999999999999999999865321 11111111111111112233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+++.+||..+|++|||+.|+++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 456899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.97 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|...+ +..+++|.+.... ..+.+.+|++++++++|+||+++++++.+.+..++++||++++
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 4579999999999999765 7899999986432 2678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....... ...
T Consensus 84 ~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 84 SVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999963 235689999999999999999999998 99999999999999999999999999988655432 122
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||++. +..++.++|||||||++|||++|+.||...... .......................+.+++.+|
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 159 VIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-RAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-hhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 34778999999986 567889999999999999999999998753221 1111111111111112223445689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++|||+.|+++
T Consensus 237 l~~~P~~Rps~~~il~ 252 (256)
T cd06612 237 LVKDPEERPSAIQLLQ 252 (256)
T ss_pred HhcChhhCcCHHHHhc
Confidence 9999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.00 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=196.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|...++..+|+|.++...... .....+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999998888999999886432211 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC---
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--- 541 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 541 (664)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++++|||++......
T Consensus 85 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 85 PGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999952 24588999999999999999999998 9999999999999999999999999998754211
Q ss_pred -----CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 542 -----LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 542 -----~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
......++..|+|||++. ...++.++|||||||++||+++|+.||..... .................+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-LAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCCh-HHHHHHhhhccCCCCCCCCCCCH
Confidence 112235788999999987 56678999999999999999999999975321 11222211111111122333456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 6899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.40 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=194.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.+++..++|+||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 357999999999999964 68899999987554433445678899999999999999999999999999999999997 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 84 DLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 8988885322 235689999999999999999999998 999999999999999999999999999875433221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc--------------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-------------------- 605 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-------------------- 605 (664)
..++..|+|||.+.+...++.++|||||||++|||+||++||...... ...........
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 346788999998865556789999999999999999999998753211 11111111000
Q ss_pred -cCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 -EDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 -~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... .......++.+++.+||+.||++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 01112345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.83 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=186.6
Q ss_pred cccccCceeEEEEEEcCC---eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLDNR---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|...++ ..+++|.+..... ....+.|.+|+..++.++||||++++++|......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999985443 3456666654322 234578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----LQ 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 543 (664)
+|.++++.... .....++.....++.||+.||+|||+. +++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999975321 234567778889999999999999998 9999999999999999999999999998643221 11
Q ss_pred CCCCCCCcccCcccccc------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC---CCchhH
Q 006031 544 DDDPDNLLYKAPETRNA------SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED---DGAEDE 613 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~------~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 613 (664)
....++..|+|||++.. ...++.++|||||||++|||++ |..||.... ....+.......... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcccccCCCccCCC
Confidence 22456788999998742 1235789999999999999997 567775421 111122211111111 111122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
....+.+++..|| .+|++||++.||++.|.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3456788999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.14 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=196.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 357999999999999965 5889999998654433334567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|..++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 86 VLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred HHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 8888874 234589999999999999999999998 99999999999999999999999999998764432 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc--------------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-------------------- 605 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-------------------- 605 (664)
..++..|+|||++.+...++.++|||||||++|||++|+.||...... ...........
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 346788999999865566789999999999999999999999754321 11111111000
Q ss_pred cCC-C--c-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 EDD-G--A-----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 ~~~-~--~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... . . .......+.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0 0 0122456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.13 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=198.0
Q ss_pred hccccccCceeEEEEEEcC--CeEEEEEEccCccc--------cCCcHHHHHHHHHHHcC-CCCCCcccceEEEecCCce
Q 006031 389 AELLGKGSLGTTYKAVLDN--RLIVCVKRLDASKL--------AGTSNEMYEQHMESVGG-LRHPNLVPLRAYFQAKEER 457 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~--------~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~ 457 (664)
.+.||+|+||.||+|.... +..+|+|.+..... .......+.+|+.++.+ ++||||+++++++.+.+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4579999999999999765 78899998753321 11223456778887765 7999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
++||||+++++|.+++.... .....+++..++.++.|++.||.|||+..+++|+||+|+||+++.++.+|++|||.+..
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceee
Confidence 99999999999999885322 22356899999999999999999999743899999999999999999999999999976
Q ss_pred ccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 538 TADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 538 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
..... .....++..|+|||.+. ...++.++||||||+++|||++|+.||... ........+...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 164 KQPESKLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred cccccccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHhhccCCcCCcccCCH
Confidence 54432 22345788999999987 566899999999999999999999998643 122222222221111111223345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
.+.+++.+||+.+|++||++.|+..++++
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 68999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.79 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=190.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 46799999999999985 45889999998654321 12346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----- 541 (664)
|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 86 GDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999953 34688888899999999999999998 9999999999999999999999999997422100
Q ss_pred ----------------------------------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHH
Q 006031 542 ----------------------------------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELL 581 (664)
Q Consensus 542 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ell 581 (664)
......||+.|+|||++. ...++.++|||||||++|||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeehh
Confidence 001135889999999987 567889999999999999999
Q ss_pred cCCCCCCCCCCChhhHHHHHHhhccC--CCchhHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 006031 582 TGKPPSQHSFLVPNEMMNWVRSARED--DGAEDERLGMLLEVAIACNSASPEQRP---TMWQVLKM 642 (664)
Q Consensus 582 tG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RP---t~~ev~~~ 642 (664)
+|+.||.... ..+....+...... ..........+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADT--PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCC--HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999997642 22221111111111 0111123345677777766 5999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.74 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred hccccccCceeEEEEEEcC-C----eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN-R----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|...+ + ..||+|.+..... ......+.+|+.++++++||||++++++|.. +..++|+||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 4689999999999998643 3 3589998865432 2234678899999999999999999999987 789999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||.++.......
T Consensus 90 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 90 MPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred CCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999963 234589999999999999999999998 999999999999999999999999999986543221
Q ss_pred C----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 D----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ~----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
. ....+..|+|||.+. ...++.++||||||+++||++| |+.||... ...++.+.+....... .+......+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (279)
T cd05057 165 EYHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDLLEKGERLP-QPPICTIDV 240 (279)
T ss_pred ceecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhCCCCCC-CCCCCCHHH
Confidence 1 122356799999886 5678899999999999999999 99998754 2334444444322211 122233558
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.+++.+||..+|.+||++.++++.|+++..
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.85 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=192.4
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
..||+|+||.||+|.. .++..|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 5799999999999985 4678899998865432 245678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccCCC--C
Q 006031 469 LFSLIHGSKSTRAKPL--HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADSL--Q 543 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~--~ 543 (664)
|.++++.. ...+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++....... .
T Consensus 92 L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 92 LSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred HHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 99999632 2334 7888899999999999999998 9999999999999986 6799999999987553221 1
Q ss_pred CCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
....++..|+|||++... ..++.++||||||+++|||++|+.||........... ...........+......+.+++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCcccCHHHHHHH
Confidence 223578899999987532 2378899999999999999999999865321111111 11111111122333455688999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.+|++|||+.|+++
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHcCCCchhCCCHHHHHh
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=335.89 Aligned_cols=252 Identities=22% Similarity=0.261 Sum_probs=201.7
Q ss_pred HhccccccCceeEEEEEEcCC-eEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEE-Eec------CCceE
Q 006031 388 SAELLGKGSLGTTYKAVLDNR-LIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAY-FQA------KEERL 458 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~-~~~------~~~~~ 458 (664)
..++|.+|||+.||.|....+ ..+|+|++-..+ ....+..++||++|++|+ |+|||.+++. ... .-+.+
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d--e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND--EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCC--HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 357899999999999997766 999999986553 356688999999999997 9999999993 221 12678
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-WRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
|.||||++|.|-+++... ....|++.++++|+.++++|+++||.. ++|||||||-+||||+.+++.||||||.+..
T Consensus 119 lLmEyC~gg~Lvd~mn~R---lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTR---LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred eehhhccCCcHHHHHHHH---HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 999999999999999643 234499999999999999999999995 5799999999999999999999999999854
Q ss_pred ccCCCCC-----------CCCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh
Q 006031 538 TADSLQD-----------DDPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 538 ~~~~~~~-----------~~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 604 (664)
.-..... ....|+.|+|||++. .+...++|+||||+||+||-|+....||+..... ..+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng~ 270 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNGN 270 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEecc
Confidence 2221110 123689999999865 2456799999999999999999999999864211 001111
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
. ..+....+...+.+||..||+++|.+||++.+|+..+.++....
T Consensus 271 Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 271 Y-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred c-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1 11123466778999999999999999999999999999987654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.06 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=195.3
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 3467999999999999965 488999999865432 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ .
T Consensus 94 ~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 94 GAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 999988853 234689999999999999999999998 999999999999999999999999999865433221 2
Q ss_pred CCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
...++..|+|||++.. ...++.++|||||||++|||++|+.||.... .........................+.+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 2347788999998742 3446789999999999999999999986532 1112222222111111122334456899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++||++.|+++
T Consensus 248 li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.30 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=199.4
Q ss_pred HhccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||.||+|...+ ...|++|....... ....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~ 87 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMEL 87 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEc
Confidence 35789999999999998643 35689998864332 2345678999999999999999999998865 567899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....+++..+..++.+++.||+|||+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 88 APLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999963 223589999999999999999999998 999999999999999999999999999876544321
Q ss_pred ---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....++..|+|||.+. ...++.++||||||+++||+++ |+.||.... ..+........... ..+...+..+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (270)
T cd05056 163 YKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGERL-PMPPNCPPTLY 238 (270)
T ss_pred eecCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCcC-CCCCCCCHHHH
Confidence 1122346799999886 5678899999999999999996 999987542 22222322221111 12233456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+++.+||..+|++|||+.++++.|++++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.05 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=200.6
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCc-HHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTS-NEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||.|+||.||-|+ ..+...||||++........+ -.++.+|+..+.+++|||+|.+.|||......+||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 3569999999999998 567889999999754331111 2578899999999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+-.+++. ...+++....+..|+.+++.||+|||+. +.||||||+.||||++.|.+|++|||.+.++.+.. ..
T Consensus 110 GSAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--sF 182 (948)
T KOG0577|consen 110 GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--SF 182 (948)
T ss_pred ccHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchh--cc
Confidence 58888885 3457899999999999999999999999 99999999999999999999999999998876654 37
Q ss_pred CCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 547 ~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
.||++|||||++. ..++|+-|+||||+||+..|+...++|+...... .-+..... .-.+.-...++...+.+++..
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQ-NesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ-NESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHh-cCCCCCCCchhHHHHHHHHHH
Confidence 8999999999875 3688999999999999999999999997543211 11222111 111112356677889999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
|+++-|.+|||.+++++.
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999999999999988753
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=330.45 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=187.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||+|.. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46799999999999985 56889999998654321 12345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----- 541 (664)
|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 g~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 86 GDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999953 24578888999999999999999998 9999999999999999999999999997432100
Q ss_pred --------------------------------------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHH
Q 006031 542 --------------------------------------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLL 577 (664)
Q Consensus 542 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl 577 (664)
......||+.|+|||++. ...++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHHH
Confidence 001135789999999987 56789999999999999
Q ss_pred HHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 006031 578 LELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLGMLLEVAIACNSASPEQRPT---MWQVLK 641 (664)
Q Consensus 578 ~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~ev~~ 641 (664)
|||++|+.||..... ............. ...........+.+++.+++ .+|++|++ +.|+++
T Consensus 239 ~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTP-LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCH-HHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999975321 1111121111111 11111122344667776655 59999997 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.25 Aligned_cols=241 Identities=25% Similarity=0.408 Sum_probs=195.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++...+..++|+||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 45699999999999985 4578899998864332 123467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||++........ ..
T Consensus 88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 88 SALDLLKP------GPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 99999842 4588999999999999999999998 999999999999999999999999999876543321 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||++. ...++.++|||||||++|||+||+.|+.... .......+..... .......+..+.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 161 FVGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLH--PMRVLFLIPKNSP-PTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred ccCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccc--hhhHHhhhhcCCC-CCCCcccCHHHHHHHHHH
Confidence 34678899999987 5678899999999999999999999986432 1222222211111 112223455688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++||+|.|+++
T Consensus 237 l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 237 LNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.20 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=197.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... ++..+|+|.++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 467999999999999854 688899998864332 234567888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++... ....+++.....++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+....... ...
T Consensus 84 ~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 84 DLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred cHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999998532 234578999999999999999999998 99999999999999999999999999987654322 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||++. ...++.++||||||+++|+|++|+.||... ........+...... ..+......+.+++.+|
T Consensus 160 ~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 160 YVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVCQGSYK-PLPSHYSYELRSLIKQM 235 (255)
T ss_pred ccCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCC--CHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHH
Confidence 45788899999986 566889999999999999999999999753 122222222111111 12233445688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.|++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.43 Aligned_cols=242 Identities=21% Similarity=0.360 Sum_probs=196.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||.|+||.||+|.. .+++.|++|.+..... ...+.+.+|+++++.++||||+++++++...+..++|+||++++
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 35799999999999984 5788999999865433 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++.++..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 102 ~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 102 SLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred cHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 99999842 3589999999999999999999999 999999999999999999999999999876543321 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++|||||||++||+++|+.||...... ..+.............+......+.+++.+|
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred cCCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 45788999999886 566889999999999999999999999764221 1221111111111112233445688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|..+|++||++.+++.
T Consensus 253 l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 253 LEMDVEKRGSAKELLQ 268 (296)
T ss_pred hhcChhhCCCHHHHhh
Confidence 9999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.59 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=198.5
Q ss_pred HhccccccCceeEEEEEEc-CCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
..+.||+|+||.||+|... ++. .||+|.+..... ......+.+|+.++++++||||++++++|... ..++++|
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 3467999999999999853 343 478888764322 12344688999999999999999999998754 5679999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 89 LMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred hcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999999963 234688999999999999999999998 99999999999999999999999999998654322
Q ss_pred C----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 543 Q----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 543 ~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
. ....++..|+|||++. ...++.++|||||||++||+++ |+.||... ...+..+++....... ........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLP-QPPICTID 239 (303)
T ss_pred cccccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCCCC-CCCCCCHH
Confidence 1 1223467899999986 5678999999999999999998 89998653 2233444443322221 12223456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+++.+||..+|++||+++|+++.|+++....
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.33 Aligned_cols=245 Identities=19% Similarity=0.294 Sum_probs=194.3
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 456799999999999985 4688999999865432 3345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
++|.++++. ...+++.+...++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 91 ~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 91 GSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 999999853 34689999999999999999999999 999999999999999999999999999875543221 2
Q ss_pred CCCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLE 620 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 620 (664)
...++..|+|||++. ....++.++|||||||++|||++|+.||...... ..+............ .....+..+.+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 345788999999863 2345788999999999999999999998643211 111111111111111 11123345889
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++||++.++++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHccCCchhCcCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.44 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=200.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||.+.. .++..+++|.+............+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 46799999999999884 56888999998765544455677889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 85 TLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 999999632 235689999999999999999999998 99999999999999999999999999987654432 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||... +..++.++||||||+++|||++|+.||.... ..+....+.... ........+..+.+++.+|
T Consensus 161 ~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 161 VVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATN--PLNLVVKIVQGN-YTPVVSVYSSELISLVHSL 236 (256)
T ss_pred cCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCC-CCCCccccCHHHHHHHHHH
Confidence 45788999999986 5567889999999999999999999987532 222222222111 1112233456689999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|..+|++||++.|+++.
T Consensus 237 l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 237 LQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCcccCCCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.07 Aligned_cols=245 Identities=31% Similarity=0.456 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||++.... ++.||+|.+..............+|+..+++++||||+++++++.+.+..++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 3679999999999999654 678999999876543333334456999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc--cCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSLQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~~~~ 545 (664)
+|.+++. ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+... .......
T Consensus 84 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 84 SLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp BHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccc-----ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 9999995 345689999999999999999999998 9999999999999999999999999999753 2223334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-----CCCchhHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-----DDGAEDERLGMLLE 620 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~ 620 (664)
..++..|+|||.+......+.++||||+|+++|||++|+.||.... ..+.......... ...........+.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5678899999998645678999999999999999999999998641 1111111111111 11111111367999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++||++.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.45 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=198.0
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceE
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERL 458 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~ 458 (664)
.+.||+|+||.||+|.+. .+..||+|++..........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 457999999999999853 3688999998754433334567889999999999999999999886532 247
Q ss_pred EEEecCCCCCHHHHhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSK-STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
+++||+++|+|.+++.... ......+++....+++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECccccccc
Confidence 8999999999998875322 11223588999999999999999999998 999999999999999999999999999886
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... ....++..|++||.+. ...++.++||||||+++|||++ |++||... ...++..++....... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~ 238 (273)
T cd05074 163 IYSGDYYRQGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--ENSEIYNYLIKGNRLK-QPP 238 (273)
T ss_pred ccCCcceecCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCcCC-CCC
Confidence 543221 1223456899999886 5667889999999999999999 88888653 2233333333221111 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3345699999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.98 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=192.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcC--CCCCCcccceEEEecCC----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG--LRHPNLVPLRAYFQAKE----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e 462 (664)
.+.||+|.||.||+|.|+++ .||||++... ++....+|.++.+. |||+||+.+++.=..++ +++||++
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe-~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGE-DVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEecCccccceeeccccCC-ceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 47899999999999999765 8999999643 45566667666644 59999999998643322 6899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-------WRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
|.+.|||+++|. ...++-...++++..+|.||++||-. |.|.|||||++|||+..++.+.|+|+|+|
T Consensus 290 YHe~GSL~DyL~------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 290 YHEHGSLYDYLN------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred cccCCcHHHHHh------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999994 25789999999999999999999963 57999999999999999999999999999
Q ss_pred ccccCCC------CCCCCCCCcccCccccccCCCC-----CchhhHHHHHHHHHHHHcC----------CCCCCCCCCCh
Q 006031 536 ALTADSL------QDDDPDNLLYKAPETRNASHQA-----TSKSDVYSFGVLLLELLTG----------KPPSQHSFLVP 594 (664)
Q Consensus 536 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~-----~~ksDVwSfGvvl~elltG----------~~P~~~~~~~~ 594 (664)
....... .....||.+|||||++..+-+. -..+||||||.|+||+.-. +.||.+....+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 7665442 2245799999999998744332 2368999999999998742 34665432222
Q ss_pred ---hhHHHHH--HhhccCCC---chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 595 ---NEMMNWV--RSAREDDG---AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 595 ---~~~~~~~--~~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
+++.+.+ +..+...+ ...+.+..+.++|+.||..+|..|-|+-.+-+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222221 22222222 356778889999999999999999999999999988865
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.46 Aligned_cols=246 Identities=18% Similarity=0.235 Sum_probs=192.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+...... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 5788999998653321 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.+++.. ..+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 128 g~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 128 GDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 999999952 2478889999999999999999998 999999999999999999999999999986543221
Q ss_pred CCCCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLL 619 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 619 (664)
....||+.|+|||.+... ..++.++|||||||++|||++|+.||..... ............... .........+.
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 234689999999988632 2378899999999999999999999975321 112222222111111 11122345578
Q ss_pred HHHHHcccCCCCC--CCCHHHHHHH
Q 006031 620 EVAIACNSASPEQ--RPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~--RPt~~ev~~~ 642 (664)
+++..|++.++.+ ||++.|+++.
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcC
Confidence 8889999755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=319.43 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=189.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||++.. ..+..||+|++............+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 46899999999999985 45889999998754433344567889999999999999999999986543 479999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++ +|.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 106 ELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 99975 6776663 2378888999999999999999999 9999999999999999999999999999764332
Q ss_pred C-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-------------hHH----HHHHh
Q 006031 542 L-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-------------EMM----NWVRS 603 (664)
Q Consensus 542 ~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-------------~~~----~~~~~ 603 (664)
. .....++..|+|||.+. +..++.++|||||||++|||+||+.||........ +.. ..+..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred ccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 2 23346789999999987 56789999999999999999999999975421100 000 00000
Q ss_pred hccCC----C-----------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 604 AREDD----G-----------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 604 ~~~~~----~-----------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..... . ........+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0 000113457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=303.64 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=197.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc---CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA---GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... ++..|++|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 367999999999999976 7889999988654321 123467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-C
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~ 543 (664)
++++|.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+....... .
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 85 PGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 99999999953 34588999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....++..|+|||.+.....++.++|+||||+++||+++|+.||.... .......+... ......+......+.+++.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRS-KELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhc-ccCCCcCCCcCHHHHHHHH
Confidence 335578889999988633338899999999999999999999987542 11122222110 1111122334456889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+||+.+|++||++.+++.
T Consensus 237 ~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 237 KCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhhcCcccCcCHHHHhc
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.98 Aligned_cols=237 Identities=20% Similarity=0.264 Sum_probs=189.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... +++.||+|.+...... ....+.+..|.+++..+. |++|+++.+++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 367999999999999854 6889999998754321 223456778888888775 5778889999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 543 (664)
+|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 85 ~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 85 GGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 9999999952 34689999999999999999999998 9999999999999999999999999998754322 12
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....|++.|+|||++. ...++.++|||||||++|||+||+.||... ....+.+.+..... ..+......+.+++.
T Consensus 159 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 233 (323)
T cd05615 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (323)
T ss_pred cCccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Confidence 2345899999999986 567899999999999999999999999753 22333333222211 122233456889999
Q ss_pred HcccCCCCCCCCH
Q 006031 624 ACNSASPEQRPTM 636 (664)
Q Consensus 624 ~Cl~~~P~~RPt~ 636 (664)
+|++.+|++|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05615 234 GLMTKHPSKRLGC 246 (323)
T ss_pred HHcccCHhhCCCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=341.78 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=199.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||+|... +++.||+|++...... ....+.|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999964 5889999998653221 12346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 467 GSLFSLIHGSK------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 467 gsL~~~l~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|+|.++++... ......+++...+.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~ 165 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence 99999986321 11123567888899999999999999999 999999999999999999999999999976521
Q ss_pred CC--------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH
Q 006031 541 SL--------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 541 ~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~ 600 (664)
.. .....||+.|+|||.+. +..++.++|||||||++|||+||+.||..... ..+...
T Consensus 166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~--~ki~~~ 242 (932)
T PRK13184 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKG--RKISYR 242 (932)
T ss_pred ccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--hhhhhh
Confidence 00 01135889999999987 56789999999999999999999999975321 111111
Q ss_pred HHhhccCC--CchhHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhc
Q 006031 601 VRSAREDD--GAEDERLGMLLEVAIACNSASPEQRP-TMWQVLKMLQEIKG 648 (664)
Q Consensus 601 ~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~i~~ 648 (664)
.....+. ....+.+..+.+++.+|++.+|++|| ++.++.+.|+....
T Consensus 243 -~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 243 -DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred -hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 11123445688999999999999996 67788888887754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.81 Aligned_cols=247 Identities=19% Similarity=0.239 Sum_probs=192.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +|..||+|++............+.+|++++++++||||+++++++.+.+..++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 357999999999999964 68899999987544333344667889999999999999999999999999999999997 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ....+++.....++.||++||.|||+. +++||||||+||+++.++.+||+|||+++....... ..
T Consensus 84 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 84 DLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 88888753 234689999999999999999999998 999999999999999999999999999876533221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||.+.+...++.++|||||||++|||+||+.|+.........+...........
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 346788999998875556789999999999999999999886543222222111111000000
Q ss_pred C---------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 G---------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ~---------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+||+.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.78 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=185.7
Q ss_pred hccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~ 463 (664)
+.+||+|+||+||+|... .+..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 457999999999999965 35789999886432 23467889999999999999999998854 4567899999
Q ss_pred CCCCCHHHHhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe----CCCCCeEEeecccc
Q 006031 464 QPNGSLFSLIHGSK----STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLT 535 (664)
Q Consensus 464 ~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla 535 (664)
+++ +|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 875 7877774221 11234588999999999999999999998 99999999999999 56789999999999
Q ss_pred ccccCCCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--------hhHHHHHH
Q 006031 536 ALTADSLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--------NEMMNWVR 602 (664)
Q Consensus 536 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--------~~~~~~~~ 602 (664)
+....... ....++..|+|||.+.+...++.++|||||||++|||+||++||....... ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86544321 223578899999998755668999999999999999999999986432110 01111111
Q ss_pred hhccC------------C---------------C--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 603 SARED------------D---------------G--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 603 ~~~~~------------~---------------~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..... . . ........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0 0 00011234778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=323.31 Aligned_cols=241 Identities=20% Similarity=0.247 Sum_probs=185.9
Q ss_pred ccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC---CCCCcccceEEEecCCceEEEEecCCC
Q 006031 392 LGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL---RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
||+|+||+||+|... +++.||+|++....... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 58899999986533211 1223344555665544 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99999985 235689999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...|+..|+|||.+.....++.++|||||||++|||+||+.||... ...++...+...... .........+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~ 231 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKG 231 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence 3568999999999864455789999999999999999999998753 222222222111111 1111234557899999
Q ss_pred cccCCCCCCCC----HHHHHH
Q 006031 625 CNSASPEQRPT----MWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt----~~ev~~ 641 (664)
||+.+|++||+ +.|+++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 99999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.00 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=196.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-ceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-ERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~ 466 (664)
.+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|+|++++++.+...+ ..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 467999999999999854 5788999998654443344567889999999999999999999876444 57899999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
++|.+++... ....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 85 GDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred CcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999642 234689999999999999999999999 99999999999999999999999999987654322 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+++.|+|||.+. ...++.++||||||+++||+++|+.||.... ............. ...+......+.+++.+
T Consensus 161 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 161 TLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKD--MNSLVYRIIEGKL-PPMPKDYSPELGELIAT 236 (257)
T ss_pred cccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCC-CCCccccCHHHHHHHHH
Confidence 345788999999986 5678899999999999999999999987532 1222111111111 12233455679999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|++|||+.|+++
T Consensus 237 ~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 237 MLSKRPEKRPSVKSILR 253 (257)
T ss_pred HhccCcccCCCHHHHhc
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.41 Aligned_cols=242 Identities=19% Similarity=0.338 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 46799999999999995 5788999999865433 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 102 ~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 102 SLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999852 3578999999999999999999998 999999999999999999999999999876543321 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++|||||||++||+++|+.||....... ...............+......+.+++.+|
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred ccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 45788999999986 5678899999999999999999999996532211 111111111111112333445688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++||++.++++
T Consensus 253 l~~~p~~Rps~~~il~ 268 (297)
T cd06656 253 LEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCChhhCcCHHHHhc
Confidence 9999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.05 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=195.8
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||.||++.. .+..||+|.+... ...+.+.+|+.++++++|||++++++++... ..++||||++++
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 357899999999999975 5668999988543 2356788999999999999999999998654 579999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (254)
T cd05083 84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSK 158 (254)
T ss_pred CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccC-CCCC
Confidence 999999642 234588999999999999999999998 99999999999999999999999999987643322 1223
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.+..|+|||++. ...++.++|||||||++|||++ |+.||.... ..+....+...... ......+..+.+++.+||
T Consensus 159 ~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 159 LPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKECVEKGYRM-EPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhCCCCC-CCCCcCCHHHHHHHHHHc
Confidence 456799999886 5678899999999999999998 999986532 22333333222211 122334567899999999
Q ss_pred cCCCCCCCCHHHHHHHHHh
Q 006031 627 SASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~ 645 (664)
+.+|++||++.++++.|++
T Consensus 235 ~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 235 ETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCChhhCcCHHHHHHHHcc
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=308.23 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 367999999999999975 5889999998754433334567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++.+. ...++|..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++........ ..
T Consensus 86 ~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 86 VLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred HHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99888742 23589999999999999999999998 999999999999999999999999999876543221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHHHhh-----------------cc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSA-----------------RE 606 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~-----------------~~ 606 (664)
..++..|+|||++.+...++.++|||||||++|||++|++||........ .+..+.... ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 34678899999987556678899999999999999999999864321110 011000000 00
Q ss_pred CC-C-------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 DD-G-------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ~~-~-------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. . .....+..+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0 01122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=308.39 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=197.0
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 4467999999999999964 688999999864322 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 87 GALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred CcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999863 234689999999999999999999999 99999999999999999999999999886543322 12
Q ss_pred CCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
...++..|+|||.+.. ...++.++||||||+++|||++|+.||..... ...+..+..........+......+.+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-MRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-HHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 2357889999998641 23467899999999999999999999875321 122222222111111122334456889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
++.+||+.+|++||++.++++.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.84 Aligned_cols=244 Identities=19% Similarity=0.206 Sum_probs=191.2
Q ss_pred cccccCceeEEEEEE-cCCeEEEEEEccCccccCCc-HHHHHHHHH---HHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 391 LLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTS-NEMYEQHME---SVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~-~~~~~~e~~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+||+|+||.||++.. .+++.+|+|.+......... ...+.+|.. ++...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 45889999988654432222 233344433 3444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
+|+|.+++.. ...+++.....|+.|++.||+|||+. +|+||||||+||++++++.++++|||++..........
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence 9999999852 34699999999999999999999998 99999999999999999999999999987654443334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+.....++.++|||||||++|||++|+.||........ .+..... ......+......+.+++.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHH
Confidence 56889999999876445678999999999999999999999975432221 2222111 11112233445668999999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 006031 625 CNSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RP-----t~~ev~~~ 642 (664)
||..+|++|| +++|+++.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.28 Aligned_cols=243 Identities=19% Similarity=0.342 Sum_probs=194.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCC-------cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGT-------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV 460 (664)
...||+|+||.||+|.. .++..||+|.+........ ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 45799999999999985 4578999998865433211 125688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++....
T Consensus 85 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 85 LEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999952 35688999999999999999999998 999999999999999999999999999876542
Q ss_pred CCC--------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 541 SLQ--------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 541 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
... ....++..|+|||.+. ...++.++|||||||++|||++|+.||..... ...+..... . .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~-~~~~~~~ 234 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIGE-N-ASPEIPS 234 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHHHHhc-c-CCCcCCc
Confidence 211 1123678899999986 56678899999999999999999999975321 112211111 1 1112223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+..+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 34566899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.26 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..|++|.++.........+.+..|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 467999999999999854 6889999998765443335678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.++++. ...+++..+..|+.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 85 ~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 85 TLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred cHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999953 34578899999999999999999998 9999999999999999999999999998765433221
Q ss_pred ---CCCCCCcccCccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHH
Q 006031 545 ---DDPDNLLYKAPETRNASH--QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGML 618 (664)
Q Consensus 545 ---~~~~~~~y~aPE~~~~~~--~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 618 (664)
...++..|+|||++.... ..+.++||||||+++||+++|+.||..... .......+....... .........+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhcCCCCCCCcccccCHHH
Confidence 234678999999986322 278899999999999999999999975321 222222222211111 1111225568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+++.+||+.+|++||++.|++.
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhc
Confidence 89999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=292.26 Aligned_cols=244 Identities=20% Similarity=0.346 Sum_probs=199.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCc------HHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTS------NEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~------~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
.++||.|..++|.+..+ .++...|+|++......... .+.-.+|+.+++++ -||||+.+.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 46799999999998874 56888999998644322111 23446889999998 599999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+|.|+.|.|+++|. ....+++....+|.+|+.+|++|||.. +||||||||+|||+|++.++||+|||++.....
T Consensus 102 Fdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999994 457799999999999999999999999 999999999999999999999999999987766
Q ss_pred CCC-CCCCCCCcccCccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHHHHhhccCC--Cch
Q 006031 541 SLQ-DDDPDNLLYKAPETRN-----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDD--GAE 611 (664)
Q Consensus 541 ~~~-~~~~~~~~y~aPE~~~-----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~--~~~ 611 (664)
... ...+||++|.|||.+. ....|+...|.||+||+||.++.|.+||... .+ -+.+.+....-+. +.+
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHHHHhcccccCCcch
Confidence 543 4568999999999765 2345778899999999999999999999863 11 1122222221111 234
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+......+++.+|++.||++|.|++|+++
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 556677899999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.76 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=198.2
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|+.+ +...|++|.+..... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 356999999999999864 346789998864332 1235679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 463 YQPNGSLFSLIHGSKSTR----AKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
|+++|+|.++++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++...
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~ 167 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEccccccccc
Confidence 999999999996432111 12689999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCC---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 539 ADSLQ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 539 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
..... ....++..|+|||.+. ....+.++||||||+++||+++ |..||... ....+.................
T Consensus 168 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd05046 168 YNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--SDEEVLNRLQAGKLELPVPEGC 244 (275)
T ss_pred CcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccc--chHHHHHHHHcCCcCCCCCCCC
Confidence 32211 1223466799999886 5567889999999999999999 78888643 2233333333222222222334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+..+.+++.+||+.+|++||++.|++..|.
T Consensus 245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 245 PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.77 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=197.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 456999999999999964 588999998864322 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........ ..
T Consensus 88 ~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 88 SALDLLRA------GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 99999852 3588899999999999999999998 999999999999999999999999999976543321 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||++. ...++.++|||||||++|||+||+.||.... .......+.. ..........+..+.+++.+|
T Consensus 161 ~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 161 FVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMH--PMRVLFLIPK-NNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred ccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--hHhHhhhhhc-CCCCCCchhhhHHHHHHHHHH
Confidence 34678899999986 5668999999999999999999999986532 1222221111 111223345567789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.|+++.
T Consensus 237 l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 237 LNKDPSFRPTAKELLKH 253 (277)
T ss_pred cccCcccCcCHHHHHhC
Confidence 99999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.59 Aligned_cols=245 Identities=20% Similarity=0.310 Sum_probs=197.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..||+|++..........+.+.+|+.++++++||||+++++++...+..++|+||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 46799999999999996 46889999999765543444678999999999999999999999999999999999999 99
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~ 544 (664)
+|.++++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++++|||.+....... ..
T Consensus 84 ~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 84 DLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 999998632 25699999999999999999999998 99999999999999999999999999998765432 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-cc-----------------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA-RE----------------- 606 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-~~----------------- 606 (664)
...++..|+|||.+.....++.++||||+|+++|||+||++||.... .......+... ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC--HHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 34578899999998655567899999999999999999988775432 11111111110 00
Q ss_pred ----CCC------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 ----DDG------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ----~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... ...+....+.+++.+|++.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00122467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=302.54 Aligned_cols=245 Identities=19% Similarity=0.316 Sum_probs=198.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++.. .+++.||+|++..........+.+.+|++++++++||||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46799999999999985 56889999998754443344568899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++++.. ....+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........ ..
T Consensus 85 ~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 85 DLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred cHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 999999632 234578999999999999999999998 999999999999999999999999999876543321 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||+.. ...++.++|||||||++||++||+.||... ...+....+..... ...+......+.+++.+|
T Consensus 161 ~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 161 CIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred ccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCC--CHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHH
Confidence 34778899999986 567889999999999999999999998653 22222221111111 112233456689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++||+|.||++
T Consensus 237 l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 237 FKRNPRDRPSVNSILE 252 (256)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.50 Aligned_cols=246 Identities=19% Similarity=0.274 Sum_probs=194.2
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||.||+|... ++..||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 57899999999999864 68899999987554433445678899999999999999999999999999999999996 68
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
|.++++.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|++|||++........ ...
T Consensus 85 l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 85 LKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred HHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 99988642 235689999999999999999999998 999999999999999999999999999876543321 223
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------------ 608 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 608 (664)
.++..|+|||.+.+...++.++|||||||++|||+||+.||..... ...+.+.........
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 4678899999886555578899999999999999999999865321 112222211111100
Q ss_pred ---C-c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---G-A----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---~-~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. . .......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 0 0112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.19 Aligned_cols=246 Identities=19% Similarity=0.247 Sum_probs=187.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC---CCCCcccceEEEec-----CCceEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVPLRAYFQA-----KEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~-----~~~~~l 459 (664)
.+.||+|+||+||+|... +++.||+|.++...........+.+|+++++++ +||||+++++++.. ....++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 367999999999999864 688999999875433223334555666666554 79999999998864 235789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++ +|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 9999974 899888632 234589999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-----------
Q 006031 540 DSLQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED----------- 607 (664)
Q Consensus 540 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~----------- 607 (664)
.... ....++..|+|||++. ...++.++|||||||++|||++|++||..... ...+..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred CcccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhhCcccccc
Confidence 3322 2345788999999986 56789999999999999999999999865321 11221211111000
Q ss_pred -------C------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 -------D------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 -------~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 001123455789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.22 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
...||+|+||.||++.. .++..||+|.+..... ...+.+.+|+..+++++|+||+++++++...+..++||||++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 45699999999999985 4688999999865332 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ..
T Consensus 105 ~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 105 ALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 99998842 3588999999999999999999998 999999999999999999999999999875433322 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|||||||++||+++|+.||.... .......+....... .........+.+++.+
T Consensus 178 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 178 LVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred eecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 34788999999986 5678899999999999999999999987532 112222222111111 1112234458899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
||..+|++|||+.|+++.
T Consensus 255 ~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 255 MLVREPSQRATAQELLQH 272 (292)
T ss_pred HccCChhHCcCHHHHhhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.95 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=197.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||.|+||.||+|... ++..||+|.+..... ......+.+|+++++.++|+||+++++++.+....++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 357999999999999964 688999999865432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++. ..+++.....++.|++.||.|||+. +++||||+|+||++++++.++++|||+++...... ...
T Consensus 85 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 85 SCLDLLKP------GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred cHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999953 2689999999999999999999998 99999999999999999999999999998765432 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||++. ...++.++|||||||++|||+||+.||.... .......+.............+..+.+++.+|
T Consensus 158 ~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 158 FVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 45778899999987 5568999999999999999999999997532 12222111111111111111455689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|..+|++|||++++++
T Consensus 235 l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 235 LNKDPKERPSAKELLK 250 (274)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.19 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHH-HcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMES-VGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +|..||+|+++..... .....+..|+.. ++..+||||+++++++..++..++||||++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 357999999999999964 6899999998754321 223444555554 667799999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
|+|.++++... .....+++..+..++.|++.||+|||+..+++||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (283)
T cd06617 84 TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162 (283)
T ss_pred ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 68888876432 22357899999999999999999999865899999999999999999999999999986544322 22
Q ss_pred CCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
..++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.........+........ ........+..+.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 241 (283)
T cd06617 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-PQLPAEKFSPEFQDFV 241 (283)
T ss_pred ccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-CCCCccccCHHHHHHH
Confidence 4578889999987532 34688999999999999999999998653222223333222111 1111223456689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.+|++||++.++++
T Consensus 242 ~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 242 NKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.53 Aligned_cols=243 Identities=19% Similarity=0.302 Sum_probs=189.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC---CcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG---TSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 462 (664)
.+.||+|+||.||+|.. ..+..|++|++....... ...+.+.+|+.++++++||||+++++++.+. +..++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 46799999999999986 458899999886443211 1235688999999999999999999988653 56789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++++|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 87 YMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred CCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999953 24588999999999999999999998 99999999999999999999999999987543211
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
.....++..|+|||.+. ...++.++|||||||++||+++|+.||..... ...+..... .......+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~ 237 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIFKIAT-QPTNPQLPSHISEH 237 (266)
T ss_pred ccCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccch-HHHHHHHhc-CCCCCCCchhcCHH
Confidence 11234778899999987 56788999999999999999999999975421 122222111 11111222233444
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++ +||..+|++||+|+||++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 56666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.10 Aligned_cols=243 Identities=17% Similarity=0.215 Sum_probs=189.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||++.. ..++.||+|++..........+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 46799999999999985 4588999999875443333456778899999999999999999988643 3479999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 102 ELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred hhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 99965 6777763 2478889999999999999999998 9999999999999999999999999999865443
Q ss_pred CC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHh-----------------
Q 006031 542 LQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRS----------------- 603 (664)
Q Consensus 542 ~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~----------------- 603 (664)
.. ....++..|+|||.+. +..++.++|||||||++|||++|+.||...... ......+..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred cccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 22 2346889999999986 567899999999999999999999999753211 111100000
Q ss_pred -hccCC---------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 604 -AREDD---------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 604 -~~~~~---------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..... .........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0011123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.59 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=199.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|+||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 357999999999999975 588999999865432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
+|.+++... ...+++.....++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+...........
T Consensus 85 ~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 85 SLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred cHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 999999632 2578899999999999999999999 7 999999999999999999999999999876544333335
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC---CCchhHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED---DGAEDERLGMLLEVAI 623 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~ 623 (664)
.++..|+|||++. ...++.++||||||+++|||++|+.||...........+........ ..........+.+++.
T Consensus 160 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 6788999999986 56789999999999999999999999875432222222222222111 1112225566899999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+||..+|++|||+.|++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 239 LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHcCCCchhCcCHHHHhh
Confidence 999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=299.81 Aligned_cols=245 Identities=21% Similarity=0.358 Sum_probs=196.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++||||+++++++...+..+++|||++++
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 367999999999999864 577899999875433 24578899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+....... ...
T Consensus 86 ~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 86 SLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred cHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999863 224689999999999999999999998 99999999999999999999999999987654322 122
Q ss_pred CCCCCcccCccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNAS--HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~--~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
..++..|+|||.+... ..++.++||||||+++|||+||+.||...... .............. ......+..+.++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-RALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 3577889999988622 26788999999999999999999998754221 11211111111111 1223345678999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||..+|.+|||+.+|+.
T Consensus 240 i~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.79 Aligned_cols=247 Identities=22% Similarity=0.330 Sum_probs=200.8
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 466 (664)
+.||+|+||.||++.. .++..||+|.+..........+.+..|++++++++|+||+++++++.. ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 5799999999999985 567889999987554433445678899999999999999999998764 3457899999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-----QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
++|.+++.... .....+++..++.++.+++.||+||| +. +++|+||||+||++++++.+|++|||++......
T Consensus 86 ~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 86 GDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 99999996432 23457899999999999999999999 77 9999999999999999999999999999876543
Q ss_pred C--CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 542 L--QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 542 ~--~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
. .....++..|+|||.+. ...++.++||||||+++|+|++|+.||.... ...+.+.+...... ..+......+.
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKFR-RIPYRYSSELN 239 (265)
T ss_pred cccccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCCC-CCccccCHHHH
Confidence 3 22345788999999987 5668899999999999999999999997642 33444433332221 22334556789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+++.+|++.+|++||++.+|++.
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.83 Aligned_cols=244 Identities=20% Similarity=0.257 Sum_probs=189.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .++..||||++..........+.+.+|++++++++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46799999999999985 5678999999875433223445677899999999999999999987543 3578999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
|++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 100 ~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 100 NLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred ecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 988 779988874 23589999999999999999999999 9999999999999999999999999999865443
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------- 608 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------- 608 (664)
. ....++..|+|||++.+...++.++|||||||++|||++|+.||..... ...+..+........
T Consensus 172 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 M-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred c-CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 2 3346889999999987556788999999999999999999999965321 111111111000000
Q ss_pred -------Cch--------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 -------GAE--------DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 -------~~~--------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0112346799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.09 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=193.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+++++.++||||+++.++|.+.+..++|+||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 467999999999999864 6889999988643321 1223568899999999999999999999999999999999997
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|++.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...... ...
T Consensus 99 g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~~ 171 (307)
T cd06607 99 GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSF 171 (307)
T ss_pred CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCC--CCc
Confidence 577777742 234689999999999999999999998 9999999999999999999999999998765433 234
Q ss_pred CCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 547 ~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
.++..|+|||++. ....++.++||||||+++|||+||+.||.... ........................+.+++.+
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 5778899999874 23567889999999999999999999986531 1111111111111111233455678999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
||+.+|++||++.+++..
T Consensus 250 ~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 250 CLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HhcCChhhCcCHHHHhcC
Confidence 999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.52 Aligned_cols=239 Identities=18% Similarity=0.227 Sum_probs=188.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||++++++...+..++||||+. +
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 467999999999999965 47889999642 2235689999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+++.. ....++|..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 245 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 245 DLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99988853 234699999999999999999999999 999999999999999999999999999976543221
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------ChhhHHHHHHhhccCCC--------
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL------VPNEMMNWVRSAREDDG-------- 609 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~------~~~~~~~~~~~~~~~~~-------- 609 (664)
....||..|+|||++. +..++.++|||||||++|||++|..|+..... ....+.+.+........
T Consensus 320 ~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 1245899999999987 56789999999999999999998876432211 11233333222111000
Q ss_pred ---------------------chh---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 610 ---------------------AED---ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 610 ---------------------~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 112357889999999999999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.22 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=198.6
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~ 466 (664)
+.||+|++|.||++.. .+++.+|+|.+..... ......+.+|++++++++||||++++++|.+. +..++||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 5799999999999996 4588999998864322 13456788999999999999999999998654 368999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.+++.... .....+++.....|+.|++.||+|||+. +++|+||+|+||++++++.++++|||++...........
T Consensus 86 ~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 163 (287)
T cd06621 86 GSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163 (287)
T ss_pred CCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeeccccccccccccccc
Confidence 99999875322 2345688899999999999999999998 999999999999999999999999999876554433344
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---ChhhHHHHHHhhccCC-----CchhHHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL---VPNEMMNWVRSAREDD-----GAEDERLGML 618 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~l 618 (664)
.++..|+|||.+. ...++.++|||||||++|||++|+.||..... ...+...+........ .........+
T Consensus 164 ~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd06621 164 TGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242 (287)
T ss_pred cCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHH
Confidence 5778899999886 56789999999999999999999999976422 2224444443321111 1112245678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 243 KDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHcCCCcccCCCHHHHHh
Confidence 99999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.35 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=195.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
..||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 4699999999999985 4688999999865433 345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
|..++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9998742 4589999999999999999999998 999999999999999999999999999875443321 224
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHHHHc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVAIAC 625 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~C 625 (664)
.++..|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+....... .........+.+++.+|
T Consensus 178 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 178 VGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 5788999999986 5668899999999999999999999987532 222222222211111 11222345688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.|+++.
T Consensus 255 l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 255 LTREPQERATAQELLDH 271 (297)
T ss_pred hcCCcccCcCHHHHhhC
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=340.97 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=197.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 465 (664)
.+.||+|+||+||+|.. ..+..||+|.+............|..|+.++++++|||||+++++|.. .+..++||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 46799999999999995 457789999987654433445778999999999999999999998854 346899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCcccCCCCCCCeEeCCC---------------
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA------WRLVHGNLKSSNVLLGPD--------------- 524 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~ivHrDlk~~NILl~~~--------------- 524 (664)
+|+|.++|.... .....+++..++.|+.||+.||+|||+. .+||||||||+||||+.+
T Consensus 98 gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 999999996422 1235699999999999999999999984 159999999999999642
Q ss_pred --CCeEEeeccccccccCCC-CCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH
Q 006031 525 --FEACLADYCLTALTADSL-QDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 525 --~~~ki~DfGla~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~ 600 (664)
..+||+|||++....... .....+|+.|+|||++.. ...++.++|||||||++|||+||+.||..... ...+...
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-~~qli~~ 255 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-FSQLISE 255 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-HHHHHHH
Confidence 348999999998654332 233468999999998753 34578999999999999999999999975321 1222222
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHHHhhhc
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVL--KMLQEIKG 648 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~--~~L~~i~~ 648 (664)
+.... ..........+.+|+..||+.+|++||++.|++ ..++.+.+
T Consensus 256 lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 256 LKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 22111 111122345689999999999999999999998 45555543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.91 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=193.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCC--------cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGT--------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|.. .+++.||+|.++....... ..+.+..|++++++++|+||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46799999999999985 4688999998854221111 12467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
|+||+++++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++++|||+++...
T Consensus 86 v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 86 FLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999953 25689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCC----CCCCCCCcccCccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---Cch
Q 006031 540 DSLQ----DDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---GAE 611 (664)
Q Consensus 540 ~~~~----~~~~~~~~y~aPE~~~~~~-~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~~ 611 (664)
.... ....++..|+|||.+.... .++.++||||||+++||+++|+.||..... .....+......... ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-HHHHHHhhccccCCcCCcccc
Confidence 3221 1234778999999876333 378899999999999999999999864321 111111111111110 111
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+..+.+++.+||+.+|++||++.||++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 233567899999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.25 Aligned_cols=245 Identities=18% Similarity=0.304 Sum_probs=198.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++.. .++..+|+|.+..........+.+.+|++++++++||||+++++.+...+..++|+||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 46799999999999985 46889999998765544445678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCCCC-CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~~-~~ 545 (664)
+|.++++.. ....+++..+.+++.+++.||+|||+. +++|+||||+||+++++ +.+|++|||.+........ ..
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 85 TLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 999999642 234589999999999999999999998 99999999999999865 4579999999986654322 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++||||||+++|||++|+.||.... .......+..... ..........+.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 161 VVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLKIMSGTF-APISDRYSPDLRQLILSM 236 (256)
T ss_pred cccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHH
Confidence 45788999999987 5667889999999999999999999987532 1222222221111 112223455689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++|||+.|+++
T Consensus 237 l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 237 LNLDPSKRPQLSQIMA 252 (256)
T ss_pred ccCChhhCCCHHHHhh
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.36 Aligned_cols=243 Identities=16% Similarity=0.216 Sum_probs=189.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||++.. ..++.||||++............+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 46899999999999985 4578899999875443334456788999999999999999999987543 3579999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 109 ELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 99975 7777773 2478889999999999999999998 9999999999999999999999999999865443
Q ss_pred CC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc--------------
Q 006031 542 LQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-------------- 606 (664)
Q Consensus 542 ~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-------------- 606 (664)
.. ....++..|+|||++. +..++.++|||||||++|||++|+.||...... ......+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 22 2346789999999987 567899999999999999999999999753211 111111100000
Q ss_pred ----CC----C-----------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 607 ----DD----G-----------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 607 ----~~----~-----------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. . ........+.+++.+|++.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0 000112457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.85 Aligned_cols=243 Identities=20% Similarity=0.230 Sum_probs=195.9
Q ss_pred ccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||++... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 4889999998654332 23456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDDPD 548 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~~~ 548 (664)
.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||.+....... .....+
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence 999953 24588999999999999999999998 99999999999999999999999999998765432 223457
Q ss_pred CCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccC
Q 006031 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSA 628 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 628 (664)
+..|+|||.+. ...++.++|+||||+++||+++|+.||........+....+.........+......+.+++.+||+.
T Consensus 155 ~~~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 88999999986 56688999999999999999999999976432222222222211122222233356799999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 006031 629 SPEQRPT-----MWQVLK 641 (664)
Q Consensus 629 ~P~~RPt-----~~ev~~ 641 (664)
+|++||+ ++|+++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.91 Aligned_cols=244 Identities=18% Similarity=0.278 Sum_probs=192.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.++++++||||+++++++...+..++|+||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 357999999999999864 578999999864432 2334567789999999999999999999999999999999997 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... ...
T Consensus 89 ~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 89 DLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 99998863 234588999999999999999999998 99999999999999999999999999987643322 122
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-C-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-D----------------- 607 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~----------------- 607 (664)
..++..|+|||.+.+...++.++|||||||++|||+||++||..... .+....+..... .
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 34678899999886555678899999999999999999999975421 111111110000 0
Q ss_pred --CC--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 --DG--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 --~~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. ........+.+++.+|++.+|.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.01 Aligned_cols=244 Identities=19% Similarity=0.230 Sum_probs=189.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+...... ......+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999864 5889999998653321 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 86 GDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred ccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999952 34689999999999999999999998 99999999999999999999999999986432110
Q ss_pred ---------------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006031 543 ---------------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589 (664)
Q Consensus 543 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~ 589 (664)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCCC
Confidence 01235889999999987 56789999999999999999999999975
Q ss_pred CCCChhhHHHHHHhhccCCC--chhHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006031 590 SFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVAIACNSASPEQRPT---MWQVLKM 642 (664)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~ev~~~ 642 (664)
.. .......+........ ........+.+++.+++ .+|++|++ +.|+.+.
T Consensus 239 ~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ET--PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CC--HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 32 2222221111111111 11112345777777766 49999995 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.70 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=193.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC-----CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK-----EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-----~~~~lV~ 461 (664)
.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++... +..++|+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 35799999999999986 568899999986432 2356778899999988 899999999998754 3589999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.++++... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 104 ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 104 ELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred EECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 9999999999986422 2345689999999999999999999998 9999999999999999999999999998765432
Q ss_pred C--CCCCCCCCcccCccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 542 L--QDDDPDNLLYKAPETRNASH----QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 542 ~--~~~~~~~~~y~aPE~~~~~~----~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
. .....++..|+|||.+.... .++.++|||||||++|||++|+.||..... ...+.++...........+...
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (291)
T cd06639 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPEKWC 260 (291)
T ss_pred cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHhcCCCCCCCcccccC
Confidence 2 12345788899999875322 257899999999999999999999875321 1223222222111111223344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+.+++.+||+.+|++||++.|+++
T Consensus 261 ~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 261 RSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 56899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.30 Aligned_cols=246 Identities=18% Similarity=0.220 Sum_probs=191.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999965 5788999998643321 12345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---Q 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 543 (664)
|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 128 g~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 128 GDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 999999952 2478888899999999999999999 99999999999999999999999999998654322 1
Q ss_pred CCCCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-CCchhHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED-DGAEDERLGMLL 619 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 619 (664)
....||+.|+|||++... ..++.++|||||||++|||++|+.||..... .............. ..........+.
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 234689999999988632 2378899999999999999999999975321 11122222111111 111123455688
Q ss_pred HHHHHcccCCCCC--CCCHHHHHHH
Q 006031 620 EVAIACNSASPEQ--RPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~--RPt~~ev~~~ 642 (664)
+++..|+...+.+ ||++.|+.+.
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcC
Confidence 9999999844433 7799888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.09 Aligned_cols=247 Identities=21% Similarity=0.256 Sum_probs=195.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc---CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA---GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... +++.||+|.+...... ......+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 357999999999999964 6889999999765432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
+|+|.++++.. ...+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 -~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 85 -ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred -CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 89999999632 13699999999999999999999999 999999999999999999999999999986644321
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--------------
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-------------- 608 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 608 (664)
....++..|+|||.+.+...++.++|||||||++|||++|.+||..... ...+...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2234577899999886556678999999999999999999887764321 111111111100000
Q ss_pred ------C-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 ------G-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 ------~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. ........+.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 011224568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.91 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC---CCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|+.++++++ |||++++++++......++||||+
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 45799999999999995 5688999999864322 234567888999998886 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++++|.++++. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 85 EGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred CCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999852 2689999999999999999999998 999999999999999999999999999876544322
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
....++..|+|||.+..+..++.++|||||||++|||++|+.||..... ....................+..+.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMMLIPKSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhccccCCCCCCCcccCCHHHHHHH
Confidence 2235788899999886455678899999999999999999999975321 1111111111111111112456789999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.+|++||++.|+++
T Consensus 236 ~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 236 AACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHcCCCcccCcCHHHHhh
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.96 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=197.7
Q ss_pred cccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 391 LLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
.||.|+||.||||..++ +...|.|++..... ...++|.-||++++.++||+||++++.|...+.+++..|||.||-+
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkse--EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSE--EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccch--hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 48999999999999665 44456676654332 4567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDDDP 547 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~~~ 547 (664)
..++- .-...|+..++..+++|++.||.|||++ +|||||||+.|||+.-+|.++++|||.+...... ......
T Consensus 117 Daiml----EL~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 117 DAIML----ELGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred hHHHH----HhccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 88875 3456799999999999999999999999 9999999999999999999999999998654332 234567
Q ss_pred CCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 548 DNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 548 ~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
||++|||||+.. ....|+.++|||||||+|.||..+.+|...... ..-+...........-.+..+...+.+++.
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVllKiaKSePPTLlqPS~Ws~~F~DfLk 270 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLLQPSHWSRSFSDFLK 270 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence 999999999765 246789999999999999999999999654311 112222222222222345667788999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+|+.++|..||+++++++
T Consensus 271 ~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 271 RCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHhcCCccCCCHHHHhh
Confidence 999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.07 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=191.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEe-----cCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQ-----AKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~-----~~~~~~lV~ 461 (664)
.+.||+|+||.||++.. ..++.+|+|.++... .....+.+|+.+++++ +||||+++++++. ..+..++||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 46799999999999985 457899999875432 2346788899999999 6999999999884 345689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.++++... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 100 ELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred eecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999999886321 2235688999999999999999999998 9999999999999999999999999998765432
Q ss_pred C--CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 542 L--QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 542 ~--~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
. .....++..|+|||++.. ...++.++|||||||++|||++|+.||..... ...+.............+....
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd06638 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRNPPPTLHQPELWS 256 (286)
T ss_pred CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhccccCCCcccCCCCcC
Confidence 2 123457889999998742 23468899999999999999999999875321 1122221111111111122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+.+++.+||+.+|++|||+.|+++.
T Consensus 257 ~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 568999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.10 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=196.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.. .++..||+|.+....... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999984 678899999986433211 1246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADSL 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~ 542 (664)
+++++|.+++.. ..++++.....++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+.......
T Consensus 85 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 85 MAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred cCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999953 34688999999999999999999999 999999999999998776 58999999987654332
Q ss_pred C------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHHHHHhhccCCCchhHHH
Q 006031 543 Q------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 543 ~------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 615 (664)
. ....++..|+|||.+. ...++.++||||+|+++||+++|+.||....... ................+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 1234678899999986 5677899999999999999999999986432211 111111111122223344455
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 67899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.22 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=190.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 367999999999999965 6789999998654321 2234567899999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++... ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+|++|||+++...... ...
T Consensus 88 ~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 88 DLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 999988632 23688999999999999999999998 99999999999999999999999999986543211 112
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||.+.+...++.++|||||||++|||++|+.||.........+....+......
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 345788999998864556789999999999999999999999654321111111111000000
Q ss_pred -----C-------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -----G-------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -----~-------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00001145779999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.61 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=192.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. |+||+++++++...+..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 46799999999999985 45789999998654332 34567889999999996 99999999999999999999999864
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
++.++...........+++.....++.+++.||+|||+..+++||||||+||+++.++.++|+|||+++...... ...
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 166 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcccc
Confidence 554433211112235689999999999999999999985589999999999999999999999999987654332 223
Q ss_pred CCCCCcccCccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--CCchhHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNAS--HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED--DGAEDERLGMLLEV 621 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~--~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 621 (664)
..++..|+|||.+... ..++.++|||||||++|||++|+.||.........+.+........ .......+..+.++
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (288)
T cd06616 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246 (288)
T ss_pred ccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHH
Confidence 4578899999998643 3688999999999999999999999875321111111111111000 01112355678999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.+|++|||+.||++.
T Consensus 247 i~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 247 INLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.07 Aligned_cols=239 Identities=17% Similarity=0.239 Sum_probs=188.9
Q ss_pred hccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++...+..++||||+.
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 467999999999999753 3578999987542 235689999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
++|.+++. ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.......
T Consensus 170 -~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 -CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 68998883 235689999999999999999999999 999999999999999999999999999976543321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccC------------
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSARED------------ 607 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~------------ 607 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+...+......
T Consensus 243 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 1345899999999986 567899999999999999999999998654221 11121111111000
Q ss_pred -------------C-Cch-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 608 -------------D-GAE-----DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 608 -------------~-~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. ..+ ......+.+++.+|+..+|++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 0123457789999999999999999999865
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.07 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .++..+++|++....... ....+.+|++.++.++|+||+++++.+...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 46799999999999995 467889999987544322 5578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.++++... ....+++.....++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 85 SLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred cHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999996421 124689999999999999999999998 999999999999999999999999999876543321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc---hhHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA---EDERLGML 618 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 618 (664)
....++..|+|||++.....++.++|||||||++|||++|+.||..... ...+............. ....+..+
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCccccccccHHH
Confidence 1234788899999987444789999999999999999999999875422 12222222221111111 12345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+++.+||+.+|++||++.|+++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.74 Aligned_cols=239 Identities=17% Similarity=0.248 Sum_probs=183.1
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... .+..||+|..... ....|+.++++++|+||+++++++...+..++|+||+.
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 3468999999999999965 4678999975322 23468899999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
++|.+++.. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 141 ~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 141 SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 689888853 345689999999999999999999999 99999999999999999999999999997543222 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCh--------hhHHHHHHhhccCC-C----ch
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP-SQHSFLVP--------NEMMNWVRSAREDD-G----AE 611 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P-~~~~~~~~--------~~~~~~~~~~~~~~-~----~~ 611 (664)
..|+..|+|||++. ...++.++|||||||++|||+++..| |....... ..+.+.+....... . ..
T Consensus 216 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 46889999999987 56789999999999999999995554 33321110 11111111111000 0 00
Q ss_pred --------------------------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 --------------------------DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 --------------------------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
........+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 011223556999999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.03 Aligned_cols=247 Identities=17% Similarity=0.197 Sum_probs=189.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||++... +++.||+|.+..... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999964 588999999864322 122346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 86 GDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred CcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999953 234688999999999999999999999 999999999999999999999999999876543221
Q ss_pred CCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC---CCchhHHHH
Q 006031 544 DDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED---DGAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 616 (664)
....|++.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+...... .......+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCcccCCCccCCCCH
Confidence 12358999999998752 2457889999999999999999999997532 11111111111110 011112345
Q ss_pred HHHHHHHHcccC--CCCCCCCHHHHHHH
Q 006031 617 MLLEVAIACNSA--SPEQRPTMWQVLKM 642 (664)
Q Consensus 617 ~l~~l~~~Cl~~--~P~~RPt~~ev~~~ 642 (664)
.+.+++.+|+.. ++..||++.++++.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 577888886654 33447899888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.72 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=202.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||+|... ++..|++|++...... ...+.+.+|++.+.+++|+||+++++++...+..++|+||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 368999999999999976 4889999998654332 34578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC--
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD-- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~-- 544 (664)
+|.+++.. ...+++..+..++.|+++||+|||+ . +++||||+|+||+++.++.++++|||.+.........
T Consensus 85 ~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 85 SLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999953 2568999999999999999999999 8 9999999999999999999999999998866543322
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-ChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL-VPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||.+. ...++.++||||||+++|||+||+.||..... ...+....+.............+..+.+++.
T Consensus 159 ~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 335678899999986 56788999999999999999999999876532 2223333333222221111214567999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~ 642 (664)
+||+.+|++||++.|+++.
T Consensus 238 ~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHccCChhhCCCHHHHHhC
Confidence 9999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.55 Aligned_cols=244 Identities=18% Similarity=0.212 Sum_probs=190.6
Q ss_pred cccccCceeEEEEEE-cCCeEEEEEEccCccccCCc-HHHHHHHH---HHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 391 LLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTS-NEMYEQHM---ESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~-~~~~~~e~---~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
+||+|+||.||+|.. .+++.||+|.+......... ...+..|. ..++...||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 45889999998654332111 22233333 34555689999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
+|+|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..........
T Consensus 81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence 999999984 234699999999999999999999998 99999999999999999999999999987655444444
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+.....++.++|||||||++|||++|+.||............... .......+......+.+++.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHH
Confidence 568899999999864446789999999999999999999999764222111111111 1111122223356689999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 006031 626 NSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RP-----t~~ev~~ 641 (664)
+..+|++|| ++.|+++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHh
Confidence 999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.77 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||+|.. .+|..||+|++..........+.+.+|++++++++|||++++++++.+.+..++||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 36799999999999985 478999999987654433445678899999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||++++++.++++|||+++....... ..
T Consensus 83 ~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 83 DLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred CHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 999998632 224689999999999999999999998 999999999999999999999999999875432211 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||++.+...++.++||||||+++|||++|+.||..... ..++.+..+......
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34578899999886455678899999999999999999999875321 112222111110000
Q ss_pred ---------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.........+.+++.+||+.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=297.18 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||.|+||.||++...+ +..||+|.+..... ....+.+..|++.+..++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4679999999999999654 47899999865432 12467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999996321 12289999999999999999999999 999999999999999999999999999976654321
Q ss_pred C---CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 D---DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ~---~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
. ...++..|+|||.+. ...++.++||||+|+++|||++ |+.||... ....+.+.+....... .....+..+.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYRLP-KPENCPPEIY 234 (258)
T ss_pred cccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCC-CCCcCCHHHH
Confidence 1 123568899999885 6778999999999999999999 88887652 2334444433322221 2223456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
+++.+|+..+|++|||+.|+++.|
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=300.21 Aligned_cols=243 Identities=18% Similarity=0.220 Sum_probs=189.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecC--CceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAK--EERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.. .++..||+|+++..... .......+|+..+.++. |+||+++++++.+. +..++|+||+
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 35799999999999985 46889999998654321 22334457888888885 99999999999887 8899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
+ |+|.+++.. ....++|..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 83 D-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred C-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 7 588888853 224689999999999999999999999 9999999999999999 9999999999976543322
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC------------C---
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED------------D--- 608 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~------------~--- 608 (664)
....++..|+|||.+.....++.++|||||||++|||++|+.||..... .+...+....... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2344688999999765456678899999999999999999999975321 1211111111100 0
Q ss_pred -Cc-----------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -GA-----------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -~~-----------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. ....+..+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 1123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.48 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=190.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC---CcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG---TSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 462 (664)
.++||+|+||.||+|.. .++..||+|.+....... ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 46899999999999986 458899999885332111 2235788999999999999999999988764 45789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS- 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 541 (664)
|+++++|.+++.. ...+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 87 HMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred ecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999852 24578888999999999999999998 9999999999999999999999999998754321
Q ss_pred ----CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 542 ----LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 542 ----~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
......++..|+|||.+. ...++.++|||||||++|||++|+.||.... ....+.... ........+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIA-TQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccc-hHHHHHHHh-cCCCCCCCchhhCHH
Confidence 112234788999999986 5668899999999999999999999986531 112222211 111112223344566
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++.+|+. +|++||+++||++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhc
Confidence 8889999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=324.57 Aligned_cols=245 Identities=18% Similarity=0.208 Sum_probs=181.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC------CCCcccceEEEecC-CceEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR------HPNLVPLRAYFQAK-EERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~g~~~~~-~~~~lV 460 (664)
.++||+|+||+||+|.. ..++.||||+++... .....+..|+++++.++ |.+++++++++... +..++|
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 46799999999999985 457889999986422 12334555666665554 45688899988764 468899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---------------
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF--------------- 525 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~--------------- 525 (664)
||++ +++|.+++.. ...+++..+..|+.||+.||+|||++.+||||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9987 7789998852 346899999999999999999999744999999999999998765
Q ss_pred -CeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh
Q 006031 526 -EACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 526 -~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 604 (664)
.+||+|||.+...... .....||+.|+|||++. +..++.++|||||||++|||+||+.||+.... .+....+...
T Consensus 285 ~~vkl~DfG~~~~~~~~-~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~ 360 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS-RTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--LEHLHLMEKT 360 (467)
T ss_pred ceEEECCCCccccCccc-cccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHH
Confidence 4999999987643322 23456899999999987 66789999999999999999999999975421 1111111100
Q ss_pred cc--------------------------CCCc--------------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--H
Q 006031 605 RE--------------------------DDGA--------------EDERLGMLLEVAIACNSASPEQRPTMWQVLK--M 642 (664)
Q Consensus 605 ~~--------------------------~~~~--------------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~ 642 (664)
.. .... .......+.+|+.+||+.||++|||++|+++ .
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 00 0000 0001234779999999999999999999986 4
Q ss_pred HHhh
Q 006031 643 LQEI 646 (664)
Q Consensus 643 L~~i 646 (664)
+.+.
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 4443
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=302.15 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=193.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... +++.+++|.++...........+.+|++++.+++||||+++++++... +..++|+||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 467999999999999965 588999999975544333345677899999999999999999998877 88999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--C
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--Q 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~ 543 (664)
++|.+++... ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 90 -~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 90 -HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred -cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 4999988632 23689999999999999999999998 99999999999999999999999999988665432 1
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc---------------C-
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE---------------D- 607 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~---------------~- 607 (664)
....++..|+|||.+.+...++.++|+||||+++|||++|++||..... ............. .
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2234678899999886555578999999999999999999999875321 1111111100000 0
Q ss_pred -----C-------CchhH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 -----D-------GAEDE-RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 -----~-------~~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ..+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00011 2455889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=301.93 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++...+..++|+||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 467999999999999965 5789999998765443445678999999999999999999999999999999999999987
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~ 544 (664)
.+..+.. ....+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++....... ..
T Consensus 86 ~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 86 LLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred HHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 7776663 234589999999999999999999999 99999999999999999999999999987655432 12
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh--------------------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA-------------------- 604 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-------------------- 604 (664)
...++..|+|||++.....++.++||||||+++|||++|++||..... ...+.......
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345678899999987443788999999999999999999999875321 11111100000
Q ss_pred c-cCCC--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 605 R-EDDG--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 605 ~-~~~~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .... .+...+..+.+++.+||..+|++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000 01122566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.61 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=194.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... .++.|++|.+...... ....+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 367999999999999964 5788999988654321 12345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
++|.+++.. ...+++.....++.+++.||+|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 86 ~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 86 GDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999953 34689999999999999999999998 99999999999999999999999999986421110
Q ss_pred -------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-HhhccCC
Q 006031 543 -------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV-RSAREDD 608 (664)
Q Consensus 543 -------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~ 608 (664)
.....++..|+|||.+. ...++.++|||||||++||+++|+.||... ...++.... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccCCC
Confidence 01124677899999986 567899999999999999999999998643 222222222 1111111
Q ss_pred CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006031 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 609 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1112345568999999999999999997666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=303.13 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=192.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCc-----eEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEE-----RLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~-----~~lV~ 461 (664)
.+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++ |+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999964 6889999988654433334467888999999995 6999999999887665 89999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTAD 540 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~ 540 (664)
||+++ +|.+++..........+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 99985 898888643322245689999999999999999999999 9999999999999998 89999999999875433
Q ss_pred CCC--CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC----------
Q 006031 541 SLQ--DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---------- 608 (664)
Q Consensus 541 ~~~--~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------- 608 (664)
... ....+++.|+|||++.+...++.++||||||+++|||++|+.||..... ...............
T Consensus 164 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHhCCCChhhCcchhhc
Confidence 211 2234678899999886556678999999999999999999999865321 112211111100000
Q ss_pred -----------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -----------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -----------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+||+.+|++||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=283.82 Aligned_cols=268 Identities=19% Similarity=0.258 Sum_probs=205.9
Q ss_pred CCceeEecCCccccCHHHHHHHHhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCC
Q 006031 366 SGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPN 443 (664)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~n 443 (664)
++.+....++.+..++.|+.. ...||.|.-|.|++++++ .|..+|||.+....- ..+.+.+...++++.+.+ .|+
T Consensus 76 tg~lti~~g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 76 TGYLTIGGGQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPY 152 (391)
T ss_pred ceeEEecCCcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCe
Confidence 333333335666677787754 456999999999999965 588999999975432 234456667777776654 799
Q ss_pred cccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 444 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
||+.+|||..+...++-||.|.. -+..++. ...+++++...-++...+.+||.||.++.+|+|||+||+|||+|+
T Consensus 153 IV~c~GyFi~n~dV~IcMelMs~-C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe 227 (391)
T KOG0983|consen 153 IVQCFGYFITNTDVFICMELMST-CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 227 (391)
T ss_pred eeeeeeEEeeCchHHHHHHHHHH-HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc
Confidence 99999999999999999998853 4555554 234568888888999999999999999879999999999999999
Q ss_pred CCCeEEeeccccccccCCCC-CCCCCCCcccCccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH
Q 006031 524 DFEACLADYCLTALTADSLQ-DDDPDNLLYKAPETRNAS--HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~~-~~~~~~~~y~aPE~~~~~--~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~ 600 (664)
.|++|+||||++..+.++.. +..+|.+.|||||.+... ..|+.++|||||||+++||.||+.||..-..+-+-+...
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 99999999999987766543 456788999999988633 457889999999999999999999998643222223333
Q ss_pred HHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 601 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+......+........+.+++..|+++|+.+||...++++
T Consensus 308 ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 308 LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 33222111223335677999999999999999999988764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.43 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=204.8
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccC-CcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|.||.||+++.+. |+.+|+|.+.+..... ...+...+|+.+|+++. |||||.+.+.|.+.+..++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3679999999999999765 9999999998765532 24578999999999998 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC----CCeEEeeccccccccCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD----FEACLADYCLTALTADS 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~~~~~ 541 (664)
||.|++.+... .+++.....++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++......
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999532 399999999999999999999998 99999999999999643 57999999999987663
Q ss_pred -CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc-cCCCchhHHHHHHH
Q 006031 542 -LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-EDDGAEDERLGMLL 619 (664)
Q Consensus 542 -~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 619 (664)
......||+.|+|||++. ...++..+||||.||++|.|++|.+||...... ........... -..+.++.....+.
T Consensus 193 ~~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-EIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred ceEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-HHHHHHHcCCCCCCCCCccccCHHHH
Confidence 334578999999999986 578999999999999999999999999874321 12222111111 11234555667799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+++.+++..||.+|+|+.++++.
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcC
Confidence 99999999999999999999984
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.65 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=196.5
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||.||+|.. .++..||+|.+...... ......+.+|++++++++|+|++++++++.+.+..++||||+.
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 346799999999999995 46889999998654321 1233568889999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
|+|.+++.. ....++|..+..++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++...... ..
T Consensus 109 -g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~ 180 (317)
T cd06635 109 -GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--NS 180 (317)
T ss_pred -CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCc--cc
Confidence 588887752 234689999999999999999999998 9999999999999999999999999998754432 23
Q ss_pred CCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||++. ....++.++|||||||++|||++|+.||.... ....+..+..... ...........+.+++.
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNES-PTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccC-CCCCCccccHHHHHHHH
Confidence 45788999999874 23567889999999999999999999986531 1112222222221 11222334556899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHh
Q 006031 624 ACNSASPEQRPTMWQVLKMLQE 645 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~ 645 (664)
+||+.+|++||++.|+++..-.
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHccCCcccCcCHHHHHhChhh
Confidence 9999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.70 Aligned_cols=243 Identities=21% Similarity=0.234 Sum_probs=192.0
Q ss_pred ccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||+||++.. .+++.||+|.+....... ...+.+..|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468899999986543221 2345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDDPD 548 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~~~ 548 (664)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||.+....... .....+
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence 9999642 224689999999999999999999998 99999999999999999999999999987654322 223456
Q ss_pred CCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
+..|+|||++. ...++.++|||||||++|||++|+.||...... ...+...... .....+......+.+++.+||
T Consensus 157 ~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 157 TPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred CCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHc
Confidence 78899999987 456889999999999999999999999754321 1122111111 111122233556899999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 006031 627 SASPEQRP-----TMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RP-----t~~ev~~ 641 (664)
+.+|++|| ++.++++
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCChhHccCCCcccHHHHHh
Confidence 99999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.85 Aligned_cols=243 Identities=19% Similarity=0.214 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... ++..||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 467999999999999965 58899999997544322 3457889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
++|.+++.. ...+++..+..|+.|++.||.|||+. +++|+||+|+||++++++.++++|||.+....... ...
T Consensus 85 ~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 85 GDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999952 25789999999999999999999998 99999999999999999999999999987654432 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-hhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-PNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|+||||+++|+|++|+.||...... ...+...... .....+...+..+.+++.+
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 159 TSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cCCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence 45778899999986 556899999999999999999999999764322 1122222111 2222333455779999999
Q ss_pred cccCCCCCCCCH--HHHH
Q 006031 625 CNSASPEQRPTM--WQVL 640 (664)
Q Consensus 625 Cl~~~P~~RPt~--~ev~ 640 (664)
||+.+|.+||++ +|+.
T Consensus 236 ~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 236 LLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HccCChhHcCCccHHHHh
Confidence 999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.57 Aligned_cols=246 Identities=22% Similarity=0.269 Sum_probs=189.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..||+|++..... ......+.+|+++++.++|+||+++++++...+..++|+||+. +
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 35799999999999985 4688999999865432 2334567789999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
++.+++.. ....+.+..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||+++...... ...
T Consensus 88 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 88 DLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 78777642 224578888999999999999999998 99999999999999999999999999987543221 122
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC----------------C-
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED----------------D- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~----------------~- 608 (664)
..++..|+|||.+.+...++.++|||||||++|||+||+.||.........+.+.......+ .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 34688899999986445578899999999999999999999975432111111111100000 0
Q ss_pred ------Cc------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ------GA------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ------~~------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. .......+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0011345789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.57 Aligned_cols=247 Identities=16% Similarity=0.194 Sum_probs=190.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||++..+ +++.+|+|.+.+.... ......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 467999999999999965 4778999998643221 12345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---Q 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 543 (664)
|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 86 g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 86 GDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999963 234689999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred CCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---CchhHHHH
Q 006031 544 DDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---GAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 616 (664)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+....... ........
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCccccCCCccccCCH
Confidence 22468999999998752 3457889999999999999999999997531 122222221111111 11123345
Q ss_pred HHHHHHHHcccCCCC--CCCCHHHHHHH
Q 006031 617 MLLEVAIACNSASPE--QRPTMWQVLKM 642 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~--~RPt~~ev~~~ 642 (664)
.+.+++.+|+..++. .|+++.|+++.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 678888887755444 36899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=296.48 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=196.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|.+..........+.+.+|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999964 5788999998765443345567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC-eEEeeccccccccCCCC--C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE-ACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~-~ki~DfGla~~~~~~~~--~ 544 (664)
+|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++. +|++|||.+........ .
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 85 DLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred cHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999632 234589999999999999999999998 9999999999999998854 69999999876544322 1
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||+.. ...++.++||||||+++||+++|+.||..... ...+.......... ........+.+++.+
T Consensus 161 ~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~ 236 (257)
T cd08225 161 TCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVLKICQGYFAP--ISPNFSRDLRSLISQ 236 (257)
T ss_pred ccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHhcccCCC--CCCCCCHHHHHHHHH
Confidence 234788899999886 56688999999999999999999999865321 11222221111111 112234568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|++|||+.|+++
T Consensus 237 ~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 237 LFKVSPRDRPSITSILK 253 (257)
T ss_pred HhccChhhCcCHHHHhh
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.07 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=196.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++.+++++||||+++++++...+..++||||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 46799999999999985 4678999998764332 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.++++. ..+++.....++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||++........ ..
T Consensus 88 ~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 88 SALDLLEP------GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 99999852 3588999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++|||||||++|||++|+.|+.... .......+.... ........+..+.+++.+|
T Consensus 161 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 161 FVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKNN-PPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcCC-CCCCCcccCHHHHHHHHHH
Confidence 35678899999986 5677889999999999999999999986532 222222222111 1112233455688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.++++.
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 237 LNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCChhhCcCHHHHHhC
Confidence 99999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.66 Aligned_cols=246 Identities=24% Similarity=0.298 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... ++..||+|.+....... ...+.+.+|++++++++|+||+++++++.+.+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 357999999999999965 48899999997654321 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
++|.+++.. .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 86 GELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999963 2235689999999999999999999998 999999999999999999999999999865422110
Q ss_pred ----------------------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh
Q 006031 544 ----------------------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN 595 (664)
Q Consensus 544 ----------------------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~ 595 (664)
....|+..|+|||++. ...++.++||||||+++|||++|+.||..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~ 239 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR-DE 239 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-HH
Confidence 0124677899999987 56678999999999999999999999875321 11
Q ss_pred hHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 006031 596 EMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPT----MWQVLK 641 (664)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----~~ev~~ 641 (664)
.+....... .........+..+.+++.+||+.+|++||+ +.|++.
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 TFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 222211111 111111224567999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.48 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=194.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... ++..+|+|++..........+.+.+|++++++++|+|++++++++... +..++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 357999999999999965 588999999976543234456788999999999999999999999888 78999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
+ +|.+++.. ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.+|++|||++.......
T Consensus 84 ~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 84 H-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred c-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 5 89988853 224689999999999999999999998 99999999999999999999999999997665432
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc----------------
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE---------------- 606 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~---------------- 606 (664)
.....++..|+|||.+.+...++.++||||||+++|||+||+.||..... ...+.........
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhhh
Confidence 22234577899999876455678999999999999999999999875431 1111111110000
Q ss_pred ----CCC-------chhH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 ----DDG-------AEDE-RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ----~~~-------~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... .... ....+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0001 1456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.06 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=201.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 465 (664)
.+.||+|++|.||+|... ++..|++|.+..........+.+.+|++.+++++|+||+++++++... +..++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 367999999999999976 688999999876544334567899999999999999999999999888 88999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
+++|.+++.. ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 85 GGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999953 23799999999999999999999998 99999999999999999999999999998765543
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
.....++..|+|||... ....+.++||||||+++|||++|+.||............ ..........+......+.++
T Consensus 159 ~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh-ccccCCCcCCCcccCHHHHHH
Confidence 23355788999999986 556899999999999999999999999764311111111 111111112233445679999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+|++.+|++||++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhCcCChhhCCCHHHHhh
Confidence 99999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.92 Aligned_cols=244 Identities=20% Similarity=0.351 Sum_probs=190.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEec------CCceEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQA------KEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~------~~~~~lV 460 (664)
.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++.. .+..++|
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 46799999999999996 567899999885432 2345688889999888 79999999999853 4578999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 98 MEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999999642 234578888999999999999999998 999999999999999999999999999875533
Q ss_pred CC--CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 541 SL--QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~--~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
.. .....++..|+|||.+.. ...++.++|||||||++|||++|+.||...... ..+.. +.............
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 251 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RALFL-IPRNPPPKLKSKKW 251 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhhhh-HhhCCCCCCccccc
Confidence 21 223457889999998752 245778999999999999999999998653211 11111 11111111122234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+++.+||+.+|++||++.|+++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=300.55 Aligned_cols=241 Identities=21% Similarity=0.328 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||++.. .++..|++|++..... ...+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 46899999999999985 5688999998864332 33566889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++++|||.+........ ..
T Consensus 102 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 102 ALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 99999952 4589999999999999999999998 999999999999999999999999998875443221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||... ...++.++|||||||++|||++|+.||.... ............... .........+.+++.+
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 175 LVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 35788999999986 5668899999999999999999999986532 222222222221111 1112234568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|++||++.++++
T Consensus 252 ~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 252 MLVRDPAQRATAAELLN 268 (285)
T ss_pred HcccChhhCcCHHHHcc
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=298.50 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=195.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCC------ceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKE------ERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~------~~~lV 460 (664)
.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++.... ..++|
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 467999999999999974 578899998865432 456789999999998 7999999999997644 48999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||+++++|.++++... .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 88 MELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 99999999999986422 1235789999999999999999999998 999999999999999999999999999876543
Q ss_pred CCC--CCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 541 SLQ--DDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~~--~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
... ....++..|+|||.+.. ...++.++|||||||++||++||+.||.... ....+.................
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd06608 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKIPRNPPPTLKSPENW 244 (275)
T ss_pred chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHhhccCCCCCCchhhc
Confidence 221 23457888999998742 2346789999999999999999999996432 1222333222222111222334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 245 SKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=301.45 Aligned_cols=240 Identities=22% Similarity=0.249 Sum_probs=195.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999864 58899999986543221 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.++++. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++..... ....
T Consensus 86 ~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 158 (290)
T cd05580 86 GELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTL 158 (290)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCC
Confidence 999999953 35689999999999999999999998 9999999999999999999999999999876544 2334
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.+++.|+|||.+. ....+.++||||||+++|||++|+.||.... .......+... ....+......+.+++.+||
T Consensus 159 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 159 CGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEG--KVRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcC--CccCCccCCHHHHHHHHHHc
Confidence 6788999999886 5567889999999999999999999987532 22222222211 11122233456889999999
Q ss_pred cCCCCCCC-----CHHHHH
Q 006031 627 SASPEQRP-----TMWQVL 640 (664)
Q Consensus 627 ~~~P~~RP-----t~~ev~ 640 (664)
+.+|++|| +++|++
T Consensus 234 ~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred cCCHHHccCcccCCHHHHH
Confidence 99999999 566655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.72 Aligned_cols=247 Identities=18% Similarity=0.193 Sum_probs=190.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+..... .......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999964 578899999865322 112345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 g~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 86 GDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999963 234688999999999999999999998 999999999999999999999999999976543321
Q ss_pred CCCCCCCcccCccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC---CCchhHHHH
Q 006031 544 DDDPDNLLYKAPETRNAS----HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED---DGAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~----~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 616 (664)
....|++.|+|||++... ..++.++|||||||++|||++|+.||.... ..+....+...... .......+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--HHHHHHHHHcCCCcccCCCccccCCH
Confidence 124589999999987531 457889999999999999999999997532 11211111111110 011122345
Q ss_pred HHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006031 617 MLLEVAIACNSASPEQ--RPTMWQVLKM 642 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~--RPt~~ev~~~ 642 (664)
.+.+++.+|+...+++ |+++.++.+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 6888999988865544 4678888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=302.80 Aligned_cols=243 Identities=20% Similarity=0.345 Sum_probs=195.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++.. .++..|++|.+..... ...+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 46799999999999985 4678899999864332 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 102 ~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 102 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999952 3478999999999999999999999 999999999999999999999999998865443221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..+++.|+|||.+. ...++.++|||||||++||+++|+.||....... .+....................+.+++.+|
T Consensus 175 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 35778899999886 5667899999999999999999999997532211 111111111111112233445688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++||++.+++..
T Consensus 253 l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 253 LEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.38 Aligned_cols=256 Identities=19% Similarity=0.288 Sum_probs=193.6
Q ss_pred cCHHHHHHHHhccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCc
Q 006031 379 YTLDQLMRASAELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEE 456 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~ 456 (664)
++++++ ...+.||+|+||.||+|..++ +..||||.++..... .....+.+|+.++.+.. |+||++++++|.+...
T Consensus 12 ~~~~~~--~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 12 ADLNDL--ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred CCcchh--eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 344443 346789999999999999765 889999998754321 23445666777666664 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.++||||+. +++.+++.. ....+++..+..++.|++.||+|||+..+|+||||+|+||++++++.+||+|||++.
T Consensus 89 ~~~v~e~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 89 VFICMELMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEEEeeccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999985 477777642 234789999999999999999999984489999999999999999999999999987
Q ss_pred cccCCCC-CCCCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 537 LTADSLQ-DDDPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 537 ~~~~~~~-~~~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
....... ....++..|+|||++... ..++.++||||||+++|||++|+.||.........+...............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 6543322 223467889999988632 237889999999999999999999986532211122222222111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.....+.+++.+||+.+|++||++.++++.
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 234568999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.52 Aligned_cols=244 Identities=20% Similarity=0.306 Sum_probs=194.4
Q ss_pred ccccCceeEEEEEEcC-CeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVLDN-RLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||++...+ ++.+++|.+...... ....+.+.+|++++++++|+||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 889999998654331 13356788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--------
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-------- 541 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-------- 541 (664)
.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++......
T Consensus 81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999953 23689999999999999999999998 9999999999999999999999999998754332
Q ss_pred --CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 542 --LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 542 --~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
......++..|+|||... ....+.++||||||+++||+++|+.||.... ..+..................+..+.
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPEDVEVSDEAI 231 (265)
T ss_pred cccccCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcCCCccccCCHHHH
Confidence 112234677899999886 4557889999999999999999999987532 22333222221111111111256689
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+++.+||+.+|++|||+.++.+.|+
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999999966655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=294.67 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=203.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++.. .++..+++|.+............+.+|++++++++|+||+++.+++.+....++|+||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999974 46789999998765443344567888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.+++.... .....+++.....++.+++.||+|||+. +++|+||+|+||++++++.+|++|||++............
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 162 (256)
T cd08530 85 DLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI 162 (256)
T ss_pred CHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCccccc
Confidence 9999986422 2235689999999999999999999998 9999999999999999999999999999877655444456
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHccc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 627 (664)
++..|+|||... ...++.++|+||||+++||+++|+.||.... ..++...+...... .........+.+++.+|++
T Consensus 163 ~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 163 GTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARS--MQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred CCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcC
Confidence 788999999986 5678889999999999999999999987542 22333333222211 2223456679999999999
Q ss_pred CCCCCCCCHHHHHH
Q 006031 628 ASPEQRPTMWQVLK 641 (664)
Q Consensus 628 ~~P~~RPt~~ev~~ 641 (664)
.+|++||++.|+++
T Consensus 239 ~~p~~Rp~~~~~l~ 252 (256)
T cd08530 239 VKPKLRPNCDKILA 252 (256)
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.14 Aligned_cols=193 Identities=24% Similarity=0.385 Sum_probs=167.0
Q ss_pred HhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-C-----CCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-H-----PNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~lV 460 (664)
..++||+|+||.|-||+ ...++.||||+++.... -..+-..|+.+|..|+ | -|+|++++||...++.|||
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 35789999999999999 55699999999976543 3455667888888886 4 3899999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC--CCCeEEeeccccccc
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP--DFEACLADYCLTALT 538 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~ 538 (664)
+|.+.. +|.+++.. .....++......|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|...
T Consensus 267 fELL~~-NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 998854 99999965 4456799999999999999999999998 9999999999999964 357999999999887
Q ss_pred cCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006031 539 ADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHS 590 (664)
Q Consensus 539 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~ 590 (664)
..... ....+..|+|||++. +..|+.+.||||||||+.||+||.+-|.+.
T Consensus 342 ~q~vy-tYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRVY-TYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcce-eeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 66654 567788999999998 789999999999999999999998877654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.80 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEEc---CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 462 (664)
.+.||+|+||.||+|... ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 357999999999999964 478999999976431 112346678899999999999999999999988 78999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC----CCCeEEeeccccccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP----DFEACLADYCLTALT 538 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~----~~~~ki~DfGla~~~ 538 (664)
|+++ ++.+++..........++......|+.|++.||+|||+. +|+||||||+||+++. ++.+|++|||++...
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 9975 777777533322334788999999999999999999998 9999999999999999 999999999998865
Q ss_pred cCCCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--------hhHHHHHHhhc
Q 006031 539 ADSLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--------NEMMNWVRSAR 605 (664)
Q Consensus 539 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--------~~~~~~~~~~~ 605 (664)
..... ....++..|+|||++.+...++.++|||||||++|||++|++||....... ..+...+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 43322 123467889999988755668899999999999999999999987543211 01111111000
Q ss_pred c-----------------------CCCch----h-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 E-----------------------DDGAE----D-------ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 ~-----------------------~~~~~----~-------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ..... . .....+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00000 0 12345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.61 Aligned_cols=243 Identities=21% Similarity=0.237 Sum_probs=187.6
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHH-HcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMES-VGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||.||+|.. .+++.||+|.+....... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999986 458899999986543211 112234444444 4556899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+++..... ...
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 153 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--KKF 153 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceecccc--ccC
Confidence 999999953 34688999999999999999999998 9999999999999999999999999998764432 234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc-cCC-CchhHHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-EDD-GAEDERLGMLLEVAIA 624 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~l~~~ 624 (664)
.++..|+|||.+. ...++.++||||||+++|||+||..||.... ............ ... ......+..+.+++.+
T Consensus 154 ~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 154 VGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred CCCcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 5778899999987 4558899999999999999999999997532 222222221111 111 1122345668999999
Q ss_pred cccCCCCCCCCHHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L 643 (664)
||+.+|++||++.++.+.|
T Consensus 231 ~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HccCCHHHccCCCcHHHHH
Confidence 9999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.62 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=196.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..|++|++..... ..+.+.+|++.+++++|+|++++++++...+..++|+||++++
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 357999999999999976 688999999865432 4667889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++... ...+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 101 SLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred cHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999999642 13799999999999999999999998 999999999999999999999999998865443221 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++|||||||++|||++|+.||..... .....................+..+.+++.+|
T Consensus 176 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 176 VVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred ccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 34678899999886 56689999999999999999999999865321 11222222211111112222456789999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|.+||++.++++
T Consensus 254 l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 254 LVKDPEKRPSAEELLQ 269 (286)
T ss_pred hccChhhCcCHHHHhh
Confidence 9999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.77 Aligned_cols=247 Identities=16% Similarity=0.190 Sum_probs=178.7
Q ss_pred hccccccCceeEEEEEEcCC----eEEEEEEccCccccCCcH---------HHHHHHHHHHcCCCCCCcccceEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDNR----LIVCVKRLDASKLAGTSN---------EMYEQHMESVGGLRHPNLVPLRAYFQAKE 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~~~---------~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 455 (664)
.++||+|+||+||+|...++ ..+|+|...........+ .....+...+..+.|+|++++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 46799999999999996553 455666543222110001 11223345567789999999999765543
Q ss_pred ----ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 456 ----ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 456 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
..++++|++.. ++.+.+.. ....++.....|+.|++.||+|||+. +|+||||||+|||++.++.++|+|
T Consensus 97 ~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 97 CRMYYRFILLEKLVE-NTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred CCceEEEEEEehhcc-CHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEEEE
Confidence 34678887643 66666632 23357888899999999999999998 999999999999999999999999
Q ss_pred ccccccccCC---------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhH----H
Q 006031 532 YCLTALTADS---------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEM----M 598 (664)
Q Consensus 532 fGla~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~----~ 598 (664)
||+++..... ......||+.|+|||... +..++.++|||||||++|||++|+.||.........+ .
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 9999765321 111235899999999887 6678999999999999999999999997652222111 1
Q ss_pred HHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 599 NWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
++..............+..+.+++..||+.+|++||++.++.+.|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 249 DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 222222222112223356689999999999999999999999876
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.46 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=193.0
Q ss_pred ccccc--CceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKG--SLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+| +||+||++.. ..++.||+|.+..........+.+.+|+.+++.++||||++++++|...+..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 47899999998754432234567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+..........
T Consensus 85 ~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998642 223588999999999999999999998 999999999999999999999999976533211100
Q ss_pred -----CCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc------------
Q 006031 544 -----DDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR------------ 605 (664)
Q Consensus 544 -----~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~------------ 605 (664)
....++..|+|||++... ..++.++|||||||++|||++|+.||...... ...........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCCCCccccccchh
Confidence 011245679999998633 34688999999999999999999999754211 11111110000
Q ss_pred --------------------------------cCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 006031 606 --------------------------------EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKG 648 (664)
Q Consensus 606 --------------------------------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~ 648 (664)
............+.+++.+||+.+|++|||+.|+++ .++.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000112234567899999999999999999999974 3455554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.40 Aligned_cols=244 Identities=25% Similarity=0.413 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||++... ++..+++|++..... ...+.+.+|++.+++++|+|++++++++...+..++++||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 367999999999999975 688999999865443 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~ 546 (664)
+|.+++... ...+++..+..++.+++.||+|||+. +++||||+|+||++++++.++|+|||.+....... ....
T Consensus 83 ~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 83 SLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 999999632 25689999999999999999999998 99999999999999999999999999987765443 2334
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+....................+.+++.+||
T Consensus 158 ~~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 158 VGTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred ecCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence 5788899999987 456889999999999999999999998753211 11111111111111111112466899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 006031 627 SASPEQRPTMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~ 641 (664)
+.+|++|||+.|+++
T Consensus 236 ~~~p~~R~t~~~~l~ 250 (253)
T cd05122 236 QKNPEKRPTAEQLLK 250 (253)
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.84 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=190.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
++.+|.|+++.||++.. +++.||+|++..........+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455666666666655 68899999987653333456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC------
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL------ 542 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~------ 542 (664)
|.++++.. ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 86 l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999642 224588899999999999999999999 99999999999999999999999999886442211
Q ss_pred ---CCCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc------------
Q 006031 543 ---QDDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE------------ 606 (664)
Q Consensus 543 ---~~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~------------ 606 (664)
.....++..|+|||++... ..++.++|||||||++|||++|+.||...... ....+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCccccccCchhhhc
Confidence 1123456789999988633 34788999999999999999999999753211 111111110000
Q ss_pred -------------------CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 607 -------------------DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 607 -------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
...........+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000112234568899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.80 Aligned_cols=246 Identities=23% Similarity=0.275 Sum_probs=191.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... ++..||+|.++...........+.+|+.++++++|+||+++++++.+. +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 467999999999999964 588999999875443323344567899999999999999999998755 46899999997
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
+ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 92 ~-~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 92 Q-DLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred C-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence 4 898888532 35689999999999999999999999 999999999999999999999999999987654321
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-----------------
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE----------------- 606 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~----------------- 606 (664)
....++..|+|||.+.+...++.++|||||||++|||++|++||.... ..+....+.....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 122356789999988655667899999999999999999999997532 1111111111000
Q ss_pred ----C-CC--c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 607 ----D-DG--A----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 607 ----~-~~--~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. .. . .......+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00 0 01124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.98 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=191.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|+||+|... +++.||+|.+..........+.+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 357999999999999964 68899999986554333345678899999999999999999999999999999999996 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccCCCC--C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~~--~ 544 (664)
+|.+++... ....+++.....++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++........ .
T Consensus 86 ~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 86 DLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 888887432 223467888889999999999999998 9999999999999985 56789999999976433221 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-----------------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED----------------- 607 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~----------------- 607 (664)
...++..|+|||++.+...++.++|||||||++|||+||+.||..... ...+.........+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 234678899999886556688999999999999999999999875321 11222111100000
Q ss_pred ----CC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 ----DG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 ----~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. ........+.+++.+|++.+|++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 01122345789999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.60 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=192.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC----------ce
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE----------ER 457 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----------~~ 457 (664)
.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+.+ ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 468999999999999975 5789999998755433344567788999999999999999999987655 78
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 92 ~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 92 YLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred EEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 999999986 77777752 234689999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCC---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------
Q 006031 538 TADSLQ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------ 608 (664)
Q Consensus 538 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------ 608 (664)
...... ....++..|+|||.+......+.++|||||||++|||++|++||..... ...+...........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhccc
Confidence 544321 1123567899999876455678899999999999999999999875321 112222111110000
Q ss_pred ---------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
......+..+.+++.+||+.+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.49 Aligned_cols=241 Identities=21% Similarity=0.317 Sum_probs=195.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+||+|+||.||++.. .++..||+|++..... ...+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999986 5688999998854332 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ..+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ ..
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 99998842 3578999999999999999999999 999999999999999999999999998875543321 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++||||||+++|||++|+.||... ...+............ .........+.+++.+
T Consensus 176 ~~~~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 176 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred cccCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 35788899999886 566789999999999999999999998653 1222222222221111 1122334568899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|.+||++.|+++
T Consensus 253 ~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 253 LLVRDPAQRATAAELLK 269 (292)
T ss_pred HHhCCcccCcCHHHHhc
Confidence 99999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.42 Aligned_cols=247 Identities=20% Similarity=0.313 Sum_probs=193.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||+|+.. ++..||+|.++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 367999999999999964 688999999875433 23356677899999999999999999999999999999999985
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........ ..
T Consensus 83 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 83 DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 8988885322 234689999999999999999999998 999999999999999999999999999975543221 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|++||++.+...++.++|||||||++||+++|+.||..... .+.............
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 34678899999886555678899999999999999999999876432 111111111000000
Q ss_pred C---------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 G---------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ~---------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00122355789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.38 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=187.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--------ceEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--------ERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~~l 459 (664)
.+.||+|+||.||+|... ++..||+|.+............+.+|++++++++||||++++++|...+ ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 467999999999999964 6889999998654433333456678999999999999999999987654 3499
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+.+ +|.+++.. ....+++.+...++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 97 VFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred EEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 9999964 88888853 224689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-------
Q 006031 540 DSLQ------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE------- 606 (664)
Q Consensus 540 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~------- 606 (664)
.... ....++..|+|||.+.+...++.++||||||+++|||+||+.||..... ......+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSITPEVW 248 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChhhc
Confidence 3221 1234577899999886555578899999999999999999999865321 111111111000
Q ss_pred --------------CCCc---------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 --------------DDGA---------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 --------------~~~~---------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... .......+.+++.+||..+|++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 0001234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=290.42 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=198.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||++... +++.|++|.+..........+.+.+|++++++++|+|++++++++.+.+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999854 5789999999766543345578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+........ ..
T Consensus 85 ~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 85 SLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred cHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 99999953 25789999999999999999999998 999999999999999999999999999987654432 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||... ...++.++||||+|+++|||++|+.|+..... ........ .......+......+.+++.+|
T Consensus 159 ~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 159 VVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIV--QDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred cccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHh--ccCCCCCCCCCCHHHHHHHHHH
Confidence 45788899999886 45578899999999999999999999875321 11111111 1111122233456688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++||++.|++.
T Consensus 235 l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 235 FQKDPNLRPTAKQLLK 250 (254)
T ss_pred HhCChhhCcCHHHHhc
Confidence 9999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.71 Aligned_cols=254 Identities=19% Similarity=0.270 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++|+||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 46899999999999985 5688999999864222 223456788999999999999999999876443 5799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++ +|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~-~l~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 89 LMET-DLYKLIK------TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred hccc-CHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9975 8888874 24589999999999999999999999 99999999999999999999999999987653321
Q ss_pred C-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc------------
Q 006031 543 Q-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR------------ 605 (664)
Q Consensus 543 ~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~------------ 605 (664)
. ....++..|+|||.+.....++.++|||||||++|||++|+.||...... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 12356888999998764566889999999999999999999999653210 11111100000
Q ss_pred -----------cCCCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhccccC
Q 006031 606 -----------EDDGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGAVLM 652 (664)
Q Consensus 606 -----------~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~~~~ 652 (664)
..... .......+.+++.+||+.+|++|||+.|+++. ++........
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~ 304 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE 304 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence 00000 01123558899999999999999999999987 6666554333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.75 Aligned_cols=244 Identities=19% Similarity=0.234 Sum_probs=190.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCC------------cHHHHHHHHHHHcCCCCCCcccceEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGT------------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKE 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 455 (664)
.+.||+|+||+||+|... +++.||+|.++....... ....+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999954 688999999865432110 1125778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++||||+|+||+++.++.++++|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccce
Confidence 9999999997 69999984 234588999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCC----------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH
Q 006031 536 ALTADS----------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 536 ~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~ 599 (664)
...... ......++..|+|||.+.+...++.++|||||||++|||+||+.||..... .+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~~ 244 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--IDQLG 244 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 765411 111223577899999987555678999999999999999999999875422 11111
Q ss_pred HHHhhcc-CC---------------------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 600 WVRSARE-DD---------------------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 600 ~~~~~~~-~~---------------------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+..... .. . ........+.+++.+||+.+|++||++.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111000 00 0 00112356889999999999999999999986
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.31 Aligned_cols=234 Identities=21% Similarity=0.242 Sum_probs=185.4
Q ss_pred ccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcC-CCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG-LRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||++.. .++..+|+|.+...... .. |+..... .+||||+++++++...+..++||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--AI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--hh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 69999999999985 46788999988654321 11 1111111 2799999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCCCCCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADSLQDDDPD 548 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~~~~~~~ 548 (664)
.+++.. ...++|..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||++....... ...+
T Consensus 97 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 168 (267)
T PHA03390 97 FDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--CYDG 168 (267)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--cCCC
Confidence 999953 23799999999999999999999999 999999999999999998 99999999987654332 2457
Q ss_pred CCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccC
Q 006031 549 NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSA 628 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 628 (664)
+..|+|||++. ...++.++||||||+++|||++|+.||............+.................+.+++.+||+.
T Consensus 169 ~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 169 TLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred CCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence 88999999987 56688999999999999999999999975433222333443333222223334556789999999999
Q ss_pred CCCCCCC-HHHHHH
Q 006031 629 SPEQRPT-MWQVLK 641 (664)
Q Consensus 629 ~P~~RPt-~~ev~~ 641 (664)
+|++||+ ++|+++
T Consensus 248 ~p~~R~~~~~~~l~ 261 (267)
T PHA03390 248 NINYRLTNYNEIIK 261 (267)
T ss_pred ChhhCCchHHHHhc
Confidence 9999995 688764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=297.12 Aligned_cols=243 Identities=22% Similarity=0.296 Sum_probs=204.8
Q ss_pred ccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|.|++|-+|+ .-.|..||||++.+.+........+.+|++.|+-++|||||++|.+.......|||.|.=++|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 569999999999998 4578899999999988877777889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe-CCCCCeEEeeccccccccCC-CCCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL-GPDFEACLADYCLTALTADS-LQDDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl-~~~~~~ki~DfGla~~~~~~-~~~~~ 546 (664)
|++++-+ ....+.+....+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-+|+.|||++-.+... .-...
T Consensus 104 l~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 104 LFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred HHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 9999963 445689999999999999999999998 89999999999876 55688999999999655443 34567
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
+|...|-|||.+.+..+..++.||||+||+||-++.|++||+.....+ -...+-...- ..+.....+..++|..|+
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--TLTmImDCKY--tvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--TLTMIMDCKY--TVPSHVSKECRDLIQSML 254 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--hhhhhhcccc--cCchhhhHHHHHHHHHHH
Confidence 899999999999976667789999999999999999999998754322 1111111111 124455677899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 006031 627 SASPEQRPTMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~ 641 (664)
..||++|.+.+||+.
T Consensus 255 vRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVS 269 (864)
T ss_pred hcCchhhccHHHHhc
Confidence 999999999999874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.39 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=192.7
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCC--ceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKE--ERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~--~~~lV~e~ 463 (664)
..+.||+|+||.||+|... ++..||+|++............+.+|+.+++++ +||||++++++|...+ ..++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3567999999999999965 588999998864332223445677899999999 9999999999986543 57999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
++ ++|..++.. ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 91 ME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred cc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 97 599999852 2688999999999999999999998 999999999999999999999999999976543221
Q ss_pred -------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh------------
Q 006031 544 -------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA------------ 604 (664)
Q Consensus 544 -------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~------------ 604 (664)
....++..|+|||.+.....++.++||||||+++|||+||+.||...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHHH
Confidence 12346788999998765566788999999999999999999998653211 1111100000
Q ss_pred -----------ccCC-----CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 006031 605 -----------REDD-----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEI 646 (664)
Q Consensus 605 -----------~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i 646 (664)
.... .........+.+++.+||+.+|++|||+.++++. ++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 0001134568899999999999999999999975 4554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=297.98 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=194.1
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||.||+|.. .++..||+|.+...... ....+.+.+|+++++.++|+|++++++++...+..++|+||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 346799999999999995 45788999988643221 1234567889999999999999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
|++.+++.. ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.++++|||++...... ..
T Consensus 99 -~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 170 (308)
T cd06634 99 -GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NX 170 (308)
T ss_pred -CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCc--cc
Confidence 688887752 234588999999999999999999998 9999999999999999999999999998765432 23
Q ss_pred CCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||.+.. ...++.++|||||||++|||++|+.||..... ......+..... ...........+.+++.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNES-PALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhcCC-CCcCcccccHHHHHHHH
Confidence 457889999998642 34578899999999999999999999865321 112222222211 11122234566899999
Q ss_pred HcccCCCCCCCCHHHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
+||+.+|++||++.++++.--
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcc
Confidence 999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=289.31 Aligned_cols=260 Identities=20% Similarity=0.258 Sum_probs=200.2
Q ss_pred ccCHHHHHHHHhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHH-HcCCCCCCcccceEEEecCC
Q 006031 378 LYTLDQLMRASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMES-VGGLRHPNLVPLRAYFQAKE 455 (664)
Q Consensus 378 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~ 455 (664)
.|+-+++.. ...||.|+||+|+|..+ +.|+..|||++..... ..+.+.+..|.+. |+.-+.||||+++|.+..++
T Consensus 60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 344444432 35699999999999885 5699999999976554 3455667777775 55557899999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..++-||.|+- ++..+-...-......+++...-+|..-+.+||.||-+..+|||||+||+|||+|..|.+|+||||++
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 99999999954 66554321111334568888888899999999999999779999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCcccCccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh-
Q 006031 536 ALTADSLQ-DDDPDNLLYKAPETRNASHQ-ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED- 612 (664)
Q Consensus 536 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 612 (664)
..+.++.. +..+|...|||||.+..... ++.+|||||+|++|||+.||+.||..-...-+++...+...........
T Consensus 216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 88776643 34678889999999886665 8999999999999999999999997632222233333322222222222
Q ss_pred --HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 613 --ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 613 --~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+....+.+++..|+.+|-.+||.+.++.+
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 24567899999999999999999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=287.22 Aligned_cols=245 Identities=25% Similarity=0.300 Sum_probs=196.6
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|.-|+||++.+++ +...|+|++.+..... ......+.|-++|+.++||.++.||+.++.++..|+|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4679999999999999876 5889999998765532 2335567888899999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC------
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD------ 540 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~------ 540 (664)
|+|..+++. +..+.++...+..++.+|+.||+|||-. |||.|||||+||||.++|++.++||.++.....
T Consensus 162 GdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 162 GDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred ccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999999975 4567899999999999999999999988 999999999999999999999999988632100
Q ss_pred ---------------------------C-CC------------------------CCCCCCCcccCccccccCCCCCchh
Q 006031 541 ---------------------------S-LQ------------------------DDDPDNLLYKAPETRNASHQATSKS 568 (664)
Q Consensus 541 ---------------------------~-~~------------------------~~~~~~~~y~aPE~~~~~~~~~~ks 568 (664)
. .. ...+||-.|.|||++.+ .-.+.++
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAV 316 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAV 316 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCchh
Confidence 0 00 01136677999999984 4457799
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCC----HHHHH
Q 006031 569 DVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPT----MWQVL 640 (664)
Q Consensus 569 DVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----~~ev~ 640 (664)
|.|+|||++|||+.|+.||.+.. ..+-+...+.....-... .+.+..+.+||++.+.+||++|-. ++||-
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 99999999999999999998753 233344433332222222 245667899999999999999997 55553
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.70 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=192.6
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||+||+|.. .++..|++|.+....... ...+.+.+|++++++++|||++++++++.+.+..++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 346799999999999985 468899999986543321 223567889999999999999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
|++.+++.. ....+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...... ..
T Consensus 105 -~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--~~ 176 (313)
T cd06633 105 -GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--NS 176 (313)
T ss_pred -CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--CC
Confidence 588887752 234689999999999999999999998 9999999999999999999999999998653322 23
Q ss_pred CCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..++..|+|||++.. ...++.++|||||||++|||++|+.||.... ........................+.+++.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 457889999998742 3567889999999999999999999986532 112112221111111122223455889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~ 642 (664)
+||+.+|++||++.++++.
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.09 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=191.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.. .++..||+|++............+.+|+.++++++||||+++++++.. ....++|+||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 46799999999999985 468899999987544333445677889999999999999999998753 3468999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+. |+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 90 ME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred hh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 95 699999852 34589999999999999999999998 999999999999999999999999999876433211
Q ss_pred ------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH------------------
Q 006031 544 ------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN------------------ 599 (664)
Q Consensus 544 ------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~------------------ 599 (664)
....++..|+|||.+.....++.++|||||||++|||++|+.||....... .+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhhhhch
Confidence 123578889999988644568899999999999999999999996532111 1100
Q ss_pred -----HHHhhccCCCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 600 -----WVRSAREDDGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 600 -----~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
........... ....+..+.+++.+||+.+|++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 11234668999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=292.67 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=192.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.|++|++..... ........+|+..+++++ |+||+++++++.+++..++||||+ +
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhcc-chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 357999999999999975 478899999865432 123344567899999999 999999999999999999999999 8
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 82 GNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred CCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 89999986422 34689999999999999999999998 999999999999999999999999999976644322 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH------------HHHhhc--------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN------------WVRSAR-------- 605 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~------------~~~~~~-------- 605 (664)
..++..|+|||.+.....++.++|+||||+++|||++|++||...... ..+.. |.....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH-HHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 457888999998865566889999999999999999999998654211 11111 000000
Q ss_pred ----cCCC---chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 ----EDDG---AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 ----~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... ........+.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=335.68 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=201.8
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.+||.|.||.||-|. .++|...|+|.++.............+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999998 677999999988765554455677889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+.++ .+...++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|.+|||.|........
T Consensus 1320 sLa~ll~-----~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE-----HGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHH-----hcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999994 445567777778889999999999999 999999999999999999999999999987665532
Q ss_pred --CCCCCCCcccCccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASH--QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~--~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....||+.|||||++.+.. ...-+.||||+|||++||+||+.||..... +-.++--|.....+. .++....+-.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~~gh~Pq-~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVAAGHKPQ-IPERLSSEGR 1471 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHhccCCCC-CchhhhHhHH
Confidence 2346999999999998543 234578999999999999999999976432 223444444333332 3444666788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++.+|++.||++|.++.|+++
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHH
Confidence 9999999999999988876654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.78 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=196.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+.||+|+||+||+|.. .++..||+|.+............+.+|+.+++.++|+||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45799999999999985 4688999999875433333455677899999999999999999988654 34799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 90 LMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred CCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 996 68999884 235689999999999999999999998 99999999999999999999999999998654331
Q ss_pred --CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh----------------------hHH
Q 006031 543 --QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN----------------------EMM 598 (664)
Q Consensus 543 --~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~----------------------~~~ 598 (664)
.....++..|+|||.+.....++.++|||||||++|||++|+.||........ ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 12235678899999876445688999999999999999999999865321100 000
Q ss_pred HHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhccc
Q 006031 599 NWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGAV 650 (664)
Q Consensus 599 ~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~~ 650 (664)
.++........ ........+.+++.+||+.+|++|||++|+++. ++.++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 11111000000 011234568899999999999999999999987 77665544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=287.50 Aligned_cols=247 Identities=22% Similarity=0.347 Sum_probs=201.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... ++..|++|++..........+.+.+|++++++++|+|++++.+.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 357999999999999964 5889999999765544445677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++... .....+++.....++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 85 ~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 162 (258)
T cd08215 85 DLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162 (258)
T ss_pred cHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcceecc
Confidence 9999996432 1246799999999999999999999999 99999999999999999999999999987654432 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||... ...++.++||||+|+++|+|++|+.||.... ..++........ ....+......+.+++.+|
T Consensus 163 ~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 163 VVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ-YPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred eeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHH
Confidence 45778899999876 5668899999999999999999999986532 222222221111 1112223456689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|..+|++|||+.|+++
T Consensus 239 l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 239 LQKDPEERPSIAQILQ 254 (258)
T ss_pred cCCChhhCcCHHHHhc
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.17 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=195.8
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|++|.||+|.. .+++.+++|++............+.+|++++++++|+||+++++++...+..++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 5699999999999986 4688999999876554334467788999999999999999999999999999999999975 8
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~ 546 (664)
|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+....... ....
T Consensus 84 l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 84 LYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred HHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 8888853 225789999999999999999999998 99999999999999999999999999987665432 1223
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED------------------- 607 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~------------------- 607 (664)
.++..|+|||.+.....++.++||||||+++|||+||+.||..... ...+..........
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4677899999987444789999999999999999999999865321 11111111110000
Q ss_pred ---C-----CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 ---D-----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 ---~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .........+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.90 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=200.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e 462 (664)
.+.||+|+||.||+|... .+..||+|++..........+.+.+|+++++.++|+||+++.+++...+ ..++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999965 4889999998754432345577899999999999999999999988765 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|++ ++|.++++. ...+++..+..++.+++.||+|||+. +|+||||||+||+++.++.++++|||++.......
T Consensus 85 ~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 85 LME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred chh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 998 489998852 33799999999999999999999998 99999999999999999999999999998765432
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-------------
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA------------- 604 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~------------- 604 (664)
.....++..|+|||.+.+...++.++||||||+++|||++|+.||..... .+....+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCChhHhhhcc
Confidence 22345678899999987444789999999999999999999999975421 1111111100
Q ss_pred -----------ccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhccc
Q 006031 605 -----------REDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGAV 650 (664)
Q Consensus 605 -----------~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~~ 650 (664)
..... ........+.+++.+||+.+|++||++.++++. ++.++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 00000 001124568899999999999999999999985 77776653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=295.07 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=195.6
Q ss_pred hccccccCceeEEEEEE----cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+++. .++..||||.++..... ....+.+.+|++++.++ +||||+++++.+...+..++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999984 35688999998643321 12345688999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++.. ...+++.....++.|+++||+|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 85 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 85 DYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred ecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999852 34688999999999999999999998 9999999999999999999999999998764433
Q ss_pred CC---CCCCCCCcccCccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHH
Q 006031 542 LQ---DDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 542 ~~---~~~~~~~~y~aPE~~~~~~-~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
.. ....++..|+|||...... ..+.++||||||+++|||+||+.||...... ..++.+.+... ....+....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 21 1234788999999876322 2688999999999999999999998642211 11222221111 112223344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 5688999999999999999999888777553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.20 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEE----cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||++.. .+|..||+|++...... ....+.+.+|++++.++ +|+||+++++++..+...++|+
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999985 36889999998653321 12346788999999999 5999999999999988999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 85 DYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999953 34688899999999999999999998 9999999999999999999999999998765432
Q ss_pred CC---CCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHH
Q 006031 542 LQ---DDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 542 ~~---~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
.. ....++..|+|||.+... ..++.++||||||+++|||++|+.||...... ..++.+.+.... ...+....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCccCC
Confidence 21 123478899999987632 24678999999999999999999998642211 112222221111 11223344
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
..+.+++.+||+.+|++|| ++.++..
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 5688999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.96 Aligned_cols=243 Identities=20% Similarity=0.278 Sum_probs=191.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcc---ccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASK---LAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 462 (664)
.+.||+|+||.||+|.. .++..||+|.+.... ........+.+|++++++++|+||+++++++.+. +..++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46899999999999985 458899999875321 1123346788999999999999999999998764 35789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 87 ~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 87 YMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred eCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999952 24588999999999999999999998 99999999999999999999999999997543211
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
.....++..|+|||++. ...++.++|||||||++||+++|+.||.... ....+.+... .......+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~p~~~~~~ 237 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYE-AMAAIFKIAT-QPTKPMLPDGVSDA 237 (264)
T ss_pred ccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccC-HHHHHHHHHc-CCCCCCCCcccCHH
Confidence 11234788899999987 4567899999999999999999999987531 1122222221 11112234445567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++.+||+ +|..||+..+++.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.38 Aligned_cols=243 Identities=17% Similarity=0.219 Sum_probs=188.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .++..||+|.+..........+.+.+|++++++++|+||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46799999999999985 4688999999865433223445677899999999999999999988643 3579999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+. ++|.+.+.. .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 101 ELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred eccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 9996 588888841 288889999999999999999998 9999999999999999999999999999876443
Q ss_pred CC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH--------------------
Q 006031 542 LQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW-------------------- 600 (664)
Q Consensus 542 ~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~-------------------- 600 (664)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 22 2345788899999986 567899999999999999999999998653210 000000
Q ss_pred --HHhhccCC------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 601 --VRSAREDD------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 601 --~~~~~~~~------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
........ .........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0011234567899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.36 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=189.8
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCC---CCCCcccceEEEecCCc-----eEE
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVPLRAYFQAKEE-----RLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~-----~~l 459 (664)
.+.||+|+||.||+|..+. +..||+|+++...........+.+|+.+++++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3679999999999999764 88999999975433222334566677666544 69999999999988776 899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
+|||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+....
T Consensus 84 ~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 84 VFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred Eehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999974 899988632 223589999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC----------
Q 006031 540 DSLQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---------- 608 (664)
Q Consensus 540 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------- 608 (664)
.... ....++..|+|||++. ...++.++|||||||++|||++|++||.... ....+..+........
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCCCccc
Confidence 3322 2334678899999987 5668899999999999999999999987532 1122222221111000
Q ss_pred ----------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ----------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ----------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+||+.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 01223456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=301.41 Aligned_cols=251 Identities=18% Similarity=0.285 Sum_probs=196.4
Q ss_pred CHHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceE
Q 006031 380 TLDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 380 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~ 458 (664)
++..-++...++||+||.+.||++...+.+.+|+|++...........-|..|+..|.+++ |.+||++++|-..++..|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3344445566789999999999999988889999988766665566788999999999995 899999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
|||||= ..||..+|.... .....| .+..+..|++.|+.++|++ ||||.||||.|+|+- +|.+||.|||+|.-.
T Consensus 437 mvmE~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999976 459999997422 223445 6788999999999999999 999999999999996 468999999999877
Q ss_pred cCCCC----CCCCCCCcccCccccccC----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh
Q 006031 539 ADSLQ----DDDPDNLLYKAPETRNAS----------HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 539 ~~~~~----~~~~~~~~y~aPE~~~~~----------~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 604 (664)
..+.. ...+||+-||+||.+... -+.+.++||||+||+||+|+.|++||.... ....-....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~aKl~aI 585 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQIAKLHAI 585 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHHHHHHhh
Confidence 65533 356799999999987521 125678999999999999999999997521 111111111
Q ss_pred ccCC---Cch-hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 605 REDD---GAE-DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 605 ~~~~---~~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+. +.+ .....++.++|+.|++.||++|||..|+++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111 111 111223899999999999999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=290.59 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=207.1
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 461 (664)
..++-+|.||.||.|.|. +.+.|.+|.++.... ......+..|--.+..+.|||+..+.+.+.+. +..+++|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 346889999999999654 455677887764432 23456788888889999999999999998654 4678999
Q ss_pred ecCCCCCHHHHhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSK---STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
.++.-|+|..+|..++ ......++-.+...++.|++.||+|||.. +|||.||.++|.++|+..++|++|=.+++..
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhcccc
Confidence 9999999999998443 23345678888899999999999999999 9999999999999999999999999999865
Q ss_pred cCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhH
Q 006031 539 ADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613 (664)
Q Consensus 539 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (664)
-... .+....+..||+||.+. ...++..+|||||||+||||+| |+.||... ++.++..+.....+-. .+-.
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~ylkdGyRla-QP~N 522 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHYLKDGYRLA-QPFN 522 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHHHhccceec-CCCC
Confidence 4332 22345678899999997 7889999999999999999999 99998764 4556666655443332 2345
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
++.+++.+|.-||+..|++||++++++..|.++...
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 666799999999999999999999999999988654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.47 Aligned_cols=246 Identities=19% Similarity=0.245 Sum_probs=187.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--------ceEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--------ERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--------~~~l 459 (664)
.+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+||+++++++.+.. ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 467999999999999964 5789999998654432333456778999999999999999999875433 4699
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
|+||+.. ++...+.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.++++|||+++...
T Consensus 93 v~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 93 VTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 9999975 78777753 234699999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCC-------------CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc
Q 006031 540 DSLQD-------------DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 540 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
..... ...++..|+|||.+.+...++.++|||||||++|||++|++||...... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~~ 245 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFKLCGT 245 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 32211 1134677999998765566889999999999999999999998753221 111111110000
Q ss_pred C----------------------CC-ch----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 D----------------------DG-AE----DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ~----------------------~~-~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .. .. ......+.+++.+|++.+|++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00 00 111245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.98 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=193.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||+|.. .++..||+|++............+.+|++++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46799999999999995 46889999998654332233456889999999999999999999986543 468999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+.. +|..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 99964 7777652 3588999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH-------------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR------------------- 602 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~------------------- 602 (664)
. ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+.....
T Consensus 171 ~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 M-TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred C-CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2 22356788999999864456889999999999999999999999753211 11111110
Q ss_pred ----hhccCC--Cc---hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhccc
Q 006031 603 ----SAREDD--GA---EDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGAV 650 (664)
Q Consensus 603 ----~~~~~~--~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~~ 650 (664)
...... .. .......+.+++.+||+.+|++||++.|++.. ++.+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000000 00 01123457899999999999999999999955 77776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=315.14 Aligned_cols=251 Identities=16% Similarity=0.192 Sum_probs=179.7
Q ss_pred hccccccCceeEEEEEEcC--CeEEEEEEc--------------cC-ccccCCcHHHHHHHHHHHcCCCCCCcccceEEE
Q 006031 389 AELLGKGSLGTTYKAVLDN--RLIVCVKRL--------------DA-SKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF 451 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l--------------~~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 451 (664)
.+.||+|+||+||++..+. +..+++|.+ .+ ..........+.+|++++++++|||||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 4689999999999987543 222222211 00 011112345688999999999999999999999
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 452 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
...+..|+|+|++. ++|.+++....-.............|+.|++.||+|||+. +||||||||+|||++.++.+||+|
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999985 5788877532211122334566778999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCC---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCh-hhHHHHHHhhcc
Q 006031 532 YCLTALTADSLQ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP-SQHSFLVP-NEMMNWVRSARE 606 (664)
Q Consensus 532 fGla~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P-~~~~~~~~-~~~~~~~~~~~~ 606 (664)
||+++....... ....|+..|+|||++. ...++.++|||||||++|||++|..+ +....... ..+.+.+.....
T Consensus 311 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~ 389 (501)
T PHA03210 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389 (501)
T ss_pred CCCceecCcccccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhccc
Confidence 999987644321 2346899999999987 56789999999999999999998754 43322111 222222221110
Q ss_pred CC----C-------------------ch------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 607 DD----G-------------------AE------DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 607 ~~----~-------------------~~------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. + .. ......+.+++.+|++.||++|||+.|+++.
T Consensus 390 ~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 390 CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0 00 0012346677899999999999999999863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=283.34 Aligned_cols=236 Identities=24% Similarity=0.292 Sum_probs=193.1
Q ss_pred ccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 392 LGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
||+|+||.||++... +++.+|+|.+....... .....+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 48899999987654322 2356788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDDDP 547 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~~~ 547 (664)
.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+...... ......
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 999953 23689999999999999999999998 9999999999999999999999999998765443 223345
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHccc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 627 (664)
++..|+|||... ....+.++|+||||+++||+++|+.||.... .......+.. .....+...+..+.+++.+||.
T Consensus 155 ~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 155 GTPEYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred CCccccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhc
Confidence 788999999886 5567889999999999999999999996532 2233333322 1112222335568999999999
Q ss_pred CCCCCCCCHHH
Q 006031 628 ASPEQRPTMWQ 638 (664)
Q Consensus 628 ~~P~~RPt~~e 638 (664)
.+|++||++++
T Consensus 230 ~~p~~R~~~~~ 240 (250)
T cd05123 230 KDPTKRLGSGG 240 (250)
T ss_pred CCHhhCCCccc
Confidence 99999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.20 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
-++||+||||.||-.+. ..|+.+|.|++.+..... ..+.....|-.++.+++.+.||.+-..|..++..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 36899999999999884 568999999887654422 3456678889999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
|||.-+|... ....+++...+.++.+|+.||++||.. +||.|||||+|||||+.|+++|+|.|+|..+..... ..
T Consensus 270 GDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 270 GDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred CceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 9999999643 345799999999999999999999999 999999999999999999999999999988766543 34
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
.+||.+|||||++. ...|+...|.||+||++|||+.|+.||...... .+++.+.+.. .+...++...++..++..
T Consensus 346 rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred ccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHHHHHH
Confidence 58999999999998 566999999999999999999999999753211 1233332221 222345666677889999
Q ss_pred HcccCCCCCCCCH
Q 006031 624 ACNSASPEQRPTM 636 (664)
Q Consensus 624 ~Cl~~~P~~RPt~ 636 (664)
..+++||++|--.
T Consensus 423 ~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 423 GLLTKDPEKRLGC 435 (591)
T ss_pred HHHccCHHHhccC
Confidence 9999999999743
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=300.24 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=202.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
...||+|.|++|..|+. ..+..||+|.+++..........+.+|+++|..++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 35799999999999984 56889999999988776666677999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-CCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-LQDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~ 546 (664)
.+++++.. ...........++.|+.+|++|||++ .|||||||++||||+.+.++||+|||++..+... ..+..
T Consensus 141 e~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 141 ELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred hhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeeccccccccc
Confidence 99999953 33455577888999999999999999 9999999999999999999999999999877644 34567
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
+|++.|.|||.+.+.....+++|+||+|+++|-|+.|..||++... .++.+.+....-.. +........+++.+.+
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--k~Lr~rvl~gk~rI--p~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--KELRPRVLRGKYRI--PFYMSCDCEDLLRKFL 290 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--ccccchheeeeecc--cceeechhHHHHHHhh
Confidence 8999999999998767778999999999999999999999986422 22222221111111 1112234678999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 006031 627 SASPEQRPTMWQVLKM 642 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~ 642 (664)
..+|.+|+++.++.+.
T Consensus 291 vl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccCccccCCHHHhhhh
Confidence 9999999999998653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.58 Aligned_cols=244 Identities=20% Similarity=0.281 Sum_probs=190.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++.. .+..++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 46799999999999985 478899999886543333345678899999999999999999999865 55789999998 5
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.++++. ..+++.....++.|++.||+|||+. +|+||||+|+||++++++.++++|||.+....... ...
T Consensus 94 ~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~ 165 (328)
T cd07856 94 TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-TGY 165 (328)
T ss_pred cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCCc-CCC
Confidence 689988842 3578888889999999999999998 99999999999999999999999999987543322 234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH-----------------------h
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR-----------------------S 603 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~-----------------------~ 603 (664)
.++..|+|||.+.....++.++|||||||++|||+||+.||...... .....+.. .
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 56788999998764467899999999999999999999998653211 01110000 0
Q ss_pred hccCCCch-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 604 AREDDGAE-----DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 604 ~~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.......+ ......+.+++.+||+.+|++||++.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 1123568999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=285.64 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=194.2
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||.||+|... +++.||+|.+..........+.+..|++++++++|+|++++++++.+.+..++|+||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 56999999999999965 48899999997654333445778899999999999999999999999999999999998 59
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
|.++++.. ...+++..+..++.+++.||+|||+. +|+||||+|+||++++++.++|+|||.+........ ...
T Consensus 84 l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 84 LKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 99999632 14689999999999999999999999 999999999999999999999999999876544321 123
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc--------------------c
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR--------------------E 606 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~--------------------~ 606 (664)
..+..|+|||.+.....++.++|||||||++||+++|+.||..... ...+........ .
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3567899999987444788999999999999999999999865321 111111111000 0
Q ss_pred CC------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 DD------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. .........+.+++.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 000112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.17 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... ++..||+|++...... ....+.+.+|++++.+++ |+||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 357999999999999964 6889999998754331 223467888999999998 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
+++|.+++.. ...+++..+..|+.|++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 86 NGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999953 34699999999999999999999998 999999999999999999999999999876543221
Q ss_pred --------------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHh
Q 006031 544 --------------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 544 --------------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 603 (664)
....++..|+|||... ...++.++||||||+++||+++|+.||.... .......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~- 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKIL- 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHH-
Confidence 1123578899999876 5668899999999999999999999987542 111112111
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTM----WQVLK 641 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~----~ev~~ 641 (664)
......+...+..+.+++.+||+.+|++||++ .|+++
T Consensus 236 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11112233345668999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=282.96 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=190.2
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCc---cccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDAS---KLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||++.... +..+++|.++.. .........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4679999999999998543 344555555432 222233456778899999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-- 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 542 (664)
++++|.++++... .....+++..+..++.|++.||.|||+. +++|+||||+||++++ +.++++|||.+.......
T Consensus 85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~ 161 (260)
T cd08222 85 EGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL 161 (260)
T ss_pred CCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence 9999999986422 2345799999999999999999999998 9999999999999975 569999999987654322
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
.....++..|+|||.+. ...++.++|+||||+++|+|++|+.||... ........... ......+......+.+++
T Consensus 162 ~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 162 ATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NFLSVVLRIVE-GPTPSLPETYSRQLNSIM 237 (260)
T ss_pred ccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHc-CCCCCCcchhcHHHHHHH
Confidence 12334678899999886 566788999999999999999999998642 11122111111 111122334556789999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.+|++||++.|+++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHhcCChhhCcCHHHHhh
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=276.74 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=197.4
Q ss_pred HhccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 461 (664)
....||+|.||.||||.-.+ .+.+|+|+++..+..........+||.+++.++||||+.+..++.+ +...++++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 34679999999999996432 2378999998665433445677899999999999999999998877 67889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC----CCeEEeecccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD----FEACLADYCLTAL 537 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~ 537 (664)
||.+. +|.+.++-.+....+.++......|..||+.|+.|||+. =|+||||||.|||+..+ |.+||+|||++++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 99987 999999755555567899999999999999999999998 79999999999999877 9999999999998
Q ss_pred ccCCCCC-----CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----h---hhHHHHHHhh
Q 006031 538 TADSLQD-----DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-----P---NEMMNWVRSA 604 (664)
Q Consensus 538 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-----~---~~~~~~~~~~ 604 (664)
..+.... ..+-|++|+|||.+.+.+.||.+.||||.||++.||+|-++-|...... + ..+.+.....
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 8765432 2345889999999998999999999999999999999988877643210 0 0111111111
Q ss_pred ccCCC-------------------------c--h-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 605 REDDG-------------------------A--E-------DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 605 ~~~~~-------------------------~--~-------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+.+ . . .......++++.++++.||.+|.|+++.++.
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11100 0 0 0011236889999999999999999998764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.08 Aligned_cols=245 Identities=22% Similarity=0.253 Sum_probs=185.9
Q ss_pred hccccccCceeEEEEEEc-C--CeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC----CceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-N--RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK----EERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~----~~~~lV 460 (664)
.+.||+|+||.||++... . +..||+|++..........+.+.+|++++.++ .||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999964 3 67899999864332223356778899999999 599999999875432 457888
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+||+. ++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 85 EELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred Eeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 89886 69999984 235689999999999999999999998 999999999999999999999999999975433
Q ss_pred CCC------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-------------
Q 006031 541 SLQ------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV------------- 601 (664)
Q Consensus 541 ~~~------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~------------- 601 (664)
... ....++..|+|||.+.+...++.++|||||||++||+++|++||...... ..+...+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 211 12357889999998764456889999999999999999999998753210 0000000
Q ss_pred ----------HhhccCC-C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 602 ----------RSAREDD-G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 602 ----------~~~~~~~-~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....... . ........+.+++.+|++.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0 00112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.28 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=201.1
Q ss_pred CHHHHHHHHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCce
Q 006031 380 TLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEER 457 (664)
Q Consensus 380 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 457 (664)
+++|+.+-+.++||+|+|+.|--+. +.+|.++|||++.+. .........+|++++..+ .|+||+.+++||.+++..
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4678888889999999999999887 788999999999765 345667788999999988 499999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeeccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCL 534 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGl 534 (664)
|||||-|.||.|..+++ ..+.+++.+..++..+||.||.|||.+ +|.||||||+|||..+.. -+|||||.+
T Consensus 152 YLVfEKm~GGplLshI~-----~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQ-----KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHH-----HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999996 346789999999999999999999999 999999999999996553 479999987
Q ss_pred cccc--cCCCC-------CCCCCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----hhh
Q 006031 535 TALT--ADSLQ-------DDDPDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-----PNE 596 (664)
Q Consensus 535 a~~~--~~~~~-------~~~~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-----~~~ 596 (664)
..-. ..... ...+|+..|||||+.. ....|+.++|.||+|||+|-|+.|.+||.+.... .++
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 6422 11111 1235777899999653 2456889999999999999999999999765331 112
Q ss_pred --------HHHHHHhhccCCC--chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 597 --------MMNWVRSAREDDG--AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 597 --------~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+-+.++...-+.+ .+.....+..+++...+..++.+|-++.++++
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1122222211111 12334556788888999999999999998886
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=294.68 Aligned_cols=243 Identities=20% Similarity=0.254 Sum_probs=190.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc------eEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE------RLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~lV~ 461 (664)
.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++|+||+++.+++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 467999999999999964 57899999986543222334567789999999999999999998766554 89999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 998 6699999852 4689999999999999999999998 9999999999999999999999999999765443
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc---------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE--------------- 606 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~--------------- 606 (664)
. ....++..|+|||.+.....++.++|||||||++||++||+.||..... ...+.........
T Consensus 172 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 M-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred c-cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 2 2345678899999876445678999999999999999999999975321 1111111110000
Q ss_pred --------CC--Cc---hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 --------DD--GA---EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 --------~~--~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.. .. .......+.+++.+|++.+|++|||+.||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 00 0112456889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=294.12 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 35799999999999984 56889999998643322223456889999999999999999999987543 358999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++++|||++......
T Consensus 100 e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 100 PFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 999 779998884 24589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-----------C---
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-----------D--- 607 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-----------~--- 607 (664)
. ....++..|+|||.+.....++.++|||||||++|++++|+.||..... ............. .
T Consensus 172 ~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 172 M-TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred c-cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 2 2345678899999886445688999999999999999999999875321 1111111110000 0
Q ss_pred ---------C--C---chhHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHHHhhhc
Q 006031 608 ---------D--G---AEDERLGMLLEVAIACNSASPEQRPTMWQVL--KMLQEIKG 648 (664)
Q Consensus 608 ---------~--~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~--~~L~~i~~ 648 (664)
. . ........+.+++.+|++.+|++|||+.+++ ..++..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 0 0012234578999999999999999999998 34455433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.54 Aligned_cols=244 Identities=20% Similarity=0.251 Sum_probs=188.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .++..||+|+++.........+.+.+|++++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 35799999999999984 5788999999875433223356678899999999999999999988543 3467888
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
+++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 102 ~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 102 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred hhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 876 7899888842 3589999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED-------------- 607 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~-------------- 607 (664)
. ....++..|+|||.+.+...++.++|||||||++|||++|+.||..... ...+..........
T Consensus 174 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 174 M-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred c-cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 2 2345788899999876445678899999999999999999999864321 11111111100000
Q ss_pred ---------CC-c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 608 ---------DG-A----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 608 ---------~~-~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. . .......+.+++.+|++.+|++||++.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0 00123457899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.70 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=185.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-------------
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------------- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------------- 454 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 46799999999999985 4588999999865443 4456788999999999999999999876543
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeec
Q 006031 455 -EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADY 532 (664)
Q Consensus 455 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~Df 532 (664)
...++|+||++ ++|.+++.. ..+++.....++.|++.||.|||+. +|+||||||+||+++. ++.+|++||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 599888842 3588999999999999999999998 9999999999999974 567899999
Q ss_pred cccccccCCCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh---
Q 006031 533 CLTALTADSLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA--- 604 (664)
Q Consensus 533 Gla~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~--- 604 (664)
|.+........ ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ..........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 238 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILESVPVV 238 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence 99876533211 12346788999998764566788999999999999999999999653211 1111111100
Q ss_pred --------------------ccCCCc----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 605 --------------------REDDGA----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 605 --------------------~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...... .......+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0112355789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.18 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=181.9
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--------------
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-------------- 454 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------------- 454 (664)
++||+||||.|||++. -||+.+|||++.... .........+|++.+++|+|||||+++..|.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 5799999999999994 489999999997654 445567788999999999999999988765110
Q ss_pred --------------------------------------------------------------------------------
Q 006031 455 -------------------------------------------------------------------------------- 454 (664)
Q Consensus 455 -------------------------------------------------------------------------------- 454 (664)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------CceEEEEecCCCCCHHHHhccCCCCCCCCC-CHHHHHHHHHHHHHHHHHHHhcCC
Q 006031 455 -------------------------EERLLIYDYQPNGSLFSLIHGSKSTRAKPL-HWTSCLKIAEDVAQGLSYIHQAWR 508 (664)
Q Consensus 455 -------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~~ia~~L~yLH~~~~ 508 (664)
...||=||||+...+.++++... .. .-...++++++|+.||+|+|++ +
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGLaYIH~~-g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGLAYIHDQ-G 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHHHHHHhC-c
Confidence 01357788888877777775321 11 3456678999999999999999 9
Q ss_pred cccCCCCCCCeEeCCCCCeEEeecccccccc----C----------------CCCCCCCCCCcccCccccccCC--CCCc
Q 006031 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTA----D----------------SLQDDDPDNLLYKAPETRNASH--QATS 566 (664)
Q Consensus 509 ivHrDlk~~NILl~~~~~~ki~DfGla~~~~----~----------------~~~~~~~~~~~y~aPE~~~~~~--~~~~ 566 (664)
||||||||.||+||++..+||+|||++.... . ...+...||.-|+|||.+.... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 0 0112346889999999987655 6999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 567 KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 567 ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
|+|+||+|||++||+. ||... .+...+..-.+....+.+ ........-.+++.++++.||.+|||+.|+++
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts-MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS-MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch-HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999995 45432 111222222232222222 23344445678999999999999999999975
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.14 Aligned_cols=199 Identities=27% Similarity=0.363 Sum_probs=169.7
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||+|+ -..|+.||||.++.... ....+.-.+|+++|++++|+|||++++.-.+.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3569999999999999 56799999999976442 345677889999999999999999999755433 568999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe--CCCCC--eEEeecccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL--GPDFE--ACLADYCLTAL 537 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl--~~~~~--~ki~DfGla~~ 537 (664)
|||.+|||+..|... .....|+....+.+..+++.||.|||+. +||||||||.||++ +++|+ -||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999754 3456799999999999999999999988 99999999999998 34444 59999999998
Q ss_pred ccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 006031 538 TADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSF 591 (664)
Q Consensus 538 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~ 591 (664)
..+.. .....||..|.+||.+...+.++..+|.|||||++||..||..||-...
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 76653 3456799999999998755788999999999999999999999997543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=274.84 Aligned_cols=221 Identities=20% Similarity=0.215 Sum_probs=175.1
Q ss_pred cCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCHHHHh
Q 006031 395 GSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI 473 (664)
Q Consensus 395 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 473 (664)
|.||.||++.. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999985 568899999986532 2334455555667999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCCCCCccc
Q 006031 474 HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK 553 (664)
Q Consensus 474 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~ 553 (664)
.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 77 ~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~y~ 149 (237)
T cd05576 77 SK-----FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-DGEAVENMYC 149 (237)
T ss_pred HH-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-ccCCcCcccc
Confidence 53 23589999999999999999999998 99999999999999999999999999876654432 2234567799
Q ss_pred CccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCC
Q 006031 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQR 633 (664)
Q Consensus 554 aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 633 (664)
|||... ...++.++||||+|+++|||++|+.|+..... .... ......+......+.+++.+|++.||++|
T Consensus 150 aPE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 150 APEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPS---GINT-----HTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred CCcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCch---hccc-----ccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 999886 56678999999999999999999988653211 0000 00001122334568899999999999999
Q ss_pred CCHHH
Q 006031 634 PTMWQ 638 (664)
Q Consensus 634 Pt~~e 638 (664)
|++.+
T Consensus 221 ~~~~~ 225 (237)
T cd05576 221 LGAGV 225 (237)
T ss_pred cCCCc
Confidence 99743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=309.25 Aligned_cols=142 Identities=21% Similarity=0.343 Sum_probs=125.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||+|+++...... .....+.+|+.++..++|+||+++++++...+..++||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999965 68899999987543311 2236788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
++|.++++. ...+++...+.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999953 34588899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=253.01 Aligned_cols=230 Identities=21% Similarity=0.287 Sum_probs=180.4
Q ss_pred CCceeEecCCccccCHHHHHHHHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHH-cCCCCCC
Q 006031 366 SGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESV-GGLRHPN 443 (664)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l-~~l~H~n 443 (664)
++.+.....+.....-+++ ...+.||+|++|.|-+-+ ..+|+..|+|++...- ..+..+....|+.+. +....|.
T Consensus 30 ~~a~i~I~~~~~eV~ad~L--~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf 106 (282)
T KOG0984|consen 30 SRALIYIGDRNFEVPADDL--VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPF 106 (282)
T ss_pred CCceEEEecCccccchhhh--hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCe
Confidence 3444444444433333444 345679999999999887 4679999999997543 234556667777765 4457999
Q ss_pred cccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 444 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
+|.++|.+......++.||.|+- ||..+-+..- .....+++...-+|+..|.+||.|||++..++|||+||+|||++.
T Consensus 107 ~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 107 TVHFYGALFREGDVWICMELMDT-SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY 184 (282)
T ss_pred EEEeehhhhccccEEEeHHHhhh-hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc
Confidence 99999999999999999999965 7776654321 345678888999999999999999999889999999999999999
Q ss_pred CCCeEEeeccccccccCCCCCC-CCCCCcccCcccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH
Q 006031 524 DFEACLADYCLTALTADSLQDD-DPDNLLYKAPETRNA---SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~~~~-~~~~~~y~aPE~~~~---~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~ 599 (664)
+|++||||||++..+.++.... ..|...|||||.+.. ...|+.|+||||+|+++.||.+++.||+..+..-+.+.+
T Consensus 185 ~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 185 DGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred CCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 9999999999999988876554 678889999998763 236889999999999999999999999875433333333
Q ss_pred H
Q 006031 600 W 600 (664)
Q Consensus 600 ~ 600 (664)
.
T Consensus 265 v 265 (282)
T KOG0984|consen 265 V 265 (282)
T ss_pred H
Confidence 3
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=263.67 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=190.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--------CceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--------EERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~~~~l 459 (664)
..+||+|.||.||+|+. +.++.||+|+.-.......--....+|++++..++|+|++.++..|... ...|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 46799999999999995 4577788887643332223345567899999999999999999988542 24799
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||++++. +|..+|. .....++..++.++..++..||.|+|.. .|+|||+||.|+|++.++.+|++|||+++.+.
T Consensus 102 Vf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 9999987 9999984 2346788999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCCCCCC------CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----
Q 006031 540 DSLQDDDP------DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----- 608 (664)
Q Consensus 540 ~~~~~~~~------~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 608 (664)
.......+ -|.+|++||.+.+.+.++++.|||+-||+|.||.||.+-+++.. +......+.......
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccCCcccC
Confidence 44333233 38999999999999999999999999999999999998876531 122222221111100
Q ss_pred -----------------C-----chhHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 -----------------G-----AEDERL------GMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 -----------------~-----~~~~~~------~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. ...+.. ....+++.+.+..||.+|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 011111 257789999999999999999998754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=267.34 Aligned_cols=237 Identities=26% Similarity=0.341 Sum_probs=193.6
Q ss_pred CceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCHHHHhc
Q 006031 396 SLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIH 474 (664)
Q Consensus 396 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 474 (664)
+||.||+|...+ +..+++|++....... ..+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999764 8899999987554321 16789999999999999999999999999999999999999999999995
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-CCCCCCCCCccc
Q 006031 475 GSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-LQDDDPDNLLYK 553 (664)
Q Consensus 475 ~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~~~~~~y~ 553 (664)
.. ..+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+...... ......++..|+
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 32 2389999999999999999999998 9999999999999999999999999999876554 223455778899
Q ss_pred CccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhH-HHHHHHHHHHHcccCCCCC
Q 006031 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDE-RLGMLLEVAIACNSASPEQ 632 (664)
Q Consensus 554 aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~P~~ 632 (664)
+||... ...++.++||||||+++||+++|+.||.... ....+.+.............. ....+.+++.+|+..+|++
T Consensus 154 ~pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 154 APEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 999886 5677889999999999999999999986531 223333333322222111111 4567899999999999999
Q ss_pred CCCHHHHHH
Q 006031 633 RPTMWQVLK 641 (664)
Q Consensus 633 RPt~~ev~~ 641 (664)
||++.++++
T Consensus 232 Rp~~~~~~~ 240 (244)
T smart00220 232 RLTAEEALQ 240 (244)
T ss_pred ccCHHHHhh
Confidence 999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=283.70 Aligned_cols=241 Identities=20% Similarity=0.305 Sum_probs=201.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||.|.||+||-|.+ ++|+.||||++.+.+.....+..+++|+.++++++||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 68999999999999985 67999999999999888888899999999999999999999999999999999999999 45
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~~-~ 543 (664)
+..+.+-. .....|+......++.||+.||.|||.+ +|+|+||||+|||+.+. -++|+||||+|++..+.. .
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 76666643 3456799988899999999999999999 99999999999999643 579999999999987754 3
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh--ccCCCchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA--REDDGAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l 621 (664)
....||+.|.|||++. .+-|...-|+||.||++|--++|..||... +++.+-++.. .-+...+.+......++
T Consensus 724 rsVVGTPAYLaPEVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhcCCccccCHHHHh-hccccccccceeeeEEEEEEecccccCCCc----cchhHHhhccccccCCCchhhcCHHHHHH
Confidence 4567999999999997 677888899999999999999999998653 3333322211 11223456666778889
Q ss_pred HHHcccCCCCCCCCHHHH
Q 006031 622 AIACNSASPEQRPTMWQV 639 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev 639 (664)
|...++..=.+|.+..+.
T Consensus 799 In~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKS 816 (888)
T ss_pred HHHHHHHHHHHhcchHhh
Confidence 999998888888887654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=263.03 Aligned_cols=242 Identities=20% Similarity=0.272 Sum_probs=192.2
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHH-cCCCCCCcccceEEEec----CCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESV-GGLRHPNLVPLRAYFQA----KEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~ 461 (664)
+.++||-|-.|.|..+.. ..++..|+|++... ...++|+++- ..-.|||||.++++|.+ ....++||
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 458899999999999885 46888999998533 3456666652 33369999999998753 45678999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~ 538 (664)
|+|+||.|+..++. .....+++.+.-.|..||..|+.|||+. +|.||||||+|+|... |-.+|++|||+|+..
T Consensus 139 E~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 99999999999965 3456799999999999999999999999 9999999999999964 566899999999976
Q ss_pred cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCC--CchhH
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDD--GAEDE 613 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~--~~~~~ 613 (664)
... .-...+-|+.|.|||++. ..+|+...|+||+||+||-|+.|.+||...... ...+...++...-.. +.+.+
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred CCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 532 223456789999999985 677999999999999999999999999764332 123333333332222 24556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.++...++++..+..+|++|-|+.|+..
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 6778899999999999999999999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=264.68 Aligned_cols=250 Identities=18% Similarity=0.254 Sum_probs=196.2
Q ss_pred cCHHHHHHHHhccccccCceeEEEEEE-cCCeEEEEEEccCccccCC-cHHHHHHHHHHHcCCCCCCcccceEEEecCCc
Q 006031 379 YTLDQLMRASAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE 456 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 456 (664)
.+.++..+ .++||+|.||+|-.++. ..++.+|+|++++.-.... +...-..|-++++..+||.+..+.-.|+..+.
T Consensus 165 vTm~dFdf--LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDFDF--LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchhhH--HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 44454432 46899999999999984 4689999999986544222 22344577889999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.+.||||..||.|+-+|. +...+++.....+..+|..||.|||+. +||.||||.+|.|+|.||++||.|||+++
T Consensus 243 lCFVMeyanGGeLf~HLs-----rer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLS-----RERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEEccCceEeeehh-----hhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccch
Confidence 999999999999999994 456788888888999999999999998 99999999999999999999999999998
Q ss_pred ccc--CCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 537 LTA--DSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 537 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
..- .......+||+.|.|||++. ...|....|.|.+|||||||+.|+.||.... .+.+-..+... +...+...
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl~e--d~kFPr~l 391 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELILME--DLKFPRTL 391 (516)
T ss_pred hcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHHhh--hccCCccC
Confidence 532 23344678999999999997 7889999999999999999999999997532 22222222111 11122222
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
..+...++...+.+||.+|- .++||.+
T Consensus 392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 33467788888999999995 4555543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=288.84 Aligned_cols=242 Identities=22% Similarity=0.373 Sum_probs=199.6
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEec-----CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQA-----KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~-----~~~~~lV~ 461 (664)
.++||+|.+|.||++. .++++.+|+|++.... ...++.+.|.++++.. .|||++.++|++.. +++++|||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 4789999999999998 6778899999986543 3567778888888777 69999999999853 56899999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
|||.+|+..+++.+.. ...+.|..+..|++++++|+.+||.. .++|||||-.|||+++++.+|++|||.+......
T Consensus 101 EfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999997543 67899999999999999999999998 9999999999999999999999999999876554
Q ss_pred C--CCCCCCCCcccCccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC---chh
Q 006031 542 L--QDDDPDNLLYKAPETRNAS----HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG---AED 612 (664)
Q Consensus 542 ~--~~~~~~~~~y~aPE~~~~~----~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~ 612 (664)
. .....||+.|||||++... ..|+.++|+||+|++..||-.|.+|+.+... ........+.+.. .+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhccCCCCCCccccchh
Confidence 3 3356799999999998643 3356789999999999999999999876422 1122222222221 356
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....++.+++..|+.+|.++||++.++++
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 67788999999999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=238.86 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=196.0
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||+|.||+||||+ .+.+..||+|++......+.......+|+-+++.++|+|||++++....+...-+|+||+..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 4689999999999999 56688999999976665555567788999999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|..+... -.+.++...+..++.|+++||.|+|++ ++.|||+||.|.|++.+|+.|++|||+++-..-.. ...
T Consensus 86 dlkkyfds----lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 86 DLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 88888753 345688899999999999999999999 99999999999999999999999999998765433 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCC---------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDG--------------- 609 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~--------------- 609 (664)
..-|.+|++|.++.+.+-|++..|+||-||++.|+.. |++-|.+.. ...++.+..+......+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 4568999999999877889999999999999999987 777676543 23344443333222110
Q ss_pred -------chhHH----HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 -------AEDER----LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 -------~~~~~----~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..... ...=.+++++.+.-+|..|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00111 112356777788888999999988764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=269.45 Aligned_cols=235 Identities=21% Similarity=0.284 Sum_probs=189.4
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCC-cHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGT-SNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+||+|+||.|-+|..++ ...+|||++++.-.... ..+--+.|-++|+-. +-|.++++..+|+.-+.+|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 3689999999999998654 56789999987644222 223233455556554 67899999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc--cCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~~ 543 (664)
||+|..+++ ..+.+.+..+..+|.+||-||-|||++ +|+.||||..|||||.+|++||+|||+++.. .....
T Consensus 434 GGDLMyhiQ-----Q~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 434 GGDLMYHIQ-----QVGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred CchhhhHHH-----HhcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 999999995 345677888899999999999999999 9999999999999999999999999999853 33344
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...+||+-|+|||.+. ...|+..+|.|||||+||||+.|++||++. ++.++-+.+..... ..+.....+...+..
T Consensus 508 kTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~ehnv--syPKslSkEAv~ick 582 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEHNV--SYPKSLSKEAVAICK 582 (683)
T ss_pred eeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHccC--cCcccccHHHHHHHH
Confidence 5678999999999997 788999999999999999999999999874 33444443332222 244455666788888
Q ss_pred HcccCCCCCCC
Q 006031 624 ACNSASPEQRP 634 (664)
Q Consensus 624 ~Cl~~~P~~RP 634 (664)
.-+.+.|.+|-
T Consensus 583 g~ltK~P~kRL 593 (683)
T KOG0696|consen 583 GLLTKHPGKRL 593 (683)
T ss_pred HHhhcCCcccc
Confidence 89999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=272.32 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=193.1
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCC-----cHHHHHHHHHHHcCCCCCCcccceEEEe-cCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGT-----SNEMYEQHMESVGGLRHPNLVPLRAYFQ-AKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 461 (664)
.++||+|||+.||||. +...+.||||+-...+.... -.+...+|.++-+.|.||.||++|+|+. +.+..+-|.
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 4789999999999998 66788999997543221111 1245678889999999999999999986 456788999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCeEeC---CCCCeEEeecccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-WRLVHGNLKSSNVLLG---PDFEACLADYCLTAL 537 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~ 537 (664)
||++|.+|.-+|. ..+.+++.....|+.||+.||.||.+. ++|||-||||.||||. ..|.+||.|||++++
T Consensus 548 EYceGNDLDFYLK-----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 548 EYCEGNDLDFYLK-----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eecCCCchhHHHH-----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999999994 446789999999999999999999984 6899999999999994 458899999999999
Q ss_pred ccCCCC---------CCCCCCCcccCccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc
Q 006031 538 TADSLQ---------DDDPDNLLYKAPETRNAS---HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605 (664)
Q Consensus 538 ~~~~~~---------~~~~~~~~y~aPE~~~~~---~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 605 (664)
+.++.. ....||.+|++||.+.-+ .+.+.|+||||.||++|..+.|+.||.... ...++.+.-....
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-sQQdILqeNTIlk 701 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-SQQDILQENTILK 701 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-hHHHHHhhhchhc
Confidence 876532 245689999999987633 356889999999999999999999998642 2233333221111
Q ss_pred cCC---CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 EDD---GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 ~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+ +.......+...+|.+|++..-++|....++..
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 122233455789999999999999988777653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=283.15 Aligned_cols=232 Identities=21% Similarity=0.245 Sum_probs=185.9
Q ss_pred ccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+|.|+|+.|-++. ..+++..++|++..... +-.+|+.++... .||||+++.+.+.+..+.++|||++.++
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 459999999999987 45678899999976522 223445444444 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe-CCCCCeEEeeccccccccCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL-GPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl-~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
-+.+.+.. ..... ..+..|+.+++.|+.|||++ +||||||||+|||+ ++.++++|+|||.++...... ...
T Consensus 402 ell~ri~~-----~~~~~-~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-~tp 473 (612)
T KOG0603|consen 402 ELLRRIRS-----KPEFC-SEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-DTP 473 (612)
T ss_pred HHHHHHHh-----cchhH-HHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchhh-ccc
Confidence 88888852 22233 67778999999999999998 99999999999999 699999999999999877662 223
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
+-|..|.|||+.. ...+++++|+||||++||||++|+.||..... ..++...+.... ..+..+....+++..|+
T Consensus 474 ~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 474 ALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-GIEIHTRIQMPK----FSECVSDEAKDLLQQLL 547 (612)
T ss_pred chhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCc-hHHHHHhhcCCc----cccccCHHHHHHHHHhc
Confidence 5678899999987 77899999999999999999999999976422 223333332222 12455566899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 006031 627 SASPEQRPTMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~ 641 (664)
+.||.+||+|.++..
T Consensus 548 ~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 548 QVDPALRLGADEIGA 562 (612)
T ss_pred cCChhhCcChhhhcc
Confidence 999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=280.60 Aligned_cols=253 Identities=18% Similarity=0.263 Sum_probs=178.3
Q ss_pred HhccccccCceeEEEEEE-----------------cCCeEEEEEEccCcccc------------CCcHHHHHHHHHHHcC
Q 006031 388 SAELLGKGSLGTTYKAVL-----------------DNRLIVCVKRLDASKLA------------GTSNEMYEQHMESVGG 438 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~------------~~~~~~~~~e~~~l~~ 438 (664)
..++||+|+||+||+|.. .+++.||||++...... ....+.+..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999964 24568999998643210 0112334457777777
Q ss_pred CCCCCc-----ccceEEEec--------CCceEEEEecCCCCCHHHHhccCCC-------------------CCCCCCCH
Q 006031 439 LRHPNL-----VPLRAYFQA--------KEERLLIYDYQPNGSLFSLIHGSKS-------------------TRAKPLHW 486 (664)
Q Consensus 439 l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~ 486 (664)
++|.++ +++++||.. ++..++||||+++|+|.++++.... .....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 876654 678888753 3568999999999999999974321 01234578
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-C--CCCCCCcccCccccccCCC
Q 006031 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-D--DDPDNLLYKAPETRNASHQ 563 (664)
Q Consensus 487 ~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~--~~~~~~~y~aPE~~~~~~~ 563 (664)
..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... . ....++.|+|||.+.....
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 88999999999999999998 999999999999999999999999999976543221 1 1234789999998752111
Q ss_pred ---------------------CCchhhHHHHHHHHHHHHcCCC-CCCCCCCC-------hhhHHHHHHhhccCCC--chh
Q 006031 564 ---------------------ATSKSDVYSFGVLLLELLTGKP-PSQHSFLV-------PNEMMNWVRSAREDDG--AED 612 (664)
Q Consensus 564 ---------------------~~~ksDVwSfGvvl~elltG~~-P~~~~~~~-------~~~~~~~~~~~~~~~~--~~~ 612 (664)
...+.||||+||++|||++|.. |+...... ...+..|........+ ..+
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d 467 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLD 467 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccccc
Confidence 1234799999999999999875 66432111 1123333322221211 223
Q ss_pred HHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASP---EQRPTMWQVLK 641 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P---~~RPt~~ev~~ 641 (664)
.......+++.+++..+| .+|+|++|+++
T Consensus 468 ~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 468 RNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 344567889999999766 68999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=293.07 Aligned_cols=245 Identities=20% Similarity=0.241 Sum_probs=192.1
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..++||+|+||.|...+++ .++.+|.|++++.... ......|..|-++|..-+.+=||.+.-.|++.++.|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 3568999999999999965 5788999999764332 2345679999999998899999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC-CC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-SL-- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-~~-- 542 (664)
||||..++. ....++......++.+|..||.-||+. |+|||||||+|||||..|++|++|||.+..+.. ..
T Consensus 159 GGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 159 GGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred CchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 999999994 334789999999999999999999999 999999999999999999999999999876653 22
Q ss_pred CCCCCCCCcccCcccccc---C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCCchhHHHH
Q 006031 543 QDDDPDNLLYKAPETRNA---S-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~---~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
....+|||-|++||++.. + +.|+..+|.||+||++|||+.|..||......+ ..++.......-+ .....+.
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~VSe 310 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETDVSE 310 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccccCH
Confidence 235679999999998752 2 678899999999999999999999986421111 1122211111111 1123456
Q ss_pred HHHHHHHHcccCCCCCCCC---HHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPT---MWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt---~~ev~~ 641 (664)
+..++|.+.+ -+|+.|-. +.|+-.
T Consensus 311 eakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 311 EAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 6778887765 46788876 666643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=286.67 Aligned_cols=247 Identities=18% Similarity=0.208 Sum_probs=161.9
Q ss_pred hccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEE------EecCCce
Q 006031 389 AELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY------FQAKEER 457 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~------~~~~~~~ 457 (664)
.+.||+|+||.||+|...+ +..||+|++..... .+....+ .+....+.++..+... +...++.
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 4789999999999999654 68999998754221 1212111 1222223333332221 2456689
Q ss_pred EEEEecCCCCCHHHHhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC
Q 006031 458 LLIYDYQPNGSLFSLIHGSKST---------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG 522 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~ 522 (664)
++||||+.+++|.++++..... .........+..|+.|++.||+|||+. +|+||||||+|||++
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl~ 289 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEEe
Confidence 9999999999999998642100 001112334567999999999999998 999999999999998
Q ss_pred C-CCCeEEeeccccccccCCC---CCCCCCCCcccCccccccCC---------------------CCCchhhHHHHHHHH
Q 006031 523 P-DFEACLADYCLTALTADSL---QDDDPDNLLYKAPETRNASH---------------------QATSKSDVYSFGVLL 577 (664)
Q Consensus 523 ~-~~~~ki~DfGla~~~~~~~---~~~~~~~~~y~aPE~~~~~~---------------------~~~~ksDVwSfGvvl 577 (664)
+ ++.+||+|||+++...... .....+++.|+|||.+.... .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 5899999999998654321 23346788999999543211 234567999999999
Q ss_pred HHHHcCCCCCCCCCC--------ChhhHHHHHHhhccCCCc--------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 578 LELLTGKPPSQHSFL--------VPNEMMNWVRSAREDDGA--------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 578 ~elltG~~P~~~~~~--------~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
|||+++..|++.... ...+...|.......... .+.......+|+.+|++.||++|||++|+++
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 999997776543100 001122332211111000 0001123458999999999999999999987
Q ss_pred H
Q 006031 642 M 642 (664)
Q Consensus 642 ~ 642 (664)
.
T Consensus 450 H 450 (566)
T PLN03225 450 H 450 (566)
T ss_pred C
Confidence 4
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=286.48 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=181.7
Q ss_pred HhccccccCce-eEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLG-TTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+++|.|+-| .||+|.+.+ ++||||++-.. ......+|+..++.- .|||||++++.-.++...||..|.|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEG-REVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCC-ceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 35679999998 579999865 49999998532 245677999988776 69999999999889999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-----CCCeEEeeccccccccC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-----DFEACLADYCLTALTAD 540 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-----~~~~ki~DfGla~~~~~ 540 (664)
. +|.+++... ........-.....+..|++.||++||+. +||||||||.||||+. ...++|+|||+++....
T Consensus 587 ~-sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 C-SLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5 999999753 11111111134567889999999999997 9999999999999975 25789999999987765
Q ss_pred CCC-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 541 SLQ-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
... ....||-+|+|||.+. ...-+.++||||+|||+|+.++ |..||++.......+..-......-....+ +
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d-~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPD-C 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHh-ccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCch-H
Confidence 432 2456899999999987 4445678999999999999999 589998643222222221111111111111 1
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..++|.++++++|..||++.+|+.
T Consensus 742 --eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 --EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 6889999999999999999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=269.97 Aligned_cols=237 Identities=17% Similarity=0.193 Sum_probs=196.5
Q ss_pred ccccccCceeEEEEEEcCCe-EEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRL-IVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..||-||||.|-+...+... ..|+|.+++...-. ...+....|-.+|..++.|.||++|-.|.+....|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 35999999999998876554 37889887665433 33466778889999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~ 546 (664)
.|+..|+ ..+.++..+...++..+.+|++|||++ +||.|||||+|.+||.+|-+|+.|||+|+....... ...
T Consensus 506 ElWTiLr-----dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 506 ELWTILR-----DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred hhhhhhh-----hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence 9999995 456788889999999999999999999 999999999999999999999999999998776654 457
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
+||+.|.|||.+. .+-.+..+|.||+|+++|||+||++||.+..+ ......+....+....+....+...+++++..
T Consensus 580 cGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 580 CGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred cCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 8999999999998 56678899999999999999999999987533 22223333333333344455566788999988
Q ss_pred cCCCCCCCC
Q 006031 627 SASPEQRPT 635 (664)
Q Consensus 627 ~~~P~~RPt 635 (664)
..+|.+|--
T Consensus 657 r~~P~ERLG 665 (732)
T KOG0614|consen 657 RDNPTERLG 665 (732)
T ss_pred hcCcHhhhc
Confidence 999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=259.17 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=190.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC--C----CcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH--P----NLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~g~~~~~~~~~lV~ 461 (664)
...+|+|.||.|.+.... .+..||+|+++... .-.+...-|++++.++.+ | -+|.+.+||.-.++.+||+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf 170 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF 170 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence 346999999999999843 47899999997543 235566788999999842 3 2788889999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC------------------
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP------------------ 523 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~------------------ 523 (664)
|.+ |-|+++++.. ....+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 171 ell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 171 ELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred ecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 987 6699999964 3457789999999999999999999999 9999999999999942
Q ss_pred --CCCeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHH
Q 006031 524 --DFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNW 600 (664)
Q Consensus 524 --~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~ 600 (664)
+..+||.|||.|....+.. .....|..|+|||++. +..++.++||||+||||.|+.||..-|+.....+. .+++.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred CCCcceEEEecCCcceeccCc-ceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 3458899999998765544 3456889999999998 67889999999999999999999998875432110 12222
Q ss_pred HHhhc------------------cC-C----------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006031 601 VRSAR------------------ED-D----------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQV 639 (664)
Q Consensus 601 ~~~~~------------------~~-~----------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 639 (664)
+.... .+ + ...+.+...+.+++.+++..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 11100 00 0 0123445679999999999999999999998
Q ss_pred HH
Q 006031 640 LK 641 (664)
Q Consensus 640 ~~ 641 (664)
+.
T Consensus 404 L~ 405 (415)
T KOG0671|consen 404 LS 405 (415)
T ss_pred hc
Confidence 75
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-31 Score=249.96 Aligned_cols=246 Identities=18% Similarity=0.268 Sum_probs=190.1
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+-||.|+||+||..+ -++|+.||.|++......-...+.+.+|++++...+|.|++..++..+-. ++.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4679999999999988 46799999999865433334567788999999999999999988876543 25788999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
.|.. +|..++ .....|+-....-+..||++||.|||+. +|.||||||.|.|++.+...||||||+++.-....
T Consensus 138 LmQS-DLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQS-DLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHh-hhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 9855 888888 4556788888888999999999999999 99999999999999999999999999998654332
Q ss_pred CC---CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------
Q 006031 543 QD---DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------- 608 (664)
Q Consensus 543 ~~---~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------- 608 (664)
.. ...-|.+|+|||.+.+.+.|+...||||.||++.|++..+.-|.... +.+..+.+.......
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 21 22346789999999989999999999999999999999988887532 222222221111111
Q ss_pred -------------C--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 609 -------------G--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 609 -------------~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
+ .....-.+...+..+.+..||.+|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1 1112223356777888999999999988877654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=236.26 Aligned_cols=210 Identities=29% Similarity=0.431 Sum_probs=182.1
Q ss_pred ccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCHH
Q 006031 392 LGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLF 470 (664)
Q Consensus 392 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 470 (664)
||+|.+|.||++...+ +..+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999764 8899999987544311 3578999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccCCC--CCCCC
Q 006031 471 SLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADSL--QDDDP 547 (664)
Q Consensus 471 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~--~~~~~ 547 (664)
+++... ...+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+....... .....
T Consensus 80 ~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 80 DLLKEN----EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 999532 14689999999999999999999999 9999999999999999 8999999999998765543 33345
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHccc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 627 (664)
+...|++||........+.++|+|++|++++++ ..+.+++..|++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 678899999886333778899999999999999 348899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 006031 628 ASPEQRPTMWQVLKM 642 (664)
Q Consensus 628 ~~P~~RPt~~ev~~~ 642 (664)
.+|++||++.++++.
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=261.09 Aligned_cols=208 Identities=22% Similarity=0.337 Sum_probs=169.2
Q ss_pred ccccccCceeEEEEE-EcCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.||-|+||.|.++. .+....+|.|.+.+...- .........|-++|..-+.+=||+||-.|++++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 569999999999998 455678899998765432 223455678888999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc--------
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA-------- 539 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~-------- 539 (664)
++..+| .+.+.+.+.....++.++..|+++.|.. |+|||||||+|||||.+|++|+.|||++.-+.
T Consensus 715 DmMSLL-----IrmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLL-----IRMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHH-----HHhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999 3456688888888899999999999999 99999999999999999999999999974211
Q ss_pred -CC-------CC----------------------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcC
Q 006031 540 -DS-------LQ----------------------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTG 583 (664)
Q Consensus 540 -~~-------~~----------------------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG 583 (664)
.. .. ....||.-|+|||++. ...++.-+|.||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhC
Confidence 00 00 0113788899999997 56678899999999999999999
Q ss_pred CCCCCCCCCCh--hhHHHHHHhh
Q 006031 584 KPPSQHSFLVP--NEMMNWVRSA 604 (664)
Q Consensus 584 ~~P~~~~~~~~--~~~~~~~~~~ 604 (664)
++||-.....+ ..+..|....
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l 890 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFL 890 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhcc
Confidence 99997643322 2455665443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=230.07 Aligned_cols=240 Identities=17% Similarity=0.248 Sum_probs=192.9
Q ss_pred HhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCC--ceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKE--ERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~~~lV~e~ 463 (664)
..+++|+|.|+.||.|. ..+...++||.++.. ..+.+.+|++++..++ ||||+++++...+.. ...||+||
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 45689999999999998 667888999999753 4577899999999997 999999999987654 56799999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSL 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~ 542 (664)
+.+.+...+- ..|+...+.....++++||.|+|++ ||+|||+||.|+++|.. -..++.|+|+|-+.....
T Consensus 117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9998877665 3577888899999999999999999 99999999999999964 568999999998764432
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------C
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------G 609 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------~ 609 (664)
......+..|.-||.+-....++..-|+|||||++.+|+..+.||-.......+++..+.-..... +
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 233456778999999876777899999999999999999999999776555555544432222111 0
Q ss_pred ----------------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 ----------------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 ----------------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...-...+..+++.+.+..|..+|||++|...
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00111256889999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=235.20 Aligned_cols=237 Identities=18% Similarity=0.260 Sum_probs=183.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcH-HHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~-~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.++||+|+|++|..+.+ +..+.+|+|++++.-....+. .-.+.|-.+..+- +||.+|.+..+|+.....+.|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 46899999999999995 457889999987654433222 2234444444443 79999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc--cCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~~ 543 (664)
+|+|.-+++ ....|++.....+..+|..||.|||+. +||.||||..|||+|..|++|+.|||+++.. .....
T Consensus 335 ggdlmfhmq-----rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 335 GGDLMFHMQ-----RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred Ccceeeehh-----hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 999988884 456799999999999999999999999 9999999999999999999999999999753 33445
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----Chh-hHHHHHHhhccCCCchhHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL-----VPN-EMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
...+||+.|.|||.+. +..|....|.|++||+|+||+.|+.||+-... ..+ .+-+.+...... -+.....+
T Consensus 409 stfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--iprslsvk 485 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IPRSLSVK 485 (593)
T ss_pred ccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--ccceeehh
Confidence 5678999999999997 67889999999999999999999999974221 111 222222211111 11122233
Q ss_pred HHHHHHHcccCCCCCCC
Q 006031 618 LLEVAIACNSASPEQRP 634 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RP 634 (664)
...+++.-+.+||++|-
T Consensus 486 as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERL 502 (593)
T ss_pred hHHHHHHhhcCCcHHhc
Confidence 55677778899999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=254.70 Aligned_cols=195 Identities=21% Similarity=0.300 Sum_probs=169.9
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccC------CcHHHHHHHHHHHcCCC---CCCcccceEEEecCCce
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG------TSNEMYEQHMESVGGLR---HPNLVPLRAYFQAKEER 457 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~ 457 (664)
+.+.+|+|+||.|+.|.++ +...|+||.+.+.+.-. ...-..--||.+|..++ |+||++++.+|++++..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 4578999999999999965 46788999886544211 11122456899999997 99999999999999999
Q ss_pred EEEEecC-CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 458 LLIYDYQ-PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 458 ~lV~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
||+||-. ++.+|++++ .....+++.....|++||+.|+++||++ +|||||||-+||.++.+|-+|+.|||.+.
T Consensus 645 yl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEEeeccchh
Confidence 9999976 567999999 4567799999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006031 537 LTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588 (664)
Q Consensus 537 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~ 588 (664)
+..........||..|.|||++.+..+....-|||++||+||.++....||.
T Consensus 719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9888877778899999999999877777888999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=229.83 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=167.6
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|++|.||++...+ +..+++|.+...... ...+.+.+|++.+.+++|+|++++++++...+..++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 3679999999999999765 889999999755431 24678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~ 544 (664)
+|.+++.... ..+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 83 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 83 DLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999996321 1288999999999999999999999 99999999999999999999999999998765442 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~ 589 (664)
...++..|++||.......++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345677899999873356677899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=237.02 Aligned_cols=126 Identities=25% Similarity=0.383 Sum_probs=105.9
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-----C---CCcccceEEEec----CC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-----H---PNLVPLRAYFQA----KE 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~g~~~~----~~ 455 (664)
.++||-|.|++||+++ ..+.+.||+|+.+.... -.+....||+++++++ | .+||+|+++|.. ..
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh---YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~ 159 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH---YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ 159 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhH---HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence 4689999999999999 45678999999875432 3456778899998874 3 369999999965 44
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL 521 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl 521 (664)
+.+||+|++ |.+|..+|..+ ..+.++.....+|++||+.||.|||++++|||-||||+|||+
T Consensus 160 HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 160 HVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred EEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 789999998 66999999653 345688899999999999999999999999999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=232.98 Aligned_cols=237 Identities=19% Similarity=0.266 Sum_probs=184.9
Q ss_pred ccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEEe
Q 006031 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIYD 462 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e 462 (664)
..+|.|.- .|.-|. .-.++.||+|++..........+...+|...+..+.|+||++++.++.-. .+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 555554 33477899999876544445567788999999999999999999998643 36799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS- 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 541 (664)
||. ++|.+.++ -.++-.+...|..|+..|+.|||+. +|+||||||+||++..++.+||.|||+|+.....
T Consensus 102 ~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 102 LMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred hhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCccc
Confidence 995 49998885 3477788899999999999999999 9999999999999999999999999999876655
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc----------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR---------------- 605 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~---------------- 605 (664)
..+....+..|.|||++.+ ..+.+.+||||.||++.||++|+.-|.+. ..+-+|.+...
T Consensus 173 ~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred ccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 3445678899999999984 45899999999999999999999887643 12222211111
Q ss_pred -----cCC---------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 -----EDD---------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 -----~~~---------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... +...-......+++.+++..+|++|.++.++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 011112244788999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=257.60 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=195.0
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
-+.+|.|.||.|||++ ...+..+|+|.++.... ....-..+|+-+++..+|||||.++|.+...+..++.|||+.+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 3579999999999999 56788999999875432 45566788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+.-| ...++++.++...+++..+||+|||++ +-+|||||-.|||+++.|.+|++|||.+....... ...
T Consensus 98 slQdiy~-----~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 98 SLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cccceee-----ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 9999885 346799999999999999999999999 99999999999999999999999999987655433 234
Q ss_pred CCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH-HHhhccCCC--chhHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW-VRSAREDDG--AEDERLGMLLE 620 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~ 620 (664)
..||++|||||+..- .+-|..++|||+.|+...|+-.-++|.-... +...... -.+..++.. ........+.+
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 679999999997542 3457889999999999999998888854322 1111111 122222221 22344566889
Q ss_pred HHHHcccCCCCCCCCHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~ 640 (664)
+++.|+.++|++||+++.++
T Consensus 250 fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHhcCCCccCCChhhhe
Confidence 99999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=223.57 Aligned_cols=255 Identities=19% Similarity=0.312 Sum_probs=188.1
Q ss_pred ccccCHHHHHHHHhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEE-Ee
Q 006031 376 AQLYTLDQLMRASAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAY-FQ 452 (664)
Q Consensus 376 ~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~-~~ 452 (664)
....+++|. +...+.+|+|.||.+-++.++ ..+.+++|.+.... ....+|.+|...--.| .|.||+.-|+. |+
T Consensus 17 l~kv~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 17 LKKVDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred ccccchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 334455553 345678999999999999975 47789999886543 3577888888764445 68999987664 67
Q ss_pred cCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe-C-CCCCeEEe
Q 006031 453 AKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL-G-PDFEACLA 530 (664)
Q Consensus 453 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl-~-~~~~~ki~ 530 (664)
..+....++||++-|+|.+-+.. ..+.+....+++.|++.|+.|||++ ++||||||.+|||+ + +...+|+|
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEee
Confidence 77888899999999999988742 4577888999999999999999999 99999999999999 3 44689999
Q ss_pred eccccccccCCCCCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc
Q 006031 531 DYCLTALTADSLQDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
|||.++..+.... ....+..|-+||.... ..+..+.+|||.|||+++.++||+.||+..........+|......
T Consensus 166 DFG~t~k~g~tV~-~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 166 DFGLTRKVGTTVK-YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred ecccccccCceeh-hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 9999876543322 1234556889996541 2234677999999999999999999998655444444444433332
Q ss_pred CCC----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 607 DDG----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 607 ~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
... ........+.++.++-+..+|++|=-..++.++
T Consensus 245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 221 122334557888888999999999444444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=215.58 Aligned_cols=165 Identities=21% Similarity=0.242 Sum_probs=130.3
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.++++. ....++|..+..|+.|+++||+|||+. + ||+|||++.++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~ 64 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---S 64 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc---C
Confidence 789999963 235699999999999999999999998 5 999999999999999 99988765432 3
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC----CchhHHHH--HHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----GAEDERLG--MLLE 620 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~l~~ 620 (664)
.+++.|||||++. ...++.++|||||||++|||+||+.||.........+..+........ ........ .+.+
T Consensus 65 ~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 65 RVDPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCcccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 5789999999997 667899999999999999999999998754332333333333322221 11222223 5899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
++.+||+.+|++||++.|+++.+..+..
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=271.82 Aligned_cols=192 Identities=17% Similarity=0.185 Sum_probs=139.5
Q ss_pred CCCC-CCcccceEEE-------ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 006031 438 GLRH-PNLVPLRAYF-------QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509 (664)
Q Consensus 438 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~i 509 (664)
.++| +||++++++| .+.+..+.++||+ +++|.++|+. ....+++.+++.|+.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQ-GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence 3456 6888888887 2334567788987 5699999963 235699999999999999999999998 99
Q ss_pred ccCCCCCCCeEeCC-------------------CCCeEEeeccccccccCCC------------------CCCCCCCCcc
Q 006031 510 VHGNLKSSNVLLGP-------------------DFEACLADYCLTALTADSL------------------QDDDPDNLLY 552 (664)
Q Consensus 510 vHrDlk~~NILl~~-------------------~~~~ki~DfGla~~~~~~~------------------~~~~~~~~~y 552 (664)
+||||||+||||+. ++.+|++|||+++...... .....+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556777777775422100 0012468889
Q ss_pred cCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCC
Q 006031 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQ 632 (664)
Q Consensus 553 ~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~ 632 (664)
||||++. ...++.++|||||||+||||++|.+|+.... ..+........ +. ..........+++.+||+++|.+
T Consensus 182 ~APE~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 182 TSPEEDN-GSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL-PP-QILLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred EChhhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc-Ch-hhhhcCHHHHHHHHHhCCCChhh
Confidence 9999987 5678999999999999999999988865321 11111111111 11 11112234568889999999999
Q ss_pred CCCHHHHHH
Q 006031 633 RPTMWQVLK 641 (664)
Q Consensus 633 RPt~~ev~~ 641 (664)
||+|.|+++
T Consensus 256 Rps~~eil~ 264 (793)
T PLN00181 256 RPSMSELLQ 264 (793)
T ss_pred CcChHHHhh
Confidence 999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=234.97 Aligned_cols=193 Identities=20% Similarity=0.229 Sum_probs=161.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC------CCcccceEEEecCCceEEEEe
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH------PNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~g~~~~~~~~~lV~e 462 (664)
...|+|-|++|.+|.. ..|..||||++..... ..+.=.+|+++|++|.. -|+++|+..|...+++|||||
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE 514 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE 514 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence 3578999999999984 4577999999975443 33445678999999853 489999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADS 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~ 541 (664)
-+ ..+|.+.|.... ....|.......++.|+.-||..|-.. +|+|.||||.|||+++. ..+||||||.|......
T Consensus 515 ~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 515 PL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccccccccc
Confidence 76 459999997532 345688888999999999999999877 99999999999999876 45799999999887766
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHS 590 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~ 590 (664)
..+...-+..|.|||++. +..|+...|+||.||+|||+.||+.-|.+.
T Consensus 591 eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCC
Confidence 555455566799999998 788999999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=229.83 Aligned_cols=240 Identities=21% Similarity=0.299 Sum_probs=186.5
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|.|++||+|... .+..||+|.+.... .......|+++|..+. +.||+++.+++..++...+|+||
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 478999999999999843 57889999986543 3456889999998884 89999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeecccccccc---
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTA--- 539 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~--- 539 (664)
++.....++.. .++......++..+..||+++|.. |||||||||+|+|.+.. +.-.|.|||++....
T Consensus 117 ~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 117 FEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred cCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999884 367888899999999999999999 99999999999999864 567899999986110
Q ss_pred --------------C-C--------C--------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHH
Q 006031 540 --------------D-S--------L--------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVL 576 (664)
Q Consensus 540 --------------~-~--------~--------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvv 576 (664)
. . . .-...||++|+|||++.....-+++.||||-||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 0 0012479999999998877777899999999999
Q ss_pred HHHHHcCCCCCCCCCCChhhHHHHH------------Hhhcc------CC------------------------------
Q 006031 577 LLELLTGKPPSQHSFLVPNEMMNWV------------RSARE------DD------------------------------ 608 (664)
Q Consensus 577 l~elltG~~P~~~~~~~~~~~~~~~------------~~~~~------~~------------------------------ 608 (664)
++-+++++.||-....+-..+.+.+ ..... ..
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 9999999999854332211111110 00000 00
Q ss_pred CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+..+..+++++.+|++.+|.+|.|++|.++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011222346899999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=264.11 Aligned_cols=192 Identities=32% Similarity=0.536 Sum_probs=125.2
Q ss_pred ChhHHHHHHHHHhccCCCCCCcCcCCCCCCCccccceEecC-CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCC
Q 006031 39 LPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQ-QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSL 117 (664)
Q Consensus 39 ~~~~~~aLl~~k~~~~~~~~~~~~~~~~~~~C~w~gv~C~~-~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l 117 (664)
.++|+.||++||+++.++.....+|+.+.+||.|.||+|++ ++|+.|+|+++++.|.++ ..+..|++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCCEEECCCCcc
Confidence 35899999999999865433334455557999999999975 799999999999999764 4788899999999999999
Q ss_pred CCCCCC--CCCCCCCCEEeccCCcCCCCCc----------------------ccccCCCCCCEEeccCCcCcCCCchhhc
Q 006031 118 TGPIPD--LSGLVNLKSLFLDHNFFTGSFP----------------------PSLLSLHRLKTLDLSYNNLSGPLPKELA 173 (664)
Q Consensus 118 ~g~~p~--~~~l~~L~~L~L~~N~l~g~~p----------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 173 (664)
+|.+|. +.++++|++|+|++|+++|.+| ..++++++|++|+|++|++++.+|..++
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 888873 3366666666666666665554 4444555555555555555555555555
Q ss_pred CCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccC
Q 006031 174 SQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFN 231 (664)
Q Consensus 174 ~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N 231 (664)
++++|++|+|++|++++.+|.. .+++|+.|+|++|++++.+|. ...+.++..+.+.+|
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCc
Confidence 5555555555555555544432 445555555555555555542 133344444444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=214.39 Aligned_cols=249 Identities=18% Similarity=0.322 Sum_probs=190.6
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCH
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL 469 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 469 (664)
.+|.+...|..|+|++.+. .+++|+++.........++|.+|.-.++...||||+.++|.|.......++..||+-|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4688889999999999766 567788887777666678899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccC-CCCCCCeEeCCCCCeEEeeccccccccCCCCCCCCC
Q 006031 470 FSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHG-NLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548 (664)
Q Consensus 470 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHr-Dlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 548 (664)
+..||+. .....+-.+..+++.++|+||+|||+.-+++-| -|.++.|++|++.+++|+- +-+++.-+.. ...-
T Consensus 275 ynvlhe~---t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsfqe~--gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEV--GRAY 348 (448)
T ss_pred HHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeeeecc--cccc
Confidence 9999863 345578889999999999999999995355544 7999999999999998752 1112111111 1233
Q ss_pred CCcccCccccccCCCC--CchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 549 NLLYKAPETRNASHQA--TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 549 ~~~y~aPE~~~~~~~~--~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.+.||+||.+...... -..+|+|||.|++||+.|...||.+....+-.+.-.....+.. -+......+.++|.-|+
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~--ippgis~hm~klm~icm 426 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH--IPPGISRHMNKLMNICM 426 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc--CCCCccHHHHHHHHHHh
Confidence 5789999988632222 3468999999999999999999986543322222111111111 22334456889999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhh
Q 006031 627 SASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i~ 647 (664)
..||.+||.+..|+-.|+++.
T Consensus 427 nedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 427 NEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCcCCCcceehhhHHHhc
Confidence 999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=211.28 Aligned_cols=155 Identities=17% Similarity=0.184 Sum_probs=119.8
Q ss_pred hccccccCceeEEEEEEc--CCeEEEEEEccCccc---cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD--NRLIVCVKRLDASKL---AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|... +++.||||++..... .....+.|.+|++++++++|+|+++.+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 467999999999999864 577889998753211 11235679999999999999999863322 2467999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC-CCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNL-KSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDl-k~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
+++++|.. +. . .. ...++.++++||+|||+. +|+|||| ||+|||++.++++||+|||+++......
T Consensus 100 ~~G~~L~~-~~----~-~~------~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 100 TEGVPLHL-AR----P-HG------DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred cCCCCHHH-hC----c-cc------hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 99999973 21 0 01 146788999999999998 9999999 9999999999999999999998654432
Q ss_pred C----------CCCCCCCcccCccccc
Q 006031 543 Q----------DDDPDNLLYKAPETRN 559 (664)
Q Consensus 543 ~----------~~~~~~~~y~aPE~~~ 559 (664)
. ....+++.|+|||++.
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCC
Confidence 1 1224677899999886
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-21 Score=199.29 Aligned_cols=249 Identities=26% Similarity=0.337 Sum_probs=195.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCC-cHHHHHHHHHHHcCCCCC-CcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHP-NLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||.|+||.||++... ..+++|.+........ ....+.+|+..++.+.|+ +++++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 357899999999999977 7889999876554332 467899999999999988 799999999777778999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADSL--- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~--- 542 (664)
+++.+++...... ..+.......+..|++.++.|+|+. +++|||+||+||+++... .++++|||.++......
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 9999777532111 3688889999999999999999999 999999999999999998 79999999998554432
Q ss_pred -----CCCCCCCCcccCccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccC-C--Cc
Q 006031 543 -----QDDDPDNLLYKAPETRNAS--HQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSARED-D--GA 610 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~--~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~-~--~~ 610 (664)
.....++..|+|||.+... ..+....|+||+|++++++++|..|+...... .......+...... . ..
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc
Confidence 2345689999999998743 57888999999999999999999997654321 22333333333222 1 11
Q ss_pred hh----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 611 ED----ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 611 ~~----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. .....+.+++..|+..+|..|.++.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 112467899999999999999998887664
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=222.89 Aligned_cols=131 Identities=32% Similarity=0.497 Sum_probs=75.2
Q ss_pred CCChhHHHHHHHHHhccCCCCCCcCcCCCCCCCc-----cccceEecCC------cEEEEEEcCCCCCCcCCCccccCCC
Q 006031 37 SLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFC-----QWQGVICYQQ------KVVRVVLQGLDLGGIFAPNSLTKLD 105 (664)
Q Consensus 37 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~~~~~~C-----~w~gv~C~~~------~v~~l~l~~~~l~g~~~p~~l~~l~ 105 (664)
.+.+.|.+||+++|+.+..+....| + .++| .|.||.|+.. .|+.|+|++++|.|.+++ ++++|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~~~W--~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLRFGW--N--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcccCCC--C--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCC
Confidence 4567899999999998865433344 3 3455 6999999531 255555555555554433 455555
Q ss_pred CCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhh
Q 006031 106 QLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 172 (664)
+|+.|+|++|+|+|.+| .++++++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence 55555555555555554 34455555555555555555555555555555555555555555555444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-20 Score=196.28 Aligned_cols=254 Identities=17% Similarity=0.177 Sum_probs=186.3
Q ss_pred HhccccccCceeEEEEEEcCC--eEEEEEEccCccccCCcHHHHHHHHHHHcCCCC----CCcccceEEE-ecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDNR--LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH----PNLVPLRAYF-QAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~g~~-~~~~~~~lV 460 (664)
..+.||+|+||.||++...+. ..+|+|........ ....+..|+.++..+.+ +++..+++.. ...+..++|
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~--~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS--KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC--CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 356899999999999996553 47888877543221 11156677777777752 5888888888 477789999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-----CCeEEeecccc
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-----FEACLADYCLT 535 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-----~~~ki~DfGla 535 (664)
|+.. |.+|.++..... ...++..+..+|+.|++.+|++||+. +++||||||.|++++.. -.+.+.|||++
T Consensus 100 M~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred Eecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9976 779999885322 46799999999999999999999999 99999999999999865 35899999999
Q ss_pred c--ccc-CCC---------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHH
Q 006031 536 A--LTA-DSL---------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWV 601 (664)
Q Consensus 536 ~--~~~-~~~---------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~ 601 (664)
+ ... ... .....||.+|.++.... ....+.+.|+||++.++.|++.|..||........ .+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 321 110 11233899999999887 67789999999999999999999999866432211 222221
Q ss_pred HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 602 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
....... .....+..+.++...+-+.+..++|....+...|++.....
T Consensus 254 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111111 11122344666666666789999999999999988775553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=204.91 Aligned_cols=211 Identities=28% Similarity=0.432 Sum_probs=167.5
Q ss_pred HcCCCCCCcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Q 006031 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLK 515 (664)
Q Consensus 436 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk 515 (664)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+.. ....++|.-...+.++|++||+|||..+-..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 4578999999999999999999999999999999999963 456799999999999999999999997434999999
Q ss_pred CCCeEeCCCCCeEEeeccccccccCC----CCCCCCCCCcccCccccccC---C---CCCchhhHHHHHHHHHHHHcCCC
Q 006031 516 SSNVLLGPDFEACLADYCLTALTADS----LQDDDPDNLLYKAPETRNAS---H---QATSKSDVYSFGVLLLELLTGKP 585 (664)
Q Consensus 516 ~~NILl~~~~~~ki~DfGla~~~~~~----~~~~~~~~~~y~aPE~~~~~---~---~~~~ksDVwSfGvvl~elltG~~ 585 (664)
++|.++|..+.+|++|||+....... .........-|.|||.+... . ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431 11111234569999987642 1 14678999999999999999999
Q ss_pred CCCCCCCC--hhhHHHHHHhhccCC-----CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 586 PSQHSFLV--PNEMMNWVRSAREDD-----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 586 P~~~~~~~--~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
||+..... ..++...+....... ....+....+..++..||..+|++||++++|-..++.+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99864433 235555554411111 112244456899999999999999999999999998887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-22 Score=221.66 Aligned_cols=247 Identities=19% Similarity=0.197 Sum_probs=179.8
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHH----HHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEM----YEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~----~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
..+++|.|++|.|+..... .....+.|.............. +..|+.+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877633 2333334433211001112222 4556777788999999988887777777667799
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|++. +|+.++. ....++...+-.+..|+..|+.|+|+. +|.|||+|++|+++..++.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999994 234678888889999999999999999 99999999999999999999999999986543322
Q ss_pred ------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc-----cCCCch
Q 006031 543 ------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-----EDDGAE 611 (664)
Q Consensus 543 ------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~ 611 (664)
.....|+..|+|||.+.+........||||.||++..|.+|+.||.................. ......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 224568889999999984444445689999999999999999999876443332211111111 111122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+.....++.++++.+|.+|.|+.+|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 344556788999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-21 Score=184.23 Aligned_cols=140 Identities=17% Similarity=0.194 Sum_probs=109.0
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCc------------------------HHHHHHHHHHHcCCCCCCcc
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS------------------------NEMYEQHMESVGGLRHPNLV 445 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~------------------------~~~~~~e~~~l~~l~H~niv 445 (664)
..||+|+||.||+|...+|+.||||+++........ .....+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999754321111 11234589999999888875
Q ss_pred cceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcccCCCCCCCeEeCCC
Q 006031 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI-HQAWRLVHGNLKSSNVLLGPD 524 (664)
Q Consensus 446 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~ivHrDlk~~NILl~~~ 524 (664)
....+.. ...++||||++++++..... ....+++.....++.|++.+|.|+ |+. +|+||||||+|||++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-C
Confidence 4443322 23489999999887765431 124688899999999999999999 577 999999999999998 4
Q ss_pred CCeEEeeccccccc
Q 006031 525 FEACLADYCLTALT 538 (664)
Q Consensus 525 ~~~ki~DfGla~~~ 538 (664)
+.++++|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=176.88 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=111.6
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCc------------------------HHHHHHHHHHHcCCCCCCcc
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS------------------------NEMYEQHMESVGGLRHPNLV 445 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~------------------------~~~~~~e~~~l~~l~H~niv 445 (664)
..||+|+||.||+|...+|+.||||+++........ ...+.+|.+.+.+++|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999999878999999998754211000 12346788999999999986
Q ss_pred cceEEEecCCceEEEEecCCCCCHHHH-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCC
Q 006031 446 PLRAYFQAKEERLLIYDYQPNGSLFSL-IHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 446 ~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~ 523 (664)
....+... ..++||||++++++... +. ...++......++.+++.++.|+|+ . +|+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~- 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH- 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-
Confidence 65554433 34899999998865443 32 2356778889999999999999999 7 999999999999999
Q ss_pred CCCeEEeeccccccccC
Q 006031 524 DFEACLADYCLTALTAD 540 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~ 540 (664)
++.++++|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-20 Score=172.24 Aligned_cols=247 Identities=16% Similarity=0.213 Sum_probs=183.9
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC-CCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH-PNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||.|+||.+|.|. ..+|..||||.-..... ...+..|.++.+.++| ..|..+..|..+.+...+|||.. |
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 3689999999999998 78899999998754332 3446667777777765 56777888888999999999987 7
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~~~ 543 (664)
.+|.++..- -...++..+.+-.+-|++.-++|+|.. ++|||||||+|+|..- ...+.+.|||+|+...+...
T Consensus 95 PsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 95 PSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 799998863 345688899999999999999999999 9999999999999964 35688999999987654322
Q ss_pred ---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHHHHhhccCCC---c
Q 006031 544 ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDDG---A 610 (664)
Q Consensus 544 ---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~---~ 610 (664)
....||.+|.+--... +..-+.+.|+-|+|.+|.++--|..||++...... +-.+.+........ .
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred cccCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 2235889999877665 34457789999999999999999999998654322 11111211111111 1
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
....+.++.-.+..|=..--++-|...-+.+.++-+
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 122344566677778777788888777666665544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-21 Score=202.24 Aligned_cols=227 Identities=25% Similarity=0.283 Sum_probs=179.2
Q ss_pred cccccCceeEEEEE----EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCC
Q 006031 391 LLGKGSLGTTYKAV----LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
++|+|.||.|+... .+.+..+|.|.+++.............|..++..++ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998754 455778888888765543333335556777788886 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
+|+|...+. ....++.........++|-+++++|+. +|+|||+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l~-----~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS-----KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc-----cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998884 344567777777888999999999998 9999999999999999999999999999987665443
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
+||..|||||++. .....+|.||||++++||+||..||.. +++..+. ......+.+......+++...
T Consensus 154 -cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il--~~~~~~p~~l~~~a~~~~~~l 221 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRIL--KAELEMPRELSAEARSLFRQL 221 (612)
T ss_pred -ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHh--hhccCCchhhhHHHHHHHHHH
Confidence 8899999999986 345678999999999999999999875 2222221 112234455556677777777
Q ss_pred ccCCCCCCCCH
Q 006031 626 NSASPEQRPTM 636 (664)
Q Consensus 626 l~~~P~~RPt~ 636 (664)
+..+|..|--.
T Consensus 222 ~~r~p~nrLg~ 232 (612)
T KOG0603|consen 222 FKRNPENRLGA 232 (612)
T ss_pred HhhCHHHHhcc
Confidence 77888888644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.3e-20 Score=184.06 Aligned_cols=195 Identities=18% Similarity=0.221 Sum_probs=137.0
Q ss_pred CCCCcccceEEEec---------------------------CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHH
Q 006031 440 RHPNLVPLRAYFQA---------------------------KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKI 492 (664)
Q Consensus 440 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 492 (664)
+|||||++.++|.+ ....|+||.-.+. +|.+++.. ...+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHHH
Confidence 69999999988743 2246899987765 99999952 34566677788
Q ss_pred HHHHHHHHHHHHhcCCcccCCCCCCCeEe--CCCC--CeEEeeccccccccC--------CCCCCCCCCCcccCcccccc
Q 006031 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLL--GPDF--EACLADYCLTALTAD--------SLQDDDPDNLLYKAPETRNA 560 (664)
Q Consensus 493 ~~~ia~~L~yLH~~~~ivHrDlk~~NILl--~~~~--~~ki~DfGla~~~~~--------~~~~~~~~~~~y~aPE~~~~ 560 (664)
+.|+++|+.|||.+ +|.|||+|++|||+ |+|. ...|+|||.+--... +..-...|...-||||+...
T Consensus 347 laQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 89999999999999 99999999999999 4444 357899997632211 11112346778999998752
Q ss_pred CCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCC
Q 006031 561 SHQ-----ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPT 635 (664)
Q Consensus 561 ~~~-----~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 635 (664)
..- .-.|+|.|+.|.+.||+++...||.......-+...+...... ..++..+..+.+++...++.+|++|++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP--alp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP--ALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC--CCcccCChHHHHHHHHHhcCCccccCC
Confidence 111 1358999999999999999999986521111122222111111 123445566889999999999999998
Q ss_pred HHHHHHHHH
Q 006031 636 MWQVLKMLQ 644 (664)
Q Consensus 636 ~~ev~~~L~ 644 (664)
..-....|.
T Consensus 504 p~iAANvl~ 512 (598)
T KOG4158|consen 504 PNIAANVLN 512 (598)
T ss_pred ccHHHhHHH
Confidence 766555543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.7e-19 Score=172.75 Aligned_cols=253 Identities=15% Similarity=0.165 Sum_probs=185.7
Q ss_pred HHhccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 387 ASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
..+++||+|.||+.+.|. +-++++||||.-..... .-+++.|.+..+.| ..++|...+-|-.+.-+..||+|.+
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 457899999999999998 67889999997654433 23445555555555 4688888888878888889999987
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-----CCeEEeecccccccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-----FEACLADYCLTALTA 539 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-----~~~ki~DfGla~~~~ 539 (664)
|.+|.++..- ....++..+...||.|+..-++|+|++ .+|.|||||+|+||... ..+.|.|||+++...
T Consensus 107 -GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7799998853 345799999999999999999999999 99999999999999753 347899999999876
Q ss_pred CCCCC---------CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh-hHHHHHHhhccCC-
Q 006031 540 DSLQD---------DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDD- 608 (664)
Q Consensus 540 ~~~~~---------~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~- 608 (664)
+.... .-.||.+||+-.... ++.-+.+.|.-|+|-|+.+.+-|..||.+...... +-.+-+.......
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 54332 235899999998877 56668889999999999999999999987643321 1111111111111
Q ss_pred --CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 609 --GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 609 --~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+..+..+.++..-+...=..+-.+-|...-+...+..+.+..
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 111223334444444444567778899888877777665544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=170.70 Aligned_cols=183 Identities=15% Similarity=0.139 Sum_probs=136.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...|++|+||+||.+.- ++..++.+.+...... ......+.+|+++|+++. |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997766 6667887777654331 112236899999999995 5789999886 45799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC-CCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNL-KSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDl-k~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
|.+|.+.+.. ....+..|++.+|+|+|+. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998755410 1135778999999999999 9999999 79999999999999999999985443221
Q ss_pred -----CC---------CCCCCcccCccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 006031 544 -----DD---------DPDNLLYKAPETRNASHQAT-SKSDVYSFGVLLLELLTGKPPSQH 589 (664)
Q Consensus 544 -----~~---------~~~~~~y~aPE~~~~~~~~~-~ksDVwSfGvvl~elltG~~P~~~ 589 (664)
.. ...++.|++|+....-...+ ...+.++-|.-+|.++|++.+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 11356677777433222233 567888999999999999988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-20 Score=203.33 Aligned_cols=242 Identities=21% Similarity=0.261 Sum_probs=176.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHH--HcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMES--VGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||.+.|=+|.+|..+.|. |+||++.+.... ...+.|.++++- ...++|||++++.-+-..+...|||=+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 467999999999999999996 889998654421 223334333332 4556899999998877777778899999976
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc--cCCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT--ADSLQ- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~~- 543 (664)
+|++.+ ..+.-|...+..-|+.|++.||.-+|.. +|+|+|||.+|||++.-.-+.++||..-+.. +.+..
T Consensus 106 -nLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 106 -NLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred -hhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999999 3455678888889999999999999999 9999999999999999999999999765432 22111
Q ss_pred ------CCCCCCCcccCccccccC----------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 544 ------DDDPDNLLYKAPETRNAS----------HQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 544 ------~~~~~~~~y~aPE~~~~~----------~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
........|.|||.+... ...+++.||||.||++.||++ |++||.- .++..+......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSGNAD 253 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhccCcc
Confidence 112234569999976531 125678999999999999998 8998853 122222221111
Q ss_pred CCCch--hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 607 DDGAE--DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 607 ~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
..... .-+...+.+++..|++.||++|-++.+.++.-+
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 10000 001124789999999999999999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=177.24 Aligned_cols=166 Identities=12% Similarity=0.147 Sum_probs=126.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCc-------HHHHHHHHHHHcCCCCCCcccceEEEecC-------
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS-------NEMYEQHMESVGGLRHPNLVPLRAYFQAK------- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~g~~~~~------- 454 (664)
.+++|.|+||.||.+.. ++..+|+|.+......... .+.+++|+..+.+++|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 47899999999999765 5668999999754331111 12268999999999999999999886543
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 455 -EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 455 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||++++++ ++++|||
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988742 221 3456999999999999 999999999999999988 9999999
Q ss_pred ccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHH
Q 006031 534 LTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELL 581 (664)
Q Consensus 534 la~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ell 581 (664)
........... ..+.. ...+..++|+||||+++.-+.
T Consensus 180 ~~~~~~e~~a~----------d~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK----------DRIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH----------HHHHH-HhHhcccccccceeEeehHHH
Confidence 88655322110 00222 445667899999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=166.09 Aligned_cols=134 Identities=15% Similarity=0.179 Sum_probs=103.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-----CCCCcccceEEEecCC---ceE-E
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-----RHPNLVPLRAYFQAKE---ERL-L 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~g~~~~~~---~~~-l 459 (664)
.+.||+|+||.||. ++.....+||++..... ...+.+.+|+++++.+ .||||++++|++.++. ..+ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46799999999996 43333346888765332 3457799999999999 5799999999998764 333 7
Q ss_pred EEec--CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCcccCCCCCCCeEeCC----CCCeEEeec
Q 006031 460 IYDY--QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL-SYIHQAWRLVHGNLKSSNVLLGP----DFEACLADY 532 (664)
Q Consensus 460 V~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~ivHrDlk~~NILl~~----~~~~ki~Df 532 (664)
|+|| +++|+|.+++.. ..+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 567999999942 124444 35677888787 999999 9999999999999974 347999995
Q ss_pred ccc
Q 006031 533 CLT 535 (664)
Q Consensus 533 Gla 535 (664)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=171.72 Aligned_cols=233 Identities=17% Similarity=0.257 Sum_probs=148.3
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCcc-ccCCcHHHHHHHHHHHcCCCC----------CCcccceEEEe----
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASK-LAGTSNEMYEQHMESVGGLRH----------PNLVPLRAYFQ---- 452 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H----------~niv~l~g~~~---- 452 (664)
++.||.|+|+.||.++... ++++|+|...... ......+.+++|.-....+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4689999999999999654 8999999875433 223345677777766555433 11222122111
Q ss_pred -----cCC--------ceEEEEecCCCCCHHHHhcc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCC
Q 006031 453 -----AKE--------ERLLIYDYQPNGSLFSLIHG---SKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKS 516 (664)
Q Consensus 453 -----~~~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~ 516 (664)
... ..+++|+-+ .+||.+++.. .. .....+....++.+..|+.+.+++||+. |+||+||||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~ 173 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKP 173 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecccce
Confidence 111 236778877 5588887642 11 1123455667788889999999999999 999999999
Q ss_pred CCeEeCCCCCeEEeeccccccccCCCCCCCCCCCcccCccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 006031 517 SNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNAS-------HQATSKSDVYSFGVLLLELLTGKPPSQH 589 (664)
Q Consensus 517 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~ksDVwSfGvvl~elltG~~P~~~ 589 (664)
+|++++.+|.++++||+........... ...+..|.+||..... ..++.+.|.|++|+++|.|.+|+.||+.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999876554433221 2334679999965421 2468899999999999999999999975
Q ss_pred CCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCC
Q 006031 590 SFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQR 633 (664)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 633 (664)
....... .| .-..+. +.++.+..++...++.+|++|
T Consensus 253 ~~~~~~~--~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADP--EW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTS--GG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCccccc--cc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 4211111 11 111233 667779999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=161.05 Aligned_cols=136 Identities=18% Similarity=0.323 Sum_probs=113.6
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCC------cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
+.||+|++|.||+|.. .+..|++|+......... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 556788997654322111 124577899999999999998888888788889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
+++++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998521 12 7889999999999999999 999999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.1e-17 Score=162.92 Aligned_cols=140 Identities=15% Similarity=0.172 Sum_probs=107.5
Q ss_pred HhccccccCceeEEEEE--EcCCeEEEEEEccCccccCC----------------------cHHHHHHHHHHHcCCCCCC
Q 006031 388 SAELLGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGT----------------------SNEMYEQHMESVGGLRHPN 443 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~~~----------------------~~~~~~~e~~~l~~l~H~n 443 (664)
..+.||+|+||.||+|. ..+|+.||+|.+........ ....+.+|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45689999999999998 57899999999875421100 1124678999999997633
Q ss_pred --cccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-cccCCCCCCCeE
Q 006031 444 --LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR-LVHGNLKSSNVL 520 (664)
Q Consensus 444 --iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-ivHrDlk~~NIL 520 (664)
+.+++++ ...++||||+++++|..... ....+.......++.|++.+++|||+. + |+||||||+||+
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIl 181 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNIL 181 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEE
Confidence 3333332 24589999999988876542 123455566789999999999999999 8 999999999999
Q ss_pred eCCCCCeEEeeccccccc
Q 006031 521 LGPDFEACLADYCLTALT 538 (664)
Q Consensus 521 l~~~~~~ki~DfGla~~~ 538 (664)
++ +++++++|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999988754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=157.46 Aligned_cols=132 Identities=18% Similarity=0.295 Sum_probs=108.1
Q ss_pred cccccCceeEEEEEEcCCeEEEEEEccCccccCC------cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 391 LLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.||+|+||.||+|.+ ++..|++|.......... ..+.+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 556899998654322111 1255778999999999988777666777777889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
++++|.+++... .. .++.+++.+|.+||+. +++|+|++|+||+++ ++.+++.|||.++.
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988421 10 7899999999999999 999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.6e-17 Score=180.09 Aligned_cols=135 Identities=21% Similarity=0.274 Sum_probs=110.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccC-----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG-----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|.+.+...++.++........ ...+.+.+|++++.+++|++++....++...+..++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 57899999999999997665443333332211100 1235688999999999999999988888887888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999883 3567999999999999998 99999999999999 6789999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=155.33 Aligned_cols=136 Identities=13% Similarity=0.155 Sum_probs=106.0
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccC--------------------CcHHHHHHHHHHHcCCCCCC--cc
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG--------------------TSNEMYEQHMESVGGLRHPN--LV 445 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--------------------~~~~~~~~e~~~l~~l~H~n--iv 445 (664)
..+.||+|+||.||++...+|+.||||++....... .....+.+|...+.++.|++ +.
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~ 98 (198)
T cd05144 19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP 98 (198)
T ss_pred cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence 357899999999999998889999999865432100 01123677888888888874 44
Q ss_pred cceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC
Q 006031 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525 (664)
Q Consensus 446 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~ 525 (664)
..++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||++++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCC
Confidence 4443 2456899999999998765420 23457889999999999998 999999999999999999
Q ss_pred CeEEeecccccccc
Q 006031 526 EACLADYCLTALTA 539 (664)
Q Consensus 526 ~~ki~DfGla~~~~ 539 (664)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-16 Score=176.62 Aligned_cols=185 Identities=20% Similarity=0.294 Sum_probs=145.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC---CCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
...||+|+||+||+|...+|+.||+|+-+..... +|.--.+++.+|+ -+-|..+...+.-.+.-+||+||.+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 4679999999999999888999999987654331 1111123344444 2345555556666778899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC-------CCCCeEEeeccccccc
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG-------PDFEACLADYCLTALT 538 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~-------~~~~~ki~DfGla~~~ 538 (664)
.|+|.+++. ..+.++|.....|+.|+++-++.||.. +|||+||||+|.||. +...++|+|||-+-.+
T Consensus 778 ~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 778 YGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999995 456789999999999999999999999 999999999999994 2356899999998543
Q ss_pred ---cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 006031 539 ---ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585 (664)
Q Consensus 539 ---~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~ 585 (664)
.+. ......+|-.+--+|+.. ++.++...|-|.+..+++-|+.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHH
Confidence 222 223345677888899887 7889999999999999999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-16 Score=167.25 Aligned_cols=171 Identities=21% Similarity=0.288 Sum_probs=128.1
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..|+.|+++...+|.++|... ......+|...+.++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 334567889999999999999999 5 8999999999999999999999999998
Q ss_pred ccccCCC--------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 536 ALTADSL--------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 536 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
.-+.... .....||..||+||.+. +.+|+.|+||||+|++|+|+++ =..+++- .....-++....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----~~t~~d~r~g~i 477 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLIQFSTQFER-----IATLTDIRDGII 477 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHHHhccHHHH-----HHhhhhhhcCCC
Confidence 7654433 23456899999999997 7889999999999999999998 2222211 011111122222
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQV 639 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 639 (664)
++....+.+. -+.++.+++.+.|++||++.++
T Consensus 478 p~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 478 PPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 2111122222 3578899999999999965554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=170.26 Aligned_cols=200 Identities=19% Similarity=0.241 Sum_probs=137.5
Q ss_pred HhccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.+.|..|+||.||..+++. .+..|. ++.+... ..++ ++.....|.+ |
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~-kiNkq~l------ilRn---ilt~a~npfv---------------v------ 135 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------ILRN---ILTFAGNPFV---------------V------ 135 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhh-cccccch------hhhc---cccccCCcce---------------e------
Confidence 34678999999999998654 556666 3433222 0110 1111122222 2
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----- 541 (664)
||=...+. ..++++. +.+.+++|||+. +|+|||+||+|.+|..-|++|+.|||+++..-..
T Consensus 136 gDc~tllk-----~~g~lPv--------dmvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 GDCATLLK-----NIGPLPV--------DMVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred chhhhhcc-----cCCCCcc--------hhhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 34444442 1123332 227899999998 9999999999999999999999999998642111
Q ss_pred ------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC
Q 006031 542 ------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG 609 (664)
Q Consensus 542 ------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 609 (664)
..+..+||+.|+|||++. ..-|...+|.|++|+++||.+.|+.||.+.. .++-+-..+.......+
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhh-hhccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhccccc
Confidence 112347899999999997 5568899999999999999999999997641 12234444444444444
Q ss_pred chhHHHHHHHHHHHHcccCCCCCCC
Q 006031 610 AEDERLGMLLEVAIACNSASPEQRP 634 (664)
Q Consensus 610 ~~~~~~~~l~~l~~~Cl~~~P~~RP 634 (664)
..+....+..+++.+.++.+|..|-
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 4444556688899999999999996
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-15 Score=143.04 Aligned_cols=136 Identities=15% Similarity=0.193 Sum_probs=96.4
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHH----------------------HHHHHHHHcCCCCCC--cc
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEM----------------------YEQHMESVGGLRHPN--LV 445 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~----------------------~~~e~~~l~~l~H~n--iv 445 (664)
+.||+|+||+||+|...+++.||||++............ ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999888999999988643221111111 134555555554433 33
Q ss_pred cceEEEecCCceEEEEecCCCCCHHHH-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCC
Q 006031 446 PLRAYFQAKEERLLIYDYQPNGSLFSL-IHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 446 ~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~ 523 (664)
+.+++ ...++||||++++++... +.. .... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~------~~~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~- 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKD------VRLL-EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD- 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhh------hhhc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-
Confidence 34332 246899999999554321 110 0011 5677899999999999999 6 999999999999999
Q ss_pred CCCeEEeeccccccc
Q 006031 524 DFEACLADYCLTALT 538 (664)
Q Consensus 524 ~~~~ki~DfGla~~~ 538 (664)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.3e-17 Score=145.66 Aligned_cols=150 Identities=27% Similarity=0.360 Sum_probs=134.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+++|.|++|.|+- +|| .+..|.+|+.|+|++|++...++++++|++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~~-vpp-nia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTV-VPP-NIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCceee-cCC-cHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 578999999999997 556 899999999999999999988889999999999999999999 99999999999999999
Q ss_pred cCCcCc-CCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLS-GPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|+++ ..+|..|..++.|+.|+|+.|.|.=.+|.. .+++|+.|.+..|.+-..+.+.+.+.++..+...||.
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccce
Confidence 999997 468999999999999999999998555543 8899999999999998777777778888888888873
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-16 Score=176.54 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=186.9
Q ss_pred ccccccCceeEEEEEEc--CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD--NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+|+.|-..... ....+|+|.+..........+....|..+-..+. |+|++.+++...+.+..+++.+|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 44899999999887753 3455666666544322223344455777777776 99999999999999999999999999
Q ss_pred CCHHHHh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccC-CC
Q 006031 467 GSLFSLI-HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-QAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTAD-SL 542 (664)
Q Consensus 467 gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~-~~ 542 (664)
+++++.+ +. .....+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..... ..
T Consensus 106 ~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 106 GSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred cccccccccC----CccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 9999888 42 2224455667789999999999999 66 999999999999999999 999999999976655 21
Q ss_pred ----CCCCCC-CCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHH
Q 006031 543 ----QDDDPD-NLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLG 616 (664)
Q Consensus 543 ----~~~~~~-~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 616 (664)
.....| ++.|+|||...+.....+..|+||.|+++.-+++|..|++...........|...... ..........
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD 260 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh
Confidence 123457 8999999998744456788999999999999999999998765555555555554322 1223333444
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~ 640 (664)
...++..+++..+|..|.+.+++.
T Consensus 261 ~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 261 QAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred hhhhcccccccCCchhcccccccc
Confidence 577888889999999999987764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-14 Score=143.57 Aligned_cols=139 Identities=19% Similarity=0.217 Sum_probs=106.5
Q ss_pred HHhcccc-ccCceeEEEEEEcCCeEEEEEEccCccc-----------cCCcHHHHHHHHHHHcCCCCCCc--ccceEEEe
Q 006031 387 ASAELLG-KGSLGTTYKAVLDNRLIVCVKRLDASKL-----------AGTSNEMYEQHMESVGGLRHPNL--VPLRAYFQ 452 (664)
Q Consensus 387 ~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~~~e~~~l~~l~H~ni--v~l~g~~~ 452 (664)
....+|| .||.|+||+.... +..+++|++..... .......+.+|++++.+++|++| +..+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3467898 8999999999886 45788888753211 11233567889999999998885 66777654
Q ss_pred cCC-c---eEEEEecCCC-CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCe
Q 006031 453 AKE-E---RLLIYDYQPN-GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEA 527 (664)
Q Consensus 453 ~~~-~---~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ 527 (664)
... . .++|+||+++ .+|.+++.. ..++.. .+.+++.++.+||+. +|+||||||.|||++.++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCE
Confidence 322 2 3599999997 699998842 234432 367899999999999 99999999999999999999
Q ss_pred EEeecccccc
Q 006031 528 CLADYCLTAL 537 (664)
Q Consensus 528 ki~DfGla~~ 537 (664)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-14 Score=131.08 Aligned_cols=131 Identities=18% Similarity=0.149 Sum_probs=110.1
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC--CCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH--PNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 568999999999999866 6789998754322 4678899999999976 58999999888888899999999887
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA--WRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
.+..+ +......++.++++++++||.. .+++|+|++|+||++++++.+++.|||.+..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66432 5566778899999999999985 2699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-15 Score=158.65 Aligned_cols=149 Identities=26% Similarity=0.373 Sum_probs=108.7
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCC-CCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG-SFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~l 159 (664)
+++-|.|...+|.- + |.+++.|.+|++|.+++|+|....-+++.|+.|+.+++..|+|.. -||+.|+.|..|..|||
T Consensus 33 ~~~WLkLnrt~L~~-v-PeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDL 110 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLEQ-V-PEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDL 110 (1255)
T ss_pred heeEEEechhhhhh-C-hHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeec
Confidence 45555555555543 2 557888888888888888887666677777788888888887753 37778888888888888
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
|+|+|+ ..|..+-.-+++-.|+||+|++. +||.. +++.|-+||||+|+|...+|....+..+..+.+.+||-
T Consensus 111 ShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 111 SHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred chhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChh
Confidence 888887 77877777777888888888876 56653 66777777888888877777766666777777777763
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.7e-15 Score=133.26 Aligned_cols=133 Identities=29% Similarity=0.392 Sum_probs=121.5
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 179 (664)
-+.++.+.+.|-||+|+++..+|.+..|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+.++.|+
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 467788899999999999999999999999999999999999 99999999999999999999998 8999999999999
Q ss_pred eeeCcCCcCccC-CCC--CCCCCCcEEEccCCcccccCCCCCcccccCccccccCCCC
Q 006031 180 SLRLDVNRFNGS-IPP--LNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSL 234 (664)
Q Consensus 180 ~L~l~~N~l~g~-~p~--~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~l 234 (664)
.|||.+|+++.. +|. +.+..|+.|+|++|.|.-.+|+.+.++++..+.+..|.-+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence 999999999864 443 2567889999999999999999999999999998888544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.7e-13 Score=143.43 Aligned_cols=143 Identities=17% Similarity=0.177 Sum_probs=100.0
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccC------------------------C--------------cHHHHHH
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG------------------------T--------------SNEMYEQ 431 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------------~--------------~~~~~~~ 431 (664)
+.||.|++|.||+|++++|+.||||+.+...... . .+-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999999999999999985421000 0 0012455
Q ss_pred HHHHHcCC----CCCCcccceEEE-ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 006031 432 HMESVGGL----RHPNLVPLRAYF-QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ-GLSYIHQ 505 (664)
Q Consensus 432 e~~~l~~l----~H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~ 505 (664)
|.+.+.++ +|.+-+.+-..+ ......+|||||++|++|.++..... ... .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHHHh
Confidence 55555444 233223322222 23456799999999999988764211 112 24567777766 4778898
Q ss_pred cCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 506 ~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
. +++|+|++|.||++++++++++.|||++.....
T Consensus 276 ~-g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D-GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C-CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-13 Score=133.91 Aligned_cols=202 Identities=21% Similarity=0.303 Sum_probs=139.3
Q ss_pred HHHHcCCCCCCcccceEEEecCC-----ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-
Q 006031 433 MESVGGLRHPNLVPLRAYFQAKE-----ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA- 506 (664)
Q Consensus 433 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~- 506 (664)
..-+-++.|.|||++..|+.+.. +..+++|||..|++..+|+..+ .....+....-.+|+.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34455567999999999986543 4688999999999999997543 2345566677789999999999999994
Q ss_pred CCcccCCCCCCCeEeCCCCCeEEeecccccccc------CCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHH
Q 006031 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTA------DSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLEL 580 (664)
Q Consensus 507 ~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~el 580 (664)
|.|+|+++..+-|++..++-+|+.---...... ........+-++|.|||+-. ..+.+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHH
Confidence 789999999999999999988875321111111 01112234567899999865 45567789999999999999
Q ss_pred HcCCCCCCCCCCChhhHHHHH-HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006031 581 LTGKPPSQHSFLVPNEMMNWV-RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 581 ltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 643 (664)
..+..-....... .+...-+ +......... =..++.+|++..|..||+|++++...
T Consensus 276 ailEiq~tnseS~-~~~ee~ia~~i~~len~l------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESK-VEVEENIANVIIGLENGL------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcce-eehhhhhhhheeeccCcc------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 8876542221111 0111111 1111111111 13577899999999999999987543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-14 Score=146.77 Aligned_cols=145 Identities=25% Similarity=0.339 Sum_probs=118.9
Q ss_pred EEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 82 VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
.+.+++.+|.+.. ++|+ .-+++.|++||...|-+...+|+++++.+|..|||..|++. .+| +|.+++.|.+|+++.
T Consensus 162 l~~l~~~~n~l~~-l~~~-~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 162 LSKLDLEGNKLKA-LPEN-HIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGE 237 (565)
T ss_pred HHHhhccccchhh-CCHH-HHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcc
Confidence 3445566666665 4453 33377888888888888878888888999999999999988 788 788889999999999
Q ss_pred CcCcCCCchhhc-CCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 162 NNLSGPLPKELA-SQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 162 N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
|+++ .+|++.+ .+++|..|||.+|+++ ..|.. -+.+|.+||+|+|.+++.++..+.+ .+..+.+.|||-
T Consensus 238 N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 238 NQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 9998 8888876 8999999999999998 55543 6678999999999999999988888 778888899974
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.2e-14 Score=148.11 Aligned_cols=131 Identities=28% Similarity=0.322 Sum_probs=90.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCC------------------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT------------------ 141 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~------------------ 141 (664)
...+.|+|++|++.. ||.+-+-+|+.|-.||||+|+|...+|.+..|.+|+.|+||+|.|.
T Consensus 126 Kn~iVLNLS~N~Iet-IPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIET-IPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCcccc-CCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 345667777777765 5554567888888888888888888887777777777777777653
Q ss_pred -------CCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC-CCCCCCcEEEccCCcccc
Q 006031 142 -------GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 142 -------g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~l~~N~l~g 212 (664)
..||.++..|.+|..+|||.|+|. .+|..+.++.+|+.|+||+|+++..--. ....+|+.||||.|+|+.
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~ 282 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTV 282 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhcc
Confidence 247777777888888888888887 7788888888888888888877632110 011244555555555543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-13 Score=143.94 Aligned_cols=133 Identities=24% Similarity=0.208 Sum_probs=102.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+...|+|..|+++. +....+.+|+.|+.||||+|.|..+-+ .+.-.++|+.||||+|+++-.-|.+|.-|..|++|+
T Consensus 269 ~kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred cccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 467788899999886 455689999999999999999987766 477788999999999999966666777788888888
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-----CCCCCcEEEccCCccccc
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-----NQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l~l~~N~l~g~ 213 (664)
|++|+++-.--..|..+++|+.|||++|.+++.|.+. .+++|+.|+|.+|+|...
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 8888887444456777788888888888888777642 556666666666666544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-11 Score=138.47 Aligned_cols=165 Identities=23% Similarity=0.324 Sum_probs=117.4
Q ss_pred CCChhHHHHHHHHHhccCCCCCC---cCcCCCCCCCccccc----------------eEecCCcEE--------------
Q 006031 37 SLLPSDAQVLLAFKAKADLRNHL---FFSQNKSLHFCQWQG----------------VICYQQKVV-------------- 83 (664)
Q Consensus 37 ~~~~~~~~aLl~~k~~~~~~~~~---~~~~~~~~~~C~w~g----------------v~C~~~~v~-------------- 83 (664)
...++|.+.+++..+.+..++.. ...|++.+++|.=.. |.|..+.|+
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~~ 138 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSAS 138 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccccCC
Confidence 35679999999999888776644 233555578886444 667544333
Q ss_pred -------------------------------------------EEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCC
Q 006031 84 -------------------------------------------RVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGP 120 (664)
Q Consensus 84 -------------------------------------------~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~ 120 (664)
.|+|.+++|+. +| ..+. ++|+.|+|++|+|+..
T Consensus 139 ~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP-~~Ip--~~L~~L~Ls~N~LtsL 214 (754)
T PRK15370 139 GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IP-ACIP--EQITTLILDNNELKSL 214 (754)
T ss_pred CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CC-cccc--cCCcEEEecCCCCCcC
Confidence 35566666665 33 2332 4788889999988865
Q ss_pred CCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCC
Q 006031 121 IPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSL 200 (664)
Q Consensus 121 ~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L 200 (664)
++.+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|.....+|
T Consensus 215 P~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL 285 (754)
T PRK15370 215 PENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEEL 285 (754)
T ss_pred Chhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCC
Confidence 44443 58899999999988 6787664 47888888888888 7887764 57888888888888 4565444678
Q ss_pred cEEEccCCcccccC
Q 006031 201 KIFNVSGNNFTGAI 214 (664)
Q Consensus 201 ~~l~l~~N~l~g~~ 214 (664)
+.|+|++|+|++.+
T Consensus 286 ~~L~Ls~N~Lt~LP 299 (754)
T PRK15370 286 RYLSVYDNSIRTLP 299 (754)
T ss_pred cEEECCCCccccCc
Confidence 88888888888643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-12 Score=132.10 Aligned_cols=89 Identities=24% Similarity=0.290 Sum_probs=65.0
Q ss_pred ccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC---CCCCCCcEEEccCCcccccCCCC-Cccccc
Q 006031 148 LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTGAITVT-STLSRF 223 (664)
Q Consensus 148 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~l~~N~l~g~~p~~-~~l~~~ 223 (664)
|..|++|+.|+|++|++++.-+.+|..+..++.|+|..|+|. .+.. .+++.|+.|+|.+|++|..-|.. ..+.++
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 445666777777777777666667777777777777777765 2221 16789999999999999887733 445677
Q ss_pred CccccccCCCCCCc
Q 006031 224 GISSFLFNPSLCGE 237 (664)
Q Consensus 224 ~~~~~~~N~~lcg~ 237 (664)
+.+.+.+||+.|..
T Consensus 349 ~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 349 STLNLLSNPFNCNC 362 (498)
T ss_pred eeeehccCcccCcc
Confidence 88899999999964
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.2e-12 Score=144.39 Aligned_cols=115 Identities=33% Similarity=0.507 Sum_probs=87.4
Q ss_pred CCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEcc
Q 006031 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVS 206 (664)
Q Consensus 129 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~ 206 (664)
.++.|+|++|.|+|.+|..|++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3677888888888888888888888888888888888888888888888888888888888888763 67788888888
Q ss_pred CCcccccCCCCCc--ccccCccccccCCCCCCccCcCCC
Q 006031 207 GNNFTGAITVTST--LSRFGISSFLFNPSLCGEIIHKEC 243 (664)
Q Consensus 207 ~N~l~g~~p~~~~--l~~~~~~~~~~N~~lcg~~~~~~c 243 (664)
+|+|+|.+|..-. +..+..+.+.+|+.+||.+....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 8888888874211 123345678899999986533344
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.8e-11 Score=129.16 Aligned_cols=225 Identities=17% Similarity=0.182 Sum_probs=149.6
Q ss_pred EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCC
Q 006031 405 LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL 484 (664)
Q Consensus 405 ~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l 484 (664)
..++.+|.|...+.... ...+...+.++.|+.+|||||++++..+...+..|||+|-+. -|..++.. +
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------L 101 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------h
Confidence 45678888888765433 335667788999999999999999999999999999999875 35555531 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCCCCCCcccCccccccCC
Q 006031 485 HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDDPDNLLYKAPETRNASH 562 (664)
Q Consensus 485 ~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~~~~~~y~aPE~~~~~~ 562 (664)
........+.||+.||.|||+.++++|++|.-..|+++..|+-||++|-+......... ....---.|..|+.+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 23344556889999999999866999999999999999999999999977654332211 1111122366777554211
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhh-----HHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHH
Q 006031 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE-----MMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMW 637 (664)
Q Consensus 563 ~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 637 (664)
...|.|-||+++||++.|..+-...-..... +....+....... ..+. ..+++..|...-+--|=.+-
T Consensus 182 ---~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~---~r~n-~~~~~~~~~~~~gff~n~fv 254 (690)
T KOG1243|consen 182 ---WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATEL---KRPN-KLRFILECRLLGGFFRNDFV 254 (690)
T ss_pred ---cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccc---cccc-hhhHHHHHHhccccccchHH
Confidence 3469999999999999993332111011111 1111111111111 1111 56677777777777777777
Q ss_pred HHHHHHHhhhc
Q 006031 638 QVLKMLQEIKG 648 (664)
Q Consensus 638 ev~~~L~~i~~ 648 (664)
+++..|++++=
T Consensus 255 d~~~fLeel~l 265 (690)
T KOG1243|consen 255 DTLLFLEELRL 265 (690)
T ss_pred HHHHHHHhccc
Confidence 77777777653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.3e-13 Score=136.39 Aligned_cols=150 Identities=25% Similarity=0.314 Sum_probs=126.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
-|+.++++.|.|... |..+..+..+.+.-+.+|+.-+.+| .+..+++|+.|+|++|-+. .+|.+++.+..||.|||
T Consensus 389 ~Vt~VnfskNqL~el--Pk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCEL--PKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHhhh--hhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence 489999999999873 5567777666554444444445666 6889999999999999998 99999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCcccccCCCCCcccccCccccccCCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSL 234 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~l 234 (664)
|+|+|. .+|..+..+..|+.+-.++||+....|. .++.+|..|||.+|.+...+|..+.+.++..+.+.|||+-
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 999998 8999998888888888888999754444 2888999999999999999999999999999999999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3e-11 Score=114.38 Aligned_cols=126 Identities=20% Similarity=0.175 Sum_probs=93.7
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCccc-ceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP-LRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.++.|.++.||++... +..|++|....... ....+.+|++.++.+.+.++++ ++.+. .+..++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 45889999999999875 66799998754321 2335678888888886666554 44433 334689999999987
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR-----LVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-----ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
+...- . ....++.+++++|+.||.. + ++|+|++|.||+++ ++.+++.|||.+.
T Consensus 78 l~~~~----------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED----------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc----------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 65320 0 1134567999999999987 5 59999999999999 6689999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=132.62 Aligned_cols=250 Identities=19% Similarity=0.143 Sum_probs=174.2
Q ss_pred cCHHHHHHHHhccccc--cCceeEEEEEE---cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEe
Q 006031 379 YTLDQLMRASAELLGK--GSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQ 452 (664)
Q Consensus 379 ~~~~~l~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 452 (664)
+++.+-......-+|. |.+|.||.+.. .++..+|+|+-+..-........-.+|...-.++ .|+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444445567899 99999999885 4677888888543332222333334555555555 4999999888899
Q ss_pred cCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCcccCCCCCCCeEeCCC-CCe
Q 006031 453 AKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ----GLSYIHQAWRLVHGNLKSSNVLLGPD-FEA 527 (664)
Q Consensus 453 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ 527 (664)
..+..++-+|++. .+|..+.+.. ...++....+.+..+... ||.++|.. .++|-|+||.||+..++ ...
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheeccccccee
Confidence 9999999999885 6888888742 233455555666666666 99999998 99999999999999999 889
Q ss_pred EEeeccccccccCCCC-------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CChhhHHH
Q 006031 528 CLADYCLTALTADSLQ-------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSF-LVPNEMMN 599 (664)
Q Consensus 528 ki~DfGla~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~-~~~~~~~~ 599 (664)
+..|||+-..+.+... ....+...|++||... +-++..+|+|++|.+..|..++..+..... ....++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9999999876654321 1124667899999874 567889999999999999998776654321 11112222
Q ss_pred HHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006031 600 WVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 640 (664)
+. .+.+........+...+..+++.+|-.|++..++.
T Consensus 341 ~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 GY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 21 11111112223355588889999999999866654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-11 Score=132.86 Aligned_cols=244 Identities=18% Similarity=0.130 Sum_probs=171.9
Q ss_pred ccccccCceeEEEEEE--cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..||.|.|+.||+... .++..+++|.+............-..|+.+...+ .|.+++.++..+...+..|+--||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4699999999999774 4677888888865544323333333455554444 589999988888888889999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~~~~ 545 (664)
+++...+. ....++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+..+.-....
T Consensus 351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~- 423 (524)
T KOG0601|consen 351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV- 423 (524)
T ss_pred cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceeccc-
Confidence 99877662 234567778889999999999999998 99999999999999886 78899999988643222111
Q ss_pred CCCCCccc-CccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYK-APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~-aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
.....+++ ..|.+.....+..+.|+||||..+.|..++..--... .+|.......-.........+..+.+.
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~i~~~~~p~~~~~~~~~q~~~kv 496 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLTIRSGDTPNLPGLKLQLQVLLKV 496 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccc-------ccceeeecccccCCCchHHhhhhhhhh
Confidence 22333444 3555555667788999999999999999987643321 122211111111111111446677788
Q ss_pred cccCCCCCCCCHHHHHHHHHhhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
...+++..||.+.++....+..+
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hcCCccccchhhhhhcccchhhh
Confidence 88999999999988876655443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.8e-12 Score=132.33 Aligned_cols=134 Identities=21% Similarity=0.185 Sum_probs=72.4
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCC------------------
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFT------------------ 141 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~------------------ 141 (664)
.+..|+|++|.++. +....|.+|.+|..|.|++|+++..++ .|.+|++|+.|||..|++.
T Consensus 174 ni~~L~La~N~It~-l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 174 NIKKLNLASNRITT-LETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CceEEeeccccccc-cccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 34555566555554 333345555555555555555554333 3444555555555555443
Q ss_pred ------CCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCccccc
Q 006031 142 ------GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 142 ------g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~ 213 (664)
-.-...|..|.++++|+|+.|+++..--.++.+|++|+.|+||+|++.-.-+. ..+.+|++|+||+|+++..
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence 11122344455666666666666644445566666666666666666644332 2455666666666666655
Q ss_pred CC
Q 006031 214 IT 215 (664)
Q Consensus 214 ~p 215 (664)
.+
T Consensus 333 ~~ 334 (873)
T KOG4194|consen 333 DE 334 (873)
T ss_pred Ch
Confidence 44
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-11 Score=134.34 Aligned_cols=143 Identities=14% Similarity=0.115 Sum_probs=90.3
Q ss_pred ccccccCceeEEEEEEcC-CeEEEEEEccCcccc--------------------C------------CcH------HHHH
Q 006031 390 ELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLA--------------------G------------TSN------EMYE 430 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--------------------~------------~~~------~~~~ 430 (664)
+.||+|++|.||+|++++ |+.||||+....... . +.. -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 569999999999999987 999999998643100 0 001 1244
Q ss_pred HHHHHHcCCC----CCCcccceEEEec-CCceEEEEecCCCCCHHHHhccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006031 431 QHMESVGGLR----HPNLVPLRAYFQA-KEERLLIYDYQPNGSLFSLIHGS-KSTRAKPLHWTSCLKIAEDVAQGLSYIH 504 (664)
Q Consensus 431 ~e~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH 504 (664)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++-.-. .+.....+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4554444442 4444443333332 45678999999999998743100 00001112222222223333 3
Q ss_pred hcCCcccCCCCCCCeEeCCCC----CeEEeeccccccccC
Q 006031 505 QAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALTAD 540 (664)
Q Consensus 505 ~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~~~ 540 (664)
.. +++|+|+||.||+++.++ ++++.|||+......
T Consensus 278 ~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35 999999999999999988 999999999876644
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-12 Score=140.40 Aligned_cols=151 Identities=31% Similarity=0.375 Sum_probs=119.1
Q ss_pred cEEEEEEcCCCCCCcCCCcccc-------------------------CCCCCCEEEecCCCCCCC-CCCCCCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLT-------------------------KLDQLRVLGLQNNSLTGP-IPDLSGLVNLKSLF 134 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~-------------------------~l~~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~ 134 (664)
.+..|+|..|+|.. +|+..+. .+..|+.|+|.+|.|+-. +|-|.+.++|++|+
T Consensus 311 sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred eeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 47788888888775 3321111 133477889999999764 57889999999999
Q ss_pred ccCCcCCCCCccc-ccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc-
Q 006031 135 LDHNFFTGSFPPS-LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG- 212 (664)
Q Consensus 135 L~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g- 212 (664)
|++|+|. ++|+. +.+|..|+.|+||+|+|+ .+|..+.++..|+.|...+|++.-.+--..++.|+.+|||.|+|+-
T Consensus 390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhh
Confidence 9999998 78875 688999999999999999 8999999999999999999999855433488999999999999984
Q ss_pred cCCCCCcccccCccccccCCCC
Q 006031 213 AITVTSTLSRFGISSFLFNPSL 234 (664)
Q Consensus 213 ~~p~~~~l~~~~~~~~~~N~~l 234 (664)
.+|..-.-.++..+.+.||.++
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhCCCcccceeeccCCccc
Confidence 3453222257778888999874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-10 Score=108.04 Aligned_cols=138 Identities=11% Similarity=0.121 Sum_probs=97.6
Q ss_pred ccccccCceeEEEEEEcC-------CeEEEEEEccCccc--------c------------CCcHHHHH----HHHHHHcC
Q 006031 390 ELLGKGSLGTTYKAVLDN-------RLIVCVKRLDASKL--------A------------GTSNEMYE----QHMESVGG 438 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~--------~------------~~~~~~~~----~e~~~l~~ 438 (664)
..||.|-=+.||.|.-.+ +..+|||..+.... . ....+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998543 47899998742110 0 01123344 88888888
Q ss_pred CCC--CCcccceEEEecCCceEEEEecCCCCCHHH-HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcccCCC
Q 006031 439 LRH--PNLVPLRAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI-HQAWRLVHGNL 514 (664)
Q Consensus 439 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~ivHrDl 514 (664)
+.. -++...+++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|.+| |+. ++||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCC
Confidence 854 355556654 56789999997654422 221 12344455677889999999999 677 9999999
Q ss_pred CCCCeEeCCCCCeEEeecccccccc
Q 006031 515 KSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 515 k~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
++.||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-10 Score=131.27 Aligned_cols=34 Identities=41% Similarity=0.524 Sum_probs=19.5
Q ss_pred CCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc
Q 006031 177 RLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 177 ~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 212 (664)
+|+.|+|++|+|++ +|.. .++|+.|++++|+|++
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l-~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL-PSELKELMVSGNRLTS 416 (788)
T ss_pred ccceEEecCCcccC-CCCc-ccCCCEEEccCCcCCC
Confidence 46666666666664 3322 2456666666666664
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.6e-10 Score=128.80 Aligned_cols=118 Identities=27% Similarity=0.330 Sum_probs=60.1
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCccccc-----------
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLL----------- 149 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~----------- 149 (664)
.++.|+|.+|+|+. +|. .+++|++|+|++|+|+.. |.+ .++|+.|+|++|.|+ .+|..+.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~LtsL-P~l--p~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~ 293 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTSL-PVL--PPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQ 293 (788)
T ss_pred CCCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCcc-cCc--ccccceeeccCCchh-hhhhchhhcCEEECcCCc
Confidence 56677777777776 432 246788888888888754 321 234444444444443 2222110
Q ss_pred ------CCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCccccc
Q 006031 150 ------SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 150 ------~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ 213 (664)
.+++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++.
T Consensus 294 Lt~LP~~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l-p~~Lq~LdLS~N~Ls~L 357 (788)
T PRK15387 294 LTSLPVLPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL-PSGLQELSVSDNQLASL 357 (788)
T ss_pred cccccccccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc-ccccceEecCCCccCCC
Confidence 12455666666666553 3331 1233344444444432 2221 13577777777777753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.5e-11 Score=110.47 Aligned_cols=109 Identities=30% Similarity=0.384 Sum_probs=32.6
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCC-CCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhh-cCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLS-GLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL-ASQGR 177 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~ 177 (664)
.+.+..++++|+|++|.|+- |..++ .+.+|+.||||+|.++ .++ .+..|++|++|+|++|+|+ .++..+ ..+++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 34555567777777777763 44555 4677777777777777 444 3666777777777777777 454444 35677
Q ss_pred CCeeeCcCCcCccCCC---CCCCCCCcEEEccCCcccc
Q 006031 178 LYSLRLDVNRFNGSIP---PLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 178 L~~L~l~~N~l~g~~p---~~~~~~L~~l~l~~N~l~g 212 (664)
|+.|+|++|++...-- -..+++|+.|+|.+|.++.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 7777777777753211 1256777777777777764
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=109.30 Aligned_cols=118 Identities=33% Similarity=0.414 Sum_probs=49.1
Q ss_pred cEEEEEEcCCCCCCcCCCcccc-CCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccc-cCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLT-KLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSL-LSLHRLKTLD 158 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~-~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ 158 (664)
+...|+|.+|.+.- + +.++ .|++|+.|||++|.|+. ++.+..|++|+.|+|++|+++ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~-I--e~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I--ENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c--cchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 56778999999886 2 2566 58899999999999984 567888999999999999999 676555 3689999999
Q ss_pred ccCCcCcCCC-chhhcCCCCCCeeeCcCCcCccCCCC------CCCCCCcEEE
Q 006031 159 LSYNNLSGPL-PKELASQGRLYSLRLDVNRFNGSIPP------LNQSSLKIFN 204 (664)
Q Consensus 159 l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~------~~~~~L~~l~ 204 (664)
|++|+|...- =..+..+++|+.|+|.+|.++.. +. ..+++|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 9999997321 14577899999999999998844 32 1556676665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.6e-10 Score=130.60 Aligned_cols=121 Identities=26% Similarity=0.353 Sum_probs=91.1
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|+|++|+|+. +|. .+. .+|+.|+|++|+|+..+..+ ..+|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~-~l~--~nL~~L~Ls~N~LtsLP~~l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELKS-LPE-NLQ--GNIKTLYANSNQLTSIPATL--PDTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCCc-CCh-hhc--cCCCEEECCCCccccCChhh--hccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 468899999999996 554 443 58999999999998644333 247889999999988 7888775 57899999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCccccc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ 213 (664)
++|+|+ .+|..+. ++|+.|+|++|+|++ +|....++|+.|++++|+|++.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccccC
Confidence 999988 5787664 578888898888885 4433234667777777777753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-11 Score=135.13 Aligned_cols=125 Identities=31% Similarity=0.419 Sum_probs=109.9
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+..|.|.+|.|+...-| .|.+..+|+.|+|++|+|...+. .+.+|..|+.|+||+|+|+ .+|..+.++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 577788999999876555 69999999999999999985443 4889999999999999999 99999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccC-CCCC-CCCCCcEEEccCCc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGS-IPPL-NQSSLKIFNVSGNN 209 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~-~~~~L~~l~l~~N~ 209 (664)
.+|+|. .+| ++..++.|+.+|||.|+|+-. +|.. ..++|++|||++|.
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 999998 888 899999999999999999843 4433 23799999999997
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=108.37 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=106.5
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCC--CcccceEEEecCC---ceEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP--NLVPLRAYFQAKE---ERLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~e~~ 464 (664)
+.|+.|.++.||++...+|..+++|........ .....+.+|+++++.+++. ++.+++.+....+ ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999999877788999987543321 2345688999999988764 4566777766543 568999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-------------------------------------- 506 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------- 506 (664)
++.++.+.+. ...++...+..++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9988866542 02466677777888888888888741
Q ss_pred -----------------CCcccCCCCCCCeEeCC--CCCeEEeecccccc
Q 006031 507 -----------------WRLVHGNLKSSNVLLGP--DFEACLADYCLTAL 537 (664)
Q Consensus 507 -----------------~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~ 537 (664)
..++|+|+.+.||++++ ++.+.|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 13689999999999998 56689999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=99.78 Aligned_cols=133 Identities=18% Similarity=0.259 Sum_probs=100.3
Q ss_pred cccccCceeEEEEEEcCCeEEEEE-EccCccccCCcH-----HHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 391 LLGKGSLGTTYKAVLDNRLIVCVK-RLDASKLAGTSN-----EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~~~~vavK-~l~~~~~~~~~~-----~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+++|+=+.+|.+.+.+.. +++| ++.+....+.-. +.-.+|.+++.+++--.|-...=|..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876554 4444 333322211112 23457888888887766666666777888899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
+|-.|.+.+... +..++..+-+-+.-||.. +|||+||.++||+++.+. +.+.|||++...
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999898421 245677777788889999 999999999999998764 999999998743
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.5e-11 Score=126.96 Aligned_cols=130 Identities=25% Similarity=0.304 Sum_probs=76.4
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 179 (664)
.+++|..|++|||+.|+++-.++.+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+
T Consensus 116 ~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr 192 (722)
T KOG0532|consen 116 AICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR 192 (722)
T ss_pred hhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH
Confidence 56666666666666666665444444443 566666666665 66666666666666666666665 5666666666666
Q ss_pred eeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 180 SLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 180 ~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
.|.+..|++.-.++....-.|..||+|.|+++-.+-....|+.+..+.+..||
T Consensus 193 ~l~vrRn~l~~lp~El~~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 193 DLNVRRNHLEDLPEELCSLPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred HHHHhhhhhhhCCHHHhCCceeeeecccCceeecchhhhhhhhheeeeeccCC
Confidence 66666666654444444445666666666666544444445555555555554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=9e-09 Score=94.85 Aligned_cols=145 Identities=15% Similarity=0.247 Sum_probs=105.2
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCC-----cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT-----SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
+++-||+-+.|+++.+.+...+.-++..+....+. ....-.+|++.+.+++--.|....-++.+.....|+|||.
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 56889999999999997776555445543322211 2344568899998887667766666777788889999999
Q ss_pred CC-CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeeccccccc
Q 006031 465 PN-GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTALT 538 (664)
Q Consensus 465 ~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~ 538 (664)
++ -++.+++...- ...........++..|-+.+.-||.. +|+|+||..+||+|..++. +.+.|||++...
T Consensus 93 ~g~~~vk~~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 93 DGASTVKDFILSTM---EDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cchhHHHHHHHHHc---cCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 76 47788775321 12222223367888888999999999 9999999999999966543 579999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.7e-08 Score=100.87 Aligned_cols=152 Identities=13% Similarity=0.068 Sum_probs=104.6
Q ss_pred HHHHHHHHhccccccCceeEEEEEEcCCeEEEEEEccCccccC---------CcHHHHHHHHHHHcCCCCCCc--ccceE
Q 006031 381 LDQLMRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG---------TSNEMYEQHMESVGGLRHPNL--VPLRA 449 (664)
Q Consensus 381 ~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~ni--v~l~g 449 (664)
++.+..-.++.+-+.....|++..+ +|+.+.||+........ .....+.+|...+.++...+| ...++
T Consensus 19 f~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 19 FEEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred HHHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 4444444445555555556777766 56689999774332110 111247788888877754443 34455
Q ss_pred EEec-----CCceEEEEecCCCC-CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 450 YFQA-----KEERLLIYDYQPNG-SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 450 ~~~~-----~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
+... ....++|+|++++- +|.+++... .....+...+..++.+++..+.-||+. ||+|+|++++|||++.
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHL 173 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEec
Confidence 5543 23578999999886 899988421 123345567788999999999999999 9999999999999975
Q ss_pred -------CCCeEEeecccccc
Q 006031 524 -------DFEACLADYCLTAL 537 (664)
Q Consensus 524 -------~~~~ki~DfGla~~ 537 (664)
++.+.++||+.+..
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cccCCCCCceEEEEECCcccc
Confidence 46789999987753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.4e-08 Score=101.22 Aligned_cols=171 Identities=23% Similarity=0.315 Sum_probs=127.6
Q ss_pred ceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEecCCC-CCHH
Q 006031 397 LGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDYQPN-GSLF 470 (664)
Q Consensus 397 fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~ 470 (664)
-.+.||++ -.||..+++|+++..+. ........-++..+++.|+|||++..++.. +...++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 35789998 56899999999954332 122223344778899999999999998763 3467899999885 5777
Q ss_pred HHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 471 SLIHGSKS----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 471 ~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
++-..... ......++...+.++.|+..||.++|+. |+.-+-|.+++|+++.+.+++|+..|.......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 76543221 1234567788999999999999999999 999999999999999999999998887765544
Q ss_pred CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 006031 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586 (664)
Q Consensus 541 ~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P 586 (664)
+.. |-+. . -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~------------~~le-~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------EPLE-S---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------cchh-H---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 1121 1 2357999999999999999553
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-08 Score=124.54 Aligned_cols=128 Identities=25% Similarity=0.333 Sum_probs=77.0
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.++.|+|.++.+.. + +..+..|++|+.|+|++|+.-+.+|+++.+++|+.|+|++|..-..+|..+.+|++|+.|+|+
T Consensus 612 ~L~~L~L~~s~l~~-L-~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLEK-L-WDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCccccc-c-ccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 34455555555543 2 234556666666666666555566666666666666666665555666666666666666666
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 212 (664)
+|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++|.++.
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~-~~nL~~L~L~~n~i~~ 739 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI-STNISWLDLDETAIEE 739 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc-cCCcCeeecCCCcccc
Confidence 654444666554 5666666666666554455432 3456667777776653
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.1e-08 Score=120.98 Aligned_cols=145 Identities=19% Similarity=0.156 Sum_probs=112.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.+..|.+.++.+.- +|. .+ .+.+|+.|+|++|++......+..+++|+.|+|++|..-+.+|. ++.+++|++|+|+
T Consensus 590 ~Lr~L~~~~~~l~~-lP~-~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLRC-MPS-NF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCCC-CCC-cC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 46667777766654 433 44 57899999999999986656788899999999998876668885 8889999999999
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC-CCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
+|..-..+|..+..+++|+.|++++|..-+.+|. .++++|+.|++++|...+.+|.. ..++..+.+.+|
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n 735 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDET 735 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc--cCCcCeeecCCC
Confidence 9877779999999999999999998755556665 47899999999999877777632 334444555544
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.6e-09 Score=81.79 Aligned_cols=58 Identities=43% Similarity=0.513 Sum_probs=29.5
Q ss_pred CCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCc
Q 006031 106 QLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 163 (664)
+|++|+|++|+|+...+ .|.++++|++|+|++|+++..-|..|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554443 34455555555555555553333445555555555555554
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.9e-10 Score=108.19 Aligned_cols=126 Identities=23% Similarity=0.205 Sum_probs=90.8
Q ss_pred CCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeC
Q 006031 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRL 183 (664)
Q Consensus 104 l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 183 (664)
-+.|+.||||+|.++-.-.+..-+++++.|+||+|.+. .+-. +..|++|+.||||+|.|+ .+-.+=..+.|.+.|.|
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45688999999998865555666789999999999998 5554 888999999999999998 56666667888999999
Q ss_pred cCCcCccCCCCCCCCCCcEEEccCCccccc--CCCCCcccccCccccccCC
Q 006031 184 DVNRFNGSIPPLNQSSLKIFNVSGNNFTGA--ITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 184 ~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~--~p~~~~l~~~~~~~~~~N~ 232 (664)
+.|.+...----.+-+|..||+++|++... +-..+.+.-+..+.+.+||
T Consensus 360 a~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 360 AQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred hhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 999875221112456788999999998742 2222333334445555554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.8e-09 Score=81.59 Aligned_cols=61 Identities=39% Similarity=0.426 Sum_probs=52.9
Q ss_pred CCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcC
Q 006031 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188 (664)
Q Consensus 128 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 188 (664)
++|++|+|++|+++..-+..|.++++|++|+|++|+++..-|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999944446788899999999999999966667889999999999999975
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.5e-08 Score=93.56 Aligned_cols=128 Identities=17% Similarity=0.242 Sum_probs=84.2
Q ss_pred eEEEEEEcCCeEEEEEEccCcccc--------------------C----CcHHHHHHHHHHHcCCCCC--CcccceEEEe
Q 006031 399 TTYKAVLDNRLIVCVKRLDASKLA--------------------G----TSNEMYEQHMESVGGLRHP--NLVPLRAYFQ 452 (664)
Q Consensus 399 ~Vy~~~~~~~~~vavK~l~~~~~~--------------------~----~~~~~~~~e~~~l~~l~H~--niv~l~g~~~ 452 (664)
.||.|.-.+|..||+|........ . ......++|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999987432100 0 0123467899999999776 455555442
Q ss_pred cCCceEEEEecCC--CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcccCCCCCCCeEeCCCCCeEE
Q 006031 453 AKEERLLIYDYQP--NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI-HQAWRLVHGNLKSSNVLLGPDFEACL 529 (664)
Q Consensus 453 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~ivHrDlk~~NILl~~~~~~ki 529 (664)
...|||||++ +..+..+... .++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEE
Confidence 4579999998 5445443321 122345567888888877775 566 99999999999999988 9999
Q ss_pred eecccccccc
Q 006031 530 ADYCLTALTA 539 (664)
Q Consensus 530 ~DfGla~~~~ 539 (664)
.|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=3e-09 Score=111.59 Aligned_cols=132 Identities=27% Similarity=0.305 Sum_probs=91.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCC---CCEEEecCCCCCCCC-C----CCCCC-CCCCEEeccCCcCCCC----Ccc
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQ---LRVLGLQNNSLTGPI-P----DLSGL-VNLKSLFLDHNFFTGS----FPP 146 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~---L~~L~L~~N~l~g~~-p----~~~~l-~~L~~L~L~~N~l~g~----~p~ 146 (664)
..++.|+|+++.+.+.. +..+..+.+ |++|+|++|++++.. + .+..+ ++|+.|+|++|.+++. ++.
T Consensus 81 ~~L~~L~l~~~~~~~~~-~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDG-CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhH-HHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 47888888888887633 224544444 888888888887421 1 24455 7888888888888853 344
Q ss_pred cccCCCCCCEEeccCCcCcCC----CchhhcCCCCCCeeeCcCCcCccCCCC------CCCCCCcEEEccCCcccc
Q 006031 147 SLLSLHRLKTLDLSYNNLSGP----LPKELASQGRLYSLRLDVNRFNGSIPP------LNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 147 ~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~------~~~~~L~~l~l~~N~l~g 212 (664)
.+..+++|++|+|++|++++. ++..+..+++|+.|+|++|.+++.-.. ..+++|+.|++++|.+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 556677888888888888742 444556667888888888887643221 145778888888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-09 Score=113.47 Aligned_cols=152 Identities=24% Similarity=0.230 Sum_probs=103.5
Q ss_pred cEEEEEEcCCCCCC-----cCCCccccCCCCCCEEEecCCCCCCCCC-CCCCC---CCCCEEeccCCcCCC----CCccc
Q 006031 81 KVVRVVLQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGL---VNLKSLFLDHNFFTG----SFPPS 147 (664)
Q Consensus 81 ~v~~l~l~~~~l~g-----~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l---~~L~~L~L~~N~l~g----~~p~~ 147 (664)
.++.+++.++.+.+ ...+..+.++++|+.|+|++|.+.+..+ .+..+ ++|+.|++++|++++ .+...
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 46777777777663 0112356778899999999999986554 23333 449999999999883 34455
Q ss_pred ccCC-CCCCEEeccCCcCcCC----CchhhcCCCCCCeeeCcCCcCccCC----CC--CCCCCCcEEEccCCcccccCC-
Q 006031 148 LLSL-HRLKTLDLSYNNLSGP----LPKELASQGRLYSLRLDVNRFNGSI----PP--LNQSSLKIFNVSGNNFTGAIT- 215 (664)
Q Consensus 148 ~~~l-~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~l~~N~l~g~~p- 215 (664)
+..+ ++|+.|+|++|++++. ++..+..+.+|+.|+|++|.+++.- +. ..+++|+.|+|++|.+++.-.
T Consensus 132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 211 (319)
T cd00116 132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS 211 (319)
T ss_pred HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH
Confidence 6667 8899999999999853 3445667788999999999988531 11 134689999999998874321
Q ss_pred ----CCCcccccCccccccCC
Q 006031 216 ----VTSTLSRFGISSFLFNP 232 (664)
Q Consensus 216 ----~~~~l~~~~~~~~~~N~ 232 (664)
....+.++..+.+.+|+
T Consensus 212 ~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 212 ALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHHhcccCCCCEEecCCCc
Confidence 11233455666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-09 Score=115.94 Aligned_cols=128 Identities=27% Similarity=0.385 Sum_probs=104.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
...+-++|+.|.|+- + |..++.|+ |+.|.++||+++..+++++.+..|..||.+.|.+. .+|..++.|.+|+.|++
T Consensus 121 ~~lt~l~ls~NqlS~-l-p~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLSH-L-PDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhhc-C-ChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 456678888888886 3 44677776 88899999999877778888888999999999988 88888999999999988
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
..|++. .+|.+++.| .|..||+|.|+++ .||.. .|+.|++|-|.+|.|+..+
T Consensus 197 rRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 888888 788888854 6888899999888 66653 7888888999988888654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.5e-09 Score=116.24 Aligned_cols=238 Identities=21% Similarity=0.170 Sum_probs=152.9
Q ss_pred cccccCceeEEEEEEc-CCeEEEEEEccCcc-ccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 391 LLGKGSLGTTYKAVLD-NRLIVCVKRLDASK-LAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
-+-.|.++.++.+.-. .|-..+.|...... ......+....+-.+.-..+||-++...--+......+||++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5667888888876522 22222233222111 100111222222222222345666655554556778899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc---------
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA--------- 539 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~--------- 539 (664)
|...||... ..+..-.......+..+++|||.. .+.|||++|.|++...++..+++|||......
T Consensus 891 ~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 891 LPSKLHNSG-----CLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred chhhhhcCC-----CcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 999998533 233333344556778899999987 79999999999999999999999998432110
Q ss_pred ------------CCC------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh
Q 006031 540 ------------DSL------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN 595 (664)
Q Consensus 540 ------------~~~------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~ 595 (664)
... .....+|+.|.+||... +......+|.|++|++++|.++|.+||.... ++
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~t--pq 1041 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAET--PQ 1041 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcc--hh
Confidence 000 01224688899999887 5667778999999999999999999997642 22
Q ss_pred hHHHHH-HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHH
Q 006031 596 EMMNWV-RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMW 637 (664)
Q Consensus 596 ~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 637 (664)
.+.+-+ .........+.+......+++.+-+..+|.+|-.|.
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 322222 222222234445555677888888888999887665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.2e-09 Score=111.87 Aligned_cols=161 Identities=29% Similarity=0.302 Sum_probs=125.6
Q ss_pred ccccceEecCCcEE---EEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCC-CCCEEeccCCcCCCCCc
Q 006031 70 CQWQGVICYQQKVV---RVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLV-NLKSLFLDHNFFTGSFP 145 (664)
Q Consensus 70 C~w~gv~C~~~~v~---~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~-~L~~L~L~~N~l~g~~p 145 (664)
+.+.+..+....+. .+++..+.+...+ ..+..++.++.|++.+|+++-..|....++ +|+.|++++|++. .+|
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~ 156 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI--SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLP 156 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCc--hhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhh
Confidence 66677776665555 5788888875532 357777899999999999998777777775 9999999999999 888
Q ss_pred ccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccC
Q 006031 146 PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFG 224 (664)
Q Consensus 146 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~ 224 (664)
..+.++++|+.|++++|+++ .+|...+.+++|+.|++++|+++...+.. ....|+.|++++|++.-.+.....+.++.
T Consensus 157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~ 235 (394)
T COG4886 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLS 235 (394)
T ss_pred hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhccccc
Confidence 88999999999999999999 88888878999999999999998444432 55569999999997555555455555665
Q ss_pred ccccccCCCC
Q 006031 225 ISSFLFNPSL 234 (664)
Q Consensus 225 ~~~~~~N~~l 234 (664)
.+...+|...
T Consensus 236 ~l~l~~n~~~ 245 (394)
T COG4886 236 GLELSNNKLE 245 (394)
T ss_pred ccccCCceee
Confidence 5555555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-09 Score=105.74 Aligned_cols=129 Identities=25% Similarity=0.303 Sum_probs=105.4
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
-++.+||++|.++- + ..++.-++.++.|+||.|++.. +-.+..|++|+.||||+|.++ .+-.+-.+|.+.++|.|+
T Consensus 285 ~LtelDLS~N~I~~-i-DESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLITQ-I-DESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchhh-h-hhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 35679999999886 3 4478888999999999999984 344788999999999999999 777777788999999999
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCC--C-CCCCCCcEEEccCCcccccCC
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP--P-LNQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~-~~~~~L~~l~l~~N~l~g~~p 215 (664)
.|.+. .+ +.+..+-+|..||+++|++...-- . .+++-|+.+.|.+|.+.+.+.
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99986 22 357778899999999999863211 1 266789999999999998764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.7e-08 Score=109.33 Aligned_cols=148 Identities=26% Similarity=0.311 Sum_probs=111.3
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCC-CCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLD-QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~-~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..++.+++.++.++- +++ ....+. +|+.|++++|++.-.+..++.+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~~-i~~-~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNITD-IPP-LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCccccc-Ccc-ccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 368889999999987 544 677775 999999999999866557899999999999999999 8998888899999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCC-CCCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP-PLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
+++|+++ .+|..+..+..|+.|.+++|++.-.+. ...+..+..|.+++|++...+-....+..+..+.+..|
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n 265 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhccccccceeccccc
Confidence 9999999 899887777789999999995332332 33566666667777776653222233333444444443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.3e-08 Score=69.60 Aligned_cols=39 Identities=31% Similarity=0.560 Sum_probs=26.2
Q ss_pred hhHHHHHHHHHhccCCCC-CC--cCcCCCCCCCccccceEec
Q 006031 40 PSDAQVLLAFKAKADLRN-HL--FFSQNKSLHFCQWQGVICY 78 (664)
Q Consensus 40 ~~~~~aLl~~k~~~~~~~-~~--~~~~~~~~~~C~w~gv~C~ 78 (664)
++|++||++||+++..++ .. .|+.+...+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998532 33 5554433799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-08 Score=110.49 Aligned_cols=145 Identities=23% Similarity=0.295 Sum_probs=100.0
Q ss_pred HHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC----CC-------CCCCcccCccccccCC
Q 006031 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD----DD-------PDNLLYKAPETRNASH 562 (664)
Q Consensus 494 ~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~----~~-------~~~~~y~aPE~~~~~~ 562 (664)
.+++.||.|+|...++||++|.|++|.++..+..||+.|+.+......... .. ....-|.|||++. ..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-GT 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-cc
Confidence 355699999999879999999999999999999999999887654331110 00 1235699999997 46
Q ss_pred CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChh-hHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006031 563 QATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 563 ~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 640 (664)
..+.++|+||+||++|-+.. |+.-+........ ....... .........+.+.++.+=+.+.+..++..||++.++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-NAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-ccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 77889999999999999995 5554443211111 1110000 0000012344556688888999999999999776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.9e-07 Score=87.93 Aligned_cols=136 Identities=19% Similarity=0.201 Sum_probs=95.4
Q ss_pred HHHHhccccccCceeEEEEEEcCCeEEEEEEccCc--------------------cccCCcHHHHHHHHHHHcCCCCC--
Q 006031 385 MRASAELLGKGSLGTTYKAVLDNRLIVCVKRLDAS--------------------KLAGTSNEMYEQHMESVGGLRHP-- 442 (664)
Q Consensus 385 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~~~~~~~~~~~~e~~~l~~l~H~-- 442 (664)
..+.++.||-|-=+.||.|..++|.++|||.=+.. ++........++|.+.|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44567899999999999999999999999953211 01012234567899999988654
Q ss_pred CcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC
Q 006031 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG 522 (664)
Q Consensus 443 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~ 522 (664)
.|.+.++ .+...+||||+++--|...- ++....-.|+..|++-+.-.-.. |+||+|+.+-||+++
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc-CccccCCchheEEEe
Confidence 5666655 35678999999885443221 12223334444555444444455 999999999999999
Q ss_pred CCCCeEEeecccc
Q 006031 523 PDFEACLADYCLT 535 (664)
Q Consensus 523 ~~~~~ki~DfGla 535 (664)
+||.+.+.||--+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-08 Score=101.97 Aligned_cols=130 Identities=22% Similarity=0.271 Sum_probs=88.4
Q ss_pred CCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC-CcCcCCCc-hhhcCCCCCCeee
Q 006031 106 QLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY-NNLSGPLP-KELASQGRLYSLR 182 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p-~~~~~l~~L~~L~ 182 (664)
.-+.|+|..|+|+.++| .|+.+++|+.||||+|+++-.-|..|..|.+|..|-|.+ |+|+ .+| ..|++|.+|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 45667777777776665 577777788888888877766677777777776655544 7777 455 4677777777777
Q ss_pred CcCCcCccCCCCC--CCCCCcEEEccCCcccccCC-CCCcccccCccccccCCCCCC
Q 006031 183 LDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAIT-VTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 183 l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p-~~~~l~~~~~~~~~~N~~lcg 236 (664)
+.-|++.-..... .+.+|..|.+-+|.+....- ....+.....+.+.-|++.|.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence 7777776443332 56667777777777764432 123455666777888998885
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-06 Score=85.83 Aligned_cols=107 Identities=21% Similarity=0.281 Sum_probs=81.8
Q ss_pred HHHHHHHHHHHcCCCCC--CcccceEEEecCC----ceEEEEecCCCC-CHHHHhccCCCCCCCCCCHHHHHHHHHHHHH
Q 006031 426 NEMYEQHMESVGGLRHP--NLVPLRAYFQAKE----ERLLIYDYQPNG-SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498 (664)
Q Consensus 426 ~~~~~~e~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 498 (664)
.....+|...+.+++.. .+.+.+++..... ..++|+|++++. +|.+++... ..++......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 34567777777666433 3455666655432 458999999874 899998531 12566677899999999
Q ss_pred HHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeeccccccc
Q 006031 499 GLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCLTALT 538 (664)
Q Consensus 499 ~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~~ 538 (664)
.++-||+. +|+|+|++++|||++.+. .+.+.||+-++..
T Consensus 130 ~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 8899999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=89.31 Aligned_cols=253 Identities=15% Similarity=0.198 Sum_probs=154.9
Q ss_pred hccccccCceeEEEEE-EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEE----Ee--cCCc-eEE
Q 006031 389 AELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAY----FQ--AKEE-RLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~----~~--~~~~-~~l 459 (664)
++-||+|+-+.+|--- ..+. +.|+....-. ....+. +..|.+. .||-+-.=+.+ .. +... .-+
T Consensus 16 gr~LgqGgea~ly~l~e~~d~---VAKIYh~Ppp--a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQ---VAKIYHAPPP--AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchhhch---hheeecCCCc--hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4669999999999633 3222 3466543322 111111 2234333 45543221111 11 1112 446
Q ss_pred EEecCCCC-CHHHHhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 460 IYDYQPNG-SLFSLIHG-SKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 460 V~e~~~~g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
.|..+.+- -...+... .+.+......|.-.++.++.+|.+.+-||.. |.+-+|+.++|+|+++++.+.+.|-.....
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceee
Confidence 66665543 22222221 1234456689999999999999999999999 999999999999999999999988544333
Q ss_pred ccCCC-CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC-------hhhHHHH--H-
Q 006031 538 TADSL-QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTG-KPPSQHSFLV-------PNEMMNW--V- 601 (664)
Q Consensus 538 ~~~~~-~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG-~~P~~~~~~~-------~~~~~~~--~- 601 (664)
..+.. .....|...|.+||...- +..-+...|.|.+||++++++.| +.||.+.... +.++... +
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 32222 123457788999996541 22335678999999999999885 9999764321 1122111 0
Q ss_pred --H--hhccCCC---chhHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHhhhccc
Q 006031 602 --R--SAREDDG---AEDERLGMLLEVAIACNSAS--PEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 602 --~--~~~~~~~---~~~~~~~~l~~l~~~Cl~~~--P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+ ....... ...-.+..+..+..+|+... +.-|||++--+..|.+++...
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0 0001100 11223345777888898764 568999999999998887665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.2e-06 Score=81.43 Aligned_cols=138 Identities=12% Similarity=0.097 Sum_probs=101.3
Q ss_pred cccCceeEEEEEEcCCeEEEEEEccCc-c--cc-CCcHHHHHHHHHHHcCCCCCC--cccceEEEe-cC----CceEEEE
Q 006031 393 GKGSLGTTYKAVLDNRLIVCVKRLDAS-K--LA-GTSNEMYEQHMESVGGLRHPN--LVPLRAYFQ-AK----EERLLIY 461 (664)
Q Consensus 393 G~G~fg~Vy~~~~~~~~~vavK~l~~~-~--~~-~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~-~~----~~~~lV~ 461 (664)
|.||.+-|++-.+.+. .+-+|+-... . .. ......|.+|...+.++..-+ +.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6789999999877666 5778876521 1 11 335678999999998885433 44444 332 21 2467999
Q ss_pred ecCCC-CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--eEEeeccccc
Q 006031 462 DYQPN-GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE--ACLADYCLTA 536 (664)
Q Consensus 462 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~ 536 (664)
|-+++ -+|.+++.. ....+.+...+..+..+++..+.-||+. ++.|+|+.+.||+++.++. +++.||--++
T Consensus 105 e~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 588888843 1223567778889999999999999999 9999999999999986666 8999996554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-09 Score=113.88 Aligned_cols=127 Identities=31% Similarity=0.279 Sum_probs=84.0
Q ss_pred CCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCch-hhcCCCCCCeeeCc
Q 006031 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPK-ELASQGRLYSLRLD 184 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~ 184 (664)
.|...+.+.|.|.-.=.++.-++.|+.|||++|+|+ ... .+..|++|++|||++|+|+ .+|. ....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 355566666666544344555677888888888887 343 6777788888888888887 5664 223343 7888888
Q ss_pred CCcCccCCCCCCCCCCcEEEccCCccccc--CCCCCcccccCccccccCCCCCC
Q 006031 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTGA--ITVTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 185 ~N~l~g~~p~~~~~~L~~l~l~~N~l~g~--~p~~~~l~~~~~~~~~~N~~lcg 236 (664)
+|.++...--.++++|+.|||++|-|.+- +--...|..+..+++.|||--|.
T Consensus 241 nN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 88777444444777888888888877753 11224455666777788876665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-06 Score=94.29 Aligned_cols=152 Identities=16% Similarity=0.257 Sum_probs=95.9
Q ss_pred HHHHHHHHh-ccccccCceeEEEEEEcCCeEEEEEEccCcc---------------------ccC---------------
Q 006031 381 LDQLMRASA-ELLGKGSLGTTYKAVLDNRLIVCVKRLDASK---------------------LAG--------------- 423 (664)
Q Consensus 381 ~~~l~~~~~-~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------------------~~~--------------- 423 (664)
++++..... +-|+.++-|.||+|++++|+.||||+....- ...
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 344443333 5688999999999999999999999974210 000
Q ss_pred --CcHHHHHHHHHHHcCCC-----CCCcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHH
Q 006031 424 --TSNEMYEQHMESVGGLR-----HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV 496 (664)
Q Consensus 424 --~~~~~~~~e~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 496 (664)
..+-+|.+|...+.+++ .+++.--.=|+.-.....|+|||++|-.+.+...- .....+ +..++..+
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l----~~~g~d---~k~ia~~~ 273 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL----KSAGID---RKELAELL 273 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH----HhcCCC---HHHHHHHH
Confidence 01122445555554442 33333222233345678999999999888877421 112233 33344444
Q ss_pred HHHH-HHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 497 AQGL-SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 497 a~~L-~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+++. ..+-.. +++|.|..|.||+++.++++.+.|||+.....+
T Consensus 274 ~~~f~~q~~~d-gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 274 VRAFLRQLLRD-GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHhc-CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4331 111123 899999999999999999999999999876544
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.6e-07 Score=63.65 Aligned_cols=37 Identities=46% Similarity=0.612 Sum_probs=23.3
Q ss_pred CCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCc
Q 006031 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165 (664)
Q Consensus 128 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 165 (664)
++|++|+|++|+++ .+|+.|++|++|++|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35666666666666 56666666666666666666666
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.4e-08 Score=84.26 Aligned_cols=104 Identities=22% Similarity=0.212 Sum_probs=80.3
Q ss_pred EEEEEcCCCCCCcCC--CccccCCCCCCEEEecCCCCCCCCCCCCC-CCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 83 VRVVLQGLDLGGIFA--PNSLTKLDQLRVLGLQNNSLTGPIPDLSG-LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 83 ~~l~l~~~~l~g~~~--p~~l~~l~~L~~L~L~~N~l~g~~p~~~~-l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++|++..|.- ++ +..+....+|+..+|++|.|...+|.|.. ++-++.|+|++|.++ .+|.++..++.|+.|++
T Consensus 30 h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 30 HFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 345555555442 11 12455667788889999999877777655 458889999999998 89999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFN 189 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 189 (664)
++|.|. ..|..+..|.+|-.|+..+|.+-
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 999998 78888888888888888888775
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-08 Score=108.76 Aligned_cols=124 Identities=28% Similarity=0.331 Sum_probs=95.9
Q ss_pred EEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCccc-ccCCCCCCEEeccC
Q 006031 83 VRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPS-LLSLHRLKTLDLSY 161 (664)
Q Consensus 83 ~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~~ 161 (664)
...+.+.|.|.-. ..+|.-|+.|+.|||++|+|+..- .+..|++|++|||++|+|. .+|.- ...+ .|+.|+|+|
T Consensus 167 ~~a~fsyN~L~~m--D~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrn 241 (1096)
T KOG1859|consen 167 ATASFSYNRLVLM--DESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRN 241 (1096)
T ss_pred hhhhcchhhHHhH--HHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhh-hheeeeecc
Confidence 3445556666543 347888999999999999998543 6888999999999999999 77753 2333 399999999
Q ss_pred CcCcCCCchhhcCCCCCCeeeCcCCcCccCC---CCCCCCCCcEEEccCCccccc
Q 006031 162 NNLSGPLPKELASQGRLYSLRLDVNRFNGSI---PPLNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 162 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~---p~~~~~~L~~l~l~~N~l~g~ 213 (664)
|.++ .+ ..+.+|.+|+.|||++|-|++.- |-+.+..|..|+|.+|.+.-.
T Consensus 242 N~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 242 NALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9997 32 35778999999999999887643 334677889999999988643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.8e-07 Score=92.95 Aligned_cols=131 Identities=26% Similarity=0.234 Sum_probs=66.8
Q ss_pred CcEEEEEEcCCCCCCcCCC-ccccCCCCCCEEEecCCCCCCCCCC--CCCCCCCCEEeccCCcCC---------------
Q 006031 80 QKVVRVVLQGLDLGGIFAP-NSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFT--------------- 141 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p-~~l~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~L~~N~l~--------------- 141 (664)
..|+.|||+.|-+..-.+- .-...|++|+.|+|+.|.|.-.+.+ -..++.|+.|.|+.+.|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 4577777777766542111 1234577777777777777644431 112444455555544444
Q ss_pred ----------CCCcccccCCCCCCEEeccCCcCcCCCc--hhhcCCCCCCeeeCcCCcCccC-CCC-------CCCCCCc
Q 006031 142 ----------GSFPPSLLSLHRLKTLDLSYNNLSGPLP--KELASQGRLYSLRLDVNRFNGS-IPP-------LNQSSLK 201 (664)
Q Consensus 142 ----------g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~-~p~-------~~~~~L~ 201 (664)
+..-.....+..|++|||++|++- ..+ ...+.++.|..|+++.+.++.. +|+ ....+|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 111122222445556666655554 233 2345555555555555555431 121 1445667
Q ss_pred EEEccCCccc
Q 006031 202 IFNVSGNNFT 211 (664)
Q Consensus 202 ~l~l~~N~l~ 211 (664)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 7777777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.8e-07 Score=80.67 Aligned_cols=111 Identities=19% Similarity=0.232 Sum_probs=90.3
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+++.++|++|.+.. +|+..-...+.++.|+|++|.|+..+.++..++.|+.|++++|.|. ..|..+..|.+|-.||.
T Consensus 53 ~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 478889999999997 6664445567999999999999976668999999999999999999 89999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 193 (664)
.+|.+. +||-.+.--+++-..++.+|.+.+.-|
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999998 888775444444445556666655433
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.2e-06 Score=61.01 Aligned_cols=40 Identities=38% Similarity=0.508 Sum_probs=32.4
Q ss_pred CCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCc
Q 006031 105 DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p 145 (664)
++|++|+|++|+|+...|++++|++|+.|+|++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 4799999999999965555999999999999999998 443
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.4e-05 Score=75.79 Aligned_cols=136 Identities=15% Similarity=0.180 Sum_probs=83.2
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC--cccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN--LVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 2445677877532 23455688998888886444 356777777777788999999986
Q ss_pred C-HHHH---------------------hccCCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc---CCcc
Q 006031 468 S-LFSL---------------------IHGSKSTRAKPLHWTSCL-KIAE----------DVAQ-GLSYIHQA---WRLV 510 (664)
Q Consensus 468 s-L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~---~~iv 510 (664)
+ +... +|.... ....+ .... .+.. .+.. ...+|... ..++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 3 2111 222110 01111 1110 0100 0111 12333321 2578
Q ss_pred cCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 511 HGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 511 HrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
|+|+.|.||++++++ +.|.||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999998664
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.2e-06 Score=94.78 Aligned_cols=181 Identities=16% Similarity=0.140 Sum_probs=130.2
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC-cccceEEEecCCceEEEEecCCCC-
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN-LVPLRAYFQAKEERLLIYDYQPNG- 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g- 467 (664)
+-+++|+++++||.+-...+....+.+. .....+-++++|.+++||| .+..++-+..++...++++|+..+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs-------~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVS-------QTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeec-------cchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 4578999999999874333333344432 2255667889999999999 777777777778889999999876
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~ 546 (664)
+...... .....+...+...+.+.-+++++|+|+. .-+||| ||+..+ +..+..||+....+.... ....
T Consensus 321 s~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 321 SSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred cccccCC----hhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence 2221111 1122344445566777888999999987 568998 777665 678999999887655442 2345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~ 588 (664)
.++..|+|||+.. ...+..+.|+|+.|+--.++--|-+|-.
T Consensus 391 ~~~~~~~~pev~~-~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQ-ENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhc-ccccccCCCccCCCcchhhcCCCCCCCC
Confidence 6889999999886 6677888999999987777777777644
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.7e-07 Score=92.48 Aligned_cols=149 Identities=21% Similarity=0.180 Sum_probs=99.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--C-CCCCCCCCEEeccCCcCCCCCcccc-cCCCCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--D-LSGLVNLKSLFLDHNFFTGSFPPSL-LSLHRLK 155 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~-~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~ 155 (664)
..+..+.|.+....-.-.......|++++.||||.|-|+..-| . ...|++|+.|+||.|+|.-.+-... ..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 3566666666655431111356789999999999999987555 2 4579999999999999984443332 3577889
Q ss_pred EEeccCCcCcCC-CchhhcCCCCCCeeeCcCCc--CccCCCCCCCCCCcEEEccCCcccccC--CCCCcccccCcccc
Q 006031 156 TLDLSYNNLSGP-LPKELASQGRLYSLRLDVNR--FNGSIPPLNQSSLKIFNVSGNNFTGAI--TVTSTLSRFGISSF 228 (664)
Q Consensus 156 ~L~l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~--l~g~~p~~~~~~L~~l~l~~N~l~g~~--p~~~~l~~~~~~~~ 228 (664)
.|.|+...|+-. +-.-+..+++|..|+|..|. +....+...+..|+.|||++|++-... +..+.+..+..+++
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 999998888721 22234567889999998884 112222335667888999988886543 44455555555443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.5e-06 Score=94.70 Aligned_cols=107 Identities=35% Similarity=0.311 Sum_probs=54.3
Q ss_pred ccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCe
Q 006031 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYS 180 (664)
Q Consensus 101 l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 180 (664)
+..+++|+.|+|.+|+|.+.-..+..+++|++|+|++|.++...+ +..++.|+.|++++|.++ .+ ..+..+.+|+.
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~~ 166 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DI-SGLESLKSLKL 166 (414)
T ss_pred cccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hc-cCCccchhhhc
Confidence 555555555555555555433335555555555555555552221 334444555555555554 22 22333555555
Q ss_pred eeCcCCcCccCCC--CCCCCCCcEEEccCCccc
Q 006031 181 LRLDVNRFNGSIP--PLNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 181 L~l~~N~l~g~~p--~~~~~~L~~l~l~~N~l~ 211 (664)
+++++|+++..-+ ...+.+|+.+++++|.+.
T Consensus 167 l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 167 LDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred ccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 5555555553333 144455555555555544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 664 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-29 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-61
Identities = 94/319 (29%), Positives = 157/319 (49%), Gaps = 47/319 (14%)
Query: 371 FCAGEAQLYTLDQLMRA-----SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS 425
G+ + ++L +L A + +LG+G G YK L + +V VKRL + G
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 426 NE-MYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPL 484
+ E +E + H NL+ LR + ERLL+Y Y NGS+ S + ++ PL
Sbjct: 72 LQFQTE--VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPL 128
Query: 485 HWTSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
W +IA A+GL+Y+H +++H ++K++N+LL +FEA + D+ L L
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----- 183
Query: 543 QDDDPDN---------LLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFL 592
D D + + APE S +++ K+DV+ +GV+LLEL+TG+ + L
Sbjct: 184 -MDYKDTHVTTAVRGTIGHIAPEY--LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 593 VPNEMMN---WVRSAREDDGAE---DERLG---------MLLEVAIACNSASPEQRPTMW 637
++ + WV+ ++ E D L L++VA+ C +SP +RP M
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 638 QVLKMLQEIKGAVLMEDGE 656
+V++ML +G L E E
Sbjct: 301 EVVRML---EGDGLAERWE 316
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 89/324 (27%), Positives = 133/324 (41%), Gaps = 45/324 (13%)
Query: 354 KVKRAQGIQVAKSGNLVFCAGEAQLYTLDQLMRA-----SAELLGKGSLGTTYKAVLDNR 408
K +A + E+ L L A L+G G G YK VL +
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 409 LIVCVKRLDASKLAGTS---NEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465
V +KR G E+ E++ RHP+LV L + + E +LIY Y
Sbjct: 64 AKVALKRRTPESSQGIEEFETEI-----ETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF 525
NG+L ++GS + W L+I A+GL Y+H ++H ++KS N+LL +F
Sbjct: 119 NGNLKRHLYGSDLPT-MSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF 176
Query: 526 EACLADYCLTALTADSLQDDDPDNLL--------YKAPETRNASHQATSKSDVYSFGVLL 577
+ D+ + + + D +L Y PE + T KSDVYSFGV+L
Sbjct: 177 VPKITDFGI----SKKGTELDQTHLSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVL 231
Query: 578 LELLTGKPPSQHSFLVPNEMMN---WVRSAREDDGAE---DERLG---------MLLEVA 622
E+L + S P EM+N W + + E D L + A
Sbjct: 232 FEVLCARSAIVQSL--PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA 289
Query: 623 IACNSASPEQRPTMWQVLKMLQEI 646
+ C + S E RP+M VL L+
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-53
Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 46/312 (14%)
Query: 369 LVFCAGEAQLYTLDQLMRA-----------SAELLGKGSLGTTYKAVLDNRLIVCVKRLD 417
L ++ +L +G+G G YK ++N V VK+L
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLA 63
Query: 418 ASKLAGTS--NEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHG 475
A T + ++Q ++ + +H NLV L + ++ L+Y Y PNGSL +
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 476 SKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535
T PL W KIA+ A G++++H+ +H ++KS+N+LL F A ++D+ L
Sbjct: 124 LDGT--PPLSWHMRCKIAQGAANGINFLHENHH-IHRDIKSANILLDEAFTAKISDFGL- 179
Query: 536 ALTADSLQDDDPDNLL--------YKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPP 586
A + + + Y APE A + T KSD+YSFGV+LLE++TG P
Sbjct: 180 ---ARASEKFAQTVMTSRIVGTTAYMAPE---ALRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 587 SQHSFLVPNEMMNWVRSAREDDGA----EDERLG--------MLLEVAIACNSASPEQRP 634
P +++ +++ D+++ + VA C +RP
Sbjct: 234 VDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 635 TMWQVLKMLQEI 646
+ +V ++LQE+
Sbjct: 293 DIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-53
Identities = 66/297 (22%), Positives = 108/297 (36%), Gaps = 50/297 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E+ +G G +KA L N V VK NE + S+ G++H N++
Sbjct: 30 EVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSWQNE---YEVYSLPGMKHENILQFIG 85
Query: 450 Y----FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ LI + GSL + + W IAE +A+GL+Y+H+
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE 139
Query: 506 AWRL---------VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----Y 552
H ++KS NVLL + AC+AD+ L D + Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 553 KAPE----TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHS---FLVPNEMMNWVRSAR 605
APE N A + D+Y+ G++L EL + + +++P E +
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259
Query: 606 ED----------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
ED + + ML E C E R + V + + ++
Sbjct: 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 58/298 (19%), Positives = 108/298 (36%), Gaps = 50/298 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +GKG G ++ V VK + + + E + LRH N++ A
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 450 ----YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ L+ DY +GSLF ++ + +K+A A GL+++H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHM 157
Query: 506 AWR-------LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLY 552
+ H +LKS N+L+ + C+AD L + D Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 553 KAPE----TRNASHQ-ATSKSDVYSFGVLLLELLTGKPPSQH--SFLVPNEMMNWVRSAR 605
APE + N H + ++D+Y+ G++ E+ + +P + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 606 ED----------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
E+ E L ++ ++ C A+ R T ++ K L ++
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 66/308 (21%), Positives = 103/308 (33%), Gaps = 61/308 (19%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL-- 447
EL+G+G G YK LD R V VK + NE +++ V + H N+
Sbjct: 19 ELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQNFINE---KNIYRVPLMEHDNIARFIV 74
Query: 448 ---RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
R + E LL+ +Y PNGSL + W S ++A V +GL+Y+H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLH 128
Query: 505 QAWRL--------VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----- 551
H +L S NVL+ D ++D+ L+ + +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 552 -----YKAPE------TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW 600
Y APE A + D+Y+ G++ E+ VP M +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 601 VRSAREDDGAEDER----------------------LGMLLEVAIACNSASPEQRPTMWQ 638
ED + + L E C E R T
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308
Query: 639 VLKMLQEI 646
+ + E+
Sbjct: 309 AEERMAEL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 50/297 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +GKG G ++ V VK + + E + + LRH N++ A
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 450 Y----FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ + LI Y GSL+ + L SCL+I +A GL+++H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 506 AWRL-------VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLY 552
H +LKS N+L+ + + C+AD L + + S D N Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 553 KAPE-----TRNASHQATSKSDVYSFGVLLLELLTGKPPSQH--SFLVPNEMMNWVRSAR 605
APE + + + D+++FG++L E+ + + P + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 606 ED----------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
ED D L L ++ C +P R T ++ K L +I
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 54/271 (19%), Positives = 107/271 (39%), Gaps = 30/271 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR- 448
L + G +K + VK L + + + + + HPN++P+
Sbjct: 16 TKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 449 AYFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-QA 506
A LI + P GSL++++H + + +K A D+A+G++++H
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD-NLLYKAPE--TRNASHQ 563
+ L S +V++ D A ++ + S Q + APE +
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADV----KFSFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM------ 617
+D++SF VLL EL+T + P L E+ V E R +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD--LSNMEIGMKV-------ALEGLRPTIPPGISP 238
Query: 618 -LLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ ++ C + P +RP ++ +L++++
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 65/298 (21%), Positives = 109/298 (36%), Gaps = 50/298 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +GKG G + V VK ++ A + E + +RH N++ A
Sbjct: 43 KQIGKGRYGEVWMGKWRGE-KVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 450 Y----FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ + LI DY NGSL+ + L S LK+A GL ++H
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 506 AWRL-------VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLY 552
H +LKS N+L+ + C+AD L + D Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 553 KAPE----TRNASHQ-ATSKSDVYSFGVLLLELLTGKPPSQH--SFLVPNEMMNWVRSAR 605
PE + N +H + +D+YSFG++L E+ + +P + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 606 ED----------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
ED + DE L + ++ C + +P R T +V K L ++
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 66/188 (35%), Positives = 89/188 (47%), Gaps = 15/188 (7%)
Query: 40 PSDAQVLLAFKAKADLRNHLFFSQ-NKSLHFCQ--WQGVIC----YQQKVVRVVLQGLDL 92
P D Q LL K DL N S + C W GV+C +V + L GL+L
Sbjct: 5 PQDKQALLQIKK--DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 93 GGIFA-PNSLTKLDQLRVLGLQN-NSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLL 149
+ P+SL L L L + N+L GPIP ++ L L L++ H +G+ P L
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 150 SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIF-NVS 206
+ L TLD SYN LSG LP ++S L + D NR +G+IP + S L +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 207 GNNFTGAI 214
N TG I
Sbjct: 183 RNRLTGKI 190
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 46/159 (28%), Positives = 65/159 (40%), Gaps = 12/159 (7%)
Query: 87 LQGLDL------GGIFAPNSLTKLDQL-RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
L G+ G I P+S +L + + N LTG IP +NL + L N
Sbjct: 151 LVGITFDGNRISGAI--PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQ 197
G S + + L+ N+L+ L ++ L L L NR G++P
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 198 SSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCG 236
L NVS NN G I L RF +S++ N LCG
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 9/113 (7%)
Query: 87 LQGLDL------GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L +DL G + + L NSL + + NL L L +N
Sbjct: 199 LAFVDLSRNMLEGDA--SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI 256
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193
G+ P L L L +L++S+NNL G +P+ Q R N+ P
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ-RFDVSAYANNKCLCGSP 308
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 50/285 (17%)
Query: 390 ELLGKGSLGTTYKAVLDNR-LIVCVKRLDASKLAGTSN-----EMYEQHMESVGGLRHPN 443
+ +GKG G +K L +V +K L G + + +++ + + L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+V L ++ ++ P G L+ + +A P+ W+ L++ D+A G+ Y+
Sbjct: 85 IVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 504 H-QAWRLVHGNLKSSNVLLGP------------DF-EACLADYCLTALTADSLQDDDPDN 549
Q +VH +L+S N+ L DF + + + ++ L N
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---------GN 189
Query: 550 LLYKAPETRNASHQA-TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD 608
+ APET A ++ T K+D YSF ++L +LTG+ P + ++ RE
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---YSYGKIKFINMIRE-- 244
Query: 609 GAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
E R + L V C S P++RP ++K L E+
Sbjct: 245 --EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +G GS GT ++A V VK L + + + + LRHPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-QAWR 508
++ +Y GSL+ L+H KS + L L +A DVA+G++Y+H +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQATS 566
+VH NLKS N+L+ + + D+ L+ L A + + APE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNE 218
Query: 567 KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM-------LL 619
KSDVYSFGV+L EL T + P + L P +++ V G + +RL + +
Sbjct: 219 KSDVYSFGVILWELATLQQPWGN--LNPAQVVAAV-------GFKCKRLEIPRNLNPQVA 269
Query: 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651
+ C + P +RP+ ++ +L+ + + +
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-38
Identities = 66/276 (23%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSN--EMYEQHMESVGGLRHPNLVPL 447
E++G G G Y+A V VK S E Q + L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-- 505
R + L+ ++ G L ++ G K + + A +A+G++Y+H
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 506 AWRLVHGNLKSSNVLLGPDFEAC--------LADYCLTALTADSLQDDDPDNLLYKAPET 557
++H +LKSSN+L+ E + D+ L + + + APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617
AS + SDV+S+GVLL ELLTG+ P + + + V L +
Sbjct: 186 IRASM-FSKGSDVWSYGVLLWELLTGEVPFRG--IDGLAVAYGV-------AMNKLALPI 235
Query: 618 -------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
++ C + P RP+ +L L I
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/276 (21%), Positives = 121/276 (43%), Gaps = 23/276 (8%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E++G+G+ G KA + V +K++++ + + + + + HPN+V L
Sbjct: 14 EVVGRGAFGVVCKAKWRAK-DVAIKQIESESE----RKAFIVELRQLSRVNHPNIVKLYG 68
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ--AW 507
L+ +Y GSL++++HG++ + +QG++Y+H
Sbjct: 69 A--CLNPVCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 508 RLVHGNLKSSNVLLGPDFEAC-LADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATS 566
L+H +LK N+LL + D+ + ++ + + APE S+ +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSN-YSE 182
Query: 567 KSDVYSFGVLLLELLTGKPP----SQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
K DV+S+G++L E++T + P +F + + N R + + + L+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL--PKPIESLMT-- 238
Query: 623 IACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELD 658
C S P QRP+M +++K++ + D L
Sbjct: 239 -RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-37
Identities = 54/196 (27%), Positives = 78/196 (39%), Gaps = 12/196 (6%)
Query: 29 SRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQ 88
S AS SL + L++FK +N L + + + C + GV C KV + L
Sbjct: 1 SFQASPSQSL-YREIHQLISFKDVLPDKNLLP-DWSSNKNPCTFDGVTCRDDKVTSIDLS 58
Query: 89 GLDLGGIFA--PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPP 146
L F+ +SL L L L L N+ + G + +L SL L N +G
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTT 118
Query: 147 --SLLSLHRLKTLDLSYNNLSGPLPKELASQ-GRLYSLRLDVNRFNGSIPPL-----NQS 198
SL S LK L++S N L P + L L L N +G+
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 199 SLKIFNVSGNNFTGAI 214
LK +SGN +G +
Sbjct: 179 ELKHLAISGNKISGDV 194
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 15/137 (10%)
Query: 87 LQGLDLGGIFAPNSLT------KLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ L + G N ++ + L L + +N+ + IP L L+ L + N
Sbjct: 180 LKHLAISG----NKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKL 235
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQ 197
+G F ++ + LK L++S N GP+P L L L N+F G IP
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFLSGAC 293
Query: 198 SSLKIFNVSGNNFTGAI 214
+L ++SGN+F GA+
Sbjct: 294 DTLTGLDLSGNHFYGAV 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 48/137 (35%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 87 LQGLDL------GGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139
LQ L L G I P +L+ +L L L N L+G IP L L L+ L L N
Sbjct: 396 LQELYLQNNGFTGKI--PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQ 197
G P L+ + L+TL L +N+L+G +P L++ L + L NR G IP
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 198 SSLKIFNVSGNNFTGAI 214
+L I +S N+F+G I
Sbjct: 514 ENLAILKLSNNSFSGNI 530
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-29
Identities = 50/140 (35%), Positives = 71/140 (50%), Gaps = 14/140 (10%)
Query: 87 LQGLDL------GGIFAPNSLTKL-DQLRVLGLQNNSLTGPIPDLSG---LVNLKSLFLD 136
L+ LDL G + P SLT L L L L +N+ +GPI L+ L+L
Sbjct: 345 LKVLDLSFNEFSGEL--PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-- 194
+N FTG PP+L + L +L LS+N LSG +P L S +L L+L +N G IP
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 195 LNQSSLKIFNVSGNNFTGAI 214
+ +L+ + N+ TG I
Sbjct: 463 MYVKTLETLILDFNDLTGEI 482
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-28
Identities = 58/181 (32%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 87 LQGLDLGGIFAPNSLT------KLDQLRVLGLQNNSLTGPIPD-LSG-LVNLKSLFLDHN 138
L+ L++ N L L+ L L N TG IPD LSG L L L N
Sbjct: 249 LKLLNISS----NQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPP--- 194
F G+ PP S L++L LS NN SG LP + L L L L N F+G +P
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 195 LNQSSLKIFNVSGNNFTGAITVTSTLSRFGISS----FLFNPSLCGEIIHKECNPRPPFF 250
+SL ++S NNF+G I L + ++ +L N G+I PP
Sbjct: 365 NLSASLLTLDLSSNNFSGPI--LPNLCQNPKNTLQELYLQNNGFTGKI--------PPTL 414
Query: 251 G 251
Sbjct: 415 S 415
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-27
Identities = 39/165 (23%), Positives = 60/165 (36%), Gaps = 31/165 (18%)
Query: 87 LQGLDL------GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNF 139
++ G + + L + N L+G IP + + L L L HN
Sbjct: 610 RNPCNITSRVYGGHT--SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
+GS P + L L LDLS N L G +P+ ++ +
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS----------------------ALTM 705
Query: 200 LKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECN 244
L ++S NN +G I F + FL NP LCG + +
Sbjct: 706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 50/154 (32%), Positives = 60/154 (38%), Gaps = 11/154 (7%)
Query: 87 LQGLDL------GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNF 139
L+ L L G I P L + L L L N LTG IP LS NL + L +N
Sbjct: 444 LRDLKLWLNMLEGEI--PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQ 197
TG P + L L L LS N+ SG +P EL L L L+ N FNG+IP Q
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 198 SSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231
S N I + L
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 60/270 (22%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +G GS GT YK V VK L+ + + ++ + + RH N++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
Y + ++ + SL+ +H S+ + IA A+G+ Y+H +
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAK-SI 141
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPET-RNASHQA 564
+H +LKS+N+ L D + D+ L + + +L+ APE R
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 565 -TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV--RSAREDDGAE-----DERLG 616
+ +SDVY+FG++L EL+TG+ P + + + + + R + D ++ +R+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSN--INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 617 MLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L+ C ++RP+ ++L ++E+
Sbjct: 260 RLMA---ECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
EL+GKG G Y V ++ +D + + +++ + + RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ +I +L+S++ +K L +IA+++ +G+ Y+H +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK-GI 151
Query: 510 VHGNLKSSNVLLG------PDF-EACLADYCLTALTADSLQDDDPDNLLYKAPE------ 556
+H +LKS NV DF ++ D L+ L + APE
Sbjct: 152 LHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQ-NGWLCHLAPEIIRQLS 210
Query: 557 --TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV--RSAREDDGAED 612
T + SDV++ G + EL + P + P E + W + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAIIWQMGTGMKPNLSQIG 267
Query: 613 --ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ + +L C + E+RPT +++ ML+++
Sbjct: 268 MGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 54/283 (19%), Positives = 106/283 (37%), Gaps = 42/283 (14%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E+LGKG G K + ++ +K L + + + + ++ + L HPN++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ I +Y G+L +I + W+ + A+D+A G++Y+H
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHS-MN 128
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------------- 553
++H +L S N L+ + +AD+ L L D + L K
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 554 -APETRNASHQA-TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
APE + ++ K DV+SFG++L E++ +
Sbjct: 189 MAPEM--INGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------YLPRTMDFGLNVRG 238
Query: 612 DERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ + C PE+RP+ ++ L+ ++
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ LG+G L + +KR+ + E M + HPN++ L
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL--FNHPNILRLV 92
Query: 449 AYF----QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
AY AK E L+ + G+L++ I + L L + + +GL IH
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCL---------TALTADSLQDDDPDN--LLYK 553
H +LK +N+LLG + + L D + A +LQD + Y+
Sbjct: 152 AK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 554 APE-TRNASHQA-TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE----- 606
APE SH ++DV+S G +L ++ G+ P + + + + V A +
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALAVQNQLSI 266
Query: 607 -DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650
L LL + + P QRP + +L L+ ++
Sbjct: 267 PQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+GS T YK + + + V L KL + + +++ E + GL+HPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 449 AYF---QAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ ++ +++ + +G+L + + R K + + +GL ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 505 -QAWRLVHGNLKSSNVLL-GPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASH 562
+ ++H +LK N+ + GP + D L L S + APE +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY 206
Query: 563 QATSKSDVYSFGVLLLELLTGKPP 586
DVY+FG+ +LE+ T + P
Sbjct: 207 --DESVDVYAFGMCMLEMATSEYP 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ-----HMESVGGLRHPNL 444
LGKG G Y A ++ I+ +K L ++L + Q ++S LRHPN+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSH--LRHPNI 71
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ L YF LI +Y P G+++ + + ++A LSY H
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH 126
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---PDNLLYKAPE-TRNA 560
R++H ++K N+LLG E +AD+ + S + D D Y PE
Sbjct: 127 SK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPEMIEGR 182
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
H K D++S GVL E L GKPP
Sbjct: 183 MH--DEKVDLWSLGVLCYEFLVGKPP 206
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 31/137 (22%), Positives = 50/137 (36%), Gaps = 9/137 (6%)
Query: 87 LQGLDLG-----GIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFF 140
L+ LD + + L L L + + +GL +L+ L + N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQ 197
+F P + + L L LDLS L P S L L + N F
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 198 SSLKIFNVSGNNFTGAI 214
+SL++ + S N+ +
Sbjct: 518 NSLQVLDYSLNHIMTSK 534
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-22
Identities = 32/135 (23%), Positives = 45/135 (33%), Gaps = 9/135 (6%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L LD+ + L L VL + NS + L NL L L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQ 197
P + SL L+ L++S+NN L L +N S
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 198 SSLKIFNVSGNNFTG 212
SSL N++ N+F
Sbjct: 543 SSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 28/136 (20%), Positives = 44/136 (32%), Gaps = 10/136 (7%)
Query: 87 LQGLDLGGI------FAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ LDL S L+ L L N + + GL L+ L H+
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 141 TGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---N 196
S+ SL L LD+S+ + L L++ N F + P
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 197 QSSLKIFNVSGNNFTG 212
+L ++S
Sbjct: 469 LRNLTFLDLSQCQLEQ 484
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 26/134 (19%), Positives = 42/134 (31%), Gaps = 8/134 (5%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
+ LDL S +L+VL L + L +L +L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQS 198
+ L L+ L NL+ + L L + N P N +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 199 SLKIFNVSGNNFTG 212
+L+ ++S N
Sbjct: 150 NLEHLDLSSNKIQS 163
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 32/140 (22%), Positives = 47/140 (33%), Gaps = 11/140 (7%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L L L G A + + L L+ L +L + L LK L + HN
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 142 G-SFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS----QGRLYSLRLDVNRFNGSIP-PL 195
P +L L+ LDLS N + +L SL L +N N P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 196 NQSSLKIFNVSGNNFTGAIT 215
+ L + N + +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVM 217
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 24/118 (20%), Positives = 32/118 (27%), Gaps = 9/118 (7%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
P S LD L N L L+ L L + SL L T
Sbjct: 27 PFSTKNLD------LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212
L L+ N + + L L + +LK NV+ N
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 7/123 (5%)
Query: 98 PNSLTKLDQLRVLGLQNNSLT--GPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRL 154
S L L L L N L+ G G +LK L L N + L L +L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 155 KTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFT 211
+ LD ++NL S L L + + + SSL++ ++GN+F
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 212 GAI 214
Sbjct: 459 ENF 461
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 29/150 (19%), Positives = 43/150 (28%), Gaps = 23/150 (15%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT----- 141
L LD + L + L + ++ + D S + L L + F
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 142 --------------GSFPPSLLSLHRLKTLDLSYNNLS--GPLPKELASQGRLYSLRLDV 185
G S + L L+ LDLS N LS G + L L L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 186 NRFNGSIPP-LNQSSLKIFNVSGNNFTGAI 214
N L L+ + +N
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMS 412
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 24/144 (16%), Positives = 34/144 (23%), Gaps = 18/144 (12%)
Query: 87 LQGLDLG-----GIFAPNSLTKLDQLRVLGLQNNSLTG-------PIPDLSGLVNLKSLF 134
L L L + L L V L L GL NL
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 135 LDHN---FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
++ L + + L + + L L +F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ- 318
Query: 192 IPPLNQSSLKIFNVSGNNFTGAIT 215
P L SLK + N A +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-22
Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVP 446
E +G+G+ G + L + +V VK + + + + + HPN+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL---KQYSHPNIVR 176
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L K+ ++ + G + + T L + L++ D A G+ Y+
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDDPDNLLYK--APETRNASH 562
+H +L + N L+ ++D+ ++ AD + + K APE N
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN-YG 290
Query: 563 QATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW-VRSAREDDGAEDERL----- 615
+ +S+SDV+SFG+LL E + G P + N R E G RL
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYP-------NLSNQQTREFVEKGG----RLPCPEL 339
Query: 616 --GMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ + C + P QRP+ + + LQ I+
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-22
Identities = 28/142 (19%), Positives = 52/142 (36%), Gaps = 17/142 (11%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
+Q + +G SL K+ +L +L N L G +P + L SL L +N T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 142 GSFPPSLLS-LHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNG-------SI 192
P + +++ L ++N L P + S + ++ N +
Sbjct: 367 E-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 193 PP--LNQSSLKIFNVSGNNFTG 212
P ++ N+S N +
Sbjct: 426 DPTPFKGINVSSINLSNNQISK 447
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 23/126 (18%), Positives = 42/126 (33%), Gaps = 12/126 (9%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRL 154
+ L + L+ N LT + D + L L + L +N F+ FP L+ L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 155 KTL------DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGN 208
K D N P+ + L L++ N + ++ + ++ N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDN 597
Query: 209 NFTGAI 214
Sbjct: 598 PNISID 603
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGP---------IPDLSGLVNLKSLFLDHN-FFTGSFPPS 147
P L L +++++ + N + D ++ +++ +N T S
Sbjct: 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS 325
Query: 148 LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNV 205
L + +L L+ YN L G LP S+ +L SL L N+ ++ +
Sbjct: 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSF 384
Query: 206 SGNNFTG 212
+ N
Sbjct: 385 AHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 14/159 (8%), Positives = 42/159 (26%), Gaps = 33/159 (20%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--------------------DLSG 126
++ + ++ +L +LR + N+
Sbjct: 190 QLSNNITFV--SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN 247
Query: 127 LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNL--------SGPLPKELASQGRL 178
L +L + + + P L +L ++ ++++ N + ++
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 179 YSLRLDVNRF-NGSIPPL--NQSSLKIFNVSGNNFTGAI 214
+ + N + L + N G +
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 20/149 (13%), Positives = 44/149 (29%), Gaps = 23/149 (15%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPI--------PDLSGLVNLKSL 133
++ L I + + + N + P +N+ S+
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 134 FLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSG-------PLPKELASQGRLYSLRLDVN 186
L +N + + L +++L N L+ + + L S+ L N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 187 RFNG---SIPPLNQSSLKIFNVSGNNFTG 212
+ L ++S N+F+
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 14/151 (9%), Positives = 38/151 (25%), Gaps = 11/151 (7%)
Query: 87 LQGLDLGGIF----APNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L + S + +G +N++T + L L+ ++ ++ F
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSL 200
+ Y + + L + + +P +
Sbjct: 221 ENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 201 KIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231
++ NV+ N + +
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 25/180 (13%), Positives = 45/180 (25%), Gaps = 22/180 (12%)
Query: 42 DAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSL 101
D L + +N W + LD+ G SL
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPG-ANWNF------------NKELDMWGAQPGVSL 77
Query: 102 TKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTG----SFPPSLLSLHRLKT 156
++ L L+ +G +PD + L L+ L L + P + + +
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 157 LDLSYNNLSGPLPKELASQG--RLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212
+ + L ++ + SI NN T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 18/136 (13%), Positives = 39/136 (28%), Gaps = 16/136 (11%)
Query: 87 LQGLDLG-----GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDH---- 137
L +DL + T L L + L NS + LK + +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDA 549
Query: 138 --NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP- 194
N +P + L L + N++ + +++ + L + N
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPN--ISVLDIKDNPNISIDLSY 606
Query: 195 -LNQSSLKIFNVSGNN 209
++ + +
Sbjct: 607 VCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 18/160 (11%), Positives = 36/160 (22%), Gaps = 33/160 (20%)
Query: 87 LQGLDLGG--------IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSG---LVNLKSLFL 135
L+ L LG +F P ++ D +L +
Sbjct: 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166
Query: 136 DHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
+ + S S + + NN++ + K + +L + + F
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225
Query: 196 ---------------------NQSSLKIFNVSGNNFTGAI 214
N L V +
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 15/106 (14%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 124 LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGP----LPKELASQGRLY 179
L+ + L L+ +G P ++ L L+ L L + PK +++
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 180 SLRLDVNRFNGSIPP----LNQSSLKIFNVSGNNFTGAITVTSTLS 221
+ + + + S L ++ + +I +S ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 10/68 (14%), Positives = 20/68 (29%), Gaps = 2/68 (2%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
P +T L L + +N + + + N+ L + N +
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 158 DLSYNNLS 165
L Y+
Sbjct: 617 MLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/111 (16%), Positives = 32/111 (28%), Gaps = 12/111 (10%)
Query: 136 DHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
+ + + SL S R+ L L SG +P + L L L + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 196 ------NQSSLKIFNVSGNNFTGAI------TVTSTLSRFGISSFLFNPSL 234
S + ++ S L + I+S S+
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 52/222 (23%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQHME----SVGGLRHPN 443
L+G+G +G Y+A D IV +K + + L+ S+ ++ M+ + G L+ P+
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSET-LS--SDPVFRTRMQREARTAGRLQEPH 95
Query: 444 LVPLRAYFQAKEERLLIYDY-QPNGSLF---SLIHGS--KS--TRAKPLHWTSCLKIAED 495
+VP I+D+ + +G L+ LI+G + R PL + I
Sbjct: 96 VVP-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL------TALTAD-----SLQD 544
+ L H A H ++K N+L+ D A L D+ + LT +L
Sbjct: 143 IGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY- 200
Query: 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE R + AT ++D+Y+ +L E LTG PP
Sbjct: 201 -------YMAPE-RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 41/220 (18%), Positives = 86/220 (39%), Gaps = 32/220 (14%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL--VPL 447
+ +G G ++ + + + I +K ++ + + + Y + + L+ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
Y + ++ + N L S + + K + +++ + + IHQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH- 146
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAPE--- 556
+VH +LK +N L+ D L D+ + A+ +Q D + Y PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGI----ANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 557 -------TRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589
+ + + KSDV+S G +L + GK P Q
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 48/279 (17%), Positives = 104/279 (37%), Gaps = 47/279 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL--VPL 447
+ +G G ++ + + + I +K ++ + + + Y + + L+ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
Y + ++ + N L S + + K + +++ + + IHQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAPE--- 556
+VH +LK +N L+ D L D+ + A+ +Q D + Y PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGI----ANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 557 -------TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE--- 606
+ + + KSDV+S G +L + GK P Q +++ + E
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 607 ----DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ +D L P+QR ++ ++L
Sbjct: 243 PDIPEKDLQDVLKCCL--------KRDPKQRISIPELLA 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 34/220 (15%), Positives = 74/220 (33%), Gaps = 29/220 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSN----EMYEQHMESVGGLRHPNLV 445
LLG+G+ Y+A + K+ K+ +N + Q ME + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ + +L+ + G+L + I+ K+T K + + A + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 506 AWRLVHGNLKSSNVLLGPDFEA-----------CLADYCLTALTADSLQDDDPDNLL--- 551
++HG++K N +LG F L D + ++ +
Sbjct: 191 C-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ----SIDMKLFPKGTIFTAK 245
Query: 552 -----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++ E + + D + + +L G
Sbjct: 246 CETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYM 284
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 32/269 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
LG+G G + + V +K L K S E + Q + + LRH LV L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E ++ +Y GSL + K K L + +A +A G++Y+ +
Sbjct: 247 VVS-EEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM-NY 301
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK--APETRNASHQATS 566
VH +L+++N+L+G + +AD+ L + + K APE + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTI 360
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERL-------GM 617
KSDV+SFG+LL EL T G+ P + N E+++ V R+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVE--------RGYRMPCPPECPES 409
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ++ C PE+RPT + L++
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-21
Identities = 38/135 (28%), Positives = 47/135 (34%), Gaps = 9/135 (6%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L LD+G P KL L+VL LQ+N L+ + NL L L N
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP----LNQ 197
+ L TLDLS+N LS L L L N+
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 198 SSLKIFNVSGNNFTG 212
SSLK +S N
Sbjct: 171 SSLKKLELSSNQIKE 185
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 28/135 (20%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L L+L ++ + L L VL L N + + GL N+ ++L +N +
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSG--PLPKELASQGRLYSLRLDVNRFNGSIPPL--N 196
S + L+ L L L P L L L N +
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
Query: 197 QSSLKIFNVSGNNFT 211
L+I ++ NN
Sbjct: 503 LEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-18
Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 14/140 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHNF 139
L LDL + +L+ L+ L L NN + + + +LK L L N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR---LDVNRFNGSIP--- 193
P ++ RL L L+ L L ++L + S+R L ++ + +
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 194 -PLNQSSLKIFNVSGNNFTG 212
L ++L + ++S NN
Sbjct: 243 LGLKWTNLTMLDLSYNNLNV 262
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-18
Identities = 42/169 (24%), Positives = 60/169 (35%), Gaps = 16/169 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLT---------GPIPDLSGLVNLKSL 133
L LDL + L L++L +L LQ+N+L GPI L GL +L L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 134 FLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193
L+ N F L LK +DL NNL+ +Q L SL L N
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 194 ---PLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEII 239
+L ++ N F + + + P L +
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-18
Identities = 32/139 (23%), Positives = 47/139 (33%), Gaps = 12/139 (8%)
Query: 84 RVVLQGLDLGGIFAPNSLTKLDQ-----LRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDH 137
V + D LT++ + VL L +N L + + L SL +
Sbjct: 3 TVSHEVADCSH----LKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 138 NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-- 195
N + P L LK L+L +N LS K A L L L N
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 196 NQSSLKIFNVSGNNFTGAI 214
Q +L ++S N +
Sbjct: 119 KQKNLITLDLSHNGLSSTK 137
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 33/146 (22%), Positives = 51/146 (34%), Gaps = 20/146 (13%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L LDL + +S L QL L+ N++ L GL N++ L L +F
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 142 GSF---------PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSI 192
S S L L+ L++ N++ G L L L + +
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 193 PP------LNQSSLKIFNVSGNNFTG 212
L S L I N++ N +
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISK 395
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 31/140 (22%), Positives = 44/140 (31%), Gaps = 14/140 (10%)
Query: 87 LQGLDLGG----IFAPNSLT----KLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDH 137
L+ L L + + T L +L L N ++ D S L +L+ L L
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 138 NFFTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG--SIPP 194
N L + + LSYN A L L L S P
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 195 L--NQSSLKIFNVSGNNFTG 212
+L I ++S NN
Sbjct: 475 PFQPLRNLTILDLSNNNIAN 494
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 32/149 (21%), Positives = 44/149 (29%), Gaps = 21/149 (14%)
Query: 87 LQGLDLGG-------IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGL--VNLKSLFLD 136
L GL L +R L L N+ L+ GL NL L L
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-- 194
+N S L +L+ L YNN+ L + L L + SI
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 195 ---------LNQSSLKIFNVSGNNFTGAI 214
L+ N+ N+ G
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 27/149 (18%), Positives = 47/149 (31%), Gaps = 12/149 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVN-----LKSLFLDH 137
L+ L++ N T L L+ L L N+ + V+ L L L
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 138 NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLP-KELASQGRLYSLRLDVNRFNGSIPPL- 195
N + + L L+ LDL N + L +E ++ + L N++
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
Query: 196 -NQSSLKIFNVSGNNFTGAITVTSTLSRF 223
SL+ + + S
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 55/269 (20%), Positives = 105/269 (39%), Gaps = 21/269 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHPNLVPL 447
+ +G+G Y+A L + + V +K++ L + + ++ + L HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 448 RAYFQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
A F E L I + G L +I K + + + + K + L ++H
Sbjct: 98 YASFIEDNE-LNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALEHMHSR 155
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDD----PDNLLYKAPETRNAS 561
R++H ++K +NV + L D L ++ + P Y +PE R
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPE-RIHE 210
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED---DGAEDERLGML 618
+ KSD++S G LL E+ + P + + + E L L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 619 LEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ C + PE+RP + V + + +
Sbjct: 271 VN---MCINPDPEKRPDVTYVYDVAKRMH 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 60/269 (22%), Positives = 115/269 (42%), Gaps = 30/269 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLI-VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G G Y+ V + V VK L K E + + + ++HPNLV L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +I ++ G+L + + + + L +A ++ + Y+ +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK-N 338
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK--APETRNASHQAT 565
+H NL + N L+G + +AD+ L+ +T D+ K APE+ ++ +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNKFS 397
Query: 566 SKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM------- 617
KSDV++FGVLL E+ T G P + + +++ + +D R+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLE--------KDYRMERPEGCPEK 447
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ E+ AC +P RP+ ++ + + +
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ---HMESVGGLRHPNLVP 446
LGKG G Y A N+ I+ +K L S+L + Q +E LRHPN++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILR 78
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ YF ++ L+ ++ P G L+ + K R S + E +A L Y H+
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDE--QRSATFMEE-LADALHYCHER 133
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---PDNLLYKAPE-TRNASH 562
+++H ++K N+L+G E +AD+ + + D Y PE +H
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD---YLPPEMIEGKTH 189
Query: 563 QATSKSDVYSFGVLLLELLTGKPP 586
K D++ GVL E L G PP
Sbjct: 190 --DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 57/285 (20%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYE---QHMESVGGLRH 441
++LG G+ GT YK + ++ V +K L TS + + + + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDN 76
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P++ L LI P G L + K + L +A+G++
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMN 131
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK-------- 553
Y+ RLVH +L + NVL+ + D+ L A L ++ + Y
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQHVKITDFGL----AKLLGAEEKE---YHAEGGKVPI 183
Query: 554 ---APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDD 608
A E+ T +SDV+S+GV + EL+T G P +P E+ + +
Sbjct: 184 KWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSILE------ 233
Query: 609 GAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ ERL + + C + RP +++ ++
Sbjct: 234 --KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 41/220 (18%), Positives = 86/220 (39%), Gaps = 32/220 (14%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL--VPL 447
+ +G G ++ + + + I +K ++ + + + Y + + L+ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
Y + ++ + N L S + + K + +++ + + IHQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAPE--- 556
+VH +LK +N L+ D L D+ + A+ +Q D + Y PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGI----ANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 557 -------TRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589
+ + + KSDV+S G +L + GK P Q
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-20
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 32/269 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
LG+G G + + V +K L K S E + Q + + LRH LV L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E ++ +Y GSL + K K L + +A +A G++Y+ +
Sbjct: 330 VVS-EEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM-NY 384
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYK--APETRNASHQATS 566
VH +L+++N+L+G + +AD+ L + + K APE + T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTI 443
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERL-------GM 617
KSDV+SFG+LL EL T G+ P + N E+++ V R+
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVE--------RGYRMPCPPECPES 492
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ++ C PE+RPT + L++
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 51/302 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNR----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+LGKG G+ +A L + V VK L A +A + E + + + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 446 PL------RAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
L ++I + +G L + L+ L + ++ D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK----- 553
G+ Y+ +H +L + N +L D C+AD+ L + + D Y+
Sbjct: 149 GMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGL----SRKIYSGD----YYRQGCAS 199
Query: 554 -------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAR 605
A E+ + T SDV++FGV + E++T G+ P + E+ N++
Sbjct: 200 KLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAG--IENAEIYNYLIGGN 256
Query: 606 EDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELD 658
RL + ++ C SA P+QRP+ + L+ I G + + D
Sbjct: 257 --------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308
Query: 659 PL 660
PL
Sbjct: 309 PL 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 50/278 (17%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ LG G G + A + V VK + K S E + + L+H LV L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
KE +I ++ GSL + KS + + +A+G+++I Q
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NY 305
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APET 557
+H +L+++N+L+ +AD+ L + ++D++ Y APE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV----IEDNE-----YTAREGAKFPIKWTAPEA 356
Query: 558 RNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERL 615
N T KSDV+SFG+LL+E++T G+ P + N E++ + R+
Sbjct: 357 IN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPG---MSNPEVIRALE--------RGYRM 404
Query: 616 -------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L + + C PE+RPT + +L +
Sbjct: 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 37/222 (16%), Positives = 71/222 (31%), Gaps = 36/222 (16%)
Query: 392 LGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG------------- 438
L +G DN+ +K+ + S L + + +
Sbjct: 39 LNQGKFNKIILCEKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 439 --LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI---HGSKSTRAKPLHWTSCLKIA 493
+++ + +E +IY+Y N S+ + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-- 551
+ V SYIH + H ++K SN+L+ + L+D+ + D +
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--------VDKKIKG 209
Query: 552 ------YKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ PE N S +K D++S G+ L + P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 24/208 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSN--EMYEQHMESVGGLRHPNLV 445
+ LG G + T Y A D L V +K + + +E+ + + L H N+V
Sbjct: 17 DKLGGGGMSTVYLA-EDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 446 PLRAYFQAKEERL--LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+ +E+ L+ +Y +L I PL + + + G+ +
Sbjct: 75 SM--IDVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHA 127
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPE-TR 558
H R+VH ++K N+L+ + + D+ + A +++L Y +PE +
Sbjct: 128 HDM-RIVHRDIKPQNILIDSNKTLKIFDFGI-AKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP 586
+D+YS G++L E+L G+PP
Sbjct: 186 --GEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 58/264 (21%), Positives = 91/264 (34%), Gaps = 32/264 (12%)
Query: 390 ELLGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL----RHPN 443
LG GS G +K D R + VKR S + + + VG +HP
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGR-LYAVKR---SMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 444 LVPLRAYFQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
V L ++ + L + + SL L D L++
Sbjct: 119 CVRLEQAWE-EGGILYLQTEL-CGPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADY-CLTALTADSLQDD---DPDNLLYKAPETR 558
+H LVH ++K +N+ LGP L D+ L L + DP Y APE
Sbjct: 173 LHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RYMAPELL 228
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618
S+ + +DV+S G+ +LE+ ++ G E L
Sbjct: 229 QGSY--GTAADVFSLGLTILEVACNMELPHGGEGW-QQLRQGYLPPEFTAGLSSE----L 281
Query: 619 LEVAIACNSASPEQRPTMWQVLKM 642
V + P+ R T +L +
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLAL 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 24/208 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ +G+GS G ++ +K ++ S+++ E + + + ++HPN+V R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F+ ++ DY G LF I + + L + L ++H +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKHVHDR-K 145
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDNLLYKAPET-R 558
++H ++KS N+ L D L D+ + A L P Y +PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGI----ARVLNSTVELARACIGTP---YYLSPEICE 198
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP 586
N + +KSD+++ G +L EL T K
Sbjct: 199 NKPY--NNKSDIWALGCVLYELCTLKHA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 9e-20
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 29/216 (13%)
Query: 390 ELLGKG--SLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE------QHMESVGGLR 440
++GKG L T A V V+R++ L SNEM +
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFLQGELHVSKL---FN 84
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
HPN+VP RA F A E ++ + GS LI + ++ + I + V + L
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKAL 141
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLAD----YCLTAL-----TADSLQDDDPDNLL 551
YIH VH ++K+S++L+ D + L+ + + L
Sbjct: 142 DYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 552 YKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ +PE + +KSD+YS G+ EL G P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 61/288 (21%)
Query: 390 ELLGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
EL+G G G +KA +D + +KR+ +NE E+ ++++ L H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGK-TYVIKRVK------YNNEKAEREVKALAKLDHVNIVHY 69
Query: 448 RAYFQ---------------AKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLK 491
+ +K + L I ++ G+L I + R + L L+
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALE 126
Query: 492 IAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-- 549
+ E + +G+ YIH +L++ +LK SN+ L + + D+ L SL++D
Sbjct: 127 LFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGL----VTSLKNDGKRTRS 181
Query: 550 ---LLYKAPE-TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
L Y +PE + + + D+Y+ G++L ELL E + R
Sbjct: 182 KGTLRYMSPEQISSQDY--GKEVDLYALGLILAELLHVCDT-------AFETSKFFTDLR 232
Query: 606 E----DDGAEDER--LGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ D + E+ L LL PE RP ++L+ L K
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSK-------KPEDRPNTSEILRTLTVWK 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 57/285 (20%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYE---QHMESVGGLRH 441
++LG G+ GT YK + ++ V +K L TS + + + + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDN 76
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
P++ L LI P G L + K + L +A+G++
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMN 131
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK-------- 553
Y+ RLVH +L + NVL+ + D+ L A L ++ + Y
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQHVKITDFGL----AKLLGAEEKE---YHAEGGKVPI 183
Query: 554 ---APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDD 608
A E+ T +SDV+S+GV + EL+T G P +P E+ + +
Sbjct: 184 KWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSILE------ 233
Query: 609 GAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ ERL + + + C + RP +++ ++
Sbjct: 234 --KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 48/290 (16%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
++GKG G Y NR+ +K L ++ E + GL HPN
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 444 LVPLRAY-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
++ L + ++ Y +G L I + + + VA+G+ Y
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEY 139
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ + + VH +L + N +L F +AD+ L A + D + ++
Sbjct: 140 LAEQ-KFVHRDLAARNCMLDESFTVKVADFGL----ARDILDREYYSVQQHRHARLPVKW 194
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
A E+ +++ T+KSDV+SFGVLL ELLT G PP +H + P ++ +++ +
Sbjct: 195 TALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRH--IDPFDLTHFLA--------Q 243
Query: 612 DERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654
RL L +V C A P RPT ++ +++I A+L +
Sbjct: 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 66/285 (23%), Positives = 110/285 (38%), Gaps = 57/285 (20%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
++LG G GT +K V ++ VC+K + + HM ++G L H
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
++V L L+ Y P GSL + + L L +A+G+ Y
Sbjct: 76 HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYY 130
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ + +VH NL + NVLL + +AD+ + AD L DD
Sbjct: 131 LEEH-GMVHRNLAARNVLLKSPSQVQVADFGV----ADLLPPDD----KQLLYSEAKTPI 181
Query: 554 ---APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDD 608
A E+ + + T +SDV+S+GV + EL+T G P + E+ + +
Sbjct: 182 KWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAG---LRLAEVPDLLE------ 231
Query: 609 GAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ ERL + V + C RPT ++ +
Sbjct: 232 --KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 27/208 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+GS G ++ VK++ + + + GL P +VPL
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLY 116
Query: 449 AYFQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + + I+ + GSL LI + L L +GL Y+H
Sbjct: 117 GAVR-EGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHTR- 169
Query: 508 RLVHGNLKSSNVLLGPDFEAC-LADY-CLTALTADSLQDDDPDNLLYK------APET-R 558
R++HG++K+ NVLL D L D+ L D L APE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP 586
+K D++S ++L +L G P
Sbjct: 230 GKPC--DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 53/210 (25%), Positives = 81/210 (38%), Gaps = 19/210 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G GS G K + I+ K LD + +M + + L+HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 449 AYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ- 505
+ L + +Y G L S+I R + L L++ + L H+
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRR 130
Query: 506 ---AWRLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDD----PDNLLYKAPET 557
++H +LK +NV L L D+ L L D+ P Y +PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP---YYMSPEQ 187
Query: 558 -RNASHQATSKSDVYSFGVLLLELLTGKPP 586
S+ KSD++S G LL EL PP
Sbjct: 188 MNRMSY--NEKSDIWSLGCLLYELCALMPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 50/281 (17%), Positives = 106/281 (37%), Gaps = 47/281 (16%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPL 447
E +G G G+ +K V + I +KR + + + + L +H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 448 RAYFQA--KEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
YF A +++ +LI +Y GSL I + + V +GL YIH
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGRGLRYIH 132
Query: 505 QAWRLVHGNLKSSNVLLGPDFEAC-------------------LADY-CLTALTADSLQD 544
LVH ++K SN+ + + D +T +++ +++
Sbjct: 133 SM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604
D + A E ++ K+D+++ + ++ +P ++ + + +R
Sbjct: 192 GDS---RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-----GDQWHEIRQG 243
Query: 605 R----EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
R +++ E+ PE+RP+ ++K
Sbjct: 244 RLPRIPQVLSQE-----FTELLKVMIHPDPERRPSAMALVK 279
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 59/280 (21%), Positives = 112/280 (40%), Gaps = 52/280 (18%)
Query: 390 ELLGKGSLGTTYKAVLDNRLI-VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G G Y+ V + V VK L K E + + + ++HPNLV L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +I ++ G+L + + + + L +A ++ + Y+ +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK-N 131
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APE 556
+H +L + N L+G + +AD+ L+ L + D Y APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRL----MTGDT-----YTAHAGAKFPIKWTAPE 182
Query: 557 TRNASHQA-TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDE 613
+ ++ + KSDV++FGVLL E+ T G P + ++ + +D
Sbjct: 183 S--LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLE--------KDY 229
Query: 614 RL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
R+ + E+ AC +P RP+ ++ + + +
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDASKLAGTSNEMYEQ--HME--SVGGLRHPN 443
E+LG G + + A D R V VK L A LA + + E + L HP
Sbjct: 18 EILGFGGMSEVHLAR-DLRDHRDVAVKVLRAD-LAR--DPSFYLRFRREAQNAAALNHPA 73
Query: 444 LVPLRAYFQAKEERLLIY----DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+V + +A+ + +Y +L ++H P+ +++ D Q
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQA 128
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNLL----YKA 554
L++ HQ ++H ++K +N+++ + D+ + A+ ++ Y +
Sbjct: 129 LNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 555 PE-TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE R ++SDVYS G +L E+LTG+PP
Sbjct: 188 PEQAR--GDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 59/288 (20%), Positives = 109/288 (37%), Gaps = 40/288 (13%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE-QHMESVGGLRHPNLVPL 447
+L +G Y+A + + +KRL +++ + E M+ + G HPN+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQF 91
Query: 448 RAYFQAKEER-------LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
+ +E L+ G L + K PL + LKI + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 501 SYIH-QAWRLVHGNLKSSNVLLGPDFEACLAD------------YCLTALTADSLQDDDP 547
++H Q ++H +LK N+LL L D Y +A ++++
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 548 DN--LLYKAPE--TRNASHQATSKSDVYSFGVLLLELLTGKPP-SQHSFL-VPNEMMNWV 601
N +Y+ PE ++ K D+++ G +L L + P + L + N +
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269
Query: 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
+ ML +PE+R ++ +V+ LQEI A
Sbjct: 270 PHDTQYTVFHSLIRAMLQV--------NPEERLSIAEVVHQLQEIAAA 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 56/292 (19%), Positives = 111/292 (38%), Gaps = 60/292 (20%)
Query: 390 ELLGKGSLGTTYKAV--LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+LG+G+ G KA LD+R +K++ ++ + + L H +V
Sbjct: 12 AVLGQGAFGQVVKARNALDSR-YYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRY 67
Query: 448 RAYFQ----------AKEERLLIY---DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAE 494
A + A +++ ++ +Y NG+L+ LIH + + +W ++
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFR 123
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD--------YCLTALTADSLQDDD 546
+ + LSYIH ++H +LK N+ + + D L L DS
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 547 PDNLL--------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM 598
+ L Y A E + + K D+YS G++ E++ ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME----RVNIL 238
Query: 599 NWVRSAR-------EDDGAEDER--LGMLLEVAIACNSASPEQRPTMWQVLK 641
+RS +D+ + E+ + +L++ P +RP +L
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-------DPNKRPGARTLLN 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 50/278 (17%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E LG G G + + V VK L K S + + + L+H LV L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E +I +Y NGSL + K+ L L +A +A+G+++I +
Sbjct: 76 VV-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER-NY 130
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APET 557
+H +L+++N+L+ +AD+ L L ++D++ Y APE
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARL----IEDNE-----YTAREGAKFPIKWTAPEA 181
Query: 558 RNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERL 615
N T KSDV+SFG+LL E++T G+ P + N E++ + R+
Sbjct: 182 IN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVIQNLE--------RGYRM 229
Query: 616 -------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ++ C PE RPT + +L++
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 34/212 (16%)
Query: 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQH------MESVGGLRHPN 443
LLGKGS Y+A + L V +K +D + M ++ L+HP+
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQ---LKHPS 72
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ L YF+ L+ + NG + + R KP + G+ Y+
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLK----NRVKPFSENEARHFMHQIITGMLYL 128
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAP 555
H ++H +L SN+LL + +AD+ L P Y +P
Sbjct: 129 HSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQL------KMPHEKHYTLCGTPNYISP 181
Query: 556 E-TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E ++H +SDV+S G + LL G+PP
Sbjct: 182 EIATRSAH--GLESDVWSLGCMFYTLLIGRPP 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 52/284 (18%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +G G G + N+ V +K + + S E + + E + L HP LV L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ L+ ++ +G L + + + L + DV +G++Y+ +A +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEA-CV 125
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APET 557
+H +L + N L+G + ++D+ + + DD Y +PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGM----TRFVLDDQ-----YTSSTGTKFPVKWASPEV 176
Query: 558 RNASHQA-TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDER 614
S +SKSDV+SFGVL+ E+ + GK P ++ N E++ + R
Sbjct: 177 --FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDIS--------TGFR 223
Query: 615 L-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651
L + ++ C PE RP ++L+ L EI + L
Sbjct: 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 56/290 (19%)
Query: 390 ELLGKGSLGTTYKAVLDNR----LIVCVKRLDASKLAGTSNEMYE---QHMESVGGLRHP 442
++LG+G G+ + L L V VK + KL +S E + HP
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 443 NLVPL-----RAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDV 496
N++ L Q + ++I + G L + L++ T K + + LK D+
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--- 553
A G+ Y+ +H +L + N +L D C+AD+ L + + D Y+
Sbjct: 157 ALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGL----SKKIYSGD----YYRQGR 207
Query: 554 ---------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603
A E+ TSKSDV++FGV + E+ T G P + +EM +++
Sbjct: 208 IAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPG--VQNHEMYDYLLH 264
Query: 604 AREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL L E+ +C P RPT + L+++
Sbjct: 265 GH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 54/285 (18%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
E++G+G G Y L ++ VK L E+ + E + HPN
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 444 LVPLRAY-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
++ L +++ L++ Y +G L + I + VA+G+ Y
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKY 143
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA-- 560
+ + VH +L + N +L F +AD+ L A + D + Y A
Sbjct: 144 LASK-KFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEY----YSVHNKTGAKL 194
Query: 561 -----------SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDD 608
+ + T+KSDV+SFGVLL EL+T G PP + ++ ++
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VNTFDITVYLL------ 246
Query: 609 GAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ RL L EV + C E RP+ +++ + I
Sbjct: 247 --QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 54/283 (19%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ LG G G + V VK + K S + + Q +++ L HP LV
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ ++ +Y NG L + + + K L + L++ DV +G++++ +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLR----SHGKGLEPSQLLEMCYDVCEGMAFLESH-QF 125
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APET 557
+H +L + N L+ D ++D+ +T + DD Y APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY----VLDDQ-----YVSSVGTKFPVKWSAPE- 175
Query: 558 RNASHQA--TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDE 613
H +SKSDV++FG+L+ E+ + GK P N E++ V +
Sbjct: 176 --VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVS--------QGH 222
Query: 614 RL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
RL + ++ +C PE+RPT Q+L ++ ++
Sbjct: 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 36/270 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +GKG G V VK + K + + + + LRH NLV L
Sbjct: 199 QTIGKGEFGDVMLGDYRGN-KVAVKCI---K-NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 450 Y-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ K ++ +Y GSL + +S L LK + DV + + Y+
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-N 309
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--APETRNASHQATS 566
VH +L + NVL+ D A ++D+ LT ++ D L K APE + ++
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDF---GLTKEASSTQDTGKLPVKWTAPEALR-EKKFST 365
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERLGM------- 617
KSDV+SFG+LL E+ + G+ P +P +++ V + ++
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVE--------KGYKMDAPDGCPPA 414
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ +V C RPT Q+ + L+ I+
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 63/292 (21%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPNLV 445
+ LG+G G ++A +D+ +KR+ +L + E L HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDC-NYAIKRI---RLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 446 PLRAYF---------QAKEERLLIY---DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA 493
+ Q ++ +Y +L ++G + + + CL I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIF 124
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNL-- 550
+A+ + ++H L+H +LK SN+ D + D+ L TA+ D + +
Sbjct: 125 LQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 551 -----------LYKAPE-TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM 598
LY +PE S+ + K D++S G++L ELL + F E +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSY--SHKVDIFSLGLILFELL-------YPFSTQMERV 234
Query: 599 NWVRSARE-------DDGAEDER--LGMLLEVAIACNSASPEQRPTMWQVLK 641
+ R E + +L SP +RP +++
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSP-------SPMERPEAINIIE 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 36/269 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +GKG G V VK + K + + + + LRH NLV L
Sbjct: 27 QTIGKGEFGDVMLGDYRGN-KVAVKCI---K-NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 450 Y-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ K ++ +Y GSL + +S L LK + DV + + Y+
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-N 137
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--APETRNASHQATS 566
VH +L + NVL+ D A ++D+ LT ++ D L K APE + ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDF---GLTKEASSTQDTGKLPVKWTAPEALR-EKKFST 193
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDERL-------GM 617
KSDV+SFG+LL E+ + G+ P +P +++ V + ++
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVE--------KGYKMDAPDGCPPA 242
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ EV C RP+ Q+ + L+ I
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 48/290 (16%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
E++G+G G Y L ++ VK L E+ + E + HPN
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 444 LVPLRAY-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
++ L +++ L++ Y +G L + I + VA+G+ +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKF 207
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ + VH +L + N +L F +AD+ L A + D + D++ K
Sbjct: 208 LASK-KFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
A E+ + + T+KSDV+SFGVLL EL+T G PP + ++ ++ +
Sbjct: 263 MALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VNTFDITVYLL--------Q 311
Query: 612 DERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654
RL L EV + C E RP+ +++ + I + E
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 51/276 (18%), Positives = 103/276 (37%), Gaps = 46/276 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
++LG G+ GT + + V VKR+ + E+ + ES HPN++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV-QLLRES---DEHPNVIRYFC 85
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ ++ + + + +L + + + + GL+++H +
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL----EPITLLQQTTSGLAHLHSL-NI 139
Query: 510 VHGNLKSSNVLLGPDFE-----ACLADYCLTALTADSLQDDDPDNLL---------YKAP 555
VH +LK N+L+ A ++D+ L L + AP
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGL----CKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 556 E--TRNASHQATSKSDVYSFGVLLLELLT-GKPP------SQHSFLVPNEMMNWVR-SAR 605
E + + T D++S G + +++ G P Q + L+ ++ +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 606 EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
ED A + L+E + P++RP+ VLK
Sbjct: 256 EDVIARE-----LIE---KMIAMDPQKRPSAKHVLK 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 34/295 (11%), Positives = 66/295 (22%), Gaps = 53/295 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
E L G + ++ +K S E + + L +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 448 RAYFQ--------------------------AKEERLLIYDYQPNGSLFSLIH--GSKST 479
R + A LL+ + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 480 RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539
+ + + + + + LVHG+ N+ + PD L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDV-SALWKV 244
Query: 540 DSLQDDDPDNLLYKAPETRNASHQA-TSKSDVYSFGVLLLELLTGKPP----SQHSFLVP 594
+ + Y E NAS T + + G+ + + P +
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 595 NEMMNWVRSAREDDGAEDER--------LGMLLEVAIACNSASPEQRPTMWQVLK 641
V +G L +R + ++
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF-------DRRRRLLPLEAME 352
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 43/216 (19%), Positives = 79/216 (36%), Gaps = 45/216 (20%)
Query: 390 ELLGKGSLGTTYKA---VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+ G LG Y A ++ R V +K L S A + M + + + HP++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDA-EAQAMAMAERQFLAEVVHPSIVQ 143
Query: 447 LRAYFQAKEERLLIYDY----QPNGSLFS-----LIHGS--KSTRAKPLHWTSCLKIAED 495
I+++ +G + G K ++ + L + +
Sbjct: 144 -------------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE 190
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNLL--- 551
+ LSY+H LV+ +LK N++L + + L D + + + L
Sbjct: 191 ILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTP 241
Query: 552 -YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++APE T +D+Y+ G L L P
Sbjct: 242 GFQAPEI--VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 44/216 (20%), Positives = 89/216 (41%), Gaps = 27/216 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG+G+ ++ + +K + ++ + E + L H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 449 AYFQAKEERL--LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
A + R LI ++ P GSL++++ + + A L + L + DV G++++ +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 507 WRLVHGNLKSSNVLLGPDFEAC----LADYCLTALTADSLQDDDPDN-----LLYKAPE- 556
+VH N+K N++ + L D+ A L+DD+ Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA----ARELEDDEQFVSLYGTEEYLHPDM 186
Query: 557 ------TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++ + + D++S GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 59/304 (19%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYE-----QHMESVGG 438
+ LG+G+ G +A V VK L K T +E + + +G
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIG- 88
Query: 439 LRHPNLVPLRAY-FQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLHW 486
H N+V L + ++I ++ G+L + L
Sbjct: 89 -HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 487 TSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546
+ + VA+G+ ++ + +H +L + N+LL + D+ L A + D
Sbjct: 148 EHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGL----ARDIYKDP 202
Query: 547 PDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLV 593
Y APET T +SDV+SFGVLL E+ + G P +
Sbjct: 203 ----DYVRKGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKI 256
Query: 594 PNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650
E ++ R D E + + + C P QRPT ++++ L + A
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
Query: 651 LMED 654
+D
Sbjct: 313 AQQD 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 54/280 (19%), Positives = 106/280 (37%), Gaps = 54/280 (19%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ LG G G + V +K + K S + + + + + L H LV L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ +I +Y NG L + + + L++ +DV + + Y+ +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESK-QF 141
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APET 557
+H +L + N L+ ++D+ L+ + DD+ Y PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY----VLDDE-----YTSSVGSKFPVRWSPPE- 191
Query: 558 RNASHQA--TSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDE 613
+ +SKSD+++FGVL+ E+ + GK P + N E + +
Sbjct: 192 --VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER---FTNSETAEHIA--------QGL 238
Query: 614 RL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL + + +C ++RPT +L + ++
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/290 (20%), Positives = 115/290 (39%), Gaps = 56/290 (19%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
LG+GS G Y+ V V +K + A + E E +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNC 87
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI-----HGSKSTRAKPLHWTSCLKIAEDV 496
++V L + L+I + G L S + + + P + +++A ++
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--- 553
A G++Y++ A + VH +L + N ++ DF + D+ + + + D Y+
Sbjct: 148 ADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETD----YYRKGG 198
Query: 554 ---------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603
+PE+ T+ SDV+SFGV+L E+ T + P + L +++ +V
Sbjct: 199 KGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVME 255
Query: 604 AREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ML E+ C +P+ RP+ +++ ++E
Sbjct: 256 GG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 50/286 (17%)
Query: 392 LGKGSLGTTYKAVLDNR---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ GT K + V VK L + + L +P +V +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ E +L+ + G L + ++ + K + +++ V+ G+ Y+ ++
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEES-N 137
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------APE 556
VH +L + NVLL A ++D+ L + +L+ D+ YK APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGL----SKALRADEN---YYKAQTHGKWPVKWYAPE 190
Query: 557 TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDER 614
N ++ +SKSDV+SFGVL+ E + G+ P + + E+ + + G ER
Sbjct: 191 CIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG---MKGSEVTAML-----EKG---ER 238
Query: 615 LGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLME 653
+G + ++ C + E RP V L+ V+ E
Sbjct: 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 17/152 (11%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRL 154
+ L + L+ N LT + D + L L ++ + +N F+ SFP L+ +L
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQL 778
Query: 155 KTLDLSY------NNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGN 208
K + + N + P + + L L++ N + L I +++ N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837
Query: 209 NFTGAITVTSTLSRFGISSFLF----NPSLCG 236
+I VTS ++ + G
Sbjct: 838 PNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 21/126 (16%), Positives = 40/126 (31%), Gaps = 15/126 (11%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
++ +L +L+++ N+ T + D+ + S +L L +
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN----SDYAKQYENEELSWSNLKDLTDV 496
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG---------SIPPL--NQSSLKIFNVS 206
+L LP L L SL + NR + ++IF +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 207 GNNFTG 212
NN
Sbjct: 557 YNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 11/122 (9%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG--PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK 155
+ ++++ + N+L L +V L L HN + + +L
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT 598
Query: 156 TLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIPPL----NQSSLKIFNVSGNNF 210
L L YN + +P++ A ++ L N+ IP + + + + S N
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 211 TG 212
Sbjct: 657 GS 658
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 21/147 (14%), Positives = 45/147 (30%), Gaps = 21/147 (14%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSG------LVNLKSLFL 135
++GL I + + + + N + ++S +N ++ L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 136 DHNFFTGSFPPSLLSLHRLKTLDLSYNNLS-------GPLPKELASQGRLYSLRLDVNRF 188
+N + + T+ LS N ++ P + L ++ L N+
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 189 NG---SIPPLNQSSLKIFNVSGNNFTG 212
L +VS N F+
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 21/144 (14%)
Query: 87 LQGLDLGGI----FAPNSLTKLDQLRVLGLQNNSLTGPI----------PDLSGLVNLKS 132
L ++L P+ L L +L+ L + N D ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 133 LFLDHNFFTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
++ +N + L + +L LD +N + L + +L L+LD N+
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIE-E 609
Query: 192 IPP---LNQSSLKIFNVSGNNFTG 212
IP ++ S N
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY 633
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 24/139 (17%), Positives = 46/139 (33%), Gaps = 20/139 (14%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDH--- 137
L +DL + T L L + + N + P LK+ + H
Sbjct: 730 LTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 138 ---NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF----NG 190
N +P + + L L + N++ + ++L Q LY L + N
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQ--LYILDIADNPNISIDVT 845
Query: 191 SIPPLNQSSLKIFNVSGNN 209
S+ P ++ + +
Sbjct: 846 SVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 35/204 (17%), Positives = 59/204 (28%), Gaps = 24/204 (11%)
Query: 41 SDAQVLLAFKAKADLRNHLFFSQ-----------NKSLHFCQWQGVICYQ----QKVVRV 85
D + L A D +N ++S N + W +V +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 86 VLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGS 143
L G G P+++ +L +L+VL +S T L S H
Sbjct: 329 SLAGFGAKGRV-PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 144 FPPSLLSLHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFN---GSIPP--LNQ 197
L RL DL + ++ P K + R+ + I
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRL 447
Query: 198 SSLKIFNVSGNNFTGAITVTSTLS 221
+ L+I + + FT
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWED 471
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 11/135 (8%), Positives = 35/135 (25%), Gaps = 12/135 (8%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLT-----GPIPDLSGLVNLKSLFLDHNFFT 141
+ + + L +L + L +++ PI S + + +
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSS 199
++ L +L+ + + + + + D + + N
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTY-DNIAV----DWEDANSDYAKQYENEELSWSNLKD 492
Query: 200 LKIFNVSGNNFTGAI 214
L + +
Sbjct: 493 LTDVELYNCPNMTQL 507
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 20/120 (16%), Positives = 36/120 (30%), Gaps = 5/120 (4%)
Query: 95 IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRL 154
N LTK + + Q I D L + N+ S +
Sbjct: 245 TVIDNKLTKDANVPI---QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN 301
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTG 212
+ + +L + GR+ L L G +P + LK+ + ++ T
Sbjct: 302 WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 53/285 (18%), Positives = 95/285 (33%), Gaps = 43/285 (15%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
++LG GS GT V VKR+ E+ + ES HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI-KLLTES---DDHPNVIRYYC 76
Query: 450 YFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ + N +L L+ K + + + +A G++++H
Sbjct: 77 SETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134
Query: 508 RLVHGNLKSSNVLL----GPDFEACLADYCLTALTAD-----SLQDDDPDNLL------- 551
+++H +LK N+L+ + L L +D L
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 552 ---YKAPE------TRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWV 601
++APE + T D++S G + +L+ GK P F + +
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP----FGDKYSRESNI 250
Query: 602 RSARED-DGAEDERLGMLLEVAI----ACNSASPEQRPTMWQVLK 641
D + L+ A P +RPT +VL+
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 61/293 (20%), Positives = 114/293 (38%), Gaps = 56/293 (19%)
Query: 390 ELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEM-YEQHMESVGGLRHPN 443
LGKG+ G+ D +V VK+L + +G + +++ ++ + L
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDF 85
Query: 444 LVPLRA--YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+V R Y ++ L+ +Y P+G L + ++ L + L + + +G+
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGME 141
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK-------- 553
Y+ R VH +L + N+L+ + +AD+ L D D Y
Sbjct: 142 YLGSR-RCVHRDLAARNILVESEAHVKIADF---GLAKLLPLDKD----YYVVREPGQSP 193
Query: 554 ----APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDD 608
APE+ + + + +SDV+SFGV+L EL T E + + R+
Sbjct: 194 IFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVP 248
Query: 609 GAED--------ERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+RL + E+ C + SP+ RP+ + L +
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 53/291 (18%)
Query: 390 ELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
LG+G G D +V VK L A + +Q ++ + L H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW-KQEIDILRTLYHEHI 95
Query: 445 VPLRA--YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+ + L+ +Y P GSL + + L A+ + +G++Y
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAY 149
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+H +H +L + NVLL D + D+ L + + Y+
Sbjct: 150 LHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-------GHEYYRVREDGDSPV 201
Query: 554 ---APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMN--WVRSARE- 606
APE ++ SDV+SFGV L ELLT + +
Sbjct: 202 FWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 607 ----DDGAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ G ERL + + C RPT ++ +L+ +
Sbjct: 261 TELLERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG---GLRHPNLV 445
+LGKG+ G Y L N++ + +K + + + E + L+H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIV 82
Query: 446 PLRAY--FQAKEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCL--KIAEDVAQGL 500
Y ++ + I+ + P GSL +L+ ++ PL + + +GL
Sbjct: 83 ---QYLGSFSENGFIKIFMEQVPGGSLSALLR----SKWGPLKDNEQTIGFYTKQILEGL 135
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEAC-LADYCLTALTADSLQDDDPDN------LLYK 553
Y+H ++VH ++K NVL+ ++D+ T+ L +P L Y
Sbjct: 136 KYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFG----TSKRLAGINPCTETFTGTLQYM 190
Query: 554 APET-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE +D++S G ++E+ TGKPP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 48/283 (16%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHPNL 444
E LG GS G + + V VK L L+ + + + + + ++ L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ L ++ + P GSL + + + + A VA+G+ Y+
Sbjct: 84 IRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 138
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK----------- 553
R +H +L + N+LL + D+ L +L +D Y
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGL----MRALPQNDD---HYVMQEHRKVPFAW 190
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611
APE+ + + SD + FGV L E+ T G+ P L +++++ + + +G
Sbjct: 191 CAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKI----DKEG-- 241
Query: 612 DERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
ERL + V + C + PE RPT + L E +
Sbjct: 242 -ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 53/285 (18%), Positives = 108/285 (37%), Gaps = 53/285 (18%)
Query: 390 ELLGKGSLGTTYKAVL--------DNRLIVCVKRLDASKLAGTSNEMYEQHME-SV-GGL 439
E LG+G+ +K V + V +K LD N S+ L
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSESFFEAASMMSKL 69
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
H +LV +E +L+ ++ GSL + + +K+ ++ L++A+ +A
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAA 125
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD-----SLQDDDPDNLLYK- 553
+ ++ + L+HGN+ + N+LL + + + L +D ++ D + +
Sbjct: 126 MHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKL-SDPGISITVLPKD----ILQE 179
Query: 554 -----APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSARE 606
PE +D +SFG L E+ + G P + + + +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA---LDSQRKLQFY----- 231
Query: 607 DDGAEDERLGM-----LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+D +L L + C P+ RP+ +++ L +
Sbjct: 232 EDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-17
Identities = 44/216 (20%), Positives = 89/216 (41%), Gaps = 27/216 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG+G+ ++ + +K + ++ + E + L H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 449 AYFQAKEERL--LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
A + R LI ++ P GSL++++ + + A L + L + DV G++++ +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 507 WRLVHGNLKSSNVLLGPDFEAC----LADYCLTALTADSLQDDDPDN-----LLYKAPE- 556
+VH N+K N++ + L D+ A L+DD+ Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA----ARELEDDEQFVSLYGTEEYLHPDM 186
Query: 557 ------TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++ + + D++S GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-17
Identities = 35/165 (21%), Positives = 55/165 (33%), Gaps = 17/165 (10%)
Query: 58 HLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGG----IFAPNSLTKLDQLRVLGLQ 113
L + + L Q L+ L+L I + L L+ L LQ
Sbjct: 404 LLDLAFTR-LKVKDAQSPFQNLHL-----LKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 114 NNSLTGPIPD----LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLP 169
N L L L+ L L + + SL + +DLS+N L+
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 170 KELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212
+ L+ +Y L L N + +P L S + N+ N
Sbjct: 518 EALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 31/135 (22%), Positives = 49/135 (36%), Gaps = 9/135 (6%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L LDL ++ +L L L N L LSG LK LF +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN----GSIPPLNQ 197
L + L++L L N++S + +L L N + + L Q
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 198 SSLKIFNVSGNNFTG 212
++ N++GN+ G
Sbjct: 179 ATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 30/138 (21%), Positives = 46/138 (33%), Gaps = 13/138 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
LQ L+L + + QL +L L L L LK L L H+
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR-LDV--NRFNGSIPPL-- 195
S L L+ L+L N+ ++ S L L L + + SI
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAF 496
Query: 196 -NQSSLKIFNVSGNNFTG 212
+ + ++S N T
Sbjct: 497 TSLKMMNHVDLSHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 11/143 (7%)
Query: 87 LQGLDL-----GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHN 138
L L + L L+ LR L L ++ + L L +L+SL L +N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPL-- 195
+ +L+ LDL++ L + + L L L + + S L
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 196 NQSSLKIFNVSGNNFTGAITVTS 218
+L+ N+ GN+F +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 35/160 (21%), Positives = 47/160 (29%), Gaps = 6/160 (3%)
Query: 58 HLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSL 117
F + V + LQ I + N+ L+ L L L
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI-SSNTFHCFSGLQELDLTATHL 290
Query: 118 TGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQG 176
+ L GL LK L L N F S + L L + N L L +
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 177 RLYSLRLDVNRFNGSIPPLNQ----SSLKIFNVSGNNFTG 212
L L L + S Q S L+ N+S N
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 33/142 (23%), Positives = 49/142 (34%), Gaps = 12/142 (8%)
Query: 77 CYQQKVVRVV-LQGLDLGGIFA--PNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKS 132
C +++V + + L L I PNS L+ N L S L+NL
Sbjct: 8 CIEKEVNKTYNCENLGLNEIPGTLPNSTECLE------FSFNVLPTIQNTTFSRLINLTF 61
Query: 133 LFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSI 192
L L + S HRL TL L+ N L L+ L L +
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 193 PPL--NQSSLKIFNVSGNNFTG 212
NQ +L+ + N+ +
Sbjct: 122 FIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 31/113 (27%), Positives = 48/113 (42%), Gaps = 9/113 (7%)
Query: 87 LQGLDLGG-------IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHN 138
LQ L+L G I NSL L +L +L L L+ + L + + L HN
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
T S LS + L+L+ N++S LP L + ++ L N + +
Sbjct: 511 RLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 30/141 (21%), Positives = 54/141 (38%), Gaps = 14/141 (9%)
Query: 87 LQGLDLGG------IFAPNSLTKLDQLRVLGLQNNSLTGPIPDL---SGLVNLKSLFLDH 137
Q L+ GG IF + + L + ++ P + ++++S+ L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 138 NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-- 195
++F + L+ LDL+ +LS LP L L L L N+F + +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFEN-LCQISA 321
Query: 196 -NQSSLKIFNVSGNNFTGAIT 215
N SL ++ GN +
Sbjct: 322 SNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 20/137 (14%), Positives = 38/137 (27%), Gaps = 12/137 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRV--LGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ LD + ++ L Q L L N + G P +SL
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 141 TGSFPPSL--LSLHRLKTLDLSYNNLSGPLPKELASQGRLY--SLRLDVNRFNGSIPPL- 195
L ++ L + P + S+ L + F
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 196 -NQSSLKIFNVSGNNFT 211
S L+ +++ + +
Sbjct: 275 HCFSGLQELDLTATHLS 291
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 32/140 (22%), Positives = 47/140 (33%), Gaps = 18/140 (12%)
Query: 87 LQGLDLGGIFAPNSLTKLD----------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLD 136
L LDL N+L+ LR L L N + GL L+ L
Sbjct: 352 LSYLDLSR----NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQ 407
Query: 137 HNFFTGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
H+ S SL +L LD+SY N L +L++ N F +
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 196 ---NQSSLKIFNVSGNNFTG 212
N ++L ++S
Sbjct: 468 VFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 24/119 (20%), Positives = 39/119 (32%), Gaps = 4/119 (3%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
S + +L+ L L + GL +L +L L N P S L L+
Sbjct: 49 SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN 108
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTG 212
L L+ + L L + N + P N ++L ++S N
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 35/141 (24%), Positives = 49/141 (34%), Gaps = 13/141 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L L L G F+P S + L L L L + L+ LK L + HNF
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 142 G-SFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS----QGRLYSLRLDVNRFNGSIPP-- 194
P +L L +DLSYN + +L SL + +N + I
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200
Query: 195 LNQSSLKIFNVSGNNFTGAIT 215
L + GN + I
Sbjct: 201 FQGIKLHELTLRGNFNSSNIM 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 28/134 (20%), Positives = 48/134 (35%), Gaps = 8/134 (5%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNFFT 141
L+ LDL I + L++L+ L Q+++L L L L + +
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQ-GRLYSLRLDVNRFNGSIPPL--NQS 198
F L L L TL ++ N+ + + L L L + +
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 199 SLKIFNVSGNNFTG 212
L++ N+S NN
Sbjct: 498 RLQLLNMSHNNLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 24/118 (20%), Positives = 35/118 (29%), Gaps = 9/118 (7%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
P+S +D L N L S L+ L L + LH L
Sbjct: 31 PSSTKNID------LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212
L L+ N + P + L +L + +LK NV+ N
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 27/136 (19%), Positives = 44/136 (32%), Gaps = 9/136 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHNFFT 141
L+ L L L L L L N+L+ G +L+ L L N
Sbjct: 330 LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPL--NQS 198
+ + L L+ LD ++ L S +L L + + +
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 199 SLKIFNVSGNNFTGAI 214
SL ++GN+F
Sbjct: 449 SLNTLKMAGNSFKDNT 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 23/109 (21%), Positives = 29/109 (26%), Gaps = 6/109 (5%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFF 140
L L + G N L L L L L L+ L + HN
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN 189
L+ L TLD S+N + L L N
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 21/146 (14%), Positives = 42/146 (28%), Gaps = 17/146 (11%)
Query: 87 LQGLDLGGIF-----APNSLTKLDQLRVLGLQNNSLTG-------PIPDLSGLVNLKSLF 134
L L L G F L L L V L + GL ++
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 135 LD--HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSI 192
+ L + + L+ ++ +++ + SL + +
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK-QF 322
Query: 193 PPLNQSSLKIFNVSGNNFTGAITVTS 218
P L+ LK ++ N + + +
Sbjct: 323 PTLDLPFLKSLTLTMNKGSISFKKVA 348
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 34/132 (25%), Positives = 48/132 (36%), Gaps = 11/132 (8%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
+ + L G I + K + + L + L P L L LKSL L N GS
Sbjct: 287 VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ-FPTLD-LPFLKSLTLTMN--KGSI 342
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR-LDVNRFNGSIPP---LNQSSL 200
++L L LDLS N LS S SLR LD++ I + L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSF-SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEEL 401
Query: 201 KIFNVSGNNFTG 212
+ + +
Sbjct: 402 QHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 18/146 (12%), Positives = 34/146 (23%), Gaps = 21/146 (14%)
Query: 84 RVVLQGLDLGGIFAPNSLTKLD-------QLRVLGLQNNSLTGPIPD--LSGLVNLKSLF 134
V LD+ N + + +L L L+ N + I L L L
Sbjct: 180 PQVNLSLDMSL----NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 135 LDHNFFTGSFPPSLLSLH--------RLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
L F + + L+Y N + + ++ L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 187 RFNGSIPPLNQSSLKIFNVSGNNFTG 212
+ ++
Sbjct: 296 SIKYLEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 38/295 (12%), Positives = 84/295 (28%), Gaps = 57/295 (19%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL--------- 439
+LG+ +A + V ++ ++ + L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 440 -----------------RHPNLVPLRAYFQAKE--ERLLIYDYQPNGSLFSLIH--GSKS 478
+ ++ +R + R +Y + +L + S S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHS 197
Query: 479 TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538
+ K L + L++ V + L+ +H LVH L+ +++L L L
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTG--FEHLV 254
Query: 539 ADSLQDDDPDNLLYKAPE----------TRNASHQATSKSDVYSFGVLLLELLTGKPPSQ 588
D + + ++ PE R+ T D ++ G+++ + P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 589 HSFLVPNEMMNWVRSARED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
W+ + ++ G L E R Q ++
Sbjct: 315 KD--AALGGSEWIFRSCKNIPQPVRALLEGFL--------RYPKEDRLLPLQAME 359
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 54/281 (19%)
Query: 392 LGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVP 446
LG G+ G+ + V ++ V +K L + EM Q M L +P +V
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM---HQLDNPYIVR 74
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L Q E +L+ + G L + G + + ++ ++ V+ G+ Y+ +
Sbjct: 75 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEK 129
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------A 554
VH +L + NVLL A ++D+ L + +L DD Y A
Sbjct: 130 -NFVHRDLAARNVLLVNRHYAKISDFGL----SKALGADDS---YYTARSAGKWPLKWYA 181
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAED 612
PE N + +S+SDV+S+GV + E L+ G+ P + + E+M ++ + G
Sbjct: 182 PECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFI-----EQG--- 229
Query: 613 ERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+R+ L + C E RP V + ++
Sbjct: 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 57/294 (19%)
Query: 390 ELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
+ LGKG+ G+ D +V VK+L T + + + +E + L+H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHD 71
Query: 443 NLVPLRA--YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
N+V + Y + LI +Y P GSL + K + L+ + +G+
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGM 127
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------- 553
Y+ R +H +L + N+L+ + + D+ LT + D +K
Sbjct: 128 EYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEFFKVKEPGES 179
Query: 554 -----APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR----SA 604
APE+ S + + SDV+SFGV+L EL T S+ M+ +
Sbjct: 180 PIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 605 RE-----DDGAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ RL + + C + + QRP+ + + +I
Sbjct: 239 FHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 61/297 (20%)
Query: 390 ELLGKGSLGTTYKAVL--------DNRLIVCVKRLDASKLAGTSNEMYE-----QHMESV 436
+ LG+G+ G A + V VK L K T ++ + + M+ +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMI 97
Query: 437 GGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLH 485
G +H N++ L +I +Y G+L + + +
Sbjct: 98 G--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545
+ + +A+G+ Y+ + +H +L + NVL+ + +AD+ L A + +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGL----ARDINNI 210
Query: 546 DPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFL 592
D YK APE T +SDV+SFGVL+ E+ T G P +
Sbjct: 211 D----YYKKTTNGRLPVKWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--I 263
Query: 593 VPNEMMNWVRS-ARED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
E+ ++ R D +E M+ + C A P QRPT Q+++ L I
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRI 316
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 59/295 (20%)
Query: 390 ELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
+ LGKG+ G+ D +V VK+L T + + + +E + L+H
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHD 102
Query: 443 NLVPLRA--YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
N+V + Y + LI +Y P GSL + K + L+ + +G+
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGM 158
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------- 553
Y+ R +H +L + N+L+ + + D+ LT + D YK
Sbjct: 159 EYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEYYKVKEPGES 210
Query: 554 -----APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD 608
APE+ S + + SDV+SFGV+L EL T S+ M+ +
Sbjct: 211 PIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK----QG 265
Query: 609 GAEDERLGMLLE-----------------VAIACNSASPEQRPTMWQVLKMLQEI 646
L LL+ + C + + QRP+ + + +I
Sbjct: 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 65/293 (22%), Positives = 126/293 (43%), Gaps = 61/293 (20%)
Query: 390 ELLGKGSLGTTYKAVLDN---RLIVCVKRLDASKLAGTSNEMYE-----QHMESVGGLRH 441
+++G+G+ G KA + R+ +KR+ K + ++ + + + +G H
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLG--HH 85
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLHWTSCL 490
PN++ L + + L +Y P+G+L ++ A L L
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
A DVA+G+ Y+ Q + +H +L + N+L+G ++ A +AD+ L+ + +
Sbjct: 146 HFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLS-------RGQE---- 193
Query: 551 LYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-E 596
+Y A E+ N T+ SDV+S+GVLL E+++ G P + E
Sbjct: 194 VYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAE 249
Query: 597 MMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ + R + +DE + ++ C P +RP+ Q+L L +
Sbjct: 250 LYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 59/283 (20%), Positives = 95/283 (33%), Gaps = 69/283 (24%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ-------HMESVGGLRH 441
LGKG ++ D + + K + S L E+ H L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRS----LAH 74
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ--- 498
++V +F+ + ++ + SL L K + E A+
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYL 121
Query: 499 -----GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-- 551
G Y+H+ R++H +LK N+ L D E + D+ L +
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKV 174
Query: 552 ------YKAPE-TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604
Y APE H + + DV+S G ++ LL GKPP + S L E ++
Sbjct: 175 LCGTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKN 230
Query: 605 RED------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A ML P RPT+ ++L
Sbjct: 231 EYSIPKHINPVAASLIQKML--------QTDPTARPTINELLN 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 61/275 (22%), Positives = 105/275 (38%), Gaps = 49/275 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ LG G+ G + +K + + ++ +SN + + + L HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+F+ K L+ + G LF I + I + V G++Y+H+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD-------AAVIIKQVLSGVTYLHKH 155
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETR 558
+VH +LK N+LL D + D+ L + ++ Y APE
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGL----SAVFENQKKMKERLGTAYYIAPEVL 210
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED--------- 607
+ K DV+S GV+L LL G PP F E++ V +
Sbjct: 211 RKKY--DEKCDVWSIGVILFILLAGYPP----FGGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 608 -DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+GA+D ML ++R + Q L+
Sbjct: 265 SEGAKDLIKQML--------QFDSQRRISAQQALE 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 61/297 (20%)
Query: 390 ELLGKGSLGTTYKAVL--------DNRLIVCVKRLDASKLAGTSNEMYE-----QHMESV 436
+ LG+G+ G A + V VK L K T ++ + + M+ +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMI 131
Query: 437 GGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLH 485
G +H N++ L +I +Y G+L + + L
Sbjct: 132 G--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545
+ A VA+G+ Y+ + +H +L + NVL+ D +AD+ L A +
Sbjct: 190 SKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGL----ARDIHHI 244
Query: 546 DPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFL 592
D YK APE T +SDV+SFGVLL E+ T G P +
Sbjct: 245 D----YYKKTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--V 297
Query: 593 VPNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
E+ ++ R D +E L + C A P QRPT Q+++ L I
Sbjct: 298 PVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE-----QHMESVGGLRHPN 443
E++G G+ A + V +KR++ L M E Q M HPN
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRIN---LEKCQTSMDELLKEIQAMSQ---CHHPN 74
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK------IAEDVA 497
+V F K+E L+ GS+ +I K AK H + L I +V
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVL 131
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK---- 553
+GL Y+H+ +H ++K+ N+LLG D +AD+ ++A L
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSA----FLATGGDITRNKVRKTF 186
Query: 554 -------APETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE K+D++SFG+ +EL TG P
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 54/281 (19%)
Query: 392 LGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVP 446
LG G+ G+ + V ++ V +K L + EM Q M L +P +V
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM---HQLDNPYIVR 400
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L Q E +L+ + G L + G + + ++ ++ V+ G+ Y+ +
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEK 455
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------------A 554
VH NL + NVLL A ++D+ L + +L DD Y A
Sbjct: 456 -NFVHRNLAARNVLLVNRHYAKISDFGL----SKALGADDS---YYTARSAGKWPLKWYA 507
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAED 612
PE N + +S+SDV+S+GV + E L+ G+ P + + E+M ++ + G
Sbjct: 508 PECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFI-----EQG--- 555
Query: 613 ERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+R+ L + C E RP V + ++
Sbjct: 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 36/294 (12%), Positives = 82/294 (27%), Gaps = 56/294 (19%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSN----EMYEQHMESVGGLRHPN 443
+LG+ +A V ++ ++ + + + G+++
Sbjct: 84 TVLGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 444 LVPLRAYFQAKEERL-----------------------LIYDYQPNGSLFSLIH--GSKS 478
+ F + + + +L + S S
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 479 TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538
+ K L + L++ V + L+ +H LVH L+ +++L L +
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 539 ADSLQDDDPDNLLYKAPET---------RNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589
S P + PET ++ T D ++ G+ + + P+
Sbjct: 262 GASAVS--PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 590 SFLVPNEMMNWVRSARED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
W+ + ++ G L E R Q ++
Sbjct: 320 D--AALGGSEWIFRSCKNIPQPVRALLEGFL--------RYPKEDRLLPLQAME 363
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 59/282 (20%), Positives = 95/282 (33%), Gaps = 67/282 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ------HMESVGGLRHP 442
LGKG ++ D + + K + S L E+ S L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRS---LAHQ 101
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ---- 498
++V +F+ + ++ + SL L K + E A+
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYLR 148
Query: 499 ----GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--- 551
G Y+H+ R++H +LK N+ L D E + D+ L +
Sbjct: 149 QIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVL 201
Query: 552 -----YKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
Y APE H + + DV+S G ++ LL GKPP + S L E ++
Sbjct: 202 CGTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKNE 257
Query: 606 ED------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A ML P RPT+ ++L
Sbjct: 258 YSIPKHINPVAASLIQKML--------QTDPTARPTINELLN 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 59/285 (20%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYE---QHMESVGGLRHP 442
+G+G G ++ + + L V +K TS+ + E Q ++ HP
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHP 76
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
++V L + +I + G L S L S L + A ++ L+
Sbjct: 77 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALA 130
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK-------- 553
Y+ R VH ++ + NVL+ + L D+ L+ ++D YK
Sbjct: 131 YLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDST----YYKASKGKLPI 181
Query: 554 ---APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDD 608
APE+ N + TS SDV+ FGV + E+L G P Q V N +++ + ++
Sbjct: 182 KWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRI-----EN 232
Query: 609 GAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
G ERL L + C + P +RP ++ L I
Sbjct: 233 G---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 27/203 (13%), Positives = 51/203 (25%), Gaps = 44/203 (21%)
Query: 390 ELLGKGSLGTTYKAVLDNRL--IVCVKRLDAS-KLAGTSNEMYEQHMESVGGLRHPNLVP 446
G ++A+ D L V + +D L + + + P +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 447 LRAYFQAKEERLLIY---DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+ R ++ GSL + ++ + +A
Sbjct: 96 V---LDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAA 145
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQ 563
H+A + S V + D + LA
Sbjct: 146 HRA-GVALSIDHPSRVRVSIDGDVVLAY------------------PATMPD-------- 178
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
A + D+ G L LL + P
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWP 201
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 390 ELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHP 442
LG+G G D V VK L K N + + + +E + L H
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILRNLYHE 83
Query: 443 NLVPLRA--YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
N+V + LI ++ P+GSL + +K+ ++ LK A + +G+
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGM 139
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK------- 553
Y+ + VH +L + NVL+ + + + D+ LT + + D Y
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLT-------KAIETDKEYYTVKDDRDS 191
Query: 554 -----APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMN--WVRSAR 605
APE + SDV+SFGV L ELLT S L + +
Sbjct: 192 PVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 606 E-----DDGAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+G +RL + ++ C P R + +++ + +
Sbjct: 251 RLVNTLKEG---KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 56/293 (19%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYE-----QHMESVGG 438
+ LG G+ G +A D L V VK L K ++E + M +G
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLG- 107
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFS---------LIHGSKSTRAKPLHWTSC 489
+H N+V L L+I +Y G L + + +
Sbjct: 108 -QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN 549
L + VAQG++++ +H ++ + NVLL A + D+ L D + D +
Sbjct: 167 LHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDF---GLARDIMNDSN--- 219
Query: 550 LLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNE 596
Y APE+ T +SDV+S+G+LL E+ + G P LV ++
Sbjct: 220 --YIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYP-GILVNSK 275
Query: 597 MMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
V+ + A + + AC + P RPT Q+ LQE
Sbjct: 276 FYKLVKDGYQMAQPAFAPKN----IYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 61/305 (20%)
Query: 390 ELLGKGSLGTTYKAVL--------DNRLIVCVKRLDASKLAGTSNEMYEQHME-----SV 436
+ LG+G G A + V VK L K T ++ + E +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMI 143
Query: 437 GGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLH 485
G +H N++ L +I +Y G+L + + +
Sbjct: 144 G--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545
+ + +A+G+ Y+ + +H +L + NVL+ + +AD+ L A + +
Sbjct: 202 FKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGL----ARDINNI 256
Query: 546 DPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFL 592
D YK APE T +SDV+SFGVL+ E+ T G P +
Sbjct: 257 D----YYKKTTNGRLPVKWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--I 309
Query: 593 VPNEMMNWVRS-ARED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649
E+ ++ R D +E L + C A P QRPT Q+++ L I
Sbjct: 310 PVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365
Query: 650 VLMED 654
E+
Sbjct: 366 TTNEE 370
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 2/112 (1%)
Query: 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
+ ++ L + N T +SGL NL+ L + T P+L L L LD+S
Sbjct: 62 IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFT 211
++ + ++ + ++ S+ L N I PL LK N+ +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 6/84 (7%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L LD+ + L ++ + L N I L L LKSL + +
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH- 172
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSG 166
+ + +L L + G
Sbjct: 173 DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-16
Identities = 34/127 (26%), Positives = 49/127 (38%), Gaps = 6/127 (4%)
Query: 87 LQGLDLGG-IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145
LQ L G + L L L L + +N ++ I L+ L NL+SL +N +
Sbjct: 158 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDI-- 214
Query: 146 PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNV 205
L L L L L+ N L LAS L L L N+ + P + L +
Sbjct: 215 TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKL 272
Query: 206 SGNNFTG 212
N +
Sbjct: 273 GANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 34/136 (25%), Positives = 50/136 (36%), Gaps = 7/136 (5%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L LG I + L L L L L N L I +S L NL L L N +
Sbjct: 267 LTELKLGANQISNISPLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDI- 324
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
+ SL +L+ L N +S LA+ + L N+ + P N + +
Sbjct: 325 -SPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLG 381
Query: 205 VSGNNFTGAITVTSTL 220
++ +T A
Sbjct: 382 LNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 9/129 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L LDL I L+ L +L L L N ++ I L+GL L +L L+ N
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLED-- 301
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIF 203
+ +L L L L +NN+S P ++S +L L N+ + + L +++
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWL 358
Query: 204 NVSGNNFTG 212
+ N +
Sbjct: 359 SAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 7/128 (5%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
LG + S T LDQ+ L + I + L NL + +N T
Sbjct: 26 KMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDI- 83
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
L +L +L + ++ N ++ P LA+ L L L N+ P N ++L
Sbjct: 84 -TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 140
Query: 205 VSGNNFTG 212
+S N +
Sbjct: 141 LSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 8/128 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L ++ + L L +L + + NN + I L+ L NL L L +N T
Sbjct: 70 LTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD-- 126
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
L +L L L+LS N +S L+ L L N+ P N ++L+ +
Sbjct: 127 IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLANLTTLERLD 183
Query: 205 VSGNNFTG 212
+S N +
Sbjct: 184 ISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 22/134 (16%), Positives = 46/134 (34%), Gaps = 10/134 (7%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
LQ L + +SL L + L +N ++ + L+ L + L L+ +T +
Sbjct: 333 LQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWT-NA 390
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPL-PKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLK 201
P + + + + N + P ++ G + N + + S
Sbjct: 391 PVNYKAN--VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPV 447
Query: 202 IFNVSGNNFTGAIT 215
F+G +T
Sbjct: 448 TIGKGTTTFSGTVT 461
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 32/136 (23%), Positives = 52/136 (38%), Gaps = 13/136 (9%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
L+ LD + + L L L + + + +GL +L+ L + N
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNS 161
Query: 140 FTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--- 195
F +F P + + L L LDLS L P S L L + N F S+
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
Query: 196 NQSSLKIFNVSGNNFT 211
+SL++ + S N+
Sbjct: 221 CLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 26/135 (19%), Positives = 41/135 (30%), Gaps = 10/135 (7%)
Query: 87 LQGLDLGG------IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L L L S L+ L L N + + GL L+ L H+
Sbjct: 54 LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 113
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
S+ L L LD+S+ + L L++ N F + P
Sbjct: 114 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 197 QSSLKIFNVSGNNFT 211
+L ++S
Sbjct: 174 LRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 32/139 (23%), Positives = 49/139 (35%), Gaps = 13/139 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTG---PIPDLSGLVNLKSLFLDHNF 139
L+L KL QL L L +N L+ G +LK L L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIPP---L 195
+ + L L +L+ LD ++NL + S L L +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
Query: 196 NQSSLKIFNVSGNNFTGAI 214
SSL++ ++GN+F
Sbjct: 148 GLSSLEVLKMAGNSFQENF 166
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 23/105 (21%), Positives = 36/105 (34%), Gaps = 9/105 (8%)
Query: 112 LQNNSLTGPIPDLSGL-VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS--GPL 168
+ LT +P +G+ + L L+ N L +L L LS N LS G
Sbjct: 14 CNSKGLTS-VP--TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 169 PKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFT 211
+ L L L N ++ L L+ + +N
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 60/290 (20%), Positives = 102/290 (35%), Gaps = 56/290 (19%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
LG G+ G Y+ + L V VK L + + + + H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNH 92
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
N+V R ++ + G L F + ++ L L +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 500 LSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLLYK--- 553
Y+ + +H ++ + N LL GP A + D+ + A + Y+
Sbjct: 153 CQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGM----ARDIYRAS----YYRKGG 203
Query: 554 ---------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603
PE TSK+D +SFGVLL E+ + G P + E++ +V S
Sbjct: 204 CAMLPVKWMPPEA-FMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTS 260
Query: 604 AREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
R+ G + + C PE RP +L+ ++
Sbjct: 261 GG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 55/283 (19%)
Query: 390 ELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPN 443
+LG+G G Y+ V N ++ V VK + M L HP+
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM---KNLDHPH 74
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+V L + +E +I + P G L L S + L + + + + ++Y
Sbjct: 75 IVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAY 128
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ VH ++ N+L+ L D+ L+ ++D+D YK
Sbjct: 129 LESI-NCVHRDIAVRNILVASPECVKLGDFGLSRY----IEDED----YYKASVTRLPIK 179
Query: 554 --APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGA 610
+PE+ N + T+ SDV+ F V + E+L+ GK P L +++ + + G
Sbjct: 180 WMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFW--LENKDVIGVL-----EKG- 230
Query: 611 EDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+RL +L + C P RP +++ L ++
Sbjct: 231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 30/131 (22%), Positives = 49/131 (37%), Gaps = 9/131 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L L I + L L L N +T I ++ + L SL + +N T
Sbjct: 179 LYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDL- 236
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIF 203
L +L +L L++ N +S + +L L + N+ + I LN S L
Sbjct: 237 -SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSL 292
Query: 204 NVSGNNFTGAI 214
++ N
Sbjct: 293 FLNNNQLGNED 303
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 9/130 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L I + + +L L + NN +T + L+ L L L + N +
Sbjct: 201 LHYFTAYVNQITDITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISD-- 257
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP-PLNQ-SSLKI 202
++ L +LK L++ N +S L + +L SL L+ N+ + ++L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 203 FNVSGNNFTG 212
+S N+ T
Sbjct: 316 LFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 30/129 (23%), Positives = 48/129 (37%), Gaps = 8/129 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L+ L L I + L L ++ L L N + LS + L L + +
Sbjct: 112 LRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDV- 170
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIF 203
+ +L L +L L+YN + LAS L+ VN+ I P+ + L
Sbjct: 171 -TPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQIT-DITPVANMTRLNSL 226
Query: 204 NVSGNNFTG 212
+ N T
Sbjct: 227 KIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 25/138 (18%), Positives = 52/138 (37%), Gaps = 7/138 (5%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L + + +L+ + L + + I + L NL+ L L+ N T
Sbjct: 24 GIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITD-- 80
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
L +L +L L + N ++ L + L L L+ + + P N + + N
Sbjct: 81 ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLN 138
Query: 205 VSGNNFTGAITVTSTLSR 222
+ N+ ++ S ++
Sbjct: 139 LGANHNLSDLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 87 LQGLDLG--GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L++G I N++ L +L++L + +N ++ I L+ L L SLFL++N
Sbjct: 245 LTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187
+ L L TL LS N+++ P LAS ++ S
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 18/105 (17%), Positives = 31/105 (29%), Gaps = 8/105 (7%)
Query: 111 GLQN-NSLTGPIPDLS---GLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSG 166
G +L PI + L L T + L + L ++ ++
Sbjct: 1 GAATLATLPAPINQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS 58
Query: 167 PLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
+ + L L L+ N+ P N L + N T
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT 101
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 14/84 (16%), Positives = 29/84 (34%), Gaps = 6/84 (7%)
Query: 130 LKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN 189
+L FP L L +++ + +E + L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELES--ITKLVVAGEKVA 57
Query: 190 GSIPPLNQ-SSLKIFNVSGNNFTG 212
SI + ++L+ N++GN T
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITD 80
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 63/276 (22%), Positives = 106/276 (38%), Gaps = 50/276 (18%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
+LGKGS G VK + ++ ++ E + ++ + L HPN++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+F+ K L+ + G LF I S +I V G++Y+H+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-------AARIIRQVLSGITYMHK 144
Query: 506 AWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPET 557
++VH +LK N+LL D + D+ L + + Y APE
Sbjct: 145 N-KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKMKDKIGTAYYIAPEV 199
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED-------- 607
+ ++ K DV+S GV+L LL+G PP F N +++ V +
Sbjct: 200 LHGTY--DEKCDVWSTGVILYILLSGCPP----FNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 608 --DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ A+D ML + P R + L
Sbjct: 254 VSESAKDLIRKML--------TYVPSMRISARDALD 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 60/283 (21%), Positives = 117/283 (41%), Gaps = 51/283 (18%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHP 442
+++G G G YK +L + V +K L K T + + E+ G H
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
N++ L + ++I +Y NG+L + + + +A G+ Y
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKY 162
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ VH +L + N+L+ + ++D+ L+ + +DDP+
Sbjct: 163 LANM-NYVHRDLAARNILVNSNLVCKVSDFGLS-----RVLEDDPEATYTTSGGKIPIRW 216
Query: 554 -APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGA 610
APE + + TS SDV+SFG+++ E++T G+ P + N E+M + +DG
Sbjct: 217 TAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWE---LSNHEVMKAI-----NDG- 266
Query: 611 EDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL + ++ + C +RP ++ +L ++
Sbjct: 267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 62/290 (21%), Positives = 104/290 (35%), Gaps = 56/290 (19%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRH 441
LG G+ G Y+ + L V VK L + + + ME++ H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNH 133
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL--FSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
N+V R ++ + G L F + ++ L L +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 500 LSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLLYK--- 553
Y+ + +H ++ + N LL GP A + D+ + D Y+
Sbjct: 194 CQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRAGYYRKGG 244
Query: 554 ---------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603
PE TSK+D +SFGVLL E+ + G P + E++ +V S
Sbjct: 245 CAMLPVKWMPPEA-FMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTS 301
Query: 604 AREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
R+ G + + C PE RP +L+ ++
Sbjct: 302 GG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 62/297 (20%), Positives = 111/297 (37%), Gaps = 60/297 (20%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYE-----QHMESVGG 438
+ LG G+ G +A D + V VK L K + E + + +G
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLG- 84
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSL-------------FSLIHGSKSTRAKPLH 485
H N+V L L+I +Y G L L
Sbjct: 85 -NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545
L + VA+G++++ +H +L + N+LL + D+ L A +++D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGL----ARDIKND 198
Query: 546 DPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFL 592
Y APE+ + T +SDV+S+G+ L EL + G P
Sbjct: 199 S----NYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYP-GMP 252
Query: 593 VPNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
V ++ ++ R + A E + ++ C A P +RPT Q+++++++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 66/295 (22%), Positives = 112/295 (37%), Gaps = 62/295 (21%)
Query: 390 ELLGKGSLGTTYKAVLDNRL------IVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
LG+G+ G + A N L +V VK L K + + + + E + L+H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---K-EASESARQDFQREAELLTMLQH 102
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFS----------LIHGSKSTRAKPLHWTSCLK 491
++V L++++Y +G L L+ G + PL L
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 492 IAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL 551
+A VA G+ Y+ VH +L + N L+G + D+ ++ D
Sbjct: 163 VASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 213
Query: 552 YK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMM 598
Y+ PE+ + T++SDV+SFGV+L E+ T GK P L E +
Sbjct: 214 YRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAI 270
Query: 599 NWVRSAREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ + R L + + C P+QR ++ V LQ +
Sbjct: 271 DCITQGR--------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 63/302 (20%), Positives = 104/302 (34%), Gaps = 65/302 (21%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYE-----QHMESVGG 438
++LG G+ G A + V VK L K S+E + M +G
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLG- 106
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSL------------------FSLIHGSKSTR 480
H N+V L LI++Y G L + +
Sbjct: 107 -SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 481 AKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540
L + L A VA+G+ ++ VH +L + NVL+ + D+ L A
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGL----AR 220
Query: 541 SLQDDDPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPS 587
+ D Y APE+ T KSDV+S+G+LL E+ + G P
Sbjct: 221 DIMSDS----NYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 588 QHSFLVPNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
V +++ + D A +E + + +C + +RP+ + L
Sbjct: 276 P-GIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTSFLG 330
Query: 645 EI 646
Sbjct: 331 CQ 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 57/284 (20%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
+G+G G ++ + + + V +K K + + + E++ HP+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFS-LIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+V L + +I + G L S L S L + A ++ L+Y
Sbjct: 453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAY 506
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK--------- 553
+ R VH ++ + NVL+ + L D+ L + ++D YK
Sbjct: 507 LESK-RFVHRDIAARNVLVSSNDCVKLGDFGL----SRYMEDST----YYKASKGKLPIK 557
Query: 554 --APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDG 609
APE+ N + TS SDV+ FGV + E+L G P Q V N +++ +
Sbjct: 558 WMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRIE------- 606
Query: 610 AEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
ERL L + C + P +RP ++ L I
Sbjct: 607 -NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 11/134 (8%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFF 140
L+ LD + + L L L + + +GL +L+ L + N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
+F P + + L L LDLS L P S L L + N+ S+P
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDR 516
Query: 197 QSSLKIFNVSGNNF 210
+SL+ + N +
Sbjct: 517 LTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLS---GLVNLKSLFLDHNFF 140
L+ LDL I ++ L+QL L Q+++L + + S L NL L + H
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHT 433
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQ-GRLYSLRLDVNRFNGSIPP---LN 196
+F L L+ L ++ N+ ++ ++ L L L + + P +
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 492
Query: 197 QSSLKIFNVSGNNFT 211
SSL++ N++ N
Sbjct: 493 LSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 28/135 (20%), Positives = 44/135 (32%), Gaps = 10/135 (7%)
Query: 87 LQGLDLGG------IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ LDL S L+ L L N + + GL L+ L H+
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 141 TGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
S+ SL L LD+S+ + L L++ N F + P
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 197 QSSLKIFNVSGNNFT 211
+L ++S
Sbjct: 469 LRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 25/134 (18%), Positives = 41/134 (30%), Gaps = 10/134 (7%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
+ LDL S +L+VL L + L +L +L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ---- 197
+ L L+ L NL+ + L L + N S
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
Query: 198 SSLKIFNVSGNNFT 211
++L+ ++S N
Sbjct: 149 TNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 33/141 (23%), Positives = 48/141 (34%), Gaps = 13/141 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
L L L G A + + L L+ L +L + L LK L + HN
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 142 -GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS----QGRLYSLRLDVNRFNGSIPP-- 194
P +L L+ LDLS N + +L SL L +N N I P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 195 LNQSSLKIFNVSGNNFTGAIT 215
+ L + N + +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVM 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 31/137 (22%), Positives = 46/137 (33%), Gaps = 11/137 (8%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTG---PIPDLSGLVNLKSLFLDHNFFT 141
L+ L S L L L L N L+ G +LK L L N
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIPP---LNQ 197
+ + L L +L+ LD ++NL S L L +
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGL 444
Query: 198 SSLKIFNVSGNNFTGAI 214
SSL++ ++GN+F
Sbjct: 445 SSLEVLKMAGNSFQENF 461
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 8/86 (9%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFF 140
L+ L + G F P+ T+L L L L L P + L +L+ L + N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
Query: 141 TGSFPPSLL-SLHRLKTLDLSYNNLS 165
S P + L L+ + L N
Sbjct: 507 K-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 26/158 (16%), Positives = 45/158 (28%), Gaps = 13/158 (8%)
Query: 58 HLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSL 117
+ + V L + + + + L ++ +
Sbjct: 261 EFRLAYLDYYLD-DIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 118 TGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS--GPLPKELASQ 175
L +LK L N + S + L L+ LDLS N LS G +
Sbjct: 320 PT-----LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 176 GRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFT 211
L L L N ++ L L+ + +N
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 22/103 (21%), Positives = 31/103 (30%), Gaps = 6/103 (5%)
Query: 112 LQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE 171
+ +L + K+L L N S S L+ LDLS +
Sbjct: 14 CMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 172 LASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
S L +L L N S+ SSL+ N
Sbjct: 72 YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 26/144 (18%), Positives = 37/144 (25%), Gaps = 18/144 (12%)
Query: 87 LQGLDLGGIF-----APNSLTKLDQLRVLGL-------QNNSLTGPIPDLSGLVNLKSLF 134
L L L F + L L V L + N L GL NL
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 135 LDHN---FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS 191
++ L + + L + + L L +F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG-Q 318
Query: 192 IPPLNQSSLKIFNVSGNNFTGAIT 215
P L SLK + N A +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 62/334 (18%), Positives = 109/334 (32%), Gaps = 68/334 (20%)
Query: 343 IQIEQENELQEKVKRAQGIQVAKSGNLVFCAGE-AQLYTLDQLMRASAELLGKGSLGTTY 401
+ + + QGI + + G+ + Y LG G+ G
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKV-------RKLGSGAYGEVL 53
Query: 402 KAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG-----------LRHPNLVPLRA 449
+ +K + S+ +++E L HPN++ L
Sbjct: 54 LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113
Query: 450 YFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F+ K+ L+ ++ G LF I I + + G+ Y+H+
Sbjct: 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD-------AANIMKQILSGICYLHKH- 165
Query: 508 RLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETRN 559
+VH ++K N+LL + D+ L + D Y APE
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGL----SSFFSKDYKLRDRLGTAYYIAPEVLK 221
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED---------- 607
+ K DV+S GV++ LL G PP F N +++ V +
Sbjct: 222 KKY--NEKCDVWSCGVIMYILLCGYPP----FGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
D A++ ML + +R T + L
Sbjct: 276 DEAKELIKLML--------TYDYNKRCTAEEALN 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 53/263 (20%), Positives = 107/263 (40%), Gaps = 23/263 (8%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHME--SVGGLRHPNLVP 446
LG G+ G +K + L++ K + L + E + P +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIV- 94
Query: 447 LRAYFQA--KEERLLIY-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ A + + I ++ GSL ++ +A + K++ V +GL+Y+
Sbjct: 95 --GFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYL 147
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQ 563
+ +++H ++K SN+L+ E L D+ ++ DS+ + Y +PE R
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTH 206
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623
+ +SD++S G+ L+E+ G+ P P+ + + +G E
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYP----IPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 624 ACNSASPEQRPTMWQVLKMLQEI 646
N + RP M + ++L I
Sbjct: 263 PLNKFGMDSRPPM-AIFELLDYI 284
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 62/300 (20%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
+ LG+G G KA V VK L K + +E+ + + + H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNH 85
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL-------------------FSLIHGSKSTRAK 482
P+++ L LLI +Y GSL +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
L + A ++QG+ Y+ + +LVH +L + N+L+ + ++D+ L + +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISDFGL----SRDV 200
Query: 543 QDDDPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQH 589
++D Y A E+ H T++SDV+SFGVLL E++T G P
Sbjct: 201 YEED----SYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 590 SFLVPNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ P + N +++ R + D +E + + + C P++RP + K L+++
Sbjct: 256 --IPPERLFNLLKTGHRMERPDNCSEE----MYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 29/128 (22%), Positives = 49/128 (38%), Gaps = 6/128 (4%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGS 143
L L L + L L + L N L + L+ L++ +N +
Sbjct: 228 LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIF 203
+ LK LDLS+N+L + + RL +L LD N ++ +LK
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNL 344
Query: 204 NVSGNNFT 211
+S N++
Sbjct: 345 TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 33/131 (25%), Positives = 45/131 (34%), Gaps = 16/131 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L L L +L L + NN+L I D +L++L L N
Sbjct: 119 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 177
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSL 200
T SL+ L ++SYN LS LA + L N N + L
Sbjct: 178 T-HVDLSLIP--SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVEL 228
Query: 201 KIFNVSGNNFT 211
I + NN T
Sbjct: 229 TILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 14/132 (10%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
++ LD NS+ + +L +L LQ+N+LT L L + L +N
Sbjct: 207 VEELDASH----NSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE 261
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSS 199
+ + RL+ L +S N L L L L L N +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 200 LKIFNVSGNNFT 211
L+ + N+
Sbjct: 320 LENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 26/136 (19%), Positives = 49/136 (36%), Gaps = 15/136 (11%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
+ + L Q+ +L L + + I + ++ L++ N
Sbjct: 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAI 105
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIPPL--- 195
PP + + L L L N+LS LP+ + + +L +L + N I
Sbjct: 106 R-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 162
Query: 196 NQSSLKIFNVSGNNFT 211
+SL+ +S N T
Sbjct: 163 ATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 21/123 (17%), Positives = 47/123 (38%), Gaps = 9/123 (7%)
Query: 95 IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLS-L 151
++ L+ +++ +N+++ +P L ++ L L+ +
Sbjct: 35 VYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYA 92
Query: 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGN 208
H ++ L + +N + P + L L L+ N + S+P N L ++S N
Sbjct: 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
Query: 209 NFT 211
N
Sbjct: 152 NLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 29/133 (21%), Positives = 44/133 (33%), Gaps = 22/133 (16%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
LQ L L N LT +D L + N L+ L+ + ++ L HN
Sbjct: 167 LQNLQLSS----NRLTHVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN 218
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQS 198
+ L L L +NNL+ L + L + L N I +
Sbjct: 219 -VVRGPVNV--ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ 272
Query: 199 SLKIFNVSGNNFT 211
L+ +S N
Sbjct: 273 RLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 16/121 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD-------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
L+ L + N L L+ L+VL L +N L + L++L+LDHN
Sbjct: 274 LERLYISN----NRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS 329
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
+ S + H LK L LS+N+ + L + +D + I +
Sbjct: 330 IV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRN--VARPAVDDADQHCKIDYQLEHG 384
Query: 200 L 200
L
Sbjct: 385 L 385
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 17/119 (14%), Positives = 40/119 (33%), Gaps = 7/119 (5%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGP-IPDLSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRLK 155
++L + + + + L N K + ++ P +LL +++
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
L+L+ + A + L + N +PP N L + + N+ +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 1e-14
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG G G + + D V +K+ +L+ + E + ++ + L HPN+V R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 449 AYFQAKEE------RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
++ LL +Y G L ++ + L + D++ L Y
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLSDISSALRY 136
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDN-----LLYKA 554
+H+ R++H +LK N++L P + + D A L + L Y A
Sbjct: 137 LHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY----AKELDQGELCTEFVGTLQYLA 191
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE + T D +SFG L E +TG P
Sbjct: 192 PELLE-QKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 46/280 (16%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
+++G G G L + V +K L K T + + E+ G HPN
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ L +++ +Y NGSL + + + + V G+ Y+
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYL 167
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLYK--AP 555
VH +L + NVL+ + ++D+ L+ + D D D + + AP
Sbjct: 168 SDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED---DPDAAYTTTGGKIPIRWTAP 223
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPN-EMMNWVRSAREDDGAEDE 613
E +S SDV+SFGV++ E+L G+ P + + N ++++ V E
Sbjct: 224 EAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWN---MTNRDVISSVE--------EGY 271
Query: 614 RLGM-------LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL L ++ + C QRP Q++ +L +
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 29/128 (22%), Positives = 49/128 (38%), Gaps = 6/128 (4%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGS 143
L L L + L L + L N L + L+ L++ +N +
Sbjct: 234 LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIF 203
+ LK LDLS+N+L + + RL +L LD N ++ +LK
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNL 350
Query: 204 NVSGNNFT 211
+S N++
Sbjct: 351 TLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 33/131 (25%), Positives = 45/131 (34%), Gaps = 16/131 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L L L +L L + NN+L I D +L++L L N
Sbjct: 125 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 183
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSL 200
T SL+ L ++SYN LS LA + L N N + L
Sbjct: 184 T-HVDLSLIP--SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVEL 234
Query: 201 KIFNVSGNNFT 211
I + NN T
Sbjct: 235 TILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 21/123 (17%), Positives = 47/123 (38%), Gaps = 9/123 (7%)
Query: 95 IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLS-L 151
++ L+ +++ +N+++ +P L ++ L L+ +
Sbjct: 41 VYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYA 98
Query: 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGN 208
H ++ L + +N + P + L L L+ N + S+P N L ++S N
Sbjct: 99 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 157
Query: 209 NFT 211
N
Sbjct: 158 NLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 32/130 (24%), Positives = 50/130 (38%), Gaps = 14/130 (10%)
Query: 87 LQGLDLGGIFAPNSLTKLD---QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
L ++ N L+ L + L +NS+ + V L L L HN T
Sbjct: 194 LFHANVSY----NLLSTLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQHNNLTD- 246
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLK 201
LL+ L +DLSYN L + RL L + NR ++ +LK
Sbjct: 247 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 304
Query: 202 IFNVSGNNFT 211
+ ++S N+
Sbjct: 305 VLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 26/136 (19%), Positives = 49/136 (36%), Gaps = 15/136 (11%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
+ + L Q+ +L L + + I + ++ L++ N
Sbjct: 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAI 111
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIPPL--- 195
PP + + L L L N+LS LP+ + + +L +L + N I
Sbjct: 112 R-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 168
Query: 196 NQSSLKIFNVSGNNFT 211
+SL+ +S N T
Sbjct: 169 ATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 16/121 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD-------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
L+ L + N L L+ L+VL L +N L + L++L+LDHN
Sbjct: 280 LERLYISN----NRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS 335
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
+ S + H LK L LS+N+ + L + +D + I +
Sbjct: 336 IV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRN--VARPAVDDADQHCKIDYQLEHG 390
Query: 200 L 200
L
Sbjct: 391 L 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 11/92 (11%), Positives = 28/92 (30%), Gaps = 4/92 (4%)
Query: 123 DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182
+L + +D F ++L+ K + + + L S ++ L
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81
Query: 183 LDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
L+ + I +++ + N
Sbjct: 82 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 52/296 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+LGKGS G K + VK ++ + + +E + L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ ++ + G LF I S +I + V G++Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARIIKQVFSGITYMHKH 140
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETR 558
+VH +LK N+LL D + + D+ L + Q + Y APE
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED--------- 607
++ K DV+S GV+L LL+G PP F N +++ V + +
Sbjct: 196 RGTY--DEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 608 -DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK---MLQEIKGAVLMEDGELDP 659
D A+D ML + P R T Q L+ + + + D
Sbjct: 250 SDDAKDLIRKML--------TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 29/132 (21%), Positives = 54/132 (40%), Gaps = 17/132 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
++ LDL G + L +L +L L +N L DL L L++L L++N+
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ- 93
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSS 199
LL ++TL + NN+S + ++ L N+ + L +S
Sbjct: 94 ----ELLVGPSIETLHAANNNISR-VSCSRGQG--KKNIYLANNKIT-MLRDLDEGCRSR 145
Query: 200 LKIFNVSGNNFT 211
++ ++ N
Sbjct: 146 VQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 26/130 (20%), Positives = 43/130 (33%), Gaps = 13/130 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFT 141
+ + + ++ L L N L+ DL+ L+ L L N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
L SL L+TLDL+ N + EL + +L N + + K
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKK 123
Query: 202 IFNVSGNNFT 211
++ N T
Sbjct: 124 NIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 104 LDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162
++ ++ + ++SL + N+K L L N + L +L+ L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 163 NLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L L L S L +L L+ N + S++ + + NN +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 12/130 (9%)
Query: 87 LQGLDLGGIFAPNSLTKLD---QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
L+ LDL N + +L + L NN+++ + S K+++L +N T
Sbjct: 82 LRTLDLNN----NYVQELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITML 135
Query: 144 FPPSLLSLHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLK 201
R++ LDL N + + AS L L L N + + LK
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLK 194
Query: 202 IFNVSGNNFT 211
++S N
Sbjct: 195 TLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 20/132 (15%), Positives = 39/132 (29%), Gaps = 14/132 (10%)
Query: 87 LQGLDLGGIFAPNSLTKLD------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ L+L N + + +L+ L L +N L P+ + + L +N
Sbjct: 171 LEHLNLQY----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLS-GPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
+L L+ DL N G L + R+ ++ +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEEC 283
Query: 200 LKIFNVSGNNFT 211
+
Sbjct: 284 TVPTLGHYGAYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 121 IPDLSG-LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179
I ++ K + + + S +K LDLS N LS +LA +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 180 SLRLDVNRFNGSIPPLNQ-SSLKIFNVSGNNFT 211
L L N L S+L+ +++ N
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 17/236 (7%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSF 144
L L + L ++ L++L L N + D S +L+ LFL N ++
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 145 PPSLLS-----LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
L L L+ L L++N L+ P + L L L+ NR ++
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN 527
Query: 200 LKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRP-PFFGPSATAAA 258
L+I ++S N + N +C EC +
Sbjct: 528 LEILDISRNQLL--APNPDVFVSLSVLDITHNKFIC------ECELSTFINWLNHTNVTI 579
Query: 259 APPPVTVLGQQSAQMHGVELTQPSPKS-HKKTAVIIGFSSGVLVLICSLVLFAMAV 313
A PP + GV L S + ++ + S +V +L LF M +
Sbjct: 580 AGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTI 635
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 42/170 (24%), Positives = 60/170 (35%), Gaps = 20/170 (11%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD---LSGLVNLKSLFLDHNF 139
L+ LDLG P++ L L L L L+ + L L L L N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 140 FTG-SFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS--QGRLYSLRLDVNR--------F 188
PS L+ LK++D S N + EL L L N +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 189 NGSIPPLNQSSLKIFNVSGNNFTGAITVTS--TLSRFGISSFLFNPSLCG 236
+ P L+I +VSGN +T IT +S+ S + + G
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 31/138 (22%), Positives = 46/138 (33%), Gaps = 15/138 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
+ L L +S L+QL++L L + I L NL+ L L +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPL--PKELASQGRLYSLRLDVNRFNGSIPP--- 194
P L L L L + LS + + L L L N+ S+
Sbjct: 86 Y-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPS 143
Query: 195 -LNQSSLKIFNVSGNNFT 211
+SLK + S N
Sbjct: 144 FGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 4/115 (3%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
L L+VL L N + GL NL+ L L +N + + L ++
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
+DL N+++ + +L +L L N +I + S+ +SGN
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI--PSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 7/120 (5%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLV--NLKSLFLDHNFFTGSFPPSLLSLHRL 154
SL + G +++ P + +GL +++ L L H F +L L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
K L+L+YN ++ + L L L N + + ++ N+
Sbjct: 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 21/118 (17%), Positives = 38/118 (32%), Gaps = 8/118 (6%)
Query: 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGP 167
R+ + +LT +P L + L L N+ S L +L+ L+L
Sbjct: 7 RIAFYRFCNLTQ-VPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 168 LPKE-LASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTGAITVTSTLS 221
+ KE + L L L ++ + P L + + A+
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 29/154 (18%), Positives = 49/154 (31%), Gaps = 29/154 (18%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQ--LRVLGLQNNSLTGPIPDLSG-------LVNLKSL 133
L+ +D + + L L L L NSL + G + L+ L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 134 FLDHNFFT------------GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSL 181
+ N +T S SL+ H + ++N+ P A R
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269
Query: 182 RLDVNRFN-GSIPPL---NQSSLKIFNVSGNNFT 211
LD++ S+ LK+ N++ N
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 61/282 (21%), Positives = 114/282 (40%), Gaps = 50/282 (17%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPN 443
+++G G G L + V +K L K+ T + + E+ G HPN
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
++ L + +++ +Y NGSL S + + + + +A G+ Y+
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYL 163
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK---------- 553
VH +L + N+L+ + ++D+ L + +DDP+
Sbjct: 164 SDM-GYVHRDLAARNILINSNLVCKVSDFGLG-----RVLEDDPEAAYTTRGGKIPIRWT 217
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNW-VRSAREDDGAE 611
+PE + TS SDV+S+G++L E+++ G+ P EM N V A + E
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYW-------EMSNQDVIKAVD----E 265
Query: 612 DERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
RL L ++ + C RP Q++ +L ++
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 75/302 (24%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
LG+G+ G + A N +++V VK L K T + + E + L+H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---K-DPTLAARKDFQREAELLTNLQH 76
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLHWTSCL 490
++V + +++++Y +G L L+ G L + L
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
IA +A G+ Y+ VH +L + N L+G + + D+ + + + D
Sbjct: 137 HIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGM----SRDVYSTD---- 187
Query: 551 LYK------------APETRNASHQA------TSKSDVYSFGVLLLELLT-GKPPSQHSF 591
Y+ PE + T++SDV+SFGV+L E+ T GK P
Sbjct: 188 YYRVGGHTMLPIRWMPPE-------SIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQ 238
Query: 592 LVPNEMMNWVRSAREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
L E++ + R L + +V + C P+QR + ++ K+L
Sbjct: 239 LSNTEVIECITQGR--------VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 645 EI 646
+
Sbjct: 291 AL 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 25/124 (20%), Positives = 51/124 (41%), Gaps = 9/124 (7%)
Query: 91 DLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLS 150
L A L L+ L L+ + ++ L NLKSL + ++ + + P++
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 151 LHRLKTLDLSYNNLSGPLPKELASQGRLYSLR-LDVNRFNG--SIPP-LNQ-SSLKIFNV 205
L +L+ LDL P G L+ L + + ++P +++ + L+ ++
Sbjct: 228 LPKLEELDLRGCTALRNYPPIF---GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 206 SGNN 209
G
Sbjct: 285 RGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 15/126 (11%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
P+ +L L+ + + L +PD + L++L L N + P S+ SL+RL+
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154
Query: 157 LDLSYNNLSGPLPKELASQG---------RLYSLRLDVNRFNGSIPP--LNQSSLKIFNV 205
L + LP+ LAS L SLRL+ S+P N +LK +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 206 SGNNFT 211
+ +
Sbjct: 214 RNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 5/127 (3%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
LQ L L P S+ L L+ L ++N+ L+ P + L L+ L L +
Sbjct: 185 LQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLK 201
+PP LK L L + LP ++ +L L L +P L +
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 202 IFNVSGN 208
I V +
Sbjct: 305 IILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 18/127 (14%), Positives = 36/127 (28%), Gaps = 7/127 (5%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL--VNLKSLFLDHNFFTGSF 144
D + + ++ +L L +L L F
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QF 96
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQ-SSLKI 202
P L L+ + + L LP + L +L L N ++P + + L+
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154
Query: 203 FNVSGNN 209
++
Sbjct: 155 LSIRACP 161
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 20/100 (20%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFL-DHNFFTGSFPPSLLSLHRLK 155
++ L +L L L+ + P G LK L L D + + P + L +L+
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
LDL LP +A + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 16/130 (12%), Positives = 33/130 (25%), Gaps = 8/130 (6%)
Query: 87 LQGLDLGGIFAPNSL-TKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145
+ L G A L Q + + + + N + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATA 72
Query: 146 PSL--LSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLK 201
L + L+L L P + L + +D +P + L+
Sbjct: 73 DLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 202 IFNVSGNNFT 211
++ N
Sbjct: 131 TLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 87 LQGLDLGGIFA----PNSLTKLDQLRVLGLQN-NSLTGPIPD-LSGLVNLKSLFLDHNFF 140
L+ LDL G A P L+ L L++ ++L +P + L L+ L L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVN 289
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172
P + L + + +L L +
Sbjct: 290 LSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 10/132 (7%)
Query: 87 LQGLDLGGI-----FAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L+ LDLG + + + L LR L L +L IP+L+ L+ L L L N +
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS 220
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQS 198
P S L L+ L + + + + L + L N +P
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLH 279
Query: 199 SLKIFNVSGNNF 210
L+ ++ N +
Sbjct: 280 HLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 34/135 (25%), Positives = 48/135 (35%), Gaps = 12/135 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
+ L+L I NS L L +L L N + I +GL NL +L L N
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRL 124
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
T + P L +LK L L N + L L L + I
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 197 QSSLKIFNVSGNNFT 211
S+L+ N++ N
Sbjct: 184 LSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 8/111 (7%)
Query: 105 DQLRVLGLQNNSLTGPIPDLSGL-VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
+Q + +L +P G+ N + L L N S L L+ L LS N+
Sbjct: 43 NQFSKVICVRKNLRE-VP--DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 164 LSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
+ L +L L NR +IP + S LK + N
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 44/241 (18%), Positives = 90/241 (37%), Gaps = 36/241 (14%)
Query: 424 TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY---DYQPNGSLFSLIHGSKSTR 480
+S + + + + Q ++ +Y +L ++ S
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 481 AKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL-TALTA 539
+ CL I +A+ + ++H L+H +LK SN+ D + D+ L TA+
Sbjct: 160 DRE--HGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 540 DSLQDDDPDNL-------------LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
D + + LY +PE + ++ + K D++S G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL----- 270
Query: 587 SQHSFLVPNEMMNWVRSARE-----DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+SF E + + R + + M+++ S SP +RP +++
Sbjct: 271 --YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325
Query: 642 M 642
Sbjct: 326 N 326
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 29/132 (21%), Positives = 54/132 (40%), Gaps = 17/132 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
++ LDL G + L +L +L L +N L DL L L++L L++N+
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ- 93
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSS 199
LL ++TL + NN+S + ++ L N+ + L +S
Sbjct: 94 ----ELLVGPSIETLHAANNNISR-VSCSRGQG--KKNIYLANNKIT-MLRDLDEGCRSR 145
Query: 200 LKIFNVSGNNFT 211
++ ++ N
Sbjct: 146 VQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 104 LDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162
++ ++ + ++SL + N+K L L N + L +L+ L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 163 NLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L L L S L +L L+ N + S++ + + NN +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 25/130 (19%), Positives = 42/130 (32%), Gaps = 13/130 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFT 141
+ + + ++ L L N L+ L+ L+ L L N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
L SL L+TLDL+ N + EL + +L N + + K
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKK 123
Query: 202 IFNVSGNNFT 211
++ N T
Sbjct: 124 NIYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 20/132 (15%), Positives = 41/132 (31%), Gaps = 12/132 (9%)
Query: 87 LQGLDLGGIFAPNSLTKLD------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L+ L+L N + + +L+ L L +N L P+ + + L +N
Sbjct: 171 LEHLNLQY----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLS-GPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSS 199
+L L+ DL N G L + R+ ++ + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 200 LKIFNVSGNNFT 211
+ +
Sbjct: 286 PTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 12/130 (9%)
Query: 87 LQGLDLGGIFAPNSLTKLD---QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
L+ LDL N + +L + L NN+++ + S K+++L +N T
Sbjct: 82 LRTLDLNN----NYVQELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITML 135
Query: 144 FPPSLLSLHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLK 201
R++ LDL N + + AS L L L N + + + LK
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLK 194
Query: 202 IFNVSGNNFT 211
++S N
Sbjct: 195 TLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 20/92 (21%), Positives = 36/92 (39%), Gaps = 1/92 (1%)
Query: 121 IPDLSG-LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179
I ++ K + + + S +K LDLS N LS +LA +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 180 SLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L L N ++ + S+L+ +++ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 11/134 (8%), Positives = 24/134 (17%), Gaps = 9/134 (6%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
+ + L + +L L L+ N N + +
Sbjct: 216 VTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP------LNQ 197
+ L + GS NQ
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 198 SSLKIFNVSGNNFT 211
+ + + +
Sbjct: 336 ARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 11/110 (10%), Positives = 25/110 (22%), Gaps = 1/110 (0%)
Query: 103 KLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162
K + +L Q + + + + + L TL+
Sbjct: 311 KRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 163 NLSGPLPKELASQGRLYSLRLDVN-RFNGSIPPLNQSSLKIFNVSGNNFT 211
L + + L + QS L++ +
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 26/236 (11%)
Query: 365 KSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAG 423
SG L + +T + L +G+G+ G+ K V + I+ VKR+
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STV 59
Query: 424 TSNEMYEQHME---SVGGLRHPNLVPLRAYFQA--KEERLLIY-DYQPNGSLFSLIHGSK 477
E + M+ + P +V ++ A +E I + + S
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWICMELM-STSFDKFYKYVY 115
Query: 478 STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537
S + KI + L+++ + +++H ++K SN+LL L D+ ++
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 538 TADSLQDDD----PDNLLYKAPETRNASHQA---TSKSDVYSFGVLLLELLTGKPP 586
DS+ Y APE + S +SDV+S G+ L EL TG+ P
Sbjct: 176 LVDSIAKTRDAGCR---PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 53/313 (16%), Positives = 100/313 (31%), Gaps = 75/313 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLV 445
+G+GS G A+ R I +K ++ +K+ + + E+ V ++ HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTS----------------- 488
L ++ ++ L+ + G L ++
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 489 ------------------CLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL- 529
I + L Y+H + H ++K N L + +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIK 210
Query: 530 -ADYCLTALTADSLQDDDPDNL-------LYKAPET-RNASHQATSKSDVYSFGVLLLEL 580
D+ L + L + + + + APE + K D +S GVLL L
Sbjct: 211 LVDFGL-SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 581 LTGKPPSQHSFLVPN--EMMNWVRSARED----------DGAEDERLGMLLEVAIACNSA 628
L G P F N + ++ V + + A D L LL
Sbjct: 270 LMGAVP----FPGVNDADTISQVLNKKLCFENPNYNVLSPLARD-LLSNLLNR------- 317
Query: 629 SPEQRPTMWQVLK 641
+ ++R + L+
Sbjct: 318 NVDERFDAMRALQ 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 11/134 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ L++G + + + L+ L L L+ +LT IP LS L L L L H
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNI 188
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQ 197
S L+RLK L++S+ + L SL + ++P L +
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247
Query: 198 SSLKIFNVSGNNFT 211
L+ N+S N +
Sbjct: 248 VYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 34/135 (25%), Positives = 53/135 (39%), Gaps = 13/135 (9%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ L+L P + L LR LGL++N L IP +GL NL L + N
Sbjct: 58 LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKI 116
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
+ L+ LK+L++ N+L + + L L L+ SIP +
Sbjct: 117 V-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH 174
Query: 197 QSSLKIFNVSGNNFT 211
L + + N
Sbjct: 175 LHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 37/160 (23%), Positives = 58/160 (36%), Gaps = 21/160 (13%)
Query: 70 CQWQG--VICYQQKVVRV------VLQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSL 117
C Q V+C++++ V V + LDLG + L L L N +
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 118 TGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELAS 174
+ + + L NL++L L N P + + L L LD+S N + L
Sbjct: 69 SA-VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 175 QGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
L SL + N I +SL+ + N T
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 13/134 (9%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
L+ L++ PN L L L L + + +LT +P + LV L+ L L +N
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGL-NLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNP 259
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
+ L L RL+ + L L+ P L L + N+ ++ +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 197 QSSLKIFNVSGNNF 210
+L+ + N
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 9/86 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ L+L + L +L +L+ + L L + GL L+ L + N
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQL 308
Query: 141 TGSFPPSLL-SLHRLKTLDLSYNNLS 165
T + S+ S+ L+TL L N L+
Sbjct: 309 T-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 63/296 (21%), Positives = 102/296 (34%), Gaps = 64/296 (21%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES 435
Q Y LD + LG+GS K V + VK + A T E+ ++
Sbjct: 8 QHYDLD----LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI--TALKL 61
Query: 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKI 492
G HPN+V L F + L+ + G LF I K T A I
Sbjct: 62 CEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YI 111
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDN 549
+ +S++H +VH +LK N+L + E + D+ + +
Sbjct: 112 MRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGF------ARLKPPDNQ 164
Query: 550 LL--------YKAPET-RNASHQATSKSDVYSFGVLLLELLTGKPP-----SQHSFLVPN 595
L Y APE + D++S GV+L +L+G+ P +
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGY--DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 596 EMMNWVRSARED----------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
E+M ++ A+D G+L + P +R M +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLL--------TVDPNKRLKMSGLRY 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 67/288 (23%), Positives = 109/288 (37%), Gaps = 56/288 (19%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES 435
+ Y + +LGKGS G K + VK ++ + + +E
Sbjct: 22 ERYNIV-------CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIA 493
+ L HPN++ L + ++ + G LF I S +I
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARII 127
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNL 550
+ V G++Y+H+ +VH +LK N+LL D + + D+ L + Q +
Sbjct: 128 KQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKD 182
Query: 551 L-----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE--MMNWVRS 603
Y APE ++ K DV+S GV+L LL+G PP F NE ++ V +
Sbjct: 183 RIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRVET 236
Query: 604 ARED----------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ D A+D ML + P R T Q L+
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKML--------TFHPSLRITATQCLE 276
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVP- 446
EL+G G+ G YK + + +K +D + G E +Q + + H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 447 ----LRAYFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPL--HWTSCLKIAEDVAQG 499
++ +++L L+ ++ GS+ LI K+T+ L W + I ++ +G
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAY--ICREILRG 141
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKA 554
LS++HQ +++H ++K NVLL + E L D+ ++A ++ + P + A
Sbjct: 142 LSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YWMA 197
Query: 555 PE--TRNASHQAT--SKSDVYSFGVLLLELLTGKPP 586
PE + + AT KSD++S G+ +E+ G PP
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 5/118 (4%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNFFTGSFPPSLLS-LHRLK 155
P L L + + +G L + V L+ L L HN + +L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGA 213
+L+LS+ L +PK L ++ L L L NR + + P + ++ GN F +
Sbjct: 257 SLNLSFTGLKQ-VPKGLPAK--LSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 33/143 (23%), Positives = 46/143 (32%), Gaps = 15/143 (10%)
Query: 87 LQGLDLGGIFAPNSL-TKLDQLRVLGLQNNSLTGPIPDLSGLVN-----LKSLFLDHNFF 140
L+ L++ G P L L +L L+N S L+ L LK L +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGR----LYSLRLDVNRFN---GSIP 193
+ L TLDLS N G A L L L G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 194 PL--NQSSLKIFNVSGNNFTGAI 214
L + L+ ++S N+ A
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAA 244
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 26/144 (18%), Positives = 47/144 (32%), Gaps = 12/144 (8%)
Query: 96 FAPNSLTKLDQLRVLGLQNNSLTGPIPD----LSGLVNLKSLFLDHNFFTGSFPPSLLSL 151
+ K L+ L ++ + I + G+ L+ L L++ TG+ PP LL
Sbjct: 59 GQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118
Query: 152 H--RLKTLDLSYNNLSGPLPKELASQG----RLYSLRLDVNRFNGSIPPLNQ--SSLKIF 203
L L+L + + Q L L + + +L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 204 NVSGNNFTGAITVTSTLSRFGISS 227
++S N G + S L +
Sbjct: 179 DLSDNPELGERGLISALCPLKFPT 202
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 23/86 (26%), Positives = 27/86 (31%), Gaps = 9/86 (10%)
Query: 87 LQGLDL-----GGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
LQGLDL S QL L L L L L L L +N
Sbjct: 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLD 287
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGP 167
+ PS L ++ L L N
Sbjct: 288 RN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ G YKA + + K ++ + E Y +E + HP +V L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + ++ ++ P G++ +++ + L + + + L+++H R
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALNFLHSK-R 137
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKAPE--TRNAS 561
++H +LK+ NVL+ + + LAD+ ++A +LQ D P + APE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWMAPEVVMCETM 194
Query: 562 HQAT--SKSDVYSFGVLLLELLTGKPP 586
K+D++S G+ L+E+ +PP
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 70/304 (23%)
Query: 390 ELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
+G+G+ G ++A +V VK L K +++ + + + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDN 109
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL-------------------FSLIHGSKSTRAK 482
PN+V L + L+++Y G L S S
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 483 PLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542
PL L IA VA G++Y+ + + VH +L + N L+G + +AD+ L+ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADF---GLSRNIY 225
Query: 543 QDDDPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQH 589
D YK PE+ ++ T++SDV+++GV+L E+ + G P
Sbjct: 226 SADY-----YKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 590 SFLVPNEMMNWVRSAREDDGAEDERLGM-------LLEVAIACNSASPEQRPTMWQVLKM 642
+ E++ +VR DG L L + C S P RP+ + ++
Sbjct: 280 --MAHEEVIYYVR-----DG---NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
Query: 643 LQEI 646
LQ +
Sbjct: 330 LQRM 333
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 60/302 (19%), Positives = 98/302 (32%), Gaps = 76/302 (25%)
Query: 390 ELLGKGSLGTTYKAVLDNRL------IVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
E LG+ G YK L V +K L K E L+H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQH 71
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSL-----------FSLIHGSKSTRAKPLHWTSCL 490
PN+V L + +I+ Y +G L T L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL 550
+ +A G+ Y+ +VH +L + NVL+ ++D L + D
Sbjct: 132 HLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGL----FREVYAAD---- 182
Query: 551 LYK------------APETRNASHQA------TSKSDVYSFGVLLLELLT-GKPPSQHSF 591
YK APE A + SD++S+GV+L E+ + G P
Sbjct: 183 YYKLLGNSLLPIRWMAPE-------AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-- 233
Query: 592 LVPN-EMMNWVRSAREDDGAEDERL-------GMLLEVAIACNSASPEQRPTMWQVLKML 643
N +++ +R + L + + I C + P +RP + L
Sbjct: 234 -YSNQDVVEMIR--------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 644 QE 645
+
Sbjct: 285 RA 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +GKGS G +K + + +V +K +D + A E +Q + + P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + +I +Y GS L+ PL T I ++ +GL Y+H +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE-K 139
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKAPETRNASHQ 563
+H ++K++NVLL E LAD+ + D+ + P + APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVI-KQSA 195
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
SK+D++S G+ +EL G+PP
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 392 LGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450
+GKG+ A + V +K +D ++L TS + + + + L HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 451 FQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ--------GL 500
+ ++ LI +Y G +F + HG ++ E A+ +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG---------------RMKEKEARSKFRQIVSAV 127
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------Y 552
Y HQ R+VH +LK+ N+LL D +AD+ + L Y
Sbjct: 128 QYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEF-------TVGGKLDAFCGAPPY 179
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
APE + DV+S GV+L L++G P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 64/288 (22%), Positives = 101/288 (35%), Gaps = 54/288 (18%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES 435
L+ LG G+ G + + L +K ++ + E E +E
Sbjct: 22 DLFIFK-------RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEV 73
Query: 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAED 495
+ L HPN++ + F+ ++ + G L I S R K L ++ +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV-SAQARGKALSEGYVAELMKQ 132
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL- 551
+ L+Y H +VH +LK N+L P + D+ L L D
Sbjct: 133 MMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-------KSDEHST 184
Query: 552 -------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVR 602
Y APE T K D++S GV++ LLTG P F + E+
Sbjct: 185 NAAGTALYMAPEVFKRDV--TFKCDIWSAGVVMYFLLTGCLP----FTGTSLEEVQQKAT 238
Query: 603 SARED---------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ A D ML + PE+RP+ QVL
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQML--------TKDPERRPSAAQVLH 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 41/128 (32%), Positives = 60/128 (46%), Gaps = 9/128 (7%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
++ LDL I L L L+VL L N +T I L+GL NL+ L + + +
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQVS-DL 166
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIF 203
P L +L +L TL N +S P LAS L + L N+ + + PL N S+L I
Sbjct: 167 TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS-DVSPLANTSNLFIV 222
Query: 204 NVSGNNFT 211
++ T
Sbjct: 223 TLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 9/128 (7%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
+ G + + LD + L +T I + L NL L L N T
Sbjct: 21 AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQIT-DL 78
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIF 203
P L +L ++ L+LS N L +A + +L L + + PL S+L++
Sbjct: 79 AP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVL 134
Query: 204 NVSGNNFT 211
+ N T
Sbjct: 135 YLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 9/128 (7%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L GL+L I L L ++ L L N L + ++GL ++K+L L T
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD-- 121
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIF 203
L L L+ L L N ++ P LA L L + + + + PL S L
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTL 178
Query: 204 NVSGNNFT 211
N +
Sbjct: 179 KADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 25/134 (18%), Positives = 47/134 (35%), Gaps = 10/134 (7%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L I + L L L + L+NN ++ + L+ NL + L + T
Sbjct: 175 LTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTITN-- 231
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPL-PKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIF 203
+ + L ++ P+ P ++ G S L N I ++ + +
Sbjct: 232 -QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN-LTSFINNVSYTFNQSV 289
Query: 204 NVSGN--NFTGAIT 215
F+G +T
Sbjct: 290 TFKNTTVPFSGTVT 303
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 24/131 (18%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L L L L + +L LGL +N + I + LS L L+ L LD+N
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKL 253
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSL 200
+ P L L L+ + L NN++ ++ VN F + ++
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNIT----------------KVGVNDFCPVGFGVKRAYY 296
Query: 201 KIFNVSGNNFT 211
++ N
Sbjct: 297 NGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 26/136 (19%), Positives = 42/136 (30%), Gaps = 17/136 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLT-GPIPD--LSGLVNLKSLFLDHNF 139
L L + + L + + + N L GL L L +
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK 183
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPP---L 195
T P L L L L +N + + E L +LY L L N+ I
Sbjct: 184 LT-GIPKDLPE--TLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSLS 238
Query: 196 NQSSLKIFNVSGNNFT 211
+L+ ++ N +
Sbjct: 239 FLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 31/118 (26%), Positives = 48/118 (40%), Gaps = 14/118 (11%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
T LD LQNN ++ D GL +L +L L +N + + L +L+
Sbjct: 53 SPDTTLLD------LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK 106
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFT 211
L +S N+L +P L S L LR+ NR +P ++ + GN
Sbjct: 107 LYISKNHLVE-IPPNLPSS--LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 12/113 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT- 141
L L LG + SL+ L LR L L NN L+ L L L+ ++L N T
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278
Query: 142 ---GSFPP--SLLSLHRLKTLDLSYNNLSGPLPKELASQG--RLYSLRLDVNR 187
F P + + L N + + + +++ +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 37/164 (22%), Positives = 54/164 (32%), Gaps = 21/164 (12%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
L+ LDL P + L +L L L L + GL L+ L+L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNA 140
Query: 140 FTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---L 195
+ P L L L L N +S + L L L NR + P
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 196 NQSSLKIFNVSGNNFT----GAITVTSTLSRFGISSFLFNPSLC 235
+ L + NN + A+ L ++ NP +C
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND---NPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 31/120 (25%), Positives = 42/120 (35%), Gaps = 8/120 (6%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRL 154
S L +L L +N L I +GL L+ L L N S P+ L RL
Sbjct: 49 AASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRL 107
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
TL L L P L L L N ++P + +L + GN +
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 19/103 (18%), Positives = 29/103 (28%), Gaps = 7/103 (6%)
Query: 113 QNNSLTGPIPDLSGL-VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE 171
L +P G+ + +FL N + S + L L L N L+
Sbjct: 19 PQQGLQA-VP--VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 172 LASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
L L L N S+ P L ++
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 44/203 (21%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT Y A+ + V +++++ + E+ + + ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 83
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +E ++ +Y GSL ++ + + + Q L ++H +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS-NQ 136
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDD----PDNLLYKAPETRNASHQ 563
++H ++KS N+LLG D L D+ A +T + + P + APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YWMAPEVVTRK-A 192
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
K D++S G++ +E++ G+PP
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 44/242 (18%), Positives = 71/242 (29%), Gaps = 38/242 (15%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQN-NSLTGPIPD--LSGLVNLKSLFLDHNF 139
L+ L L + ++ L L L L I + GL NLK L L
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCN 207
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
P+L L L+ L++S N+ P L L + ++ + I
Sbjct: 208 IK--DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDG 264
Query: 197 QSSLKIFNVSGNNFT----GAITVTSTLSRFGISSFLFNPSLCGEIIHKECN-------- 244
+SL N++ NN + T L + NP C C+
Sbjct: 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH---NPWNCD------CDILWLAWWL 315
Query: 245 -PRPPFFGPSATAAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLI 303
P AP + G+ ++ +P + + L
Sbjct: 316 REYIPTNSTCCGRCHAPMHMR--GRYLVEVDQASFQCSAPFIMDAPRDLNISEGRMAELK 373
Query: 304 CS 305
C
Sbjct: 374 CR 375
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 34/134 (25%), Positives = 49/134 (36%), Gaps = 12/134 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ L LG + L L L L +N LT IP L L+ L+L +N
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPI 159
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPL-NQ 197
S P + + L LDL + + L L L + +P L
Sbjct: 160 E-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPL 217
Query: 198 SSLKIFNVSGNNFT 211
L+ +SGN+F
Sbjct: 218 VGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 31/135 (22%), Positives = 47/135 (34%), Gaps = 12/135 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
+ L+L + ++ L L VL L NS+ I +GL +L +L L N+
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWL 135
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LN 196
T P L +L+ L L N + L L L + I
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 197 QSSLKIFNVSGNNFT 211
+LK N+ N
Sbjct: 195 LFNLKYLNLGMCNIK 209
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 8/111 (7%)
Query: 105 DQLRVLGLQNNSLTGPIPDLSGL-VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
+Q + L+ +P G+ N + L L N + LH L+ L L N+
Sbjct: 54 NQFSKVVCTRRGLSE-VP--QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 164 LSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFT 211
+ L +L L N IP S L+ + N
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 31/114 (27%), Positives = 46/114 (40%), Gaps = 10/114 (8%)
Query: 99 NSLTKL-DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
+L+ L L LG+ NN L +P+L LK + +D+N P S L+ +
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFI 178
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
N L LP EL + L ++ D N +P L SL+ N
Sbjct: 179 AAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLP-LSLESIVAGNNILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 39/148 (26%), Positives = 56/148 (37%), Gaps = 33/148 (22%)
Query: 87 LQGLDLGGIFAPNSLTKL----DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L+ +D+ NSL KL L + NN L +P+L L L +++ D+N
Sbjct: 155 LKIIDVDN----NSLKKLPDLPPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLKK 209
Query: 143 ------------------SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184
P L +L L T+ N L LP L +L +
Sbjct: 210 LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLP---PSLEALNVR 265
Query: 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTG 212
N +P L Q SL +VS N F+G
Sbjct: 266 DNYLT-DLPELPQ-SLTFLDVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 27/129 (20%), Positives = 41/129 (31%), Gaps = 17/129 (13%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS 143
L+ L P L L V +L+ P L+ L + +N
Sbjct: 93 LESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLEKL 146
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKI 202
P L + LK +D+ N+L LP L + N+ +P L N L
Sbjct: 147 --PELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELPELQNLPFLTA 199
Query: 203 FNVSGNNFT 211
N+
Sbjct: 200 IYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 31/107 (28%), Positives = 43/107 (40%), Gaps = 13/107 (12%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165
Q L L N L+ +P+L +L+SL N T P SL L + + LS
Sbjct: 72 QAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 166 GPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFT 211
P L L + N+ +P L N S LKI +V N+
Sbjct: 128 DLPPL-------LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK 166
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 37/145 (25%), Positives = 54/145 (37%), Gaps = 33/145 (22%)
Query: 87 LQGLDLGGIFAPNSLTKLD----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L + N L L L L +++N LT +P+L +L L + N F+G
Sbjct: 239 LTTIYADN----NLLKTLPDLPPSLEALNVRDNYLTD-LPELPQ--SLTFLDVSENIFSG 291
Query: 143 --SFPPSLLSLH--------------RLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
PP+L L+ L+ L++S N L LP RL L N
Sbjct: 292 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFN 347
Query: 187 RFNGSIPPLNQSSLKIFNVSGNNFT 211
+P L +LK +V N
Sbjct: 348 HLA-EVPELP-QNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 31/129 (24%), Positives = 45/129 (34%), Gaps = 22/129 (17%)
Query: 87 LQGLDLGGIFAPNSLTKL----DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L L+ N + L L L + NN L +P L L+ L N
Sbjct: 299 LYYLNASS----NEIRSLCDLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA- 350
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKI 202
P +L K L + YN L P + LR++ + +P L Q +LK
Sbjct: 351 EVPELPQNL---KQLHVEYNPLRE-FPDIP---ESVEDLRMN-SHLA-EVPELPQ-NLKQ 400
Query: 203 FNVSGNNFT 211
+V N
Sbjct: 401 LHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 24/128 (18%), Positives = 39/128 (30%), Gaps = 24/128 (18%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSG--------------LVNLKSLFLDHNFFTGS 143
P + + P +G L L++ + S
Sbjct: 27 PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIF 203
P L++L S N+L+ LP+ L SL +D N ++ L L+
Sbjct: 86 LPELPPH---LESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL-PPLLEYL 136
Query: 204 NVSGNNFT 211
VS N
Sbjct: 137 GVSNNQLE 144
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 20/124 (16%), Positives = 39/124 (31%), Gaps = 30/124 (24%)
Query: 87 LQGLDLGGIFAPNSLTKLD----QLRVLGLQNNSLTGPIPDLSG---------------- 126
L+ L N L ++ L+ L ++ N L PD+
Sbjct: 339 LERLIASF----NHLAEVPELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPE 393
Query: 127 -LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDV 185
NLK L ++ N FP ++ L ++ + P + +L +
Sbjct: 394 LPQNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
Query: 186 NRFN 189
+ +
Sbjct: 450 HHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 7/90 (7%), Positives = 19/90 (21%), Gaps = 10/90 (11%)
Query: 122 PDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSL 181
P L+ + T P ++ +++ P Q +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 182 RLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
R + ++ +
Sbjct: 64 R---------LRDCLDRQAHELELNNLGLS 84
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 22/115 (19%), Positives = 35/115 (30%), Gaps = 9/115 (7%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
L L L L + N+ ++ L L + L+ L
Sbjct: 380 GEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVL 436
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFT 211
D+S NNL L L L + N+ ++P L + +S N
Sbjct: 437 DVSNNNLDS-FSLFLPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 28/165 (16%), Positives = 46/165 (27%), Gaps = 20/165 (12%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNF 139
L+ L+L G + + L L+ L + N I D +GL +L L +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG--------- 190
SL S+ + L L + + L + L L
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
Query: 191 ----SIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231
+ L + + S N + LS N
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 28/136 (20%), Positives = 50/136 (36%), Gaps = 12/136 (8%)
Query: 87 LQGLDLGGIFAPNSLTKLD--QLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGS 143
L + + L K++ +R L + L + S L +K + ++++
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 144 FPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR---LDVNRFNGSIPPLNQ--- 197
L L+ LDLS N + K A +G SL+ L N S+ +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILL 384
Query: 198 --SSLKIFNVSGNNFT 211
+L ++S N F
Sbjct: 385 TLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 28/122 (22%), Positives = 43/122 (35%), Gaps = 12/122 (9%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
++ LD L N +T DL NL+ L L + + SL L+
Sbjct: 25 TAAMKSLD------LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP----LNQSSLKIFNVSGNNFTG 212
LDLS N+LS L L L N + ++ N ++L+ +
Sbjct: 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 213 AI 214
I
Sbjct: 138 EI 139
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 14/108 (12%)
Query: 87 LQGLDLGGIFAPNSLTKL-----DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
++ L+L + + L VL + NN+L L L+ L++ N
Sbjct: 412 MRFLNLSS----TGIRVVKTCIPQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKLK 464
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN 189
+ P + L L + +S N L L + L N ++
Sbjct: 465 -TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 14/119 (11%), Positives = 36/119 (30%), Gaps = 4/119 (3%)
Query: 96 FAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK 155
F + LT +L L L + + + + ++
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFT 211
L + L L + ++ + ++ ++ +P + SL+ ++S N
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHME---SVGGLRHPNLV 445
LG+G+ G K + + I+ VKR+ A+ S E M+ S+ + P V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 446 PLRAYFQA--KEERLLI---Y-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
++ A +E + I D SL + + + KIA + +
Sbjct: 70 ---TFYGALFREGDVWICMELMD----TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKA 121
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD----PDNLLYKAP 555
L ++H ++H ++K SNVL+ + + D+ ++ D + D Y AP
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK---PYMAP 178
Query: 556 ETRNASHQA---TSKSDVYSFGVLLLELLTGKPP 586
E N + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/287 (20%), Positives = 106/287 (36%), Gaps = 63/287 (21%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN------EMYEQHMESVGGLRHP 442
+ LG G+ G A V ++ + K A S E +E + L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGL 500
++ ++ +F A E+ ++ + G LF + + C + +
Sbjct: 201 CIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEAT-------CKLYFYQMLLAV 252
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDNLL------ 551
Y+H+ ++H +LK NVLL E C + D+ + + +L+
Sbjct: 253 QYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------GETSLMRTLCGT 304
Query: 552 --YKAPE--TRNASHQATSKSDVYSFGVLLLELLTGKPP-SQHSFLVPNEMMNWVRSARE 606
Y APE + D +S GV+L L+G PP S+H + + + S +
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQITSGKY 362
Query: 607 D----------DGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ + A D ++ LL V P+ R T + L+
Sbjct: 363 NFIPEVWAEVSEKALDLVKK---LLVV-------DPKARFTTEEALR 399
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 57/301 (18%), Positives = 112/301 (37%), Gaps = 47/301 (15%)
Query: 312 AVKKQKQRKDKKSKAMIASDEAAATAQALAMIQIEQENELQEKVKRAQGIQVAKSGNLVF 371
++ ++ +A I S + A + + ++ N+ Q K Q + +
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELP 84
Query: 372 CAGEA----QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN 426
A Q Y +++G+G + V VK ++ + +
Sbjct: 85 DWAAAKEFYQKYDPK-------DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 427 EMYEQH---------MESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HG 475
++ E + V G HP+++ L +++ L++D G LF +
Sbjct: 138 QLEEVREATRRETHILRQVAG--HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV 195
Query: 476 SKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535
+ S + I + + +S++H +VH +LK N+LL + + L+D+
Sbjct: 196 ALSEKE-------TRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGF- 246
Query: 536 ALTADSLQDDDPDNLL-----YKAPETRNASHQATSKS-----DVYSFGVLLLELLTGKP 585
+ L+ + L Y APE S T D+++ GV+L LL G P
Sbjct: 247 ---SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
Query: 586 P 586
P
Sbjct: 304 P 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 59/308 (19%), Positives = 111/308 (36%), Gaps = 67/308 (21%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE-QHME 434
+Y L + ++LG+G+ + L VK ++ S E + +
Sbjct: 12 DVYQLQE------DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 435 SVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIH--GSKSTRAKPLHWTSCLKI 492
G H N++ L +F+ ++ L+++ GS+ S IH + +
Sbjct: 66 QCQG--HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE-------ASVV 116
Query: 493 AEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCL-TALTADSLQDDDPD 548
+DVA L ++H + H +LK N+L + D+ L + + +
Sbjct: 117 VQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 549 NLL--------YKAPET-RNASHQATS---KSDVYSFGVLLLELLTGKPP---------- 586
L Y APE S +A+ + D++S GV+L LL+G PP
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 587 ---SQHSFLVPNEMMNWVRSARED----------DGAEDERLGMLLEVAIACNSASPEQR 633
+ N + ++ + + A+D +L +QR
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLL--------VRDAKQR 287
Query: 634 PTMWQVLK 641
+ QVL+
Sbjct: 288 LSAAQVLQ 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/211 (23%), Positives = 77/211 (36%), Gaps = 31/211 (14%)
Query: 391 LLGKGSLGTTYKAVL-DNRLIVCVKRLDAS---KLAGTSNEMYEQHMESVGGLRHPNLVP 446
+LG+GS T A +K L+ K E+ + + L HP V
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV--MSRLDHPFFVK 94
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDVAQGLSYI 503
L FQ E+ Y NG L I S T + AE + L Y+
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR-------FYTAE-IVSALEYL 146
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-------PDNLLYKAPE 556
H ++H +LK N+LL D + D+ + + + Y +PE
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ---YVSPE 202
Query: 557 T-RNASHQATSKSDVYSFGVLLLELLTGKPP 586
S SD+++ G ++ +L+ G PP
Sbjct: 203 LLTEKSA--CKSSDLWALGCIIYQLVAGLPP 231
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 31/213 (14%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ-HME---SVGGLRHPNL 444
+G G+ G +K ++ VK++ S + E ++ M+ + P +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS----GNKEENKRILMDLDVVLKSHDCPYI 86
Query: 445 VPLRAYFQA--KEERLLI---Y-DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
V F + I L K P+ K+ + +
Sbjct: 87 V---QCFGTFITNTDVFIAMELMG----TCAEKL----KKRMQGPIPERILGKMTVAIVK 135
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDDPDNLLYKAPE- 556
L Y+ + ++H ++K SN+LL + L D+ ++ D +D Y APE
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195
Query: 557 ---TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++DV+S G+ L+EL TG+ P
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 45/229 (19%)
Query: 379 YTLD--QLMRASAELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAG---TSNEMY 429
D +++RA +GKGS G K + D + + +K ++ K N
Sbjct: 12 VNFDHFEILRA----IGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 430 EQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR-----AKPL 484
E + + GL HP LV L FQ +E+ ++ D G L H ++ K
Sbjct: 65 ELQI--MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRY--HLQQNVHFKEETVK-- 118
Query: 485 HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544
L I E + L Y+ R++H ++K N+LL + D+ + A L
Sbjct: 119 -----LFICE-LVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNI----AAMLPR 167
Query: 545 DDPDNLL-----YKAPE--TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ + Y APE + + D +S GV ELL G+ P
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 33/218 (15%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG----LR---- 440
E+LG+G + + VK +D + S E ++ E+ LR
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ 498
HPN++ L+ ++ L++D G LF + + S + KI + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE-------TRKIMRALLE 135
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YK 553
+ +H+ +VH +LK N+LL D L D+ + L + + Y
Sbjct: 136 VICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGF----SCQLDPGEKLREVCGTPSYL 190
Query: 554 APETRNASHQATSKS-----DVYSFGVLLLELLTGKPP 586
APE S D++S GV++ LL G PP
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 58/282 (20%), Positives = 99/282 (35%), Gaps = 65/282 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQH-------MESV-GGLR 440
LLGKG GT + L +RL V +K + +++ G S + V G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 441 HPNLVPLRAYFQAKEERLLIYDY-QPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVA 497
HP ++ L +F+ +E +L+ + P LF I G + E +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---------------PLGEGPS 141
Query: 498 --------QGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDD 546
+ + H +VH ++K N+L+ D L D+ AL D D
Sbjct: 142 RCFFGQVVAAIQHCHSR-GVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTDF 198
Query: 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP-------SQHSFLVPNEMMN 599
+Y PE + + V+S G+LL +++ G P + P +
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV-- 256
Query: 600 WVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
S L + P RP++ ++L
Sbjct: 257 ---S----PDCCALIRRCL--------APKPSSRPSLEEILL 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 29/210 (13%)
Query: 391 LLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLA---GTSNEMYEQHM-ESVGGLRHPNLV 445
++G+G G Y D + +K LD ++ G + + E+ M V P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDVAQGLSY 502
+ F ++ I D G L + + AE + GL +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-------FYAAE-IILGLEH 307
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPE-- 556
+H +V+ +LK +N+LL ++D L A P + Y APE
Sbjct: 308 MHNR-FVVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVL 362
Query: 557 TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ ++ S +D +S G +L +LL G P
Sbjct: 363 QKGVAY--DSSADWFSLGCMLFKLLRGHSP 390
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+GS G A + V VK +D K E+ + + +H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ EE ++ ++ G+L ++ L+ + E V Q L+Y+H A
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLH-AQG 161
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTA-LTADSLQDDD----PDNLLYKAPE--TRNAS 561
++H ++KS ++LL D L+D+ A ++ D + P + APE +R+
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP---YWMAPEVISRSLY 218
Query: 562 HQATSKSDVYSFGVLLLELLTGKPP 586
++ D++S G++++E++ G+PP
Sbjct: 219 ---ATEVDIWSLGIMVIEMVDGEPP 240
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 31/137 (22%), Positives = 48/137 (35%), Gaps = 19/137 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLDQ-----LRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFF 140
L + + ++T + Q L L L N +T L GL NL L L N
Sbjct: 173 LSYIRIAD----TNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR--------FNGSI 192
+ SL + L+ L L+ N L +P LA + + L N F
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 193 PPLNQSSLKIFNVSGNN 209
++S ++ N
Sbjct: 288 YNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 30/158 (18%), Positives = 49/158 (31%), Gaps = 20/158 (12%)
Query: 70 CQWQGVICYQQKVVRV------VLQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTG 119
C + V C + +V LDL L L L L NN ++
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 120 PIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGR 177
I + LV L+ L+L N P + L+ L + N ++ +
Sbjct: 91 -ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQ 146
Query: 178 LYSLRLDVNRF-NGSIPP---LNQSSLKIFNVSGNNFT 211
+ + L N + I L ++ N T
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 11/132 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L L L +P + L +L L L N L +P+ L+ L + N T
Sbjct: 78 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM-PKTLQELRVHENEIT- 134
Query: 143 SFPPSLLS-LHRLKTLDLSYNNL-SGPLPKE-LASQGRLYSLRLDVNRFNGSIPPLNQSS 199
S+ + L+++ ++L N L S + +L +R+ +IP S
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS 193
Query: 200 LKIFNVSGNNFT 211
L ++ GN T
Sbjct: 194 LTELHLDGNKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 20/113 (17%), Positives = 34/113 (30%), Gaps = 12/113 (10%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT- 141
L L L SL LR L L NN L L+ ++ ++L +N +
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 277
Query: 142 ---GSFPP--SLLSLHRLKTLDLSYNNLS-GPLPKEL-ASQGRLYSLRLDVNR 187
F P + L N + + +++L +
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 52/235 (22%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG--------- 438
+ +GKGS G A DN +K L KL +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTY-YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 439 ---------------LRHPNLVPLR-AYFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRA 481
L HPN+V L E+ L ++++ G + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TL 131
Query: 482 KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541
KPL +D+ +G+ Y+H +++H ++K SN+L+G D +AD+ ++
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--- 187
Query: 542 LQDDDPDNLL--------YKAPETRNASHQATS--KSDVYSFGVLLLELLTGKPP 586
D LL + APE+ + + + S DV++ GV L + G+ P
Sbjct: 188 ---KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 30/160 (18%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDV 496
RHP L L+ FQ + + +Y G LF + + RA+ AE +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAE-I 257
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PD 548
L Y+H +V+ +LK N++L D + D+ L + ++D P+
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF---GLCKEGIKDGATMKTFCGTPE 314
Query: 549 NLLYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + + ++ D + GV++ E++ G+ P
Sbjct: 315 ---YLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLP 348
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 60/312 (19%), Positives = 111/312 (35%), Gaps = 70/312 (22%)
Query: 360 GIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDA 418
G++ K + Y + E LG G K L K +
Sbjct: 1 GMETFKQQKV------EDFYDIG-------EELGSGQFAIVKKCREKSTGLEYAAKFIKK 47
Query: 419 SKLAGTSN----EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI- 473
+ + E E+ + + + HPN++ L ++ + + +LI + G LF +
Sbjct: 48 RQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA 107
Query: 474 -HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEAC 528
S S + + G++Y+H ++ H +LK N++L P
Sbjct: 108 QKESLSEEE-------ATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 529 LADYCLTALTADSLQDDDPDNLL-----YKAPETRNASHQATSKSDVYSFGVLLLELLTG 583
L D+ L A ++D + + APE N ++D++S GV+ LL+G
Sbjct: 160 LIDFGL----AHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSG 214
Query: 584 KPPSQHSFLVPN--EMMNWVRSARED----------DGAED--ERLGMLLEVAIACNSAS 629
P FL E + + + D + A+D + LL
Sbjct: 215 ASP----FLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK---LLVK-------E 260
Query: 630 PEQRPTMWQVLK 641
+R T+ + L+
Sbjct: 261 TRKRLTIQEALR 272
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 63/279 (22%), Positives = 105/279 (37%), Gaps = 59/279 (21%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+GS G AV R+ K++ + + ++Q +E + L HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNIIRLY 72
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTR-AKPLHWTSCLKIAEDVAQGLSYIHQ 505
F+ + L+ + G LF + A +I +DV ++Y H+
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHK 124
Query: 506 AWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL--------YKA 554
+ H +LK N L PD L D+ L A P ++ Y +
Sbjct: 125 L-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-------KPGKMMRTKVGTPYYVS 176
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE--MMNWVRSARED----- 607
P+ + + D +S GV++ LL G PP F P + +M +R
Sbjct: 177 PQVLEGLY--GPECDEWSAGVMMYVLLCGYPP----FSAPTDSEVMLKIREGTFTFPEKD 230
Query: 608 -----DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
AE +L + SP+QR T Q L+
Sbjct: 231 WLNVSPQAESLIRRLL--------TKSPKQRITSLQALE 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LGKG+ + V L K ++ KL+ + E+ L+HPN+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
Q + L++D G LF I S + + + ++Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILESIAYCHSN 124
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPET- 557
+VH NLK N+LL LAD+ L A + D + + Y +PE
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAVKLADFGL----AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ + + D+++ GV+L LL G PP
Sbjct: 180 KKDPY--SKPVDIWACGVILYILLVGYPP 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 31/181 (17%)
Query: 482 KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541
L + + VA+G+ ++ + +H +L + N+LL + D+ L D
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDF---GLARDI 243
Query: 542 LQDDDPDNLLYK------------APETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQ 588
+D D Y APET T +SDV+SFGVLL E+ + G P
Sbjct: 244 YKDPD-----YVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 589 HSFLVPNEMMNWVRSA-RED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQE 645
+ E ++ R D E + + + C P QRPT ++++ L
Sbjct: 298 -GVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 352
Query: 646 I 646
+
Sbjct: 353 L 353
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 26/112 (23%), Positives = 39/112 (34%), Gaps = 8/112 (7%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159
S +L L L N+S+T + + L L L N T + S + L L
Sbjct: 37 SEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT-TLDLSQNT--NLTYLAC 92
Query: 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
N L+ L + +L L D N+ + L N + N T
Sbjct: 93 DSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 33/137 (24%), Positives = 48/137 (35%), Gaps = 18/137 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L LD N +T+LD L L N++T DL+ + L L N T
Sbjct: 172 LTTLDCSF----NKITELDVSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLT 225
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
+ L+ +L D S N L+ L S+ L +L I + + L
Sbjct: 226 -EIDVTPLT--QLTYFDCSVNPLT-ELDVSTLSK--LTTLHCIQTDLL-EIDLTHNTQLI 278
Query: 202 IFNVSGNNFTGAITVTS 218
F G + VT
Sbjct: 279 YFQAEGCRKIKELDVTH 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 32/138 (23%), Positives = 49/138 (35%), Gaps = 19/138 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
L LD +S+T + L L +N++T DLS NL L D N
Sbjct: 44 LTSLDCHN----SSITDMTGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSL 200
T + + L +L L+ N L+ L ++ L L N I + + L
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQL 150
Query: 201 KIFNVSGNNFTGAITVTS 218
+ N + VT
Sbjct: 151 TELDCHLNKKITKLDVTP 168
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 17/130 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L L+ N++TKLD QL L +N LT D++ L L N T
Sbjct: 193 LNRLNCDT----NNITKLDLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPLT 246
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
S LS +L TL +L + L +L + + R + + + L
Sbjct: 247 -ELDVSTLS--KLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLY 300
Query: 202 IFNVSGNNFT 211
+ + T
Sbjct: 301 LLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 32/130 (24%), Positives = 45/130 (34%), Gaps = 17/130 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L L+ N LTKLD L L N+LT D+S L L N
Sbjct: 108 LTYLNCDT----NKLTKLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKI 161
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
+ +L TLD S+N ++ +++ L L D N + L
Sbjct: 162 TK--LDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLT 215
Query: 202 IFNVSGNNFT 211
+ S N T
Sbjct: 216 FLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 25/130 (19%), Positives = 45/130 (34%), Gaps = 13/130 (10%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L LD +T+LD +L L L N LT + D+S LKSL +
Sbjct: 299 LYLLDCQA----AGITELDLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHIQ 352
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLK 201
F + + L + + L + ++ D+ G+ +
Sbjct: 353 -DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 202 IFNVSGNNFT 211
+++ + N T
Sbjct: 411 VYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 24/134 (17%), Positives = 38/134 (28%), Gaps = 25/134 (18%)
Query: 87 LQGLDLGGIFAPNSLTKLD-----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
L D N LT+LD +L L L I DL+ L +
Sbjct: 235 LTYFDCSV----NPLTELDVSTLSKLTTLHCIQTDLLE-I-DLTHNTQLIYFQAEGCRKI 288
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLS----GPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ 197
+ +L LD ++ PK L L L+ + +
Sbjct: 289 KE--LDVTHNTQLYLLDCQAAGITELDLSQNPK-------LVYLYLNNTELT-ELDVSHN 338
Query: 198 SSLKIFNVSGNNFT 211
+ LK + +
Sbjct: 339 TKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 17/99 (17%), Positives = 29/99 (29%), Gaps = 7/99 (7%)
Query: 113 QNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172
Q S PD N S + S L L +LD ++++ + +
Sbjct: 7 QTQSFNDWFPD----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GI 60
Query: 173 ASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L L N ++ ++L N T
Sbjct: 61 EKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKLT 98
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 9e-11
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
HP LV L + FQ + + +Y G L H + + H + AE ++
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEH--ARFYSAE-ISLA 122
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L+Y+H+ +++ +LK NVLL + L DY + + L+ D P+
Sbjct: 123 LNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPN--- 175
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE R + S D ++ GVL+ E++ G+ P
Sbjct: 176 YIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSP 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG+GS G+ YKA+ + IV +K++ + + + + P++V
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYY 90
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + ++ +Y GS+ +I R K L I + +GL Y+H R
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHFM-R 145
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD-----PDNLLYKAPET-RNASH 562
+H ++K+ N+LL + A LAD+ + D++ + P + APE + +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP---FWMAPEVIQEIGY 202
Query: 563 QATSKSDVYSFGVLLLELLTGKPP 586
+D++S G+ +E+ GKPP
Sbjct: 203 --NCVADIWSLGITAIEMAEGKPP 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 47/270 (17%), Positives = 93/270 (34%), Gaps = 43/270 (15%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES----VGGLRH--P 442
LLG G G+ Y + + + L V +K ++ +++ + + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 443 NLVPLRAYFQAKEERLLIYDY-QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
++ L +F+ + +LI + +P LF I T L V + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVR 163
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDNLLYKAPETR 558
+ H ++H ++K N+L+ D L D+ AL D++ D +Y PE
Sbjct: 164 HCHNC-GVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 220
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPP-------SQHSFLVPNEMMNWVRSAREDDGAE 611
+ V+S G+LL +++ G P + + +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQ 271
Query: 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641
L + P RPT ++
Sbjct: 272 HLIRWCL--------ALRPSDRPTFEEIQN 293
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+ P L L + FQ + + +Y G L I + + AE +A G
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-IAIG 454
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L ++ +++ +LK NV+L + +AD+ + +++ D PD
Sbjct: 455 LFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKTFCGTPD--- 507
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + KS D ++FGVLL E+L G+ P
Sbjct: 508 YIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAP 541
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
HP LV L + FQ + + +Y G L H + + H + AE ++
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEH--ARFYSAE-ISLA 165
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L+Y+H+ +++ +LK NVLL + L DY + + L+ D P+
Sbjct: 166 LNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPN--- 218
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE R + S D ++ GVL+ E++ G+ P
Sbjct: 219 YIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSP 252
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/279 (21%), Positives = 103/279 (36%), Gaps = 55/279 (19%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LGKG+ + V + ++ KL+ ++ E+ L+HPN+V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ LI+D G LF I S + + + + + HQ
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD-------ASHCIQQILEAVLHCHQM 129
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAP 555
+VH NLK N+LL LAD+ L +++ + Y +P
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGL------AIEVEGEQQAWFGFAGTPGYLSP 182
Query: 556 ET-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE--MMNWVRSARED----- 607
E R + D+++ GV+L LL G PP F ++ + +++ D
Sbjct: 183 EVLRKDPY--GKPVDLWACGVILYILLVGYPP----FWDEDQHRLYQQIKAGAYDFPSPE 236
Query: 608 -----DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A+D ML + +P +R T + LK
Sbjct: 237 WDTVTPEAKDLINKML--------TINPSKRITAAEALK 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 53/222 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ------HMESVGGLRHP 442
+ LG G+ G V VK L+ K+ S ++ + +++ RHP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKL---FRHP 71
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ-- 498
+++ L + ++ +Y G LF I HG ++ E A+
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---------------RVEEMEARRL 116
Query: 499 ------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL- 551
+ Y H+ +VH +LK NVLL A +AD+ L+ + +D L
Sbjct: 117 FQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-------GEFLR 168
Query: 552 -------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE + A + D++S GV+L LL G P
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 60/312 (19%), Positives = 110/312 (35%), Gaps = 70/312 (22%)
Query: 360 GIQVAKSGNLVFCAGEAQLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDA 418
G++ K + Y + E LG G K L K +
Sbjct: 1 GMEPFKQQKV------EDFYDIG-------EELGSGQFAIVKKCREKSTGLEYAAKFIKK 47
Query: 419 SKLAGTSN----EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI- 473
+ + E E+ + + + H N++ L ++ + + +LI + G LF +
Sbjct: 48 RQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA 107
Query: 474 -HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEAC 528
S S + + G++Y+H ++ H +LK N++L P
Sbjct: 108 QKESLSEEE-------ATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 529 LADYCLTALTADSLQDDDPDNLL-----YKAPETRNASHQATSKSDVYSFGVLLLELLTG 583
L D+ L A ++D + + APE N ++D++S GV+ LL+G
Sbjct: 160 LIDFGL----AHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSG 214
Query: 584 KPPSQHSFLVPN--EMMNWVRSARED----------DGAED--ERLGMLLEVAIACNSAS 629
P FL E + + S D + A+D + LL
Sbjct: 215 ASP----FLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK---LLVK-------E 260
Query: 630 PEQRPTMWQVLK 641
+R T+ + L+
Sbjct: 261 TRKRLTIQEALR 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LGKG+ + V L K ++ KL+ + E+ L+HPN+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
Q + L++D G LF I S + + + ++Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILESIAYCHSN 147
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPET- 557
+VH NLK N+LL LAD+ L A + D + + Y +PE
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGL----AIEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ + + D+++ GV+L LL G PP
Sbjct: 203 KKDPY--SKPVDIWACGVILYILLVGYPP 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/274 (21%), Positives = 101/274 (36%), Gaps = 48/274 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG G+ G ++ K + + E + ++++ LRHP LV L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLH 220
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT--SCLKIAEDVAQGLSYIHQA 506
F+ E ++IY++ G LF + + + ++ V +GL ++H+
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKV------ADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 507 WRLVHGNLKSSNVLLGPDFEACL--ADYCLTALTADSLQDDDPDNLL-----YKAPETRN 559
VH +LK N++ L D+ L L + + APE
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGL----TAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED---------- 607
+D++S GVL LL+G P F N E + V+S +
Sbjct: 330 -GKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ +D + LL P R T+ Q L+
Sbjct: 385 EDGKD-FIRKLLLA-------DPNTRMTIHQALE 410
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
HP L L FQ + + ++ G L H KS R + AE +
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEAR--ARFYAAE-IISA 136
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L ++H +++ +LK NVLL + LAD+ + + + + PD
Sbjct: 137 LMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPD--- 189
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + + + D ++ GVLL E+L G P
Sbjct: 190 YIAPEILQEMLY---GPAVDWWAMGVLLYEMLCGHAP 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 34/212 (16%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLD-ASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+G GS G Y A + N +V +K++ + K + + + + + LRHPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
R + + L+ +Y GS L+ KPL + QGL+Y+H
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH- 173
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYK-----------APE 556
++H ++K+ N+LL L D+ + ++ APE
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSAS-------------IMAPANSFVGTPYWMAPE 220
Query: 557 TRNASHQAT--SKSDVYSFGVLLLELLTGKPP 586
A + K DV+S G+ +EL KPP
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 27/135 (20%), Positives = 50/135 (37%), Gaps = 5/135 (3%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L+ L LG I L++L +L L L++N ++ I L+GL L++L+L N +
Sbjct: 133 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS-DL 190
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
L L L L+L ++ +++ + + N
Sbjct: 191 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249
Query: 205 VSGNNFTGAITVTST 219
V + V+
Sbjct: 250 VKWHLPEFTNEVSFI 264
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 41/120 (34%), Positives = 55/120 (45%), Gaps = 8/120 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L+ L L I N L L QL L L NN +T I LS L L +L L+ N +
Sbjct: 111 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DI 168
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
P L L +L+ L LS N++S + LA L L L + P +QS+L + N
Sbjct: 169 VP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 33/132 (25%), Positives = 50/132 (37%), Gaps = 17/132 (12%)
Query: 87 LQGLDLGGIFAPNSLTKLD------QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
+ + + + + + L L N LT I L+ L NL LFLD N
Sbjct: 45 IDQIIANN----SDIKSVQGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKI 99
Query: 141 TGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSS 199
L L +LK+L L +N +S L +L SL L N+ I L +
Sbjct: 100 K-DLSS-LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITVLSRLTK 154
Query: 200 LKIFNVSGNNFT 211
L ++ N +
Sbjct: 155 LDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 21/112 (18%), Positives = 41/112 (36%), Gaps = 7/112 (6%)
Query: 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
+ L+ S+T + L ++ + +++ S + L + L L+
Sbjct: 17 DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLN 73
Query: 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIFNVSGNNFT 211
N L+ P L + L L LD N+ + L LK ++ N +
Sbjct: 74 GNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS 122
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 55/274 (20%), Positives = 103/274 (37%), Gaps = 48/274 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG G+ G ++ V + K ++ + + + L HP L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKLINLH 114
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F+ K E +LI ++ G LF I + + + +GL ++H+
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH-S 169
Query: 509 LVHGNLKSSNVLLGPDFEACL--ADYCLTALTADSLQDDDPDNLL-----YKAPETRNAS 561
+VH ++K N++ + + D+ L A L D+ + + APE +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGL----ATKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 562 HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED----------DG 609
+D+++ GVL LL+G P F + E + V+ +
Sbjct: 226 P-VGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280
Query: 610 AED--ERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A+D + LL+ P +R T+ L+
Sbjct: 281 AKDFIKN---LLQK-------EPRKRLTVHDALE 304
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 29/114 (25%), Positives = 41/114 (35%), Gaps = 16/114 (14%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
P L +L + L +P L L++ N T S P L+ L
Sbjct: 97 PVLPPGLLELSIFSNPLTHLP-ALPS-----GLCKLWIFGNQLT-SLPVLPPG---LQEL 146
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
+S N L+ LP L L N+ S+P L S L+ +VS N
Sbjct: 147 SVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPMLP-SGLQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 29/129 (22%), Positives = 42/129 (32%), Gaps = 17/129 (13%)
Query: 87 LQGLDLGGIFAPNSLTKLD----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L L N LT L L+ L + N LT +P L LK L + N T
Sbjct: 203 LYKLWAYN----NRLTSLPALPSGLKELIVSGNRLTS-LPVLPS--ELKELMVSGNRLT- 254
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKI 202
S P L +L + N L+ LP+ L ++ L+ N + +
Sbjct: 255 SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQALREITS 309
Query: 203 FNVSGNNFT 211
Sbjct: 310 APGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 12/131 (9%)
Query: 87 LQGLDLGGIFAPNSLTKLD----QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L+ L + G N LT L +L+ L + N LT +P L L SL + N T
Sbjct: 223 LKELIVSG----NRLTSLPVLPSELKELMVSGNRLTS-LPMLPS--GLLSLSVYRNQLT- 274
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKI 202
P SL+ L T++L N LS + L + RF+ + + + +
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
Query: 203 FNVSGNNFTGA 213
+ + A
Sbjct: 335 HLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 12/108 (11%)
Query: 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
+ VL + + LT +PD ++ +L + N T S P L +TL++S N
Sbjct: 39 NNGNAVLNVGESGLTT-LPD-CLPAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQ 92
Query: 164 LSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L+ LP L L + N +P L S L + GN T
Sbjct: 93 LTS-LPVLP---PGLLELSIFSNPLT-HLPALP-SGLCKLWIFGNQLT 134
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 17/116 (14%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157
P ++L +L + SL P L LK L + N T S P LK L
Sbjct: 197 PTLPSELYKLWAYNNRLTSL----PAL--PSGLKELIVSGNRLT-SLPV---LPSELKEL 246
Query: 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFT 211
+S N L+ LP L SL + N+ +P ++ SS N+ GN +
Sbjct: 247 MVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 58/296 (19%), Positives = 96/296 (32%), Gaps = 67/296 (22%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES 435
Y L + ++LG G G + +K L S A E H
Sbjct: 28 DDYQLSK------QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR--QE--VDHHWQ 77
Query: 436 VGGLRHPNLVPLRAYFQ----AKEERLLIYDYQPNGSLFSLI----HGSKSTRAKPLHWT 487
G P++V + ++ K L+I + G LFS I + + R
Sbjct: 78 ASG--GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE------ 129
Query: 488 SCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQD 544
+I D+ + ++H + H ++K N+L D L D+ T
Sbjct: 130 -AAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET------ 181
Query: 545 DDPDNLL-------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP--SQHSFLVPN 595
+ L Y APE D++S GV++ LL G PP S +
Sbjct: 182 -TQNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 596 EMMNWVRSARED----------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
M +R + + A+ +L P +R T+ Q +
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLL--------KTDPTERLTITQFMN 287
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDV 496
HP L + FQ KE + +Y G L I +RA AE +
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-------FYAAE-I 127
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PD 548
GL ++H +V+ +LK N+LL D +AD+ + +++ D PD
Sbjct: 128 ILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGDAKTNTFCGTPD 183
Query: 549 NLLYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + + S D +SFGVLL E+L G+ P
Sbjct: 184 ---YIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSP 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 29/123 (23%), Positives = 44/123 (35%), Gaps = 11/123 (8%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRL 154
S ++L L+ L ++ + I + GL +L L LD+N F L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 155 KTLDLSYNNL-SGPLPKEL-ASQGRLYSLRLDVNRFNGSIPP----LNQSSLKIFNVSGN 208
+ L L+ NL L L L L N I P LN + +++ N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFN 164
Query: 209 NFT 211
Sbjct: 165 KVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 28/139 (20%), Positives = 44/139 (31%), Gaps = 15/139 (10%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
LQ L + + N+ L L +L L N + +GL NL+ L L
Sbjct: 56 LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCN 114
Query: 140 FTGSFPP--SLLSLHRLKTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRF----NGSI 192
G+ L L+ L L NN+ P + R + L L N+ +
Sbjct: 115 LDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDL 174
Query: 193 PPLNQSSLKIFNVSGNNFT 211
+ +S
Sbjct: 175 LNFQGKHFTLLRLSSITLQ 193
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 26/110 (23%), Positives = 34/110 (30%), Gaps = 9/110 (8%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ L L N+ L L L L N L I L L+ L L +N
Sbjct: 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHI 359
Query: 141 TGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN 189
+ L LK L L N L L + L N ++
Sbjct: 360 R-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 31/147 (21%), Positives = 50/147 (34%), Gaps = 24/147 (16%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTG-PIPD--LSGLVNLKSLFLDHNF 139
L L L + L L VL L +L G + L +L+ L L N
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 140 FTGSFPPSLL--SLHRLKTLDLSYNNLSGPLPKELAS--QGRLYSLRLDVNRFNGSIP-- 193
P+ ++ R LDL++N + ++L + LRL +
Sbjct: 141 IK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEY 198
Query: 194 ---------PLNQSSLKIFNVSGNNFT 211
P +S+ ++SGN F
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 20/106 (18%), Positives = 38/106 (35%), Gaps = 8/106 (7%)
Query: 113 QNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172
N L +P+L ++ + L N S L L+ L + +
Sbjct: 18 INRGLHQ-VPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT 74
Query: 173 -ASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTGAI 214
L L+LD N+F + ++L++ ++ N GA+
Sbjct: 75 FRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+ P L L + FQ + + +Y G L I + + AE +A G
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-IAIG 133
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L ++ +++ +LK NV+L + +AD+ + +++ D PD
Sbjct: 134 LFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD--- 186
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + KS D ++FGVLL E+L G+ P
Sbjct: 187 YIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAP 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 6/134 (4%)
Query: 54 DLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQ 113
D + +S + + V + L DL + L +L + L L
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL---CHLEQLLLVTHLDLS 471
Query: 114 NNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSG-PLPKEL 172
+N L P L+ L L+ L N + + +L RL+ L L N L + L
Sbjct: 472 HNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPL 529
Query: 173 ASQGRLYSLRLDVN 186
S RL L L N
Sbjct: 530 VSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 5/83 (6%)
Query: 87 LQGLDLGG---IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG- 142
+ LDL P +L L L VL +N+L + ++ L L+ L L +N
Sbjct: 465 VTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQS 523
Query: 143 SFPPSLLSLHRLKTLDLSYNNLS 165
+ L+S RL L+L N+L
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 46/281 (16%), Positives = 88/281 (31%), Gaps = 65/281 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYE---------QHMESVGGL 439
LG G+ G + AV + V VK + K+ + +
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR---V 86
Query: 440 RHPNLVPLRAYFQAKEERLLIY----DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAED 495
H N++ + E + + LF+ I R L I
Sbjct: 87 EHANIIKV---LDIFENQGFFQLVMEKHGSGLDLFAFI-----DRHPRLDEPLASYIFRQ 138
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---- 551
+ + Y+ ++H ++K N+++ DF L D+ A + L
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-------ERGKLFYTFC 190
Query: 552 ----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP-------SQHSFLVPNEMMNW 600
Y APE + + +++S GV L L+ + P + + P +
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV--- 247
Query: 601 VRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ LL+ PE+R T+ +++
Sbjct: 248 ------SKELMS-LVSGLLQP-------VPERRTTLEKLVT 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 61/279 (21%), Positives = 102/279 (36%), Gaps = 56/279 (20%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G GS + + + VK +D SK + E + + G HPN++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-TEE--IEILLRYGQ--HPNIITLK 82
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ + ++ + G L I S R + + + + Y+H
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE-------ASAVLFTITKTVEYLHAQ 135
Query: 507 WRLVHGNLKSSNVLLGPDFEAC----LADYCLTALTADSLQDDDPDNLL--------YKA 554
+VH +LK SN+L + + D+ + Q + LL + A
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGF------AKQLRAENGLLMTPCYTANFVA 188
Query: 555 PETRNASHQATSKS-DVYSFGVLLLELLTGKPP-SQHSFLVPNEMMNWVRSARED----- 607
PE Q + D++S GVLL +LTG P + P E++ + S +
Sbjct: 189 PEVLE--RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246
Query: 608 -----DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
D A+D ML P QR T VL+
Sbjct: 247 WNSVSDTAKDLVSKML--------HVDPHQRLTAALVLR 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 18/157 (11%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+ L FQ L+ DY G L +L+ SK P + +AE +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEM-ARFYLAE-MVIA 187
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDD----PDNLLYK 553
+ +HQ VH ++K N+L+ + LAD+ CL + ++Q PD Y
Sbjct: 188 IDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD---YI 243
Query: 554 APE---TRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
+PE D +S GV + E+L G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 41/120 (34%), Positives = 55/120 (45%), Gaps = 8/120 (6%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L+ L L I N L L QL L L NN +T I LS L L +L L+ N +
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DI 171
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
P L L +L+ L LS N++S + LA L L L + P +QS+L + N
Sbjct: 172 VP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPN 227
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 35/128 (27%), Positives = 51/128 (39%), Gaps = 9/128 (7%)
Query: 87 LQGLDLG--GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
+ + I + + L + L L N LT I L+ L NL LFLD N
Sbjct: 48 IDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVK-DL 105
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIF 203
L L +LK+L L +N +S L +L SL L N+ I L + L
Sbjct: 106 SS-LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTL 161
Query: 204 NVSGNNFT 211
++ N +
Sbjct: 162 SLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 24/124 (19%), Positives = 46/124 (37%), Gaps = 13/124 (10%)
Query: 95 IFAPNSLTK------LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSL 148
I P + + + L+ S+T + L ++ + +++ S +
Sbjct: 8 ITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQG-I 64
Query: 149 LSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIFNVSG 207
L + L L+ N L+ P LA+ L L LD N+ + L LK ++
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEH 121
Query: 208 NNFT 211
N +
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 21/83 (25%), Positives = 31/83 (37%), Gaps = 3/83 (3%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L L I L L +L+ L L N ++ + L+GL NL L L
Sbjct: 158 LDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKP 216
Query: 145 PPSLLSLHRLKTLDLSYNNLSGP 167
+L T+ + +L P
Sbjct: 217 INHQSNLVVPNTVKNTDGSLVTP 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 20/159 (12%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
+ L FQ + L+ +Y G L +L+ SK P + +AE +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-ARFYLAE-IVMA 174
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDD----PDNLLYK 553
+ +H+ VH ++K N+LL LAD+ CL +++ PD Y
Sbjct: 175 IDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD---YL 230
Query: 554 APETRNASHQATSKS------DVYSFGVLLLELLTGKPP 586
+PE A D ++ GV E+ G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 27/210 (12%)
Query: 391 LLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLA---GTSNEMYEQHM-ESVGGLRHPNLV 445
+LG+G G + + + K+L+ +L G M E+ + V +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV---HSRFIV 248
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L F+ K + L+ G + I+ + A+ + GL ++HQ
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ 307
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLLYKAPET 557
+++ +LK NVLL D ++D L + P + APE
Sbjct: 308 R-NIIYRDLKPENVLLDDDGNVRISDL---GLAVELKAGQTKTKGYAGTPG---FMAPEL 360
Query: 558 -RNASHQATSKSDVYSFGVLLLELLTGKPP 586
+ D ++ GV L E++ + P
Sbjct: 361 LLGEEY--DFSVDYFALGVTLYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 391 LLGKGSLGTTYKA-VLDNRLIVCVKRLDASKLA---GTSNEMYEQHM-ESVGGLRHPNLV 445
+LGKG G V + K+L+ ++ G + + E+ + E V +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV---NSRFVV 247
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L ++ K+ L+ G L I+ + AE + GL +H+
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAE-ICCGLEDLHR 304
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPET-RN 559
R+V+ +LK N+LL ++D L A + + Y APE +N
Sbjct: 305 E-RIVYRDLKPENILLDDHGHIRISDLGL----AVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPP 586
+ T D ++ G LL E++ G+ P
Sbjct: 360 ERY--TFSPDWWALGCLLYEMIAGQSP 384
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 27/126 (21%), Positives = 47/126 (37%), Gaps = 10/126 (7%)
Query: 87 LQGLDLG--GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
+Q + I + + L+ L L +N ++ + L L L+ L ++ N
Sbjct: 43 VQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLKN-- 99
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIF 203
+ + L L L N L L L L + N+ SI L S L++
Sbjct: 100 -LNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVL 155
Query: 204 NVSGNN 209
++ GN
Sbjct: 156 DLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 10/121 (8%)
Query: 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
L L S+T + L +++ D++ S + LK L LS
Sbjct: 15 DPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLS 71
Query: 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTL 220
+N +S P L +L L ++ NR ++ + + L + N + T +L
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNE----LRDTDSL 124
Query: 221 S 221
Sbjct: 125 I 125
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 17/111 (15%), Positives = 36/111 (32%), Gaps = 11/111 (9%)
Query: 112 LQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE 171
+ + + GL N L T S L ++ + +N+
Sbjct: 4 QRPTPINQ-VFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LAG 58
Query: 172 LASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIFNVSGNNFTGAITVTSTLS 221
+ L L L N+ + + PL + L+ +V+ N + + +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRNR----LKNLNGIP 104
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 25/157 (15%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
RHP L L+ FQ + + +Y G LF H S+ + AE +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFF--HLSRERVFTEER--ARFYGAE-IVSA 117
Query: 500 LSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNLL 551
L Y+H +V+ ++K N++L D + D+ L + + D P+
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPE--- 170
Query: 552 YKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + + ++ D + GV++ E++ G+ P
Sbjct: 171 YLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLP 204
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 29/115 (25%), Positives = 39/115 (33%), Gaps = 14/115 (12%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFF 140
L+ LDL + L L VL L NN + + + L+ L+L N
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQI 148
Query: 141 TGSFPP----SLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY--SLRLDVNRFN 189
+ FP L +L LDLS N L +L L L N
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 31/136 (22%), Positives = 49/136 (36%), Gaps = 20/136 (14%)
Query: 98 PNSLTKLDQLRVLGLQNNSLT--GPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRL 154
P+ LD L +N+L+ + L NL SL L HN + L
Sbjct: 38 PSYTALLD------LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 155 KTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNF 210
+ LDLS N+L L + + L L L N + + + L+ +S N
Sbjct: 91 RYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 211 T----GAITVTSTLSR 222
+ I + L +
Sbjct: 149 SRFPVELIKDGNKLPK 164
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 38/212 (17%), Positives = 74/212 (34%), Gaps = 24/212 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG---GLRHPNLV 445
E++GKG + + + VK +D +K + E L+HP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L + + +++++ L I ++ + + L Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 506 AWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL--------YKA 554
++H ++K VLL L + + ++Q + + + A
Sbjct: 149 N-NIIHRDVKPHCVLLASKENSAPVKLGGFGV------AIQLGESGLVAGGRVGTPHFMA 201
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE DV+ GV+L LL+G P
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLP 232
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 391 LLGKGSLGT----TYKAVLDNRLIVCVKRLDASKLAGTSNE----MYEQH-MESVGGLRH 441
+LGKG G + I +K L + + + + E++ +E V +H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV---KH 80
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDVAQ 498
P +V L FQ + LI +Y G LF + A +AE ++
Sbjct: 81 PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC-------FYLAE-ISM 132
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PDNL 550
L ++HQ +++ +LK N++L L D+ L +S+ D +
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDF---GLCKESIHDGTVTHTFCGTIE-- 186
Query: 551 LYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + H +++ D +S G L+ ++LTG PP
Sbjct: 187 -YMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAPP 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 55/283 (19%), Positives = 103/283 (36%), Gaps = 59/283 (20%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES----VGGLRHPNL 444
E LG G K L K + + + + + +E + ++HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+ L ++ K + +LI + G LF + S + + + + G+ Y
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFLKQILNGVYY 129
Query: 503 IHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLTALTADSLQDDDPDNLL-----YK 553
+H ++ H +LK N++L P + D+ L A + + + +
Sbjct: 130 LHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL----AHKIDFGNEFKNIFGTPEFV 184
Query: 554 APE-TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARED--- 607
APE ++D++S GV+ LL+G P FL E + V + +
Sbjct: 185 APEIVNYEPL--GLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFED 238
Query: 608 -------DGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A+D R LL P++R T+ L+
Sbjct: 239 EYFSNTSALAKDFIRR---LLVK-------DPKKRMTIQDSLQ 271
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 35/159 (22%), Positives = 55/159 (34%), Gaps = 22/159 (13%)
Query: 70 CQWQGVICYQQK-----------VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLT 118
C+ V C QK + L + + A KL QLR + NN +T
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 119 GPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKEL-AS 174
I + G + + L N + + L LKTL L N ++ + +
Sbjct: 71 D-IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIG 127
Query: 175 QGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNF 210
+ L L N+ ++ P SL N+ N F
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 8/101 (7%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRL 154
P + + +LR + L NN ++ + GL +L SL L N T P SL L L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106
Query: 155 KTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIPP 194
+ L L+ N ++ L + L L L N+ +I
Sbjct: 107 QLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 26/110 (23%), Positives = 38/110 (34%), Gaps = 15/110 (13%)
Query: 87 LQGLDLGGIFAPNSLT--------KLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDH 137
L+ +DL N ++ L L L L N +T P GL +L+ L L+
Sbjct: 58 LRRIDLSN----NQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113
Query: 138 NFFTGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
N LH L L L N L + + ++ L N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 53/222 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ------HMESVGGLRHP 442
+ LG G+ G V VK L+ K+ S ++ + +++ RHP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKL---FRHP 76
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ-- 498
+++ L + ++ +Y G LF I +G ++ E ++
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---------------RLDEKESRRL 121
Query: 499 ------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL- 551
G+ Y H+ +VH +LK NVLL A +AD+ L+ + +D L
Sbjct: 122 FQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-------GEFLR 173
Query: 552 -------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE + A + D++S GV+L LL G P
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 50/221 (22%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMY-E-QHMESVGGLRHPNLVP 446
+ LG+G+ G AV V VK +D + + E + L H N+V
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM---LNHENVVK 69
Query: 447 LRAYFQAKEERLLIY---DYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ--- 498
+ + E + Y +Y G LF I + E AQ
Sbjct: 70 F---YGHRREGNIQYLFLEYCSGGELFDRIEPDI---------------GMPEPDAQRFF 111
Query: 499 -----GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-- 551
G+ Y+H + H ++K N+LL ++D+ L + + ++ + LL
Sbjct: 112 HQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNK 166
Query: 552 ------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE DV+S G++L +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 64/295 (21%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN----EMYEQ 431
Y + E LG G K K + +L+ + E E+
Sbjct: 5 DHYEMG-------EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 432 HMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSC 489
+ + +RHPN++ L F+ K + +LI + G LF + S +
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE-------A 110
Query: 490 LKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLTALTADSLQDD 545
+ + + G+ Y+H R+ H +LK N++L P+ L D+ + A ++
Sbjct: 111 TQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI----AHKIEAG 165
Query: 546 DPDNLL-----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMM 598
+ + + APE N ++D++S GV+ LL+G P FL E +
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP----FLGETKQETL 220
Query: 599 NWVRSARED----------DGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ + D + A+D R LL P++R T+ Q L+
Sbjct: 221 TNISAVNYDFDEEYFSNTSELAKDFIRR---LLVK-------DPKRRMTIAQSLE 265
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 53/287 (18%)
Query: 377 QLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES 435
YT+ + E+LG G G +K L + K + + E + +
Sbjct: 87 SFYTVSKT-----EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISV 139
Query: 436 VGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAED 495
+ L H NL+ L F++K + +L+ +Y G LF I + L + +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTILFMKQ 195
Query: 496 VAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL--ADYCLTALTADSLQDDDPDNLL-- 551
+ +G+ ++HQ ++H +LK N+L + D+ L A + + +
Sbjct: 196 ICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGL----ARRYKPREKLKVNFG 250
Query: 552 ---YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARE 606
+ APE N + +D++S GV+ LL+G P FL N E +N + + R
Sbjct: 251 TPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSP----FLGDNDAETLNNILACRW 305
Query: 607 D----------DGAED--ERLGMLLEVAIACNSASPEQRPTMWQVLK 641
D + A++ + LL R + + LK
Sbjct: 306 DLEDEEFQDISEEAKEFISK---LLIK-------EKSWRISASEALK 342
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 31/160 (19%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDV 496
HP +V L FQ + + LI D+ G LF+ + K +AE +
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK-------FYLAE-L 135
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PD 548
A L ++H +++ +LK N+LL + L D+ L+ +S+ + +
Sbjct: 136 ALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDF---GLSKESIDHEKKAYSFCGTVE 191
Query: 549 NLLYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE H ++S D +SFGVL+ E+LTG P
Sbjct: 192 ---YMAPEVVNRRGH---TQSADWWSFGVLMFEMLTGTLP 225
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 56/280 (20%), Positives = 104/280 (37%), Gaps = 61/280 (21%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG+G+ Y+ + +K L + ++ + + L HPN++ L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
F+ E L+ + G LF I G S R + + + ++Y+H+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERD-------AADAVKQILEAVAYLHEN 167
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAP 555
+VH +LK N+L PD +AD+ L+ + + L+ Y AP
Sbjct: 168 -GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMKTVCGTPGYCAP 219
Query: 556 ET-RNASHQATSKSDVYSFGVLLLELLTGKPPSQHSF---LVPNEMMNWVRSARED---- 607
E R ++ + D++S G++ LL G P F M + +
Sbjct: 220 EILRGCAY--GPEVDMWSVGIITYILLCGFEP----FYDERGDQFMFRRILNCEYYFISP 273
Query: 608 ------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
A+D ++ P++R T +Q L+
Sbjct: 274 WWDEVSLNAKDLVRKLI--------VLDPKKRLTTFQALQ 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 25/207 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E+LG G+ + + +K + K + E + + ++H N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+++ L+ G LF I G + + + + V + Y+H+
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD-------ASLVIQQVLSAVKYLHEN 125
Query: 507 WRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDD---PDNLLYKAPET-RN 559
+VH +LK N+L + + + D+ L+ + + + P Y APE
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG---YVAPEVLAQ 181
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPP 586
+ + D +S GV+ LL G PP
Sbjct: 182 KPY--SKAVDCWSIGVITYILLCGYPP 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 24/158 (15%)
Query: 440 RHPNLVPLRAYFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
+ P LV L FQ E +L LI DY G LF+ H S+ R + + E +
Sbjct: 117 QSPFLVTLHYAFQT-ETKLHLILDYINGGELFT--HLSQRERFTEHE--VQIYVGE-IVL 170
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---------PDN 549
L ++H+ +++ ++K N+LL + L D+ L+ + + D+ +
Sbjct: 171 ALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDF---GLSKEFVADETERAYDFCGTIE- 225
Query: 550 LLYKAPETRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y AP+ K+ D +S GVL+ ELLTG P
Sbjct: 226 --YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKS---TRAKPLHWTSCLKIAEDV 496
+HP LV L FQ ++ + DY G LF + + RA+ AE +
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR-------FYAAE-I 148
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD--------PD 548
A L Y+H +V+ +LK N+LL L D+ L ++++ + P+
Sbjct: 149 ASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204
Query: 549 NLLYKAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
Y APE + ++ D + G +L E+L G PP
Sbjct: 205 ---YLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPP 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 49/219 (22%), Positives = 83/219 (37%), Gaps = 38/219 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN------EMYEQHMESVGGLRHP 442
+ LG G+ G A V +K + K A S E +E + L HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQGL 500
++ ++ +F A E+ ++ + G LF + + C + +
Sbjct: 76 CIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEAT-------CKLYFYQMLLAV 127
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDNLL------ 551
Y+H+ ++H +LK NVLL E C + D+ + + +L+
Sbjct: 128 QYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------GETSLMRTLCGT 179
Query: 552 --YKAPETRNASHQA--TSKSDVYSFGVLLLELLTGKPP 586
Y APE + A D +S GV+L L+G PP
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 48/276 (17%), Positives = 93/276 (33%), Gaps = 67/276 (24%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG G G + + +K L A E + P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--RE--VELHWRASQ--CPHIVRIV 77
Query: 449 AYFQ----AKEERLLIYDYQPNGSLFSLI----HGSKSTRAKPLHWTSCLKIAEDVAQGL 500
++ ++ L++ + G LFS I + + R +I + + + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE-------ASEIMKSIGEAI 130
Query: 501 SYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLLYKAPET 557
Y+H + H ++K N+L P+ L D+ A ET
Sbjct: 131 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------AKET 170
Query: 558 RNASHQATSKSDVYSFGVLLLELLTGKPP--SQHSFLVPNEMMNWVRSARED-------- 607
+ D++S GV++ LL G PP S H + M +R + +
Sbjct: 171 TGEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228
Query: 608 --DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ + +L P QR T+ + +
Sbjct: 229 VSEEVKMLIRNLL--------KTEPTQRMTITEFMN 256
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKR--LDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+++G GS G Y+A L D+ +V +K+ D + E+ Q M L H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNREL--QIMRK---LDHCNIVR 111
Query: 447 LRAYFQAKEERL------LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
LR +F + E+ L+ DY P +++ + S + L + + L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEAC-LADYCLTALTADSLQDDDPDN-----LLYKA 554
+YIH + H ++K N+LL PD L D+ A L +P+ Y+A
Sbjct: 170 AYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGS----AKQLVRGEPNVSYICSRYYRA 224
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKP 585
PE + TS DV+S G +L ELL G+P
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 50/221 (22%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMY-E-QHMESVGGLRHPNLVP 446
+ LG+G+ G AV V VK +D + + E + L H N+V
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM---LNHENVVK 69
Query: 447 LRAYFQAKEERLLIY---DYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ--- 498
+ + E + Y +Y G LF I + E AQ
Sbjct: 70 F---YGHRREGNIQYLFLEYCSGGELFDRIEPDI---------------GMPEPDAQRFF 111
Query: 499 -----GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-- 551
G+ Y+H + H ++K N+LL ++D+ L + + ++ + LL
Sbjct: 112 HQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNK 166
Query: 552 ------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE DV+S G++L +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 24/153 (15%), Positives = 52/153 (33%), Gaps = 17/153 (11%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
L L+L G + + + L +L++L + N I +GL L+ L +D +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG----SIPPL 195
P SL S+ + L L L + + L L + +
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 196 ------NQSSLKIFNVSGNNFTGAITVTSTLSR 222
+ + + ++ + + + + +S
Sbjct: 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISG 278
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 97 APNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLK 155
NSL K R + + + SL + L+ + L L N S P + L L+
Sbjct: 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQ 304
Query: 156 TLDLSYNNL 164
+ L N
Sbjct: 305 KIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 18/117 (15%), Positives = 34/117 (29%), Gaps = 16/117 (13%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGLQNNSL---------TGPIPDLSGLVNLKSL 133
+ L L + + + L L++ L TG L +++
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 134 FLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFN 189
+ L + L L+ S N L +P L + L N ++
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 13/156 (8%)
Query: 86 VLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL-VNLKSLFLDHNFFTGSF 144
V+ L SL+ D+ + + SL IP SGL +KSL L +N T
Sbjct: 13 VIISLSKEESSNQASLS-CDRNGICKGSSGSLNS-IP--SGLTEAVKSLDLSNNRIT-YI 67
Query: 145 PPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSL 200
S L L+ L L+ N ++ +S G L L L N ++ SSL
Sbjct: 68 SNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSL 126
Query: 201 KIFNVSGNNFT--GAITVTSTLSRFGISSFLFNPSL 234
N+ GN + G ++ S L++ I +
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 23/97 (23%), Positives = 34/97 (35%), Gaps = 3/97 (3%)
Query: 86 VLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145
VL + ++L L N LT I +L L LK L L N +G
Sbjct: 23 VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLE 81
Query: 146 PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182
L L+LS N + + +L +L+
Sbjct: 82 VLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLK 116
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 59/320 (18%), Positives = 104/320 (32%), Gaps = 72/320 (22%)
Query: 356 KRAQGIQVAKSGNLVFCAGE-AQLYTLDQLMRASAELLGKGSLGTTYKAV-LDNRLIVCV 413
+ G+ + Y L + LG+G + +
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTS------KELGRGKFAVVRQCISKSTGQEYAA 59
Query: 414 KRLDASKLAGTSNEMYEQH---MESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGSLF 470
K L + +E P ++ L ++ E +LI +Y G +F
Sbjct: 60 KFLKKRRRGQDCRAEILHEIAVLELAKS--CPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 471 SLI----HGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GP 523
SL S +++ + + +G+ Y+HQ +VH +LK N+LL P
Sbjct: 118 SLCLPELAEMVSEND-------VIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYP 169
Query: 524 DFEACLADYCLTALTADSLQDDDPDNLL--------YKAPETRNASHQATSKSDVYSFGV 575
+ + D+ ++ L Y APE N T+ +D+++ G+
Sbjct: 170 LGDIKIVDFGMSRKI-------GHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGI 221
Query: 576 LLLELLTGKPPSQHSFLVPN--EMMNWVRSARED----------DGAED--ERLGMLLEV 621
+ LLT P F+ + E + D A D + LL
Sbjct: 222 IAYMLLTHTSP----FVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS---LLVK 274
Query: 622 AIACNSASPEQRPTMWQVLK 641
+PE+RPT L
Sbjct: 275 -------NPEKRPTAEICLS 287
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 29/166 (17%), Positives = 47/166 (28%), Gaps = 8/166 (4%)
Query: 114 NNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPP-SLLSLHRLKTLDLSYNNLSGPLPKEL 172
+ + L G NL L++++ L L L+ L + + L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 173 ASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFT--GAITVTSTLSRFGISSF 228
RL L L N S+ + SL+ +SGN A+ G+
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGV 135
Query: 229 LFNPSLCGEIIHKECNPRPPFFGPSATAAAAPPPVTVLGQQSAQMH 274
C P P+ P +V +
Sbjct: 136 PEQKLQCHGQGPLAHMPNASCGVPTLK--VQVPNASVDVGDDVLLR 179
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 26/170 (15%), Positives = 38/170 (22%), Gaps = 17/170 (10%)
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPP---LNQS 198
L L L + L L G L +L + + + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 199 SLKIFNVSGNNFT---GAITVTSTLSRFGISSFLFNPSLCGEIIHKECNPRPPFFGPSAT 255
L N+S N +L +S NP C C R
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSG---NPLHC------SCALRWLQRWEEEG 131
Query: 256 AAAAPPPVTVLGQQSAQMHGVELTQPSPKSHKKTAVIIGFSSGVLVLICS 305
P Q H + P + ++L C
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQ 181
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVK--RLDASKLAGTSNEMYEQHMESVGGLRHPNLVPL 447
+++G GS G ++A L V +K D + E+ Q M ++HPN+V L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNREL--QIMRI---VKHPNVVDL 97
Query: 448 RAYFQAKEERL------LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
+A+F + ++ L+ +Y P +++ + + + + + L+
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR-HYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEAC-LADYCLTALTADSLQDDDPD-----NLLYKAP 555
YIH + H ++K N+LL P L D+ A L +P+ + Y+AP
Sbjct: 156 YIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGS----AKILIAGEPNVSYICSRYYRAP 210
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKP 585
E + T+ D++S G ++ EL+ G+P
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 27/135 (20%), Positives = 42/135 (31%), Gaps = 13/135 (9%)
Query: 87 LQGLDLGGIFAPNSLTKL----DQLRVLGLQNNSLTGPIPDLSGLVNLKS----LFLDHN 138
L+ L + N LT L + L L + N L + + N
Sbjct: 162 LEVLSVRN----NQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCREN 217
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQS 198
T P ++LSL T+ L N LS + + L+ Q F+ S N
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 199 SLKIFNVSGNNFTGA 213
+ + F
Sbjct: 277 HRPLADAVTAWFPEN 291
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 34/135 (25%), Positives = 54/135 (40%), Gaps = 26/135 (19%)
Query: 87 LQGLDLGGIFAPNSLTKL----DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG 142
L+ LD N L+ L L+ L + NN LT +P+L L+ + D+N T
Sbjct: 102 LEYLDACD----NRLSTLPELPASLKHLDVDNNQLTM-LPELPA--LLEYINADNNQLT- 153
Query: 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL------N 196
P L+ L + N L+ LP+ S L +L + N S+P + +
Sbjct: 154 MLPELP---TSLEVLSVRNNQLTF-LPELPES---LEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 197 QSSLKIFNVSGNNFT 211
+ + F N T
Sbjct: 206 EETEIFFRCRENRIT 220
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 7/113 (6%)
Query: 99 NSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158
N+ L Q + + + N L++ + L
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQ 65
Query: 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
L+ NLS LP L Q + L + N S+P L +SL+ + N +
Sbjct: 66 LNRLNLSS-LPDNLPPQ--ITVLEITQNAL-ISLPELP-ASLEYLDACDNRLS 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 26/122 (21%), Positives = 43/122 (35%), Gaps = 6/122 (4%)
Query: 95 IFAPNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPS---LLS 150
+ +K+ L NN LT + L L++L L N
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372
Query: 151 LHRLKTLDLSYNNLSGPLPKELASQ-GRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNN 209
+ L+ LD+S N++S K S L SL + N +I +K+ ++ N
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432
Query: 210 FT 211
Sbjct: 433 IK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 9/109 (8%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT 141
LQ LD+ + L L + +N LT I +K L L N
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLHSNKIK 434
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFN 189
S P ++ L L+ L+++ N L +P L + L N ++
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 15/119 (12%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156
T L+ + N ++ D+ L L+ L + HN L+
Sbjct: 20 SQKTTILN------ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEY 73
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL----NQSSLKIFNVSGNNFT 211
LDLS+N L + L L L N F+ ++P N S LK +S +
Sbjct: 74 LDLSHNKLVKISCHPTVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 33/221 (14%), Positives = 61/221 (27%), Gaps = 9/221 (4%)
Query: 3 IRRKPLLPQLLFFLSNTFLLITSCSASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFS 62
I+ + +FLS L T+ S + +L + + S
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW-YFSIS 255
Query: 63 QNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSL--TKLDQLRVLGLQNNSLTG- 119
K ++ + + + + P S + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 120 PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS--GPLPKELASQGR 177
+ S + L +N T + + L L+TL L N L + +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375
Query: 178 LYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAIT 215
L L + N + SL N+S N T I
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 27/208 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG+G G ++ V ++ K + + ++ + + RH N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLH 67
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWT--SCLKIAEDVAQGLSYIHQA 506
F++ EE ++I+++ +F I + V + L ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI------NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 507 WRLVHGNLKSSNVLLGPDFEACL--ADYCLTALTADSLQDDDPDNLL-----YKAPETRN 559
+ H +++ N++ + + ++ A L+ D LL Y APE
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQ----ARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 560 ASHQATSKS-DVYSFGVLLLELLTGKPP 586
H S + D++S G L+ LL+G P
Sbjct: 177 --HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 25/97 (25%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 86 VLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP 145
VL + L L L N L + +L L LK L L N G
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLD 88
Query: 146 PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182
L L L+LS N L L +L L+
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 13/117 (11%)
Query: 97 APNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT--GSFPPSLLSLHRL 154
P ++ +L VL ++ + VNL+ L L + + P L +L
Sbjct: 22 TPAAVREL----VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKL 73
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN--GSIPPLNQ-SSLKIFNVSGN 208
K L+LS N + G L L L L N+ ++ PL + LK ++
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 54/222 (24%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ------HMESVGGLRHP 442
E LG+GS G A + V +K + L ++M+ + +++ LRHP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKL---LRHP 69
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ-- 498
+++ L + +++ +Y G LF I ++ ED +
Sbjct: 70 HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK---------------RMTEDEGRRF 113
Query: 499 ------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL- 551
+ Y H+ ++VH +LK N+LL + +AD+ L+ + D N L
Sbjct: 114 FQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-------GNFLK 165
Query: 552 -------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
Y APE N A + DV+S G++L +L G+ P
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 30/134 (22%), Positives = 56/134 (41%), Gaps = 20/134 (14%)
Query: 87 LQGLDLGGIFAPNSLTKLD--------QLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLD 136
+ L L NS+++L +LRVL L +N + + +L+ L +
Sbjct: 54 TKALSLSQ----NSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNL-SGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
HN + ++ L+ LDLS+N+ P+ KE + +L L L +F + L
Sbjct: 109 HNRLQ-NISCCPMA--SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLL 164
Query: 196 NQSSLKIFNVSGNN 209
+ L + + +
Sbjct: 165 PVAHLHLSCILLDL 178
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 26/168 (15%), Positives = 51/168 (30%), Gaps = 12/168 (7%)
Query: 58 HLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSL--TKLDQLRVLGLQNN 115
+L + + + ++++ + + ++ + L +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 116 SLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS 174
+ + L N FT S +L RL+TL L N L K
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALM 398
Query: 175 QGRLYSLRLDVNRFNGSIPPL-------NQSSLKIFNVSGNNFTGAIT 215
+ SL N S+ S+ + N+S N TG++
Sbjct: 399 TKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
+ + VL L +N LTG + +K L L +N S P + L L+ L+++ N
Sbjct: 427 AESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 164 LSGPLPKE-LASQGRLYSLRLDVNRF 188
L +P L + L N +
Sbjct: 485 LKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 30/140 (21%), Positives = 50/140 (35%), Gaps = 23/140 (16%)
Query: 87 LQGLDLGGIFAPNSLTKLD--------QLRVLGLQNNSLTGPIPDLSG-LVNLKSLFLDH 137
L+ N T +L+ L LQ N L ++ N+ SL
Sbjct: 355 FTFLNFTQ----NVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLD 409
Query: 138 NFFT----GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193
++ + + L+LS N L+G + + L + + L L NR SIP
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIP 466
Query: 194 P--LNQSSLKIFNVSGNNFT 211
+ +L+ NV+ N
Sbjct: 467 KDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 12/84 (14%)
Query: 87 LQGLDLGGIFAPNSLTKL------DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFF 140
+ L+L N LT +++VL L NN + D++ L L+ L + N
Sbjct: 430 ILVLNLSS----NMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485
Query: 141 TGSFPPSLL-SLHRLKTLDLSYNN 163
S P + L L+ + L N
Sbjct: 486 K-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/116 (24%), Positives = 43/116 (37%), Gaps = 34/116 (29%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLKSLFLDHNFFTGSFPPSL-LSLHRLK 155
P L L NS++ +PD+S L L+ L L HN S + L L+
Sbjct: 51 PPRTKALS------LSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211
LD+S+N L +I +SL+ ++S N+F
Sbjct: 104 YLDVSHNRLQ-------------------------NISCCPMASLRHLDLSFNDFD 134
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 14/103 (13%)
Query: 87 LQGLDLGGIFAPNSLTK-------LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
+ LDL G + LDQ + +N + + L LK+L +++N
Sbjct: 21 DRELDLRG----YKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182
+L L L L+ N+L +L L SL
Sbjct: 76 ICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLT 116
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 28/118 (23%), Positives = 41/118 (34%), Gaps = 11/118 (9%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNFFT--GSFPPSLLSLHRLKT 156
T + R L L+ + I +L + L ++ N FP L RLKT
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFN--GSIPPLNQ-SSLKIFNVSGNNFT 211
L ++ N + + L L L N G + PL SL + N T
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 40/164 (24%), Positives = 60/164 (36%), Gaps = 35/164 (21%)
Query: 440 RHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ- 498
P +V L FQ ++ +Y P G L +L+ S + E A+
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARF 172
Query: 499 -------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY--CLTALTADSLQDDD--- 546
L IH +H ++K N+LL LAD+ C+ ++ D
Sbjct: 173 YTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 547 -PDNLLYKAPE--TRNASHQATSKS-DVYSFGVLLLELLTGKPP 586
PD Y +PE + D +S GV L E+L G P
Sbjct: 232 TPD---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 43/207 (20%), Positives = 80/207 (38%), Gaps = 28/207 (13%)
Query: 391 LLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNE---MYEQHMESVGGLRHPNLVP 446
LG GS G ++ +K LD K+ + E+ + + + P LV
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI--LQAVNFPFLVK 105
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
L F+ ++ +Y G +FS + + R H + A+ + Y+H
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPH--ARFYAAQ-IVLTFEYLHSL 160
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPET-RNA 560
L++ +LK N+L+ + D+ + + L APE +
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRTWTLCGTPEALAPEIILSK 213
Query: 561 SHQATSKS-DVYSFGVLLLELLTGKPP 586
+ +K+ D ++ GVL+ E+ G PP
Sbjct: 214 GY---NKAVDWWALGVLIYEMAAGYPP 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 49/224 (21%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHME----SVGGLRHPNL 444
+LLG+GS G + + + VK L KL E +++ + LRH N+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL--RRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 445 VPLR--AYFQAKEERLLIYDYQPNGS--LFSLI-HGSKSTRAKPLHWTSCLKIAEDVAQ- 498
+ L Y + K++ ++ +Y G + + + A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------------RFPVCQAHG 113
Query: 499 -------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL 551
GL Y+H +VH ++K N+LL ++ + L D+
Sbjct: 114 YFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEA----LHPFAADDTC 168
Query: 552 --------YKAPE-TRNASHQATSKSDVYSFGVLLLELLTGKPP 586
++ PE + K D++S GV L + TG P
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 26/110 (23%), Positives = 34/110 (30%), Gaps = 11/110 (10%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQNNSLTG-PIPDLSGLVNLK----SLFLD 136
L+ L++ P + L L L L +N + DL L + SL L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
N P RLK L L N L L + L N
Sbjct: 186 LNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 24/120 (20%), Positives = 34/120 (28%), Gaps = 15/120 (12%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRL 154
P S LD L N L + L+ L L + L L
Sbjct: 27 PFSTKNLD------LSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFT 211
TL L+ N + + L L S+ + +LK NV+ N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 54/286 (18%), Positives = 98/286 (34%), Gaps = 66/286 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG G G + + +K L A E+ + P++V +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--REV--ELHWRASQ--CPHIVRIV 121
Query: 449 AYFQ----AKEERLLIYDYQPNGSLFSLIHGSKSTR-----AKPLHWTSCLKIAEDVAQG 499
++ ++ L++ + G LFS I A +I + + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 173
Query: 500 LSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQDDDPDNLL----- 551
+ Y+H + H ++K N+L P+ L D+ T N L
Sbjct: 174 IQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCY 225
Query: 552 ---YKAPETRNASHQATSKS-DVYSFGVLLLELLTGKPP--SQHSFLVPNEMMNWVRSAR 605
Y APE + KS D++S GV++ LL G PP S H + M +R +
Sbjct: 226 TPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 606 ED----------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ + + +L P QR T+ + +
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLL--------KTEPTQRMTITEFMN 321
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKR--LDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+ G+G+ GT + V +K+ D N Q M+ + L HPN+V
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNREL-QIMQDLAVLHHPNIVQ 83
Query: 447 LRAYFQAKEER-------LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQG 499
L++YF ER ++ +Y P+ +L + R + +
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-NYYRRQVAPPPILIKVFLFQLIRS 141
Query: 500 LSYIHQ-AWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPD-----NL 550
+ +H + + H ++K NVL+ + L D+ A L +P+ +
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGS----AKKLSPSEPNVAYICSR 195
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE + T+ D++S G + E++ G+P
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 18/110 (16%), Positives = 35/110 (31%), Gaps = 9/110 (8%)
Query: 107 LRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRLKTLDLS-YN 162
L L I SG +L+ + + N + S L +L + + N
Sbjct: 32 AIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 163 NLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNN 209
NL P+ + L L + +P + + + ++ N
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 16/121 (13%), Positives = 33/121 (27%), Gaps = 7/121 (5%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLS-LHRL 154
+ + L + + N + I S L L + ++ P L L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLN----QSSLKIFNVSGNNF 210
+ L +S + + L + N +I + I ++ N
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 211 T 211
Sbjct: 167 Q 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 18/137 (13%)
Query: 87 LQGLDLGG-----IFAPNSLTKLDQLRVLGLQN-NSLTGPIPD--LSGLVNLKSLFLDHN 138
L+ +++ + + + L +L + ++ N+L I L NL+ L + +
Sbjct: 56 LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNT 114
Query: 139 FFTGSFPP-SLLSLHRLKTLDLSYNNLSGPLPKELASQG---RLYSLRLDVNRFNGSIPP 194
P + + LD+ N + + G L L+ N I
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE-RNSFVGLSFESVILWLNKNGIQ-EIHN 171
Query: 195 --LNQSSLKIFNVSGNN 209
N + L N+S NN
Sbjct: 172 SAFNGTQLDELNLSDNN 188
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 20/131 (15%), Positives = 40/131 (30%), Gaps = 13/131 (9%)
Query: 87 LQGLDLGG-----IFAPNSLTKL-DQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHN 138
LD+ NS L + +L L N + I + +G + D+N
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNN 188
Query: 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ- 197
LD+S + L + +L + + +P L +
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKL 245
Query: 198 SSLKIFNVSGN 208
+L +++
Sbjct: 246 VALMEASLTYP 256
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 24/139 (17%), Positives = 45/139 (32%), Gaps = 16/139 (11%)
Query: 87 LQGLDLGG----IFAPNSLTKLDQLRVLGL-QNNSLTGPIPD--LSGLVNLKSLFLDHNF 139
Q L L ++ + L + + + + +L + L + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ-LESHSFYNLSKVTHIEIRNTR 91
Query: 140 FTGSFPPSLLS-LHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIPP--- 194
P L L LK L + L P ++ S + L + N + SIP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 195 --LNQSSLKIFNVSGNNFT 211
L + + N FT
Sbjct: 152 QGLC-NETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 27/123 (21%), Positives = 51/123 (41%), Gaps = 11/123 (8%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLF---LDHNFFTGSFPPSLLS--LH 152
P++L +L L+ LG+ N L PDL+ + + F + N + S P + +
Sbjct: 98 PDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 153 RLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL----NQSSLKIFNVSGN 208
TL L N + + + +L ++ L+ N++ I S + +VS
Sbjct: 157 ETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 209 NFT 211
+ T
Sbjct: 216 SVT 218
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 34/116 (29%), Positives = 41/116 (35%), Gaps = 15/116 (12%)
Query: 87 LQGLDLGGIFAPNSLT------KLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNF 139
L L+L LT L L L L +N L +P L L L L + N
Sbjct: 57 LTQLNLDR----AELTKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNR 111
Query: 140 FTGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP 194
T S P L L L+ L L N L P L +L L L N +P
Sbjct: 112 LT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPA 165
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 28/86 (32%), Positives = 34/86 (39%), Gaps = 16/86 (18%)
Query: 87 LQGLDLGGIFAPNSLT--------KLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLD 136
LQ L L G N L +L L L NN+LT +P L+GL NL +L L
Sbjct: 126 LQELYLKG----NELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQ 180
Query: 137 HNFFTGSFPPSLLSLHRLKTLDLSYN 162
N + P H L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR-AKPLHWTSCLKIAEDVA 497
+ HP ++ + FQ ++ +I DY G LFSL+ KS R P + AE V
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNP---VAKFYAAE-VC 116
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----Y 552
L Y+H +++ +LK N+LL + + D+ + D L Y
Sbjct: 117 LALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGF------AKYVPDVTYTLCGTPDY 169
Query: 553 KAPET-RNASHQATSKS-DVYSFGVLLLELLTGKPP 586
APE + +KS D +SFG+L+ E+L G P
Sbjct: 170 IAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTP 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 48/217 (22%), Positives = 79/217 (36%), Gaps = 33/217 (15%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR--------- 440
+ GS G V + V +KR+ + G + + LR
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 441 HPNLVPLRAYFQAKEERLL--IYDYQP--NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDV 496
HPN++ LR F EE + +Y L +IH + P H +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQH---IQYFMYHI 143
Query: 497 AQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----- 551
GL +H+A +VH +L N+LL + + + D+ L ++D D
Sbjct: 144 LLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLA-------REDTADANKTHYVT 195
Query: 552 ---YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE T D++S G ++ E+ K
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 47/235 (20%), Positives = 83/235 (35%), Gaps = 65/235 (27%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH------- 441
LG G T + A + N V +K + K E + + L+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNT 78
Query: 442 -------PNLVPLRAYFQAKEER---------LLIYDYQPNGSLFSLIHGSKSTRAKPLH 485
+++ L +F K +L +L +LI K + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL------GENLLALI---KKYEHRGIP 129
Query: 486 WTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-------------DF-EACLAD 531
+I++ + GL Y+H+ ++H ++K NVL+ D AC D
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 532 YCLTALTADSLQDDDPDNLLYKAPE-TRNASHQATSKSDVYSFGVLLLELLTGKP 585
T +S+Q Y++PE A +D++S L+ EL+TG
Sbjct: 190 EHYT----NSIQTR-----EYRSPEVLLGAPW--GCGADIWSTACLIFELITGDF 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 53/222 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH------- 441
+++GKGS G KA V +K + K + Q E + L H
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK------RFHRQAAEEIRILEHLRKQDKD 156
Query: 442 --PNLVPLRAYFQAKE------ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA 493
N++ + F + E L + +L+ LI K + + K A
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-------NLYELI---KKNKFQGFSLPLVRKFA 206
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---------DF-EACLADYCLTALTADSLQ 543
+ Q L +H+ R++H +LK N+LL DF +C + +Q
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY----IQ 261
Query: 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
+ Y+APE + D++S G +L ELLTG P
Sbjct: 262 -----SRFYRAPEVI-LGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 31/117 (26%), Positives = 50/117 (42%), Gaps = 15/117 (12%)
Query: 99 NSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158
+L+ L + L L N++ I LSG+ NL+ L L N L+ L
Sbjct: 42 ATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 159 LSYNNLSGPLPKELASQGRLYSLR-LDVNRFN-----GSIPPLNQ-SSLKIFNVSGN 208
+SYN ++ L+ +L +LR L ++ N G I L L+ ++GN
Sbjct: 100 ISYNQIA-----SLSGIEKLVNLRVLYMS-NNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 22/114 (19%), Positives = 40/114 (35%), Gaps = 12/114 (10%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFT---GSFPPSLLSLHRLKT 156
T+ +++ L + LS L K L L N L + L+
Sbjct: 21 VATEAEKVE-LHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRI 74
Query: 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIFNVSGNN 209
L L N + + A L L + N+ S+ + + +L++ +S N
Sbjct: 75 LSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNK 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 16/103 (15%)
Query: 87 LQGLDLGGIFAPNSLTK------LDQLRVLGLQNNSLTGPIPDLSGLVN-LKSLFLDHNF 139
+ L L N++ K ++ LR+L L N + I +L + + L+ L++ +N
Sbjct: 50 CKHLALST----NNIEKISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQ 104
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLR 182
S + L L+ L +S N ++ E+ L L
Sbjct: 105 IA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDKLE 143
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/237 (21%), Positives = 80/237 (33%), Gaps = 63/237 (26%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQ------HMESVGGLRHP 442
+ +G G+ G + +V VK ++ + E + S LRHP
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRS---LRHP 76
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLI--HGSKSTRAKPLHWTSCLKIAEDVAQ-- 498
N+V + +I +Y G L+ I G + +ED A+
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---------------RFSEDEARFF 121
Query: 499 ------GLSYIHQAWRLVHGNLKSSNVLLGPDFEACL--ADYCLTALTADSLQDDDPDNL 550
G+SY H ++ H +LK N LL L D+ + + +
Sbjct: 122 FQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-------HSQ 173
Query: 551 L--------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599
Y APE +DV+S GV L +L G P F P E +
Sbjct: 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP----FEDPEEPRD 226
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 32/111 (28%), Positives = 38/111 (34%), Gaps = 17/111 (15%)
Query: 87 LQGLDLGGIFAPNSLT--------KLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLD 136
L L L N L L +L L L N L +P L +LK L L
Sbjct: 111 LAELRLDR----NQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLY 165
Query: 137 HNFFTGSFPPSLL-SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
+N P L LKTL L N L S +L L+L N
Sbjct: 166 NNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 6/100 (6%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRL 154
+ +L +LR+L L +N L +P L NL++L++ N + P + L L
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNL 111
Query: 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP 194
L L N L P+ S +L L L N S+P
Sbjct: 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL------- 551
GL YIH A ++H +LK SN+LL + + D+ L A AD D D L
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGL-ARVADP--DHDHTGFLTEYVATR 195
Query: 552 -YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE S T D++S G +L E+L+ +P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAP 555
GL YIH A ++H +LK N+ + D E + D+ L A + ++ Y+AP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGL----ARQADSEMTGYVVTRWYRAP 194
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKP 585
E + T D++S G ++ E++TGK
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 23/99 (23%), Positives = 46/99 (46%), Gaps = 13/99 (13%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY----CLTALTADSLQDDDPDNLL--- 551
+ +H + ++H +LK SN+L+ + + + D+ + AD+ + + +
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 552 -----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE S + + DV+S G +L EL +P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 39/243 (16%), Positives = 79/243 (32%), Gaps = 62/243 (25%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKR--LDASKLAGTSNEMYEQHMESVGGLRHPNLVP 446
+ LG GS G + +++ +K+ D + E+ + L H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKV-----LDHVNIIK 64
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLK----------IAEDV 496
L YF + P+ + + + + + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 497 AQ--------------------------GLSYIHQAWRLVHGNLKSSNVLLGPDFEAC-- 528
+ + +IH + H ++K N+L+ + +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLV--NSKDNTL 181
Query: 529 -LADYCLTALTADSLQDDDPD-----NLLYKAPETRNASHQATSKSDVYSFGVLLLELLT 582
L D+ A L +P + Y+APE + + T D++S G + EL+
Sbjct: 182 KLCDFGS----AKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 583 GKP 585
GKP
Sbjct: 238 GKP 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAP 555
GL YIH A ++H +LK SN+ + D E + D+ L A D+ + Y+AP
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGL----ARHTADEMTGYVATRWYRAP 198
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKP 585
E D++S G ++ ELLTG+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 17/98 (17%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDNLL---- 551
GL YIH A ++H +LK +N+ + + E + D+ L A D L
Sbjct: 132 GLKYIHSA-NVLHRDLKPANLFI--NTEDLVLKIGDFGL-ARIMDP--HYSHKGHLSEGL 185
Query: 552 ----YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y++P + + T D+++ G + E+LTGK
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAP 555
GL YIH A +VH +LK N+ + D E + D+ L A + ++ Y+AP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGL----ARHADAEMTGYVVTRWYRAP 192
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKP 585
E + D++S G ++ E+LTGK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 15/97 (15%)
Query: 498 QGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC---LADYCLTALTADSLQDDDPDN----- 549
+ L Y H ++H ++K NV++ D E L D+ L A+ N
Sbjct: 141 KALDYCHSM-GIMHRDVKPHNVMI--DHEHRKLRLIDWGL----AEFYHPGQEYNVRVAS 193
Query: 550 LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
+K PE D++S G +L ++ K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 2e-05
Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 11/92 (11%)
Query: 91 DLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDL----SGLVNLKSLFLDHNFFTGS--- 143
+F+ + L + LG+ + + ++ L L+++ + T
Sbjct: 241 VFRPLFSKDRFPNL---KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297
Query: 144 -FPPSLLSLHRLKTLDLSYNNLSGPLPKELAS 174
+ + LK +++ YN LS + KEL
Sbjct: 298 LLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 49/221 (22%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG---------- 438
E LG G+ T YK + + V +K + ++S G
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---------------KLDSEEGTPSTAIREIS 55
Query: 439 ----LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLI-HGSKSTRAKPLHWTSCLKIA 493
L+H N+V L + + L++++ N L + + + L
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 494 EDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDN--- 549
+ QGL++ H+ L H +LK N+L+ + L D+ L A P N
Sbjct: 115 WQLLQGLAFCHENKIL-HRDLKPQNLLINKRGQLKLGDFGLARAFG-------IPVNTFS 166
Query: 550 -----LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
L Y+AP+ S ++ D++S G +L E++TGKP
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 20/95 (21%), Positives = 41/95 (43%), Gaps = 17/95 (17%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL------- 551
G+ ++H A ++H +LK SN+++ D + D+ L + ++
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTR 190
Query: 552 -YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE D++S G ++ E++ G
Sbjct: 191 YYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 41/215 (19%)
Query: 390 ELLGKGSLGTTYKAVLDNRL---IVCVKRLDASKLAGTSNEMYEQHMESVG--------G 438
+G+GS G +K NR IV +K+ + ++ +
Sbjct: 9 GKIGEGSYGVVFKCR--NRDTGQIVAIKKF---LE-----SEDDPVIKKIALREIRMLKQ 58
Query: 439 LRHPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
L+HPNLV L F+ K L+++Y + ++ + + + I Q
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITWQTLQ 113
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN--------L 550
+++ H+ + H ++K N+L+ L D+ A L P +
Sbjct: 114 AVNFCHKHNCI-HRDVKPENILITKHSVIKLCDFGF----ARLLT--GPSDYYDDEVATR 166
Query: 551 LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y++PE Q DV++ G + ELL+G P
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLK 155
P L+ L ++ L NN ++ S + L +L L +N PP L L+
Sbjct: 47 PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLR 105
Query: 156 TLDLSYNNLS 165
L L N++S
Sbjct: 106 LLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 5/88 (5%)
Query: 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLKTLDLSYNNLSG 166
L L N T +LS +L + L +N + + ++ +L TL LSYN L
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 167 PLPKEL-ASQGRLYSLRLDVNRFNGSIP 193
+P L L L N + +P
Sbjct: 93 -IPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 24/110 (21%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD---------------YCLTALTADSLQ 543
+ Y+H L+H ++K SN+LL + +AD ++ ++
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 544 DDDPDNLL--------YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
DD +L Y+APE S + T D++S G +L E+L GKP
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 20/95 (21%), Positives = 41/95 (43%), Gaps = 17/95 (17%)
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL------- 551
G+ ++H A ++H +LK SN+++ D + D+ L + ++
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTR 227
Query: 552 -YKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Y+APE D++S G ++ E++ K
Sbjct: 228 YYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKI 261
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 25/82 (30%), Positives = 36/82 (43%), Gaps = 10/82 (12%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSF 144
L + G+F +L L L L+ N LTG I G +++ L L N
Sbjct: 41 LGRISSDGLF-----GRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK-EI 93
Query: 145 PPSLL-SLHRLKTLDLSYNNLS 165
+ LH+LKTL+L N +S
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQIS 115
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 37/213 (17%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG--------GLR 440
L+G+GS G K D IV +K+ ++ ++ + LR
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF---LE-----SDDDKMVKKIAMREIKLLKQLR 82
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
H NLV L + K+ L++++ + ++ + L + K + G+
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLFQIINGI 137
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN--------LLY 552
+ H + H ++K N+L+ L D+ A +L P Y
Sbjct: 138 GFCHSHNII-HRDIKPENILVSQSGVVKLCDFGF----ARTLA--APGEVYDDEVATRWY 190
Query: 553 KAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
+APE + DV++ G L+ E+ G+P
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 42/242 (17%), Positives = 68/242 (28%), Gaps = 71/242 (29%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH------- 441
+G G+ G +DN+ VK + K + L+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK------KYTRSAKIEADILKKIQNDDIN 94
Query: 442 -PNLVPLRAYFQAKE------ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAE 494
N+V F + E L SL+ +I H
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGP-------SLYEII---TRNNYNGFHIEDIKLYCI 144
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--- 551
++ + L+Y+ + L H +LK N+LL + +Q +
Sbjct: 145 EILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 552 ---------------------YKAPETRNASHQA-------TSKSDVYSFGVLLLELLTG 583
Y+APE SD++SFG +L EL TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPE--------VILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 584 KP 585
Sbjct: 256 SL 257
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 34/236 (14%), Positives = 63/236 (26%), Gaps = 44/236 (18%)
Query: 392 LGKGSLGTTYKAVLDNRLIVC-VKRLDASKLAGTSNEMYEQ-------------HMESVG 437
+G+G G ++ + D+ + + ++ L S++ + +
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 438 GLRHPNLVPLRAYFQAK----EERLLIYDY--QPNGSLFSLIHGSKST------------ 479
R + L + + L +D+ GS K
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 480 ------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533
R K + I + L+ + R H +L NVLL L
Sbjct: 148 IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY-- 205
Query: 534 LTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQH 589
T + P L + S V+ + +L TG Q
Sbjct: 206 ----TLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVK--RLDASK--LAGTS----NEMYEQHMESVGGLRH 441
E +G+G+ G YKA IV +K RLDA + T+ + + E L H
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE--------LHH 78
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
PN+V L ++ L++++ L ++ L + + +G++
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD----ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN--------LLYK 553
+ HQ L H +LK N+L+ D LAD+ L A + P L Y+
Sbjct: 134 HCHQHRIL-HRDLKPQNLLINSDGALKLADFGL----ARAFG--IPVRSYTHEVVTLWYR 186
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKP 585
AP+ S + ++ D++S G + E++TGKP
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 44/159 (27%), Positives = 62/159 (38%), Gaps = 46/159 (28%)
Query: 24 TSCS------ASRSASAVNSLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVIC 77
SCS S+ ++V + +P++AQ+L +L +Q L + +
Sbjct: 17 CSCSGTTVDCRSKRHASVPAGIPTNAQIL-----------YLHDNQITKLEPGVFDSL-- 63
Query: 78 YQQKVVRVVLQGLDLGGIFAPNSLT--------KLDQLRVLGLQNNSLTGPIPDLSG--- 126
+ L+ L LG N L L QL VL L N LT +P S
Sbjct: 64 -------INLKELYLGS----NQLGALPVGVFDSLTQLTVLDLGTNQLTV-LP--SAVFD 109
Query: 127 -LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNL 164
LV+LK LF+ N T P + L L L L N L
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 33/105 (31%), Positives = 45/105 (42%), Gaps = 15/105 (14%)
Query: 94 GIFAPNSLTKLDQLRVLGLQNNSLTG-P--IPDLSGLVNLKSLFLDHNFFTGSFPPSLL- 149
G+F + LT+L L L NN L P + D L L L+L N S P +
Sbjct: 77 GVF--DDLTELGTLG---LANNQLASLPLGVFD--HLTQLDKLYLGGNQLK-SLPSGVFD 128
Query: 150 SLHRLKTLDLSYNNLSGPLPKEL-ASQGRLYSLRLDVNRFNGSIP 193
L +LK L L+ N L +P L +L L N+ S+P
Sbjct: 129 RLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQ-SVP 171
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 53/223 (23%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH------- 441
L+GKGS G KA + V +K + K Q V L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK------AFLNQAQIEVRLLELMNKHDTE 113
Query: 442 --PNLVPLRAYFQAKE------ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIA 493
+V L+ +F + E L +L+ L+ ++T + + K A
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-------NLYDLL---RNTNFRGVSLNLTRKFA 163
Query: 494 EDVAQGLSYIHQA-WRLVHGNLKSSNVLLGP---------DF-EACLADYCLTALTADSL 542
+ + L ++ ++H +LK N+LL DF +C + +
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY----I 219
Query: 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585
Q + Y++PE D++S G +L+E+ TG+P
Sbjct: 220 Q-----SRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEP 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 664 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.91 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.74 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.74 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.73 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.73 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.72 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.72 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.72 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.71 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.71 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.7 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.69 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.69 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.68 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.66 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.65 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.65 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.64 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.64 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.63 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.63 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.63 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.62 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.62 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.62 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.62 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.61 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.61 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.6 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.6 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.59 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.58 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.58 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.58 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.58 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.57 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.57 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.54 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.53 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.52 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.51 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.5 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.5 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.48 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.47 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.47 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.33 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.3 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.29 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.27 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.27 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.27 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.03 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.03 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.89 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.57 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.46 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.43 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.38 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.19 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.15 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.15 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.61 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.98 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.72 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.61 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.31 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.63 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.91 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.7 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.64 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.61 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.33 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.28 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.15 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.04 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=449.62 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=206.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|++++ .||||+++.........+.|.+|+++|++++|||||+++|+|.+ +..+||||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 5789999999999998764 59999997655433456789999999999999999999999864 57899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----QD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~~ 544 (664)
|.++|+. ....++|.++..|+.|||+||+|||++ +||||||||+||||++++++||+|||+|+...... ..
T Consensus 118 L~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 118 LYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp HHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred HHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 9999974 235699999999999999999999998 99999999999999999999999999998754321 23
Q ss_pred CCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---CchhHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD---GAEDERLGMLL 619 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 619 (664)
...||+.|||||++.. ...++.|+|||||||+||||+||+.||.... ....+...+....... ..+...+..+.
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 271 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHTTCCCCCSTTSCTTSCHHHH
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCCCCcccccccchHHHH
Confidence 4579999999999853 3458999999999999999999999997642 2223333333322221 12344566799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
+++.+||+.+|++||||.||++.|+.++....
T Consensus 272 ~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 272 RLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 99999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=451.77 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=212.1
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|.+. +++.||||+++... .....+.|.+|+.++++++|||||+++|+|.+.+..+||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEE
Confidence 467999999999999873 46899999997543 23456889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 463 YQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
||++|+|.++|+.... .....++|.++++|+.|||+||+|||+. +||||||||+||||++++++||+|
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECC
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCCEEECC
Confidence 9999999999964321 1134699999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhcc
Q 006031 532 YCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606 (664)
Q Consensus 532 fGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 606 (664)
||+++...... .....||++|||||++. ...++.++|||||||+||||+| |+.||.+. ...++...+.....
T Consensus 189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~~i~~~~~ 265 (308)
T 4gt4_A 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEMIRNRQV 265 (308)
T ss_dssp SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHHHHHTTCC
T ss_pred cccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC
Confidence 99998654322 23356899999999987 6789999999999999999999 89999764 34566665554332
Q ss_pred CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
. +.++..+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 266 ~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 266 L-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred C-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2 234455667999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=452.28 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=207.9
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.++||+|+||+||+|++. +++.||||+++.... ...+.|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999864 478999999975432 345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 463 YQPNGSLFSLIHGSKS----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
||++|+|.++++.... ....+++|.+++.|+.|||+||+|||+. +||||||||+||||++++.+||+||
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEEccc
Confidence 9999999999975321 1235799999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC
Q 006031 533 CLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED 607 (664)
Q Consensus 533 Gla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 607 (664)
|+++...... .....||+.|||||++. ...++.++|||||||+||||+| |+.||... ...++...+......
T Consensus 203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~g~~~ 279 (329)
T 4aoj_A 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQGREL 279 (329)
T ss_dssp C----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHHHHHHTCCC
T ss_pred ccceeccCCCcceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC
Confidence 9998754332 12356899999999987 6789999999999999999999 99999763 344555555443322
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..+...+..+.+++.+||+.||++||||.||++.|+.+.+..
T Consensus 280 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 280 -ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 233345567999999999999999999999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=450.50 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=211.8
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|.+. ++..||||+++.... ...+.|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 468999999999999864 478899999975432 346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 463 YQPNGSLFSLIHGSK--------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
||++|+|.++|+... ......++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECCccc
Confidence 999999999997532 12345799999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCC
Q 006031 535 TALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDG 609 (664)
Q Consensus 535 a~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 609 (664)
|+....... ....||+.|||||++. ...++.|+|||||||++|||+| |+.||... ...++...+...... .
T Consensus 175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~~~~~-~ 250 (299)
T 4asz_A 175 SRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQGRVL-Q 250 (299)
T ss_dssp HHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHHTCCC-C
T ss_pred ceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC-C
Confidence 986544321 2234789999999997 6789999999999999999999 99999763 344555555443322 2
Q ss_pred chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 610 AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 610 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+...+..+.+++.+||+.||++||||+||++.|+++....
T Consensus 251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 251 RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 23345567999999999999999999999999999987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=428.57 Aligned_cols=243 Identities=21% Similarity=0.352 Sum_probs=201.6
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 464 (664)
++||+|+||+||+|... ++..||+|++..........+.|.+|++++++++|||||+++++|.+ ++..|||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 56999999999999964 58899999997665544456789999999999999999999999865 34579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeCC-CCCeEEeeccccccccCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLGP-DFEACLADYCLTALTADS 541 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~ 541 (664)
++|+|.++++. ...+++..+..|+.||+.||+|||++ + ||||||||+||||+. ++.+||+|||+|+.....
T Consensus 112 ~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 112 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999963 35699999999999999999999997 6 999999999999984 799999999999876665
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
......||+.|||||++. ..++.++|||||||++|||+||+.||.... ....+...+.....+...+...+..+.++
T Consensus 186 ~~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred ccCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-cHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 555678999999999885 468999999999999999999999997532 22344444433322222222334568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.||++|||+.|+++
T Consensus 263 i~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=437.18 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=210.5
Q ss_pred HhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC-CCcccceEEEecC-CceEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH-PNLVPLRAYFQAK-EERLL 459 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~-~~~~l 459 (664)
..+.||+|+||+||+|.+.+ ++.||||+++.... ....+.|.+|+++|.+++| ||||+++|+|.+. +..++
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 35789999999999998643 36899999975432 1235679999999999965 8999999999764 56899
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 460 IYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
|||||++|+|.++|+.... .....++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+|
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceeeCCCCCEE
Confidence 9999999999999975321 1235689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+|+....... ....||+.|||||++. ...++.++|||||||+||||+| |+.||.+... ...+...+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-~~~~~~~i~~ 303 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKE 303 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-HHHHHHHHHc
Confidence 999999987644321 2345789999999997 6789999999999999999998 9999976432 2344444443
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCC
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLME 653 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~ 653 (664)
.... ..++..+.++.+++.+||+.||++||||.||++.|+++.+...++
T Consensus 304 g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~q 352 (353)
T 4ase_A 304 GTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352 (353)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC--
T ss_pred CCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCC
Confidence 3222 223334566899999999999999999999999999987665543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=425.36 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=196.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC----ceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE----ERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~ 464 (664)
.+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+.+ ..+||||||
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 46899999999999998 578999999964321 2334456677778899999999999998754 579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-------WRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
++|+|.++++. ..++|..+.+|+.|+|+||+|||++ ++||||||||+|||||+++++||+|||+++.
T Consensus 84 ~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 84 EHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999963 3589999999999999999999974 3899999999999999999999999999987
Q ss_pred ccCCCC------CCCCCCCcccCccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCC----------C---
Q 006031 538 TADSLQ------DDDPDNLLYKAPETRNASH-----QATSKSDVYSFGVLLLELLTGKPPSQHSFL----------V--- 593 (664)
Q Consensus 538 ~~~~~~------~~~~~~~~y~aPE~~~~~~-----~~~~ksDVwSfGvvl~elltG~~P~~~~~~----------~--- 593 (664)
...... ....||+.|||||++.+.. .++.|+|||||||++|||+||++|+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644321 2346999999999986321 357799999999999999999887643211 1
Q ss_pred hhhHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 594 PNEMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 594 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
...+...+........ ...+.+..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1122222221111111 1235567789999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=427.06 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=201.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|+. .+|+.||||+++.... +.+|++++++++|||||++++++.+.+..|||||||++|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 45799999999999996 4589999999975433 246999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADSL---- 542 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~---- 542 (664)
+|.++++. ...+++..+..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+......
T Consensus 136 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 136 SLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999963 35699999999999999999999999 999999999999999987 69999999998764421
Q ss_pred ---CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 543 ---QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 543 ---~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....+||+.|||||++. +..++.++|||||||++|||+||+.||...... .-+.............+...+..+.
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp ----CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred eecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHcCCCCchhcCccCCHHHH
Confidence 12246999999999997 677899999999999999999999999764322 1222222221111112334456689
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+++.+||+.||++|||+.|+++.|.+....
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999998776443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=426.79 Aligned_cols=241 Identities=21% Similarity=0.309 Sum_probs=205.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|||||||++|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 367999999999999964 689999999975443 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.++++. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..... ....
T Consensus 157 ~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 157 ALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp EHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred cHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999963 3589999999999999999999999 9999999999999999999999999999876543 2345
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~ 624 (664)
..||+.|||||++. ...|+.++|||||||++|||++|+.||... ...++...+..... ........+..+.+++.+
T Consensus 230 ~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 230 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 68999999999986 677899999999999999999999999753 33344444433222 222334455678999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.||++|||+.|+++
T Consensus 307 ~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 307 LLVRDPAQRATAAELLK 323 (346)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=430.34 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=199.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|+. .+|+.||||++..........+.+.+|+++|++++|||||++++++.+++..||||||+++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 46899999999999996 46899999999766554445678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++.. ....+++.....|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+...... ...
T Consensus 109 ~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 184 (350)
T 4b9d_A 109 DLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184 (350)
T ss_dssp BHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHH
T ss_pred cHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccc
Confidence 999999642 335678999999999999999999999 99999999999999999999999999998765432 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|||||.+. +..++.++|||||||++|||+||+.||... ...++...+...... ..+...+..+.+++.+|
T Consensus 185 ~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 185 CIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred cCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHH
Confidence 46999999999987 677899999999999999999999999763 233333333222211 12233455689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.||++|||+.|+++
T Consensus 261 L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=404.40 Aligned_cols=242 Identities=21% Similarity=0.316 Sum_probs=189.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||+|+++..... ....+.+.+|++++++++|||||++++++.+.+..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46899999999999995 56899999999765432 234567999999999999999999999999999999999999 6
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|+|.+++.. ...+++.....++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+...... ...
T Consensus 97 g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 97 NELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp EEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 899999953 35699999999999999999999999 99999999999999999999999999998765432 334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|||||.+.+...++.++||||+||++|||+||+.||... ...++.+.+...... .+...+..+.+++.+|
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGVYT--LPKFLSPGAAGLIKRM 246 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC--CCTTSCHHHHHHHHHH
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 679999999999975445578999999999999999999999753 233333333322221 2233445688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.||++|||+.|+++
T Consensus 247 L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHHc
Confidence 9999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=427.33 Aligned_cols=241 Identities=21% Similarity=0.314 Sum_probs=204.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+.+..|||||||++|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG 233 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 233 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCC
Confidence 467999999999999964 689999999975543 34567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... ...
T Consensus 234 ~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 234 ALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp EHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred cHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99999953 3589999999999999999999999 99999999999999999999999999998765432 334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-CCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED-DGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~ 624 (664)
.+||+.|||||++. ...|+.++|||||||++|||++|+.||.+. ...++...+...... ..........+.+|+.+
T Consensus 307 ~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 307 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CEECTTTCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 67999999999987 677899999999999999999999999753 233444444333221 12233345568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.||++|||+.|+++
T Consensus 384 ~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 384 LLVRDPAQRATAAELLK 400 (423)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=413.07 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=204.2
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||+||+|+. .+++.||||++.+... .....+.+.+|+++|++++|||||++++++.+++..|+||||++
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 357899999999999995 5689999999975432 23456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--- 542 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 542 (664)
+|+|.+++.. ...+++.....|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 116 gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 116 NGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp TEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999953 35699999999999999999999999 99999999999999999999999999998764332
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....+||+.|||||++. +..++.++||||+||++|||+||+.||... ...++...+.... ...+.....++.++
T Consensus 190 ~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKLE--YDFPEKFFPKARDL 264 (311)
T ss_dssp CBCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTC--CCCCTTCCHHHHHH
T ss_pred cccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCcccCHHHHHH
Confidence 23457999999999997 677899999999999999999999999753 2334443333222 12233345568999
Q ss_pred HHHcccCCCCCCCCHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVL 640 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~ 640 (664)
+.+||+.||++|||+.|+.
T Consensus 265 i~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGT
T ss_pred HHHHccCCHhHCcChHHHc
Confidence 9999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=412.94 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=195.5
Q ss_pred HhccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||+||+|+.. .++.||+|+++...........+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 3578999999999999852 468899999976554334445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-- 541 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 541 (664)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 108 LRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp CTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 999999999963 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
......||+.|||||.+. ...++.++||||+||++|||+||+.||.+. ...++...+..... ..+...+..+.++
T Consensus 182 ~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~l 256 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKL--GMPQFLSPEAQSL 256 (304)
T ss_dssp CCCSCCCCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred cccccccCcccCCHHHhc-cCCCCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHHHcCCC--CCCCcCCHHHHHH
Confidence 233467999999999987 677899999999999999999999999763 23344443332222 2233345668999
Q ss_pred HHHcccCCCCCCCCH-----HHHHH
Q 006031 622 AIACNSASPEQRPTM-----WQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~-----~ev~~ 641 (664)
+.+||+.||++|||+ +|+++
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=398.46 Aligned_cols=241 Identities=20% Similarity=0.322 Sum_probs=184.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------------
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------------ 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------------ 455 (664)
.+.||+|+||+||+|+. .+++.||||+++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 46899999999999996 4688999999864432 123467899999999999999999999987654
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
..|+||||+++|+|.++++... .....++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCccc
Confidence 3689999999999999997432 223456777899999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC--------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH
Q 006031 536 ALTADSLQ--------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 536 ~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~ 601 (664)
+....... ....||+.|||||.+. +..++.++|||||||++|||++ ||.. ..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~----~~~~~~~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFST----QMERVRTL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSS----HHHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCC----ccHHHHHH
Confidence 87644221 1246999999999987 6779999999999999999997 6643 22222222
Q ss_pred HhhccCC--CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 602 RSAREDD--GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 602 ~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....... ...........+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111111 122333445778999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=398.90 Aligned_cols=244 Identities=18% Similarity=0.254 Sum_probs=196.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec------CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA------KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV~ 461 (664)
.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+..||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 46899999999999996 568999999997654433345678899999999999999999998753 35789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
|||+ |+|.+++. ....+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 139 E~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 139 DLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp ECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred eCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9995 68999995 345799999999999999999999999 9999999999999999999999999999865432
Q ss_pred ------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc-cCC------
Q 006031 542 ------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR-EDD------ 608 (664)
Q Consensus 542 ------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~------ 608 (664)
......||+.|||||++.+...++.++||||+||++|||++|++||.+.. ..+....+.... ...
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCGGGTC-
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCChHHhhh
Confidence 22345799999999998755678999999999999999999999997632 222222221111 100
Q ss_pred -----------------C-ch----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -----------------G-AE----DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -----------------~-~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .. ......+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00 112345789999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=385.28 Aligned_cols=240 Identities=19% Similarity=0.263 Sum_probs=191.2
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|+.+ .++.||+|++... .....+.+|+++++.+ +|||||++++++.+.+..|+||||
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 468999999999999853 4688999998643 2356788999999988 699999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSL 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~ 542 (664)
+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...+..
T Consensus 102 ~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 102 LEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999993 388999999999999999999999 99999999999999877 799999999997543221
Q ss_pred ------------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006031 543 ------------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL 592 (664)
Q Consensus 543 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~ 592 (664)
.....||+.|||||++.+...++.++||||+||++|||+||+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 12246999999999987556789999999999999999999999965432
Q ss_pred ChhhHHHHHHhh----------------------------------ccCC-----------------CchhHHHHHHHHH
Q 006031 593 VPNEMMNWVRSA----------------------------------REDD-----------------GAEDERLGMLLEV 621 (664)
Q Consensus 593 ~~~~~~~~~~~~----------------------------------~~~~-----------------~~~~~~~~~l~~l 621 (664)
....+....... .... ......+.++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 211211111100 0000 0011123457899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+|++.||++|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=403.79 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=200.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHH---HHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMY---EQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~---~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|+||+||+|+.. +|+.||+|++++.... ....... +.++.+++.++|||||++++++.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 468999999999999964 6899999999754321 1223333 3446778889999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
++||+|.++|.. ...+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.......
T Consensus 274 ~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 274 MNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp CCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC
T ss_pred CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCCCCC
Confidence 999999999953 35699999999999999999999999 999999999999999999999999999998777666
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-hhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-PNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
...+||+.|||||++..+..|+.++||||+||++|||++|++||...... ..++...+... ....+......+.+++
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLL 425 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHHHHHHH
Confidence 66789999999999864557899999999999999999999999753222 12233222222 1222334456689999
Q ss_pred HHcccCCCCCCCC-----HHHHHH
Q 006031 623 IACNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt-----~~ev~~ 641 (664)
.+||+.||++|++ +.||.+
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHccCCHhHCCCCCCCCHHHHhc
Confidence 9999999999998 677754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=369.11 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=203.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|.. ++..||||++..........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 46899999999999987 57789999997655433445678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
|.++++... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 121 L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 197 (309)
T 3p86_A 121 LYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197 (309)
T ss_dssp HHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred HHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence 999996421 123489999999999999999999998 8 9999999999999999999999999998654432 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...||+.|+|||.+. ...++.++|||||||++|||+||+.||... ...+....+.........+...+..+.+++.+
T Consensus 198 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 274 (309)
T 3p86_A 198 SAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274 (309)
T ss_dssp ----CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 356899999999987 567899999999999999999999999753 23344444433333333334445668999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
||+.+|++|||+.|+++.|+.+.......+
T Consensus 275 ~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 275 CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987654433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=401.06 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=203.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+|+.||+|.+..... ...+.+.+|+++|+.++|||||++++++.+.+..|+|||||++|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 56899999999999996 4689999999865433 34567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC--CCeEEeeccccccccCCC-CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD--FEACLADYCLTALTADSL-QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~--~~~ki~DfGla~~~~~~~-~~ 544 (664)
+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++...... ..
T Consensus 240 ~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 240 ELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp BHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred cHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999952 335699999999999999999999999 99999999999999854 899999999998765432 23
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~ 622 (664)
...||+.|||||++. +..++.++||||+||++|||++|+.||.+. ...+....+....... .........+.+|+
T Consensus 315 ~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 315 VTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 457999999999997 677899999999999999999999999763 2334444333322211 12233455688999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||+.|+++
T Consensus 392 ~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.40 Aligned_cols=256 Identities=30% Similarity=0.481 Sum_probs=212.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 467999999999999988899999999865432 456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----QD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~~ 544 (664)
|.+++.... .....++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 122 L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 122 LKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp TGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 999996432 2334699999999999999999999998 99999999999999999999999999997644322 12
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHHHHHhhccC------------CCch
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMNWVRSARED------------DGAE 611 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~------------~~~~ 611 (664)
...|++.|+|||.+. ...++.++|||||||++|||+||+.||....... .....|....... ....
T Consensus 200 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278 (321)
T ss_dssp CCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSC
T ss_pred ccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccC
Confidence 234789999999986 5678999999999999999999999997643322 2344443221111 1134
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+.+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 56778899999999999999999999999999988653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.57 Aligned_cols=249 Identities=22% Similarity=0.399 Sum_probs=205.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 478999999999999964 588999998854322 34678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 93 ~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 93 TLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp BHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999974 235699999999999999999999999 9999999999999999999999999999865433211
Q ss_pred -------------CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh----hHHHHHHhhccC
Q 006031 545 -------------DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN----EMMNWVRSARED 607 (664)
Q Consensus 545 -------------~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~----~~~~~~~~~~~~ 607 (664)
...||+.|+|||.+. ...++.++||||||+++|||++|..|+........ ...........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP- 245 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC-
T ss_pred cccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC-
Confidence 345899999999987 67789999999999999999999999875432211 22222222111
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.+|++|||+.|+++.|++++...
T Consensus 246 ----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 246 ----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 122234889999999999999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.94 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=209.9
Q ss_pred hccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|... ++..||||+++.... ....+.+.+|+++++++ +||||++++++|.+.+..++
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 568999999999999852 456899999975422 22346789999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 460 IYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
||||+++|+|.++++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCCCCEE
Confidence 9999999999999975321 1234689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+++...... .....+++.|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+..
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~~~~~~~~~~ 320 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKE 320 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHT
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhc
Confidence 99999998654432 12234678899999987 6778999999999999999999 99999764 23344444433
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
.... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 321 ~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 321 GHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp TCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 3222 2223345568999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.00 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=209.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 468999999999999998899999999975433 46789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~~ 545 (664)
|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 92 L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 92 LSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9999963 334689999999999999999999999 99999999999999999999999999998654432 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..+++.|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+....... .+...+..+.+++.+
T Consensus 167 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 167 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY-KPRLASTHVYQIMNH 242 (269)
T ss_dssp TTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHH
T ss_pred cccccccCCHHHhc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCccCC-CCCcCCHHHHHHHHH
Confidence 45677899999986 5678999999999999999999 99998753 2333333333322221 122234568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
||+.+|++|||+.|+++.|+++.+.
T Consensus 243 ~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=361.25 Aligned_cols=271 Identities=31% Similarity=0.542 Sum_probs=218.8
Q ss_pred ccccCHHHHHHHH-----hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEE
Q 006031 376 AQLYTLDQLMRAS-----AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAY 450 (664)
Q Consensus 376 ~~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~ 450 (664)
...+++.++.... .+.||+|+||.||+|...+++.||||++...... .....+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456666665543 4689999999999999888999999999764432 223368999999999999999999999
Q ss_pred EecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCCCeEeCCCCCeE
Q 006031 451 FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW--RLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 451 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~ivHrDlk~~NILl~~~~~~k 528 (664)
+.+.+..++||||+++|+|.++++... .....++|..+..|+.|++.||+|||+.. +|+||||||+|||+++++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999997543 23456999999999999999999999863 899999999999999999999
Q ss_pred EeeccccccccCCC---CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---CCChhhHHHHHH
Q 006031 529 LADYCLTALTADSL---QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHS---FLVPNEMMNWVR 602 (664)
Q Consensus 529 i~DfGla~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~---~~~~~~~~~~~~ 602 (664)
|+|||+++...... .....||+.|+|||.+. ...++.++|||||||++|||+||+.||+.. ........+|+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999998764332 22345899999999986 566899999999999999999999999631 112234555554
Q ss_pred hhccCC------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 603 SAREDD------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 603 ~~~~~~------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
...... ....+....+.+++.+||+.+|++|||+.||++.|++..-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 433322 23456678899999999999999999999999999875433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=376.07 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=207.7
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... +++.||||.++.... ....+.|.+|++++++++||||++++++|...+..++||||+++
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 3578999999999999976 688999999874321 12235688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD- 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~- 545 (664)
|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 197 g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 197 GDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp CBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999999963 234689999999999999999999999 99999999999999999999999999998654432211
Q ss_pred ---CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 546 ---DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 546 ---~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
..++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.++
T Consensus 272 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 347 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGGRL-PCPELCPDAVFRL 347 (377)
T ss_dssp SSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred CCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 22466799999986 5678999999999999999999 99998753 233444444433222 2223345568999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+.+||+.+|++|||+.++++.|++++..
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.31 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=206.0
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... .+..||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 478999999999999974 456799999975322 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++|+|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 133 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 133 ENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999963 235699999999999999999999999 999999999999999999999999999987654321
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....+|+.|+|||.+. ...++.++|||||||++|||++ |+.||... ...++...+...... ..+...+..+
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l 283 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGYRL-PAPMGCPHAL 283 (325)
T ss_dssp CEECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred eeeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCCC-CCCCCcCHHH
Confidence 1234577899999986 5678999999999999999999 99999753 233444433332221 1223345568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+++.+||+.+|++|||+.||++.|+++....
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999987554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=378.77 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=210.7
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+++|+
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 46899999999999999989999999997543 35788999999999999999999999986 667899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~~ 545 (664)
|.++++.. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 269 L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 269 LLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 99999632 123588999999999999999999999 99999999999999999999999999998764421 122
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+++.+
T Consensus 345 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 345 AKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYRM-PRPENCPEELYNIMMR 420 (454)
T ss_dssp SSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred CcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 34677899999986 5678999999999999999999 99999753 233444444333222 1233445668999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhccccCC
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVLME 653 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~ 653 (664)
||+.+|++||||.+|++.|+++......+
T Consensus 421 cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred HccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 99999999999999999999997765443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.71 Aligned_cols=242 Identities=19% Similarity=0.338 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 46799999999999984 6788999999865443 45678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 103 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp BHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 99999963 3589999999999999999999999 99999999999999999999999999988665432 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|+|||.+. ...++.++|||||||++|||+||+.||..... .................+......+.+++.+|
T Consensus 176 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred ccCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 56899999999987 66789999999999999999999999975321 11222222222222233444556689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.||++|||+.|+++
T Consensus 254 l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred ccCChhHCcCHHHHhh
Confidence 9999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.52 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=202.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46899999999999996 67899999999765543344567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-CCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-LQDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~ 546 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||++...... .....
T Consensus 100 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 100 EVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp BHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 99999953 24589999999999999999999999 9999999999999999999999999999765433 22345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|+|||.+.+....+.++|||||||++|||+||+.||... ...++...+...... .+......+.+++.+||
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--NLKELRERVLRGKYR--IPFYMSTDCENLLKRFL 249 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHC
T ss_pred cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHC
Confidence 78999999999874444468999999999999999999999763 233333333322221 12223455889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 006031 627 SASPEQRPTMWQVLKM 642 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~ 642 (664)
+.||++|||+.|+++.
T Consensus 250 ~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.15 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=202.5
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 47999999999999976 689999999875433 456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~ 546 (664)
|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 129 L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 129 LTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp HHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 9999852 3589999999999999999999999 99999999999999999999999999998765432 2345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHHHHc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVAIAC 625 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~C 625 (664)
.||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...+....+....... ......+..+.+++.+|
T Consensus 202 ~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 202 VGTPYWMAPEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 6899999999986 667899999999999999999999999753 2333333333322221 22233455689999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.||++|||+.|+++.
T Consensus 279 l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 279 LVRDPQERATAQELLDH 295 (321)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=349.30 Aligned_cols=250 Identities=27% Similarity=0.477 Sum_probs=204.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcH-----HHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSN-----EMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~-----~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|.. .+++.||+|++.......... +.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 46899999999999996 578899999986544322222 67899999999999999999999986554 79999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeCCCCC-----eEEeecccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLGPDFE-----ACLADYCLT 535 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~~~~~-----~ki~DfGla 535 (664)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +||+|||++
T Consensus 102 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 102 FVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp CCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred ecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 9999999998863 345799999999999999999999998 8 999999999999988776 999999999
Q ss_pred ccccCCCCCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 536 ALTADSLQDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 536 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
+...... ....+++.|+|||.+.. ...++.++|||||||++|||++|+.||.......................+...
T Consensus 177 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 4f0f_A 177 QQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255 (287)
T ss_dssp BCCSSCE-ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTS
T ss_pred ccccccc-cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCccc
Confidence 8654432 23568999999998842 345688999999999999999999999765433333344433333333333445
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 56799999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=360.67 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=200.7
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC----ceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE----ERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~ 464 (664)
.++||+|+||+||+|... ++.||||++.... .....+++|+.++++++||||+++++++.... ..++||||+
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 468999999999999876 6899999996433 23456677899999999999999999998754 369999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW---------RLVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------~ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
++|+|.++++. ..++|..+..|+.|++.||+|||+.. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 105 EKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999963 34899999999999999999999752 8999999999999999999999999999
Q ss_pred ccccCCCC----CCCCCCCcccCccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------------
Q 006031 536 ALTADSLQ----DDDPDNLLYKAPETRNAS----HQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-------------- 593 (664)
Q Consensus 536 ~~~~~~~~----~~~~~~~~y~aPE~~~~~----~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-------------- 593 (664)
+....... ....+|+.|+|||.+.+. ..++.++|||||||++|||+||+.||......
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 76544322 234689999999998642 34566889999999999999999999754221
Q ss_pred hhhHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 594 PNEMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 594 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..++...+........ .....+..+.+++.+||+.||++|||+.||++.|+++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112222211111111 1234566799999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.04 Aligned_cols=251 Identities=20% Similarity=0.379 Sum_probs=197.4
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... ++..||||+++.... ....+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 478999999999999865 577899999975421 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++|+|.++++. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 129 ~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 129 ENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp TTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999973 235699999999999999999999999 999999999999999999999999999987654321
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....++..|+|||++. ...++.++|||||||++|||++ |+.||... ...++...+....... .+...+..+
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~~~~~~-~~~~~~~~l 279 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGYRLP-PPMDCPAAL 279 (373)
T ss_dssp ----------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHTTEECC-CCTTCBHHH
T ss_pred ceeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCC-CCccccHHH
Confidence 1123467899999987 6778999999999999999998 99999753 2334444443332221 222344568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+++.+||+.+|++||+|.||++.|+++...
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.32 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=203.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +..||+|+++.........+.+.+|++++++++||||+++++++.+. +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 468999999999999985 78899999976554334457799999999999999999999999877 778999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
|+|.++++.. ....+++..+..|+.|++.||+|||+. + |+||||||+||+++.++.++++|||++..... .
T Consensus 94 ~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---~ 166 (271)
T 3kmu_A 94 GSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---P 166 (271)
T ss_dssp CBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---T
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc---c
Confidence 9999999742 233689999999999999999999998 7 99999999999999999999999988754322 2
Q ss_pred CCCCCCcccCccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASH--QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~--~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
...+|+.|+|||.+.+.. .++.++||||||+++|||+||+.||... ...+....+.........+...+..+.+++
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKVALEGLRPTIPPGISPHVSKLM 244 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--CHHHHHHHHHHSCCCCCCCTTCCHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 346789999999986322 2334899999999999999999999753 222222222222222222334456689999
Q ss_pred HHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 623 IACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.+||+.+|++|||+.|+++.|+++.+
T Consensus 245 ~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 245 KICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=349.96 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=206.8
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|+++.... ..+.+.+|++++.+++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 467999999999999999999999999975443 46779999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 90 L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 90 LLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9999963 234689999999999999999999999 999999999999999999999999999986654322 22
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...+....+...... ..+...+..+.+++.+
T Consensus 165 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 165 TKFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--TNSEVVLKVSQGHRL-YRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHH
T ss_pred CCcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCcccc--ChHHHHHHHHcCCCC-CCCCcChHHHHHHHHH
Confidence 34567899999986 5668899999999999999999 99998753 222322222222111 1122234568899999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
||+.+|++|||+.|+++.|+.+++..
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 99999999999999999999997653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=348.58 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +..||||++...... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 468999999999999975 789999998654322 23357899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---cccCCCCCCCeEeCC--------CCCeEEeecccc
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR---LVHGNLKSSNVLLGP--------DFEACLADYCLT 535 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~---ivHrDlk~~NILl~~--------~~~~ki~DfGla 535 (664)
++|.+++. ...+++..+..++.|++.||+|||+. + |+||||||+||+++. ++.+||+|||++
T Consensus 91 ~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 91 GPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999994 24689999999999999999999998 7 899999999999986 778999999999
Q ss_pred ccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHH
Q 006031 536 ALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 536 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
............+++.|+|||.+. ...++.++||||||+++|||+||+.||... ........+.........+...+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp ------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccccccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHhhhcCCCCCCCCcccC
Confidence 876655544567899999999987 567899999999999999999999999753 22222222222222222233445
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
..+.+++.+||+.+|++|||+.|+++.|++|
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 6689999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.32 Aligned_cols=249 Identities=19% Similarity=0.330 Sum_probs=205.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|...++..||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 468999999999999999999999999975443 46789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~~ 545 (664)
|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 106 L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 106 LLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9999963 234699999999999999999999999 99999999999999999999999999998654432 123
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...+....+....... .+......+.+++.+
T Consensus 181 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 181 SKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRLY-RPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHH
T ss_pred CccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccc--ChhHHHHHHhcccCCC-CCCcCCHHHHHHHHH
Confidence 44677899999987 5678999999999999999999 99998753 2233333333222111 122234568899999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
||+.+|++|||+.|+++.|+++.+.
T Consensus 257 ~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 257 CWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.29 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=204.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC-ceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE-ERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+++|++++||||+++++++.+.+ ..++||||+++|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 468999999999999986 6799999997543 4567999999999999999999999987665 789999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 273 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~ 347 (450)
T 1k9a_A 273 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGK 347 (450)
T ss_dssp BHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------C
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-cCCC
Confidence 999999742 223479999999999999999999999 99999999999999999999999999998654332 2235
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
++..|+|||.+. ...++.++|||||||++|||+| |+.||.... ..++...+...... ..+...+..+.+++.+||
T Consensus 348 ~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl 423 (450)
T 1k9a_A 348 LPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKM-DAPDGCPPAVYDVMKNCW 423 (450)
T ss_dssp CCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC--TTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHT
T ss_pred CCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHc
Confidence 678999999987 6778999999999999999999 999997642 23444444332221 223344567899999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcc
Q 006031 627 SASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+.+|++|||+.|+++.|+++...
T Consensus 424 ~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 424 HLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=375.39 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=208.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 46899999999999999988899999997543 346789999999999999999999999876 77899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.++++.. ....+++..+..|+.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 265 L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 265 LLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 99999531 224589999999999999999999999 999999999999999999999999999987654322 12
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+++.+
T Consensus 341 ~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 341 AKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRM-PCPPECPESLHDLMCQ 416 (452)
T ss_dssp --CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHH
T ss_pred CcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 34678899999987 5678999999999999999999 99999753 233444444332221 1233445668999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhccccCCCCCCC
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVLMEDGELD 658 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~~~~ 658 (664)
||+.+|++|||+.++++.|+++......++.+.+
T Consensus 417 cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~ 450 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450 (452)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HccCChhhCcCHHHHHHHHHHHhccCCccccccc
Confidence 9999999999999999999999877655554443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.35 Aligned_cols=267 Identities=28% Similarity=0.482 Sum_probs=215.1
Q ss_pred ccccCHHHHHHHHh-----------ccccccCceeEEEEEEcCCeEEEEEEccCccc--cCCcHHHHHHHHHHHcCCCCC
Q 006031 376 AQLYTLDQLMRASA-----------ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKL--AGTSNEMYEQHMESVGGLRHP 442 (664)
Q Consensus 376 ~~~~~~~~l~~~~~-----------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~H~ 442 (664)
...|+++++..++. +.||+|+||.||+|.. ++..||+|++..... .....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34677788777653 5799999999999987 577899999865432 123457899999999999999
Q ss_pred CcccceEEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC
Q 006031 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG 522 (664)
Q Consensus 443 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~ 522 (664)
||+++++++.+.+..++||||+++|+|.+++... .....++|..+..|+.|++.||+|||+. +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999999632 1235699999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hh
Q 006031 523 PDFEACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NE 596 (664)
Q Consensus 523 ~~~~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~ 596 (664)
+++.+||+|||+++...... .....+++.|+|||.+. +.++.++||||||+++|||++|+.||....... ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999998654422 22346899999999875 357899999999999999999999997643221 12
Q ss_pred HHHHHHhhc---------cCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 597 MMNWVRSAR---------EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 597 ~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
+........ .........+..+.+++.+||+.+|++|||+.||++.|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222111110 0112345567789999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.55 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=197.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 468999999999999998899999999976554444457889999999999999999999999999999999999985 8
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~ 546 (664)
|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 105 l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 179 (311)
T 3niz_A 105 LKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179 (311)
T ss_dssp HHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CC
T ss_pred HHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCC
Confidence 8888863 334689999999999999999999999 99999999999999999999999999998764332 2335
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-----------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG----------------- 609 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----------------- 609 (664)
.+|+.|+|||.+.+...++.++|||||||++|||++|+.||...... ..+............
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 68999999999875567899999999999999999999999764322 222222221111100
Q ss_pred ----------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 ----------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 ----------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.......++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00112346889999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=352.93 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=199.5
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 461 (664)
.+.||+|+||+||+|.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 92 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 92 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEE
Confidence 46899999999999985 3688999999875432 3346789999999999999999999998653 5689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 93 EYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp ECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999999642 34589999999999999999999999 9999999999999999999999999999876443
Q ss_pred C-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----------Chh----hHHHHHH
Q 006031 542 L-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL----------VPN----EMMNWVR 602 (664)
Q Consensus 542 ~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~----------~~~----~~~~~~~ 602 (664)
. .....++..|+|||.+. ...++.++||||||+++|||+||..|+..... ... .+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp --------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 2 12234677899999987 56789999999999999999999999864210 000 1111111
Q ss_pred hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 603 SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 603 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
... ....+...+..+.+++.+||+.+|++|||+.|++++|+++++..
T Consensus 247 ~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111 11123344566999999999999999999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.82 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=193.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHc--CCCCCCcccceEEEecC----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVG--GLRHPNLVPLRAYFQAK----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~g~~~~~----~~~~lV~e 462 (664)
.+.||+|+||+||+|.. +++.||||++... ....+.+|.+++. .++||||+++++++... +..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 46899999999999988 6889999998643 3344555555554 48999999999987543 45899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH--------QAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
|+++|+|.++++. ..+++..+..|+.|++.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 87 YHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp CCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred hccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999942 36999999999999999999999 77 999999999999999999999999999
Q ss_pred cccccCCCC------CCCCCCCcccCccccccCC-----CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 006031 535 TALTADSLQ------DDDPDNLLYKAPETRNASH-----QATSKSDVYSFGVLLLELLTG----------KPPSQHSFLV 593 (664)
Q Consensus 535 a~~~~~~~~------~~~~~~~~y~aPE~~~~~~-----~~~~ksDVwSfGvvl~elltG----------~~P~~~~~~~ 593 (664)
++....... ....||+.|+|||.+.... .++.++|||||||++|||+|| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 976544321 2346899999999987432 334789999999999999999 8888654332
Q ss_pred hh---hHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 594 PN---EMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 594 ~~---~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
.. .+...+........ .....+..+.+++.+||+.||++|||+.||++.|++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22 22222211111111 2345677899999999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.00 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=209.8
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|+++|++++||||++++++|.+.+..++||||+++|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 4689999999999999865 8899999997543 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~ 544 (664)
+|.++++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 302 ~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 302 NLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp BHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 999999742 235689999999999999999999999 999999999999999999999999999987654321 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+++.
T Consensus 378 ~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 453 (495)
T 1opk_A 378 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM-ERPEGCPEKVYELMR 453 (495)
T ss_dssp TCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred CCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence 234567899999986 5678999999999999999999 99999764 233444444333222 123334566899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+||+.+|++||||.||++.|+.+...
T Consensus 454 ~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 454 ACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.00 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=211.3
Q ss_pred hccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|... .+..||||+++.... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 478999999999999852 346799999975422 22346788999999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 460 IYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
||||+++|+|.+++..... .....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCCCcEE
Confidence 9999999999999975331 1134699999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+++...... .....+++.|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+..
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~--~~~~~~~~~~~ 308 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKE 308 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHT
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHc
Confidence 99999998664432 22344678899999987 6778999999999999999999 99998753 23344444443
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCC
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLME 653 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~ 653 (664)
..... .+......+.+++.+||+.+|++|||+.||++.|+++......+
T Consensus 309 ~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 309 GHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp TCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 32222 22234456899999999999999999999999999997666433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.61 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=197.8
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 467999999999999998899999999976554444457788999999999999999999999999999999999975 9
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~~ 546 (664)
|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 86 l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 86 LKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp HHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred HHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 9999863 235689999999999999999999999 99999999999999999999999999998654322 2234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------------ 608 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 608 (664)
.+|+.|+|||.+.+...++.++|||||||++|||+||+.||..... ...+...........
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 6799999999987556689999999999999999999999976421 122222222111100
Q ss_pred --------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001123456889999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.75 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEc-CCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|... ++. .||+|.+.... .....+.+.+|++++++++||||++++++|.+. ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 468999999999999954 333 46888876433 234567899999999999999999999999875 47899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 98 MPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred cCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999974 235699999999999999999999999 999999999999999999999999999987644322
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....+|..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+....... .+......+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLP-QPPICTIDV 248 (327)
T ss_dssp -------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCC-CCTTBCHHH
T ss_pred cccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHHHHcCCCCC-CCccCCHHH
Confidence 1234678999999987 6778999999999999999999 99999764 2334444444333222 223344568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.+++.+||+.+|++||++.|+++.|+++..
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=355.11 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=202.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|... +|+.||+|.++...... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 468999999999999965 58899999997654322 2457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----CeEEeecccccccc
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALTA 539 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~~ 539 (664)
+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||+++...
T Consensus 97 ~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 97 VSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp CCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999994 345799999999999999999999999 999999999999998877 79999999998765
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHH
Q 006031 540 DSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLG 616 (664)
Q Consensus 540 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 616 (664)
... .....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...+....+.......+ .......
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCCccccCCCCccEECchHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCchhccCCCH
Confidence 432 23456899999999986 567899999999999999999999999753 22333333322222111 1122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+.+++.+||..||++|||+.|+++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 6899999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=341.26 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=208.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 467999999999999998899999999976443 45789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~~ 545 (664)
|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 90 L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 90 LSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 99999642 34689999999999999999999999 99999999999999999999999999998654321 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++||||||+++|||++ |+.||... ...+....+....... .+...+..+.+++.+
T Consensus 165 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 165 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY-KPRLASTHVYQIMNH 240 (267)
T ss_dssp TTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHH
T ss_pred ccccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCcCC-CCccCcHHHHHHHHH
Confidence 45678899999986 5678999999999999999999 89998753 2333333333222211 122234568899999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
||+.+|++|||+.|+++.|+++.+.
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=380.60 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=208.0
Q ss_pred cccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|.+. ++..||||+++... .....+.|.+|+++|++++|||||+++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999864 56789999997643 23456889999999999999999999999976 6799999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.++++. ....+++..+..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 421 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 421 PLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp BHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999963 345699999999999999999999999 999999999999999999999999999987643221
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....+++.|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.++
T Consensus 496 ~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 571 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRM-ECPPECPPELYAL 571 (613)
T ss_dssp ------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CSHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 1223467899999987 6788999999999999999998 99999764 233454444433222 2233445669999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhhhccccCCCCCC
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGEL 657 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~~~ 657 (664)
+.+||+.+|++||+|.+|++.|+.+......+....
T Consensus 572 i~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 999999999999999999999999876654444333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.06 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=207.3
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... +++.||+|.++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 467999999999999975 348999999975432 2235679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 463 YQPNGSLFSLIHGSKST-------------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
|+++|+|.++++..... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~ 209 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE 209 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECG
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEECC
Confidence 99999999999753211 125799999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHH
Q 006031 524 DFEACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMM 598 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~ 598 (664)
++.+||+|||+++...... .....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...++.
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~ 286 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHEEVI 286 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHH
T ss_pred CCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCC--ChHHHH
Confidence 9999999999997653321 12345788999999887 5678999999999999999999 99998753 233444
Q ss_pred HHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 599 NWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
..+...... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.+...
T Consensus 287 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 287 YYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 433332221 1223344568999999999999999999999999999876553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.75 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=203.2
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999964 588999999976554333456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeeccccccccCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCLTALTADSL- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~~~~~~- 542 (664)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.......
T Consensus 113 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 113 GELFEDIV-----AREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999995 335689999999999999999999999 999999999999998654 59999999998765433
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLE 620 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 620 (664)
.....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+....... ......+..+.+
T Consensus 187 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CCCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 23457899999999987 567899999999999999999999999753 2233333333322221 122334566899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
++.+||+.||++|||+.|+++.
T Consensus 264 li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=348.69 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=198.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|... ++.||+|++... ...+.|.+|++++++++||||+++++++. +..++||||+++|+
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 468999999999999975 678999998643 34678999999999999999999999886 45899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCCCCCeEeCCCCC-eEEeeccccccccCCCCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ---AWRLVHGNLKSSNVLLGPDFE-ACLADYCLTALTADSLQD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~---~~~ivHrDlk~~NILl~~~~~-~ki~DfGla~~~~~~~~~ 544 (664)
|.++++... ....+++..++.++.|+++||+|||+ . +|+||||||+||+++.++. +||+|||++....... .
T Consensus 86 L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-~ 161 (307)
T 2eva_A 86 LYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-T 161 (307)
T ss_dssp HHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred HHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEccccccccccccc-c
Confidence 999997432 22357889999999999999999999 5 8999999999999998887 7999999997654332 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++||||||+++|||+||+.||.........+....... .........+..+.+++.+
T Consensus 162 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 239 (307)
T 2eva_A 162 NNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPLIKNLPKPIESLMTR 239 (307)
T ss_dssp ---CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCCBTTCCHHHHHHHHH
T ss_pred cCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCcccccCHHHHHHHHH
Confidence 346899999999987 56789999999999999999999999976433322322222222 1222223344568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhccccC
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVLM 652 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~~ 652 (664)
||+.+|++|||+.|+++.|+.+......
T Consensus 240 ~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 240 CWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 9999999999999999999999876643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.34 Aligned_cols=255 Identities=18% Similarity=0.309 Sum_probs=202.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .++..||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 46899999999999995 468899999986443221 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 96 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 96 PTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp CBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 999999953 34689999999999999999999999 999999999999999999999999999986644321
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|+|||.+. ...++.++||||||+++|||+||+.||...... .............. ......+..+.++
T Consensus 170 ~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-SIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -----CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-HHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred CccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 2345899999999987 567899999999999999999999999763211 11111111111100 0112334668999
Q ss_pred HHHcccCCCCCCC-CHHHHHHHHHhhhcccc
Q 006031 622 AIACNSASPEQRP-TMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 622 ~~~Cl~~~P~~RP-t~~ev~~~L~~i~~~~~ 651 (664)
+.+||+.+|++|| ++.++.+.|+.+.....
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 9999999999999 99999999998865543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.00 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=195.6
Q ss_pred HhccccccCceeEEEEEEcCC----eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCce------
Q 006031 388 SAELLGKGSLGTTYKAVLDNR----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEER------ 457 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~------ 457 (664)
..+.||+|+||.||+|..... ..||||.++.........+.+.+|++++++++||||+++++++...+..
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 357899999999999986543 2799999976544444567899999999999999999999999877655
Q ss_pred EEEEecCCCCCHHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKS-TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
++||||+++|+|.+++..... .....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Dfg~a~ 185 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSR 185 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeeccccc
Confidence 999999999999999964221 1223689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 537 LTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 537 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
....... ....+++.|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~ 261 (323)
T 3qup_A 186 KIYSGDYYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--ENAEIYNYLIGGNRL-KQP 261 (323)
T ss_dssp ---------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCC-CCC
T ss_pred cccccccccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCCCCCcccc--ChHHHHHHHhcCCCC-CCC
Confidence 6544321 1234677899999987 5678999999999999999999 99998764 233443333322221 122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
...+..+.+++.+||+.||++|||+.|+++.|+++........
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 3344568999999999999999999999999999976654333
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.07 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=201.9
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
..+.||+|+||.||+|... ++..||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 3578999999999999965 58899999987543321 246789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----CeEEeeccccccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALT 538 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~ 538 (664)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 95 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 95 LVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp CCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999994 345699999999999999999999999 999999999999999887 7999999999876
Q ss_pred cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHH
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERL 615 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 615 (664)
... ......+|+.|+|||.+. ...++.++|||||||++|||++|+.||... ...+....+........ .....+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCCccccccCCcCcCCceeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHHhcCCCcCccccccCC
Confidence 433 223456899999999986 567899999999999999999999999753 22233322222221111 112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 56889999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.08 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=206.8
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|.+. ++..||||++..... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 468999999999999853 467899999964322 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSKS--TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~ 537 (664)
|+++|+|.++++.... .....+++..++.|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence 9999999999975321 2234689999999999999999999999 999999999999999555 599999999975
Q ss_pred ccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
..... .....+|+.|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+....... .+.
T Consensus 234 ~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~~~~~~~-~~~ 309 (367)
T 3l9p_A 234 IYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGRMD-PPK 309 (367)
T ss_dssp HHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCCC-CCT
T ss_pred cccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCC-CCc
Confidence 43221 12234688999999987 5678999999999999999998 99999763 3344444444333221 223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..+..+.+++.+||+.+|++|||+.||++.|+.+....
T Consensus 310 ~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 310 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 34456899999999999999999999999999886544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.82 Aligned_cols=246 Identities=21% Similarity=0.258 Sum_probs=200.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 468999999999999965 788999999865433 123467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----LQ 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 543 (664)
+|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 91 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 91 ELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp EGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999995 335699999999999999999999998 9999999999999999999999999999765322 12
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||.+......+.++|||||||++|||++|+.||............+....... .........+.+++.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLALLH 243 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-TTGGGSCHHHHHHHH
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-CccccCCHHHHHHHH
Confidence 3456899999999987444457899999999999999999999986543334444444332222 222334556889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~ 642 (664)
+||+.||++|||+.|+++.
T Consensus 244 ~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 244 KILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHccCChhhCcCHHHHhhC
Confidence 9999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.99 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=205.0
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCc-eEEE
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEE-RLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~-~~lV 460 (664)
.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|++++.++ +||||++++++|.+.+. .++|
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 46899999999999974 3468999999975432 12346799999999999 79999999999987654 8999
Q ss_pred EecCCCCCHHHHhccCCCC-------------------------------------------------------------
Q 006031 461 YDYQPNGSLFSLIHGSKST------------------------------------------------------------- 479 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 479 (664)
|||+++|+|.++++.....
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 9999999999999754321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----CCCCCCCcccCc
Q 006031 480 RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ----DDDPDNLLYKAP 555 (664)
Q Consensus 480 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aP 555 (664)
....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....+|+.|+||
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence 012389999999999999999999999 999999999999999999999999999986543321 223467889999
Q ss_pred cccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCC
Q 006031 556 ETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRP 634 (664)
Q Consensus 556 E~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 634 (664)
|.+. ...++.++|||||||++|||+| |+.||...... ..+...+...... ..+......+.+++.+||+.+|++||
T Consensus 265 E~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rp 341 (359)
T 3vhe_A 265 ETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRP 341 (359)
T ss_dssp HHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9987 6778999999999999999999 99999764322 2333333322221 12233445689999999999999999
Q ss_pred CHHHHHHHHHhhhccc
Q 006031 635 TMWQVLKMLQEIKGAV 650 (664)
Q Consensus 635 t~~ev~~~L~~i~~~~ 650 (664)
|+.|+++.|+++....
T Consensus 342 s~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 342 TFSELVEHLGNLLQAN 357 (359)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHh
Confidence 9999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.56 Aligned_cols=251 Identities=22% Similarity=0.401 Sum_probs=195.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|...+ .||+|+++.........+.+.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 4689999999999998654 599999976554334457899999999999999999999965 4567899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----LQD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~~ 544 (664)
|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 106 L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (289)
T 3og7_A 106 LYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180 (289)
T ss_dssp HHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceecccccccccccccc
Confidence 9999963 345699999999999999999999999 9999999999999999999999999999765432 112
Q ss_pred CCCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC---chhHHHHHHH
Q 006031 545 DDPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG---AEDERLGMLL 619 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 619 (664)
...+++.|+|||.+. ....++.++||||||+++|||++|+.||.... ....+...+........ .....+..+.
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (289)
T 3og7_A 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259 (289)
T ss_dssp ---CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCCCTTSSCTTSCHHHH
T ss_pred ccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCcchhhccccCCHHHH
Confidence 345899999999875 24567889999999999999999999997642 23344444433322221 2234456799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
+++.+||+.+|++|||+.|++++|+++..
T Consensus 260 ~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 260 RLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=352.86 Aligned_cols=242 Identities=18% Similarity=0.242 Sum_probs=200.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||+|+++.... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999965 688999999975432 234567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 544 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 90 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 90 GELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp CBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 999999953 34689999999999999999999999 999999999999999999999999999986432 2233
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+.... ...+......+.+++.+
T Consensus 164 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred ccccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCC--CHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 456899999999987 567899999999999999999999999753 2233333322211 11223344568999999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 006031 625 CNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RP-----t~~ev~~ 641 (664)
||+.+|++|| ++.|+++
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhhcCHHHhcCCCCCCHHHHHc
Confidence 9999999999 8999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=347.37 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC------------------------CcHHHHHHHHHHHcCCCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG------------------------TSNEMYEQHMESVGGLRHPN 443 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~------------------------~~~~~~~~e~~~l~~l~H~n 443 (664)
.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46899999999999986 468899999986543211 12356889999999999999
Q ss_pred cccceEEEec--CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe
Q 006031 444 LVPLRAYFQA--KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL 521 (664)
Q Consensus 444 iv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl 521 (664)
|+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLV 170 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEE
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEE
Confidence 9999999986 567899999999999987652 34699999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccccccccCCC--CCCCCCCCcccCccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhH
Q 006031 522 GPDFEACLADYCLTALTADSL--QDDDPDNLLYKAPETRNASHQ--ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEM 597 (664)
Q Consensus 522 ~~~~~~ki~DfGla~~~~~~~--~~~~~~~~~y~aPE~~~~~~~--~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~ 597 (664)
+.++.+||+|||+++...... .....+|+.|+|||.+..... ++.++|||||||++|||++|+.||... ....+
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~ 248 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE--RIMCL 248 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc--cHHHH
Confidence 999999999999998765432 234568999999999864332 478899999999999999999999753 22223
Q ss_pred HHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 598 MNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 22222222221112233456899999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=367.08 Aligned_cols=244 Identities=23% Similarity=0.268 Sum_probs=201.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 47899999999999985 56899999999766544345577899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC---CCCCeEEeeccccccccCCCC-
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG---PDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~~~- 543 (664)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++.......
T Consensus 96 ~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 96 ELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp BHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 99999963 35699999999999999999999999 999999999999998 568899999999987654322
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLE 620 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 620 (664)
....||+.|+|||.+. ...++.++||||+||++|||++|+.||... ...++...+........ .....+..+.+
T Consensus 170 ~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred eecccCCcccCCHHHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 3456899999999986 567899999999999999999999999753 23344333333222211 12234566899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.||++|||+.|+++
T Consensus 247 li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=378.16 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=212.4
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 356899999999999999988899999997543 346789999999999999999999999876 7789999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~ 544 (664)
+|.++++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 347 sL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 347 SLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp EHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred cHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 999999531 224589999999999999999999999 99999999999999999999999999998764321 12
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+++.
T Consensus 423 ~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 423 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRM-PCPPECPESLHDLMC 498 (535)
T ss_dssp STTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred CCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence 334678899999987 5678999999999999999999 99999753 233444444332221 122334556899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhhhccccCCCCC
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEIKGAVLMEDGE 656 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~~~ 656 (664)
+||+.+|++|||+.+|++.|+++......++.+
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~ 531 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred HHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence 999999999999999999999997766554443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=345.07 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999964 588999999976655445567889999999999999999999999999999999999976
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 86 ~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 86 DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 66666542 235699999999999999999999999 99999999999999999999999999998764332 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG---------------- 609 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---------------- 609 (664)
..+|..|+|||.+.+...++.++|||||||++|||+||..|+.........+............
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 5689999999998755558999999999999999999888865433222223222222111110
Q ss_pred ----------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 ----------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 ----------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 01123456889999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.35 Aligned_cols=252 Identities=13% Similarity=0.167 Sum_probs=204.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++.++++ +|+|++++++++.+....++||||+ +
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 46799999999999995 678999999986433 234578889999998 7999999999999999999999999 9
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC-----eEEeeccccccccCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE-----ACLADYCLTALTADS 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~-----~ki~DfGla~~~~~~ 541 (664)
++|.++++.. ...+++..+..|+.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.....
T Consensus 90 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 90 PSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999999642 34599999999999999999999999 9999999999999988776 999999999876543
Q ss_pred CC---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-hhhHHHHHHhhccCCC--
Q 006031 542 LQ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-PNEMMNWVRSAREDDG-- 609 (664)
Q Consensus 542 ~~---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~-- 609 (664)
.. ....||+.|+|||.+. ...++.++|||||||++|||++|+.||...... .......+........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 21 2345899999999987 567899999999999999999999999864322 2222222221111111
Q ss_pred -chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 610 -AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 610 -~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
.....+..+.+++.+||+.+|++||++.+|++.|+++.....
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111234568999999999999999999999999999976653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=358.85 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=197.6
Q ss_pred hccccccCceeEEEEEEc--C--CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD--N--RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--~--~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|... + +..||+|.++.... ....+.|.+|+.++++++||||++++++|.+ .+..++||||
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 468999999999999863 2 24689999864322 2345789999999999999999999998754 4578999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 173 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 173 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999963 335688999999999999999999999 999999999999999999999999999986543221
Q ss_pred ------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 544 ------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 544 ------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
....+++.|+|||.+. ...++.++|||||||++|||+| |.+||.... ..++...+...... ..+...+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~~~~~-~~p~~~~~ 323 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRL-LQPEYCPD 323 (373)
T ss_dssp ----------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHTTCCC-CCCTTCCH
T ss_pred ccccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHcCCCC-CCCCCCCH
Confidence 1234677899999987 6778999999999999999999 677776532 22333333322221 12233445
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
.+.+++.+||+.+|++|||+.|+++.|+++......+.
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 68999999999999999999999999999987775443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=351.65 Aligned_cols=250 Identities=13% Similarity=0.135 Sum_probs=203.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 46899999999999995 6789999999865432 34588999999999 9999999999999999999999999 9
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC-----eEEeeccccccccCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE-----ACLADYCLTALTADS 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~-----~ki~DfGla~~~~~~ 541 (664)
++|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 ~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 89 PSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9999999642 35799999999999999999999999 9999999999999999887 999999999865433
Q ss_pred CC---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHHHHHhhccCCCc-
Q 006031 542 LQ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMNWVRSAREDDGA- 610 (664)
Q Consensus 542 ~~---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~- 610 (664)
.. ....||+.|+|||.+. ...++.++|||||||++|||++|+.||....... .+....+.........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 21 2456899999999987 5778999999999999999999999998643221 1222222111111110
Q ss_pred --hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 611 --EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 611 --~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
....+ .+.+++..||+.+|++||++.+|++.|+++....
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11123 6999999999999999999999999999886654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.29 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEEcC-C-------eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEE
Q 006031 389 AELLGKGSLGTTYKAVLDN-R-------LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV 460 (664)
.+.||+|+||+||+|.... + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILV 90 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEE
Confidence 4679999999999998543 2 5799999865432 4567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--------eEEeec
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE--------ACLADY 532 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~--------~ki~Df 532 (664)
|||+++|+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 91 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999964 234489999999999999999999999 9999999999999998887 999999
Q ss_pred cccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 533 CLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 533 Gla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
|++....... ...++..|+|||.+.....++.++|||||||++|||++|..|+.... ............... +.
T Consensus 166 g~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~~~~~~~~~~~~~---~~ 239 (289)
T 4fvq_A 166 GISITVLPKD--ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRKLQFYEDRHQL---PA 239 (289)
T ss_dssp CSCTTTSCHH--HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC---CC
T ss_pred cccccccCcc--ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chHHHHHHhhccCCC---CC
Confidence 9986543321 12367889999998744678999999999999999999655443322 222222222221111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 12334889999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.93 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=207.9
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 47899999999999985 3458899999975322 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 463 YQPNGSLFSLIHGSKST-------------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE 185 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEET
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchheEEEcC
Confidence 99999999999753221 123589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHH
Q 006031 524 DFEACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMM 598 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~ 598 (664)
++.+||+|||+++...... .....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ....+.
T Consensus 186 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~ 262 (314)
T 2ivs_A 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLF 262 (314)
T ss_dssp TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 9999999999998654332 12345678899999886 5678999999999999999999 99999764 233444
Q ss_pred HHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 599 NWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..+...... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 263 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 263 NLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 444333222 12233455689999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.35 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=205.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--ceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--ERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~ 465 (664)
.++||+|+||+||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 468999999999999975 488999999975443 234677889999999999999999999988655 7799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe----CCCCCeEEeeccccccccCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLTALTADS 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~~~~~~ 541 (664)
+|+|.+++.... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 93 ~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 93 CGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp TCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 999999997432 223499999999999999999999999 99999999999999 88888999999999876544
Q ss_pred CC-CCCCCCCcccCcccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhH-HHHHHhhccC---
Q 006031 542 LQ-DDDPDNLLYKAPETRNA-------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEM-MNWVRSARED--- 607 (664)
Q Consensus 542 ~~-~~~~~~~~y~aPE~~~~-------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~-~~~~~~~~~~--- 607 (664)
.. ....+|..|+|||.+.. ...++.++|||||||++|||+||+.||....... .++ ..........
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (319)
T 4euu_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (319)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCE
T ss_pred CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccch
Confidence 32 34568999999998742 3568899999999999999999999997533221 122 2222211110
Q ss_pred -------------------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 608 -------------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 608 -------------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
..........+.+++.+||+.||++|||+.|+++...+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0123566777999999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=359.42 Aligned_cols=255 Identities=17% Similarity=0.200 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEcC------CeEEEEEEccCccccC---------CcHHHHHHHHHHHcCCCCCCcccceEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAG---------TSNEMYEQHMESVGGLRHPNLVPLRAYFQA 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 453 (664)
.+.||+|+||.||+|.... ++.||||++....... .....+.+|+..++.++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4689999999999999765 4789999986543110 011223456667888999999999999876
Q ss_pred C----CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC--CCCCe
Q 006031 454 K----EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG--PDFEA 527 (664)
Q Consensus 454 ~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~--~~~~~ 527 (664)
. ...++||||+ +++|.+++.. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.+
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTTCE
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCCeE
Confidence 4 4589999999 9999999964 235699999999999999999999999 999999999999999 88999
Q ss_pred EEeeccccccccCCCC---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHH
Q 006031 528 CLADYCLTALTADSLQ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM 598 (664)
Q Consensus 528 ki~DfGla~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~ 598 (664)
||+|||+++....... ....||+.|+|||.+. ...++.++|||||||++|||+||+.||......... .
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~-~ 271 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY-V 271 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-H
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH-H
Confidence 9999999976543211 2234899999999987 567899999999999999999999999854333221 1
Q ss_pred HHHHhhccCC-C-c------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 599 NWVRSAREDD-G-A------EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 599 ~~~~~~~~~~-~-~------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
.......... . . ....+..+.+++..||+.+|++||++.+|++.|+++.....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1111111100 0 0 01224568999999999999999999999999999876553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.27 Aligned_cols=240 Identities=20% Similarity=0.202 Sum_probs=188.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||+|... +++.||||++............+..|+..+.++ +||||++++++|.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 468999999999999976 789999999865433222334455555555444 8999999999999999999999999 6
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
++|.+++... ...++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 141 ~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 141 PSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp CBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 7999988642 34699999999999999999999999 999999999999999999999999999987654332 33
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|+|||++. +.++.++|||||||++|||++|..|+... ...... ................+.+++.+|
T Consensus 216 ~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 216 QEGDPRYMAPELLQ--GSYGTAADVFSLGLTILEVACNMELPHGG----EGWQQL-RQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp CCCCGGGCCGGGGG--TCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHH-TTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred cCCCccccCHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHH-hccCCCcccccCCCHHHHHHHHHH
Confidence 46899999999886 36899999999999999999997765431 121111 111111111223346689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.+|++|||+.|+++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 289 LEPDPKLRATAEALLA 304 (311)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=354.46 Aligned_cols=248 Identities=18% Similarity=0.261 Sum_probs=200.6
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCcccc---CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA---GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||+||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 457899999999999986 46899999998643321 23467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~~~ 540 (664)
+++|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 108 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 185 (351)
T 3c0i_A 108 MDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185 (351)
T ss_dssp CSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence 99999998885321 1234589999999999999999999999 9999999999999987655 99999999987654
Q ss_pred CC--CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc--hhHHHH
Q 006031 541 SL--QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA--EDERLG 616 (664)
Q Consensus 541 ~~--~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 616 (664)
.. .....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ..++...+......... ....+.
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 186 SGLVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp TSCBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCeeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHcCCCCCCccccccCCH
Confidence 32 23456899999999987 567899999999999999999999999752 23333322222211111 122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 6899999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=382.17 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=204.6
Q ss_pred ccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||.||+|.+. .++.||||+++.........+.+.+|+++|++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 4678999999765544455688999999999999999999999996 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.++++. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999963 34689999999999999999999999 999999999999999999999999999987644321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
....+++.|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+
T Consensus 528 ~~~~~~~t~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~l~~ 603 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERM-GCPAGCPREMYD 603 (635)
T ss_dssp -------CGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccCCCCceeeeChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 1234578899999986 6778999999999999999999 99999763 233444444433222 223344566999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
++.+||+.||++||++.+|++.|+++...
T Consensus 604 li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.12 Aligned_cols=243 Identities=19% Similarity=0.290 Sum_probs=193.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc-----------
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE----------- 456 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----------- 456 (664)
.+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||++++++|.+.+.
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 468999999999999976 78999999997543 23456789999999999999999999999865432
Q ss_pred ----------------------------------------------eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHH
Q 006031 457 ----------------------------------------------RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCL 490 (664)
Q Consensus 457 ----------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~ 490 (664)
.++||||+++|+|.+++.... .....++..+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHH
Confidence 799999999999999997532 23456777899
Q ss_pred HHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--------------CCCCCCCCcccCcc
Q 006031 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--------------QDDDPDNLLYKAPE 556 (664)
Q Consensus 491 ~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--------------~~~~~~~~~y~aPE 556 (664)
.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....||+.|+|||
T Consensus 168 ~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 9999999999999999 99999999999999999999999999998765432 12345899999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCH
Q 006031 557 TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTM 636 (664)
Q Consensus 557 ~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 636 (664)
.+. ...++.++|||||||++|||++|..|+.. ........... ............+.+++.+||+.||++|||+
T Consensus 247 ~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 247 QIH-GNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp HHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred Hhc-CCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 987 56789999999999999999998776421 11222211111 1111223445567899999999999999999
Q ss_pred HHHHH
Q 006031 637 WQVLK 641 (664)
Q Consensus 637 ~ev~~ 641 (664)
.|+++
T Consensus 321 ~~~l~ 325 (332)
T 3qd2_B 321 TDIIE 325 (332)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 99986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=343.56 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=194.5
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence 5789999999999998643 56799999865322 123567899999999999999999999984 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 98 TLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp TTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 99999999963 234689999999999999999999999 999999999999999999999999999987654321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
....+++.|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+...... ..+...+..+.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 248 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL-PMPPNCPPTLYS 248 (281)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ccccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcC--CHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 2234677899999986 5678999999999999999997 99999764 233444433322211 122334556899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.06 Aligned_cols=242 Identities=18% Similarity=0.245 Sum_probs=199.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... ++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 467999999999999965 58899999986432 24567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC--CCCeEEeeccccccccCCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP--DFEACLADYCLTALTADSLQ-D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~~-~ 544 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 87 ~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 87 DIFERINT----SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp BHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999953 234689999999999999999999999 9999999999999987 78999999999987644321 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~ 622 (664)
...+++.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+........ .....+..+.+++
T Consensus 162 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCC--CHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 345789999999986 556789999999999999999999999763 22333333322222211 1123345689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||+.|+++
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=358.71 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=197.3
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 5799999999999986 4688999999975433 345789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe--CCCCCeEEeeccccccccCCC-CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL--GPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl--~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...... ...
T Consensus 173 L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 173 LFDRIID----ESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp EHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999863 234689999999999999999999999 99999999999999 677899999999998765432 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhH-HHHHHhhccCC-CchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEM-MNWVRSAREDD-GAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~l~~ 623 (664)
..||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+. ........... .........+.+++.
T Consensus 248 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 248 NFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCSSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred ccCCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 56899999999986 667899999999999999999999999753 22222 22222211111 112234566899999
Q ss_pred HcccCCCCCCCCHHHHHH--HHHhh
Q 006031 624 ACNSASPEQRPTMWQVLK--MLQEI 646 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~--~L~~i 646 (664)
+||+.+|++|||+.|+++ .+++.
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999987 44443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.50 Aligned_cols=260 Identities=19% Similarity=0.282 Sum_probs=200.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 46899999999999996 57899999999754322 12356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--D 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~ 544 (664)
|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 117 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 194 (310)
T 2wqm_A 117 GDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194 (310)
T ss_dssp CBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred CCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcccc
Confidence 99999985321 1235689999999999999999999999 999999999999999999999999999876544321 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++||||||+++|||++|+.||.........+...+.............+..+.+++.+
T Consensus 195 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 273 (310)
T 2wqm_A 195 SLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273 (310)
T ss_dssp ----CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHH
T ss_pred ccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHH
Confidence 345789999999987 5678999999999999999999999997643333344443333222222223345568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
||+.||++|||+.||++.|++++....
T Consensus 274 ~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 274 CINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=351.47 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=200.0
Q ss_pred hccccccCceeEEEEEEc-CCeE----EEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLI----VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|... ++.. ||+|.+..... ....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 468999999999999964 3443 78887754322 233456778999999999999999999986 5678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 96 LPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp CTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999963 235789999999999999999999999 999999999999999999999999999987644322
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....++..|+|||.+. ...++.++|||||||++|||+| |+.||.... ..++...+....... .+......+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKGERLA-QPQICTIDV 246 (325)
T ss_dssp CCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTTCBCC-CCTTBCTTT
T ss_pred cccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHHHcCCCCC-CCCcCcHHH
Confidence 2345678999999987 5678999999999999999999 999997642 234444443332221 122233458
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999998543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.56 Aligned_cols=244 Identities=21% Similarity=0.367 Sum_probs=200.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.. .++..||+|.+..........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 35799999999999986 457889999997655544456789999999999999999999999865 3458999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeC-CCCCeEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLG-PDFEACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~~ 540 (664)
+++|+|.+++.. ...+++..+..|+.|++.||+|||+. + |+||||||+||+++ +++.+||+|||++.....
T Consensus 111 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 111 MTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred cCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999953 35689999999999999999999998 7 99999999999997 789999999999987665
Q ss_pred CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 541 ~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
.......+++.|+|||.+. ..++.++||||||+++|||++|+.||.... ........+.............+..+.+
T Consensus 185 ~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred cccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCCccccCCCCCHHHHH
Confidence 5544567899999999875 458999999999999999999999997532 2223333333322222222233356899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++|||+.|+++
T Consensus 262 li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 262 IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhh
Confidence 999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.35 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=206.1
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCce-EEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEER-LLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~ 463 (664)
.++||+|+||+||+|...+ +..||+|.+..... ....+.+.+|++++++++||||+++++++.+.+.. ++|+||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 4789999999999998533 33799999865322 12346789999999999999999999999876665 999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-- 541 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 541 (664)
+.+|+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 105 ~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999963 345689999999999999999999999 9999999999999999999999999999755332
Q ss_pred ----CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 542 ----LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 542 ----~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
......++..|+|||.+. ...++.++||||||+++|||+||..|+... ....++...+....... .+...+..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRH-IDPFDLTHFLAQGRRLP-QPEYCPDS 256 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCGGGHHHHHHTTCCCC-CCTTCCHH
T ss_pred cccccCcCCCCCccccChhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCcc-CCHHHHHHHhhcCCCCC-CCccchHH
Confidence 122345688999999987 667899999999999999999965554332 23344444444333222 22233456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
+.+++.+||+.+|++|||+.|++++|+++......+.
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 8999999999999999999999999999988765443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.30 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=207.4
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 57899999999999985 3578999999975432 12357799999999999 9999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 462 DYQPNGSLFSLIHGSKS-------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
||+++|+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~k 185 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITK 185 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCCCCEE
Confidence 99999999999975321 1123589999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+++....... ....+++.|+|||.+. ...++.++||||||+++|||+| |+.||...... ......+..
T Consensus 186 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~ 263 (313)
T 1t46_A 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKE 263 (313)
T ss_dssp ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHH
T ss_pred EccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHHHHhcc
Confidence 999999987654322 1233567899999886 5678999999999999999999 99999764322 233333332
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..... .+...+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 264 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 264 GFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 22221 2223445689999999999999999999999999988654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.56 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=201.5
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe-cCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ-AKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|...+ ...||+|.+..... ....+.+.+|++++++++||||++++++|. ..+..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 4689999999999998643 34689998865322 123467899999999999999999999865 45678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL- 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 542 (664)
+++|+|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 109 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 109 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999963 345689999999999999999999999 99999999999999999999999999998654322
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
.....+++.|+|||.+. ...++.++||||||+++|||++ |.+||.... ..+............ .+...+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~ 259 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL-QPEYCPD 259 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC--TTTHHHHHHTTCCCC-CCTTCCH
T ss_pred hccccccCCCCCccccChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhcCCCCC-CCccCCH
Confidence 12234677899999986 5678999999999999999999 555665432 223333332222221 1222345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCC
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLME 653 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~ 653 (664)
.+.+++.+||+.+|++|||+.|+++.|+++......+
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 6899999999999999999999999999998766543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.73 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=200.4
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 461 (664)
.+.||+|+||.||+|.+ .+++.||+|++..... ....+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 46899999999999984 4689999999975432 34567899999999999999999999999876 6689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 105 EFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp ECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999953 234589999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----------CChhhHHHHHHhhcc
Q 006031 542 L-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSF----------LVPNEMMNWVRSARE 606 (664)
Q Consensus 542 ~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~----------~~~~~~~~~~~~~~~ 606 (664)
. .....+|..|+|||.+. ...++.++||||||+++|||+||+.|+.... ...............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 2 22345788899999886 5677899999999999999999999864321 001111111111111
Q ss_pred --CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 607 --DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 607 --~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11122334456899999999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.57 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=197.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999995 67899999998654321 1223578899999999999999999999999999999999997
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 138 g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~ 210 (348)
T 1u5q_A 138 GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSF 210 (348)
T ss_dssp EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCC
T ss_pred CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--Ccc
Confidence 688888853 235689999999999999999999999 9999999999999999999999999999876543 335
Q ss_pred CCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 547 ~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
.||+.|+|||.+.. ...++.++|||||||++|||+||+.||..... ...+...... ..........+..+.+++.+
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN-ESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHS-CCCCCCCTTSCHHHHHHHHH
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 78999999998742 45689999999999999999999999875321 1122222221 11111222334568899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
||+.+|++|||+.|+++.
T Consensus 289 ~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HTCSSGGGSCCHHHHTTC
T ss_pred HcccChhhCcCHHHHhhC
Confidence 999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.88 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=204.0
Q ss_pred HhccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
..+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 357899999999999996 2467899999975432 23456789999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC
Q 006031 461 YDYQPNGSLFSLIHGSKST------------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG 522 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~ 522 (664)
|||+++|+|.+++...... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVT 206 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEEc
Confidence 9999999999999753211 113489999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhH
Q 006031 523 PDFEACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEM 597 (664)
Q Consensus 523 ~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~ 597 (664)
.++.+||+|||++........ ....+++.|+|||.+. ...++.++|||||||++|||+| |+.||..... ...+
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~ 284 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANF 284 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHH
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-HHHH
Confidence 999999999999986543321 1233577899999886 5678999999999999999998 9999976432 2233
Q ss_pred HHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 598 MNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
...+...... ..+...+..+.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 285 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 285 YKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3333332222 1222334568999999999999999999999999999876554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.48 Aligned_cols=245 Identities=19% Similarity=0.243 Sum_probs=187.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 468999999999999965 688999999965432 3467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--eEEeeccccccccCC-CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE--ACLADYCLTALTADS-LQD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~~~~~-~~~ 544 (664)
+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..... ...
T Consensus 102 ~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 102 ELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999953 34699999999999999999999999 9999999999999987766 999999999753322 223
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
...||+.|+|||.+.+....+.++|||||||++|||++|+.||........ .....+................+.+++
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 456899999999987433334459999999999999999999976432211 222222211111111112345688999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+||+.+|++|||+.|+++.
T Consensus 256 ~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHHhC
Confidence 99999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.38 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=200.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcc-ccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASK-LAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+.... ......+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 478999999999999965 57899999986543 2234567889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-CCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS-LQDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~ 545 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 100 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 100 GDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp EEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCCceec
Confidence 999999963 35699999999999999999999999 9999999999999999999999999999876443 2345
Q ss_pred CCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-hhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-PNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
..||+.|+|||++.. ...++.++|||||||++|||++|+.||...... ..++......... ..+......+.+++
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~~~li 251 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQEMVSLL 251 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred cCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcCCHHHHHHH
Confidence 679999999999863 234788999999999999999999999754322 2233333222221 22233445689999
Q ss_pred HHcccCCCCCCCC-HHHHHH
Q 006031 623 IACNSASPEQRPT-MWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt-~~ev~~ 641 (664)
.+||+.+|++||+ +.++.+
T Consensus 252 ~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 252 KKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHSCSSGGGSCCSHHHHHT
T ss_pred HHHhcCCHhHhcccHHHHHc
Confidence 9999999999998 666654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.55 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=202.0
Q ss_pred cccccCceeEEEEEE---cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.||+|+||.||+|.. ..++.||||+++.........+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 3468899999976544333467899999999999999999999999 567889999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 543 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (291)
T 1xbb_A 103 PLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176 (291)
T ss_dssp EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence 99999963 34589999999999999999999999 999999999999999999999999999986644321
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....++..|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+...... ..+...+..+.++
T Consensus 177 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 252 (291)
T 1xbb_A 177 QTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERM-GCPAGCPREMYDL 252 (291)
T ss_dssp ----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred cccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 1234568899999986 5667899999999999999999 99999763 233444444333222 2223345568999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+||+.+|++||++.|+++.|+++-...
T Consensus 253 i~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.18 Aligned_cols=252 Identities=21% Similarity=0.390 Sum_probs=201.0
Q ss_pred hccccccCceeEEEEEEcC-----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.... +..||+|.++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 4689999999999998643 34699999875432 22345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 128 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 128 MENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp CTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999963 235689999999999999999999999 999999999999999999999999999987644321
Q ss_pred -----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 544 -----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 544 -----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
....++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+....... .+...+..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~~~~-~~~~~~~~ 278 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLP-TPMDCPSA 278 (333)
T ss_dssp --------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC-CCTTCBHH
T ss_pred cccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHCCCcCC-CcccCCHH
Confidence 1234577899999986 6778999999999999999999 99999753 2334444443322211 22234456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 899999999999999999999999999986554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.80 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=206.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 46899999999999999989999999986543 35678999999999999999999999986 456899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ..
T Consensus 94 L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 94 LVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 99999531 123689999999999999999999999 999999999999999999999999999987654321 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+...... ..+...+..+.+++.+
T Consensus 170 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 170 AKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYRM-VRPDNCPEELYQLMRL 245 (279)
T ss_dssp CCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHH
T ss_pred CCCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHHhcccCC-CCcccccHHHHHHHHH
Confidence 34677899999986 5678899999999999999999 99998753 233333333322211 1222344568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
||+.+|++|||+.++++.|+++.....
T Consensus 246 ~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 246 CWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.13 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=198.5
Q ss_pred HhccccccCceeEEEEEEc----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc-----eE
Q 006031 388 SAELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE-----RL 458 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-----~~ 458 (664)
..+.||+|+||.||+|... .+..||+|.++.........+.+.+|++++++++||||+++++++.+.+. .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 3568999999999999864 35589999997654433345678999999999999999999999987553 49
Q ss_pred EEEecCCCCCHHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKS-TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
+||||+++|+|.+++..... .....+++..++.|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~ 196 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKK 196 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCSCC--
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999999999853221 2345699999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
..... .....+++.|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+...... ..+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~ 272 (313)
T 3brb_A 197 IYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--QNHEMYDYLLHGHRL-KQPE 272 (313)
T ss_dssp --------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC-CCBT
T ss_pred cccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHHcCCCC-CCCc
Confidence 54322 12234678899999986 6778999999999999999999 88998754 233444433332222 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..+..+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 34456899999999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.39 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=190.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .+++.||+|+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 46799999999999985 4688999999875442 2344678899999999999999999999999999999999998 5
Q ss_pred CHHHHhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 468 SLFSLIHGSK-STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 468 sL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
+|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCC
Confidence 9999886321 12234689999999999999999999999 99999999999999999999999999998764332 23
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-HhhccCC---------------
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV-RSAREDD--------------- 608 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~--------------- 608 (664)
...+|+.|+|||.+.+...++.++|||||||++|||+||+.||.... ..+....+ .......
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T 2pmi_A 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244 (317)
T ss_dssp CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence 45689999999998755678999999999999999999999997642 22222221 1111000
Q ss_pred --------C--------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------G--------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------~--------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. ........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00122346899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=344.74 Aligned_cols=241 Identities=21% Similarity=0.237 Sum_probs=200.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 468999999999999965 689999999975432 224567788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 91 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-~~~ 163 (318)
T 1fot_A 91 GELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-YTL 163 (318)
T ss_dssp CBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-CCC
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCcc-ccc
Confidence 999999963 34689999999999999999999999 99999999999999999999999999998765432 346
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...+....+... ....+......+.+++.+|+
T Consensus 164 ~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 164 CGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp CSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHT
T ss_pred cCCccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence 7899999999987 567899999999999999999999999753 222222222211 11122233456899999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 006031 627 SASPEQRP-----TMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RP-----t~~ev~~ 641 (664)
+.+|++|| ++.|+++
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHT
T ss_pred ccCHHHcCCCcCCCHHHHhc
Confidence 99999999 8888874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.70 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=183.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 468999999999999976 57889999987532 3467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 134 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 134 ELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp BHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 9999995 335689999999999999999999999 9999999999999975 8999999999998764432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||..... ...+...+....... ......+..+.++
T Consensus 208 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERG-DQFMFRRILNCEYYFISPWWDEVSLNAKDL 285 (349)
T ss_dssp -----CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-HHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-cHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence 3456899999999987 56789999999999999999999999975432 222222222211111 1123345568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.||++|||+.|+++
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.98 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=207.7
Q ss_pred HhccccccCceeEEEEEEc--------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceE
Q 006031 388 SAELLGKGSLGTTYKAVLD--------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERL 458 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 458 (664)
..+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 117 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence 3578999999999999863 467899999975432 12346788999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCe
Q 006031 459 LIYDYQPNGSLFSLIHGSKST-----------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEA 527 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ 527 (664)
+||||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCE
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCCCCE
Confidence 999999999999999753211 123589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHH
Q 006031 528 CLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVR 602 (664)
Q Consensus 528 ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 602 (664)
||+|||+++...... .....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+.
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~ 273 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLK 273 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CHHHHHHHHh
Confidence 999999998654432 12344678899999886 5668999999999999999999 99998753 2334444433
Q ss_pred hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 603 SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 603 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
...... .+...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 274 ~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 274 EGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 332221 223344568999999999999999999999999999976554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.05 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=209.1
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 4689999999999999764 8899999986533 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 95 ~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 95 NLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp EHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred cHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 999999642 335689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
...+++.|+|||.+. ...++.++||||||+++|||++ |+.||... ....+...+...... ..+...+..+.+++.
T Consensus 171 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 171 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM-ERPEGCPEKVYELMR 246 (288)
T ss_dssp TEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred CCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhccCCC-CCCCCCCHHHHHHHH
Confidence 223567899999986 5678999999999999999999 99998764 233444444333222 122334456899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 624 ACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+||+.+|++|||+.|+++.|+++....
T Consensus 247 ~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999886543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.54 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred ccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.||+|+||.||+|... ++..||+|+++.... ....+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 47999999999999853 678899999975422 23456789999999999999999999999 55679999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 94 ~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 94 GPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 999999953 345699999999999999999999999 999999999999999999999999999987643221
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+...... ..+...+..+.+
T Consensus 169 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 244 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRM-ECPPECPPELYA 244 (287)
T ss_dssp CCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHhcCCcC-CCCCCcCHHHHH
Confidence 2234678899999986 5678999999999999999999 99999764 233444444333222 222344566899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
++.+||+.+|++||++.|+++.|+++....
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999986544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.66 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=197.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46899999999999996 67889999998643221 223467899999999999999999999999999999999999 7
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ...
T Consensus 93 g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 93 GELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp EEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 899999853 34699999999999999999999999 99999999999999999999999999998765443 334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|+|||.+.+....+.++|||||||++|||++|+.||....... +...+... ....+...+..+.+++.+|
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~--~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKVNSC--VYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--CBCCCCSS--CCCCCTTSCHHHHHHHHTT
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--HHHHHHcC--CCCCcccCCHHHHHHHHHH
Confidence 5789999999998744445789999999999999999999997642211 00000000 0112223345688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.||++|||+.|+++.
T Consensus 243 L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCSSGGGSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHHhC
Confidence 99999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.81 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=195.0
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcC--CCCCCcccceEEEecC----CceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG--LRHPNLVPLRAYFQAK----EERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~----~~~~lV~ 461 (664)
..+.||+|+||.||+|... ++.||||++... ....+.+|.+++.. ++||||+++++++... +..++||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 3578999999999999976 789999998532 23444455555544 4999999999999877 6789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW-------RLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
||+++|+|.++++. ..+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+
T Consensus 115 e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 115 DYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp CCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 99999999999953 35899999999999999999999752 899999999999999999999999999
Q ss_pred cccccCCCC------CCCCCCCcccCccccccCCCCCc------hhhHHHHHHHHHHHHcC----------CCCCCCCCC
Q 006031 535 TALTADSLQ------DDDPDNLLYKAPETRNASHQATS------KSDVYSFGVLLLELLTG----------KPPSQHSFL 592 (664)
Q Consensus 535 a~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~------ksDVwSfGvvl~elltG----------~~P~~~~~~ 592 (664)
++....... ....||+.|+|||.+. ....+. ++|||||||++|||+|| +.||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHT-TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcc-cccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 976543322 1346899999999986 333333 49999999999999999 666654332
Q ss_pred Chh---hHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 593 VPN---EMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 593 ~~~---~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
... .....+........ ...+.+..+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 222 22222222111111 13467788999999999999999999999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=340.23 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=201.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999964 5889999999765543344577889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeeccccccccCCCC-
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTALTADSLQ- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~~~~~~- 543 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++........
T Consensus 91 ~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 91 ELFEDIVA-----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99998853 34689999999999999999999999 9999999999999987655 99999999977654432
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||... ........+....... .........+.++
T Consensus 165 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp CCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCC--chhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 3456899999999987 567899999999999999999999999753 2233333332222111 1112344568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.+|++|||+.|+++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcccChhhCCCHHHHhc
Confidence 99999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.24 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=199.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 468999999999999965 688999999865432 23467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC--CCCeEEeeccccccccCCC-CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP--DFEACLADYCLTALTADSL-QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~-~~ 544 (664)
+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 134 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 134 ELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp BHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999953 234689999999999999999999999 9999999999999974 5789999999998765432 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--CCchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED--DGAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~ 622 (664)
...+|+.|+|||++. ...++.++|||||||++|||+||+.||... ...+....+...... .......+..+.+++
T Consensus 209 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 209 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 346899999999987 567899999999999999999999999763 222333333222111 112223455689999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+||+.||++|||+.|+++.
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.15 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=195.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999975 4889999998665443333567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 88 ~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 88 VLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp HHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred hHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99999852 35689999999999999999999999 99999999999999999999999999998765332 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..++..|+|||.+.+...++.++||||||+++|||+||+.||.... ..+....+.......
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhcccccccccccccccccccC
Confidence 5688999999998755778999999999999999999999997642 222211111110000
Q ss_pred ------C------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 ------G------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 ------~------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. ........+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 001234458899999999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=334.23 Aligned_cols=245 Identities=21% Similarity=0.263 Sum_probs=202.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 468999999999999975 688999999865433 234578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----LQ 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 543 (664)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...... ..
T Consensus 91 ~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 91 ELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp EGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999985 235689999999999999999999999 9999999999999999999999999999765322 12
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....++..|+|||.+......+.++||||||+++|||++|+.||............+....... ......+..+.+++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLALLH 243 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS-TTGGGSCHHHHHHHH
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc-CchhhcCHHHHHHHH
Confidence 3456889999999987444457899999999999999999999986543333444444322211 122334556889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+||+.+|++|||+.|+++
T Consensus 244 ~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 244 KILVENPSARITIPDIKK 261 (276)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHCCCCchhCCCHHHHhc
Confidence 999999999999999976
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.19 Aligned_cols=239 Identities=18% Similarity=0.242 Sum_probs=193.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.++||+|+||+||+|+.. +++.||+|+++...... ...+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 468999999999999965 57899999997654322 2234577888888776 89999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 137 gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 137 GGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp TCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 9999999953 34699999999999999999999999 999999999999999999999999999985322 233
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------hhhHHHHHHhhccCCCchhHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-------PNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+.+.+.... ...+.....
T Consensus 211 ~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~ 287 (396)
T 4dc2_A 211 STFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSV 287 (396)
T ss_dssp CCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred ccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcCCH
Confidence 4567899999999987 567899999999999999999999999643211 112222222211 122233445
Q ss_pred HHHHHHHHcccCCCCCCCCH
Q 006031 617 MLLEVAIACNSASPEQRPTM 636 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~ 636 (664)
.+.+++.+||+.||++||++
T Consensus 288 ~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 288 KAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHHhcCCHhHcCCC
Confidence 68999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.93 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEEc-CCeE----EEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLI----VCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|... ++.. ||+|.+.... .....+.+.+|++++++++||||+++++++... ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~ 97 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEe
Confidence 468999999999999954 4443 5777775432 234678899999999999999999999999865 48899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 98 MPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred cCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999974 235689999999999999999999999 999999999999999999999999999987543321
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....+++.|+|||.+. ...++.++|||||||++|||++ |+.||... ...++...+....... .+...+..+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~l 248 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLP-QPPICTIDV 248 (327)
T ss_dssp -------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCC-CCTTBCHHH
T ss_pred cccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCC-CCccCCHHH
Confidence 2234677899999987 6778999999999999999999 99999764 2334444443332222 222344568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=338.63 Aligned_cols=243 Identities=27% Similarity=0.414 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... ++..||+|++...... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 468999999999999865 5678999998643321 13456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 94 ~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (279)
T 3fdn_A 94 GTVYRELQK-----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL 167 (279)
T ss_dssp EEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCccccccc
Confidence 999999953 24689999999999999999999998 999999999999999999999999999876655554556
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.++..|+|||.+. ...++.++||||||+++|||++|+.||... ...+....+..... ..+......+.+++.+||
T Consensus 168 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 168 CGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEF--TFPDFVTEGARDLISRLL 242 (279)
T ss_dssp CCCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHC
T ss_pred CCCCCccCHhHhc-cCCCCccchhHhHHHHHHHHHHCCCCCCCC--cHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHh
Confidence 7899999999987 567889999999999999999999999753 22222222222211 122233456889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 006031 627 SASPEQRPTMWQVLKM 642 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~ 642 (664)
+.+|++|||+.|+++.
T Consensus 243 ~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEH 258 (279)
T ss_dssp CSSGGGSCCHHHHHHC
T ss_pred ccChhhCCCHHHHhhC
Confidence 9999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.32 Aligned_cols=252 Identities=17% Similarity=0.197 Sum_probs=194.9
Q ss_pred hccccccCceeEEEEEEc----CCeEEEEEEccCccccC---------CcHHHHHHHHHHHcCCCCCCcccceEEEec--
Q 006031 389 AELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLAG---------TSNEMYEQHMESVGGLRHPNLVPLRAYFQA-- 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-- 453 (664)
.+.||+|+||.||+|... .+..||+|++....... .....+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 468999999999999975 57889999986543210 012346678889999999999999999987
Q ss_pred --CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC--CeEE
Q 006031 454 --KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF--EACL 529 (664)
Q Consensus 454 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~--~~ki 529 (664)
.+..++||||+ +++|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSEEE
T ss_pred CCCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcEEE
Confidence 67889999999 9999999953 23799999999999999999999999 999999999999998887 9999
Q ss_pred eeccccccccCCCC---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH
Q 006031 530 ADYCLTALTADSLQ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW 600 (664)
Q Consensus 530 ~DfGla~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~ 600 (664)
+|||+++....... ....++..|+|||.+. ...++.++|||||||++|||+||+.||.............
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999976543211 2346899999999987 5678999999999999999999999996533333333332
Q ss_pred HHhhccCCCch-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 601 VRSAREDDGAE-------DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 601 ~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
........... ...+..+.+++.+||+.+|++|||+.+|++.|+++.-
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22222221110 1234569999999999999999999999999988764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.53 Aligned_cols=245 Identities=19% Similarity=0.274 Sum_probs=194.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC--CCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR--HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 4689999999999999888999999999765443344578999999999996 5999999999999999999999 568
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
++|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 140 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 140 IDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 899999963 34689999999999999999999999 999999999999996 5899999999998764332
Q ss_pred CCCCCCCCcccCcccccc----------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 543 QDDDPDNLLYKAPETRNA----------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~----------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+...+... .....+.
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~ 291 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-HEIEFPD 291 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT-SCCCCCC
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc-ccCCCCc
Confidence 234568999999998853 13688999999999999999999999975322112222222211 1111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 223458899999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.98 Aligned_cols=242 Identities=19% Similarity=0.259 Sum_probs=189.4
Q ss_pred hccccccCceeEEEEEE----cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||++.. .+++.||+|+++..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 46899999999999997 47899999999765331 1234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS- 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 541 (664)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 102 YLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp CCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred CCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 9999999999953 34688999999999999999999999 9999999999999999999999999999754322
Q ss_pred -CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 542 -LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 542 -~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...+....+..... ..+......+.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~ 250 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKL--NLPPYLTQEARD 250 (327)
T ss_dssp ---CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCC--CCCTTSCHHHHH
T ss_pred ccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 223456899999999987 567899999999999999999999999753 22233222222211 122233456899
Q ss_pred HHHHcccCCCCCCC-----CHHHHHH
Q 006031 621 VAIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
++.+||+.+|++|| ++.|+++
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999 7778765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=350.71 Aligned_cols=245 Identities=19% Similarity=0.275 Sum_probs=193.7
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC--CCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH--PNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++...+++.||||++..........+.+.+|++++.+++| +||+++++++.+.+..++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 46899999999999999889999999997654433345778999999999976 999999999999999999999 568
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 93 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 93 IDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp EEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 899999963 35689999999999999999999999 999999999999997 57899999999987644322
Q ss_pred -CCCCCCCcccCcccccc----------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 544 -DDDPDNLLYKAPETRNA----------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~----------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+...+.... ....+.
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 244 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-EIEFPD 244 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS-CCCCCC
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc-ccCCcc
Confidence 23568999999998752 256889999999999999999999999754222222222222111 111222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 223458899999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.62 Aligned_cols=242 Identities=20% Similarity=0.243 Sum_probs=195.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.++||+|+||+||+|+.. +++.||+|+++.... .....+.+.+|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999965 588999999975422 223456788899999887 79999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 543 (664)
+|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 108 gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 108 GGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp SCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 9999999953 34699999999999999999999999 9999999999999999999999999999854322 22
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ...++...+..... ..+......+.+++.
T Consensus 182 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEV--VYPTWLHEDATGILK 256 (353)
T ss_dssp ----CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred cccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 3456899999999987 567899999999999999999999999753 23333333322221 122334456889999
Q ss_pred HcccCCCCCCCCH------HHHHH
Q 006031 624 ACNSASPEQRPTM------WQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~------~ev~~ 641 (664)
+||+.+|++||++ .|+++
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHhhhCHHHccCCcccCCHHHHhh
Confidence 9999999999998 66654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=360.52 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=201.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999975 6899999999654321 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 101 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 101 GELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp EEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence 99999995 345699999999999999999999999 99999999999999999999999999998765432 334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|+|||.+.+....+.++|||||||++|||++|+.||.... ...+...+...... .+......+.+++.+|
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGIFY--TPQYLNPSVISLLKHM 250 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHHHHHTTCCC--CCTTCCHHHHHHHHHH
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCcC--CCccCCHHHHHHHHHH
Confidence 6789999999998744445789999999999999999999997632 22332222222111 1222345588999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.||++|||+.|+++
T Consensus 251 L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 251 LQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCSSTTTSCCHHHHHT
T ss_pred cCCCchhCcCHHHHHh
Confidence 9999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=346.86 Aligned_cols=239 Identities=18% Similarity=0.243 Sum_probs=194.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|+.. +++.||+|+++...... ...+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 58899999997654322 2245678899999887 89999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 94 gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 94 GGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp SCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 9999999953 34689999999999999999999999 999999999999999999999999999986322 223
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------hhhHHHHHHhhccCCCchhHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-------PNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ...+.+.+.... ...+.....
T Consensus 168 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~ 244 (345)
T 3a8x_A 168 STFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSV 244 (345)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSCH
T ss_pred cccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCCH
Confidence 4467899999999987 567899999999999999999999999653211 112222222211 112233445
Q ss_pred HHHHHHHHcccCCCCCCCCH
Q 006031 617 MLLEVAIACNSASPEQRPTM 636 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~ 636 (664)
.+.+++.+||+.||++||++
T Consensus 245 ~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHhcCCHhHCCCC
Confidence 68999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.78 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=204.0
Q ss_pred hccccccCceeEEEEEEc-----CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC--CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-----NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK--EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 461 (664)
.+.||+|+||+||++.+. +++.||||+++.... ....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 468999999999998753 688999999975422 23356789999999999999999999999874 5689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++.. ..+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 115 e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 115 EYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred ecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999953 2489999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------hh----hHHHHHHh
Q 006031 542 L-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV---------PN----EMMNWVRS 603 (664)
Q Consensus 542 ~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~---------~~----~~~~~~~~ 603 (664)
. .....++..|+|||.+. ...++.++||||||+++|||+||+.||...... .. .+...+..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 2 22345778899999987 567789999999999999999999998642110 00 11111111
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccC
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLM 652 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~ 652 (664)
.. ....+...+..+.+++.+||+.+|++|||+.|+++.|+++.+....
T Consensus 267 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 267 GE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11 1122334456699999999999999999999999999999876643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.07 Aligned_cols=241 Identities=18% Similarity=0.196 Sum_probs=201.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999965 688999999965432 224567788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 126 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-~~~ 198 (350)
T 1rdq_E 126 GEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-WTL 198 (350)
T ss_dssp CBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-CCC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCCc-ccc
Confidence 999999963 24589999999999999999999999 99999999999999999999999999998765432 345
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+..... ..+......+.+++.+||
T Consensus 199 ~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 199 CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp EECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHS
T ss_pred cCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 6899999999987 567899999999999999999999999753 22333333322211 122334556899999999
Q ss_pred cCCCCCCCC-----HHHHHH
Q 006031 627 SASPEQRPT-----MWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt-----~~ev~~ 641 (664)
+.||++||+ +.|+.+
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHT
T ss_pred hcCHHhccCCccCCHHHHHh
Confidence 999999998 777764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.99 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=197.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||.||+|...+ .||+|.++.........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4789999999999999765 49999997654444445668889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC-------
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS------- 541 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~------- 541 (664)
|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 116 L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~ 189 (319)
T 2y4i_B 116 LYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189 (319)
T ss_dssp HHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence 9999963 234689999999999999999999999 999999999999998 679999999998754321
Q ss_pred CCCCCCCCCcccCcccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhH
Q 006031 542 LQDDDPDNLLYKAPETRNA--------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~--------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (664)
......++..|+|||.+.. ...++.++||||||+++|||++|+.||... ....+...+............
T Consensus 190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 2y4i_B 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMKPNLSQIG 267 (319)
T ss_dssp SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--CHHHHHHHHHTTCCCCCCCSS
T ss_pred ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhccCCCCCCCcCC
Confidence 1122347889999998763 245788999999999999999999999753 222333322222222211122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
.+..+.+++.+||+.+|++|||+.|++++|+++.....
T Consensus 268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 268 MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 33458899999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.32 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCce----EEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEER----LLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~----~lV~e 462 (664)
.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++...+.. ++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46899999999999995 678999999997643321 2245788999999999999999999998765543 99999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 97 YVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp CCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 9999999999963 34689999999999999999999999 99999999999999999999999999998654432
Q ss_pred C-----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhH-HHHHHhhccCC-CchhHHH
Q 006031 543 Q-----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEM-MNWVRSAREDD-GAEDERL 615 (664)
Q Consensus 543 ~-----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~ 615 (664)
. ....|++.|+|||.+. ...++.++|||||||++|||+||+.||.... ..+. ........... ......+
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -----------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCCCcccccCCCC
Confidence 1 1245899999999987 5678999999999999999999999997532 2222 11111111110 0112234
Q ss_pred HHHHHHHHHcccCCCCCCCC-HHHHHHHHHhhhcc
Q 006031 616 GMLLEVAIACNSASPEQRPT-MWQVLKMLQEIKGA 649 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt-~~ev~~~L~~i~~~ 649 (664)
..+.+++.+||+.||++||+ +.++...+.++...
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 56899999999999999995 45566677766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.72 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 589999999975432 223456778888888876 99999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 102 gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 102 GGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp TCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcc
Confidence 9999999953 34689999999999999999999999 999999999999999999999999999986432 233
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++...+..... ..+......+.+++.
T Consensus 176 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNP--FYPRWLEKEAKDLLV 250 (345)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred cCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCC--CCCcccCHHHHHHHH
Confidence 4567899999999987 567899999999999999999999999753 23333333332221 122334456899999
Q ss_pred HcccCCCCCCCCHH-HHH
Q 006031 624 ACNSASPEQRPTMW-QVL 640 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~-ev~ 640 (664)
+||+.+|++||++. |+.
T Consensus 251 ~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 251 KLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHSCSSGGGSBTTBSCGG
T ss_pred HHhcCCHhHcCCChHHHH
Confidence 99999999999987 554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=351.74 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=200.1
Q ss_pred hcccccc--CceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKG--SLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+| +||.||+|... +++.||||++..........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4689999 99999999975 68999999997655433445778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS---- 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 541 (664)
+|+|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 110 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~ 185 (389)
T 3gni_B 110 YGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185 (389)
T ss_dssp TCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred CCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence 99999999642 234689999999999999999999999 9999999999999999999999999988643211
Q ss_pred -----CCCCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc---------
Q 006031 542 -----LQDDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE--------- 606 (664)
Q Consensus 542 -----~~~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~--------- 606 (664)
......+|..|+|||.+.+. ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HHHHC---------------
T ss_pred cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCccccccccc
Confidence 11234688899999998743 568999999999999999999999997643221 11111100000
Q ss_pred ----------------------------------CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhh
Q 006031 607 ----------------------------------DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIK 647 (664)
Q Consensus 607 ----------------------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~ 647 (664)
...........+.+++.+||+.||++|||+.|+++. +++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000112233568899999999999999999999864 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.68 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=201.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe----cCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ----AKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~ 463 (664)
.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++. .....++||||
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 47899999999999996 6789999998864322 34567899999999999999999999987 34478999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.... .....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 112 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 112 FKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp CTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred CCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 99999999996422 1245799999999999999999999999 999999999999999999999999998875432111
Q ss_pred -----------CCCCCCCcccCccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 544 -----------DDDPDNLLYKAPETRNASH--QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 544 -----------~~~~~~~~y~aPE~~~~~~--~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
....+++.|+|||.+.... .++.++||||||+++|||++|+.||.........+......... ...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 268 (317)
T 2buj_A 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-IPQ 268 (317)
T ss_dssp SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCC
T ss_pred cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC-CCc
Confidence 0123588999999886322 26889999999999999999999986422112222222222111 111
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
....+..+.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 22334568999999999999999999999999999876554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.85 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=201.9
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
..+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 3578999999999999965 58899999997544322 246789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----CeEEeeccccccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALT 538 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~ 538 (664)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++...
T Consensus 96 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 96 LVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp CCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999953 35689999999999999999999999 999999999999999888 7999999999876
Q ss_pred cCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHH
Q 006031 539 ADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERL 615 (664)
Q Consensus 539 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 615 (664)
.... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||... ...+....+........ .....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred CccccccccCCCCCccCccccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcccccChhhhcccC
Confidence 5432 23456899999999986 567899999999999999999999999753 22233332222221111 112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 56899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=337.11 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=195.7
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||.||++.. .++..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 357899999999999996 4688999999875442 34568899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSL- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~- 542 (664)
|+|.+++.... .....+++..+..|+.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.......
T Consensus 105 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 105 GELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp CBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred CcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence 99999985321 1235689999999999999999999999 99999999999999 456889999999998654432
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-chhHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG-AEDERLGMLLEV 621 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 621 (664)
.....+++.|+|||.+. ..++.++||||||+++|||++|+.||... ...++............ ........+.++
T Consensus 183 ~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 183 STNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp ----CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred CcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCC--CHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 23456899999999874 56899999999999999999999999763 22233332222221111 111124558899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.||++|||+.|+++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=346.37 Aligned_cols=242 Identities=19% Similarity=0.244 Sum_probs=198.9
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccc-cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKL-AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|.... ++.||+|+++.... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 4689999999999999764 78999999975432 224567788999999888 89999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 105 gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 105 GGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp SCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccc
Confidence 9999999953 24689999999999999999999999 999999999999999999999999999986432 223
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++.+.+..... ..+......+.+++.
T Consensus 179 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNV--AYPKSMSKEAVAICK 253 (353)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 3467899999999987 567899999999999999999999999753 23333333322211 122334556899999
Q ss_pred HcccCCCCCCCC-----HHHHHH
Q 006031 624 ACNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt-----~~ev~~ 641 (664)
+||+.+|++||+ +.|+.+
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999995 466654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.56 Aligned_cols=252 Identities=14% Similarity=0.152 Sum_probs=201.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEE-ecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF-QAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|++++++++|++++..++++ ...+..++||||+ +
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 46899999999999996 6789999999865432 34688999999999998877777766 5566789999999 8
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~ 543 (664)
++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 89 ~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 89 PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999999963 234699999999999999999999999 99999999999999 4889999999999987654322
Q ss_pred ---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-hhh-HHHHHHhhccCCC--c
Q 006031 544 ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-PNE-MMNWVRSAREDDG--A 610 (664)
Q Consensus 544 ---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-~~~-~~~~~~~~~~~~~--~ 610 (664)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+ +............ .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 2346899999999987 567899999999999999999999999864322 112 2222221111110 1
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
....+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 12234568999999999999999999999999999876654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.92 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=199.5
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 4689999999999999654 67899999875443 45778999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....... .
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 92 ELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp BHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999853 34589999999999999999999999 99999999999999 888999999999997654432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc--hhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA--EDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 621 (664)
....+++.|+|||.+. +.++.++||||||+++|||++|+.||... ...+....+......... ....+..+.++
T Consensus 166 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred hccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 3456899999999885 35899999999999999999999999763 223333332222222111 11234668999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.+|++|||+.|+++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.41 Aligned_cols=244 Identities=20% Similarity=0.261 Sum_probs=192.5
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
++||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence 5799999999999994 578899999997543 24567889999999884 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeeccccccccCCC--
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTALTADSL-- 542 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~~~~~-- 542 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++.......
T Consensus 97 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 97 SILSHIHK-----RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred cHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999963 24689999999999999999999999 9999999999999998776 9999999987543211
Q ss_pred -------CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-------------hhHH
Q 006031 543 -------QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-------------NEMM 598 (664)
Q Consensus 543 -------~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-------------~~~~ 598 (664)
.....+|+.|+|||.+.. ...++.++|||||||++|||++|+.||....... ..+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 112358999999998752 1447889999999999999999999997643211 1122
Q ss_pred HHHHhhccCCCc--hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 599 NWVRSAREDDGA--EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 599 ~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+......... .......+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 222222111111 1123456899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.89 Aligned_cols=250 Identities=17% Similarity=0.191 Sum_probs=202.1
Q ss_pred hccccccCceeEEEEEEcC---------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCccc-------------
Q 006031 389 AELLGKGSLGTTYKAVLDN---------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP------------- 446 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~------------- 446 (664)
.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 4689999999999999764 789999998643 35789999999999999988
Q ss_pred --ceEEEec-CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 447 --LRAYFQA-KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 447 --l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
+++++.. .+..++||||+ +++|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEET
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcC
Confidence 5677765 67889999999 99999999642 135799999999999999999999999 9999999999999999
Q ss_pred CC--CeEEeeccccccccCCCC---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006031 524 DF--EACLADYCLTALTADSLQ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL 592 (664)
Q Consensus 524 ~~--~~ki~DfGla~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~ 592 (664)
++ .+||+|||+++....... ....+|+.|+|||.+. ...++.++|||||||++|||+||+.||.....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 98 899999999976543221 2236889999999987 56789999999999999999999999986543
Q ss_pred ChhhHHHHHHhhccCCC-c------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 593 VPNEMMNWVRSAREDDG-A------EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 593 ~~~~~~~~~~~~~~~~~-~------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
....+............ . ....+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 33444444332222211 1 11234568999999999999999999999999999976654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.00 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=196.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-CceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-EERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++.||+|.++.. ...+.+.+|++++++++||||+++++++.+. +..++||||+++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 468999999999999875 789999998643 2457789999999999999999999997654 4789999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 101 ~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 175 (278)
T 1byg_A 101 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGK 175 (278)
T ss_dssp EHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccccc-cCCC
Confidence 999999631 122378999999999999999999999 99999999999999999999999999987654432 2345
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
++..|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+...... ..+...+..+.+++.+||
T Consensus 176 ~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 251 (278)
T 1byg_A 176 LPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM-DAPDGCPPAVYEVMKNCW 251 (278)
T ss_dssp CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCC-CCCTTCCHHHHHHHHHHT
T ss_pred ccccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHh
Confidence 678899999986 5678999999999999999999 99998754 233443333322211 222334556899999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhhccc
Q 006031 627 SASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+|++|||+.|+++.|++++...
T Consensus 252 ~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 252 HLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCChhhCCCHHHHHHHHHHHHhhh
Confidence 999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.42 Aligned_cols=246 Identities=19% Similarity=0.272 Sum_probs=197.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 467999999999999975 688999999875421 233567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++. ...+++..+..|+.+++.||+|||+..+|+||||||+||+++.++.+||+|||++............
T Consensus 117 ~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 191 (360)
T 3eqc_A 117 SLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191 (360)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCC
Confidence 99999963 2468999999999999999999998438999999999999999999999999999765544444567
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--------------------------------
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-------------------------------- 595 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~-------------------------------- 595 (664)
+++.|+|||.+. ...++.++|||||||++|||+||+.||........
T Consensus 192 gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 192 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 899999999987 56789999999999999999999999975321110
Q ss_pred --------hHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 596 --------EMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 596 --------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+................+.+++.+||+.||++|||++|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0011111111111111223456899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=335.38 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=204.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 468999999999999976 68899999987543321 2467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----CeEEeecccccccc
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALTA 539 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~~ 539 (664)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++....
T Consensus 90 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 90 VSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999953 34689999999999999999999999 999999999999998877 89999999998664
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHH
Q 006031 540 DSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLG 616 (664)
Q Consensus 540 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 616 (664)
... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||... ...+....+........ .....+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp --------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred CCCcccccCCCcCccCcceec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCc--chHHHHHHhHhcccCCcchhcccCCH
Confidence 432 22346889999999986 567899999999999999999999999753 22232222222221111 1122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhcccc
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLK--MLQEIKGAVL 651 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~~~~ 651 (664)
.+.+++.+||+.+|++|||+.|+++ .+++++....
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 6899999999999999999999997 5677765543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.67 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=180.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++.+++ ||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 367999999999999975 5889999998542 4567889999999997 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeeccccccccCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYCLTALTADSL- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~~~~~~- 542 (664)
|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999963 35699999999999999999999999 999999999999997665 89999999998654432
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----hhhHHHHHHhhccCCC--chhHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-----PNEMMNWVRSAREDDG--AEDER 614 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-----~~~~~~~~~~~~~~~~--~~~~~ 614 (664)
.....+|+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..++...+........ .....
T Consensus 165 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cccccCCCcCccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 22345789999999986 667899999999999999999999999764321 1223332222221111 11223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+++.+||+.||++|||+.|+++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 566899999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.85 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=187.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||+|++..........+.+.++...++.++||||+++++++.+.+..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 46799999999999996 578999999997553322233445566666888999999999999999999999999997 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~ 546 (664)
+|.+++.... .....+++..+..|+.|++.||+|||+..+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 91 ~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (290)
T 3fme_A 91 SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169 (290)
T ss_dssp EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccccccc
Confidence 8888775311 12457999999999999999999999865999999999999999999999999999987654432 234
Q ss_pred CCCCcccCccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRN---ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 547 ~~~~~y~aPE~~~---~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
.+++.|+|||.+. ....++.++||||||+++|||+||+.||.........+.......... ......+..+.+++.
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-LPADKFSAEFVDFTS 248 (290)
T ss_dssp CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-CCTTTSCHHHHHHHH
T ss_pred CCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-cccccCCHHHHHHHH
Confidence 6899999999862 356788999999999999999999999975332223333333322222 222334556899999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+||+.+|++|||+.|+++
T Consensus 249 ~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 249 QCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHhhcChhhCcCHHHHHh
Confidence 999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=336.30 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=200.5
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|...+ +..||+|.+..... ....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 4689999999999998643 34699999875422 1245778999999999999999999999864 4678999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 543 (664)
++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 95 ~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 95 PYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp TTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999963 234589999999999999999999999 999999999999999999999999999986654321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
....++..|+|||.+. ...++.++||||||+++|||+| |+.||... ...+....+....... .+...+..+.+
T Consensus 170 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 245 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDRLP-KPDLCPPVLYT 245 (281)
T ss_dssp ---CCCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHHTCCCC-CCTTCCHHHHH
T ss_pred ccccCCCCcceeCchhhc-cCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhcCCCCC-CCCCCCHHHHH
Confidence 2344678899999986 5678999999999999999999 99998753 2233333333222211 22233456899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
++.+||+.+|++|||+.|+++.|+++...
T Consensus 246 li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999988653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.62 Aligned_cols=238 Identities=19% Similarity=0.238 Sum_probs=195.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC------CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG------TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 46899999999999985 568999999997654321 13346778999999999999999999999999999999
Q ss_pred ecCCCC-CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 462 DYQPNG-SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 462 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
||+.+| +|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 109 e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 109 EKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp ECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999777 99999953 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred CC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 541 SL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 541 ~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
.. .....||+.|+|||.+.+....+.++|||||||++|||++|+.||..... . .. .....+......+.
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~---~~---~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----T---VE---AAIHPPYLVSKELM 252 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----G---TT---TCCCCSSCCCHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----H---Hh---hccCCCcccCHHHH
Confidence 32 22346899999999987444458899999999999999999999965211 0 00 01111122344589
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+++.+||+.+|++|||+.|+++.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.29 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=205.2
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCC-ceEEE
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKE-ERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~-~~~lV 460 (664)
.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 46899999999999984 3568999999975432 12346788999999999 7999999999987755 58999
Q ss_pred EecCCCCCHHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEE
Q 006031 461 YDYQPNGSLFSLIHGSKST-----------RAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL 529 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki 529 (664)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl 189 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKI 189 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEE
Confidence 9999999999999753211 022389999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhh
Q 006031 530 ADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 530 ~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 604 (664)
+|||+++....... ....+++.|+|||.+. ...++.++||||||+++|||+| |+.||...... ..+...+...
T Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~ 267 (316)
T 2xir_A 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEG 267 (316)
T ss_dssp CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHHHHHHHT
T ss_pred CCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchh-HHHHHHhccC
Confidence 99999986543321 1234677899999987 5678999999999999999999 99999764322 2333333222
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
... ..+......+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 268 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 268 TRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 211 1122234568999999999999999999999999999876554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=344.60 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=199.2
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.||+|+||.||+|... +++.||+|++............+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999965 589999999986655445578899999999998 4699999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++.. .....+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 115 ~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 190 (327)
T 3lm5_A 115 EIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190 (327)
T ss_dssp EGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred cHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccc
Confidence 99999853 2345699999999999999999999999 9999999999999998 7899999999998765432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||.... ..+....+....... .........+.++
T Consensus 191 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 191 REIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ---CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccCCcCccCCeeec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 3356899999999987 6778999999999999999999999997632 222222222221111 1223345568999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.+|++|||++|+++.
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.07 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=200.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcC--CCCCCcccceEEEecCC----ceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG--LRHPNLVPLRAYFQAKE----ERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e 462 (664)
.+.||+|+||.||+|.. +++.||||++... ....+.+|++++.. ++||||+++++++...+ ..++|||
T Consensus 47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 120 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120 (342)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred EeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence 47899999999999998 4889999998542 34567778887766 79999999999998776 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH--------QAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
|+++|+|.+++.. ..+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 121 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999963 35899999999999999999999 66 999999999999999999999999999
Q ss_pred cccccCCC------CCCCCCCCcccCccccccCCC-----CCchhhHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 006031 535 TALTADSL------QDDDPDNLLYKAPETRNASHQ-----ATSKSDVYSFGVLLLELLTG----------KPPSQHSFLV 593 (664)
Q Consensus 535 a~~~~~~~------~~~~~~~~~y~aPE~~~~~~~-----~~~ksDVwSfGvvl~elltG----------~~P~~~~~~~ 593 (664)
+....... .....+++.|+|||.+..... ++.++|||||||++|||+|| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 97654432 233468999999999863322 23689999999999999999 7787654332
Q ss_pred hh---hHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 594 PN---EMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 594 ~~---~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.. .+...+........ ...+....+.+++.+||+.+|++|||+.||++.|+++.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 22 22222221111111 12356678999999999999999999999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.13 Aligned_cols=246 Identities=16% Similarity=0.194 Sum_probs=197.6
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||+|.... ++.||+|+++.... .....+.+.+|+.++..++||||++++++|.+.+..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 4689999999999999764 78999999965322 112234588999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---Q 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 543 (664)
|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 159 g~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 159 GDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 999999963 235699999999999999999999999 99999999999999999999999999997654332 2
Q ss_pred CCCCCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHh-h--ccCCCchhHHHH
Q 006031 544 DDDPDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRS-A--REDDGAEDERLG 616 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 616 (664)
....||+.|+|||++. +...++.++|||||||++|||++|+.||... ...+....+.. . ............
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--ChhHHHHhhhhccccccCCcccccCCH
Confidence 2357999999999885 2456899999999999999999999999763 22222222211 1 111111122345
Q ss_pred HHHHHHHHcccCCCCC--CCCHHHHHH
Q 006031 617 MLLEVAIACNSASPEQ--RPTMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~--RPt~~ev~~ 641 (664)
.+.+++.+|+..+|++ ||++.|+++
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhC
Confidence 5889999999888888 999999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.34 Aligned_cols=251 Identities=19% Similarity=0.224 Sum_probs=195.6
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccc---cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL---AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||+||+|.. .++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 357899999999999996 4678999999865432 234567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006031 464 QPNGSLFSLIHGSKST-----------------------------------RAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 508 (664)
+++|+|.+++...... ....+++..+..|+.|++.||+|||+. +
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ 188 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-G 188 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence 9999999999521000 012245677888999999999999999 9
Q ss_pred cccCCCCCCCeEeCCCC--CeEEeeccccccccCCC------CCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHH
Q 006031 509 LVHGNLKSSNVLLGPDF--EACLADYCLTALTADSL------QDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLE 579 (664)
Q Consensus 509 ivHrDlk~~NILl~~~~--~~ki~DfGla~~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~e 579 (664)
|+||||||+||+++.++ .+||+|||+++...... .....+|+.|+|||.+.. ...++.++|||||||++||
T Consensus 189 ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 268 (345)
T 3hko_A 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268 (345)
T ss_dssp EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHH
T ss_pred ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999998776 89999999998653321 123468999999998863 2678899999999999999
Q ss_pred HHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 580 LLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 580 lltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
|++|+.||.... ..+....+....... .........+.+++.+||+.+|++|||+.|+++
T Consensus 269 l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 269 LLMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHSSCSSCCSS--HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHCCCCCCCCC--hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999997542 222222222111111 122234566899999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=340.93 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=196.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 468999999999999965 68899999997543322 2246789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 119 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 119 VDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 999999963 24689999999999999999999999 999999999999999999999999999876544321
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-CchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-GAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~ 622 (664)
....+++.|+|||.+. ...++.++||||||+++|||+||+.||.... ...+...+....... ......+..+.+++
T Consensus 193 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 193 GNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp ----CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred cccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 2345889999999987 5678899999999999999999999997531 112222222111111 11223345688999
Q ss_pred HHcccCCCCCCC-CHHHHHHHHHhhhccc
Q 006031 623 IACNSASPEQRP-TMWQVLKMLQEIKGAV 650 (664)
Q Consensus 623 ~~Cl~~~P~~RP-t~~ev~~~L~~i~~~~ 650 (664)
.+||+.+|++|| ++.++++.|+++....
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 999999999999 9999999999876554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.13 Aligned_cols=252 Identities=14% Similarity=0.153 Sum_probs=200.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEE-ecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYF-QAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..++++ ...+..++||||+ +
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 46899999999999995 6789999998754332 23478899999999998888777766 5566789999999 9
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~ 543 (664)
++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 89 ~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 89 PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999999963 234699999999999999999999999 99999999999999 7889999999999987654321
Q ss_pred ---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCCC--c
Q 006031 544 ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDDG--A 610 (664)
Q Consensus 544 ---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~--~ 610 (664)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||....... ..+............ .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 2346899999999987 5678999999999999999999999997643221 122222221111110 0
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
....+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 11224568999999999999999999999999999977654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=339.65 Aligned_cols=242 Identities=19% Similarity=0.295 Sum_probs=197.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 468999999999999965 688999999975432 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++.........
T Consensus 92 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 92 ELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp BHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999853 24689999999999999999999999 99999999999999 78899999999999765543332
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~ 622 (664)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||... ....+...+....... ......+..+.+++
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 166 TACGTPGYVAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp HHHSCCCBCCTTTBS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 345789999999987 667899999999999999999999998753 2233333333222111 12233456689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||+.|+++
T Consensus 243 ~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.82 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=205.5
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|... .++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 578999999999999864 378899999975432 1234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSK-----STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
|+++|+|.++++... ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCccccc
Confidence 999999999996321 11224679999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... ....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+...... ..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~ 263 (322)
T 1p4o_A 188 IYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGGLL-DKPD 263 (322)
T ss_dssp GGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTTCCC-CCCT
T ss_pred cccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccC--CHHHHHHHHHcCCcC-CCCC
Confidence 543221 1234578899999986 5678999999999999999999 89998753 233444333322211 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 3445689999999999999999999999999887543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=348.90 Aligned_cols=247 Identities=15% Similarity=0.140 Sum_probs=198.2
Q ss_pred hccccccCceeEEEEE------EcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC---CCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAV------LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||+||+|. ...++.||+|+++.. ....+.+|++++.+++ |+||+++++++...+..++
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 4689999999999994 556889999998643 3566778888887776 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-----------CCCeE
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-----------DFEAC 528 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-----------~~~~k 528 (664)
||||+++|+|.++++.........++|..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999999643323456799999999999999999999998 9999999999999998 89999
Q ss_pred EeeccccccccC----CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh
Q 006031 529 LADYCLTALTAD----SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 529 i~DfGla~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 604 (664)
|+|||+++.... .......||+.|+|||++. +..++.++|||||||++|||+||+.||.........
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------- 294 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------- 294 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--------
Confidence 999999975432 1223456899999999987 566899999999999999999999998643221111
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhhccc
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQR-PTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Pt~~ev~~~L~~i~~~~ 650 (664)
.............+.+++..|++.+|.+| |++.++.+.|+++....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000000123457789999999999999 58899999998876553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.56 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=195.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--------CCceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--------KEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------~~~~~l 459 (664)
.+.||+|+||+||+|.. .+++.||+|++............+.+|++++++++||||+++++++.. .+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46899999999999997 578999999997665544456678899999999999999999999876 346899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++ +|.+.+.. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp EEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 9999975 78887753 335699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC----
Q 006031 540 DSL------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG---- 609 (664)
Q Consensus 540 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---- 609 (664)
... .....+|+.|+|||.+.+...++.++|||||||++|||+||+.||.... ..+....+........
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhc
Confidence 221 1234578999999988755668999999999999999999999997632 2222222221111000
Q ss_pred --------------------chhH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 --------------------AEDE------RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 --------------------~~~~------~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+ ....+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 1245789999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.79 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEE-cCCeE--EEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLI--VCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.. .++.. ||+|.+..... ....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 57899999999999985 45654 48998864322 23456789999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 465 PNGSLFSLIHGSK-----------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 465 ~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
++|+|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeEEEcccC
Confidence 9999999997432 01234799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 534 LTALTADSLQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 534 la~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
+++....... ....++..|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+...... ..+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~~~-~~~ 263 (327)
T 1fvr_A 188 LSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYRL-EKP 263 (327)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGGTCCC-CCC
T ss_pred cCccccccccccCCCCCccccChhhhc-cccCCchhcchHHHHHHHHHHcCCCCCCCCC--cHHHHHHHhhcCCCC-CCC
Confidence 9975433221 2234678899999986 5667899999999999999998 99999753 223333333322111 122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 264 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 233456899999999999999999999999999986654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.52 Aligned_cols=246 Identities=19% Similarity=0.255 Sum_probs=203.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 368999999999999975 689999999965432 224567788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 269 g~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 344 (576)
T 2acx_A 269 GDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344 (576)
T ss_dssp CBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEEC
T ss_pred CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCccccc
Confidence 9999999642 234589999999999999999999999 99999999999999999999999999998765432 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+...+..... ..+......+.+++.
T Consensus 345 ~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~s~~~~dLI~ 421 (576)
T 2acx_A 345 RVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERFSPQARSLCS 421 (576)
T ss_dssp CCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred cCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccCCHHHHHHHH
Confidence 57999999999987 567899999999999999999999999764321 2234443333222 122334556899999
Q ss_pred HcccCCCCCCC-----CHHHHHH
Q 006031 624 ACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RP-----t~~ev~~ 641 (664)
+||+.||++|| ++.||++
T Consensus 422 ~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 422 QLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HhccCCHHHcCCCCCCCHHHHHh
Confidence 99999999999 7888875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.26 Aligned_cols=242 Identities=18% Similarity=0.240 Sum_probs=191.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||||++..... .......+.+|++++++++||||++++++|.+.+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 47899999999999995 4688999999975432 123345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 543 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 233 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 233 GELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp CBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 999999953 3468999999999999999999998 6 9999999999999999999999999999864332 22
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ....+...+..... ..+......+.+++.
T Consensus 307 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEI--RFPRTLGPEAKSLLS 381 (446)
T ss_dssp CCSSSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccCCccccCHhhcC-CCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Confidence 3457899999999986 677899999999999999999999999753 22333333322211 122234456899999
Q ss_pred HcccCCCCCCC-----CHHHHHH
Q 006031 624 ACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RP-----t~~ev~~ 641 (664)
+||+.||++|| +++|+++
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999 9999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.69 Aligned_cols=243 Identities=17% Similarity=0.246 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|... +++.||+|++............+.+|+..+.++ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 468999999999999975 789999999976544444567788999999888 999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-------------------CCCe
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-------------------DFEA 527 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-------------------~~~~ 527 (664)
|+|.+++.... .....+++..+..|+.|++.||+|||+. +|+||||||+||+++. ...+
T Consensus 96 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (289)
T 1x8b_A 96 GSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173 (289)
T ss_dssp CBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------CCCE
T ss_pred CcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEE
Confidence 99999996421 1124689999999999999999999999 9999999999999984 4479
Q ss_pred EEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC
Q 006031 528 CLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED 607 (664)
Q Consensus 528 ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 607 (664)
||+|||.+....... ...++..|+|||.+.....++.++|||||||++|||++|++|+... ............
T Consensus 174 kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~~~- 246 (289)
T 1x8b_A 174 KIGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQGRLP- 246 (289)
T ss_dssp EECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHTTCCC-
T ss_pred EEcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHcCCCC-
Confidence 999999998765432 3468999999999875446778999999999999999999876432 222222221111
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 247 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 247 -RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 122233456899999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.92 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=189.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHH-HcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMES-VGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|+.+ +++.||+|+++...... ...+.+.+|..+ ++.++||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 57889999997654322 233456666666 577899999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 123 gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 123 GGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp SCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence 9999999953 34688999999999999999999999 999999999999999999999999999986432 223
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ...++.+.+.... ...+......+.+++.
T Consensus 197 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKP--LQLKPNITNSARHLLE 271 (373)
T ss_dssp CSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--BHHHHHHHHHHSC--CCCCSSSCHHHHHHHH
T ss_pred ccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcc--cCCCCCCCHHHHHHHH
Confidence 3457899999999987 667899999999999999999999999753 2223333222211 1122233456889999
Q ss_pred HcccCCCCCCCCHHHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLKML 643 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~L 643 (664)
+||+.||++||++.+.++++
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHH
T ss_pred HHcccCHHhCCCCCCCHHHH
Confidence 99999999999986444443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=344.75 Aligned_cols=245 Identities=18% Similarity=0.246 Sum_probs=188.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 46899999999999985 478999999997655444445678899999999999999999999999999999999998 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe-----CCCCCeEEeeccccccccCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL-----GPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl-----~~~~~~ki~DfGla~~~~~~~ 542 (664)
+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 118 ~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 118 DLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred CHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 99999963 34589999999999999999999999 99999999999999 455569999999998654332
Q ss_pred --CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-----------
Q 006031 543 --QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG----------- 609 (664)
Q Consensus 543 --~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 609 (664)
.....+|..|+|||.+.+...++.++|||||||++|||++|+.||..... ...+............
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 22345799999999987556689999999999999999999999975321 1222222221111100
Q ss_pred ----------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 ----------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 ----------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
........+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00112356889999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.41 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=206.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--ceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--ERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~~ 465 (664)
.++||+|+||+||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+ ..++||||++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 468999999999999975 488999999975443 234677889999999999999999999998755 6799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe----CCCCCeEEeeccccccccCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLTALTADS 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~~~~~~ 541 (664)
+|+|.+++.... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 93 ~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 93 CGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp TEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 999999996421 223499999999999999999999999 99999999999999 78888999999999876543
Q ss_pred C-CCCCCCCCcccCccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHH-HHHHhhccC---
Q 006031 542 L-QDDDPDNLLYKAPETRNAS-------HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMM-NWVRSARED--- 607 (664)
Q Consensus 542 ~-~~~~~~~~~y~aPE~~~~~-------~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~-~~~~~~~~~--- 607 (664)
. .....||..|+|||.+... ..++.++|||||||++|||+||+.||....... .++. .........
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (396)
T 4eut_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (396)
T ss_dssp GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCE
T ss_pred CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccch
Confidence 3 2345689999999987521 456789999999999999999999996533211 1222 222211110
Q ss_pred -------------------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 608 -------------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 608 -------------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..........+.+++.+||+.||++||++.|+++.++++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 012355677789999999999999999999999999988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.26 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=201.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... ++..||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 468999999999999965 578999999865432 123457899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 99 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 99 GELYKELQK-----HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp EEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccccccc
Confidence 999999963 24689999999999999999999999 999999999999999999999999999977665544556
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.++..|+|||.+. ...++.++||||||+++|||++|+.||.... ..+....+.... ...+......+.+++.+||
T Consensus 173 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 173 CGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVNVD--LKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp CSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHS
T ss_pred cCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhccc--cCCCCcCCHHHHHHHHHHh
Confidence 7899999999987 5678999999999999999999999997532 222222222111 1122233456889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 006031 627 SASPEQRPTMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~ 641 (664)
+.+|++|||+.|+++
T Consensus 248 ~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 248 RYHPPQRLPLKGVME 262 (284)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred hcCHhhCCCHHHHhh
Confidence 999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.35 Aligned_cols=241 Identities=19% Similarity=0.266 Sum_probs=187.6
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHH-cCCCCCCcccceEEEec----CCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESV-GGLRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
++||+|+||+||+|... +++.||||+++. ...+.+|++++ +..+||||+++++++.. .+..++||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 57999999999999965 588999999853 23567788776 45589999999999865 5678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 540 (664)
+++|+|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 141 ~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 141 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999999742 234699999999999999999999998 9999999999999997 78999999999986543
Q ss_pred CC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh--hhHHHHHHhhccCC--CchhHHH
Q 006031 541 SL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--NEMMNWVRSAREDD--GAEDERL 615 (664)
Q Consensus 541 ~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~ 615 (664)
.. .....+|+.|+|||++. ...++.++|||||||++|||++|+.||....... ......+....... .......
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 217 HNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp ----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred CCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence 32 23456899999999986 6778999999999999999999999997643221 12223222221111 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
..+.+++.+||+.||++|||+.|+++.
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 568999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.89 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=199.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--------------
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-------------- 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-------------- 453 (664)
.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 468999999999999975 78999999986432 356789999999999999999998854
Q ss_pred --CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 454 --KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 454 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
....++||||+++|+|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECc
Confidence 34579999999999999999642 235689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc
Q 006031 532 YCLTALTADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA 610 (664)
Q Consensus 532 fGla~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 610 (664)
||++....... .....+++.|+|||.+. ...++.++||||||+++|||++|..|+.. .............
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~----~~~~~~~~~~~~~---- 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLRDGII---- 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHH----HHHHHHHHHTTCC----
T ss_pred chhheeccccccccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchh----HHHHHHHhhcccc----
Confidence 99998765432 23456899999999987 56789999999999999999999988642 1122221211111
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
....+..+.+++.+||+.+|++|||+.|+++.|+.++....
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 12233458899999999999999999999999999986654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=343.12 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=201.0
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe--cCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ--AKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.+ .++..||||++..... ...+.+.+|++++++++||||+++++++. +.+..++||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 105 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 105 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence 46899999999999984 4688999999975432 34567899999999999999999999987 455689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 106 EYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred eecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999999632 24589999999999999999999999 9999999999999999999999999999876433
Q ss_pred C-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------------hhhHHHHHHh
Q 006031 542 L-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV-------------PNEMMNWVRS 603 (664)
Q Consensus 542 ~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~-------------~~~~~~~~~~ 603 (664)
. .....++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...+...+..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 2 12345778899999986 566789999999999999999999998542110 0011111111
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 260 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 260 GQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111 1123334566899999999999999999999999999986554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.69 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=194.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 468999999999999975 4889999998655443334567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 110 ~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (331)
T 4aaa_A 110 ILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183 (331)
T ss_dssp HHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred hHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCC
Confidence 99988742 34699999999999999999999999 9999999999999999999999999999765432 2234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC------------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED------------------ 607 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~------------------ 607 (664)
..++..|+|||.+.+...++.++|||||||++|||++|+.||..... ...+..........
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 56899999999987555789999999999999999999999976421 11222211110000
Q ss_pred --C----Cc----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 --D----GA----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 --~----~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00 0123456899999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.79 Aligned_cols=245 Identities=18% Similarity=0.217 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||+|... +++.||+|+++.... .....+.+.+|+.+++.++|||||+++++|.+.+..|+||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999975 588999999865322 122345588999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---Q 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 543 (664)
|+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 154 g~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 154 GDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999963 2488999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred CCCCCCCcccCccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc--cCCCchhHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASH---QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR--EDDGAEDERLGML 618 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~---~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 618 (664)
....||+.|+|||++.... .++.++|||||||++|||+||+.||... ...+....+.... ............+
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--ChhhHHHHHHhccccccCCCcccccHHH
Confidence 3467999999999986322 1678999999999999999999999753 2222222221111 1111111234558
Q ss_pred HHHHHHcccCCCCC--CCCHHHHHHH
Q 006031 619 LEVAIACNSASPEQ--RPTMWQVLKM 642 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~--RPt~~ev~~~ 642 (664)
.+++.+|++.+|++ ||++.||.+.
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcC
Confidence 89999999999988 9999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=351.97 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=187.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCC--ceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKE--ERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~~~lV~e~~ 464 (664)
.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++.+++ ||||+++++++...+ ..|+||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46899999999999985 56889999998654332334567789999999997 999999999997544 689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC---
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--- 541 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 541 (664)
+ |+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 94 E-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp S-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred C-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 7 599999963 3689999999999999999999999 9999999999999999999999999999765321
Q ss_pred --------------------CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH
Q 006031 542 --------------------LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 542 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~ 601 (664)
......||+.|+|||.+.+...++.++|||||||++|||++|++||.+... ...+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-MNQLERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 112346899999999987557789999999999999999999999976421 11121111
Q ss_pred HhhccCC-------------------------------Cc-------------hhHHHHHHHHHHHHcccCCCCCCCCHH
Q 006031 602 RSAREDD-------------------------------GA-------------EDERLGMLLEVAIACNSASPEQRPTMW 637 (664)
Q Consensus 602 ~~~~~~~-------------------------------~~-------------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 637 (664)
.....+. .. .......+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 1111000 00 001234688999999999999999999
Q ss_pred HHHHH--HHhhh
Q 006031 638 QVLKM--LQEIK 647 (664)
Q Consensus 638 ev~~~--L~~i~ 647 (664)
|+++. ++.+.
T Consensus 325 e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 325 DALKHPFVSIFH 336 (388)
T ss_dssp HHTTSTTTTTTC
T ss_pred HHhCCHHHHHhc
Confidence 99875 44443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.66 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=180.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999996 5788999999864432 123457789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~ 544 (664)
++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 96 ~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 96 GEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp EEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 999999963 235689999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||...... +....+ .......+......+.+++.+
T Consensus 171 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 171 TLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLNKV--VLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------C--CSSCCCCCTTSCHHHHHHHHH
T ss_pred eccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHHHH--hhcccCCccccCHHHHHHHHH
Confidence 346889999999986 567789999999999999999999999754221 111111 011111222334568899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.||++|||+.|+++
T Consensus 246 ~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HSCSSGGGSCCHHHHTT
T ss_pred HcccCHhhCCCHHHHhc
Confidence 99999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.78 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=193.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-----CCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-----HPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|.. .+++.||||+++... ...+.+..|++++++++ ||||+++++++...+..++|||
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 46899999999999996 568899999996432 23466778888888886 9999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-------------------
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP------------------- 523 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~------------------- 523 (664)
|+ +++|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 117 PL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp CC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred CC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 99 89999999642 234589999999999999999999999 9999999999999986
Q ss_pred ------CCCeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhH
Q 006031 524 ------DFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEM 597 (664)
Q Consensus 524 ------~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~ 597 (664)
++.+||+|||+++...... ....+|+.|+|||.+. ...++.++|||||||++|||+||+.||.... ..+.
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~ 267 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH-GSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHE--HMEH 267 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC-CSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHH
T ss_pred cccccCCCCEEEEeccCceecCCCC-cCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCc--HHHH
Confidence 7899999999998654432 3456899999999987 6678999999999999999999999997532 2222
Q ss_pred HHHHHhhccCCC-----------------------------c---------------hhHHHHHHHHHHHHcccCCCCCC
Q 006031 598 MNWVRSAREDDG-----------------------------A---------------EDERLGMLLEVAIACNSASPEQR 633 (664)
Q Consensus 598 ~~~~~~~~~~~~-----------------------------~---------------~~~~~~~l~~l~~~Cl~~~P~~R 633 (664)
...+........ . .......+.+++.+||+.||++|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 222211111110 0 00001457799999999999999
Q ss_pred CCHHHHHH
Q 006031 634 PTMWQVLK 641 (664)
Q Consensus 634 Pt~~ev~~ 641 (664)
||++|+++
T Consensus 348 pta~elL~ 355 (360)
T 3llt_A 348 PSPAELLK 355 (360)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=344.57 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHH--HHHHHHcCCCCCCcccceEEEec-----CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRHPNLVPLRAYFQA-----KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~--~e~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~ 461 (664)
.+.||+|+||.||+|.. +++.||||++.... ...+. .|+..+..++||||+++++++.. ....++||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 46899999999999976 67899999986432 33344 44444556899999999986532 23568999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW--------RLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
||+++|+|.+++.. ...++..+..|+.|++.||+|||+.. +|+||||||+|||++.++.+||+|||
T Consensus 92 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 92 EYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp CCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred ecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 99999999999953 23589999999999999999999752 89999999999999999999999999
Q ss_pred ccccccCCC----------CCCCCCCCcccCccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh---
Q 006031 534 LTALTADSL----------QDDDPDNLLYKAPETRNAS------HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP--- 594 (664)
Q Consensus 534 la~~~~~~~----------~~~~~~~~~y~aPE~~~~~------~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~--- 594 (664)
+++...... .....||+.|+|||.+.+. ..++.++|||||||++|||+||+.|+.......
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998654321 1134589999999988632 345678999999999999999977754322111
Q ss_pred -------------hhHHHHHHhhccCCC------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 595 -------------NEMMNWVRSAREDDG------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 595 -------------~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
.+....+........ .....+..+.+++.+||+.||++|||+.|+++.|+++........
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 011111111111111 123356679999999999999999999999999999987765443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.75 Aligned_cols=244 Identities=24% Similarity=0.322 Sum_probs=202.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||||++............+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 478999999999999965 6889999999765544456788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC---CCCCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG---PDFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++...... .
T Consensus 107 ~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 107 ELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 99999853 34689999999999999999999999 999999999999995 56679999999998664432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|+|||++. +.++.++||||+||++|||++|+.||... ...++...+....... ......+..+.++
T Consensus 181 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp -CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 3456899999999986 35899999999999999999999999753 2334444333332221 1223345668999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.+|++|||+.|+++.
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.79 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=197.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... ++..||+|++............+.+|+++++.++||||++++++|.+.+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 578999999999999965 6889999999766554455678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++...... .
T Consensus 122 ~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 122 ELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 99998853 34689999999999999999999999 99999999999999764 559999999998765432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 621 (664)
....||+.|+|||++. ..++.++|||||||++|||++|+.||... ...++...+........ .....+..+.++
T Consensus 196 ~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred cccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3457899999999875 56899999999999999999999999763 23344444433322221 122345668999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.+|++|||+.|+++.
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=342.99 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=202.3
Q ss_pred hccccccCceeEEEEEE-----cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC--ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE--ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 461 (664)
.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 46899999999999984 368899999987542 234568999999999999999999999987654 789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 124 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred ECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999999642 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----------Chh----hHHHHHH
Q 006031 542 L-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL----------VPN----EMMNWVR 602 (664)
Q Consensus 542 ~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~----------~~~----~~~~~~~ 602 (664)
. .....++..|+|||.+. ...++.++||||||+++|||+||+.|+..... ... .+...+.
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 2 12344677899999986 56678999999999999999999998764210 000 1111111
Q ss_pred hhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 603 SAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 603 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++++..
T Consensus 278 ~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 278 NNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 1122334566899999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.79 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=188.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC------CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG------TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||+||+|... +++.||||++....... .....+.+|++++++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 467999999999999864 57899999987543221 12235889999999999999999999985 45689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~ 538 (664)
||+++|+|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 219 e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 219 ELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp ECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 9999999999984 345699999999999999999999999 99999999999999754 45999999999876
Q ss_pred cCCC-CCCCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhH
Q 006031 539 ADSL-QDDDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDE 613 (664)
Q Consensus 539 ~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 613 (664)
.... .....||+.|+|||++.. ...++.++|||||||++|||+||+.||..... ...+...+........ ....
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-SCCHHHHHHTTCCCCCHHHHTT
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-hHHHHHHHhcCCCCCCchhhcc
Confidence 5432 234568999999998752 35678899999999999999999999976432 2233333332222211 1122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....+.+++.+||+.+|++|||+.|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 3456899999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.23 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=205.2
Q ss_pred hccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.... ...||+|.+..... ....+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 4789999999999999643 24799999865432 12356789999999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 462 DYQPNGSLFSLIHGSKS---------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
||+++|+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Df 208 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDF 208 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEEEBCCC
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeEEECcc
Confidence 99999999999963210 0134689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC
Q 006031 533 CLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED 607 (664)
Q Consensus 533 Gla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 607 (664)
|+++....... ....+++.|+|||.+. ...++.++|||||||++|||+| |+.||..... ...+...+......
T Consensus 209 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~ 286 (333)
T 2i1m_A 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-NSKFYKLVKDGYQM 286 (333)
T ss_dssp GGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-SHHHHHHHHHTCCC
T ss_pred ccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-hHHHHHHHhcCCCC
Confidence 99986543321 1234577899999887 5678999999999999999999 9999876432 22333333332222
Q ss_pred CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 608 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
. .+...+..+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 287 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 287 A-QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1 12223456899999999999999999999999999886543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=337.86 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEEc--CC--eEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD--NR--LIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||+||+|.+. ++ ..||+|+++..... ....+.+.+|++++++++||||+++++++.+.+ .++|+||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 468999999999999853 23 36899998754332 234578899999999999999999999997654 8999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 102 APLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp CTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred ccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 999999999963 234689999999999999999999999 999999999999999999999999999987644321
Q ss_pred -----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 544 -----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 544 -----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
....++..|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+.............+..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp EEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred chhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccC--CHHHHHHHHHccCCCCCCCcCcCHH
Confidence 2234677899999986 5667899999999999999999 99999754 2334433333322222223344566
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 899999999999999999999999999987544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=349.23 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEE----cCCeEEEEEEccCccc--cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKL--AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 57899999999999997 4789999999875432 112345677889999998 6999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 139 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 139 DYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp CCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999963 24689999999999999999999999 9999999999999999999999999999865332
Q ss_pred C---CCCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--hhhHHHHHHhhccCCCchhHHH
Q 006031 542 L---QDDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--PNEMMNWVRSAREDDGAEDERL 615 (664)
Q Consensus 542 ~---~~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 615 (664)
. .....||+.|+|||++.+. ..++.++|||||||++|||+||+.||...... ...+...+... ....+....
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 290 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMS 290 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCTTSC
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCCcccC
Confidence 1 1234689999999998742 34788999999999999999999999754322 12232222221 112233344
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRP-----TMWQVLKM 642 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RP-----t~~ev~~~ 642 (664)
..+.+++.+||+.||++|| ++.|+++.
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 5688999999999999999 99999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=359.47 Aligned_cols=242 Identities=18% Similarity=0.220 Sum_probs=199.3
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
++||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 57999999999999975 6899999999654321 234577889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~ 545 (664)
+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 271 ~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 348 (543)
T 3c4z_A 271 DIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348 (543)
T ss_dssp BHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCC
T ss_pred CHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccccc
Confidence 9999996432 2245699999999999999999999999 999999999999999999999999999987654332 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--ChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL--VPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
..||+.|+|||++. +..++.++|||||||++|||+||+.||..... ...++...+.... ...+...+..+.+++.
T Consensus 349 ~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 425 (543)
T 3c4z_A 349 YAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSPASKDFCE 425 (543)
T ss_dssp CCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred ccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccCHHHHHHHH
Confidence 47999999999987 56789999999999999999999999976432 1223333332221 1223334556899999
Q ss_pred HcccCCCCCCCCH
Q 006031 624 ACNSASPEQRPTM 636 (664)
Q Consensus 624 ~Cl~~~P~~RPt~ 636 (664)
+||+.+|++||++
T Consensus 426 ~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 426 ALLQKDPEKRLGF 438 (543)
T ss_dssp HHSCSSGGGSCCC
T ss_pred HhccCCHhHCCCC
Confidence 9999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.04 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=196.0
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 4799999999999995 5688999999875432 445779999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeeccccccccCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++....... ...
T Consensus 106 L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 106 LSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp HHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred HHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 999997432 234567889999999999999999999 9999999999999987 8999999999998654322 234
Q ss_pred CCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+... ..++.++||||||+++|||++|+.||............ ..........+...+..+.+++.+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHHHHHHHH
Confidence 5689999999988633 23789999999999999999999998643221111111 111111222233345568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|++|||+.|+++
T Consensus 262 ~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 262 CFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTCSSTTTSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.54 Aligned_cols=252 Identities=18% Similarity=0.227 Sum_probs=182.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-----CCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-----KEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e 462 (664)
.+.||+|+||+||+|... +++.||||++..........+.+.+|++++++++|||||++++++.. .+..|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 468999999999999854 68899999996543322345678999999999999999999999844 356899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+ +|+|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 138 IA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred cc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 98 5799999953 35699999999999999999999999 99999999999999999999999999998754221
Q ss_pred -----------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-----------
Q 006031 543 -----------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT----------- 582 (664)
Q Consensus 543 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt----------- 582 (664)
.....||+.|+|||++.....++.++|||||||++|||+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1223579999999987556779999999999999999999
Q ss_pred CCCCCCCCCCCh------------------hh-HHHHHHhhccCC----------------------------CchhHHH
Q 006031 583 GKPPSQHSFLVP------------------NE-MMNWVRSAREDD----------------------------GAEDERL 615 (664)
Q Consensus 583 G~~P~~~~~~~~------------------~~-~~~~~~~~~~~~----------------------------~~~~~~~ 615 (664)
|+++|.+....+ .+ +........... .......
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 566664421100 00 100100000000 0011224
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhh
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLKM--LQEIK 647 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~ 647 (664)
..+.+|+.+||+.||++|||++|+++. ++++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 568899999999999999999999873 44443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.11 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=199.6
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 465 (664)
.+.||+|+||.||+|... +++.||+|.+..........+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999965 68899999997655433445779999999999999999999998753 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR-----LVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-----ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+|+|.+++.... .....+++..+..|+.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 91 GGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp TEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 999999996422 1234589999999999999999999998 7 99999999999999999999999999976543
Q ss_pred CCC--CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 541 SLQ--DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 541 ~~~--~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
... ....++..|+|||.+. ...++.++||||||+++|||+||+.||... ...++...+...... ..+...+..+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l 244 (279)
T 2w5a_A 169 DTSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-RIPYRYSDEL 244 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred ccccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCccc--CHHHHHHHHhhcccc-cCCcccCHHH
Confidence 321 1234788999999987 567899999999999999999999999764 233343333332221 1222344568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
.+++.+||+.+|++|||+.|+++.+.
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChh
Confidence 99999999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=328.79 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=193.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++.+++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 468999999999999975 688999999865432 223467889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~ 545 (664)
++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 96 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 96 GELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp CBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred CcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcceec
Confidence 999999953 24589999999999999999999999 99999999999999999999999999998765432 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..+++.|+|||.+.+....+.++||||||+++|||++|+.||... ....+.+.+...... .+......+.+++.+|
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--HVPTLFKKIRGGVFY--IPEYLNRSVATLLMHM 245 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCccc--CchhcCHHHHHHHHHH
Confidence 468899999999874444478999999999999999999999753 222333333322211 1222345588999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++|||+.|+++.
T Consensus 246 l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREH 262 (276)
T ss_dssp TCSSGGGSCCHHHHHHS
T ss_pred ccCChhhCCCHHHHHhC
Confidence 99999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.93 Aligned_cols=246 Identities=19% Similarity=0.254 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc---CCcHHHHHHHHHHHcCC---CCCCcccceEEEecCC-----c
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA---GTSNEMYEQHMESVGGL---RHPNLVPLRAYFQAKE-----E 456 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~-----~ 456 (664)
.+.||+|+||+||+|.. .+++.||+|++...... ......+.+|+++++++ +||||++++++|...+ .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46799999999999995 56889999998643321 12234566777776666 4999999999998755 4
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.++||||+. |+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred EEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 799999997 5999999642 234499999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC------
Q 006031 537 LTADSLQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG------ 609 (664)
Q Consensus 537 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------ 609 (664)
....... ....+|+.|+|||.+. ...++.++|||||||++|||++|+.||..... ...+............
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccCCCcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccch
Confidence 6644322 2346899999999987 56789999999999999999999999976321 1122222221111000
Q ss_pred ------------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 610 ------------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 610 ------------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00123456889999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.45 Aligned_cols=243 Identities=17% Similarity=0.210 Sum_probs=188.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||+||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++... ...|+||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 46899999999999985 4689999999976543334456788999999999999999999999654 3579999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 147 E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 147 ELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp ECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 99976 5777773 2389999999999999999999999 9999999999999999999999999999876544
Q ss_pred C-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC-------------
Q 006031 542 L-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED------------- 607 (664)
Q Consensus 542 ~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~------------- 607 (664)
. .....+|+.|+|||.+. +..++.++|||||||++|||++|+.||.+... ...+...+.....+
T Consensus 218 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp CCC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred cccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 2 23457899999999987 56789999999999999999999999976421 11111111111100
Q ss_pred ---------CC-----------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 608 ---------DG-----------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 608 ---------~~-----------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. ........+.+++.+||+.||++|||++|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 011124568999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.78 Aligned_cols=242 Identities=26% Similarity=0.412 Sum_probs=201.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 46899999999999985 4688999999875443 245678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 99999942 4689999999999999999999999 99999999999999999999999999997765432 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..++..|+|||.+. ...++.++||||||+++|||++|+.||... ........+...... ......+..+.+++.+|
T Consensus 179 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 179 FVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSEL--HPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp CCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-CCCSSCCHHHHHHHHHH
T ss_pred cCCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCc--CHHHHHHHhhcCCCC-CCccccCHHHHHHHHHH
Confidence 56889999999987 567889999999999999999999998753 222333333222211 12223345589999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 006031 626 NSASPEQRPTMWQVLKM 642 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~ 642 (664)
|+.+|++|||+.|+++.
T Consensus 255 l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSGGGSCCHHHHTTC
T ss_pred cCCChhhCcCHHHHhhC
Confidence 99999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=353.34 Aligned_cols=245 Identities=14% Similarity=0.158 Sum_probs=195.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||+||+++.+ +++.||+|++++... .....+.+.+|.+++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 468999999999999974 689999999965322 112234578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---C
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---Q 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 543 (664)
|+|.++++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...... .
T Consensus 146 g~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 146 GDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 9999999632 24689999999999999999999998 99999999999999999999999999998764432 1
Q ss_pred CCCCCCCcccCcccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh---ccCCCchhHH
Q 006031 544 DDDPDNLLYKAPETRNA------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA---REDDGAEDER 614 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 614 (664)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||... ...+....+... ..........
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCC----CC
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccCcCCCccccCC
Confidence 23579999999998862 346789999999999999999999999763 222222222111 1111111223
Q ss_pred HHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQR---PTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~R---Pt~~ev~~ 641 (664)
+..+.+++.+||. +|++| |++.|+.+
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 4568999999998 99998 58988865
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.59 Aligned_cols=252 Identities=18% Similarity=0.275 Sum_probs=193.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 367999999999999975 6889999998644321 111235578999999999999999999999999999999997 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 85 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 85 DLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 99999864 234689999999999999999999999 99999999999999999999999999997654322 223
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-ccCCC---------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA-REDDG--------------- 609 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~--------------- 609 (664)
..+|..|+|||.+.+...++.++|||||||++|||++|+.||.... ..+....+... .....
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4679999999998755678999999999999999999999997642 22222222211 11100
Q ss_pred ------------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhcc
Q 006031 610 ------------AEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKGA 649 (664)
Q Consensus 610 ------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~~ 649 (664)
........+.+++.+||+.||++|||++|+++ .+.++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00112355789999999999999999999987 34555443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.61 Aligned_cols=247 Identities=17% Similarity=0.248 Sum_probs=202.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCc---------------HHHHHHHHHHHcCCCCCCcccceEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTS---------------NEMYEQHMESVGGLRHPNLVPLRAYFQA 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---------------~~~~~~e~~~l~~l~H~niv~l~g~~~~ 453 (664)
.+.||+|+||.||+|.. +++.||+|.+......... .+.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46899999999999999 8999999998654332111 1789999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHH------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeCCCCC
Q 006031 454 KEERLLIYDYQPNGSLFSL------IHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLGPDFE 526 (664)
Q Consensus 454 ~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~~~~~ 526 (664)
.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTTSC
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCCCc
Confidence 9999999999999999998 532 224679999999999999999999999 7 9999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc
Q 006031 527 ACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATS-KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 605 (664)
+||+|||.+............++..|+|||.+.+...++. ++||||||+++|||++|+.||...... .++...+....
T Consensus 191 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~i~~~~ 269 (348)
T 2pml_X 191 VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELFNNIRTKN 269 (348)
T ss_dssp EEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHHHHHTSCC
T ss_pred EEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccC
Confidence 9999999998765554455678999999999874435555 999999999999999999999764321 33333332221
Q ss_pred cCCCc-----------------hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 606 EDDGA-----------------EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 606 ~~~~~-----------------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..... ....+..+.+++.+||+.+|++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110 0234456899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.49 Aligned_cols=247 Identities=24% Similarity=0.277 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC---CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG---TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 468999999999999964 58899999997543211 11246789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-- 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 542 (664)
++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 95 ET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp SE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred CC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 86 89998853 335689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC-------------
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG------------- 609 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 609 (664)
.....+|+.|+|||.+.+...++.++|||||||++|||++|++||.... ....+............
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 2345689999999998755668999999999999999999999987532 11222222221111100
Q ss_pred --------c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 610 --------A----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 610 --------~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. .......+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 01223568999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.99 Aligned_cols=249 Identities=20% Similarity=0.254 Sum_probs=192.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46799999999999996 56899999999654332233567889999999999999999999997653 469999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 110 PFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp ECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 999 8899999963 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------- 608 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------- 608 (664)
.....+|+.|+|||.+.+...++.++||||+||++|||++|+.||..... ...+...........
T Consensus 182 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 182 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 23457899999999987557789999999999999999999999976421 111111111111000
Q ss_pred ------------C---chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhh
Q 006031 609 ------------G---AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIK 647 (664)
Q Consensus 609 ------------~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~ 647 (664)
. ........+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 011224568899999999999999999999873 44443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.17 Aligned_cols=243 Identities=21% Similarity=0.315 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 468999999999999975 57889999986543221 2356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 100 ~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 100 RSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp CBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 999999853 34689999999999999999999999 9999999999999999999999999999865432 223
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++||||||+++|||+||+.||.... ..+....+... ....+......+.+++.+
T Consensus 174 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 174 VLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKN--EYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCCSCCSSCCHHHHT-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTT--CCCCCTTSCHHHHHHHHH
T ss_pred cccCCCCcCCcchhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhc--cCCCccccCHHHHHHHHH
Confidence 356889999999986 5678999999999999999999999997532 22222222111 111222334568899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
||+.+|++|||+.|+++.
T Consensus 249 ~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 249 MLQTDPTARPTINELLND 266 (294)
T ss_dssp HTCSSGGGSCCGGGGGGS
T ss_pred HcccChhhCcCHHHHhhC
Confidence 999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=350.53 Aligned_cols=253 Identities=18% Similarity=0.234 Sum_probs=193.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++... +..|+|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 46899999999999996 4588999999975433223456789999999999999999999999766 57899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. |+|.+++.. ...+++..+..|+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 111 ~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 111 IAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp CCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred cCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 986 599999953 35699999999999999999999999 99999999999999999999999999998754321
Q ss_pred ------------------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC----------
Q 006031 543 ------------------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQ---------- 588 (664)
Q Consensus 543 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~---------- 588 (664)
.....+|+.|+|||.+.....++.++|||||||++|||++|..||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1345689999999987556779999999999999999998555443
Q ss_pred -CCCCC----------------hhh-----------------------HHHHHHhhccCCCc-----hhHHHHHHHHHHH
Q 006031 589 -HSFLV----------------PNE-----------------------MMNWVRSAREDDGA-----EDERLGMLLEVAI 623 (664)
Q Consensus 589 -~~~~~----------------~~~-----------------------~~~~~~~~~~~~~~-----~~~~~~~l~~l~~ 623 (664)
+.... ... ...++......... .......+.+++.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 21100 000 11111111111000 0123456889999
Q ss_pred HcccCCCCCCCCHHHHHHH--HHhhhc
Q 006031 624 ACNSASPEQRPTMWQVLKM--LQEIKG 648 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~~--L~~i~~ 648 (664)
+||+.||++|||+.|+++. +++++.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999873 455543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.37 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||.||+|.. .++..||||.+..... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 46899999999999984 3467899999964322 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeecccccc
Q 006031 463 YQPNGSLFSLIHGSKS--TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTAL 537 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~ 537 (664)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||++. +..+||+|||+++.
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 9999999999975321 1224589999999999999999999999 9999999999999984 45699999999975
Q ss_pred ccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 538 TADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 538 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
...... ....+++.|+|||.+. ...++.++||||||+++|||+| |+.||... ...++...+....... ...
T Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~ 268 (327)
T 2yfx_A 193 IYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGRMD-PPK 268 (327)
T ss_dssp HHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCCC-CCT
T ss_pred cccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHHhcCCCCC-CCC
Confidence 433221 1234678999999986 5678999999999999999999 99998753 2334444444332221 222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..+..+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 34456899999999999999999999999999886544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=357.83 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=203.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||+|... +++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999965 7889999999655432 34578899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~ 543 (664)
|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 111 ~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 111 GELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999999953 35699999999999999999999999 99999999999999 5678999999999986644321
Q ss_pred -CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHH
Q 006031 544 -DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLE 620 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 620 (664)
....||+.|+|||.+. +.++.++||||+||++|||++|+.||... ...++...+....... +.....+..+.+
T Consensus 185 ~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGA--NEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp HHHHTTGGGTCCHHHHH--TCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccCCCCccccCceeec--CCCCCcceeHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 2346899999999986 36899999999999999999999999763 2334444443332222 122344566899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++|||+.|+++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.22 Aligned_cols=245 Identities=20% Similarity=0.314 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 467999999999999975 588999999865432 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ....
T Consensus 102 ~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 102 AVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred cHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999863 234689999999999999999999999 9999999999999999999999999997543221 1223
Q ss_pred CCCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 546 ~~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
..++..|+|||.+. ....++.++||||||+++|||++|+.||..... ...+.............+...+..+.++
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHHHHhccCCcccCCccccCHHHHHH
Confidence 46889999999873 256678999999999999999999999875321 1122222222222222233445668999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.+|++|||+.|+++
T Consensus 256 i~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 256 LKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHcccChhhCCCHHHHhc
Confidence 99999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.87 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 468999999999999965 47889999986543321 2356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
++|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 126 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 126 RSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp CBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 999999853 34689999999999999999999999 9999999999999999999999999999865432 223
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...++..|+|||.+. ...++.++||||||+++|||++|+.||.... ..+....+.... ...+......+.+++.+
T Consensus 200 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 200 VLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNE--YSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTC--CCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHhcCC--CCCCccCCHHHHHHHHH
Confidence 456899999999987 5678999999999999999999999997532 222222222111 11222334558899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~ 642 (664)
||+.||++|||+.|+++.
T Consensus 275 ~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 275 MLQTDPTARPTINELLND 292 (335)
T ss_dssp HTCSSGGGSCCGGGGGGS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.03 Aligned_cols=243 Identities=21% Similarity=0.307 Sum_probs=197.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-----------CcHHHHHHHHHHHcCCCCCCcccceEEEecCCc
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-----------TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE 456 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 456 (664)
.+.||+|+||+||+|... ++..||+|++....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 468999999999999965 57899999997544321 345778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC---CeEEeecc
Q 006031 457 RLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---EACLADYC 533 (664)
Q Consensus 457 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---~~ki~DfG 533 (664)
.++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 121 ~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 9999999999999999953 34699999999999999999999999 999999999999998775 69999999
Q ss_pred ccccccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc--
Q 006031 534 LTALTADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA-- 610 (664)
Q Consensus 534 la~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 610 (664)
+++...... .....||+.|+|||.+. ..++.++||||+||++|||++|+.||... ...++...+.........
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCHHH
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCccc
Confidence 998765432 23457899999999985 46899999999999999999999999763 233444444333222111
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....+..+.+++.+||+.+|++|||+.|+++
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1223456899999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.57 Aligned_cols=240 Identities=21% Similarity=0.280 Sum_probs=193.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.++.... ...+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 478999999999999965 688999999965432 234677777776 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC----CCeEEeeccccccccCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD----FEACLADYCLTALTADS- 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~~~~~- 541 (664)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 101 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 101 GELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999953 35689999999999999999999999 99999999999998543 34999999999865443
Q ss_pred -CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-ChhhHHHHHHhhccCCC--chhHHHHH
Q 006031 542 -LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFL-VPNEMMNWVRSAREDDG--AEDERLGM 617 (664)
Q Consensus 542 -~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~ 617 (664)
......+|+.|+|||.+. ...++.++|||||||++|||++|+.||..... ...++...+........ ........
T Consensus 175 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred CceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 223456899999999986 45578899999999999999999999975322 23344444433222211 12334566
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhc
Confidence 899999999999999999999886
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=342.39 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=198.3
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccC------CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG------TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 78999999999999975 68999999986543211 1135678999999998 7999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 180 e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 180 DLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp CCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999953 34689999999999999999999999 9999999999999999999999999999866543
Q ss_pred -CCCCCCCCCcccCcccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCc--hhH
Q 006031 542 -LQDDDPDNLLYKAPETRNA-----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGA--EDE 613 (664)
Q Consensus 542 -~~~~~~~~~~y~aPE~~~~-----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 613 (664)
......||+.|+|||++.+ ...++.++|||||||++|||+||+.||... ........+......... ...
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCHHHHSS
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCCccccc
Confidence 2334578999999998752 235788999999999999999999999753 222333333222221111 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3456899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.26 Aligned_cols=248 Identities=13% Similarity=0.147 Sum_probs=188.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHH---HHHcCCCCCCcccce-------EEEecCC-
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHM---ESVGGLRHPNLVPLR-------AYFQAKE- 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~---~~l~~l~H~niv~l~-------g~~~~~~- 455 (664)
.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|+ +.+++++|||||+++ +++.+.+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999995 5689999999975432 223457899999 566777899999998 6665543
Q ss_pred ----------------ceEEEEecCCCCCHHHHhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCC
Q 006031 456 ----------------ERLLIYDYQPNGSLFSLIHGSK--STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSS 517 (664)
Q Consensus 456 ----------------~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~ 517 (664)
..++||||+ +|+|.+++.... ......++|..+..|+.||+.||+|||+. +|+||||||+
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~ 235 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPV 235 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHH
Confidence 278999999 689999996421 11123455788999999999999999999 9999999999
Q ss_pred CeEeCCCCCeEEeeccccccccCCCCCCCCCCCcccCccccccC----------CCCCchhhHHHHHHHHHHHHcCCCCC
Q 006031 518 NVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNAS----------HQATSKSDVYSFGVLLLELLTGKPPS 587 (664)
Q Consensus 518 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~ksDVwSfGvvl~elltG~~P~ 587 (664)
|||++.++.+||+|||+++...... ....| +.|+|||.+... ..++.++|||||||++|||+||+.||
T Consensus 236 NIll~~~~~~kL~DFG~a~~~~~~~-~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf 313 (377)
T 3byv_A 236 DIVLDQRGGVFLTGFEHLVRDGARV-VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313 (377)
T ss_dssp GEEECTTCCEEECCGGGCEETTCEE-ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred HEEEcCCCCEEEEechhheecCCcc-cCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999998654322 23456 899999998733 26899999999999999999999999
Q ss_pred CCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 006031 588 QHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKG 648 (664)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~ 648 (664)
...... .....+ ... ....+..+.+++.+||+.||++|||+.|+++ .++++++
T Consensus 314 ~~~~~~--~~~~~~---~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 314 TKDAAL--GGSEWI---FRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp --------CCSGGG---GSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred cccccc--cchhhh---hhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 753211 111111 111 1122345889999999999999999999986 4455443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.83 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 468999999999999975 48899999986532 3467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 110 ~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 110 SVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp EHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 99999952 235689999999999999999999999 99999999999999999999999999997665432 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~ 624 (664)
..++..|+|||.+. ...++.++||||||+++|||++|+.||.... ............. ....+...+..+.+++.+
T Consensus 185 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 185 VIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIH--PMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 56889999999987 5678999999999999999999999997532 2222222211111 112233345668999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.+|++|||+.|+++
T Consensus 262 ~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 262 CLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HTCSCTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHHh
Confidence 99999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.78 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=183.0
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEe--------cCCce
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQ--------AKEER 457 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~--------~~~~~ 457 (664)
..++||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.++. ||||+++++++. .....
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 357899999999999996 4688999999854322 34567889999999996 999999999984 33357
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeCCCCCeEEeecccc
Q 006031 458 LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLGPDFEACLADYCLT 535 (664)
Q Consensus 458 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~~~~~~ki~DfGla 535 (664)
++|+||+. |+|.+++.... ....+++..+..|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999996 79999885321 234699999999999999999999998 7 999999999999999999999999999
Q ss_pred ccccCCCC--------------CCCCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH
Q 006031 536 ALTADSLQ--------------DDDPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 536 ~~~~~~~~--------------~~~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~ 599 (664)
+....... ....+++.|+|||.+. ....++.++|||||||++|||+||+.||..... ..+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~ 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--LRIVN 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--HHhhc
Confidence 87644221 1234788999999873 255678999999999999999999999975321 11111
Q ss_pred HHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 600 WVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
..... .........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 264 ---~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 264 ---GKYSI-PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----CCC-CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---CcccC-CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11111 111112234789999999999999999999999999997654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.56 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=180.6
Q ss_pred hccccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~ 463 (664)
+++||+|+||+||+|... +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++||||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 568999999999999975 57889999996543 23568899999999999999999999954 6688999999
Q ss_pred CCCCCHHHHhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe----CCCCCeEEeecccc
Q 006031 464 QPNGSLFSLIHGSK----STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL----GPDFEACLADYCLT 535 (664)
Q Consensus 464 ~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla 535 (664)
+. |+|.+++.... ......+++..+..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 96 58888775211 12233599999999999999999999999 99999999999999 77899999999999
Q ss_pred ccccCCC-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------hhhHHHHHH
Q 006031 536 ALTADSL-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV--------PNEMMNWVR 602 (664)
Q Consensus 536 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~--------~~~~~~~~~ 602 (664)
+...... .....+|+.|+|||++.+...++.++|||||||++|||+||+.||...... ...+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 8765421 123468999999999875566899999999999999999999999653221 112222221
Q ss_pred hhccCCC---------------------------chh--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 603 SAREDDG---------------------------AED--------ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 603 ~~~~~~~---------------------------~~~--------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....... ... .....+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111110 000 00345789999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.35 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=181.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 46899999999999984 4688999999865432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--
Q 006031 468 SLFSLIHGS---KSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-- 542 (664)
Q Consensus 468 sL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 542 (664)
+|.+++... .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 999998531 112345689999999999999999999999 99999999999999999999999999987654321
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-------Cc
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-------GA 610 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------~~ 610 (664)
.....+++.|+|||.+.....++.++||||||+++|||+||+.||...... .............. ..
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T 2vwi_A 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-KVLMLTLQNDPPSLETGVQDKEM 256 (303)
T ss_dssp ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHTSSCCCTTC-----CC
T ss_pred cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-hHHHHHhccCCCccccccccchh
Confidence 123458899999998864456899999999999999999999999764221 11111111111110 01
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.......+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1223356889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.50 Aligned_cols=239 Identities=17% Similarity=0.235 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEec--CCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQA--KEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~~ 464 (664)
.+.||+|+||+||+|.. .+++.||+|+++. ...+.+.+|++++++++ ||||+++++++.+ ....++||||+
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 46899999999999985 5788999999863 34578999999999997 9999999999987 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCCC-
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADSL- 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~- 542 (664)
++++|.++++ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 116 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred CchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999984 388999999999999999999999 999999999999999776 89999999998654432
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH------------hhccCC--
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR------------SAREDD-- 608 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~------------~~~~~~-- 608 (664)
.....++..|+|||.+.....++.++|||||||++|||++|+.||.........+..... ......
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 234568899999999875577899999999999999999999999654332222222111 111000
Q ss_pred --------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.........+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001113566899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.25 Aligned_cols=243 Identities=16% Similarity=0.193 Sum_probs=185.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 46899999999999985 46889999999754332234567889999999999999999999997655 689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++ +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 110 ELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp ECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred EcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 99975 8888884 2488999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc---------------
Q 006031 542 L-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR--------------- 605 (664)
Q Consensus 542 ~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~--------------- 605 (664)
. .....+|+.|+|||.+. ...++.++|||||||++|||++|+.||..... ...+...+....
T Consensus 181 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ---------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 2 23356899999999987 56789999999999999999999999976321 111111111000
Q ss_pred -------cCC---------------C--chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 606 -------EDD---------------G--AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 606 -------~~~---------------~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
... . ........+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 0 011235678999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=341.54 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=178.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 46899999999999985 5689999999965433223456788999999999999999999998654 5679999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 999 6899998842 4699999999999999999999999 9999999999999999999999999999875543
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED-------------- 607 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~-------------- 607 (664)
. ....+|..|+|||.+.+...++.++|||||||++|||++|+.||.+... ...+.........+
T Consensus 186 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 186 M-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred C-CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 2 3356899999999987557789999999999999999999999976421 11111111111110
Q ss_pred ---------CC-ch----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 608 ---------DG-AE----DERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 608 ---------~~-~~----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.. .. ......+.+++.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 00 1123458899999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.60 Aligned_cols=251 Identities=15% Similarity=0.193 Sum_probs=199.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC-CCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH-PNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.++||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++| +++..+..++.+.+..++||||+ +
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 46899999999999995 5688999998765432 2347889999999987 45556666667788889999999 9
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe---CCCCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL---GPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~ 543 (664)
++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 87 ~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 87 PSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999632 34699999999999999999999999 99999999999999 6889999999999987654322
Q ss_pred ---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHH-HHHhhccCC--Cc
Q 006031 544 ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMN-WVRSAREDD--GA 610 (664)
Q Consensus 544 ---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~-~~~~~~~~~--~~ 610 (664)
....||..|+|||.+. ...++.++|||||||++|||++|+.||....... .+... ......... ..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 1356899999999987 6678999999999999999999999998653321 12222 211111111 01
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
....+.++.+++..||+.+|++||++.+|++.|+++....
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1223456899999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.79 Aligned_cols=242 Identities=21% Similarity=0.266 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC------CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL------RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.++||+|+||+||+|... +++.||||++.... ...+.+.+|+++++.+ +|+||+++++++...+..++||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 478999999999999864 58999999996532 2345667777776655 6779999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--eEEeecccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE--ACLADYCLTALTA 539 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~~~ 539 (664)
||+. ++|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 179 e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 179 ELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred eccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9996 6999999642 234589999999999999999999999 9999999999999999987 9999999997654
Q ss_pred CCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------
Q 006031 540 DSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------- 608 (664)
Q Consensus 540 ~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------- 608 (664)
... ....+|+.|+|||++. ...++.++|||||||++|||+||++||..... ...+...+.......
T Consensus 254 ~~~-~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 254 QRV-YTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp CCC-CSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred Ccc-cccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 432 3457899999999987 56789999999999999999999999976421 112222221110000
Q ss_pred --------------------------------------C--ch-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------------------------------------G--AE-----DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------------------------------------~--~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. .. ......+.+++.+||+.||++|||+.|+++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 0 00 011345889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.32 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=188.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCC---------cHHHHHHHHHHHcCCCCCCcccceEEEecC-----
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT---------SNEMYEQHMESVGGLRHPNLVPLRAYFQAK----- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----- 454 (664)
.+.||+|+||.||+|...++..||||++........ ..+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 468999999999999988899999999864332111 137789999999999999999999998542
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 455 EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 455 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
...++||||++ |+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEecCc
Confidence 35799999998 689888863 335699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----
Q 006031 535 TALTADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----- 608 (664)
Q Consensus 535 a~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 608 (664)
++...... .....++..|+|||.+.+...++.++|||||||++|||++|+.||..... ...+...+.......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChHHhh
Confidence 97544332 23356889999999987557789999999999999999999999976421 111111111111000
Q ss_pred ------------------C------chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 ------------------G------AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 ------------------~------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
. ........+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 011123458899999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.54 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc------CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA------GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|... +++.||||.+...... ......+.+|++++++++||||+++++++...+ .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 468999999999999964 5889999998754321 112345889999999999999999999987654 89999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~ 538 (664)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 94 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 94 ELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp ECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 9999999999995 345689999999999999999999999 9999999999999987655 999999999876
Q ss_pred cCCCC-CCCCCCCcccCccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhH
Q 006031 539 ADSLQ-DDDPDNLLYKAPETRN--ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDE 613 (664)
Q Consensus 539 ~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 613 (664)
..... ....+++.|+|||.+. ....++.++|||||||++|||++|+.||...... ..+...+........ ....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHTCCCCCHHHHTT
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhCccccCchhhhh
Confidence 43311 1234789999999863 2456789999999999999999999999754322 233333332222111 1122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 3456899999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=326.62 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=200.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|+||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 468999999999999975 6889999999766554556788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC---CCeEEeeccccccccCCCC-
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD---FEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~~~- 543 (664)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++........
T Consensus 107 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 107 ELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 99998853 24689999999999999999999999 99999999999999754 4699999999986644322
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 621 (664)
....++..|+|||.+. +.++.++||||||+++|||++|+.||... ...++...+........ .....+..+.++
T Consensus 181 ~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SCHHHHHTTCCHHHHT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred ccccCcccccChHHhc--CCCCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 2234678899999885 35899999999999999999999999753 23333333332222111 122345568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.+|++|||+.|+++
T Consensus 257 i~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhc
Confidence 99999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.32 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=190.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEec------CCceEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQA------KEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~------~~~~~lV 460 (664)
.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++|
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 46899999999999996 468899999986433 3457788999999998 89999999999976 4578999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 106 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 9999999999999642 235689999999999999999999999 999999999999999999999999999986543
Q ss_pred CC--CCCCCCCCcccCcccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHH
Q 006031 541 SL--QDDDPDNLLYKAPETRNA----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~--~~~~~~~~~y~aPE~~~~----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 614 (664)
.. .....++..|+|||.+.. ...++.++|||||||++|||+||+.||.... .......+.............
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCSCS
T ss_pred CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCccccCCcccc
Confidence 32 223468999999998752 3567899999999999999999999996532 222222222222221112233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+++.+||+.+|++|||+.|+++
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 456899999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=363.85 Aligned_cols=242 Identities=19% Similarity=0.245 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.++||+|+||.||+|... +++.||||+++.... .....+.+..|.+++..+ +||||+.+++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 468999999999999965 578899999975422 223456778889999887 79999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC--CCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~ 543 (664)
+|+|.++++. ...+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.... ...
T Consensus 426 gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 426 GGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp SCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 9999999963 24699999999999999999999999 999999999999999999999999999986432 223
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ...++.+.+.... ...+......+.+++.
T Consensus 500 ~~~~GT~~Y~APE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHN--VAYPKSMSKEAVAICK 574 (674)
T ss_dssp CCCCSCSSSCCHHHHT-CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHSSC--CCCCTTSCHHHHHHHH
T ss_pred ccccCCCcccCHhhhc-CCCCCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCC--CCCCccCCHHHHHHHH
Confidence 4467999999999987 677899999999999999999999999763 2333333332221 2233344566899999
Q ss_pred HcccCCCCCCCCH-----HHHHH
Q 006031 624 ACNSASPEQRPTM-----WQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~-----~ev~~ 641 (664)
+||+.||++||++ .||.+
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHccCCHHHCCCCCCCcHHHHhc
Confidence 9999999999987 56653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.00 Aligned_cols=241 Identities=20% Similarity=0.356 Sum_probs=188.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-------------C
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-------------K 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-------------~ 454 (664)
.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ .
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 46899999999999996 478899999985432 245678999999999999999999998865 3
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccc
Q 006031 455 EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCL 534 (664)
Q Consensus 455 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 534 (664)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 467999999999999999963 234678899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC----------------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHH
Q 006031 535 TALTADSL----------------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM 598 (664)
Q Consensus 535 a~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~ 598 (664)
+....... .....++..|+|||.+.+...++.++|||||||++|||++ ||.... ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hHHHHH
Confidence 97654221 1234578899999998755578999999999999999998 443211 111222
Q ss_pred HHHHhhccC--CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 599 NWVRSARED--DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 599 ~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+...... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222221111 1123334456889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.91 Aligned_cols=243 Identities=18% Similarity=0.230 Sum_probs=191.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCce------EEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEER------LLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~------~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 46799999999999985 4689999999976443323357788999999999999999999999877654 9999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 127 PFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp ECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred cccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 9997 68988873 2489999999999999999999999 9999999999999999999999999999865443
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhc----------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR---------------- 605 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~---------------- 605 (664)
. ....+|+.|+|||.+.+...++.++|||||||++|||+||+.||..... ...+........
T Consensus 198 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 198 M-TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred c-CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 2 3456899999999987557789999999999999999999999976421 111111111111
Q ss_pred -------cCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 606 -------EDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 606 -------~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.... ........+.+++.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 011224568999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=362.56 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=202.2
Q ss_pred HhccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 388 SAELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
..+.||+|+||.||+|.... +..||+|.++.... ....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 35789999999999998643 56799999865322 123467899999999999999999999985 4678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 472 ~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 472 CTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp CTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred CCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999963 234689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ---CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 544 ---DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 544 ---~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
....+++.|+|||.+. ...++.++|||||||++|||++ |+.||... ...++...+...... ..+...+..+.
T Consensus 547 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~ 622 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL-PMPPNCPPTLY 622 (656)
T ss_dssp -------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCCC-CCCTTCCHHHH
T ss_pred eeccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCC-CCCccccHHHH
Confidence 1234678899999986 5678999999999999999997 99998753 233444433332221 12233455689
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 623 ~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 623 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.64 Aligned_cols=245 Identities=12% Similarity=0.045 Sum_probs=176.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHH---HHHHcCCCCCCcccce-------EEEecC--
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQH---MESVGGLRHPNLVPLR-------AYFQAK-- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e---~~~l~~l~H~niv~l~-------g~~~~~-- 454 (664)
.+.||+|+||+||+|... +++.||+|++..... .....+.+.+| ++.++. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 578999999999999964 789999999976543 11234567777 455666 799988754 444332
Q ss_pred ---------------CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCcccCC
Q 006031 455 ---------------EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSC------LKIAEDVAQGLSYIHQAWRLVHGN 513 (664)
Q Consensus 455 ---------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~ivHrD 513 (664)
...++||||++ |+|.++++.. ...+.+..+ ..|+.||+.||+|||+. +|+|||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHrD 219 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGH 219 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccCc
Confidence 23799999999 8999999642 234566666 78889999999999999 999999
Q ss_pred CCCCCeEeCCCCCeEEeeccccccccCCCCCCCCCCCcccCcccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 006031 514 LKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA-SHQATSKSDVYSFGVLLLELLTGKPPSQHSFL 592 (664)
Q Consensus 514 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~ 592 (664)
|||+|||++.++.+||+|||+++....... ...+++.|+|||.+.. ...++.++|||||||++|||+||+.||.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999987654331 2446699999999862 15689999999999999999999999976532
Q ss_pred ChhhHHHH---HHhhccCC--CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 593 VPNEMMNW---VRSAREDD--GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 593 ~~~~~~~~---~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
........ ........ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11110000 00000000 111233456899999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.04 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=198.9
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-------CcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-------TSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-------~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|++++++++ ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999975 68999999986543111 12356789999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 102 VFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 9999999999999963 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-CCCCCCCCcccCccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--Cch
Q 006031 540 DSL-QDDDPDNLLYKAPETRN-----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAE 611 (664)
Q Consensus 540 ~~~-~~~~~~~~~y~aPE~~~-----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~ 611 (664)
... .....++..|+|||.+. ....++.++||||||+++|||++|+.||... ........+....... ...
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTG
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHHHHhcCCcccCcccc
Confidence 432 23456899999999874 2345788999999999999999999999753 2223333322222111 112
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+..+.+++.+||+.+|++|||+.|+++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 344566899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.75 Aligned_cols=243 Identities=20% Similarity=0.308 Sum_probs=193.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|++++.+++||||+++++++... ...++|+|
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 468999999999999854 688999999864322 12346788999999999999999999998654 36899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. |+|.+++.. ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 111 ~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 111 LME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 997 599999953 3589999999999999999999999 99999999999999999999999999998664332
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC----------
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED---------- 607 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~---------- 607 (664)
.....+|+.|+|||.+.....++.++|||||||++|||++|+.||...... ..+..........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhhh
Confidence 123468999999998765666899999999999999999999999764321 1121111111110
Q ss_pred -------------CCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 -------------DGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 -------------~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... .......+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0112356889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.95 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=192.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc------eEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE------RLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~lV~e 462 (664)
.++||+|+||+||+|....+..||+|++..... ...+|+++++.++||||+++++++...+. .++|||
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 468999999999999988777799998854322 22368999999999999999999865443 789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC-CCCCeEEeeccccccccCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG-PDFEACLADYCLTALTADS 541 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~ 541 (664)
|++++.+....+.. .....+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 99875444333211 1235689999999999999999999999 999999999999999 7999999999999875433
Q ss_pred C-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------
Q 006031 542 L-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------ 608 (664)
Q Consensus 542 ~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------ 608 (664)
. .....+|+.|+|||.+.+...++.++|||||||++|||++|+.||..... ...+...+.....+.
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 2 23456899999999987556789999999999999999999999976421 122222222111100
Q ss_pred ----------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhcc
Q 006031 609 ----------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGA 649 (664)
Q Consensus 609 ----------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~ 649 (664)
. ........+.+++.+||+.||++|||+.|+++. +++++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 0 011133568999999999999999999999874 5555543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.98 Aligned_cols=250 Identities=16% Similarity=0.266 Sum_probs=192.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-------------
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------------- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------------- 454 (664)
.+.||+|+||+||+|.. .+++.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 46899999999999985 5789999999864322 234789999999999999999998543
Q ss_pred -------------------------CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 006031 455 -------------------------EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509 (664)
Q Consensus 455 -------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~i 509 (664)
...++||||++ |+|.+.+.... .....+++..+..++.|+++||+|||+. +|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi 162 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHSL-GI 162 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTT-TE
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC-cC
Confidence 33789999998 58877775211 1235699999999999999999999998 99
Q ss_pred ccCCCCCCCeEeC-CCCCeEEeeccccccccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006031 510 VHGNLKSSNVLLG-PDFEACLADYCLTALTADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPS 587 (664)
Q Consensus 510 vHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~ 587 (664)
+||||||+|||++ .++.+||+|||+++...... .....++..|+|||.+.+...++.++|||||||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999997 68899999999998654432 334568999999999875566899999999999999999999999
Q ss_pred CCCCCChhhHHHHHHhhccCC----------------------C----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 588 QHSFLVPNEMMNWVRSAREDD----------------------G----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~~~----------------------~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... ....+...+.....+. . .+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 243 SGET-SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSS-HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCC-hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7632 1122222222111110 0 11123455899999999999999999999984
Q ss_pred --HHHhhhc
Q 006031 642 --MLQEIKG 648 (664)
Q Consensus 642 --~L~~i~~ 648 (664)
.+++++.
T Consensus 322 hp~f~~~~~ 330 (383)
T 3eb0_A 322 HPFFDHLRN 330 (383)
T ss_dssp SGGGHHHHH
T ss_pred CHHHHHHHh
Confidence 3455544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.02 Aligned_cols=245 Identities=19% Similarity=0.252 Sum_probs=193.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc--CCcHHHHHHHHHHHcCCCCCCcccceEEEe--cCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA--GTSNEMYEQHMESVGGLRHPNLVPLRAYFQ--AKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.. .++..||+|.+...... ....+.+.+|++++++++||||+++++++. +.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46799999999999996 46889999999754321 234678999999999999999999999984 45578999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL- 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 542 (664)
++++ |.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 90 CVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164 (305)
T ss_dssp CSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred ccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence 9876 77777542 245689999999999999999999999 99999999999999999999999999998654321
Q ss_pred ---CCCCCCCCcccCccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 543 ---QDDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 543 ---~~~~~~~~~y~aPE~~~~~~-~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
.....++..|+|||.+.+.. ..+.++||||||+++|||++|+.||... ...++...+..... ..+......+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~--~~~~~~~~~l 240 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--NIYKLFENIGKGSY--AIPGDCGPPL 240 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCC--CCCSSSCHHH
T ss_pred ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--hHHHHHHHHhcCCC--CCCCccCHHH
Confidence 12346899999999886322 2477999999999999999999999753 22233332222211 1222334568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=328.75 Aligned_cols=246 Identities=19% Similarity=0.257 Sum_probs=192.0
Q ss_pred hccccccCceeEEEEEE--cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC---CCCCcccceEEEe-----cCCceE
Q 006031 389 AELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL---RHPNLVPLRAYFQ-----AKEERL 458 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~-----~~~~~~ 458 (664)
.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46899999999999997 4688999999875443222333456666666555 8999999999987 456789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
+||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 96 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred EEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 9999998 6999999642 234589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC---------
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--------- 608 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--------- 608 (664)
... ......++..|+|||.+. ...++.++|||||||++|||+||+.||..... ...+...........
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cCCCCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCcccCccccc
Confidence 433 223456899999999987 56789999999999999999999999976421 112222221111000
Q ss_pred ---------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ---------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ---------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
......+..+.+++.+||+.+|++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001223456889999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.10 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=191.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC----C--ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK----E--ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~--~~~lV~ 461 (664)
.+.||+|+||+||+|... +++.||||++.... ..+.+|++++++++|||||+++++|... + ..++||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 468999999999999975 58999999986432 2234789999999999999999998542 1 367999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-CCeEEeeccccccccC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTAD 540 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~ 540 (664)
||+++ ++.+.+.... .....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 133 e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp ECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred hcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99986 6666553211 1235699999999999999999999998 99999999999999965 5689999999987543
Q ss_pred CC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------
Q 006031 541 SL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------- 608 (664)
Q Consensus 541 ~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------- 608 (664)
.. .....+|+.|+|||++.+...++.++|||||||++|||++|+.||..... ...+...+.......
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 32 23456899999999987555789999999999999999999999976421 122333222111000
Q ss_pred ----------C-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhcc
Q 006031 609 ----------G-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKGA 649 (664)
Q Consensus 609 ----------~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~~ 649 (664)
. ........+.+++.+||+.||++|||+.|+++ .+++++..
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 0 01122456899999999999999999999985 34555443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.16 Aligned_cols=247 Identities=18% Similarity=0.269 Sum_probs=197.0
Q ss_pred hccccccCceeEEEEEE--cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCC------CcccceEEEecCCceEEE
Q 006031 389 AELLGKGSLGTTYKAVL--DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP------NLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~------niv~l~g~~~~~~~~~lV 460 (664)
.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+++++.++|+ +++++++++...+..++|
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv 95 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence 46799999999999986 368899999986432 2356788898888887665 499999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-----------------
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP----------------- 523 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~----------------- 523 (664)
|||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 96 ~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 96 FELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999 88999999642 234689999999999999999999999 9999999999999987
Q ss_pred --CCCeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH
Q 006031 524 --DFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 524 --~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~ 601 (664)
++.+||+|||+++...... ....+|+.|+|||.+. ...++.++|||||||++|||++|+.||.... ..+....+
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~ 246 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHH-STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHD--SKEHLAMM 246 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCC-CSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--HHHHHHHH
T ss_pred ccCCCceEeeCcccccCcccc-ccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Confidence 6789999999998754432 3456899999999987 5678999999999999999999999997532 22222111
Q ss_pred HhhccC------------------------------------------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006031 602 RSARED------------------------------------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQV 639 (664)
Q Consensus 602 ~~~~~~------------------------------------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 639 (664)
...... ..........+.+++.+||+.||++|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 111110 01123445678999999999999999999999
Q ss_pred HHH--HHhhh
Q 006031 640 LKM--LQEIK 647 (664)
Q Consensus 640 ~~~--L~~i~ 647 (664)
++. +++++
T Consensus 327 l~hp~f~~~~ 336 (339)
T 1z57_A 327 LKHPFFDLLK 336 (339)
T ss_dssp TTSGGGGGGG
T ss_pred hcCHHHHHHh
Confidence 854 44444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.19 Aligned_cols=245 Identities=19% Similarity=0.267 Sum_probs=192.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC--CCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR--HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||++...+++.||+|++..........+.+.+|++++.+++ |+||+++++++.+.+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999888999999999765443344578899999999997 5999999999999999999999 568
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
++|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++.......
T Consensus 112 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 112 IDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp EEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence 899999963 34689999999999999999999999 9999999999999964 8999999999986544321
Q ss_pred -CCCCCCCcccCcccccc----------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchh
Q 006031 544 -DDDPDNLLYKAPETRNA----------SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612 (664)
Q Consensus 544 -~~~~~~~~y~aPE~~~~----------~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (664)
....+++.|+|||.+.. ...++.++||||||+++|||++|+.||.........+......... ...+.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 263 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPD 263 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC-CCCCC
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc-cCCcc
Confidence 23458999999998753 1467889999999999999999999997643222222222222111 11122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 613 ERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 613 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.....+.+++.+||+.+|++||++.|+++.
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 223558899999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.49 Aligned_cols=248 Identities=18% Similarity=0.243 Sum_probs=178.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|... +++.||||++..........+.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 468999999999999975 6889999999755432222344555666788899999999999999999999999999 45
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-QDDD 546 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~ 546 (664)
.+..+... ....+++..+..++.|++.||+|||+..+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 109 ~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (318)
T 2dyl_A 109 CAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184 (318)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred cHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccccc
Confidence 55555532 235689999999999999999999983389999999999999999999999999997654432 2234
Q ss_pred CCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 547 ~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
.+++.|+|||.+. ....++.++||||||+++|||++|+.||.........+.................+..+.+++
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 264 (318)
T 2dyl_A 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV 264 (318)
T ss_dssp --CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHH
T ss_pred CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHH
Confidence 6889999999984 245678899999999999999999999975322222222222222211111122345689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++||++.|+++
T Consensus 265 ~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 265 KDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHTCSCTTTSCCHHHHTT
T ss_pred HHHccCChhHCcCHHHHhh
Confidence 9999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=325.97 Aligned_cols=242 Identities=19% Similarity=0.252 Sum_probs=184.9
Q ss_pred hccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe--------------c
Q 006031 389 AELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ--------------A 453 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--------------~ 453 (664)
.+.||+|+||.||+|.... ++.||+|++..... ...+.+.+|++++++++||||+++++++. +
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 4679999999999999764 89999999865432 34567899999999999999999999874 3
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC-CCCCeEEeec
Q 006031 454 KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG-PDFEACLADY 532 (664)
Q Consensus 454 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~-~~~~~ki~Df 532 (664)
.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 467899999997 699999942 4589999999999999999999999 999999999999997 5679999999
Q ss_pred cccccccCCC-----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-
Q 006031 533 CLTALTADSL-----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE- 606 (664)
Q Consensus 533 Gla~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~- 606 (664)
|+++...... .....++..|+|||.+.....++.++|||||||++|||+||+.||..... ...+.........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC
Confidence 9998754321 11234688899999886557789999999999999999999999976421 1111111111100
Q ss_pred ----------------------CCC----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 607 ----------------------DDG----AEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 607 ----------------------~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00123456899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.48 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=174.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHH-HHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHME-SVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||||++...... .....+..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 467999999999999974 6899999999754321 22344555555 78888999999999999999999999999985
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC-CC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-DD 545 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~ 545 (664)
+|.+++..........+++..+..++.|++.||.|||+..+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 184 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccccc
Confidence 8887774211122456899999999999999999999955899999999999999999999999999987654332 23
Q ss_pred CCCCCcccCccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHH
Q 006031 546 DPDNLLYKAPETRN---ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLE 620 (664)
Q Consensus 546 ~~~~~~y~aPE~~~---~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 620 (664)
..++..|+|||.+. ....++.++||||||+++|||++|+.||.........+........... .........+.+
T Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 264 (327)
T 3aln_A 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264 (327)
T ss_dssp ---------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHH
T ss_pred CCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHH
Confidence 46889999999983 2456889999999999999999999999753211111111111000000 011223456899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.+|++|||+.|+++
T Consensus 265 li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 265 FVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhhCChhhCcCHHHHHh
Confidence 999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.99 Aligned_cols=242 Identities=20% Similarity=0.254 Sum_probs=168.2
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
.++||+|+||+||+|... +++.||+|++... .....+....++.++||||+++++++.. ....++||||
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 357999999999999976 6899999998542 2222333344666799999999999876 4458999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 540 (664)
+++|+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 108 ~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 108 MEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred cCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 9999999999742 234699999999999999999999999 9999999999999976 45599999999987665
Q ss_pred CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHHHhhcc--CCCchhHHHH
Q 006031 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSARE--DDGAEDERLG 616 (664)
Q Consensus 541 ~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~ 616 (664)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .....+..... ........+.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred cccccCCCCcCccChhhhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 5545567899999999986 56788999999999999999999999975422111 11111111111 1111123455
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 6899999999999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=337.16 Aligned_cols=244 Identities=18% Similarity=0.245 Sum_probs=192.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC--------CCCcccceEEEe----cCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR--------HPNLVPLRAYFQ----AKE 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~g~~~----~~~ 455 (664)
.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|++++++++ |+||+++++++. ...
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 118 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT 118 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence 46899999999999985 568899999996432 23567889999998885 788999999987 556
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----------
Q 006031 456 ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF---------- 525 (664)
Q Consensus 456 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~---------- 525 (664)
..++||||+ +++|.+++.. .....+++..+..|+.||+.||+|||++.+|+||||||+|||++.++
T Consensus 119 ~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 119 HICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred eEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 789999999 5677666643 22356999999999999999999999855899999999999999775
Q ss_pred ---------------------------------------CeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCc
Q 006031 526 ---------------------------------------EACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATS 566 (664)
Q Consensus 526 ---------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 566 (664)
.+||+|||+++...... ....+|..|+|||.+. ...++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLI-GSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-CSCCSCGGGCCHHHHH-TSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-ccCCCCCcccCChhhc-CCCCCc
Confidence 89999999998765442 3457899999999987 567899
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCCh----hhHHHHHHhhccC-----------------------------------
Q 006031 567 KSDVYSFGVLLLELLTGKPPSQHSFLVP----NEMMNWVRSARED----------------------------------- 607 (664)
Q Consensus 567 ksDVwSfGvvl~elltG~~P~~~~~~~~----~~~~~~~~~~~~~----------------------------------- 607 (664)
++|||||||++|||+||+.||....... .+....+......
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999997543221 1111111110000
Q ss_pred -----CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 608 -----DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 608 -----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.....+....+.+++.+||+.||++|||+.|+++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0113455677899999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=335.39 Aligned_cols=237 Identities=20% Similarity=0.337 Sum_probs=195.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCC--CCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLR--HPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||.||+|.. .+++.||||.+....... ...+.+.+|++++++++ |+||+++++++...+..++|+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 46899999999999985 568999999997554321 12345677888998886 599999999999999999999
Q ss_pred ecCCC-CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC-CCCCeEEeecccccccc
Q 006031 462 DYQPN-GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG-PDFEACLADYCLTALTA 539 (664)
Q Consensus 462 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~ 539 (664)
||+.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 128 e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 128 ERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp ECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 99976 899999953 34689999999999999999999999 999999999999999 78999999999998876
Q ss_pred CCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 540 DSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 540 ~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
........+++.|+|||.+......+.++||||||+++|||+||+.||... ... ..... ......+..+.
T Consensus 202 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~---~~~~~---~~~~~~~~~~~ 271 (320)
T 3a99_A 202 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEI---IRGQV---FFRQRVSSECQ 271 (320)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH---HHCCC---CCSSCCCHHHH
T ss_pred cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhh---hcccc---cccccCCHHHH
Confidence 665555678999999998874444578899999999999999999998642 111 11111 11122334588
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++.+||+.+|++|||+.|+++
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=331.62 Aligned_cols=243 Identities=18% Similarity=0.228 Sum_probs=190.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc------eEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE------RLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~------~~lV~ 461 (664)
.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46799999999999996 468999999997544322335678899999999999999999999987654 49999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+. |+|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 109 PFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp ECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred cccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 9997 58887773 2489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-----------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA----------------- 604 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~----------------- 604 (664)
. ....+++.|+|||.+.+...++.++|||||||++|||++|+.||..... ...+.......
T Consensus 180 ~-~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 180 M-TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred c-cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 2 3356899999999987556789999999999999999999999976421 11111111110
Q ss_pred ------ccCC-----CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 605 ------REDD-----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 605 ------~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0112334568999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.40 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=184.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc-------eEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE-------RLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-------~~lV 460 (664)
.+.||+|+||+||+|... ++..||||++..... ....+.++++.++.++||||+++++++...+. .++|
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 367999999999999974 688999999854332 23456677888888999999999999976443 7899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCCCCCeEeCC-CCCeEEeecccccc
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH--QAWRLVHGNLKSSNVLLGP-DFEACLADYCLTAL 537 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~ 537 (664)
|||+++ +|...+.... .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred eecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 999986 5544432111 23456899999999999999999999 77 9999999999999997 89999999999987
Q ss_pred ccCCCC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--------
Q 006031 538 TADSLQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-------- 608 (664)
Q Consensus 538 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------- 608 (664)
...... ....+|+.|+|||.+.+...++.++|||||||++|||+||+.||..... ...+....+......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCCCHHHHHhcc
Confidence 654432 3456899999999987556689999999999999999999999976421 122222222111110
Q ss_pred ---------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhcc
Q 006031 609 ---------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGA 649 (664)
Q Consensus 609 ---------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~ 649 (664)
.........+.+++.+||+.||++|||+.|+++. ++++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0011134678999999999999999999999874 5555443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.62 Aligned_cols=237 Identities=23% Similarity=0.358 Sum_probs=188.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCC----CCCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGL----RHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l----~H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 46899999999999985 568899999997543321 1223456788888777 89999999999999999999
Q ss_pred EEec-CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC-CCCCeEEeecccccc
Q 006031 460 IYDY-QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG-PDFEACLADYCLTAL 537 (664)
Q Consensus 460 V~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~ 537 (664)
|+|| +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|||++..
T Consensus 116 v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp EEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 9999 789999999963 34689999999999999999999999 999999999999999 889999999999988
Q ss_pred ccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 538 TADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 538 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
..........++..|+|||.+......+.++||||||+++|||++|+.||... .++. ... ..........
T Consensus 190 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~---~~~---~~~~~~~~~~ 259 (312)
T 2iwi_A 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEIL---EAE---LHFPAHVSPD 259 (312)
T ss_dssp CCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHH---HTC---CCCCTTSCHH
T ss_pred cccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHHh---hhc---cCCcccCCHH
Confidence 76665556678999999998874444456899999999999999999998642 1111 111 1112233455
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+++.+||+.+|++|||+.|+++
T Consensus 260 ~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 260 CCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=331.38 Aligned_cols=250 Identities=19% Similarity=0.229 Sum_probs=194.8
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 468999999999999965 689999999964321 12345688999999999999999999988654 67899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 95 LMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 997 699999853 3589999999999999999999999 99999999999999999999999999998654321
Q ss_pred C------------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHH--------
Q 006031 543 Q------------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVR-------- 602 (664)
Q Consensus 543 ~------------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~-------- 602 (664)
. ....||+.|+|||.+.....++.++|||||||++|||++|+.||..... ...+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-RHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCST
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCchh
Confidence 1 1235789999999876557789999999999999999999999976421 111111111
Q ss_pred ----------------hhccCCCc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 006031 603 ----------------SAREDDGA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIKG 648 (664)
Q Consensus 603 ----------------~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~~ 648 (664)
........ ....+..+.+++.+||+.||++|||+.|+++ .++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 10000000 0123456889999999999999999999987 3454443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=341.68 Aligned_cols=243 Identities=19% Similarity=0.267 Sum_probs=185.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+. |
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4679999999998777778999999998542 245678899999876 89999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC-------------CCeEEeec
Q 006031 468 SLFSLIHGSKSTRA--KPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD-------------FEACLADY 532 (664)
Q Consensus 468 sL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~-------------~~~ki~Df 532 (664)
+|.+++........ ....+..+..|+.||+.||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99999975321111 1123445678999999999999999 99999999999999654 58999999
Q ss_pred cccccccCCCC------CCCCCCCcccCcccccc------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHH
Q 006031 533 CLTALTADSLQ------DDDPDNLLYKAPETRNA------SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMN 599 (664)
Q Consensus 533 Gla~~~~~~~~------~~~~~~~~y~aPE~~~~------~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~ 599 (664)
|+++....... ....||+.|+|||++.+ ...++.++|||||||++|||+| |+.||....... ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~ 249 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---SN 249 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---HH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---HH
Confidence 99987654321 23468999999998863 2568999999999999999999 999997543221 22
Q ss_pred HHHhhccCC----CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 600 WVRSAREDD----GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 600 ~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
......... .........+.+++.+||+.||++|||+.||++
T Consensus 250 i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 222221111 123345677999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=328.98 Aligned_cols=193 Identities=20% Similarity=0.325 Sum_probs=162.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CC-----CcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HP-----NLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||+||+|... +++.||||+++... .....+..|+++++.++ |+ +|+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 468999999999999865 68899999997432 23456777888887774 54 4999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCeEeC--CCCCeEEeeccccccc
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ-AWRLVHGNLKSSNVLLG--PDFEACLADYCLTALT 538 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~ivHrDlk~~NILl~--~~~~~ki~DfGla~~~ 538 (664)
||++ |+|.+++... ....+++..+..|+.|++.||+|||. ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus 136 e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp ECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred ecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9996 5999999742 23458999999999999999999995 23899999999999994 5788999999999876
Q ss_pred cCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 006031 539 ADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHS 590 (664)
Q Consensus 539 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~ 590 (664)
.... ....+|+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 212 ~~~~-~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 212 GQRI-YQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCCC-CSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc-ccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5432 3457899999999987 567899999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=335.87 Aligned_cols=240 Identities=19% Similarity=0.268 Sum_probs=182.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++||||+. |
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 468999999997666567788999999865332 2356789999988 89999999999999999999999996 5
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-----CCCeEEeeccccccccCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-----DFEACLADYCLTALTADSL 542 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-----~~~~ki~DfGla~~~~~~~ 542 (664)
+|.+++... ...+.+..+..|+.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++......
T Consensus 103 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 103 TLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 999999743 23345556789999999999999999 9999999999999943 3468899999998765331
Q ss_pred -----CCCCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccC-CCchhH
Q 006031 543 -----QDDDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARED-DGAEDE 613 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 613 (664)
.....||+.|+|||++.. ...++.++|||||||++|||+| |+.||.... .............. ......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL--QRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT--THHHHHHTTCCCCTTSCTTCH
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh--HHHHHHHhccCCccccCcccc
Confidence 223568999999999863 3456789999999999999999 999986432 11111111111111 112234
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
....+.+++.+||+.||++|||+.||++
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 4556889999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=324.54 Aligned_cols=241 Identities=17% Similarity=0.238 Sum_probs=191.5
Q ss_pred hccccccCceeEEEEEEc-C-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC------cccceEEEecCCceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-N-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN------LVPLRAYFQAKEERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~~~lV 460 (664)
.+.||+|+||+||+|... + +..||+|+++... ...+.+.+|++++++++|++ ++.+++++...+..++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv 100 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA 100 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence 468999999999999964 3 4789999996432 24567888999998887765 89999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEe-------------------
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLL------------------- 521 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl------------------- 521 (664)
|||+ ++++.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 101 ~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 101 FELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred Eecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999 66777777532 234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH
Q 006031 522 GPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601 (664)
Q Consensus 522 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~ 601 (664)
+.++.+||+|||+++...... ....+|+.|+|||.+. ...++.++|||||||++|||+||+.||.... ..+....+
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~ 251 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHH-TTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHE--NREHLVMM 251 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCC-CSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH
T ss_pred cCCCcEEEeecCccccccccc-cCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence 567899999999998754432 3456899999999987 6678999999999999999999999997532 22211111
Q ss_pred HhhccCC------------------------------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006031 602 RSAREDD------------------------------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQV 639 (664)
Q Consensus 602 ~~~~~~~------------------------------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 639 (664)
....... .........+.+++.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 1111100 0112334578899999999999999999999
Q ss_pred HH
Q 006031 640 LK 641 (664)
Q Consensus 640 ~~ 641 (664)
++
T Consensus 332 l~ 333 (355)
T 2eu9_A 332 LL 333 (355)
T ss_dssp TT
T ss_pred hc
Confidence 84
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=328.02 Aligned_cols=244 Identities=17% Similarity=0.242 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-----------CCCcccceEEEecCC-
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-----------HPNLVPLRAYFQAKE- 455 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~~~- 455 (664)
.+.||+|+||+||+|.. .+++.||||++..... ..+.+.+|++++++++ |+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 100 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence 46899999999999996 5789999999964332 3567888999988876 899999999987654
Q ss_pred ---ceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC------CCCC
Q 006031 456 ---ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG------PDFE 526 (664)
Q Consensus 456 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~------~~~~ 526 (664)
..++||||+ +++|.+++... ....+++..+..|+.||+.||+|||++.+|+||||||+|||++ .++.
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 101 NGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp TEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 789999999 88999999642 2345899999999999999999999955899999999999994 4458
Q ss_pred eEEeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----h-hhHHHHH
Q 006031 527 ACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV----P-NEMMNWV 601 (664)
Q Consensus 527 ~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~----~-~~~~~~~ 601 (664)
+||+|||+++...... ....+|+.|+|||.+. ...++.++|||||||++|||+||+.||...... . ..+....
T Consensus 177 ~kl~Dfg~a~~~~~~~-~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 177 IKIADLGNACWYDEHY-TNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEECCCTTCEETTBCC-CSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred EEEcccccccccCCCC-CCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 9999999998765432 3457899999999987 567899999999999999999999999754211 1 1122221
Q ss_pred Hhhcc---------------------------------------CCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 602 RSARE---------------------------------------DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 602 ~~~~~---------------------------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..... ....+......+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 11110 00123455677999999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.58 Aligned_cols=226 Identities=13% Similarity=0.097 Sum_probs=178.7
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|++.+.+++||||+++++++.+.+..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 367999999999999975 48999999997654321 2236789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
++|.+++.. . ....+..+|+.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 116 GSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred CCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999942 1 34557889999999999999999 99999999999999999999998442
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC----chhHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG----AEDERLGMLLEVA 622 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~ 622 (664)
|++| ++.++|||||||++|||+||+.||........ +............ .....+..+.+++
T Consensus 175 -----~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 175 -----TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp -----CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred -----ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 3333 57899999999999999999999986432110 0000000000000 1122345689999
Q ss_pred HHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 623 IACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.+||+.||++| |+.|+++.|+++....
T Consensus 241 ~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 241 ARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 99999999999 9999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=346.38 Aligned_cols=235 Identities=20% Similarity=0.224 Sum_probs=189.5
Q ss_pred hccccccCceeEEEEEEc--CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCc-----eEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD--NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE-----RLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-----~~lV~ 461 (664)
.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+. .|+||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 467999999999999975 689999999864322 1234678899999999999999999999987765 79999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+++++|.+++. ..++|..+..|+.||+.||+|||+. +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 164 E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 164 EYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp ECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 9999999998773 2689999999999999999999999 99999999999999986 9999999999876544
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
....||+.|+|||.+.. .++.++|||||||++|||++|.+|+........ ............+.++
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRL 300 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHH
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHHHHHH
Confidence 34568999999998863 348899999999999999999998764321100 0111122234568899
Q ss_pred HHHcccCCCCCCC-CHHHHHHHHHhhh
Q 006031 622 AIACNSASPEQRP-TMWQVLKMLQEIK 647 (664)
Q Consensus 622 ~~~Cl~~~P~~RP-t~~ev~~~L~~i~ 647 (664)
+.+||+.||++|| ++.++.+.|..+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999 5777777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.43 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=198.5
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec------CCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA------KEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV 460 (664)
..+.||+|+||.||+|.. .++..||||++.... .....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 357899999999999986 568899999986532 22345678999999999999999999998765 6678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC---eEEeecccccc
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE---ACLADYCLTAL 537 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~ 537 (664)
|||+++|+|.+++.... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 97 mEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp EECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999997432 234689999999999999999999998 9999999999999997765 89999999987
Q ss_pred ccCCC-CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh------------
Q 006031 538 TADSL-QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA------------ 604 (664)
Q Consensus 538 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~------------ 604 (664)
..... .....++..|+|||.+. ...++.++|||||||++|||++|+.||.... ....|....
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSC-CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC------CCSCC
T ss_pred cccccccccccCCcccCChHHhc-cCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccchhhhhhh
Confidence 65433 23456899999999987 6778999999999999999999999996531 111111000
Q ss_pred ------------ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHhhhcc
Q 006031 605 ------------REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQ-----VLKMLQEIKGA 649 (664)
Q Consensus 605 ------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e-----v~~~L~~i~~~ 649 (664)
..........+..+.+++.+||+.||++|||+.| ..+.++++...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000123345677999999999999999999988 55666666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=325.15 Aligned_cols=241 Identities=14% Similarity=0.079 Sum_probs=176.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCC-CCcccceE---------E------
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRH-PNLVPLRA---------Y------ 450 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H-~niv~l~g---------~------ 450 (664)
.++||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+.+++.++| +|...... .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46899999999999994 5688999999873322 22335779999999999987 32221111 1
Q ss_pred ------Eec-----CCceEEEEecCCCCCHHHHhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCC
Q 006031 451 ------FQA-----KEERLLIYDYQPNGSLFSLIHGSK--STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSS 517 (664)
Q Consensus 451 ------~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~ 517 (664)
+.. ....+++|+++ +++|.+++.... ......+++..++.|+.|+++||+|||+. +|+||||||+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrDiKp~ 240 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPV 240 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGG
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcccc
Confidence 111 12356777765 679999884110 12345688999999999999999999999 9999999999
Q ss_pred CeEeCCCCCeEEeeccccccccCCCCCCCCCCCcccCccccc---------cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006031 518 NVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRN---------ASHQATSKSDVYSFGVLLLELLTGKPPSQ 588 (664)
Q Consensus 518 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~ksDVwSfGvvl~elltG~~P~~ 588 (664)
|||++.++.+||+|||+++...... ....| +.|+|||.+. ....++.++|||||||++|||+||+.||.
T Consensus 241 NILl~~~~~~kL~DFG~a~~~~~~~-~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~ 318 (413)
T 3dzo_A 241 DIVLDQRGGVFLTGFEHLVRDGASA-VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318 (413)
T ss_dssp GEEECTTCCEEECCGGGCEETTEEE-CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred eEEEecCCeEEEEeccceeecCCcc-ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999998765442 33456 9999999883 24557889999999999999999999997
Q ss_pred CCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 589 HSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..... +... ...... ...+..+.+++.+||+.+|++||++.|+++
T Consensus 319 ~~~~~--~~~~---~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 319 DDAAL--GGSE---WIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp TTGGG--SCSG---GGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccchh--hhHH---HHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 53211 1111 111111 112355899999999999999999777643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.20 Aligned_cols=218 Identities=18% Similarity=0.284 Sum_probs=172.9
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHH-cCCCCCCcccceEEEec----CCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESV-GGLRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
++||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 5799999999999996 5688999999853 24567788877 66699999999999876 6678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 540 (664)
+++|+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred cCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999999742 234699999999999999999999999 9999999999999998 7899999999886432
Q ss_pred CCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-HhhccCC-Cch----hHH
Q 006031 541 SLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV-RSAREDD-GAE----DER 614 (664)
Q Consensus 541 ~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~-~~~----~~~ 614 (664)
...++.++|||||||++|||+||+.||...... ...... ....... ..+ ...
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch--hhhHHHHHHHhhccccCCchhcccC
Confidence 234577999999999999999999999653211 000000 0000000 011 223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+..+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 566899999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.47 Aligned_cols=235 Identities=14% Similarity=0.137 Sum_probs=179.3
Q ss_pred HHhccccccCceeEEEEEEcCCeEEEEEEccCccc------cCCcHHHHHHHHHHHcCCC---------CCCcccceEEE
Q 006031 387 ASAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKL------AGTSNEMYEQHMESVGGLR---------HPNLVPLRAYF 451 (664)
Q Consensus 387 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~~~e~~~l~~l~---------H~niv~l~g~~ 451 (664)
...+.||+|+||+||+|+. +++.||||++..... .....+.+.+|+++++.++ |||||++.+.+
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 4568899999999999998 679999999975432 2234477889999888775 66666666553
Q ss_pred -----------------ec-------------CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 006031 452 -----------------QA-------------KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501 (664)
Q Consensus 452 -----------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 501 (664)
.+ .+..++||||+++|++.+.+.. ..+++..+..|+.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 32 6789999999999987777631 45899999999999999999
Q ss_pred HHH-hcCCcccCCCCCCCeEeCCCC--------------------CeEEeeccccccccCCCCCCCCCCCcccCcccccc
Q 006031 502 YIH-QAWRLVHGNLKSSNVLLGPDF--------------------EACLADYCLTALTADSLQDDDPDNLLYKAPETRNA 560 (664)
Q Consensus 502 yLH-~~~~ivHrDlk~~NILl~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~ 560 (664)
||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||.+.+
T Consensus 176 ~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCC
T ss_pred HHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcC
Confidence 999 78 999999999999999887 8999999999876543 2468999999999873
Q ss_pred CCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCChhhHHHHHH-hhccCC----CchhHHHHHHHHHHHHcccCCCCCCC
Q 006031 561 SHQATSKSDVYSFGVL-LLELLTGKPPSQHSFLVPNEMMNWVR-SAREDD----GAEDERLGMLLEVAIACNSASPEQRP 634 (664)
Q Consensus 561 ~~~~~~ksDVwSfGvv-l~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RP 634 (664)
. .+.++||||+|++ .+++++|..||..... ...+.+... ...... ......+..+.+++.+||+.+
T Consensus 252 -~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 252 -D-GDYQFDIYRLMKKENNNRWGEYHPYSNVLW-LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp -C-SSHHHHHHHHHHHHHTTCTTSCCTHHHHHH-HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred -C-CccceehhhhhCCCCcccccccCCCcchhh-hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 3 3889999998777 7788889999743100 011111111 111111 123456778999999999866
Q ss_pred CHHHHH
Q 006031 635 TMWQVL 640 (664)
Q Consensus 635 t~~ev~ 640 (664)
|++|++
T Consensus 324 sa~e~l 329 (336)
T 2vuw_A 324 SATDLL 329 (336)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 888887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=256.70 Aligned_cols=193 Identities=33% Similarity=0.496 Sum_probs=167.1
Q ss_pred CCChhHHHHHHHHHhccCCCCCCcCcCCCCCCCcc--ccceEecC----CcEEEEEEcCCCCCC--cCCCccccCCCCCC
Q 006031 37 SLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ--WQGVICYQ----QKVVRVVLQGLDLGG--IFAPNSLTKLDQLR 108 (664)
Q Consensus 37 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~~~~~~C~--w~gv~C~~----~~v~~l~l~~~~l~g--~~~p~~l~~l~~L~ 108 (664)
.|.++|++||++||+++.++..+ -+|+.+.+||. |.||+|+. ++|+.|+|+++++.| .+++ .++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l-~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccc-cCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 48899999999999998655433 23444578999 99999975 799999999999999 7755 899999999
Q ss_pred EEEecC-CCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCC
Q 006031 109 VLGLQN-NSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186 (664)
Q Consensus 109 ~L~L~~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 186 (664)
+|+|++ |++.+.+| .|+++++|++|+|++|+++|.+|..|.++++|++|+|++|+++|.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 99999998 6999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCC--CCC-CCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 187 RFNGSIPPL--NQS-SLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 187 ~l~g~~p~~--~~~-~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
+++|.+|.. .+. .|+.|++++|+++|.+|..-.-..+..+.+.+|
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N 207 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSS
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCC
Confidence 999999864 565 899999999999998884322112555666665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=279.90 Aligned_cols=184 Identities=11% Similarity=0.009 Sum_probs=127.5
Q ss_pred cccccCceeEEEEE-EcCCeEEEEEEccCccccC--------CcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 391 LLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAG--------TSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
..+.|++|.+++++ .--|..+++|.+....... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35677777766654 3457789999996542211 2235799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
|||++|++|.++|.. ..+++.. +|+.||+.||+|+|++ +||||||||+|||+++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999963 3456543 5899999999999999 999999999999999999999999999987654
Q ss_pred CCCC--CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 006031 541 SLQD--DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP 585 (664)
Q Consensus 541 ~~~~--~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~ 585 (664)
.... ...||+.|||||.+. +++..++|+||+|++++++.++..
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred CCccccCceechhhccHHHhC--CCCCCcccccccccchhhhccccc
Confidence 3321 235899999999985 456778999999999887765543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=276.43 Aligned_cols=193 Identities=27% Similarity=0.318 Sum_probs=162.6
Q ss_pred ChhHHHHHHHHHhccCCCCCCcCcCCCCCCCccccceEecCCcEEEEEEcCCCCCCc---CCC-----------------
Q 006031 39 LPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGI---FAP----------------- 98 (664)
Q Consensus 39 ~~~~~~aLl~~k~~~~~~~~~~~~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~g~---~~p----------------- 98 (664)
.++|++|||+||+++.++. ..-+|+.++|||+|.||+|+.++|+.|+|+++++.|. +++
T Consensus 10 ~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~ 88 (768)
T 3rgz_A 10 LYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSH 88 (768)
T ss_dssp HHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSC
T ss_pred CHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCC
Confidence 4689999999999987555 4334445689999999999999999999999999986 433
Q ss_pred -----ccccCCCCCCEEEecCCCCCCCCC---CCCCCCCCCEEeccCCcCCCCCcccc-cCCCCCCEEeccCCcCcCCCc
Q 006031 99 -----NSLTKLDQLRVLGLQNNSLTGPIP---DLSGLVNLKSLFLDHNFFTGSFPPSL-LSLHRLKTLDLSYNNLSGPLP 169 (664)
Q Consensus 99 -----~~l~~l~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p 169 (664)
..+++|++|++|+|++|.|+|.+| .++++++|++|||++|.++|.+|..+ .++++|++|||++|++++..|
T Consensus 89 ~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 168 (768)
T 3rgz_A 89 INGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168 (768)
T ss_dssp EEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETH
T ss_pred cCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCC
Confidence 467888899999999999988776 47888999999999999988888876 788999999999999998888
Q ss_pred hh---hcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 170 KE---LASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 170 ~~---~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
.. +.++++|++|+|++|+++|.+|...+++|++|+|++|++++.+|....+.++..+.+.+|.
T Consensus 169 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~ 234 (768)
T 3rgz_A 169 VGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK 234 (768)
T ss_dssp HHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSC
T ss_pred hhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCc
Confidence 77 7888899999999999988888888889999999999999888876667777777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=258.35 Aligned_cols=183 Identities=13% Similarity=0.131 Sum_probs=144.6
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCC------cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGT------SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.++||+|+||+||+|.. .+..+++|+......... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 56899999999999954 456788888654332111 13458999999999999999987777778888899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++++|.++++. +..|+.|+++||+|||++ +|+||||||+|||+++ ++||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999952 458999999999999999 9999999999999999 99999999998765432
Q ss_pred C---------CCCCCCCcccCccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 006031 543 Q---------DDDPDNLLYKAPETRNAS-HQATSKSDVYSFGVLLLELLTGKPPSQ 588 (664)
Q Consensus 543 ~---------~~~~~~~~y~aPE~~~~~-~~~~~ksDVwSfGvvl~elltG~~P~~ 588 (664)
. ....||+.|||||++... ..|+.++|+|+..+-.++-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 123578999999998621 346778899999999999888887764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=261.90 Aligned_cols=189 Identities=20% Similarity=0.283 Sum_probs=160.0
Q ss_pred ChhHHHHHHHHHhccCCCCCCcCcCCC---CCCC--ccc------------cceEecC-CcEEEEEEcCCCCCCcCCCcc
Q 006031 39 LPSDAQVLLAFKAKADLRNHLFFSQNK---SLHF--CQW------------QGVICYQ-QKVVRVVLQGLDLGGIFAPNS 100 (664)
Q Consensus 39 ~~~~~~aLl~~k~~~~~~~~~~~~~~~---~~~~--C~w------------~gv~C~~-~~v~~l~l~~~~l~g~~~p~~ 100 (664)
..+|+.||++||+++..+ .|+.+. ..+| |.| .||+|+. ++|+.|+|++++|.|.+|+ +
T Consensus 267 ~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~-~ 342 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD-A 342 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG-G
T ss_pred chHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch-H
Confidence 457999999999998655 554332 2355 999 9999984 8999999999999999876 8
Q ss_pred ccCCCCCCEEEe-cCCCCCCC-----------------------------------------------------------
Q 006031 101 LTKLDQLRVLGL-QNNSLTGP----------------------------------------------------------- 120 (664)
Q Consensus 101 l~~l~~L~~L~L-~~N~l~g~----------------------------------------------------------- 120 (664)
|++|++|+.|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77766554
Q ss_pred -----------------CC-CCCCCCCCCEEeccCCcCCC-----------------CCccccc--CCCCCCEEeccCCc
Q 006031 121 -----------------IP-DLSGLVNLKSLFLDHNFFTG-----------------SFPPSLL--SLHRLKTLDLSYNN 163 (664)
Q Consensus 121 -----------------~p-~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~N~ 163 (664)
+| .|++|++|++|+|++|+|+| .+|..++ +|++|++|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 55 58889999999999999998 4999988 99999999999999
Q ss_pred CcCCCchhhcCCCCCCeeeCcCCc-Ccc-CCCCC---------CCCCCcEEEccCCcccccCCC---CCcccccCccccc
Q 006031 164 LSGPLPKELASQGRLYSLRLDVNR-FNG-SIPPL---------NQSSLKIFNVSGNNFTGAITV---TSTLSRFGISSFL 229 (664)
Q Consensus 164 l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~---------~~~~L~~l~l~~N~l~g~~p~---~~~l~~~~~~~~~ 229 (664)
+.|.+|..++++++|+.|+|++|+ |+| .+|.. .+++|+.|+|++|+|+ .+|. ...+.++..+.+.
T Consensus 503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls 581 (876)
T 4ecn_A 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV 581 (876)
T ss_dssp TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECT
T ss_pred CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECC
Confidence 999999999999999999999998 998 77742 4458999999999999 6664 4566777777777
Q ss_pred cCC
Q 006031 230 FNP 232 (664)
Q Consensus 230 ~N~ 232 (664)
+|.
T Consensus 582 ~N~ 584 (876)
T 4ecn_A 582 HNK 584 (876)
T ss_dssp TSC
T ss_pred CCC
Confidence 774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=254.17 Aligned_cols=189 Identities=19% Similarity=0.288 Sum_probs=149.6
Q ss_pred hhHHHHHHHHHhccCCCCCC--------cCcCCCCCCCccc---cceEecC-CcEEEEEEcCCCCCCcCCCccccCCCCC
Q 006031 40 PSDAQVLLAFKAKADLRNHL--------FFSQNKSLHFCQW---QGVICYQ-QKVVRVVLQGLDLGGIFAPNSLTKLDQL 107 (664)
Q Consensus 40 ~~~~~aLl~~k~~~~~~~~~--------~~~~~~~~~~C~w---~gv~C~~-~~v~~l~l~~~~l~g~~~p~~l~~l~~L 107 (664)
..|+.||.+||.+++.+++. .-+|..+.+||.| .||+|+. ++|+.|+|++++|.|.+|+ ++++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhcCccc
Confidence 47999999999998655322 0135556899999 9999965 7999999999999998875 89999999
Q ss_pred CEEEecCCC-----------------------------------------------------------------------
Q 006031 108 RVLGLQNNS----------------------------------------------------------------------- 116 (664)
Q Consensus 108 ~~L~L~~N~----------------------------------------------------------------------- 116 (664)
++|+|++|+
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999884
Q ss_pred -------CCCCCC-CCCCCCCCCEEeccCCcCCCC-----------------Cccccc--CCCCCCEEeccCCcCcCCCc
Q 006031 117 -------LTGPIP-DLSGLVNLKSLFLDHNFFTGS-----------------FPPSLL--SLHRLKTLDLSYNNLSGPLP 169 (664)
Q Consensus 117 -------l~g~~p-~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p 169 (664)
|+| +| +|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 345 45 588899999999999999986 999988 99999999999999999999
Q ss_pred hhhcCCCCCCeeeCcCCc-Ccc-CCCCC--C------CCCCcEEEccCCcccccCCC---CCcccccCccccccC
Q 006031 170 KELASQGRLYSLRLDVNR-FNG-SIPPL--N------QSSLKIFNVSGNNFTGAITV---TSTLSRFGISSFLFN 231 (664)
Q Consensus 170 ~~~~~l~~L~~L~l~~N~-l~g-~~p~~--~------~~~L~~l~l~~N~l~g~~p~---~~~l~~~~~~~~~~N 231 (664)
..++++++|+.|+|++|+ ++| .+|.. . +++|+.|++++|+++ .+|. ...+.++..+.+.+|
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 999999999999999998 888 66642 2 266777777777777 4553 344555555555555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=247.91 Aligned_cols=164 Identities=28% Similarity=0.471 Sum_probs=142.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC------------------------------------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD------------------------------------ 123 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~------------------------------------ 123 (664)
..+..|+|++|.+.|.+| ..++++++|+.|+|++|.++|.+|.
T Consensus 514 ~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIP-AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592 (768)
T ss_dssp TTCCEEECCSSCCEEECC-GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred CCCCEEECCCCcccCcCC-HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence 345666666666666553 3677777777788877777776661
Q ss_pred -----------------------------------CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCC
Q 006031 124 -----------------------------------LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPL 168 (664)
Q Consensus 124 -----------------------------------~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 168 (664)
++++++|++|||++|+|+|.+|.+|+++++|+.|+|++|+|+|.+
T Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 672 (768)
T 3rgz_A 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672 (768)
T ss_dssp EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence 233578999999999999999999999999999999999999999
Q ss_pred chhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCccCcCCCCC
Q 006031 169 PKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKECNP 245 (664)
Q Consensus 169 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~~~~~~c~~ 245 (664)
|..++++++|+.|+|++|+++|.||.. .+++|++|||++|+|+|.||....+..+....|.||+++||.|+. .|..
T Consensus 673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 999999999999999999999999975 789999999999999999999989999999999999999999887 8864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-24 Score=223.05 Aligned_cols=192 Identities=21% Similarity=0.273 Sum_probs=159.7
Q ss_pred CChhHHHHHHHHHhccCCCC-C-C-cCc--CCCCCCCccccceEecC----------CcEEEEEEcCCCCCCcCCCcccc
Q 006031 38 LLPSDAQVLLAFKAKADLRN-H-L-FFS--QNKSLHFCQWQGVICYQ----------QKVVRVVLQGLDLGGIFAPNSLT 102 (664)
Q Consensus 38 ~~~~~~~aLl~~k~~~~~~~-~-~-~~~--~~~~~~~C~w~gv~C~~----------~~v~~l~l~~~~l~g~~~p~~l~ 102 (664)
...+|++||++||+.+..+. . . .|. .....++|.|.||.|+. .+|+.|+|+++++.. +++ .++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~-lp~-~l~ 101 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPD-QAF 101 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSS-CCS-CGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCchh-cCh-hhh
Confidence 45689999999999874332 2 2 452 12347899999999952 789999999999994 654 799
Q ss_pred CCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcC-------
Q 006031 103 KLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS------- 174 (664)
Q Consensus 103 ~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~------- 174 (664)
+|++|++|+|++|+|+ .+| .++++++|++|+|++|+++ .+|..++++++|++|+|++|++.|.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 9999999999999999 555 6999999999999999999 89999999999999999999999999988765
Q ss_pred --CCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCC
Q 006031 175 --QGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSL 234 (664)
Q Consensus 175 --l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~l 234 (664)
+++|+.|+|++|+++ .+|.. .+++|+.|+|++|++++.++....+.++..+.+.+|...
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~ 242 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch
Confidence 999999999999998 66653 678899999999999987666566777777778777543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=194.53 Aligned_cols=168 Identities=20% Similarity=0.217 Sum_probs=143.6
Q ss_pred CCccccceEecC--------------------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCC
Q 006031 68 HFCQWQGVICYQ--------------------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSG 126 (664)
Q Consensus 68 ~~C~w~gv~C~~--------------------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~ 126 (664)
+||.|.|.+|.. ..+..|+|++|++.+ +++..+.++++|++|+|++|+|++.+|. |.+
T Consensus 3 ~Cp~~~gC~C~~~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 3 TCETVTGCTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp -CHHHHSSEEEGGGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred cCCCCCceEcCCCCeEEecCCCCccccCCCCCCCCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 577787777731 246789999999998 5566899999999999999999998885 889
Q ss_pred CCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEE
Q 006031 127 LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFN 204 (664)
Q Consensus 127 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~ 204 (664)
+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+|++.++.. .+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 999999999999999777778899999999999999999766667899999999999999999777742 778999999
Q ss_pred ccCCcccccCCC-CCcccccCccccccCCCCCC
Q 006031 205 VSGNNFTGAITV-TSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 205 l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~lcg 236 (664)
|++|+|++.++. ...+.++..+.+.+|++.|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999988773 45677788889999998775
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-22 Score=206.65 Aligned_cols=141 Identities=12% Similarity=0.143 Sum_probs=114.6
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccC----------------CcHHHHHHHHHHHcCCCCCCcccceEEEec
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAG----------------TSNEMYEQHMESVGGLRHPNLVPLRAYFQA 453 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 453 (664)
+.||+|+||.||+|...+|+.||+|.++...... .....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 7899999999999999889999999996432211 12456899999999998 5 777776544
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 454 KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 454 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
+..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 56799999999999988 521 23457999999999999998 999999999999999 9999999999
Q ss_pred ccccccCCCCCCCCCCCcccCccccc
Q 006031 534 LTALTADSLQDDDPDNLLYKAPETRN 559 (664)
Q Consensus 534 la~~~~~~~~~~~~~~~~y~aPE~~~ 559 (664)
+++.. ..|+|||++.
T Consensus 238 ~a~~~-----------~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVEV-----------GEEGWREILE 252 (282)
T ss_dssp TCEET-----------TSTTHHHHHH
T ss_pred CCeEC-----------CCCCHHHHHH
Confidence 98743 2467899774
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-21 Score=201.94 Aligned_cols=161 Identities=29% Similarity=0.467 Sum_probs=115.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCC-CCCEEeccCCcCCCCCcccccC-------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLV-NLKSLFLDHNFFTGSFPPSLLS------- 150 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~-~L~~L~L~~N~l~g~~p~~~~~------- 150 (664)
..+..|+|++|.+.+.+ |..+.++++|++|+|++|+++|.+| .+++++ +|++|+|++|+++|.+|..+..
T Consensus 125 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTL-PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCC-CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCCEEeCCCCccCCcC-ChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 46777888888887755 3477778888888888888877766 466666 6677777666666655555554
Q ss_pred ----------------CCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccc
Q 006031 151 ----------------LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 151 ----------------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g 212 (664)
+++|+.|+|++|++++.+|. +..+++|++|+|++|+++|.+|.. .+++|+.|+|++|+|+|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 44455555555555444433 455566666666666666666653 67889999999999999
Q ss_pred cCCCCCcccccCccccccCCCCCCccCcCCC
Q 006031 213 AITVTSTLSRFGISSFLFNPSLCGEIIHKEC 243 (664)
Q Consensus 213 ~~p~~~~l~~~~~~~~~~N~~lcg~~~~~~c 243 (664)
.+|....+.++..+.+.+|+++||.|++ .|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9998888899999999999999998775 46
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.6e-20 Score=183.70 Aligned_cols=148 Identities=24% Similarity=0.231 Sum_probs=113.0
Q ss_pred CCCCccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEE
Q 006031 66 SLHFCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSL 133 (664)
Q Consensus 66 ~~~~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L 133 (664)
+.+.|+|++|.|+. ..++.|+|++|.+.+ ++|..+.++++|++|+|++|+|++.++. |.++++|++|
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCc-cCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 37889999999975 256778888888887 4455778888888888888888766554 6778888888
Q ss_pred eccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCccc
Q 006031 134 FLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFT 211 (664)
Q Consensus 134 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~ 211 (664)
+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|.++
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 88888888655556777888888888888887 77888888888888888888887655542 5677888888888887
Q ss_pred ccCC
Q 006031 212 GAIT 215 (664)
Q Consensus 212 g~~p 215 (664)
+..+
T Consensus 173 c~c~ 176 (229)
T 3e6j_A 173 CECR 176 (229)
T ss_dssp TTBG
T ss_pred CCcc
Confidence 7654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=184.36 Aligned_cols=150 Identities=22% Similarity=0.240 Sum_probs=100.9
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++.|+|++|.+.+ +++..+.++++|++|+|++|+|+...+. |.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 35677888888776 4555788888888888888888866654 567888888888888887555556677777777777
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFN 231 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N 231 (664)
++|++++..|..+..+++|+.|+|++|++++.++.. .+++|+.|+|++|++++..+. ...+.++..+.+.+|
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 777777666666677777777777777776554431 455666666666666555442 123344444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=183.42 Aligned_cols=146 Identities=23% Similarity=0.249 Sum_probs=95.5
Q ss_pred ccccceEecCC-----------cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccC
Q 006031 70 CQWQGVICYQQ-----------KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDH 137 (664)
Q Consensus 70 C~w~gv~C~~~-----------~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~ 137 (664)
|.|..+.|+.. .++.|+|++|.+++..++..+.++++|++|+|++|+|++..| .|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 67887777541 345666677766664333446666777777777777766665 466667777777777
Q ss_pred CcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCC
Q 006031 138 NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 138 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p 215 (664)
|++++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|.+++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7776555556666777777777777776666666666677777777777776665543 55666677777776665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=175.45 Aligned_cols=146 Identities=22% Similarity=0.222 Sum_probs=119.5
Q ss_pred CccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEecc
Q 006031 69 FCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLD 136 (664)
Q Consensus 69 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~ 136 (664)
.|.|.+|.|+. ..++.|+|++|++.+ +++..+.++++|++|+|++|+|++.++. |.++++|++|+|+
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 48899999964 257888999998886 5565688889999999999999877664 6788999999999
Q ss_pred CCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 137 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
+|++++..+..+.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|++++|.+++..
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 99998655566788899999999999998766666888889999999999988766642 6788899999999888776
Q ss_pred C
Q 006031 215 T 215 (664)
Q Consensus 215 p 215 (664)
|
T Consensus 165 ~ 165 (208)
T 2o6s_A 165 P 165 (208)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.2e-19 Score=173.62 Aligned_cols=153 Identities=20% Similarity=0.235 Sum_probs=87.7
Q ss_pred ccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccc
Q 006031 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSL 148 (664)
Q Consensus 70 C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~ 148 (664)
|.|..|.|+. ++|.. +|. .+. ++|+.|+|++|+|++..| .|.++++|++|+|++|++++..|..|
T Consensus 11 C~~~~v~c~~----------~~l~~-iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 76 (220)
T 2v9t_B 11 CSNNIVDCRG----------KGLTE-IPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF 76 (220)
T ss_dssp EETTEEECTT----------SCCSS-CCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ECCCEEEcCC----------CCcCc-CCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHh
Confidence 7788888754 33333 222 232 456666666666665555 45566666666666666665556666
Q ss_pred cCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCc
Q 006031 149 LSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGI 225 (664)
Q Consensus 149 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~ 225 (664)
.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+. ...+.++..
T Consensus 77 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 156 (220)
T 2v9t_B 77 QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156 (220)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred hCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCE
Confidence 66666666666666666333333455666666666666666555442 455666666666666655542 233445555
Q ss_pred cccccCCCCCC
Q 006031 226 SSFLFNPSLCG 236 (664)
Q Consensus 226 ~~~~~N~~lcg 236 (664)
+.+.+|++.|.
T Consensus 157 L~L~~N~~~c~ 167 (220)
T 2v9t_B 157 MHLAQNPFICD 167 (220)
T ss_dssp EECCSSCEECS
T ss_pred EEeCCCCcCCC
Confidence 55666666554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.6e-18 Score=173.85 Aligned_cols=155 Identities=23% Similarity=0.198 Sum_probs=138.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.+ + + .+.++++|++|+|++|++++.+|. |.++++|++|+|++|++++..|..+.++++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~-~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-S-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-C-G-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-c-h-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 678999999999998 3 3 799999999999999999988875 78999999999999999977777799999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccCCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNPSLC 235 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~~lc 235 (664)
|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|++++.+|.. ..+.++..+.+.+|++.|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999777777899999999999999999877753 7899999999999999988753 567788889999999887
Q ss_pred Cc
Q 006031 236 GE 237 (664)
Q Consensus 236 g~ 237 (664)
..
T Consensus 220 ~~ 221 (272)
T 3rfs_A 220 TC 221 (272)
T ss_dssp CT
T ss_pred cC
Confidence 64
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-18 Score=168.75 Aligned_cols=158 Identities=20% Similarity=0.173 Sum_probs=136.2
Q ss_pred ceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC--CCCCCCCCEEeccCCcCCCCCcccccCC
Q 006031 74 GVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSL 151 (664)
Q Consensus 74 gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~L~~N~l~g~~p~~~~~l 151 (664)
+-+|.. ..++++++.|+. +|. .+. ..++.|+|++|+|++.+|. |.++++|+.|+|++|++++..|..|.++
T Consensus 8 ~C~C~~---~~l~~s~n~l~~-iP~-~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l 80 (220)
T 2v70_A 8 KCRCEG---TTVDCSNQKLNK-IPE-HIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA 80 (220)
T ss_dssp TCEEET---TEEECCSSCCSS-CCS-CCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCEECC---CEeEeCCCCccc-Ccc-CCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC
Confidence 445654 379999999987 543 453 4578999999999998763 8899999999999999998778899999
Q ss_pred CCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCcccc
Q 006031 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSF 228 (664)
Q Consensus 152 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~ 228 (664)
++|++|+|++|+|++..|..|..+++|+.|+|++|++++.+|.. .+++|+.|+|++|+|++.+|. ...+.++..+.+
T Consensus 81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 160 (220)
T 2v70_A 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL 160 (220)
T ss_dssp TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEe
Confidence 99999999999999888888999999999999999999988764 789999999999999999773 355677888899
Q ss_pred ccCCCCCCcc
Q 006031 229 LFNPSLCGEI 238 (664)
Q Consensus 229 ~~N~~lcg~~ 238 (664)
.+|++.|...
T Consensus 161 ~~N~l~c~c~ 170 (220)
T 2v70_A 161 LANPFNCNCY 170 (220)
T ss_dssp CSCCEECSGG
T ss_pred cCcCCcCCCc
Confidence 9999988644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=187.28 Aligned_cols=165 Identities=19% Similarity=0.168 Sum_probs=141.4
Q ss_pred ccccceEecC-----------CcEEEEEEcCCCCCCcCCCcccc-CCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEecc
Q 006031 70 CQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLT-KLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLD 136 (664)
Q Consensus 70 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~-~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~ 136 (664)
|.|..|.|+. ..++.|+|++|.|++ +++..+. ++++|+.|+|++|+|++..| .|.++++|++|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 7799999964 247789999999998 5565677 99999999999999999887 59999999999999
Q ss_pred CCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-----CCCCCcEEEccCCccc
Q 006031 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-----NQSSLKIFNVSGNNFT 211 (664)
Q Consensus 137 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-----~~~~L~~l~l~~N~l~ 211 (664)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999777778999999999999999999888999999999999999999999755442 5889999999999999
Q ss_pred ccCCCCCccccc-----CccccccCCCCCCc
Q 006031 212 GAITVTSTLSRF-----GISSFLFNPSLCGE 237 (664)
Q Consensus 212 g~~p~~~~l~~~-----~~~~~~~N~~lcg~ 237 (664)
+..+ ..+..+ ..+.+.+|++.|..
T Consensus 177 ~l~~--~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 177 KLPL--TDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCCH--HHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ccCH--HHhhhccHhhcceEEecCCCccCCc
Confidence 7654 223322 45788999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=5.3e-19 Score=170.22 Aligned_cols=150 Identities=22% Similarity=0.220 Sum_probs=120.9
Q ss_pred EEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC--CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCC
Q 006031 85 VVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162 (664)
Q Consensus 85 l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 162 (664)
|++++++|.. +|. .+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 l~~s~~~l~~-ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 13 VDCTGRGLKE-IPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCSS-CCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEcCCCCcCc-Ccc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4445666754 543 4543 899999999999998884 889999999999999999988999999999999999999
Q ss_pred cCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCcc
Q 006031 163 NLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEI 238 (664)
Q Consensus 163 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~~ 238 (664)
+|++..|..+..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|.|++..+.......+....+.++...|+.|
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 999888888999999999999999999988864 7889999999999999887632111122223445555667654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-18 Score=167.49 Aligned_cols=133 Identities=20% Similarity=0.246 Sum_probs=120.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..++.|+|++|.+.+ +++..+..+++|+.|+|++|+|++..| .|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 32 ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEE
Confidence 478999999999998 666689999999999999999999877 699999999999999999944444578899999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCccccc
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ 213 (664)
|++|+|++..|..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|.++..
T Consensus 111 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999999988999999999999999999999887753 688999999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=167.93 Aligned_cols=166 Identities=26% Similarity=0.323 Sum_probs=129.6
Q ss_pred CccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEecc
Q 006031 69 FCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLD 136 (664)
Q Consensus 69 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~ 136 (664)
.|.|+.|.|+. ..++.|+|++|.+++..+...++++++|++|+|++|+|++.+| .|.++++|++|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 38899999974 2688999999999984332358999999999999999999987 69999999999999
Q ss_pred CCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCC-CCCcEEEccCCcccccCC
Q 006031 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQ-SSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 137 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~L~~l~l~~N~l~g~~p 215 (664)
+|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|.+++..+...+ ..|+...+..+......|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 9999988888899999999999999999999999999999999999999999987763211 112222334444444444
Q ss_pred CCCcccccCccccccCCCCCC
Q 006031 216 VTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 216 ~~~~l~~~~~~~~~~N~~lcg 236 (664)
..+.......+..+...|.
T Consensus 167 --~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 167 --SKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp --TTTTTSBGGGSCTTTCCCC
T ss_pred --hHHcCCChhhCcHhhcCcC
Confidence 3444444455555555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=176.12 Aligned_cols=135 Identities=15% Similarity=0.147 Sum_probs=104.4
Q ss_pred hccccccCceeEEEEEE-cCCeE--EEEEEccCccccC----------------------CcHHHHHHHHHHHcCCCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLI--VCVKRLDASKLAG----------------------TSNEMYEQHMESVGGLRHPN 443 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~~----------------------~~~~~~~~e~~~l~~l~H~n 443 (664)
.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+..+.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 36799999999999997 78888 9999875432110 01236889999999998886
Q ss_pred c--ccceEEEecCCceEEEEecCCC-C----CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCC
Q 006031 444 L--VPLRAYFQAKEERLLIYDYQPN-G----SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH-QAWRLVHGNLK 515 (664)
Q Consensus 444 i--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~ivHrDlk 515 (664)
+ ..++++ +..++||||+.+ | +|.++... .++.....++.|++.||.||| +. +|+|||||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~-givHrDlk 198 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA-ELVHADLS 198 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS-CEECSSCS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC-CEEeCCCC
Confidence 5 333332 367899999942 4 77776531 235567889999999999999 77 99999999
Q ss_pred CCCeEeCCCCCeEEeeccccccc
Q 006031 516 SSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 516 ~~NILl~~~~~~ki~DfGla~~~ 538 (664)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.75 E-value=8.6e-18 Score=172.70 Aligned_cols=155 Identities=21% Similarity=0.129 Sum_probs=107.3
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+++ +++ .+.+++|++|+|++|+|+..+..+.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 55 ~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELTK-LQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCCE-EEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCc-ccC--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 455566666666655 222 25666677777777777644445677777788888888877655666777788888888
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~ 237 (664)
++|+|++..|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|+..++.......+..+.+.+||+.|..
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 888887655556677778888888888887544432 567888888888888865554455556777788889888853
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=3e-17 Score=162.55 Aligned_cols=159 Identities=21% Similarity=0.208 Sum_probs=133.6
Q ss_pred cccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCccccc
Q 006031 71 QWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLL 149 (664)
Q Consensus 71 ~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~ 149 (664)
.|..-.|+. +.++.+++++.. +|. .+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|.
T Consensus 13 ~~~~~~Cs~---~~v~c~~~~l~~-ip~-~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 13 CPSQCSCSG---TTVDCRSKRHAS-VPA-GIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp CCTTCEEET---TEEECTTSCCSS-CCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCCEEeC---CEeEccCCCcCc-cCC-CCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 355666764 468899999887 543 443 899999999999999887 588999999999999999855556679
Q ss_pred CCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCcc
Q 006031 150 SLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGIS 226 (664)
Q Consensus 150 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~ 226 (664)
++++|++|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+. ...+.++..+
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 9999999999999999777777899999999999999999 56653 789999999999999987763 3556788888
Q ss_pred ccccCCCCCCc
Q 006031 227 SFLFNPSLCGE 237 (664)
Q Consensus 227 ~~~~N~~lcg~ 237 (664)
.+.+|++.|..
T Consensus 165 ~l~~N~~~c~c 175 (229)
T 3e6j_A 165 YLFGNPWDCEC 175 (229)
T ss_dssp ECTTSCBCTTB
T ss_pred EeeCCCccCCc
Confidence 99999998864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=182.73 Aligned_cols=158 Identities=20% Similarity=0.175 Sum_probs=122.7
Q ss_pred ccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc
Q 006031 72 WQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 72 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~ 139 (664)
|..|.|.. ..++.|+|++|++.+ +++..|.++++|+.|+|++|+|++..| .|.++++|++|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCce-ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 56777753 368899999999998 556689999999999999999999887 68999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCCcccccCCC
Q 006031 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 140 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|+..+.+|.. .+++|+.|+|++|++++. |.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~ 213 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PN 213 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-cc
Confidence 99666667899999999999999999655557777777777777775444455432 556677777777777653 44
Q ss_pred CCcccccCccccccC
Q 006031 217 TSTLSRFGISSFLFN 231 (664)
Q Consensus 217 ~~~l~~~~~~~~~~N 231 (664)
...+.++..+.+.+|
T Consensus 214 ~~~l~~L~~L~Ls~N 228 (452)
T 3zyi_A 214 LTPLVGLEELEMSGN 228 (452)
T ss_dssp CTTCTTCCEEECTTS
T ss_pred ccccccccEEECcCC
Confidence 455555555555555
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=171.14 Aligned_cols=155 Identities=23% Similarity=0.243 Sum_probs=86.5
Q ss_pred cEEEEEEcCCC-CCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 81 KVVRVVLQGLD-LGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 81 ~v~~l~l~~~~-l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+..|+|++|. +.. +++..+..+++|++|+|++|++++.+| .+.++++|++|+|++|++++..+..+.++++|++|+
T Consensus 81 ~L~~L~l~~n~~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TCCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCCCCCccc-cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 45555555554 333 334455555555555555555555544 255556666666666666544444455566666666
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPSLC 235 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~lc 235 (664)
|++|++++..+..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|++++.++. ...+.++..+.+.+|++.|
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 6666665444444555666666666666666554432 455666666666666655432 2334555566666776666
Q ss_pred C
Q 006031 236 G 236 (664)
Q Consensus 236 g 236 (664)
.
T Consensus 240 ~ 240 (285)
T 1ozn_A 240 D 240 (285)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.5e-18 Score=190.72 Aligned_cols=161 Identities=17% Similarity=0.164 Sum_probs=137.2
Q ss_pred CccccceEecC-------------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEe
Q 006031 69 FCQWQGVICYQ-------------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLF 134 (664)
Q Consensus 69 ~C~w~gv~C~~-------------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ 134 (664)
.|.|.|| |+. ..++.|+|++|.+++ ++|..+.++++|++|+|++|++++.+| .|+++++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 5999999 863 368999999999998 556689999999999999999999887 599999999999
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcC-CCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCCcc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNF 210 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l 210 (664)
|++|++++..|..|+++++|++|+|++|++++ .+|..++.+++|+.|+|++|++.+.+|.. .+++|+.|++++|++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999998878889999999999999999997 57888999999999999999977777642 788999999999999
Q ss_pred cccCCCC-CcccccCccccccC
Q 006031 211 TGAITVT-STLSRFGISSFLFN 231 (664)
Q Consensus 211 ~g~~p~~-~~l~~~~~~~~~~N 231 (664)
++.+|.. ..+.++..+.+.+|
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECS
T ss_pred cccChhhhhccccCceEecccC
Confidence 9987732 33444444445444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-17 Score=168.44 Aligned_cols=152 Identities=22% Similarity=0.207 Sum_probs=130.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc-CCCCCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF-FTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L 157 (664)
..++.|+|+++.+.+ +++..+.++++|++|+|++|.+++..| .|.++++|++|+|++|. +++..|..+.++++|++|
T Consensus 32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 468899999999988 566689999999999999999998876 68899999999999997 776668889999999999
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCC
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~ 232 (664)
+|++|++++..|..+..+++|++|+|++|++++.++.. .+++|+.|+|++|++++..+. ...+.++..+.+.+|.
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence 99999999888888999999999999999999776652 688999999999999987763 4556677777777774
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=181.78 Aligned_cols=158 Identities=23% Similarity=0.204 Sum_probs=119.2
Q ss_pred ccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc
Q 006031 72 WQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 72 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~ 139 (664)
|..|.|.. ..++.|+|++|.+.+ +++..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCE-ECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCe-eCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 56778854 357789999999988 556689999999999999999988776 58889999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCCcccccCCC
Q 006031 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 140 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~~p~ 216 (664)
|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|+..+.+|.. .+++|+.|+|++|+|+. +|.
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~ 202 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN 202 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccc
Confidence 98555567888999999999999988666667777888888888775544455442 56677777777777763 344
Q ss_pred CCcccccCccccccC
Q 006031 217 TSTLSRFGISSFLFN 231 (664)
Q Consensus 217 ~~~l~~~~~~~~~~N 231 (664)
...+.++..+.+.+|
T Consensus 203 ~~~l~~L~~L~Ls~N 217 (440)
T 3zyj_A 203 LTPLIKLDELDLSGN 217 (440)
T ss_dssp CTTCSSCCEEECTTS
T ss_pred cCCCcccCEEECCCC
Confidence 555556666666665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-17 Score=168.78 Aligned_cols=150 Identities=25% Similarity=0.224 Sum_probs=132.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|+|++|.+++ +++..+.++++|++|+|++|+|++..+ .+.+++|++|+|++|+|+ .+|..+.++++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 468899999999988 556689999999999999999997655 488999999999999999 89999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~ 232 (664)
++|+|++..|..|..+++|+.|+|++|++++.++.. .+++|+.|+|++|+|++.++.. ..+.++..+.+.+|.
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 183 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence 999999777788999999999999999999776653 6789999999999999877643 456777788888774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=182.21 Aligned_cols=149 Identities=23% Similarity=0.261 Sum_probs=132.1
Q ss_pred CCCccccc--eEecC----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCE
Q 006031 67 LHFCQWQG--VICYQ----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKS 132 (664)
Q Consensus 67 ~~~C~w~g--v~C~~----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~ 132 (664)
...|.|.+ |.|+. .+++.|+|++|.+.+ ++|..++++++|++|+|++|.+.+.+| .|.++++|++
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~ 83 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCE-ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCc-CChhHhccCccccEEECcCCcccceECcccccccccCCE
Confidence 34577666 88865 358999999999998 556689999999999999999988775 5999999999
Q ss_pred EeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchh--hcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccC
Q 006031 133 LFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKE--LASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSG 207 (664)
Q Consensus 133 L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~ 207 (664)
|+|++|++++..|..|+++++|++|+|++|++++.+|.. +..+++|+.|+|++|++++..|.. .+++|++|++++
T Consensus 84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred EeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence 999999999889999999999999999999999877776 999999999999999999988863 789999999999
Q ss_pred CcccccCCC
Q 006031 208 NNFTGAITV 216 (664)
Q Consensus 208 N~l~g~~p~ 216 (664)
|++++..|.
T Consensus 164 n~l~~~~~~ 172 (455)
T 3v47_A 164 NKVKSICEE 172 (455)
T ss_dssp CCBSCCCTT
T ss_pred CcccccChh
Confidence 999998873
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-17 Score=167.24 Aligned_cols=157 Identities=18% Similarity=0.194 Sum_probs=97.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.+ +++..+.++++|++|+|++|.+++..| .|.++++|++|+|++|++++..+..+.++++|++|+
T Consensus 52 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp TTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred cCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 356666666666665 334456666666666666666666554 355666666666666666654444566666666666
Q ss_pred ccCCcCcC-CCchhhcCCCCCCeeeCcCCcCccCCC----------------------------CC-CCCCCcEEEccCC
Q 006031 159 LSYNNLSG-PLPKELASQGRLYSLRLDVNRFNGSIP----------------------------PL-NQSSLKIFNVSGN 208 (664)
Q Consensus 159 l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p----------------------------~~-~~~~L~~l~l~~N 208 (664)
|++|++++ .+|..+..+++|+.|+|++|++++..+ .. ...+|+.|+|++|
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n 210 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTN 210 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSS
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCC
Confidence 66666654 246666666666666666666554432 21 2336888888888
Q ss_pred cccccCCCC-CcccccCccccccCCCCCCc
Q 006031 209 NFTGAITVT-STLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 209 ~l~g~~p~~-~~l~~~~~~~~~~N~~lcg~ 237 (664)
+|++.++.. ..+.++..+.+.+|++.|..
T Consensus 211 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 211 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred ceeecCHhHhcccccccEEEccCCcccccC
Confidence 888776643 45667777888888888753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=197.22 Aligned_cols=136 Identities=22% Similarity=0.254 Sum_probs=121.0
Q ss_pred ccCCCCCCEEEecCCCCCCCCCC--CCCCCCCCEEeccCCcCC-----CCCcccccCCCCCCEEeccCCcCcCCCchhhc
Q 006031 101 LTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFT-----GSFPPSLLSLHRLKTLDLSYNNLSGPLPKELA 173 (664)
Q Consensus 101 l~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~L~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 173 (664)
+.++++|+.|+|++|+|++..+. +..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..+.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 45789999999999999987663 667899999999999997 45567789999999999999999998899999
Q ss_pred CCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCcc
Q 006031 174 SQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEI 238 (664)
Q Consensus 174 ~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~~ 238 (664)
.+++|+.|+|++|+|++.+|....++|+.|||++|+|++.+| ..+.++..+.+.+||+.|...
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~--~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNP--DVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCS--CCCSSCCEEEEEEECCCCSSS
T ss_pred chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCCh--hHhCCcCEEEecCCCcccccc
Confidence 999999999999999988777655899999999999999999 557788899999999999644
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-17 Score=170.97 Aligned_cols=150 Identities=17% Similarity=0.222 Sum_probs=96.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccC---------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLS--------- 150 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~--------- 150 (664)
..+..|+|++|.+. .+| ..+++|++|++|+|++|+|+..++.++++++|++|+|++|++.|.+|..++.
T Consensus 104 ~~L~~L~L~~n~l~-~lp-~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELP-DTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCC-SCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chh-HHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 45677777777777 343 3677777777777777777733235667777777777777777677766554
Q ss_pred CCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCC-CCcccccCcccc
Q 006031 151 LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSF 228 (664)
Q Consensus 151 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~ 228 (664)
+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++.++.. .+++|+.|+|++|++.+.+|. ...+.++..+.+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 667777777777776 66666666777777777777776544332 456666666666666666653 233445555555
Q ss_pred ccCC
Q 006031 229 LFNP 232 (664)
Q Consensus 229 ~~N~ 232 (664)
.+|.
T Consensus 261 ~~n~ 264 (328)
T 4fcg_A 261 KDCS 264 (328)
T ss_dssp TTCT
T ss_pred CCCC
Confidence 5553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.7e-17 Score=164.38 Aligned_cols=136 Identities=25% Similarity=0.270 Sum_probs=124.1
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+++ +++..+.++++|++|+|++|++++.+|. |.++++|++|+|++|++++..|..+.++++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 579999999999998 5666789999999999999999988885 78999999999999999977777789999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~ 216 (664)
|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|.+++..|.
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 9999999877778899999999999999999887753 789999999999999998874
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8.1e-17 Score=161.71 Aligned_cols=135 Identities=23% Similarity=0.269 Sum_probs=121.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..++.|+|++|.+.+ +++..+.++++|++|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|.++++|++|+
T Consensus 59 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 579999999999998 5566899999999999999999988874 78999999999999999966666689999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p 215 (664)
|++|+|++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|.+++...
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 9999999777778999999999999999999877743 67899999999999998754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-17 Score=155.05 Aligned_cols=134 Identities=19% Similarity=0.189 Sum_probs=112.5
Q ss_pred CccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCccc
Q 006031 69 FCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPS 147 (664)
Q Consensus 69 ~C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~ 147 (664)
.|+|++|.|+. +++.. +|. .+ .++|+.|+|++|++++.++. |.++++|++|+|++|++++..|..
T Consensus 6 ~C~~~~l~~~~----------~~l~~-~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 6 SCSGTEIRCNS----------KGLTS-VPT-GI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EEETTEEECCS----------SCCSS-CCT-TC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred EeCCCEEEecC----------CCCcc-CCC-CC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 37899988865 34444 332 23 36899999999999987774 789999999999999999666667
Q ss_pred ccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC
Q 006031 148 LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 148 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.++.. .+++|+.|+|++|.+++..|.
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 899999999999999999777777899999999999999999766643 588999999999999998763
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=175.45 Aligned_cols=163 Identities=17% Similarity=0.179 Sum_probs=132.4
Q ss_pred CCCccccceEecC-------------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCE
Q 006031 67 LHFCQWQGVICYQ-------------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKS 132 (664)
Q Consensus 67 ~~~C~w~gv~C~~-------------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~ 132 (664)
..+|.|.|+ |+- ..++.|+|++|++.+ +++..+.++++|++|+|++|++++..| .|.++++|++
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 567999988 752 368899999999998 566689999999999999999999877 4899999999
Q ss_pred EeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCch--hhcCCCCCCeeeCcCCc-CccCCCCC--CCCCCcEEEccC
Q 006031 133 LFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPK--ELASQGRLYSLRLDVNR-FNGSIPPL--NQSSLKIFNVSG 207 (664)
Q Consensus 133 L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~-l~g~~p~~--~~~~L~~l~l~~ 207 (664)
|+|++|++++..+..+.++++|++|+|++|+++ .+|. .+..+++|+.|++++|+ +++..|.. .+++|+.|++++
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 999999999544445899999999999999999 5665 78899999999999995 66554442 678999999999
Q ss_pred CcccccCCC-CCcccccCccccccCC
Q 006031 208 NNFTGAITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 208 N~l~g~~p~-~~~l~~~~~~~~~~N~ 232 (664)
|++++.+|. ...+.++..+.+.+|.
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred CCcCccCHHHHhccccCCeecCCCCc
Confidence 999998763 2445555666666663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-16 Score=154.06 Aligned_cols=151 Identities=20% Similarity=0.157 Sum_probs=128.6
Q ss_pred EEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 83 VRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 83 ~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
+.+++.++++.. ++. .+ .++|++|+|++|++++.++. |.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 10 ~~v~c~~~~l~~-~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPT-GI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCSS-CCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCccC-CCC-CC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 578888998887 432 33 56999999999999987774 78999999999999999966566678999999999999
Q ss_pred CcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCCCCCCc
Q 006031 162 NNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 162 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~lcg~ 237 (664)
|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|+|++|++++.++. ...+.++..+.+.+|++.|..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999766667899999999999999999877753 689999999999999987774 355778888999999888753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-17 Score=157.33 Aligned_cols=148 Identities=18% Similarity=0.219 Sum_probs=127.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+++.|+|+++.+.. ++ .+..+++|++|+|++|.++ .++.+.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~l~~n~~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVTD-LT--GIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCSC-CT--TGGGCTTCSEEEEESCCCS-CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCccC-hH--HHhcCCCCCEEEccCCCCC-cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 468899999999985 43 6999999999999999776 3457899999999999999999889999999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|++++..|..+..+++|+.|+|++|++.+.+|.. .+++|+.|++++|++++.. ....+.++..+.+.+|+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC-
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcc
Confidence 999999989999999999999999999844455543 7889999999999999843 55667778888888875
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-17 Score=165.97 Aligned_cols=134 Identities=19% Similarity=0.170 Sum_probs=121.7
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++.|+|++|.+.+ +++..+.++++|++|+|++|++++..+ .|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 29 ~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 58999999999998 556689999999999999999998877 6899999999999999999888889999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccC-CCCC--CCCCCcEEEccCCcccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGS-IPPL--NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~--~~~~L~~l~l~~N~l~g~~p 215 (664)
++|++++..+..+..+++|+.|+|++|++++. +|.. .+++|+.|++++|++++..+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 99999987777899999999999999999873 5653 77899999999999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-17 Score=170.99 Aligned_cols=161 Identities=22% Similarity=0.280 Sum_probs=103.7
Q ss_pred CccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCC---CCCCCCCCCCCEEe
Q 006031 69 FCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGP---IPDLSGLVNLKSLF 134 (664)
Q Consensus 69 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~---~p~~~~l~~L~~L~ 134 (664)
.|.|++|.|+. ..++.|+|++|.+.. +++..+.++++|++|+|++|.++.. .+.+.++++|++|+
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCc-cCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 38999999975 368899999999996 6666689999999999999999843 22444566666666
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCc-hhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCccc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLP-KELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFT 211 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~ 211 (664)
|++|.++ .+|..+.++++|++|+|++|++++..+ ..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|.++
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 6666666 456556666666666666666664333 35556666666666666665555442 4455556666666555
Q ss_pred c-cCC-CCCcccccCccccccC
Q 006031 212 G-AIT-VTSTLSRFGISSFLFN 231 (664)
Q Consensus 212 g-~~p-~~~~l~~~~~~~~~~N 231 (664)
+ .+| ....+.++..+.+.+|
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTS
T ss_pred cccchhHHhhCcCCCEEECCCC
Confidence 4 223 1233344444444444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-17 Score=186.06 Aligned_cols=134 Identities=19% Similarity=0.170 Sum_probs=121.5
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++.|+|++|.|++ +++.+|.+|++|++|+|++|+|++.+| .|.+|++|++|+|++|+|++..|..|.+|++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 68999999999998 677789999999999999999999888 5999999999999999999766678999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccC-CCCC--CCCCCcEEEccCCcccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGS-IPPL--NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~--~~~~L~~l~l~~N~l~g~~p 215 (664)
++|+|++..|..|+++++|+.|+|++|++++. +|.. .+++|++|++++|+|++..|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 99999976667899999999999999999864 4543 68899999999999999877
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.8e-18 Score=194.02 Aligned_cols=174 Identities=21% Similarity=0.196 Sum_probs=114.3
Q ss_pred CChhHHHHHHHHHhccCCCCCC---cCcCCCCCCCccccceEecCCcEEEEEEcCCCCCC--------------------
Q 006031 38 LLPSDAQVLLAFKAKADLRNHL---FFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGG-------------------- 94 (664)
Q Consensus 38 ~~~~~~~aLl~~k~~~~~~~~~---~~~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~g-------------------- 94 (664)
....++++|+++........+. .|.. ..+..+.|.+++++..++++|+|.++++..
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTG-DSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcC-CCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 4457889999998775322211 2322 224567899999988888887775554432
Q ss_pred ------cCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCC
Q 006031 95 ------IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPL 168 (664)
Q Consensus 95 ------~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 168 (664)
.+++..+..++.|+.|+|++|.|....+.+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp --------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 12355688899999999999999955557889999999999999999 99999999999999999999999 89
Q ss_pred chhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCC
Q 006031 169 PKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 169 p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p 215 (664)
|..|+.|++|++|+|++|.|+ .+|.. .+++|+.|+|++|+|+|.+|
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 999999999999999999997 66653 78899999999999999988
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=174.48 Aligned_cols=154 Identities=25% Similarity=0.242 Sum_probs=103.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--------------------------CCCCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--------------------------DLSGLVNLKSLF 134 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--------------------------~~~~l~~L~~L~ 134 (664)
.+..|+|++|.|++ +++..+..+++|++|+|++|.|++..+ .|.++++|++|+
T Consensus 113 ~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 113 NLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SCCEEECCSSCCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred cCCEEECCCCcCCe-eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 45555555555554 334445555555555555555554332 133445555555
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g 212 (664)
|++|+++ .+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|.. .+++|+.|+|++|+|++
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 5555555 444 3566667777777777777777777888888888888888888766653 67899999999999998
Q ss_pred cCCCC-CcccccCccccccCCCCCCc
Q 006031 213 AITVT-STLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 213 ~~p~~-~~l~~~~~~~~~~N~~lcg~ 237 (664)
..+.. ..+.++..+.+.+||+.|..
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred cChhHhccccCCCEEEcCCCCccCCC
Confidence 77643 45677888899999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.2e-17 Score=183.77 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=124.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+++.|+|++|.+.+ +++..+.++++|++|+|++|++++.+| .|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 478999999999998 556689999999999999999999888 589999999999999999988899999999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc-CCCCC--CCCCCcEEEccCCcccccCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNG-SIPPL--NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~--~~~~L~~l~l~~N~l~g~~p~ 216 (664)
|++|++++..|..++.+++|++|+|++|++++ .+|.. .+++|+.|++++|++++..|.
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99999998777889999999999999999986 56763 789999999999999998773
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.2e-17 Score=168.04 Aligned_cols=157 Identities=20% Similarity=0.218 Sum_probs=111.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCC-CCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTG-SFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L 157 (664)
..+..|+|++|.+.+..+...+.++++|++|+|++|.+++.+|. +.++++|+.|+|++|.+++ .+|..+.++++|++|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 45566666666666632224677777777777777777776663 6677778888888887776 467777778888888
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCcccccCCCC-Ccc-cccCccccccCCC
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITVT-STL-SRFGISSFLFNPS 233 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~~p~~-~~l-~~~~~~~~~~N~~ 233 (664)
+|++|++++..|..+..+++|+.|+|++|++++..+. ..+++|+.|+|++|++++.+|.. ..+ .++..+.+.+|+.
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 8888888777777777788888888888887765552 25677888888888888776632 223 3566677778877
Q ss_pred CCC
Q 006031 234 LCG 236 (664)
Q Consensus 234 lcg 236 (664)
-|.
T Consensus 261 ~~~ 263 (306)
T 2z66_A 261 ACT 263 (306)
T ss_dssp ECS
T ss_pred ecc
Confidence 664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.1e-17 Score=181.40 Aligned_cols=147 Identities=23% Similarity=0.275 Sum_probs=122.6
Q ss_pred CCCCc-----cccce-EecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCc
Q 006031 66 SLHFC-----QWQGV-ICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 66 ~~~~C-----~w~gv-~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~ 139 (664)
+.++| .|.|+ .|..++++.|+|++|+|++ +|+ .+ +++|+.|+|++|+|+ .+| ..+++|++|+|++|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N~ 111 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALI-SLP--ELPASLEYLDACDNR 111 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCS-CCC--CCCTTCCEEECCSSC
T ss_pred cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCc-ccc--cccCCCCEEEccCCC
Confidence 35678 79999 7988899999999999998 655 45 388999999999999 566 668999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCc
Q 006031 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTST 219 (664)
Q Consensus 140 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~ 219 (664)
|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|...
T Consensus 112 l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp~l~- 179 (571)
T 3cvr_A 112 LST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LPELP- 179 (571)
T ss_dssp CSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCCCC-
T ss_pred CCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-cchhh-
Confidence 996 888 765 89999999999997 787 68899999999999997 665 67889999999999998 55422
Q ss_pred ccccCccccccCC
Q 006031 220 LSRFGISSFLFNP 232 (664)
Q Consensus 220 l~~~~~~~~~~N~ 232 (664)
.++..+.+.+|.
T Consensus 180 -~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 180 -ESLEALDVSTNL 191 (571)
T ss_dssp -TTCCEEECCSSC
T ss_pred -CCCCEEECcCCC
Confidence 566677777763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=174.23 Aligned_cols=111 Identities=23% Similarity=0.205 Sum_probs=81.7
Q ss_pred CCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEE
Q 006031 126 GLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIF 203 (664)
Q Consensus 126 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l 203 (664)
++++|++|+|++|+++ .+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|.. .+++|+.|
T Consensus 194 ~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 271 (452)
T 3zyi_A 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271 (452)
T ss_dssp TCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence 3444444444444444 233 3555667777777788888777888888888888888888888777753 67899999
Q ss_pred EccCCcccccCCCC-CcccccCccccccCCCCCCcc
Q 006031 204 NVSGNNFTGAITVT-STLSRFGISSFLFNPSLCGEI 238 (664)
Q Consensus 204 ~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~~lcg~~ 238 (664)
+|++|+|++.++.. ..+.++..+.+.+||+.|...
T Consensus 272 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp ECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 99999999877643 456778888999999988643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.6e-17 Score=181.65 Aligned_cols=150 Identities=23% Similarity=0.137 Sum_probs=102.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-----------------CCCCCCCCEEeccCCcCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-----------------LSGLVNLKSLFLDHNFFTG 142 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-----------------~~~l~~L~~L~L~~N~l~g 142 (664)
..+..|+|++|.+++.. | ++.+++|++|+|++|.|++.++. ...+++|+.|+|++|.+++
T Consensus 58 ~~L~~L~Ls~N~l~~~~-~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 58 TKLELLNLSSNVLYETL-D--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp TTCCEEECTTSCCEEEE-E--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCCEEEeeCCCCCCCc-c--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 35556666666665532 1 55555555555555555443220 1124566677777777777
Q ss_pred CCcccccCCCCCCEEeccCCcCcCCCchhhc-CCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCccc
Q 006031 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELA-SQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLS 221 (664)
Q Consensus 143 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~ 221 (664)
..|..++++++|++|+|++|+|++.+|..+. .+++|+.|+|++|+|++..+...+++|+.|+|++|+|++.+|....+.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~ 214 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCHhHcCCC
Confidence 7777778888888888888888877777775 678888888888888877665677888888888888888777655666
Q ss_pred ccCccccccCC
Q 006031 222 RFGISSFLFNP 232 (664)
Q Consensus 222 ~~~~~~~~~N~ 232 (664)
++..+.+.+|.
T Consensus 215 ~L~~L~Ls~N~ 225 (487)
T 3oja_A 215 GVTWISLRNNK 225 (487)
T ss_dssp TCSEEECTTSC
T ss_pred CccEEEecCCc
Confidence 67777777663
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=183.37 Aligned_cols=148 Identities=16% Similarity=0.165 Sum_probs=125.1
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+..+++.++.+.. +|+..+.++++|++|+|++|.|++.+| .|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~~-lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCCC-cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 45678888888877 667678899999999999999999887 7999999999999999999888888899999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
++|+|++..|..|..+++|++|+|++|++++.+|.. .+++|+.|+|++|.|++..+ ..+.++..+.+.+|
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n 202 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYN 202 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSS
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccC
Confidence 999999554555789999999999999999888753 78899999999999998643 55566666666555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.2e-17 Score=185.13 Aligned_cols=158 Identities=17% Similarity=0.124 Sum_probs=115.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCC-CcccccCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGS-FPPSLLSLHRLKTLD 158 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~ 158 (664)
.+..|+|++|.+.+..+...+.++++|++|+|++|.+++.+| .+.++++|+.|+|++|++++. +|..+.++++|++|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 455566666666654332467777777777777777777666 467778888888888888763 677778888888888
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCccc-ccCccccccCCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLS-RFGISSFLFNPSLC 235 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~-~~~~~~~~~N~~lc 235 (664)
|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|+|+..++....+. ++..+.+.+|++.|
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCccc
Confidence 8888888777778888888888888888888776653 67788888888888885544434443 46777888999888
Q ss_pred Ccc
Q 006031 236 GEI 238 (664)
Q Consensus 236 g~~ 238 (664)
..+
T Consensus 560 ~c~ 562 (606)
T 3vq2_A 560 ICE 562 (606)
T ss_dssp SST
T ss_pred CCc
Confidence 644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-17 Score=188.80 Aligned_cols=134 Identities=16% Similarity=0.289 Sum_probs=119.8
Q ss_pred CccccCCCCCCEEEecCCCCCCC-----------------CC-CCC--CCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 006031 98 PNSLTKLDQLRVLGLQNNSLTGP-----------------IP-DLS--GLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 98 p~~l~~l~~L~~L~L~~N~l~g~-----------------~p-~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 157 (664)
|.++++|++|++|+|++|+|+|. +| +++ ++++|++|+|++|++.|.+|..|+++++|++|
T Consensus 199 p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 278 (636)
T 4eco_A 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278 (636)
T ss_dssp CGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEE
T ss_pred CHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEE
Confidence 44799999999999999999994 55 788 99999999999999999999999999999999
Q ss_pred eccCCc-CcC-CCchhhcCC------CCCCeeeCcCCcCccCCCC----CCCCCCcEEEccCCcccccCCCCCcccccCc
Q 006031 158 DLSYNN-LSG-PLPKELASQ------GRLYSLRLDVNRFNGSIPP----LNQSSLKIFNVSGNNFTGAITVTSTLSRFGI 225 (664)
Q Consensus 158 ~l~~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~g~~p~----~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~ 225 (664)
+|++|+ ++| .+|..++.+ ++|+.|+|++|+++ .+|. ..+++|+.|++++|+++|.+|....+.++..
T Consensus 279 ~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~ 357 (636)
T 4eco_A 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLAS 357 (636)
T ss_dssp ECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESE
T ss_pred ECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCE
Confidence 999998 999 899999887 99999999999999 7776 3888999999999999999996666777777
Q ss_pred cccccCC
Q 006031 226 SSFLFNP 232 (664)
Q Consensus 226 ~~~~~N~ 232 (664)
+.+.+|.
T Consensus 358 L~L~~N~ 364 (636)
T 4eco_A 358 LNLAYNQ 364 (636)
T ss_dssp EECCSSE
T ss_pred EECCCCc
Confidence 7777773
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.3e-17 Score=167.37 Aligned_cols=148 Identities=18% Similarity=0.195 Sum_probs=75.4
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCC---CCC--CCCCCCCCEEeccCCcCCCCCcc----cccCC
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGP---IPD--LSGLVNLKSLFLDHNFFTGSFPP----SLLSL 151 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~---~p~--~~~l~~L~~L~L~~N~l~g~~p~----~~~~l 151 (664)
++..|+|++|.+.+ +++..++++++|++|+|++|++.+. .+. ++++++|++|+|++|+++ .+|. .+.++
T Consensus 146 ~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 146 GLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp CCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred CCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 45555555555544 3334555555555555555555441 111 244555555555555554 2222 13445
Q ss_pred CCCCEEeccCCcCcCCCchhhcCC---CCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCcccc
Q 006031 152 HRLKTLDLSYNNLSGPLPKELASQ---GRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSF 228 (664)
Q Consensus 152 ~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~ 228 (664)
++|++|||++|+|++.+|..+..+ ++|++|+|++|+|+ .+|....++|+.|+|++|+|++. |....+.++..+.+
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L 301 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRA-PQPDELPEVDNLTL 301 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSC-CCTTSCCCCSCEEC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCC-chhhhCCCccEEEC
Confidence 555555555555555555555444 35555555555555 34443335555666666665553 22244455555555
Q ss_pred ccCC
Q 006031 229 LFNP 232 (664)
Q Consensus 229 ~~N~ 232 (664)
.+|+
T Consensus 302 ~~N~ 305 (310)
T 4glp_A 302 DGNP 305 (310)
T ss_dssp SSTT
T ss_pred cCCC
Confidence 5553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=175.98 Aligned_cols=160 Identities=20% Similarity=0.156 Sum_probs=134.9
Q ss_pred ccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc
Q 006031 72 WQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 72 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~ 139 (664)
|..|.|+. ..++.|+|++|.+.+ +++..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 78899964 367889999999998 556689999999999999999999877 69999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-
Q 006031 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV- 216 (664)
Q Consensus 140 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~- 216 (664)
+++..+..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 99555556899999999999999999988999999999999999999999877753 778999999999999876542
Q ss_pred CCcccccCccccccCC
Q 006031 217 TSTLSRFGISSFLFNP 232 (664)
Q Consensus 217 ~~~l~~~~~~~~~~N~ 232 (664)
...+.++..+.+.+|.
T Consensus 172 l~~l~~L~~L~l~~n~ 187 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLN 187 (477)
T ss_dssp HTTCTTCCEEEEESCC
T ss_pred hcccCCCcEEeCCCCc
Confidence 2345556666666653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=149.20 Aligned_cols=133 Identities=23% Similarity=0.137 Sum_probs=117.2
Q ss_pred CcEEEEEEcCCCCC-CcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLG-GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~-g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..++.|+|++|.+. |.++. .+..+++|++|+|++|.+++. +.+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57899999999998 66654 689999999999999999987 8899999999999999999988898888899999999
Q ss_pred ccCCcCcCC-CchhhcCCCCCCeeeCcCCcCccCCC----C-CCCCCCcEEEccCCcccccC
Q 006031 159 LSYNNLSGP-LPKELASQGRLYSLRLDVNRFNGSIP----P-LNQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 159 l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p----~-~~~~~L~~l~l~~N~l~g~~ 214 (664)
|++|++++. .+..+..+++|+.|+|++|++++.++ . ..+++|++|++++|.++...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 999999953 22789999999999999999998776 2 37889999999999987654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=158.71 Aligned_cols=152 Identities=14% Similarity=0.095 Sum_probs=127.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCC-CCCCCC-CCCCCCCCCEEeccC-CcCCCCCcccccCCCCCCE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNS-LTGPIP-DLSGLVNLKSLFLDH-NFFTGSFPPSLLSLHRLKT 156 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~-l~g~~p-~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~ 156 (664)
..++.|+|++|.+++ +++..+.++++|++|+|++|+ +++..+ .|.++++|++|+|++ |++++..|..|.++++|++
T Consensus 31 ~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 478999999999998 566689999999999999997 887776 688999999999999 9999666678999999999
Q ss_pred EeccCCcCcCCCchhhcCCCCCC---eeeCcCC-cCccCCCCC--CCCCCc-EEEccCCcccccCCCCCcccccCccccc
Q 006031 157 LDLSYNNLSGPLPKELASQGRLY---SLRLDVN-RFNGSIPPL--NQSSLK-IFNVSGNNFTGAITVTSTLSRFGISSFL 229 (664)
Q Consensus 157 L~l~~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~--~~~~L~-~l~l~~N~l~g~~p~~~~l~~~~~~~~~ 229 (664)
|+|++|++++ +|. +..+++|+ .|++++| ++++..+.. .+++|+ .|++++|+++...+......++..+.+.
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECT
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcC
Confidence 9999999996 887 88888888 9999999 998766642 688999 9999999999544433333566677777
Q ss_pred cCCCC
Q 006031 230 FNPSL 234 (664)
Q Consensus 230 ~N~~l 234 (664)
+|+.+
T Consensus 188 ~n~~l 192 (239)
T 2xwt_C 188 KNKYL 192 (239)
T ss_dssp TCTTC
T ss_pred CCCCc
Confidence 77534
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=174.93 Aligned_cols=134 Identities=18% Similarity=0.156 Sum_probs=119.0
Q ss_pred CCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeC
Q 006031 105 DQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRL 183 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 183 (664)
++|+.|+|++|++++.+| .++++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 589999999999999888 4889999999999999999888999999999999999999999888999999999999999
Q ss_pred cCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccCCCCCCcc
Q 006031 184 DVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNPSLCGEI 238 (664)
Q Consensus 184 ~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~~lcg~~ 238 (664)
++|++++.+|.. .+++|++|+|++|+|++.++.. ..+.++..+.+.+|+..|..+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999887763 7889999999999999877643 567788888999999888643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.9e-17 Score=147.37 Aligned_cols=126 Identities=22% Similarity=0.166 Sum_probs=106.2
Q ss_pred CcEEEEEEcCCCCC-CcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLG-GIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~-g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+++.|+|++|.+. +.+++ .+..+++|+.|+|++|++++. +.+.++++|++|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46888999999998 66654 788999999999999999887 7788899999999999999987888888899999999
Q ss_pred ccCCcCcCC-CchhhcCCCCCCeeeCcCCcCccCCC---C--CCCCCCcEEEccC
Q 006031 159 LSYNNLSGP-LPKELASQGRLYSLRLDVNRFNGSIP---P--LNQSSLKIFNVSG 207 (664)
Q Consensus 159 l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~--~~~~~L~~l~l~~ 207 (664)
|++|++++. .|..+..+++|+.|++++|++++.++ . ..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999863 45788899999999999999987766 1 2678888888764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.4e-17 Score=167.10 Aligned_cols=149 Identities=17% Similarity=0.172 Sum_probs=118.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCC-----CCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCC--Ccccc--c
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKL-----DQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGS--FPPSL--L 149 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l-----~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~--~p~~~--~ 149 (664)
..++.|+|++|.+++. |..++.+ ++|++|+|++|++++.+| .|+++++|++|+|++|++.|. +|..+ .
T Consensus 121 ~~L~~L~Ls~N~l~~~--~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR--DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS--SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch--hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 5789999999999985 4577776 899999999999998886 688999999999999998876 45555 8
Q ss_pred CCCCCCEEeccCCcCcC--CCch-hhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCCcccccCCCCCccccc
Q 006031 150 SLHRLKTLDLSYNNLSG--PLPK-ELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAITVTSTLSRF 223 (664)
Q Consensus 150 ~l~~L~~L~l~~N~l~g--~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~~p~~~~l~~~ 223 (664)
++++|++|+|++|+|++ .+|. .+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..-. .++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCc
Confidence 89999999999999983 3333 3467889999999999999877532 4688999999999998 5553222 566
Q ss_pred CccccccCC
Q 006031 224 GISSFLFNP 232 (664)
Q Consensus 224 ~~~~~~~N~ 232 (664)
..+.+.+|.
T Consensus 277 ~~L~Ls~N~ 285 (312)
T 1wwl_A 277 SVLDLSYNR 285 (312)
T ss_dssp EEEECCSSC
T ss_pred eEEECCCCC
Confidence 667777763
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.3e-16 Score=167.87 Aligned_cols=148 Identities=18% Similarity=0.217 Sum_probs=126.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..+++.++.+.. +++..+.++++|++|+|++|++++..| .|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 356778899988877 666568899999999999999998887 799999999999999999988888899999999999
Q ss_pred ccCCcCcCCCchh-hcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 159 LSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 159 l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
|++|+++ .+|.. +..+++|++|+|++|++++..|.. .+++|+.|++++|++++... ..+.++..+.+.+|
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYN 196 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCG--GGCTTCSEEECCSS
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccc--ccccccceeecccc
Confidence 9999999 56655 689999999999999999877753 78899999999999998632 55666666666665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=179.09 Aligned_cols=159 Identities=18% Similarity=0.102 Sum_probs=134.9
Q ss_pred ccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc
Q 006031 72 WQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 72 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~ 139 (664)
+.-|.|+. ..++.|+|++|.+++ ++|..|+++++|++|+|++|++++..| .|.++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 45677853 468999999999998 567799999999999999999999887 59999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccC-CCC-CCCCCCcEEEccCCcccccCCC-
Q 006031 140 FTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS-IPP-LNQSSLKIFNVSGNNFTGAITV- 216 (664)
Q Consensus 140 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~-~~~~~L~~l~l~~N~l~g~~p~- 216 (664)
+++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++. +|. ..+++|+.|++++|++++..|.
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 9999999999999999999999999977688899999999999999999984 354 3688999999999999987662
Q ss_pred CCcccccC--ccccccC
Q 006031 217 TSTLSRFG--ISSFLFN 231 (664)
Q Consensus 217 ~~~l~~~~--~~~~~~N 231 (664)
...+.++. .+.+.+|
T Consensus 173 ~~~l~~L~~l~L~l~~n 189 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGN 189 (606)
T ss_dssp HHTTTTCCSEEEECTTC
T ss_pred hhhhcccceeEEecCCC
Confidence 12334444 3445555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-16 Score=150.61 Aligned_cols=126 Identities=22% Similarity=0.176 Sum_probs=106.6
Q ss_pred EEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcC
Q 006031 85 VVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNL 164 (664)
Q Consensus 85 l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 164 (664)
+++++++|.. +|. .+. ++|++|+|++|+|+..++.|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~~-ip~-~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLKV-LPK-GIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCSS-CCS-CCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCCc-CCC-CCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 4445666665 443 443 689999999999995555799999999999999999987788899999999999999999
Q ss_pred cCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 165 SGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 165 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|.+...-
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 9888889999999999999999999766642 6789999999999998643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=9.4e-17 Score=177.18 Aligned_cols=153 Identities=16% Similarity=0.109 Sum_probs=130.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCccccc-CCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L 157 (664)
..+..|+|++|.+++. ++ ..+++|+.|+|++|+|++.+| .++++++|+.|+|++|.|++.+|..+. ++++|++|
T Consensus 99 ~~L~~L~L~~N~l~~~-~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRV-SC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCE-EE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCC-Cc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 4566777777777773 22 346889999999999999887 688999999999999999999999887 79999999
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCC
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg 236 (664)
+|++|+|++. |. +..+++|+.|+|++|+|++.+|.+ .+++|+.|+|++|+|++.++....+.++..+.+.+|+..|+
T Consensus 175 ~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 9999999965 43 446999999999999999977764 67899999999999999766666778888899999999887
Q ss_pred cc
Q 006031 237 EI 238 (664)
Q Consensus 237 ~~ 238 (664)
.+
T Consensus 253 ~~ 254 (487)
T 3oja_A 253 TL 254 (487)
T ss_dssp HH
T ss_pred ch
Confidence 43
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.2e-17 Score=167.60 Aligned_cols=152 Identities=22% Similarity=0.194 Sum_probs=124.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccc--cCCCCCCEEEecCCCCCCCCCCCCCC-----CCCCEEeccCCcCCCCCcccccCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSL--TKLDQLRVLGLQNNSLTGPIPDLSGL-----VNLKSLFLDHNFFTGSFPPSLLSLH 152 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l--~~l~~L~~L~L~~N~l~g~~p~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~ 152 (664)
.++..|+|++|.++|.++. .+ ..+++|++|+|++|+|++.++.++++ ++|++|+|++|++++..|..|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPP-PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCC-CSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHH-HHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 4788999999999987755 44 89999999999999999984445555 8999999999999988889999999
Q ss_pred CCCEEeccCCcCcCC--Cchhh--cCCCCCCeeeCcCCcCccC--CCC---CCCCCCcEEEccCCcccccCC--CCCccc
Q 006031 153 RLKTLDLSYNNLSGP--LPKEL--ASQGRLYSLRLDVNRFNGS--IPP---LNQSSLKIFNVSGNNFTGAIT--VTSTLS 221 (664)
Q Consensus 153 ~L~~L~l~~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~g~--~p~---~~~~~L~~l~l~~N~l~g~~p--~~~~l~ 221 (664)
+|++|+|++|+++|. +|..+ ..+++|+.|+|++|++++. ++. ..+++|+.|+|++|++++.+| ....+.
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 999999999999876 45555 8899999999999999842 222 166899999999999999774 334467
Q ss_pred ccCccccccCC
Q 006031 222 RFGISSFLFNP 232 (664)
Q Consensus 222 ~~~~~~~~~N~ 232 (664)
++..+.+.+|.
T Consensus 254 ~L~~L~Ls~N~ 264 (312)
T 1wwl_A 254 QLNSLNLSFTG 264 (312)
T ss_dssp TCCEEECTTSC
T ss_pred CCCEEECCCCc
Confidence 77778887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-15 Score=159.71 Aligned_cols=158 Identities=18% Similarity=0.236 Sum_probs=118.5
Q ss_pred CCccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEec
Q 006031 68 HFCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFL 135 (664)
Q Consensus 68 ~~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L 135 (664)
..|.|+.+.|+. ..++.|+|++|.+++ +++..+.++++|++|+|++|++++..| .|.++++|++|+|
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 347899999974 357889999999998 556689999999999999999999877 6999999999999
Q ss_pred cCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc--CCCCC--CCCCCcEEEccCCccc
Q 006031 136 DHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG--SIPPL--NQSSLKIFNVSGNNFT 211 (664)
Q Consensus 136 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~--~~~~L~~l~l~~N~l~ 211 (664)
++|+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|+|++|+++. ..+.. .+++|+.|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 999998 7887765 678888888888887666677777788888887777753 33322 4566666666666666
Q ss_pred ccCCCCCcccccCccccccC
Q 006031 212 GAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 212 g~~p~~~~l~~~~~~~~~~N 231 (664)
.... ....++..+.+.+|
T Consensus 185 ~l~~--~~~~~L~~L~l~~n 202 (330)
T 1xku_A 185 TIPQ--GLPPSLTELHLDGN 202 (330)
T ss_dssp SCCS--SCCTTCSEEECTTS
T ss_pred cCCc--cccccCCEEECCCC
Confidence 5332 11234444444444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=184.15 Aligned_cols=161 Identities=22% Similarity=0.196 Sum_probs=136.3
Q ss_pred ccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCC-C-CCCCCCCCCEEeccCCcCCCCCccc
Q 006031 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPI-P-DLSGLVNLKSLFLDHNFFTGSFPPS 147 (664)
Q Consensus 70 C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~-p-~~~~l~~L~~L~L~~N~l~g~~p~~ 147 (664)
|.|..|-+-..+++.|+|++|.+++ +.+.++.+|++|++|+|++|++.+.+ | .|.+|++|++|+|++|++++..|..
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~-i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCE-ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCc-cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 5688887755789999999999998 45668999999999999999887777 4 5999999999999999999889999
Q ss_pred ccCCCCCCEEeccCCcCcCCCchh--hcCCCCCCeeeCcCCcCccCCCC---CCCCCCcEEEccCCcccccCCCC-Ccc-
Q 006031 148 LLSLHRLKTLDLSYNNLSGPLPKE--LASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTGAITVT-STL- 220 (664)
Q Consensus 148 ~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~l~~N~l~g~~p~~-~~l- 220 (664)
|.++++|++|+|++|++++.+|.. +.++++|+.|+|++|++++..|. ..+++|+.|+|++|++++..|.. ..+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999999999888876 89999999999999999987764 37899999999999999877632 112
Q ss_pred -cccCccccccC
Q 006031 221 -SRFGISSFLFN 231 (664)
Q Consensus 221 -~~~~~~~~~~N 231 (664)
.++..+.+.+|
T Consensus 173 ~~~L~~L~L~~n 184 (844)
T 3j0a_A 173 GKTLSFFSLAAN 184 (844)
T ss_dssp HCSSCCCEECCS
T ss_pred CCccceEECCCC
Confidence 34555555555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.7e-16 Score=178.41 Aligned_cols=134 Identities=20% Similarity=0.177 Sum_probs=70.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC--CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD--LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 157 (664)
..+..|+|++|.+.+. +|..+.++++|+.|+|++|.+++.+|. +.++++|+.|+|++|.+++..|..+.++++|++|
T Consensus 376 ~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSL-KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEE-CTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcC-CHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 3566666666666552 344555666666666666666555441 5555555555555555555555555555555555
Q ss_pred eccCCcCcCC---CchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 158 DLSYNNLSGP---LPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 158 ~l~~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
+|++|++++. .+..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++.+
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 516 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGG
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCC
Confidence 5555555541 2234455555555555555555444432 3444444444444444443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=171.95 Aligned_cols=155 Identities=21% Similarity=0.173 Sum_probs=132.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCC--C-CCCCCCCCCEEeccCCcCCCCCccc-ccCCCCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPI--P-DLSGLVNLKSLFLDHNFFTGSFPPS-LLSLHRLK 155 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~--p-~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~ 155 (664)
..++.|+|++|.+++.+ |..++++++|+.|+|++|++++.. | .+.++++|+.|+|++|++++.+|.. +..+++|+
T Consensus 353 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSV-FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTT-TTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccch-hhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 57899999999999855 458999999999999999999754 3 5889999999999999999878775 78899999
Q ss_pred EEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCcccccCCC-CCcccccCccccccCC
Q 006031 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 156 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~ 232 (664)
+|+|++|++++.+|..+. ++|+.|+|++|+++ .+|. ..+++|+.|+|++|+|++.++. ...+.++..+.+.+|+
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCC
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCC
Confidence 999999999988887665 79999999999999 5654 3788999999999999965554 4667788889999999
Q ss_pred CCCCcc
Q 006031 233 SLCGEI 238 (664)
Q Consensus 233 ~lcg~~ 238 (664)
+.|..+
T Consensus 509 ~~c~c~ 514 (562)
T 3a79_B 509 WDCTCP 514 (562)
T ss_dssp BCCCHH
T ss_pred cCCCcc
Confidence 998643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.2e-16 Score=178.62 Aligned_cols=151 Identities=19% Similarity=0.167 Sum_probs=124.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+++.|+|++|.+.+ +++..+.++++|++|+|++|++++.+|. |+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 478899999999998 5666799999999999999999998885 78899999999999999944444689999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC---CcccccCccccccC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT---STLSRFGISSFLFN 231 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~---~~l~~~~~~~~~~N 231 (664)
|++|++++..|..++.+++|++|+|++|++++.+|.. .+++|+.|++++|++++..+.. ....++..+.+.+|
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCC
Confidence 9999998777788999999999999999999887764 7889999999999998876631 12245666666666
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.5e-16 Score=158.23 Aligned_cols=145 Identities=25% Similarity=0.370 Sum_probs=121.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|+|++|.+.+ +++ +.++++|++|+|++|.+++ +|.+.++++|++|+|++|++++ + +.+.++++|++|+|
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 578899999999988 333 8899999999999999987 5668899999999999999985 4 46888999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
++|++++. ..+..+++|+.|+|++|++++..|-..+++|+.|+|++|++++. |....+.++..+.+.+|+.
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEE
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcc
Confidence 99999864 57889999999999999999877756888999999999999874 4456677777788888754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=172.56 Aligned_cols=154 Identities=21% Similarity=0.204 Sum_probs=112.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCC--CCC-CCCCCCCCCEEeccCCcCCCCCccc-ccCCCCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG--PIP-DLSGLVNLKSLFLDHNFFTGSFPPS-LLSLHRLK 155 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~ 155 (664)
..++.|+|++|.+++.+ |..++++++|+.|+|++|++++ .+| .+.++++|++|+|++|++++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTV-FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTT-TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhh-hhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 46777778888777754 3467778888888888888776 333 4677788888888888887767765 66777888
Q ss_pred EEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCcccccCCC-CCcccccCccccccCC
Q 006031 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 156 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~ 232 (664)
+|+|++|++++.+|..+. ++|+.|+|++|+++ .+|. ..+++|+.|+|++|+|++..+. ...+.++..+.+.+|+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 479 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCC
Confidence 888888888777776654 67888888888887 5554 2677888888888888854443 3456677778888888
Q ss_pred CCCCc
Q 006031 233 SLCGE 237 (664)
Q Consensus 233 ~lcg~ 237 (664)
..|..
T Consensus 480 ~~c~c 484 (520)
T 2z7x_B 480 WDCSC 484 (520)
T ss_dssp BCCCH
T ss_pred CcccC
Confidence 87753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=159.19 Aligned_cols=157 Identities=19% Similarity=0.268 Sum_probs=127.6
Q ss_pred CccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEecc
Q 006031 69 FCQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLD 136 (664)
Q Consensus 69 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~ 136 (664)
.|.|+.+.|+. ..++.|+|++|.+.+ +++..+.++++|++|+|++|++++..| .|.++++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 37899999964 367899999999987 556689999999999999999999877 58999999999999
Q ss_pred CCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc--CCCCC-CCCCCcEEEccCCccccc
Q 006031 137 HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG--SIPPL-NQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 137 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~-~~~~L~~l~l~~N~l~g~ 213 (664)
+|+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|+|++|+++. ..|.. ...+|+.|++++|++++.
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI 187 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCcc
Confidence 99999 8888776 899999999999996666678999999999999999963 44432 222788888888888874
Q ss_pred CCCCCcccccCccccccC
Q 006031 214 ITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 214 ~p~~~~l~~~~~~~~~~N 231 (664)
... ...++..+.+.+|
T Consensus 188 ~~~--~~~~L~~L~l~~n 203 (332)
T 2ft3_A 188 PKD--LPETLNELHLDHN 203 (332)
T ss_dssp CSS--SCSSCSCCBCCSS
T ss_pred Ccc--ccCCCCEEECCCC
Confidence 432 2245666666665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.3e-16 Score=175.27 Aligned_cols=155 Identities=21% Similarity=0.207 Sum_probs=132.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 157 (664)
..+..|+|++|.+.+ +++ .+..+++|+.|+|++|.+++.+| .+.++++|++|+|++|.+++.+|..+.++++|++|
T Consensus 373 ~~L~~L~l~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCcccc-ccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 456667777777766 334 48889999999999999988876 58889999999999999999999999999999999
Q ss_pred eccCCcCc-CCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCCC
Q 006031 158 DLSYNNLS-GPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPS 233 (664)
Q Consensus 158 ~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~ 233 (664)
+|++|+++ +.+|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|++++.+|. ...+.++..+.+.+|++
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 530 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence 99999998 689999999999999999999999887754 778999999999999998874 35667788888999998
Q ss_pred CCC
Q 006031 234 LCG 236 (664)
Q Consensus 234 lcg 236 (664)
.|.
T Consensus 531 ~~~ 533 (570)
T 2z63_A 531 DCS 533 (570)
T ss_dssp CCC
T ss_pred cCC
Confidence 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-16 Score=182.76 Aligned_cols=149 Identities=19% Similarity=0.212 Sum_probs=132.2
Q ss_pred CcEEEEEEcCCCCCC-----------------cCCCcccc--CCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCc
Q 006031 80 QKVVRVVLQGLDLGG-----------------IFAPNSLT--KLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNF 139 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g-----------------~~~p~~l~--~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~ 139 (664)
..+..|+|++|.|+| .+| ..++ +|++|++|+|++|++.|.+| .|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP-~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN-EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT-SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCC-hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 678999999999999 354 4787 99999999999999999999 59999999999999998
Q ss_pred -CCC-CCcccccCCC-------CCCEEeccCCcCcCCCch--hhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccC
Q 006031 140 -FTG-SFPPSLLSLH-------RLKTLDLSYNNLSGPLPK--ELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSG 207 (664)
Q Consensus 140 -l~g-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~ 207 (664)
|+| .+|..+++++ +|++|+|++|+|+ .+|. .++.+++|+.|+|++|+++ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 999 8999887766 9999999999999 9999 9999999999999999999 78754 778999999999
Q ss_pred CcccccCC-CCCcccc-cCccccccCC
Q 006031 208 NNFTGAIT-VTSTLSR-FGISSFLFNP 232 (664)
Q Consensus 208 N~l~g~~p-~~~~l~~-~~~~~~~~N~ 232 (664)
|+++ .+| ....+.+ +..+.+.+|.
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred Cccc-cchHHHhhccccCCEEECcCCC
Confidence 9999 555 4455666 7778888875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=146.68 Aligned_cols=129 Identities=21% Similarity=0.314 Sum_probs=111.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCC-CCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGP-IPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.. +..+..+++|++|+|++|++++. ++.++++++|++|+|++|++++..|..+.++++|++|+
T Consensus 66 ~~L~~L~l~~n~~~~---~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHATN---YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCSC---CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCCc---chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 578999999997765 23799999999999999999985 45799999999999999999998999999999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 212 (664)
|++|++.+.+| .+..+++|+.|+|++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999444777 799999999999999999985544578999999999999875
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.4e-15 Score=150.74 Aligned_cols=156 Identities=24% Similarity=0.263 Sum_probs=138.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.++..|+|++|.++. +++..+.++++|++|+|++|++++.++. |.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 61 ~~L~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCSC-CCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCe-eChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 578999999999997 6666789999999999999999988774 78999999999999999987788899999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPSLC 235 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~lc 235 (664)
|++|+|++..+..+..+++|+.|+|++|++++..+.. .+++|+.|+|++|++++.++. ...+.++..+.+.+|++.|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 9999999766667899999999999999999876643 679999999999999987764 3456778889999999988
Q ss_pred C
Q 006031 236 G 236 (664)
Q Consensus 236 g 236 (664)
.
T Consensus 220 ~ 220 (270)
T 2o6q_A 220 T 220 (270)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=153.43 Aligned_cols=146 Identities=18% Similarity=0.194 Sum_probs=118.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|+|+++++.. + + .+..+++|+.|+|++|+|++..| +.++++|+.|+|++|++++ +|.... ++|++|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l-~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-L-A-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-C-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCccc-c-h-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 568889999998886 4 3 68889999999999999998777 8899999999999999984 565333 88999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLC 235 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lc 235 (664)
++|++++ +| .+..+++|+.|+|++|++++..+-..+++|+.|+|++|++++. +....+.++..+.+.+|+..+
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence 9999985 44 5888999999999999998764334778899999999999887 555667777788888886543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=163.76 Aligned_cols=150 Identities=23% Similarity=0.141 Sum_probs=111.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--C---------------CCCCCCCCEEeccCCcCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--D---------------LSGLVNLKSLFLDHNFFTG 142 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~---------------~~~l~~L~~L~L~~N~l~g 142 (664)
..+..|+|++|.+.+.. .+..+++|++|+|++|+|++..+ . ...+++|+.|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~---~~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETL---DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEE---EETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcch---hhhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 56888888888887742 27788888888888888776432 0 1235677777777888876
Q ss_pred CCcccccCCCCCCEEeccCCcCcCCCchhhc-CCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCccc
Q 006031 143 SFPPSLLSLHRLKTLDLSYNNLSGPLPKELA-SQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLS 221 (664)
Q Consensus 143 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~ 221 (664)
..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|++++..+...+++|+.|+|++|++++.++....+.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~ 214 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcchhhhcccC
Confidence 6677788888888888888888877676664 678888888888888876555567888888888888888776655666
Q ss_pred ccCccccccCC
Q 006031 222 RFGISSFLFNP 232 (664)
Q Consensus 222 ~~~~~~~~~N~ 232 (664)
++..+.+.+|.
T Consensus 215 ~L~~L~L~~N~ 225 (317)
T 3o53_A 215 GVTWISLRNNK 225 (317)
T ss_dssp TCSEEECTTSC
T ss_pred cccEEECcCCc
Confidence 77777777763
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.5e-15 Score=143.48 Aligned_cols=128 Identities=25% Similarity=0.312 Sum_probs=112.6
Q ss_pred CEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCc
Q 006031 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187 (664)
Q Consensus 108 ~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 187 (664)
+.+++++|+|+..++.+ .++|+.|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 68999999999654444 369999999999999 899999999999999999999998888899999999999999999
Q ss_pred CccCCCCC--CCCCCcEEEccCCcccccCCC-CCcccccCccccccCCCCCCcc
Q 006031 188 FNGSIPPL--NQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPSLCGEI 238 (664)
Q Consensus 188 l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~lcg~~ 238 (664)
|++.+|.. .+++|+.|+|++|+|++..+. ...+.++..+.+.+|++.|...
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99887753 789999999999999987764 3557788889999999998643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=173.06 Aligned_cols=157 Identities=20% Similarity=0.202 Sum_probs=134.6
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCC-CCCcccccCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFT-GSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~ 158 (664)
.+..+++.+++.....++..+..+++|+.++++.|.+++..| .+..+++|+.|+|++|++. +.+|..|..+++|++||
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 455666776766665556678899999999999999999888 4778999999999999854 45788899999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-Ccc-cccCccccccCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STL-SRFGISSFLFNPSL 234 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l-~~~~~~~~~~N~~l 234 (664)
|++|+|++..|..|.++++|+.|+|++|+|++.+|.. .+++|+.|||++|+|++.+|.. ..+ .++..+.+.+||+.
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999999887753 7899999999999999998843 233 56778899999999
Q ss_pred CCc
Q 006031 235 CGE 237 (664)
Q Consensus 235 cg~ 237 (664)
|..
T Consensus 581 C~C 583 (635)
T 4g8a_A 581 CTC 583 (635)
T ss_dssp CSG
T ss_pred ccC
Confidence 964
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=155.53 Aligned_cols=144 Identities=23% Similarity=0.318 Sum_probs=102.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++..|+|++|.+.+ +++ +.++++|++|+|++|.+++. |.+.++++|+.|+|++|++++ +|. +..+++|++|+|
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 567788888888877 333 77888888888888887763 567778888888888888874 444 777888888888
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|++++. |. +..+++|+.|+|++|++++..+-..+++|+.|++++|++++..+ ...+.++..+.+.+|.
T Consensus 137 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 137 DLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSC
T ss_pred CCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCc
Confidence 88888743 33 77777888888888887765554466777777777777776554 4455556666666653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-15 Score=169.40 Aligned_cols=110 Identities=20% Similarity=0.221 Sum_probs=89.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.+ +++..++++++|++|+|++|.|++.+|. |+++++|++|+|++|.|++..|..|+++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 367788888888887 4556888888888888888888888774 68888888888888888844444468888888888
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNG 190 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 190 (664)
|++|+|++..|..+..+++|+.|+|++|++++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 88888888778788888888888888888775
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.6e-15 Score=169.24 Aligned_cols=145 Identities=26% Similarity=0.383 Sum_probs=127.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.|.+. ++ +.+|++|+.|+|++|.|++ +|.+..|++|+.|+|++|+|++ + +.+.+|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~-~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDI-KP--LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCC-GG--GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCC-hh--hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 6799999999999984 33 9999999999999999987 5689999999999999999995 4 46899999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
++|+|++. ..+..+++|+.|+|++|+|++.+|-..+++|+.|+|++|+|++. |....+.++..+.+.+|+.
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 99999965 67999999999999999999988866889999999999999985 5566777888888887753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.6e-16 Score=165.53 Aligned_cols=135 Identities=9% Similarity=0.087 Sum_probs=96.2
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCcccc------------CCcHHH--------HHHHHHHHcCCCCCCcccce
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA------------GTSNEM--------YEQHMESVGGLRHPNLVPLR 448 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~--------~~~e~~~l~~l~H~niv~l~ 448 (664)
.+.||+|+||.||+|...+|+.||||+++..... ...... ..+|...|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 4679999999999999999999999987542211 011111 23455666666544432222
Q ss_pred EEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC--
Q 006031 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE-- 526 (664)
Q Consensus 449 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~-- 526 (664)
-+.. ...+|||||++++.|..+.. ......++.|++.+|.|||+. +||||||||.|||+++++.
T Consensus 180 p~~~--~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 180 PIAQ--SRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp EEEE--ETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECSS
T ss_pred eeec--cCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCcc
Confidence 2211 23479999999988865542 112456889999999999998 9999999999999988763
Q ss_pred --------eEEeecccccc
Q 006031 527 --------ACLADYCLTAL 537 (664)
Q Consensus 527 --------~ki~DfGla~~ 537 (664)
+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 88999987654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=150.69 Aligned_cols=149 Identities=19% Similarity=0.161 Sum_probs=124.6
Q ss_pred CcEEEEEEcCCC-CCCcCCCccccCCCCCCEEEecC-CCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCC-
Q 006031 80 QKVVRVVLQGLD-LGGIFAPNSLTKLDQLRVLGLQN-NSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK- 155 (664)
Q Consensus 80 ~~v~~l~l~~~~-l~g~~~p~~l~~l~~L~~L~L~~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~- 155 (664)
.++..|+|++|. +++ +++..+.++++|++|+|++ |+|++..+ .|.++++|++|+|++|++++ +|. +.++++|+
T Consensus 55 ~~L~~L~l~~n~~l~~-i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQ-LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCCE-ECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcce-eCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 578999999997 776 6676899999999999998 99998776 58899999999999999995 887 88999998
Q ss_pred --EEeccCC-cCcCCCchhhcCCCCCC-eeeCcCCcCccCCCCC--CCCCCcEEEccCCc-ccccCCCC-Ccc-cccCcc
Q 006031 156 --TLDLSYN-NLSGPLPKELASQGRLY-SLRLDVNRFNGSIPPL--NQSSLKIFNVSGNN-FTGAITVT-STL-SRFGIS 226 (664)
Q Consensus 156 --~L~l~~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~-l~g~~p~~-~~l-~~~~~~ 226 (664)
+|+|++| ++++..+..+..+++|+ .|+|++|+++ .+|.. ..++|+.|++++|+ +++..+.. ..+ .++..+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99976667799999999 9999999998 55543 44789999999995 98776632 345 667777
Q ss_pred ccccCC
Q 006031 227 SFLFNP 232 (664)
Q Consensus 227 ~~~~N~ 232 (664)
.+.+|.
T Consensus 211 ~l~~N~ 216 (239)
T 2xwt_C 211 DVSQTS 216 (239)
T ss_dssp ECTTCC
T ss_pred ECCCCc
Confidence 777764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=165.51 Aligned_cols=154 Identities=20% Similarity=0.207 Sum_probs=132.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.+ +.|..+.+|++|++|+|++|+|++.++. |.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 56 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCE-eChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 578999999999998 5566899999999999999999987774 78999999999999999988899999999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--CCCCCCcEEEccCCcccccCCC-CCcccccCccccccCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNPSL 234 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~~l 234 (664)
|++|++++..|..+..+++|+.|+|++|++++.++. ..+++|+.|+|++|++++..+. ...+.++..+.+.+|+.+
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 999999988889999999999999999999976553 3788999999999999987762 344556666777766543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.7e-15 Score=156.52 Aligned_cols=156 Identities=21% Similarity=0.200 Sum_probs=128.1
Q ss_pred CccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CC-CCCCCCEEeccCCcCCCCCcc
Q 006031 69 FCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LS-GLVNLKSLFLDHNFFTGSFPP 146 (664)
Q Consensus 69 ~C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~-~l~~L~~L~L~~N~l~g~~p~ 146 (664)
.|- .+=.|.. ..+++.+++|.. +|. .+. ..|+.|+|++|+|++..+. +. ++++|+.|+|++|+|++..|.
T Consensus 11 ~Cp-~~C~C~~---~~l~c~~~~l~~-iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~ 82 (361)
T 2xot_A 11 SCP-ANCLCAS---NILSCSKQQLPN-VPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE 82 (361)
T ss_dssp TCC-TTCEEET---TEEECCSSCCSS-CCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTT
T ss_pred CCC-CCCEECC---CEEEeCCCCcCc-cCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChh
Confidence 453 3455654 368999999988 543 444 4689999999999998885 55 899999999999999977778
Q ss_pred cccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC----Ccc
Q 006031 147 SLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT----STL 220 (664)
Q Consensus 147 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~----~~l 220 (664)
.|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+.. ..+
T Consensus 83 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l 162 (361)
T 2xot_A 83 AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKL 162 (361)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----C
T ss_pred hccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccC
Confidence 8999999999999999999777778999999999999999999877753 7899999999999999865532 345
Q ss_pred cccCccccccCC
Q 006031 221 SRFGISSFLFNP 232 (664)
Q Consensus 221 ~~~~~~~~~~N~ 232 (664)
.++..+.+.+|.
T Consensus 163 ~~L~~L~L~~N~ 174 (361)
T 2xot_A 163 PKLMLLDLSSNK 174 (361)
T ss_dssp TTCCEEECCSSC
T ss_pred CcCCEEECCCCC
Confidence 667777777763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=155.08 Aligned_cols=145 Identities=25% Similarity=0.374 Sum_probs=127.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+.+. + .+.++++|++|+|++|++++. |.+.++++|+.|+|++|++++ +|. +.++++|++|+|
T Consensus 85 ~~L~~L~L~~n~l~~~--~-~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKNV--S-AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSCC--G-GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCc--h-hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 5799999999999983 3 799999999999999999985 559999999999999999995 444 899999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
++|++++ +|. +..+++|+.|+|++|++++..+-..+++|+.|+|++|++++..| ...+.++..+.+.+|+.
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEE
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCee
Confidence 9999995 555 99999999999999999987665588999999999999998775 56677788888888864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=141.03 Aligned_cols=128 Identities=24% Similarity=0.195 Sum_probs=109.8
Q ss_pred CCCCCCEEEecCCCCC-CCCCC-CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCe
Q 006031 103 KLDQLRVLGLQNNSLT-GPIPD-LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYS 180 (664)
Q Consensus 103 ~l~~L~~L~L~~N~l~-g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 180 (664)
..++|+.|+|++|+++ |.+|. +..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999998 77775 68899999999999999965 88999999999999999999889999989999999
Q ss_pred eeCcCCcCccCC--CC-CCCCCCcEEEccCCcccccCC----CCCcccccCccccccCC
Q 006031 181 LRLDVNRFNGSI--PP-LNQSSLKIFNVSGNNFTGAIT----VTSTLSRFGISSFLFNP 232 (664)
Q Consensus 181 L~l~~N~l~g~~--p~-~~~~~L~~l~l~~N~l~g~~p----~~~~l~~~~~~~~~~N~ 232 (664)
|+|++|++++.. +. ..+++|+.|++++|.+++..+ ....+.++..+.+.+|.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence 999999999754 22 378899999999999998776 34556666666666663
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5.9e-15 Score=151.55 Aligned_cols=144 Identities=25% Similarity=0.327 Sum_probs=125.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|+++++.+... + .+..+++|++|+|++|++++..| +.++++|++|+|++|++++ +| .+.++++|++|+|
T Consensus 46 ~~L~~L~l~~~~i~~~--~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC--T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC--h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4688999999999873 3 59999999999999999998777 9999999999999999995 44 4999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|++++ + ..+..+++|+.|+|++|++++...-..+++|+.|++++|++++..| ...+.++..+.+.+|.
T Consensus 120 ~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCCcCCC-C-hhhcCCCCCCEEEccCCcCCcchhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCc
Confidence 9999996 4 4789999999999999999976222378999999999999999876 6677778888888774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-15 Score=170.49 Aligned_cols=156 Identities=28% Similarity=0.338 Sum_probs=122.2
Q ss_pred cEEEEEEcCCCCCC-cCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCC----Cc----ccccC
Q 006031 81 KVVRVVLQGLDLGG-IFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGS----FP----PSLLS 150 (664)
Q Consensus 81 ~v~~l~l~~~~l~g-~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~----~p----~~~~~ 150 (664)
.+..|+|.+|.+.+ ...|..+.++++|+.|+|++|+|++.+|. |.++++|++|+|++|++++. +| ..+.+
T Consensus 455 ~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~ 534 (680)
T 1ziw_A 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534 (680)
T ss_dssp TCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred ccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence 34445555555542 12355788899999999999999987774 88899999999999998853 22 23788
Q ss_pred CCCCCEEeccCCcCcCCCch-hhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCC--cccccCc
Q 006031 151 LHRLKTLDLSYNNLSGPLPK-ELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTS--TLSRFGI 225 (664)
Q Consensus 151 l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~--~l~~~~~ 225 (664)
+++|++|+|++|+|+ .+|. .|..+++|+.|+|++|++++.++.. .+++|+.|+|++|+|++.+|... .+.++..
T Consensus 535 l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 613 (680)
T 1ziw_A 535 LSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613 (680)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSE
T ss_pred CCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCE
Confidence 999999999999998 5665 6889999999999999999665543 67899999999999999877421 4677888
Q ss_pred cccccCCCCCCc
Q 006031 226 SSFLFNPSLCGE 237 (664)
Q Consensus 226 ~~~~~N~~lcg~ 237 (664)
+.+.+||+.|..
T Consensus 614 l~l~~N~~~c~c 625 (680)
T 1ziw_A 614 LDMRFNPFDCTC 625 (680)
T ss_dssp EECTTCCCCBCC
T ss_pred EEccCCCcccCC
Confidence 899999999963
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.4e-15 Score=158.81 Aligned_cols=110 Identities=20% Similarity=0.230 Sum_probs=57.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCcc--cccCCCCCCE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPP--SLLSLHRLKT 156 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~ 156 (664)
..++.|+|++|.+.+ +++..+.++++|++|+|++|++++.++. |.++++|++|+|++|+++ .+|. .+.++++|++
T Consensus 76 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 355566666666655 3344555666666666666666554443 555555555555555555 3333 4455555555
Q ss_pred EeccCC-cCcCCCchhhcCCCCCCeeeCcCCcCccC
Q 006031 157 LDLSYN-NLSGPLPKELASQGRLYSLRLDVNRFNGS 191 (664)
Q Consensus 157 L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 191 (664)
|+|++| .+++..|..+..+++|+.|++++|++++.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 555555 23333334444444444444444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=157.63 Aligned_cols=151 Identities=17% Similarity=0.096 Sum_probs=111.3
Q ss_pred cEEEEEEcCCCCCCcCCCccc--cCCCCCCEEEecCCCCCCCCCC-----CCCCCCCCEEeccCCcCCCCCcccccCCCC
Q 006031 81 KVVRVVLQGLDLGGIFAPNSL--TKLDQLRVLGLQNNSLTGPIPD-----LSGLVNLKSLFLDHNFFTGSFPPSLLSLHR 153 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l--~~l~~L~~L~L~~N~l~g~~p~-----~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 153 (664)
++..|+|++|.+.+..+. .+ .++++|++|+|++|.+++..|. +..+++|++|+|++|++++..|..+.++++
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 488899999999886544 55 8889999999999999887662 456888999999999998777888888999
Q ss_pred CCEEeccCCcCcCC--Cch--hhcCCCCCCeeeCcCCcCccCCCC-----CCCCCCcEEEccCCcccccCCC-CCcc---
Q 006031 154 LKTLDLSYNNLSGP--LPK--ELASQGRLYSLRLDVNRFNGSIPP-----LNQSSLKIFNVSGNNFTGAITV-TSTL--- 220 (664)
Q Consensus 154 L~~L~l~~N~l~g~--~p~--~~~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~l~~N~l~g~~p~-~~~l--- 220 (664)
|++|+|++|++.+. +|. .+..+++|++|+|++|+++...+. ..+++|++|||++|+|++.+|. ...+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999988753 322 235778888888888888632221 1557788888888888877542 2333
Q ss_pred cccCccccccCC
Q 006031 221 SRFGISSFLFNP 232 (664)
Q Consensus 221 ~~~~~~~~~~N~ 232 (664)
.++..+.+.+|.
T Consensus 251 ~~L~~L~Ls~N~ 262 (310)
T 4glp_A 251 SALNSLNLSFAG 262 (310)
T ss_dssp TTCCCEECCSSC
T ss_pred CcCCEEECCCCC
Confidence 456666666663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-14 Score=151.27 Aligned_cols=149 Identities=16% Similarity=0.182 Sum_probs=97.1
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCC--CCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG--PIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKT 156 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 156 (664)
..+..|+|++|.+.+ +++..+.++++|+.|+|++|.++. ..| .+.++++|++|+|++|+++ .+|..+. ++|++
T Consensus 121 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~ 196 (330)
T 1xku_A 121 KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTE 196 (330)
T ss_dssp TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSE
T ss_pred ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCE
Confidence 357778888888876 445567778888888888887753 444 4666777777777777776 4665554 56777
Q ss_pred EeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 157 LDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 157 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
|+|++|++++..|..+..+++|+.|+|++|++++..+.. .+++|+.|+|++|+++..+.....+.++..+.+.+|+
T Consensus 197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~ 274 (330)
T 1xku_A 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274 (330)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSC
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCc
Confidence 777777776666666666777777777777766655532 5566667777777666433333444555555555553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.6e-15 Score=166.16 Aligned_cols=130 Identities=20% Similarity=0.224 Sum_probs=85.0
Q ss_pred cCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCC--CCcccccCCCCCCEEeccCCcCcCCCchh-hcCCCC
Q 006031 102 TKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTG--SFPPSLLSLHRLKTLDLSYNNLSGPLPKE-LASQGR 177 (664)
Q Consensus 102 ~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~ 177 (664)
..+++|++|+|++|++++.+| .++++++|+.|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 556677777777777776555 46667777777777777775 33456677777777777777777656553 566677
Q ss_pred CCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 178 LYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 178 L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
|+.|+|++|++++.+|..-.++|+.|+|++|+|+..++....+.++..+.+.+|
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N 483 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASN 483 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSS
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCC
Confidence 777777777777666554335677777777777744444445556666666665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=157.34 Aligned_cols=152 Identities=16% Similarity=0.103 Sum_probs=125.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCccccc-CCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLL-SLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L 157 (664)
..+..|+|++|.+.+. ++ ..+++|+.|+|++|++++..| .++.+++|++|+|++|.+++..|..+. ++++|++|
T Consensus 99 ~~L~~L~l~~n~l~~~-~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISRV-SC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSEE-EE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCCc-Cc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 4566677777777763 22 346889999999999999877 688899999999999999987777774 79999999
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCC
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg 236 (664)
+|++|++++. |. ...+++|+.|+|++|++++.++.. .+++|+.|+|++|+|++.++....+.++..+.+.+|+..|+
T Consensus 175 ~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 9999999854 43 345899999999999999876654 67899999999999997665556677888899999998876
Q ss_pred c
Q 006031 237 E 237 (664)
Q Consensus 237 ~ 237 (664)
.
T Consensus 253 ~ 253 (317)
T 3o53_A 253 T 253 (317)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-14 Score=154.86 Aligned_cols=109 Identities=22% Similarity=0.288 Sum_probs=71.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCC-CCCCCCCCEEeccCCcCCCCCccc-ccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSGLVNLKSLFLDHNFFTGSFPPS-LLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L 157 (664)
..+..|+|+++.+.+ +++..+.++++|++|+|++|++++.+|. |+++++|++|+|++|+++ .+|.. |.++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 356667777777665 4444667777777777777777766664 566777777777777776 44444 4667777777
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG 190 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 190 (664)
+|++|++++..|..+..+++|+.|+|++|++++
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 777777766556666666666666666666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-14 Score=150.96 Aligned_cols=146 Identities=18% Similarity=0.241 Sum_probs=76.3
Q ss_pred EEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCC--CCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 82 VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG--PIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
+..|+|++|.+.+ +++..+.++++|+.|+|++|.++. ..| .+..+ +|+.|+|++|+++ .+|..+. ++|++|+
T Consensus 125 L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 125 LVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELH 199 (332)
T ss_dssp CCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCB
T ss_pred CCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEE
Confidence 4444444454444 334345666666666666666642 333 23333 4444444444443 2333332 4566666
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
|++|++++..|..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|+++..++....+.++..+.+.+|.
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCC
Confidence 6666666555556666666666666666666555432 4556666666666666333223344445555555553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.2e-15 Score=137.19 Aligned_cols=111 Identities=23% Similarity=0.210 Sum_probs=98.9
Q ss_pred CCCCCCEEEecCCCCC-CCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCe
Q 006031 103 KLDQLRVLGLQNNSLT-GPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYS 180 (664)
Q Consensus 103 ~l~~L~~L~L~~N~l~-g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 180 (664)
..++|+.|+|++|+++ +.+| .+..+++|++|+|++|++++. ..+.++++|++|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999999 7777 568999999999999999965 78999999999999999999889999999999999
Q ss_pred eeCcCCcCccCC--CC-CCCCCCcEEEccCCcccccCC
Q 006031 181 LRLDVNRFNGSI--PP-LNQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 181 L~l~~N~l~g~~--p~-~~~~~L~~l~l~~N~l~g~~p 215 (664)
|+|++|++++.. +. ..+++|+.|++++|++++..+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999999742 22 378899999999999998765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.3e-15 Score=167.07 Aligned_cols=140 Identities=19% Similarity=0.210 Sum_probs=127.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCC-CCCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFT-GSFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L 157 (664)
..+..|+|++|.+.+..+...+.++++|++|+|++|.+++.+| .+.++++|+.|+|++|+++ +.+|..+..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 5788999999999986555679999999999999999999888 5889999999999999998 6899999999999999
Q ss_pred eccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCc
Q 006031 158 DLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTST 219 (664)
Q Consensus 158 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~ 219 (664)
+|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|.+++.+|....
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~ 539 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHH
Confidence 99999999999999999999999999999999987753 789999999999999999885433
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.6e-14 Score=134.19 Aligned_cols=129 Identities=17% Similarity=0.117 Sum_probs=110.5
Q ss_pred CCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCC
Q 006031 107 LRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186 (664)
Q Consensus 107 L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 186 (664)
.+.+++++|+++..+..+ .++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 9 ~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 578999999998765444 479999999999999766667899999999999999999766677899999999999999
Q ss_pred cCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccCCCCCCc
Q 006031 187 RFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 187 ~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~~lcg~ 237 (664)
++++.++.. .+++|+.|+|++|+|++.++.. ..+.++..+.+.+|++.|..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 999877753 7899999999999999877754 55778888899999888753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-14 Score=162.24 Aligned_cols=149 Identities=19% Similarity=0.227 Sum_probs=118.0
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCC--CCcccccCCCCCCEE
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTG--SFPPSLLSLHRLKTL 157 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L 157 (664)
.+..|+++++++.+.. ....+++|++|+|++|++++.+| .++++++|+.|+|++|++++ .+|..+.++++|++|
T Consensus 303 ~L~~L~l~~n~l~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L 379 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML---CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL 379 (520)
T ss_dssp CCSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEE
T ss_pred ceeEEEcCCCcccccc---chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEE
Confidence 3666777777665521 23688899999999999998666 68889999999999999986 677888999999999
Q ss_pred eccCCcCcCCCchh-hcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 158 DLSYNNLSGPLPKE-LASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 158 ~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
+|++|++++.+|.. +..+++|+.|+|++|++++.+|....++|+.|+|++|+++..++....+.++..+.+.+|.
T Consensus 380 ~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~ 455 (520)
T 2z7x_B 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455 (520)
T ss_dssp ECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCc
Confidence 99999999878875 7788899999999999988877654478999999999998443334566677777777773
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=163.19 Aligned_cols=107 Identities=28% Similarity=0.235 Sum_probs=52.3
Q ss_pred EEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 82 VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
+..|+|++|.|++ + | .+++|++|+.|+|++|+|+..++.|++|++|+.|+|++|+|++ +| .|++|++|++|+|++
T Consensus 443 L~~L~Ls~n~l~~-l-p-~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-L-C-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-C-C-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-C-c-CccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 3445555555554 2 2 1555555555555555555222234455555555555555553 44 455555555555555
Q ss_pred CcCcCCC-chhhcCCCCCCeeeCcCCcCccCCC
Q 006031 162 NNLSGPL-PKELASQGRLYSLRLDVNRFNGSIP 193 (664)
Q Consensus 162 N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p 193 (664)
|+|++.+ |..++.+++|+.|+|++|+|++.+|
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 5555443 5555555555555555555554444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-14 Score=160.69 Aligned_cols=152 Identities=21% Similarity=0.177 Sum_probs=129.1
Q ss_pred eEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCC
Q 006031 75 VICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHR 153 (664)
Q Consensus 75 v~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 153 (664)
..|....+ .++++++++. +|+ .+. ++|++|+|++|++++.+| .|.++++|++|+|++|++++..|..|.++++
T Consensus 2 ~~C~~~~~--c~~~~~~l~~-ip~-~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFTS-IPS-GLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp CEECTTSE--EECTTSCCSS-CCS-CCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ccCCCCce--EECCCCcccc-ccc-cCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 35876666 7889999987 554 454 799999999999999887 6999999999999999999888899999999
Q ss_pred CCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccC-CCC--CCCCCCcEEEccCCcccccCC--CCCcccccCcccc
Q 006031 154 LKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGS-IPP--LNQSSLKIFNVSGNNFTGAIT--VTSTLSRFGISSF 228 (664)
Q Consensus 154 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~--~~~~~L~~l~l~~N~l~g~~p--~~~~l~~~~~~~~ 228 (664)
|++|+|++|++++..|..++.+++|++|+|++|++++. +|. ..+++|+.|++++|++.+.+| ....+.++..+.+
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L 155 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeec
Confidence 99999999999988888899999999999999999963 443 378999999999999766665 3455667777777
Q ss_pred ccCC
Q 006031 229 LFNP 232 (664)
Q Consensus 229 ~~N~ 232 (664)
.+|.
T Consensus 156 ~~n~ 159 (549)
T 2z81_A 156 KALS 159 (549)
T ss_dssp EETT
T ss_pred cCCc
Confidence 7764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.4e-16 Score=178.48 Aligned_cols=131 Identities=28% Similarity=0.311 Sum_probs=116.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.. +++ .+++|++|++|+|++|.|+ .+| .|++|++|++|+|++|+|+ .+|..|++|++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~~-l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIFN-ISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCSC-CCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCcEEECCCCCCCC-CCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 678999999999985 655 7889999999999999999 555 6999999999999999999 8999999999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CC-CCCcEEEccCCcccccCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQ-SSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~-~~L~~l~l~~N~l~g~~p 215 (664)
|++|+|+ .||..|+.+++|+.|+|++|+|+|.+|.. .+ ..+..|+|++|.++|.+|
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 9999997 89999999999999999999999988864 11 122357899999999998
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=136.32 Aligned_cols=105 Identities=24% Similarity=0.211 Sum_probs=75.1
Q ss_pred EEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCC
Q 006031 84 RVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162 (664)
Q Consensus 84 ~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 162 (664)
.|++++++|.. +|. .+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 ~l~~s~n~l~~-ip~-~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLAS-VPT-GIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCSS-CCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCc-cCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34455666666 433 443 778888888888888776 4778888888888888888555555678888888888888
Q ss_pred cCcCCCchhhcCCCCCCeeeCcCCcCccCC
Q 006031 163 NLSGPLPKELASQGRLYSLRLDVNRFNGSI 192 (664)
Q Consensus 163 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 192 (664)
+|++..|..+..+++|+.|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888655556777777777777777766543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.6e-15 Score=138.86 Aligned_cols=128 Identities=18% Similarity=0.151 Sum_probs=103.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCC-CCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLD-QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~-~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.+.. + + .+..+. +|++|+|++|+|++. +.+.++++|++|+|++|++++..|..+..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~-i-~-~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-I-E-NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-C-C-CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-h-H-HhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 467889999999986 4 3 466655 999999999999886 7888999999999999999854334458899999999
Q ss_pred ccCCcCcCCCch--hhcCCCCCCeeeCcCCcCccCCCC-----CCCCCCcEEEccCCcccc
Q 006031 159 LSYNNLSGPLPK--ELASQGRLYSLRLDVNRFNGSIPP-----LNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 159 l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~l~~N~l~g 212 (664)
|++|+|+ .+|. .+..+++|+.|+|++|.++...+. ..+++|+.||+++|.+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999996 6776 788899999999999999854332 267889999999988764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=158.41 Aligned_cols=143 Identities=27% Similarity=0.339 Sum_probs=77.3
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+.+. + .+..+++|+.|+|++|.+++..| +.++++|+.|+|++|.+++. |. +..+++|++|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--G-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--G-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--h-hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEc
Confidence 3456666666666652 2 45666666666666666665544 55566666666666666532 22 555566666666
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
++|++++..| +..+++|+.|+|++|++++.+|...+++|+.|++++|++++. +....+.++..+.+.+|
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHN 363 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCC
Confidence 6666654322 555555566666555555554433445555555555555543 22333344444444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=161.46 Aligned_cols=109 Identities=30% Similarity=0.382 Sum_probs=99.5
Q ss_pred CCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcC
Q 006031 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDV 185 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 185 (664)
.|+.|+|++|+|++ +|.|++|++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .++.+++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 57899999999998 567999999999999999999 999999999999999999999996 88 899999999999999
Q ss_pred CcCccCC-CCC--CCCCCcEEEccCCcccccCCCCC
Q 006031 186 NRFNGSI-PPL--NQSSLKIFNVSGNNFTGAITVTS 218 (664)
Q Consensus 186 N~l~g~~-p~~--~~~~L~~l~l~~N~l~g~~p~~~ 218 (664)
|+|++.+ |.. .+++|+.|+|++|+|++.+|...
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 9999986 653 78999999999999999987543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-14 Score=158.60 Aligned_cols=113 Identities=26% Similarity=0.322 Sum_probs=65.7
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.++.|+|++|.|+. +| ..+++|+.|+|++|+|++ +|.+.+ +|++|+|++|+|++ +|. .+++|++|+|+
T Consensus 81 ~L~~L~Ls~N~l~~-ip----~~l~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALIS-LP----ELPASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCSC-CC----CCCTTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCcc-cc----cccCCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 46677777777764 43 345666677777776666 443443 66666666666664 555 45566666666
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCccc
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~ 211 (664)
+|+|++ +|. .+++|+.|+|++|+|++ +|.+. ++|+.|+|++|+|+
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE 193 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC
Confidence 666654 554 34556666666666555 33322 55555555555555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=162.26 Aligned_cols=144 Identities=25% Similarity=0.323 Sum_probs=126.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|+++.+.. + + .+..|++|+.|+|++|+|++.+| +.+|++|+.|+|++|+|++ +| .+.+|++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~-l-~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-V-Q-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCC-C-T-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-C-h-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 567889999999987 3 3 69999999999999999998777 9999999999999999995 55 7999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|+|++ + ..+..+++|+.|+|++|+|++...-..+++|+.|+|++|+|++.+| ...+.++..+.+.+|.
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCC
Confidence 9999996 4 4699999999999999999986223488999999999999999887 6777888888888874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=5.3e-14 Score=132.26 Aligned_cols=108 Identities=21% Similarity=0.158 Sum_probs=96.2
Q ss_pred CCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCC
Q 006031 107 LRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186 (664)
Q Consensus 107 L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 186 (664)
.+.|++++|+|+..+..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 578999999999755555 389999999999999888999999999999999999999766667899999999999999
Q ss_pred cCccCCCCC--CCCCCcEEEccCCcccccCCC
Q 006031 187 RFNGSIPPL--NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 187 ~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+|++.++.. .+++|+.|+|++|.|++..+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 999877753 789999999999999987653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.6e-14 Score=141.44 Aligned_cols=126 Identities=21% Similarity=0.308 Sum_probs=110.7
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+++ +++ +.++++|+.|+|++|++++. |.+.. ++|+.|+|++|++++ +| .+.++++|++|+|
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~l-~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKNL-NGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSCC-TTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCCc-Ccccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 679999999999998 433 99999999999999999984 44555 999999999999995 44 6999999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~ 214 (664)
++|+|++ +| .+..+++|+.|+|++|++++...-..+++|+.|++++|.+++..
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCCc
Confidence 9999995 55 79999999999999999998733347899999999999999774
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.4e-14 Score=151.82 Aligned_cols=137 Identities=19% Similarity=0.181 Sum_probs=67.7
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.+..|+|++|.+++. | ++.+++|++|+|++|+|++. | ++++++|++|+|++|++++ +| ++++++|++|+|+
T Consensus 65 ~L~~L~Ls~n~l~~~--~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 65 GLTKLICTSNNITTL--D--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TCSEEECCSSCCSCC--C--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCEEEccCCcCCeE--c--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 444455555555441 1 44455555555555555443 2 4455555555555555553 33 4455555555555
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
+|+|++ +| ++.+++|+.|++++|++.+.++-..+++|+.|++++|++++. | ...+.++..+.+.+|
T Consensus 136 ~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 136 RNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTN 201 (457)
T ss_dssp TSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSS
T ss_pred CCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCcccee-c-cccCCCCCEEECcCC
Confidence 555554 22 444555555555555444444444555566666666666553 2 334444444544444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=149.68 Aligned_cols=160 Identities=11% Similarity=0.063 Sum_probs=118.5
Q ss_pred ccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCE-Eec
Q 006031 70 CQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKS-LFL 135 (664)
Q Consensus 70 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~-L~L 135 (664)
|+|+.|.|+. ..++.|+|++|.|+. +++..|.+|++|++|+|++|++.+.+| .|.++++|.. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 7899999974 257889999999997 777789999999999999999988777 4788988775 777
Q ss_pred cCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcC-CcCccCCCCC--C-CCCCcEEEccCCccc
Q 006031 136 DHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDV-NRFNGSIPPL--N-QSSLKIFNVSGNNFT 211 (664)
Q Consensus 136 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~--~-~~~L~~l~l~~N~l~ 211 (664)
++|++++..|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+.. . ...|+.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 88999977788899999999999999999966665666666677777754 4454332221 2 235677777777777
Q ss_pred ccCCCCCcccccCcccccc
Q 006031 212 GAITVTSTLSRFGISSFLF 230 (664)
Q Consensus 212 g~~p~~~~l~~~~~~~~~~ 230 (664)
...+......++..+.+.+
T Consensus 168 ~i~~~~f~~~~L~~l~l~~ 186 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSD 186 (350)
T ss_dssp EECTTSSTTEEEEEEECTT
T ss_pred CCChhhccccchhHHhhcc
Confidence 6555433333444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.3e-14 Score=153.80 Aligned_cols=141 Identities=18% Similarity=0.074 Sum_probs=101.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|...+.+ .++.+++|+.|+|++|+|++ +| ++.+++|+.|+|++|++++. .++++++|++|+|
T Consensus 148 ~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~-l~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL---DVTPQTQLTTLDCSFNKITE-LD-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC---CCTTCTTCCEEECCSSCCCC-CC-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc---ccccCCcCCEEECCCCccce-ec-cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence 46778888888666654 47788888888888888887 44 77888888888888888854 3778888888888
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCC----------CCcEEEccCCcccccCCCCCcccccCccccc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQS----------SLKIFNVSGNNFTGAITVTSTLSRFGISSFL 229 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~----------~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~ 229 (664)
++|+|++ +| +..+++|+.|+|++|++++.++ ..++ +|+.|++++|++.|.+|. ..+.++..+.+.
T Consensus 220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~-~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls 294 (457)
T 3bz5_A 220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV-STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVT 294 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC-TTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCT
T ss_pred cCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH-HHCCCCCEEeccCCCCCEEECCCCccCCcccc-cccccCCEEECC
Confidence 8888886 66 7778888888888888887543 2233 445556666666666662 445666666666
Q ss_pred cCCC
Q 006031 230 FNPS 233 (664)
Q Consensus 230 ~N~~ 233 (664)
+|+.
T Consensus 295 ~n~~ 298 (457)
T 3bz5_A 295 HNTQ 298 (457)
T ss_dssp TCTT
T ss_pred CCcc
Confidence 6653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.9e-14 Score=147.61 Aligned_cols=144 Identities=20% Similarity=0.258 Sum_probs=86.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+.+. + .+..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++ +|. +..+++|++|+|
T Consensus 177 ~~L~~L~l~~n~l~~~-~--~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDI-S--PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCC-G--GGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccc-c--cccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEEC
Confidence 4677778887777762 2 26666667777777776665544 6666666666666666663 333 666666666666
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC-CCCCCCcEEEccCCcccccCCC-CCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFTGAITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~l~~N~l~g~~p~-~~~l~~~~~~~~~~N~ 232 (664)
++|++++ + ..+..+++|+.|++++|++++. |. ..+++|+.|++++|++++..|. ...+.++..+.+.+|+
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 6666664 3 3456666666666666666653 32 2455666666666666655442 1233444555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=130.33 Aligned_cols=105 Identities=25% Similarity=0.270 Sum_probs=75.1
Q ss_pred EEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 83 VRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 83 ~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
+.+++++++|.. +|. .+. ++|+.|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~~-iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCSS-CCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCCc-cCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 467777777765 443 443 778888888888887776 477788888888888888854444467788888888888
Q ss_pred CcCcCCCchhhcCCCCCCeeeCcCCcCccC
Q 006031 162 NNLSGPLPKELASQGRLYSLRLDVNRFNGS 191 (664)
Q Consensus 162 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 191 (664)
|+|++..|..+..+++|+.|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 888754444577777777777777776643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=6.2e-17 Score=156.45 Aligned_cols=132 Identities=23% Similarity=0.316 Sum_probs=113.0
Q ss_pred cEEEEEEcCCCCCCcCCC-----ccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCC
Q 006031 81 KVVRVVLQGLDLGGIFAP-----NSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK 155 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p-----~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 155 (664)
.++.++|.++.+.|.+++ ..+.++++|++|+|++|+|++ +|.+.++++|++|+|++|+++ .+|..+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 455566666677775432 278999999999999999998 668999999999999999999 8999888899999
Q ss_pred EEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCC--C-CCCCCCcEEEccCCcccccCCC
Q 006031 156 TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP--P-LNQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 156 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~-~~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+|+|++|++++ +| .+..+++|+.|+|++|++++..+ . ..+++|+.|++++|.+++.+|.
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999999996 66 68899999999999999986433 2 3788999999999999998774
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-13 Score=130.05 Aligned_cols=108 Identities=19% Similarity=0.178 Sum_probs=94.2
Q ss_pred CCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCC
Q 006031 107 LRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186 (664)
Q Consensus 107 L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 186 (664)
-+.+++++|+|+..++.+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3789999999975554554 89999999999999888999999999999999999999755556789999999999999
Q ss_pred cCccCCCC-C-CCCCCcEEEccCCcccccCCC
Q 006031 187 RFNGSIPP-L-NQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 187 ~l~g~~p~-~-~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+|++.++. + .+++|+.|+|++|.|....+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 99977765 2 689999999999999977653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.48 E-value=8.8e-14 Score=152.61 Aligned_cols=144 Identities=28% Similarity=0.345 Sum_probs=100.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|.+|.+.+. ++ ++.+++|+.|+|++|++++ ++.+..+++|+.|+|++|.+++..| +..+++|++|+|
T Consensus 199 ~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 272 (466)
T 1o6v_A 199 TNLESLIATNNQISDI-TP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272 (466)
T ss_dssp TTCSEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEEecCCccccc-cc--ccccCCCCEEECCCCCccc-chhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEEC
Confidence 4677777777777763 22 6677777777777777775 3567777777777777777775444 777777777777
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|++++. |. +..+++|+.|+|++|++++..|-..+++|+.|++++|++++..| ...+.++..+.+.+|.
T Consensus 273 ~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 273 GANQISNI-SP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSC
T ss_pred CCCccCcc-cc-ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCc
Confidence 77777753 33 67777777777777777766554566777777777777777665 3455666666666663
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=2.8e-14 Score=134.90 Aligned_cols=128 Identities=18% Similarity=0.117 Sum_probs=103.8
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCCCCC-CCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLV-NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRL 178 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 178 (664)
.+.++.+|+.|+|++|+++. +|.+..+. +|++|+|++|++++. ..+.++++|++|+|++|+|++..|..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 57788999999999999995 57787776 999999999999964 689999999999999999996544556999999
Q ss_pred CeeeCcCCcCccCCCC----CCCCCCcEEEccCCcccccCCC----CCcccccCccccccC
Q 006031 179 YSLRLDVNRFNGSIPP----LNQSSLKIFNVSGNNFTGAITV----TSTLSRFGISSFLFN 231 (664)
Q Consensus 179 ~~L~l~~N~l~g~~p~----~~~~~L~~l~l~~N~l~g~~p~----~~~l~~~~~~~~~~N 231 (664)
+.|+|++|+++. +|. ..+++|+.|++++|.++...+. ...+.++..+.+.+|
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n 150 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKV 150 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEEC
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcC
Confidence 999999999964 443 2788999999999999865431 234445555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.7e-14 Score=157.54 Aligned_cols=133 Identities=22% Similarity=0.267 Sum_probs=88.1
Q ss_pred CCCCCCCccccceE--------ecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEe
Q 006031 63 QNKSLHFCQWQGVI--------CYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLF 134 (664)
Q Consensus 63 ~~~~~~~C~w~gv~--------C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ 134 (664)
|....+||.|+|.. |....++.|++++++|+. +|. .+. ++|+.|+|++|+|++ +|. .+++|++|+
T Consensus 15 W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~-lp~-~l~--~~L~~L~L~~N~l~~-lp~--~l~~L~~L~ 87 (622)
T 3g06_A 15 WRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPD-CLP--AHITTLVIPDNNLTS-LPA--LPPELRTLE 87 (622)
T ss_dssp HHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSC-CCS-CCC--TTCSEEEECSCCCSC-CCC--CCTTCCEEE
T ss_pred HHhcCCcchhccccccCcccccccCCCCcEEEecCCCcCc-cCh-hhC--CCCcEEEecCCCCCC-CCC--cCCCCCEEE
Confidence 44457899997754 333568889999999884 544 454 788888888888885 443 567888888
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 212 (664)
|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|++++ +|. .+++|++|+|++|++++
T Consensus 88 Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 88 VSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS 155 (622)
T ss_dssp ECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC
T ss_pred cCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC
Confidence 8888887 5666 56777777777777773 444 44556666666666654 232 12455555555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-15 Score=159.25 Aligned_cols=160 Identities=19% Similarity=0.206 Sum_probs=104.9
Q ss_pred CCccccceEecCCcEEEEEEcCCCCCCcCCCccccCC--CCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCC-C
Q 006031 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKL--DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGS-F 144 (664)
Q Consensus 68 ~~C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l--~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~-~ 144 (664)
-|..|.++.|+...+..++++++.+.. ..+..+ ++|+.|+|++|.+++.+|.+.++++|++|+|++|.+++. +
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 345588888776667777777776652 345555 677777777777777777666777777777777777655 6
Q ss_pred cccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCC-cCccC-CCCC--CCCCCcEEEccCC-ccccc-CCC-C
Q 006031 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN-RFNGS-IPPL--NQSSLKIFNVSGN-NFTGA-ITV-T 217 (664)
Q Consensus 145 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~--~~~~L~~l~l~~N-~l~g~-~p~-~ 217 (664)
|..+.++++|++|+|++|++++.+|..++.+++|+.|+|++| .+++. +|.. .+++|+.|++++| ++++. ++. .
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence 767777777777777777777777777777777777777777 56642 3331 4566777777777 66643 221 1
Q ss_pred Cccc-ccCccccccC
Q 006031 218 STLS-RFGISSFLFN 231 (664)
Q Consensus 218 ~~l~-~~~~~~~~~N 231 (664)
..+. ++..+.+.+|
T Consensus 191 ~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 191 AHVSETITQLNLSGY 205 (336)
T ss_dssp HHSCTTCCEEECCSC
T ss_pred HhcccCCCEEEeCCC
Confidence 2233 4445555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.1e-14 Score=146.13 Aligned_cols=144 Identities=22% Similarity=0.280 Sum_probs=124.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..+++.+|.+.+. + .+..+++|+.|+|++|++++..+ +..+++|+.|+|++|.+++ + +.+..+++|++|+|
T Consensus 199 ~~L~~L~l~~n~l~~~-~--~~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDI-T--PVANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCC-G--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCC-c--hhhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 5788999999999884 2 38999999999999999998766 8999999999999999995 4 46899999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|++++ + ..+..+++|+.|+|++|++++..|.. .+++|+.|++++|++++.+| ...+.++..+.+.+|+
T Consensus 273 ~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 273 GSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred cCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 9999996 4 46889999999999999999877753 78899999999999999887 5667788888888875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.47 E-value=3.9e-13 Score=146.82 Aligned_cols=117 Identities=26% Similarity=0.286 Sum_probs=69.6
Q ss_pred CCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCc
Q 006031 105 DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 184 (664)
++|++|+|++|++++ +|+|+++++|++|+|++|++++ +|..+ ++|++|+|++|++++ +| .++.+++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 456666666666665 4556666666666666666663 55433 356666666666664 55 46666666666666
Q ss_pred CCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 185 ~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
+|++++ +|.. ..+|+.|++++|+++ .+|....+.++..+.+.+|
T Consensus 204 ~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N 247 (454)
T 1jl5_A 204 NNSLKK-LPDL-PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNN 247 (454)
T ss_dssp SSCCSS-CCCC-CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSS
T ss_pred CCcCCc-CCCC-cCcccEEECcCCcCC-cccccCCCCCCCEEECCCC
Confidence 666665 3322 246666666666666 4454455555555555555
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=145.62 Aligned_cols=107 Identities=25% Similarity=0.258 Sum_probs=86.5
Q ss_pred ccccceEecCCcEEEEEEcCC-CCCCcCCCccccCCCCCCEEEecC-CCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcc
Q 006031 70 CQWQGVICYQQKVVRVVLQGL-DLGGIFAPNSLTKLDQLRVLGLQN-NSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPP 146 (664)
Q Consensus 70 C~w~gv~C~~~~v~~l~l~~~-~l~g~~~p~~l~~l~~L~~L~L~~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~ 146 (664)
|.|.+|.|+. + +|++ + |. |..+++|+.|+|++ |+|++.+| .|++|++|+.|+|++|+|+|..|.
T Consensus 8 C~~~~v~~~~----------~n~l~~-i-p~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTR----------DGALDS-L-HH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCS----------SCCCTT-T-TT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCC----------CCCCCc-c-CC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 8888888853 4 6776 5 44 99999999999996 99998886 588999999999999999988888
Q ss_pred cccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCcc
Q 006031 147 SLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNG 190 (664)
Q Consensus 147 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 190 (664)
.|.+|++|++|+|++|+|++..|..+..++ |+.|+|++|.|..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 889999999999999999854444455554 8888888887764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-12 Score=142.01 Aligned_cols=136 Identities=21% Similarity=0.228 Sum_probs=108.5
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..+..|+|++|.+.+ ++ +++++++|++|+|++|++++ +|.. ..+|++|+|++|++++ +| .++++++|++|+|
T Consensus 131 ~~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 478889999999988 54 69999999999999999997 5532 3599999999999996 77 6899999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFN 231 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N 231 (664)
++|++++ +|... ++|+.|++++|+++ .+|.. .+++|+.|++++|++++. | ..+.++..+.+.+|
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~l-~--~~~~~L~~L~l~~N 267 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKTL-P--DLPPSLEALNVRDN 267 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSSC-C--SCCTTCCEEECCSS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCcc-c--ccccccCEEECCCC
Confidence 9999985 66432 58889999999888 56654 678888999999988873 3 23355666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=137.90 Aligned_cols=106 Identities=22% Similarity=0.220 Sum_probs=93.8
Q ss_pred CEEEecCC-CCCCCCCCCCCCCCCCEEeccC-CcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcC
Q 006031 108 RVLGLQNN-SLTGPIPDLSGLVNLKSLFLDH-NFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDV 185 (664)
Q Consensus 108 ~~L~L~~N-~l~g~~p~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 185 (664)
..+++++| +|++.++ |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|+|..|..|.++++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 35799998 8998655 99999999999996 999988888999999999999999999999999999999999999999
Q ss_pred CcCccCCCCC-CCCCCcEEEccCCcccccC
Q 006031 186 NRFNGSIPPL-NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 186 N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~ 214 (664)
|+|++.+|.. ....|+.|+|++|.|....
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 9999766653 3344999999999998653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.34 E-value=6.1e-14 Score=146.73 Aligned_cols=153 Identities=19% Similarity=0.153 Sum_probs=121.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCC-CC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGP-IP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~-~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 157 (664)
..+..+++.++.+.+.. + .+.++++|++|+|++|.+++. +| .+.++++|++|+|++|.+++.+|..++++++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~-~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPL-A-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCC-C-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccc-h-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 57889999999999854 3 477899999999999998875 55 47889999999999999998899999999999999
Q ss_pred eccCC-cCcC-CCchhhcCCCCCCeeeCcCC-cCccC-CCCC--CCC-CCcEEEccCC--ccc-ccCCC-CCcccccCcc
Q 006031 158 DLSYN-NLSG-PLPKELASQGRLYSLRLDVN-RFNGS-IPPL--NQS-SLKIFNVSGN--NFT-GAITV-TSTLSRFGIS 226 (664)
Q Consensus 158 ~l~~N-~l~g-~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~--~~~-~L~~l~l~~N--~l~-g~~p~-~~~l~~~~~~ 226 (664)
+|++| .+++ .+|..+..+++|+.|+|++| ++++. ++.. .++ +|+.|++++| .++ +.+|. ...+.++..+
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 99999 7886 37778889999999999999 88864 3432 567 8999999998 455 33332 1345566667
Q ss_pred ccccCCCC
Q 006031 227 SFLFNPSL 234 (664)
Q Consensus 227 ~~~~N~~l 234 (664)
.+.+|..+
T Consensus 228 ~l~~~~~l 235 (336)
T 2ast_B 228 DLSDSVML 235 (336)
T ss_dssp ECTTCTTC
T ss_pred eCCCCCcC
Confidence 77776543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.4e-12 Score=141.38 Aligned_cols=116 Identities=28% Similarity=0.243 Sum_probs=73.9
Q ss_pred CCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCc
Q 006031 105 DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 184 (664)
++|+.|+|++|+|++.++ .+++|+.|+|++|.++ .+|.. +++|++|+|++|+|++ +| ..+++|+.|+|+
T Consensus 181 ~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls 249 (622)
T 3g06_A 181 SGLQELSVSDNQLASLPT---LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVS 249 (622)
T ss_dssp TTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECC
T ss_pred CCCcEEECCCCCCCCCCC---ccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECC
Confidence 445555555555554222 1245555555555555 34432 3678888888888884 66 456788888888
Q ss_pred CCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCCC
Q 006031 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 185 ~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~ 233 (664)
+|+|++ +|. .+++|+.|+|++|+|+..++....+.++..+.+.+|+.
T Consensus 250 ~N~L~~-lp~-~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l 296 (622)
T 3g06_A 250 GNRLTS-LPM-LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 296 (622)
T ss_dssp SSCCSC-CCC-CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCC
T ss_pred CCCCCc-CCc-ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCC
Confidence 888884 554 67788888888888884433344556666677777754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.6e-13 Score=146.72 Aligned_cols=155 Identities=19% Similarity=0.197 Sum_probs=124.4
Q ss_pred CCcEEEEEEcCCCCCCcC---CCccccCC---------CCCCEEEecCCCCC-CCCC----CCCCCCCCCEEeccCCcCC
Q 006031 79 QQKVVRVVLQGLDLGGIF---APNSLTKL---------DQLRVLGLQNNSLT-GPIP----DLSGLVNLKSLFLDHNFFT 141 (664)
Q Consensus 79 ~~~v~~l~l~~~~l~g~~---~p~~l~~l---------~~L~~L~L~~N~l~-g~~p----~~~~l~~L~~L~L~~N~l~ 141 (664)
...+..|+|++|.+++.. .+..+..+ ++|++|+|++|+|+ +.+| .+..+++|+.|+|++|+++
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 468999999999996421 13356666 89999999999998 5555 4667899999999999998
Q ss_pred --C---CCcccccCCCCCCEEeccCCcCc----CCCchhhcCCCCCCeeeCcCCcCccC----CCC----CCCCCCcEEE
Q 006031 142 --G---SFPPSLLSLHRLKTLDLSYNNLS----GPLPKELASQGRLYSLRLDVNRFNGS----IPP----LNQSSLKIFN 204 (664)
Q Consensus 142 --g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~----~p~----~~~~~L~~l~ 204 (664)
| .+|..+.++++|++|+|++|+|+ +.+|..+..+++|+.|+|++|++++. +|. ..+++|+.|+
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 3 45658899999999999999997 78999999999999999999999876 343 2478999999
Q ss_pred ccCCcccc----cCCCC--CcccccCccccccCCC
Q 006031 205 VSGNNFTG----AITVT--STLSRFGISSFLFNPS 233 (664)
Q Consensus 205 l~~N~l~g----~~p~~--~~l~~~~~~~~~~N~~ 233 (664)
|++|++++ .+|.. ..+.++..+.+.+|+.
T Consensus 281 L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred CcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 99999998 35522 2246777777887753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.8e-13 Score=146.25 Aligned_cols=152 Identities=20% Similarity=0.234 Sum_probs=85.0
Q ss_pred CcEEEEEEcCCCCCCcCC---CccccCCCCCCEEEecCC---CCCCCCCC--------CCCCCCCCEEeccCCcCCC---
Q 006031 80 QKVVRVVLQGLDLGGIFA---PNSLTKLDQLRVLGLQNN---SLTGPIPD--------LSGLVNLKSLFLDHNFFTG--- 142 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~---p~~l~~l~~L~~L~L~~N---~l~g~~p~--------~~~l~~L~~L~L~~N~l~g--- 142 (664)
..++.|+|++|.+++..+ +..+.++++|++|+|++| ++++.+|. +..+++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 346666666666655311 113556666777777664 34445541 3566667777777777665
Q ss_pred -CCcccccCCCCCCEEeccCCcCcCCCchhh----cCC---------CCCCeeeCcCCcCc-cCCCCC-----CCCCCcE
Q 006031 143 -SFPPSLLSLHRLKTLDLSYNNLSGPLPKEL----ASQ---------GRLYSLRLDVNRFN-GSIPPL-----NQSSLKI 202 (664)
Q Consensus 143 -~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~----~~l---------~~L~~L~l~~N~l~-g~~p~~-----~~~~L~~ 202 (664)
.+|..+.++++|++|+|++|+|++..+..+ ..+ ++|+.|+|++|+++ +.+|.. .+++|+.
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 366666666667777777766654333322 223 66666666666665 333321 4456666
Q ss_pred EEccCCccc--c---cCC-CCCcccccCccccccC
Q 006031 203 FNVSGNNFT--G---AIT-VTSTLSRFGISSFLFN 231 (664)
Q Consensus 203 l~l~~N~l~--g---~~p-~~~~l~~~~~~~~~~N 231 (664)
|+|++|+++ | .+| ....+.++..+.+.+|
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n 226 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSS
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCC
Confidence 666666666 3 233 3334444555555554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.27 E-value=5.5e-13 Score=141.22 Aligned_cols=107 Identities=24% Similarity=0.302 Sum_probs=49.7
Q ss_pred EEEEEEcCCCCCCcCCC----ccccCCC-CCCEEEecCCCCCCCCC-CCCCC-----CCCCEEeccCCcCCCCCcccccC
Q 006031 82 VVRVVLQGLDLGGIFAP----NSLTKLD-QLRVLGLQNNSLTGPIP-DLSGL-----VNLKSLFLDHNFFTGSFPPSLLS 150 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p----~~l~~l~-~L~~L~L~~N~l~g~~p-~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~ 150 (664)
++.|+|++|.+++ .++ ..+.+++ +|++|+|++|+|++..+ .+..+ ++|++|+|++|++++..+..++.
T Consensus 24 L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 24 VTSLDLSLNNLYS-ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp CCEEECTTSCGGG-SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceEEEccCCCCCh-HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 4555555555544 222 2344444 55555555555554433 12221 45555555555555444443322
Q ss_pred C-----CCCCEEeccCCcCcCCCchhhcC-----CCCCCeeeCcCCcCc
Q 006031 151 L-----HRLKTLDLSYNNLSGPLPKELAS-----QGRLYSLRLDVNRFN 189 (664)
Q Consensus 151 l-----~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~ 189 (664)
. ++|++|+|++|+|++..+..+.. .++|+.|+|++|+++
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 2 45555555555555444333222 235555555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-14 Score=139.51 Aligned_cols=129 Identities=22% Similarity=0.223 Sum_probs=110.1
Q ss_pred ccCCCCCCEEEecCCCCCCCCCC-------CCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhc
Q 006031 101 LTKLDQLRVLGLQNNSLTGPIPD-------LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELA 173 (664)
Q Consensus 101 l~~l~~L~~L~L~~N~l~g~~p~-------~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~ 173 (664)
+.....++.++|+.|.|+|.+|. +.++++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45567889999999999999884 6779999999999999996 88 8999999999999999999 7999888
Q ss_pred CCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccC--CCCCcccccCccccccCCC
Q 006031 174 SQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAI--TVTSTLSRFGISSFLFNPS 233 (664)
Q Consensus 174 ~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~--p~~~~l~~~~~~~~~~N~~ 233 (664)
.+++|+.|+|++|++++. |.. .+++|+.|++++|++++.. +....+.++..+.+.+|+.
T Consensus 91 ~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l 152 (198)
T 1ds9_A 91 VADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred cCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence 899999999999999974 433 6789999999999999643 2345667777888888854
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=130.64 Aligned_cols=135 Identities=16% Similarity=0.130 Sum_probs=86.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCE-EEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCC----
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRV-LGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHR---- 153 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~-L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---- 153 (664)
..++.|+|++|.+.+.+++..+.+|++|.. +++++|+|++..| .|.++++|++|++++|++++..+..+.+..+
T Consensus 54 ~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 133 (350)
T 4ay9_X 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133 (350)
T ss_dssp TTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEE
T ss_pred CCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhh
Confidence 578899999999888777777888888765 6667788988877 4788999999999999888544444444444
Q ss_pred ----------------------CCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC---CCCCCCcEEEccCC
Q 006031 154 ----------------------LKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGN 208 (664)
Q Consensus 154 ----------------------L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~l~~N 208 (664)
|+.|+|++|+|+ .||.......+|+.|++++|+.-+.+|. ..+++|+.|||++|
T Consensus 134 ~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTS
T ss_pred hhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCC
Confidence 444555555554 3444444444555555543222223332 14455666666666
Q ss_pred cccccCC
Q 006031 209 NFTGAIT 215 (664)
Q Consensus 209 ~l~g~~p 215 (664)
+|+..++
T Consensus 213 ~l~~lp~ 219 (350)
T 4ay9_X 213 RIHSLPS 219 (350)
T ss_dssp CCCCCCS
T ss_pred CcCccCh
Confidence 6665443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-12 Score=138.55 Aligned_cols=147 Identities=19% Similarity=0.116 Sum_probs=115.7
Q ss_pred EEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-----CCCCCC-CCCEEeccCCcCCCCCcccccCC-----C
Q 006031 84 RVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-----DLSGLV-NLKSLFLDHNFFTGSFPPSLLSL-----H 152 (664)
Q Consensus 84 ~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-----~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~ 152 (664)
..+|+.++++|.+ |..+...++|++|+|++|+|++..+ .+.+++ +|+.|+|++|++++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPV-EEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHH-HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHH-HHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 3578899999965 4456666779999999999998775 467888 99999999999998888888876 9
Q ss_pred CCCEEeccCCcCcCCCchhhcC----C-CCCCeeeCcCCcCccCCCCC------C-CCCCcEEEccCCcccccCCCC---
Q 006031 153 RLKTLDLSYNNLSGPLPKELAS----Q-GRLYSLRLDVNRFNGSIPPL------N-QSSLKIFNVSGNNFTGAITVT--- 217 (664)
Q Consensus 153 ~L~~L~l~~N~l~g~~p~~~~~----l-~~L~~L~l~~N~l~g~~p~~------~-~~~L~~l~l~~N~l~g~~p~~--- 217 (664)
+|++|+|++|++++..+..+.. + ++|+.|+|++|++++..+.. . .++|+.|+|++|+++..-+..
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999999888876544 4 89999999999998766532 2 469999999999999532200
Q ss_pred --Ccc-cccCccccccC
Q 006031 218 --STL-SRFGISSFLFN 231 (664)
Q Consensus 218 --~~l-~~~~~~~~~~N 231 (664)
..+ .++..+.+.+|
T Consensus 161 ~l~~~~~~L~~L~Ls~n 177 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGN 177 (362)
T ss_dssp HHHTSCTTCCEEECTTS
T ss_pred HHhcCCccccEeeecCC
Confidence 111 25556666665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=116.82 Aligned_cols=134 Identities=16% Similarity=0.037 Sum_probs=103.1
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
..++.|+.+.||+.... +..+++|....... .....+.+|+++++.+. |..+.++++++.+.+..|+||||++|.+
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 35677788899999854 56899999864321 12235788888888774 6778889999988889999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA------------------------------------------ 506 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 506 (664)
|.+.+. +......++.+++++|+.||+.
T Consensus 97 l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 97 CSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp HHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred hhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 987641 1122457889999999999981
Q ss_pred ----------------CCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 507 ----------------WRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 507 ----------------~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
..++|+|+++.||+++++..+.|.||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 248999999999999876556799997654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.03 E-value=9e-13 Score=132.06 Aligned_cols=146 Identities=13% Similarity=0.119 Sum_probs=85.8
Q ss_pred CCccccceEecCC--cEEEEEEcC---CCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCE--EeccCC
Q 006031 68 HFCQWQGVICYQQ--KVVRVVLQG---LDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKS--LFLDHN 138 (664)
Q Consensus 68 ~~C~w~gv~C~~~--~v~~l~l~~---~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~--L~L~~N 138 (664)
..|+|.|+.|+.. +|+.+...+ ..+.|.+.|+.+..|+. .|....|..++.++ .|...+.|.. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 4689999999764 777666655 34455555544444433 23333333333332 2444445554 566666
Q ss_pred cCC---CCCcccccCCCCCCEEeccCCcCcC--CCchhhcCCCCCCeeeCcCCcCccCCCCCCCC--CCcEEEccCCccc
Q 006031 139 FFT---GSFPPSLLSLHRLKTLDLSYNNLSG--PLPKELASQGRLYSLRLDVNRFNGSIPPLNQS--SLKIFNVSGNNFT 211 (664)
Q Consensus 139 ~l~---g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~--~L~~l~l~~N~l~ 211 (664)
+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|+.|+|++|.++
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence 432 2222222456777777777777776 55566667777777777777777641111222 7788888888887
Q ss_pred ccCC
Q 006031 212 GAIT 215 (664)
Q Consensus 212 g~~p 215 (664)
+.+|
T Consensus 234 ~~~~ 237 (267)
T 3rw6_A 234 DTFR 237 (267)
T ss_dssp GGCS
T ss_pred cccC
Confidence 7665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.03 E-value=1.4e-11 Score=134.58 Aligned_cols=153 Identities=18% Similarity=0.162 Sum_probs=103.0
Q ss_pred CcEEEEEEcCCCCCCc----CCCccccCCCCCCEEEecCCCCCCC----CC-CCCCCCCCCEEeccCCcCCCCCcccccC
Q 006031 80 QKVVRVVLQGLDLGGI----FAPNSLTKLDQLRVLGLQNNSLTGP----IP-DLSGLVNLKSLFLDHNFFTGSFPPSLLS 150 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~----~~p~~l~~l~~L~~L~L~~N~l~g~----~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 150 (664)
..+..|+|++|.+++. +.+.....+++|++|+|++|++++. ++ .+.++++|+.|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 5778888888887652 1122234578888888888888763 33 4566788888888888887554444433
Q ss_pred -----CCCCCEEeccCCcCcCC----CchhhcCCCCCCeeeCcCCcCccCCCCC-------CCCCCcEEEccCCcccc--
Q 006031 151 -----LHRLKTLDLSYNNLSGP----LPKELASQGRLYSLRLDVNRFNGSIPPL-------NQSSLKIFNVSGNNFTG-- 212 (664)
Q Consensus 151 -----l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~~L~~l~l~~N~l~g-- 212 (664)
.++|++|+|++|++++. +|..+..+++|+.|+|++|++++..+.. ..++|+.|+|++|++++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 26888888888888765 5666777788888888888877653321 25678888888888875
Q ss_pred --cCCC-CCcccccCccccccCC
Q 006031 213 --AITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 213 --~~p~-~~~l~~~~~~~~~~N~ 232 (664)
.+|. ...+.++..+.+.+|+
T Consensus 387 ~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHHhCCCccEEECCCCC
Confidence 4442 1234555666666664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.99 E-value=6.7e-12 Score=137.08 Aligned_cols=152 Identities=19% Similarity=0.142 Sum_probs=117.3
Q ss_pred CcEEEEEEcCCCCCCc----CCCccccCCCCCCEEEecCCCCCCCC-----CC-CCCCCCCCEEeccCCcCCCC----Cc
Q 006031 80 QKVVRVVLQGLDLGGI----FAPNSLTKLDQLRVLGLQNNSLTGPI-----PD-LSGLVNLKSLFLDHNFFTGS----FP 145 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~----~~p~~l~~l~~L~~L~L~~N~l~g~~-----p~-~~~l~~L~~L~L~~N~l~g~----~p 145 (664)
..+..|+|++|.+++. + +..+..+++|++|+|++|.+++.. +. +..+++|+.|+|++|++++. +|
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l-~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDL-CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHH-HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHH-HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 4899999999999873 2 346788999999999999987642 22 34689999999999999964 78
Q ss_pred ccccCCCCCCEEeccCCcCcCCCchhhcC-----CCCCCeeeCcCCcCccC----CCCC--CCCCCcEEEccCCcccccC
Q 006031 146 PSLLSLHRLKTLDLSYNNLSGPLPKELAS-----QGRLYSLRLDVNRFNGS----IPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 146 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~g~----~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
..+.++++|++|+|++|++++..+..+.. .++|+.|+|++|++++. +|.. .+++|+.|+|++|++++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 88889999999999999998665555543 36999999999999875 2222 5689999999999998753
Q ss_pred CC-C-C----cccccCccccccCC
Q 006031 215 TV-T-S----TLSRFGISSFLFNP 232 (664)
Q Consensus 215 p~-~-~----~l~~~~~~~~~~N~ 232 (664)
+. . . ....+..+.+.+|.
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHHcCCCCceEEEECCCCC
Confidence 21 0 0 13466667777763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=5.7e-10 Score=111.70 Aligned_cols=127 Identities=12% Similarity=0.086 Sum_probs=94.8
Q ss_pred cc-ccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC--cccceEEEecCCceEEEEecCCCCC
Q 006031 392 LG-KGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN--LVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 392 lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
++ .|..+.||+....+|..+++|..... ....+.+|+++++.+++.+ +.+++++....+..++||||++|.+
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 44 55569999998877888999987543 1235778888888875545 4558888887778999999999988
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW----------------------------------------- 507 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------- 507 (664)
+. .. . . ....++.++++.|..||+..
T Consensus 102 l~--~~----~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 102 LL--SS----H----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp TT--TS----C----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cC--cC----c----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 74 21 0 1 12357778888888888641
Q ss_pred ----------------CcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 508 ----------------RLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 508 ----------------~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.++|+|++|.||+++++..+.|.||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 29999999999999877666799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.9e-09 Score=113.70 Aligned_cols=139 Identities=17% Similarity=0.261 Sum_probs=102.9
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEcc--CccccCCcHHHHHHHHHHHcCCC--CCCcccceEEEecC---CceEEEEe
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLD--ASKLAGTSNEMYEQHMESVGGLR--HPNLVPLRAYFQAK---EERLLIYD 462 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e 462 (664)
+.++.|.++.||+....++ .+++|+.. .... ......+.+|+.+++.++ +..+.++++++.+. +..++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~~~-~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQ-TYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECSSC-EEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEECCc-eEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4688999999999987664 67788765 3221 122456788888888886 45578888888766 45899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA------------------------------------ 506 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------ 506 (664)
|++|..+.+.. ...++...+..++.++++.|+.||..
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99987764321 23467888899999999999999972
Q ss_pred ---------------------CCcccCCCCCCCeEeCCCCC--eEEeecccccc
Q 006031 507 ---------------------WRLVHGNLKSSNVLLGPDFE--ACLADYCLTAL 537 (664)
Q Consensus 507 ---------------------~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~ 537 (664)
..++|+|+++.||++++++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997754 58999998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=5e-11 Score=126.41 Aligned_cols=107 Identities=21% Similarity=0.139 Sum_probs=49.8
Q ss_pred CCCCEEEecCCCCCCCCC-CC-CCCCCCCEEeccCCcCCCCCcccc-----cCCCCCCEEeccCCcCcC----CCchhhc
Q 006031 105 DQLRVLGLQNNSLTGPIP-DL-SGLVNLKSLFLDHNFFTGSFPPSL-----LSLHRLKTLDLSYNNLSG----PLPKELA 173 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p-~~-~~l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~l~~N~l~g----~~p~~~~ 173 (664)
++|+.|+|++|.|+.... .+ ..+++|+.|+|++|+|+..-...+ ...++|++|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 455555555555543211 11 124455555555555553322222 123455555555555542 2333344
Q ss_pred CCCCCCeeeCcCCcCccCC----CC--CCCCCCcEEEccCCccc
Q 006031 174 SQGRLYSLRLDVNRFNGSI----PP--LNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 174 ~l~~L~~L~l~~N~l~g~~----p~--~~~~~L~~l~l~~N~l~ 211 (664)
.+++|++|+|++|++++.- +. ...++|+.|+|++|+|+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 5555555555555554311 00 02235555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.77 E-value=9.1e-11 Score=124.37 Aligned_cols=134 Identities=22% Similarity=0.215 Sum_probs=103.3
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CC-----CCCCCCCEEeccCCcCCC----CCccccc
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DL-----SGLVNLKSLFLDHNFFTG----SFPPSLL 149 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~-----~~l~~L~~L~L~~N~l~g----~~p~~~~ 149 (664)
..+..|+|++|.++..-...-...|++|+.|+|++|+|+.... .+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 5899999999998753112122346789999999999975433 12 356899999999999974 3566678
Q ss_pred CCCCCCEEeccCCcCcC----CCchhhcCCCCCCeeeCcCCcCccCCC----CC--CCCCCcEEEccCCccccc
Q 006031 150 SLHRLKTLDLSYNNLSG----PLPKELASQGRLYSLRLDVNRFNGSIP----PL--NQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 150 ~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p----~~--~~~~L~~l~l~~N~l~g~ 213 (664)
.+++|++|||++|+|+. .++..+..+++|+.|+|++|+++..-. .. ..++|+.|||++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 89999999999999984 346677888999999999999975321 11 457899999999998754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.5e-09 Score=122.37 Aligned_cols=131 Identities=12% Similarity=0.090 Sum_probs=68.7
Q ss_pred cCCCCCCEEEecCCCCCCCCC-CCCC-CCCCCEEecc----CCcCCCC-----CcccccCCCCCCEEeccC--CcCcCCC
Q 006031 102 TKLDQLRVLGLQNNSLTGPIP-DLSG-LVNLKSLFLD----HNFFTGS-----FPPSLLSLHRLKTLDLSY--NNLSGPL 168 (664)
Q Consensus 102 ~~l~~L~~L~L~~N~l~g~~p-~~~~-l~~L~~L~L~----~N~l~g~-----~p~~~~~l~~L~~L~l~~--N~l~g~~ 168 (664)
..+++|++|+|+.|++++..+ .++. +++|+.|+|+ .|++++. ++..+.++++|++|+|++ |.+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 346666777776666665433 2333 5666666664 5566542 333355566666666653 2355444
Q ss_pred chhhcC-CCCCCeeeCcCCcCccC-CCC--CCCCCCcEEEccCCccccc-CCC-CCcccccCccccccCC
Q 006031 169 PKELAS-QGRLYSLRLDVNRFNGS-IPP--LNQSSLKIFNVSGNNFTGA-ITV-TSTLSRFGISSFLFNP 232 (664)
Q Consensus 169 p~~~~~-l~~L~~L~l~~N~l~g~-~p~--~~~~~L~~l~l~~N~l~g~-~p~-~~~l~~~~~~~~~~N~ 232 (664)
+..+.. +++|+.|+|++|++++. ++. ..+++|+.|+|++|.|++. ++. ...+.++..+.+.+|.
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 444433 56666666666666542 221 2455666666666665533 111 1223444555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.2e-09 Score=109.27 Aligned_cols=92 Identities=24% Similarity=0.227 Sum_probs=60.3
Q ss_pred cccCCCCCCE--EEecCCCCC---CCCCC-CCCCCCCCEEeccCCcCCC--CCcccccCCCCCCEEeccCCcCcCCCchh
Q 006031 100 SLTKLDQLRV--LGLQNNSLT---GPIPD-LSGLVNLKSLFLDHNFFTG--SFPPSLLSLHRLKTLDLSYNNLSGPLPKE 171 (664)
Q Consensus 100 ~l~~l~~L~~--L~L~~N~l~---g~~p~-~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 171 (664)
.+...+.|.. ++++.|... +.++. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 136 ~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 136 GLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp TGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred HcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 3444555555 666777432 21111 1357778888888888886 5566777788888888888888754 33
Q ss_pred hcCCC--CCCeeeCcCCcCccCCC
Q 006031 172 LASQG--RLYSLRLDVNRFNGSIP 193 (664)
Q Consensus 172 ~~~l~--~L~~L~l~~N~l~g~~p 193 (664)
+..+. +|+.|+|++|.+++.+|
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhhcccCCcceEEccCCcCccccC
Confidence 44444 78888888888887766
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=8.6e-09 Score=106.02 Aligned_cols=180 Identities=17% Similarity=0.111 Sum_probs=116.8
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCC--cccceEEEecCC---ceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPN--LVPLRAYFQAKE---ERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~ 463 (664)
+.++.|.+..||+.. ..+++|..... .....+.+|.++++.+. +.. +.+++.+....+ ..|+||||
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458899999999863 45788875432 23467889999988773 333 334444433332 34789999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA------------------------------------- 506 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 506 (664)
++|.++.+... ..++..++..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 98 IKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 99988865332 2356667777888888888888751
Q ss_pred --------------------CCcccCCCCCCCeEeCC--CCCeEEeeccccccccCCC----CCCC---CCC--------
Q 006031 507 --------------------WRLVHGNLKSSNVLLGP--DFEACLADYCLTALTADSL----QDDD---PDN-------- 549 (664)
Q Consensus 507 --------------------~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~----~~~~---~~~-------- 549 (664)
+.++|+|+++.||++++ +..+.|.||+.+....... .... .+.
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 13799999999999998 4567899999886543211 0000 000
Q ss_pred -CcccC-ccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 006031 550 -LLYKA-PETRNASHQATSKSDVYSFGVLLLELLTGKPPS 587 (664)
Q Consensus 550 -~~y~a-PE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~ 587 (664)
.++.. |+... ......+.|++|.++|++.+|+.+|
T Consensus 251 ~Y~~~~~~~~~~---r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLE---KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHH---HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHH---HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 22211 1122368999999999999998875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.57 E-value=1.7e-07 Score=97.38 Aligned_cols=38 Identities=13% Similarity=0.334 Sum_probs=27.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG 119 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g 119 (664)
..++.|+|++ ++.. +++..|.++++|+.|+|++|.+..
T Consensus 101 ~~L~~l~L~~-~i~~-I~~~aF~~~~~L~~l~l~~n~i~~ 138 (329)
T 3sb4_A 101 QTLEKVILSE-KIKN-IEDAAFKGCDNLKICQIRKKTAPN 138 (329)
T ss_dssp TTCCC-CBCT-TCCE-ECTTTTTTCTTCCEEEBCCSSCCE
T ss_pred CCCcEEECCc-cccc-hhHHHhhcCcccceEEcCCCCccc
Confidence 4577777777 6665 666678888888888888887653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.46 E-value=1.5e-08 Score=96.17 Aligned_cols=112 Identities=19% Similarity=0.188 Sum_probs=77.8
Q ss_pred cccCCCCCCEEEecCC-CCCCCC-----CCCCCCCCCCEEeccCCcCCCC----CcccccCCCCCCEEeccCCcCcCC--
Q 006031 100 SLTKLDQLRVLGLQNN-SLTGPI-----PDLSGLVNLKSLFLDHNFFTGS----FPPSLLSLHRLKTLDLSYNNLSGP-- 167 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N-~l~g~~-----p~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~-- 167 (664)
.+...+.|++|+|++| .|...- ..+...++|++|+|++|+++.. +...+...++|++|+|++|+|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4566778888888888 775321 1355677888888888888642 344455667888888888888743
Q ss_pred --CchhhcCCCCCCeeeC--cCCcCccCCCC------CCCCCCcEEEccCCccc
Q 006031 168 --LPKELASQGRLYSLRL--DVNRFNGSIPP------LNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 168 --~p~~~~~l~~L~~L~l--~~N~l~g~~p~------~~~~~L~~l~l~~N~l~ 211 (664)
+...+...++|+.|+| ++|.++..--. ...+.|+.|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4556777788888888 77887643111 03467888888888875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.43 E-value=4e-07 Score=94.56 Aligned_cols=77 Identities=10% Similarity=0.091 Sum_probs=52.4
Q ss_pred CcEEEEEEcCCCCCC-------------------cCCCccccC--------CCCCCEEEecCCCCCCCCC-CCCCCCCCC
Q 006031 80 QKVVRVVLQGLDLGG-------------------IFAPNSLTK--------LDQLRVLGLQNNSLTGPIP-DLSGLVNLK 131 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g-------------------~~~p~~l~~--------l~~L~~L~L~~N~l~g~~p-~~~~l~~L~ 131 (664)
.+++.|+|++|.+.. .+++..|.+ +++|+.|+|.+ +++...+ .|.+|++|+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~ 127 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK 127 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence 456777777776660 245567778 99999999999 8876555 599999999
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEE
Q 006031 132 SLFLDHNFFTGSFPPSLLSLHRLKTL 157 (664)
Q Consensus 132 ~L~L~~N~l~g~~p~~~~~l~~L~~L 157 (664)
.|+|++|.++..-+..|.++.++..|
T Consensus 128 ~l~l~~n~i~~i~~~aF~~~~~l~~l 153 (329)
T 3sb4_A 128 ICQIRKKTAPNLLPEALADSVTAIFI 153 (329)
T ss_dssp EEEBCCSSCCEECTTSSCTTTCEEEE
T ss_pred eEEcCCCCccccchhhhcCCCceEEe
Confidence 99999998753333333333333333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.4e-08 Score=112.35 Aligned_cols=126 Identities=15% Similarity=0.193 Sum_probs=73.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCC--CCCCEEEecCCC-CCC-CCCC-CCCCCCCCEEeccCCcCCCC----CcccccC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKL--DQLRVLGLQNNS-LTG-PIPD-LSGLVNLKSLFLDHNFFTGS----FPPSLLS 150 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l--~~L~~L~L~~N~-l~g-~~p~-~~~l~~L~~L~L~~N~l~g~----~p~~~~~ 150 (664)
..++.|+|+++.+++.. +..++.+ .+|++|+|++|. ++. .++. ..++++|++|+|++|.+++. ++..+.+
T Consensus 112 ~~L~~L~L~~~~i~~~~-~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~ 190 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLD-LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190 (592)
T ss_dssp TTCCEEEEESCBCCHHH-HHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH
T ss_pred CCCCeEEeeccEecHHH-HHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc
Confidence 56888888888776532 2234442 337777777765 110 0111 23566777777777776655 4444556
Q ss_pred CCCCCEEeccCCcCc----CCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccC
Q 006031 151 LHRLKTLDLSYNNLS----GPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSG 207 (664)
Q Consensus 151 l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~ 207 (664)
+++|++|+|++|+++ +.++..+.++++|+.|+|++|.+.+ +|.. .+++|+.|+++.
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 677777777777776 3344445566777777777776665 2221 445555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.4e-08 Score=112.45 Aligned_cols=128 Identities=13% Similarity=0.068 Sum_probs=67.2
Q ss_pred CCCCCEEEecCCCCCCCCC-CCC-CCCCCCEEecc--C----CcCCCC-----CcccccCCCCCCEEeccCCcCcCCCch
Q 006031 104 LDQLRVLGLQNNSLTGPIP-DLS-GLVNLKSLFLD--H----NFFTGS-----FPPSLLSLHRLKTLDLSYNNLSGPLPK 170 (664)
Q Consensus 104 l~~L~~L~L~~N~l~g~~p-~~~-~l~~L~~L~L~--~----N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~~p~ 170 (664)
+++|+.|+++.|++++..+ .+. ++++|+.|+|+ + |++++. ++..+.++++|+.|+|++ ++++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 5666666666666655432 222 35666666666 3 444411 112245566666666655 55544444
Q ss_pred hhcC-CCCCCeeeCcCCcCccCCCC---CCCCCCcEEEccCCcccccCC--CCCcccccCccccccCC
Q 006031 171 ELAS-QGRLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNFTGAIT--VTSTLSRFGISSFLFNP 232 (664)
Q Consensus 171 ~~~~-l~~L~~L~l~~N~l~g~~p~---~~~~~L~~l~l~~N~l~g~~p--~~~~l~~~~~~~~~~N~ 232 (664)
.++. +++|+.|+|++|.+++..+. ..+++|+.|+|++|.+++... ....+.++..+.+.+|+
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 4544 66666666666666543221 135566666666666643321 11234455555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.19 E-value=1.3e-07 Score=89.63 Aligned_cols=110 Identities=18% Similarity=0.240 Sum_probs=86.5
Q ss_pred CCcEEEEEEcCC-CCCCc----CCCccccCCCCCCEEEecCCCCCCCCC-----CCCCCCCCCEEeccCCcCCCC----C
Q 006031 79 QQKVVRVVLQGL-DLGGI----FAPNSLTKLDQLRVLGLQNNSLTGPIP-----DLSGLVNLKSLFLDHNFFTGS----F 144 (664)
Q Consensus 79 ~~~v~~l~l~~~-~l~g~----~~p~~l~~l~~L~~L~L~~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----~ 144 (664)
...++.|+|++| .++.. + ...+...++|++|+|++|+|...-- .+...++|++|+|++|.++.. +
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l-~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHH-HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 357899999999 88641 2 2256778999999999999864211 245568899999999999853 5
Q ss_pred cccccCCCCCCEEec--cCCcCcCC----CchhhcCCCCCCeeeCcCCcCc
Q 006031 145 PPSLLSLHRLKTLDL--SYNNLSGP----LPKELASQGRLYSLRLDVNRFN 189 (664)
Q Consensus 145 p~~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 189 (664)
...+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 677888899999999 88999843 4455667799999999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=9.2e-06 Score=83.34 Aligned_cols=133 Identities=14% Similarity=0.048 Sum_probs=89.3
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCC---CcccceEEEe-cCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP---NLVPLRAYFQ-AKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~ 465 (664)
+.++.|....||+. +..+++|.-... .....+.+|.++|+.+.+. .+.+.+.++. ..+..++||||++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 45788888899987 456778874221 2346788999999988653 2555666664 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA--------------------------------------- 506 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 506 (664)
|..+.+... ..++...+..++.++++.|+.||+.
T Consensus 97 G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 97 GQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp SEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 988866321 1133344444455555555444431
Q ss_pred --------------------CCcccCCCCCCCeEeCC---CCCe-EEeecccccc
Q 006031 507 --------------------WRLVHGNLKSSNVLLGP---DFEA-CLADYCLTAL 537 (664)
Q Consensus 507 --------------------~~ivHrDlk~~NILl~~---~~~~-ki~DfGla~~ 537 (664)
+.++|+|+++.||++++ ++.+ .|.||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 14599999999999987 4554 7999987654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=6e-07 Score=94.30 Aligned_cols=111 Identities=18% Similarity=0.102 Sum_probs=60.5
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCccccc--CCCCCCEEeccC--CcCcCC-----Cch
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLL--SLHRLKTLDLSY--NNLSGP-----LPK 170 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~ 170 (664)
.+..+++|+.|+|++|.-. .+|.+. +++|+.|+|..|.++...-..+. .+++|+.|+|+. |...|. +-.
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~ 244 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred HHhcCCCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence 3455677777777766211 223332 66777777776666543333343 567777777652 222111 111
Q ss_pred hh--cCCCCCCeeeCcCCcCccCCCC-----CCCCCCcEEEccCCcccc
Q 006031 171 EL--ASQGRLYSLRLDVNRFNGSIPP-----LNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 171 ~~--~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~l~~N~l~g 212 (664)
.+ ..+++|+.|+|++|++++..+. ..+++|+.|+|++|.|++
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 12 2356777777777766543221 135667777777777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.8e-07 Score=105.20 Aligned_cols=104 Identities=18% Similarity=0.180 Sum_probs=62.3
Q ss_pred CCCCCCEEEecCCCCCCCCC-CCC-CCCCCCEEeccCC-cCCCC-CcccccCCCCCCEEeccCCcCcCCCchhhc----C
Q 006031 103 KLDQLRVLGLQNNSLTGPIP-DLS-GLVNLKSLFLDHN-FFTGS-FPPSLLSLHRLKTLDLSYNNLSGPLPKELA----S 174 (664)
Q Consensus 103 ~l~~L~~L~L~~N~l~g~~p-~~~-~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~ 174 (664)
.+++|+.|+|++|.+++..+ .+. ++++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 46677777777776665443 233 4667777777776 44422 444444677777777777776655444443 4
Q ss_pred CCCCCeeeCcCCcCccCCCC-------CCCCCCcEEEccCC
Q 006031 175 QGRLYSLRLDVNRFNGSIPP-------LNQSSLKIFNVSGN 208 (664)
Q Consensus 175 l~~L~~L~l~~N~l~g~~p~-------~~~~~L~~l~l~~N 208 (664)
+++|+.|+|++|. +.+.. ..+++|+.|+|++|
T Consensus 183 ~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 183 YTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 5577777777765 22221 13467777777776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=80.97 Aligned_cols=132 Identities=17% Similarity=0.165 Sum_probs=91.0
Q ss_pred cccccCce-eEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLG-TTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556555 68987754 5667888876432 3456788888887764 333667889998889999999999998
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ------------------------------------------ 505 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~------------------------------------------ 505 (664)
++.+.... .......+..++++.|.-||.
T Consensus 106 ~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 87765421 112233455555555555552
Q ss_pred ---------c------CCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 506 ---------A------WRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 506 ---------~------~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
. +.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 027899999999999987777799997664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=9e-07 Score=92.94 Aligned_cols=129 Identities=17% Similarity=0.208 Sum_probs=92.0
Q ss_pred CcEEEEEEcCCC-CCCcCCCccccCCCCCCEEEecCCCCCCCCC-CC--CCCCCCCEEeccC--CcCCCC-----Ccccc
Q 006031 80 QKVVRVVLQGLD-LGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DL--SGLVNLKSLFLDH--NFFTGS-----FPPSL 148 (664)
Q Consensus 80 ~~v~~l~l~~~~-l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~--~~l~~L~~L~L~~--N~l~g~-----~p~~~ 148 (664)
..+..|+|.++. + .+++ +. +++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +-..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 579999998873 2 2333 43 8999999999888754221 23 3689999999864 332222 11223
Q ss_pred --cCCCCCCEEeccCCcCcCCCchhhc---CCCCCCeeeCcCCcCccC----CCCC--CCCCCcEEEccCCccccc
Q 006031 149 --LSLHRLKTLDLSYNNLSGPLPKELA---SQGRLYSLRLDVNRFNGS----IPPL--NQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 149 --~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~g~----~p~~--~~~~L~~l~l~~N~l~g~ 213 (664)
..+++|++|+|++|.+++..+..+. .+++|+.|+|+.|++++. ++.. .+++|+.|+|++|.++..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 3589999999999999866555554 478999999999999863 2221 568999999999988743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=1.1e-05 Score=84.44 Aligned_cols=81 Identities=9% Similarity=-0.032 Sum_probs=52.6
Q ss_pred ccc-cccCceeEEEEEEc-------CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCC-C--CCcccceEEEecC---
Q 006031 390 ELL-GKGSLGTTYKAVLD-------NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLR-H--PNLVPLRAYFQAK--- 454 (664)
Q Consensus 390 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~--- 454 (664)
+.| +.|....+|+.... ++..+++|....... .......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998765 266788887654320 0001234667777777664 2 2466778777654
Q ss_pred CceEEEEecCCCCCHH
Q 006031 455 EERLLIYDYQPNGSLF 470 (664)
Q Consensus 455 ~~~~lV~e~~~~gsL~ 470 (664)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00012 Score=75.79 Aligned_cols=140 Identities=18% Similarity=0.262 Sum_probs=77.8
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-----CCCCcccce-E--EEecCCceEEEE
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-----RHPNLVPLR-A--YFQAKEERLLIY 461 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~ 461 (664)
+.|+.|..+.||+....+|. +++|+.... ......|..++..+ ..|.++... | +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 34666778899999877664 888988642 22333344444333 334444311 1 123456789999
Q ss_pred ecCCCCCHH--------------HHhccCCC-C--C------CCCCCHHHHH----------------------------
Q 006031 462 DYQPNGSLF--------------SLIHGSKS-T--R------AKPLHWTSCL---------------------------- 490 (664)
Q Consensus 462 e~~~~gsL~--------------~~l~~~~~-~--~------~~~l~~~~~~---------------------------- 490 (664)
||++|..+. ..+|.... . . ...-.|....
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 12221100 0 0 0112343211
Q ss_pred ---HHHHHHHHHHHHHHh------------cCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 491 ---KIAEDVAQGLSYIHQ------------AWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 491 ---~i~~~ia~~L~yLH~------------~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
.+...+..++++|++ ...++|+|+++.||+++.++.+.|.||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446677763 2479999999999999888899999997653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00025 Score=75.45 Aligned_cols=77 Identities=14% Similarity=0.171 Sum_probs=39.6
Q ss_pred EEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 82 VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
++.+.|++ .+.. +.+..|.++++|+.++|++|+++.........++|+.+.|.+| ++-.-...|.++++|+.|+|.+
T Consensus 159 L~~i~lp~-~l~~-I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQ-LKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCE-ECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccE-ehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 45555553 3433 4455667777777777777766644332222355555555532 4322223344555555555544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00025 Score=75.31 Aligned_cols=76 Identities=11% Similarity=0.069 Sum_probs=47.0
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccc--c---CCcHHHHHHHHHHHcCCCC--CCcc-cceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL--A---GTSNEMYEQHMESVGGLRH--PNLV-PLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~---~~~~~~~~~e~~~l~~l~H--~niv-~l~g~~~~~~~~~lV 460 (664)
+.||.|.++.||++... ++..+++|....... . ....+.+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 467899997643211 0 1123445677777766532 3333 45543 34567899
Q ss_pred EecCCCC
Q 006031 461 YDYQPNG 467 (664)
Q Consensus 461 ~e~~~~g 467 (664)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00025 Score=71.68 Aligned_cols=74 Identities=12% Similarity=0.175 Sum_probs=52.9
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCC---CcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP---NLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.+|.|..+.||+.++.+|+.|++|+-..... .....|+.|...|+.+.-. -+.+++++ +..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 45899999999999999999999998654322 3345788898888777422 23444443 234789999987
Q ss_pred CCH
Q 006031 467 GSL 469 (664)
Q Consensus 467 gsL 469 (664)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00035 Score=74.37 Aligned_cols=127 Identities=13% Similarity=0.145 Sum_probs=90.9
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCC-----CCCcccccCCCCC
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFT-----GSFPPSLLSLHRL 154 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~-----g~~p~~~~~l~~L 154 (664)
.+..|+|+++ +.. +....|.+ .+|+.+.| .|+++...+ .|.++++|+.|+|.+|.+. ..-+..|.+|++|
T Consensus 227 ~L~~l~l~~~-l~~-I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 227 QLKTIEIPEN-VST-IGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TCCCEECCTT-CCE-ECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCEEecCCC-ccC-cccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 5666777653 433 55556777 78999999 455654433 6889999999999988875 2334567889999
Q ss_pred CEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC--C-CCCCCcEEEccCCcccccCC
Q 006031 155 KTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--L-NQSSLKIFNVSGNNFTGAIT 215 (664)
Q Consensus 155 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~-~~~~L~~l~l~~N~l~g~~p 215 (664)
+.++|. |+++-.-...|.+|++|+.++|..| ++ .|+. + ++ +|+.+++++|.+....+
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-GIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-CCCEEEECCSSCCBCCC
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-CCCEEEEcCCCCccccc
Confidence 999998 4577334457888999999999665 54 3333 2 56 89999999998765443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.001 Score=58.64 Aligned_cols=36 Identities=28% Similarity=0.266 Sum_probs=15.6
Q ss_pred CCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcC
Q 006031 153 RLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188 (664)
Q Consensus 153 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 188 (664)
+|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 344444444444422222334444444444444433
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00013 Score=67.60 Aligned_cols=81 Identities=12% Similarity=0.119 Sum_probs=44.6
Q ss_pred CCCEEEecCCCCCCC-CCCCCCCCCCCEEeccCCc-CCCCCcccccCC----CCCCEEeccCC-cCcCCCchhhcCCCCC
Q 006031 106 QLRVLGLQNNSLTGP-IPDLSGLVNLKSLFLDHNF-FTGSFPPSLLSL----HRLKTLDLSYN-NLSGPLPKELASQGRL 178 (664)
Q Consensus 106 ~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l----~~L~~L~l~~N-~l~g~~p~~~~~l~~L 178 (664)
.|+.|||+++.++.. +..+.++++|+.|+|+++. ++..-=..|..+ ++|++|+|+++ ++|..==..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 466677776665432 2345566677777777664 543322334443 35777777665 3552212345556666
Q ss_pred CeeeCcCC
Q 006031 179 YSLRLDVN 186 (664)
Q Consensus 179 ~~L~l~~N 186 (664)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0024 Score=65.23 Aligned_cols=136 Identities=15% Similarity=0.163 Sum_probs=89.0
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC---CCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR---HPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
+.|+.|.+..+|+.... +..+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45889999999998864 557788876432 3567888988887773 35677888888878889999999998
Q ss_pred CCHH-----------HHhccCCC-CCC----------------CCCCHHHHH---HHHHH----------------HHH-
Q 006031 467 GSLF-----------SLIHGSKS-TRA----------------KPLHWTSCL---KIAED----------------VAQ- 498 (664)
Q Consensus 467 gsL~-----------~~l~~~~~-~~~----------------~~l~~~~~~---~i~~~----------------ia~- 498 (664)
..+. ..||.... ... -.-+|.... ++..+ +..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 13343211 000 012454321 11111 111
Q ss_pred HHHHHHh---cCCcccCCCCCCCeEeCCCCCeEEeec
Q 006031 499 GLSYIHQ---AWRLVHGNLKSSNVLLGPDFEACLADY 532 (664)
Q Consensus 499 ~L~yLH~---~~~ivHrDlk~~NILl~~~~~~ki~Df 532 (664)
....|.. .+.++|+|+.+.||+++.++ +.|.|+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~ 231 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP 231 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence 1223421 34699999999999999887 888887
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0023 Score=68.33 Aligned_cols=75 Identities=15% Similarity=0.111 Sum_probs=45.8
Q ss_pred CcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC-CC--CCCcccCccccccC--CCCCchhhHHHHHHHHHHHHc
Q 006031 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD-DP--DNLLYKAPETRNAS--HQATSKSDVYSFGVLLLELLT 582 (664)
Q Consensus 508 ~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~-~~--~~~~y~aPE~~~~~--~~~~~ksDVwSfGvvl~ellt 582 (664)
.++|+|+++.|||+++++ ++|.||+.+........-. .. -...|.+|+..... .......++......+|+.++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 799999999999998876 9999998876543211000 00 01235566544211 111223556678888888776
Q ss_pred C
Q 006031 583 G 583 (664)
Q Consensus 583 G 583 (664)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0021 Score=56.48 Aligned_cols=37 Identities=30% Similarity=0.250 Sum_probs=23.5
Q ss_pred CCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCc
Q 006031 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165 (664)
Q Consensus 129 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 165 (664)
+|+.|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666677777766333334566777777777777653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.01 Score=60.75 Aligned_cols=141 Identities=11% Similarity=0.080 Sum_probs=78.5
Q ss_pred cccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCC--CcccceEE-----EecCCceEEEEec
Q 006031 391 LLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHP--NLVPLRAY-----FQAKEERLLIYDY 463 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~e~ 463 (664)
.++ |....||+....+|..+++|...... ...+.+..|..++..+... .+.+++.. ....+..++||+|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 355 77789999887777778999885322 2345666677776655322 23344432 1224556889999
Q ss_pred CCCCCHH-----H---------HhccC----CCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHh-
Q 006031 464 QPNGSLF-----S---------LIHGS----KSTRAKPLHWTSC----LKI---------------AEDVAQGLSYIHQ- 505 (664)
Q Consensus 464 ~~~gsL~-----~---------~l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~- 505 (664)
++|..+. . .+|.. .......+++... ..+ ...+.+.++.+.+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875431 1 12210 0001112222211 001 1111122333322
Q ss_pred -----cCCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 506 -----AWRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 506 -----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
...++|+|+++.||+++ + .+.|.||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 12589999999999999 4 899999977654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0003 Score=66.43 Aligned_cols=85 Identities=12% Similarity=0.164 Sum_probs=49.6
Q ss_pred cCCCCCCEEEecCC-CCCCC----C-CCCCCCCCCCEEeccCCcCCCC----CcccccCCCCCCEEeccCCcCcCC----
Q 006031 102 TKLDQLRVLGLQNN-SLTGP----I-PDLSGLVNLKSLFLDHNFFTGS----FPPSLLSLHRLKTLDLSYNNLSGP---- 167 (664)
Q Consensus 102 ~~l~~L~~L~L~~N-~l~g~----~-p~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~---- 167 (664)
.+-+.|+.|+|++| +|... + ..+..-+.|+.|+|++|++... |-..+..-+.|++|+|++|+|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34567778888775 55321 0 1244456777788888777632 333344456777777777777632
Q ss_pred CchhhcCCCCCCeeeCcCC
Q 006031 168 LPKELASQGRLYSLRLDVN 186 (664)
Q Consensus 168 ~p~~~~~l~~L~~L~l~~N 186 (664)
|-..+..-+.|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 2223444556777777654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0054 Score=62.19 Aligned_cols=137 Identities=9% Similarity=0.056 Sum_probs=71.1
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEEEEecC-CCC
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLLIYDYQ-PNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~g 467 (664)
+.|+.|....+|+. ..+++|+........ ....+|...++.+....+ .+++++ +.+..++|+||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 46888999999998 457788765421111 112456666655533233 345543 344567899999 554
Q ss_pred CHHH------------------HhccCCCCCCCCCCH-HHHHHHHH--------------HHHHHHH----HHHh---cC
Q 006031 468 SLFS------------------LIHGSKSTRAKPLHW-TSCLKIAE--------------DVAQGLS----YIHQ---AW 507 (664)
Q Consensus 468 sL~~------------------~l~~~~~~~~~~l~~-~~~~~i~~--------------~ia~~L~----yLH~---~~ 507 (664)
++.. .+|............ .....+.. .+.+.+. .+.. ..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 223221111111111 11111111 1111111 1211 12
Q ss_pred CcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 508 RLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 508 ~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
.++|+|+.+.||+ .+++.+.+.||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667889999977654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.49 E-value=0.008 Score=61.39 Aligned_cols=142 Identities=10% Similarity=0.103 Sum_probs=75.9
Q ss_pred ccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCC--cccceEE------EecCCceEEEE
Q 006031 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN--LVPLRAY------FQAKEERLLIY 461 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~ 461 (664)
+.|+.|....+|+....++ .+++|...... ..+.+..|+.++..+.... +.+++.. ....+..++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3467788889999987776 57788875421 1223445565555443211 2223221 12235678999
Q ss_pred ecCCCCCHH--------------HHhccCC-C--CCC----CCCCHHHHHH------------HHHHHHHHHHHHHhc--
Q 006031 462 DYQPNGSLF--------------SLIHGSK-S--TRA----KPLHWTSCLK------------IAEDVAQGLSYIHQA-- 506 (664)
Q Consensus 462 e~~~~gsL~--------------~~l~~~~-~--~~~----~~l~~~~~~~------------i~~~ia~~L~yLH~~-- 506 (664)
+|++|..+. ..+|... . ... ....|..... +...+.+.++++++.
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999886431 1122110 0 000 0112332111 111244556666532
Q ss_pred ----CCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 507 ----WRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 507 ----~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
..++|+|+.+.||+++++..+.|.||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 268999999999999987556899997654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0084 Score=62.91 Aligned_cols=140 Identities=15% Similarity=0.182 Sum_probs=80.9
Q ss_pred ccccccCceeEEEEEEcC--------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLDN--------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 460 (664)
+.|..|-...+|+....+ +..+++|+.... ......+.+|.++++.+.-.++ .++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 346677778899988652 467888885321 1234566688888877743333 456666543 299
Q ss_pred EecCCCCCHHH-----------------HhccCCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHH
Q 006031 461 YDYQPNGSLFS-----------------LIHGSKSTRAKPLH--WTSCLKIAEDVA-------------------QGLSY 502 (664)
Q Consensus 461 ~e~~~~gsL~~-----------------~l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~y 502 (664)
+||++|..|.. .||........... |.+..++..++. ..+.+
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999755421 22332211122222 455555554432 22344
Q ss_pred HHh----c---CCcccCCCCCCCeEeCCC----CCeEEeeccccc
Q 006031 503 IHQ----A---WRLVHGNLKSSNVLLGPD----FEACLADYCLTA 536 (664)
Q Consensus 503 LH~----~---~~ivHrDlk~~NILl~~~----~~~ki~DfGla~ 536 (664)
|.+ . ..++|+|+.+.||+++++ +.+.+.||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 432 1 158999999999999876 789999997664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.001 Score=61.51 Aligned_cols=82 Identities=9% Similarity=0.049 Sum_probs=60.2
Q ss_pred CCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCc-CcCCCchhhcCC----CCCCeeeCcCCc-CccC--CCCCCCCC
Q 006031 128 VNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN-LSGPLPKELASQ----GRLYSLRLDVNR-FNGS--IPPLNQSS 199 (664)
Q Consensus 128 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~--~p~~~~~~ 199 (664)
-+|+.|||+++.++..=-..+.++++|++|+|+++. ++..-=..+..+ ++|++|+|+++. +|.. ..-..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999886545667899999999999985 664322345554 479999999974 6531 11125789
Q ss_pred CcEEEccCCc
Q 006031 200 LKIFNVSGNN 209 (664)
Q Consensus 200 L~~l~l~~N~ 209 (664)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.022 Score=58.48 Aligned_cols=31 Identities=23% Similarity=0.356 Sum_probs=26.7
Q ss_pred CcccCCCCCCCeEeCCC----CCeEEeeccccccc
Q 006031 508 RLVHGNLKSSNVLLGPD----FEACLADYCLTALT 538 (664)
Q Consensus 508 ~ivHrDlk~~NILl~~~----~~~ki~DfGla~~~ 538 (664)
.++|+|+.+.||+++.+ ..+.|.||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 68999999999999875 67899999877643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.99 E-value=0.022 Score=60.87 Aligned_cols=71 Identities=13% Similarity=0.077 Sum_probs=46.6
Q ss_pred ccccccCceeEEEEEEcC--------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLDN--------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 460 (664)
+.|+.|....+|+....+ +..+++|+.... ...+.+..|..+++.+...++ .++++.+.+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 357788889999998753 467888887321 122445578888777743344 456665532 389
Q ss_pred EecCCCCC
Q 006031 461 YDYQPNGS 468 (664)
Q Consensus 461 ~e~~~~gs 468 (664)
+||+++.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998633
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.023 Score=59.91 Aligned_cols=108 Identities=15% Similarity=0.217 Sum_probs=73.4
Q ss_pred CccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCc-ccccCCCCCCEEeccCCcCcCCCchhhcCCC
Q 006031 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP-PSLLSLHRLKTLDLSYNNLSGPLPKELASQG 176 (664)
Q Consensus 98 p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 176 (664)
...+.++..|+.+.+.++-.+-.--.|.++++|+.+++. +.++ .|+ ..|.++.+|+.++|..| ++-.-..+|.+|+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 346778888888888765543222257788888888886 4455 344 45677888888888754 5522235678888
Q ss_pred CCCeeeCcCCcCccCCCC---CCCCCCcEEEccCCcc
Q 006031 177 RLYSLRLDVNRFNGSIPP---LNQSSLKIFNVSGNNF 210 (664)
Q Consensus 177 ~L~~L~l~~N~l~g~~p~---~~~~~L~~l~l~~N~l 210 (664)
+|+.+.|..+ ++ .|.. .++++|+.+++.+|..
T Consensus 335 ~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 335 QLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 8888888654 44 4443 2778888888887754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.63 E-value=0.065 Score=50.91 Aligned_cols=100 Identities=13% Similarity=0.080 Sum_probs=66.0
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
.-+|.++|.. ...++++.+.+.++.|.+++|.-+-....-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 4489999973 4578999999999999999987762110111233346899999999998764 1110
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT 582 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt 582 (664)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1223467888763 455788999999999999887
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.042 Score=57.88 Aligned_cols=81 Identities=14% Similarity=0.185 Sum_probs=51.9
Q ss_pred CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCc-hhhcCCCCCCeeeCcCCcCccCCCCC---CCC
Q 006031 123 DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLP-KELASQGRLYSLRLDVNRFNGSIPPL---NQS 198 (664)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~ 198 (664)
.|.++++|+.+.+.++..+ .-...|.++++|+.+.+. +.++ .|+ ..|.++++|+.++|..| ++ .|... ++.
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~ 334 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCE 334 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCT
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCC
Confidence 4677788888887665443 334456777888888885 4455 333 46777888888887654 33 33331 567
Q ss_pred CCcEEEccCC
Q 006031 199 SLKIFNVSGN 208 (664)
Q Consensus 199 ~L~~l~l~~N 208 (664)
+|+.+.+..|
T Consensus 335 ~L~~i~ip~s 344 (394)
T 4gt6_A 335 QLERIAIPSS 344 (394)
T ss_dssp TCCEEEECTT
T ss_pred CCCEEEECcc
Confidence 7888877543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0044 Score=58.42 Aligned_cols=84 Identities=14% Similarity=0.182 Sum_probs=60.1
Q ss_pred CCCCCCCEEeccCC-cCCC----CCcccccCCCCCCEEeccCCcCcC----CCchhhcCCCCCCeeeCcCCcCccCCCC-
Q 006031 125 SGLVNLKSLFLDHN-FFTG----SFPPSLLSLHRLKTLDLSYNNLSG----PLPKELASQGRLYSLRLDVNRFNGSIPP- 194 (664)
Q Consensus 125 ~~l~~L~~L~L~~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p~- 194 (664)
.+-+.|+.|+|++| ++.. .+-..+..-+.|+.|+|++|+|.. .|-..+..-+.|+.|+|++|+++..--.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34578999999986 7752 144456667889999999999972 2344566678899999999998732110
Q ss_pred -----CCCCCCcEEEccCC
Q 006031 195 -----LNQSSLKIFNVSGN 208 (664)
Q Consensus 195 -----~~~~~L~~l~l~~N 208 (664)
...+.|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 13356999999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.095 Score=56.36 Aligned_cols=73 Identities=11% Similarity=0.045 Sum_probs=44.8
Q ss_pred ccccccCceeEEEEEEcC-CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEEEEecCCCC
Q 006031 390 ELLGKGSLGTTYKAVLDN-RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+.|+.|-...+|+....+ +..+++|+...... ......+|..++..+...++ .++++++. + .+|+||+++.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 457788889999998776 46788887643211 11112567777777755455 45677662 2 3599999874
Q ss_pred CH
Q 006031 468 SL 469 (664)
Q Consensus 468 sL 469 (664)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.91 E-value=0.11 Score=54.19 Aligned_cols=72 Identities=11% Similarity=0.007 Sum_probs=40.6
Q ss_pred ccccccCceeEEEEEEcC---------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEE
Q 006031 390 ELLGKGSLGTTYKAVLDN---------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLL 459 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~l 459 (664)
+.++.|....+|+....+ +..+++|+....... ......|.++++.+...++ .++++.. .-++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec----CCcE
Confidence 356778888999988754 257888876532211 1123566666666643333 3565543 2378
Q ss_pred EEecCCCCC
Q 006031 460 IYDYQPNGS 468 (664)
Q Consensus 460 V~e~~~~gs 468 (664)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.021 Score=38.97 Aligned_cols=26 Identities=23% Similarity=0.379 Sum_probs=10.7
Q ss_pred eehhhHH-HHHHHHHHHHHHHHHHHHh
Q 006031 292 IIGFSSG-VLVLICSLVLFAMAVKKQK 317 (664)
Q Consensus 292 ii~i~vg-~~vl~~~v~~~~~~~~~~~ 317 (664)
|++.++| ++++++++++++++++||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 4444444 4444444333333444433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.067 Score=55.81 Aligned_cols=103 Identities=15% Similarity=0.131 Sum_probs=48.4
Q ss_pred cccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRL 178 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 178 (664)
.+....+|+.+.+..+ +..... .+.++.+|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|..+++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3445556666665443 221111 3555566666666544 33122233445555666555433 331122344555566
Q ss_pred CeeeCcCCcCccCCCCC---CCCCCcEEEcc
Q 006031 179 YSLRLDVNRFNGSIPPL---NQSSLKIFNVS 206 (664)
Q Consensus 179 ~~L~l~~N~l~g~~p~~---~~~~L~~l~l~ 206 (664)
+.+.+.+|.++ .|+.. ++.+|+.++|.
T Consensus 289 ~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 289 TKVVMDNSAIE-TLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CEEEECCTTCC-EECTTTTTTCTTCCEEECC
T ss_pred ccccccccccc-eehhhhhcCCCCCCEEEcC
Confidence 66665555554 22221 44555555554
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.69 E-value=0.047 Score=37.35 Aligned_cols=27 Identities=11% Similarity=0.172 Sum_probs=11.3
Q ss_pred eehhhH-HHHHHHHHHHHHHHHHHHHhc
Q 006031 292 IIGFSS-GVLVLICSLVLFAMAVKKQKQ 318 (664)
Q Consensus 292 ii~i~v-g~~vl~~~v~~~~~~~~~~~~ 318 (664)
|++.++ |++++++++++++++++||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 444444 444444444333344444433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.64 E-value=0.095 Score=55.08 Aligned_cols=98 Identities=14% Similarity=0.111 Sum_probs=45.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.+..+.+... +. .+....+..+..|+.+.+..|..+-....|.++..|+.+.+..+.+. ...+..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ce-ecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccc
Confidence 4555555432 21 13334566777777777776654322223455555555555443321 1223444555555554
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCc
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLD 184 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~ 184 (664)
+| ++..=..+|.++++|+.++|.
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCC
T ss_pred cc-cceechhhhcCCCCCCEEEeC
Confidence 33 331112234445555555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.61 E-value=0.088 Score=54.92 Aligned_cols=120 Identities=13% Similarity=0.121 Sum_probs=81.3
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+..+.+..+ +.. +....+.++..|+.+.+..+ ++..-. .|.++.+|+.+.+..+ ++-.-...|.++++|+.+++
T Consensus 218 ~l~~i~~~~~-~~~-i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VTT-LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CCE-ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-eeE-EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 3444555432 222 33457788899999999765 443333 5788999999999754 55223345778999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEcc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVS 206 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~ 206 (664)
.+|.++-.=...|.++++|+.+.|..| ++ .|... ++++|+.+.+.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEEC
Confidence 998887333457889999999999755 43 34432 66777777653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.33 E-value=0.027 Score=37.36 Aligned_cols=32 Identities=13% Similarity=0.077 Sum_probs=20.9
Q ss_pred CCccceeeehhhHHHHHHHHHHHHHHHHHHHH
Q 006031 285 SHKKTAVIIGFSSGVLVLICSLVLFAMAVKKQ 316 (664)
Q Consensus 285 ~~~~~~~ii~i~vg~~vl~~~v~~~~~~~~~~ 316 (664)
+....+.|+++++|+++.+++++.+.++++||
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34456788899998877666555555544443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.28 E-value=0.047 Score=37.17 Aligned_cols=28 Identities=25% Similarity=0.520 Sum_probs=12.9
Q ss_pred eeeehhhHHHHHHHHHHHHHHHHHHHHh
Q 006031 290 AVIIGFSSGVLVLICSLVLFAMAVKKQK 317 (664)
Q Consensus 290 ~~ii~i~vg~~vl~~~v~~~~~~~~~~~ 317 (664)
..|+++++|+++++++.+.++++.+||+
T Consensus 12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 12 TSIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHHHHHHHHHHHhheehhh
Confidence 3466667774433333333333334433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.91 E-value=0.081 Score=55.61 Aligned_cols=120 Identities=13% Similarity=0.095 Sum_probs=84.7
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.+..+.+..+... +....+..+..|+.+.+..+.+.. ..|.++.+|+.+.+..| ++-.-...|.++++|+.++|.
T Consensus 254 ~l~~~~~~~~~~~--i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNNKLR--IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCTTCE--ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCCcce--eeccccccccccceeccCceeecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 4556666655432 345578888999999887664211 14788999999999765 552234567889999999997
Q ss_pred CCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC---CCCCCcEEEccCC
Q 006031 161 YNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGN 208 (664)
Q Consensus 161 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~L~~l~l~~N 208 (664)
++ ++-.=..+|.+|++|+.+.|..| ++ .|+.. ++.+|+.+++..|
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 54 66223457889999999999877 54 44442 7789999988644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.80 E-value=0.17 Score=52.03 Aligned_cols=30 Identities=27% Similarity=0.447 Sum_probs=26.8
Q ss_pred CcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 508 RLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 508 ~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
.++|+|+.+.||++++++.+.|.||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 689999999999999888899999977654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.15 E-value=2.8 Score=44.22 Aligned_cols=73 Identities=11% Similarity=0.019 Sum_probs=43.7
Q ss_pred ccccccCceeEEEEEEcC--------CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-ccceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLDN--------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-VPLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 460 (664)
+.+..|-...+|+....+ +..+++|+...... ..-...+|..+++.+...++ .++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 346677778999988763 46788888643221 11123456666665532233 34555332 3789
Q ss_pred EecCCCCCH
Q 006031 461 YDYQPNGSL 469 (664)
Q Consensus 461 ~e~~~~gsL 469 (664)
+||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.04 E-value=0.075 Score=57.27 Aligned_cols=60 Identities=8% Similarity=0.026 Sum_probs=16.5
Q ss_pred ccccccCceeEEEEEEcC-CeEEEE------EEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEe
Q 006031 390 ELLGKGSLGTTYKAVLDN-RLIVCV------KRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQ 452 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~-~~~vav------K~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 452 (664)
+.|| ||.||+|.+.. ..+||| |..+...........|.+|..++..++|||+++.+++..
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4566 99999999865 467888 776554443344456888889999999999999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 664 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 18/267 (6%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +G GS GT YK V VK L+ + + ++ + + RH N++
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ + ++ + SL+ +H + + IA AQG+ Y+H +
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK-SI 125
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPE--TRNASHQ 563
+H +LKS+N+ L D + D+ L + + + +L+ APE +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM---LLE 620
+ +SDVY+FG++L EL+TG+ P + ++++ V R +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 621 VAIACNSASPEQRPTMWQVLKMLQEIK 647
+ C ++RP Q+L ++ +
Sbjct: 245 LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-47
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 14/260 (5%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E LG G G + + V VK L + S + + + L+H LV L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E +I +Y NGSL + L L +A +A+G+++I +
Sbjct: 76 VVT-QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER-NY 130
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDPDNLLYKAPETRNASHQATS 566
+H +L+++N+L+ +AD+ L L D+ ++ + + APE N T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TI 189
Query: 567 KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626
KSDV+SFG+LL E++T P + N R R D L ++ C
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--PDNCPEELYQLMRLCW 247
Query: 627 SASPEQRPTMWQVLKMLQEI 646
PE RPT + +L++
Sbjct: 248 KERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-47
Identities = 60/263 (22%), Positives = 118/263 (44%), Gaps = 20/263 (7%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +G G G + N+ V +K + + S E + + E + L HP LV L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ L++++ +G L + T+ + L + DV +G++Y+ + +
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEE-ACV 122
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN---LLYKAPETRNASHQATS 566
+H +L + N L+G + ++D+ +T D + + +PE + + +S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-FSRYSS 181
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM--LLEVAI 623
KSDV+SFGVL+ E+ + GK P ++ +E++ + + RL + ++
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRL---YKPRLASTHVYQIMN 236
Query: 624 ACNSASPEQRPTMWQVLKMLQEI 646
C PE RP ++L+ L EI
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-45
Identities = 68/260 (26%), Positives = 110/260 (42%), Gaps = 16/260 (6%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ +GKG G V VK + A + + + LRH NLV L
Sbjct: 13 QTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLG 67
Query: 450 YFQAKEERL-LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
++ L ++ +Y GSL + S L LK + DV + + Y+
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-N 123
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKS 568
VH +L + NVL+ D A ++D+ A S QD + + APE + ++KS
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFG-LTKEASSTQDTGKLPVKWTAPEALR-EKKFSTKS 181
Query: 569 DVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627
DV+SFG+LL E+ + G+ P + +++ V + D A D + EV C
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPR--IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNCWH 238
Query: 628 ASPEQRPTMWQVLKMLQEIK 647
RP+ Q+ + L+ IK
Sbjct: 239 LDAAMRPSFLQLREQLEHIK 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 56/298 (18%), Positives = 103/298 (34%), Gaps = 50/298 (16%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +GKG G ++ V VK + + + E + LRH N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWRGE-EVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA 64
Query: 450 YFQ----AKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
+ L+ DY +GSLF ++ + +K+A A GL+++H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHM 118
Query: 506 AW-------RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD------NLLY 552
+ H +LKS N+L+ + C+AD L + D Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 553 KAPE-----TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV------ 601
APE ++ ++D+Y+ G++ E+ + V
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 602 ------------RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
R + E L ++ ++ C A+ R T ++ K L ++
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-44
Identities = 48/261 (18%), Positives = 101/261 (38%), Gaps = 16/261 (6%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
+ LG G G + V +K + + S + + + + + L H LV L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+ +I +Y NG L + + + L++ +DV + + Y+ +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES-KQF 121
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDPDNLLYKAPETRNASHQATS 566
+H +L + N L+ ++D+ L+ D + + PE + +S
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-YSKFSS 180
Query: 567 KSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625
KSD+++FGVL+ E+ + GK P + +E + + + +C
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYER--FTNSETAEHIAQGLRLYRPHLA-SEKVYTIMYSC 237
Query: 626 NSASPEQRPTMWQVLKMLQEI 646
++RPT +L + ++
Sbjct: 238 WHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-43
Identities = 49/248 (19%), Positives = 103/248 (41%), Gaps = 12/248 (4%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ G +K + L++ K + N++ + ++ + P +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-IRELQVLHECNSPYIVGFY 70
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F + E + ++ GSL ++ +A + K++ V +GL+Y+ + +
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKS 568
++H ++K SN+L+ E L D+ ++ DS+ + Y +PE + +S
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ-GTHYSVQS 184
Query: 569 DVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNSA 628
D++S G+ L+E+ G+ P P+ + + +G E +S
Sbjct: 185 DIWSMGLSLVEMAVGRYP----IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 629 SPEQRPTM 636
+ RP M
Sbjct: 241 GMDSRPPM 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 68/260 (26%), Positives = 114/260 (43%), Gaps = 14/260 (5%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
LG+G G + + V +K L + S E + Q + + LRH LV L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
+E ++ +Y GSL + G K L + +A +A G++Y+ +
Sbjct: 80 VVS-EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER-MNY 134
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDPDNLLYKAPETRNASHQATS 566
VH +L+++N+L+G + +AD+ L L D+ + + + APE + T
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTI 193
Query: 567 KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626
KSDV+SFG+LL EL T +V E+++ V E L ++ C
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECPESLHDLMCQCW 251
Query: 627 SASPEQRPTMWQVLKMLQEI 646
PE+RPT + L++
Sbjct: 252 RKEPEERPTFEYLQAFLEDY 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 8e-42
Identities = 60/285 (21%), Positives = 113/285 (39%), Gaps = 32/285 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRL------IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
+G+G+ G ++A L +V VK L A + ++ + +PN
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF-QREAALMAEFDNPN 77
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK-------------------STRAKPL 484
+V L + L+++Y G L + S PL
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 485 HWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544
L IA VA G++Y+ + + VH +L + N L+G + +AD+ L+ +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 545 DDPDNL---LYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV 601
N + P ++ T++SDV+++GV+L E+ + + + E++ +V
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVIYYV 255
Query: 602 RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
R E+ L L + C S P RP+ + ++LQ +
Sbjct: 256 RDGNILACPENCPLE-LYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-42
Identities = 61/279 (21%), Positives = 113/279 (40%), Gaps = 26/279 (9%)
Query: 390 ELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
E++G+G G Y L + ++ VK L+ G ++ + HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTEGIIMKDFSHPNVL 91
Query: 446 PLRAY-FQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
L +++ L++ Y +G L + I + VA+G+ ++
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLYKAPETR 558
+ VH +L + N +L F +AD+ L D D + + + A E+
Sbjct: 148 S-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE---DDGAEDERL 615
+ + T+KSDV+SFGVLL EL+T P + ++ ++ R + D
Sbjct: 207 Q-TQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRLLQPEYCPDP-- 262
Query: 616 GMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654
L EV + C E RP+ +++ + I + E
Sbjct: 263 --LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 54/259 (20%), Positives = 110/259 (42%), Gaps = 15/259 (5%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+GS T YK + + + V L KL + + +++ E + GL+HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 449 AYFQA----KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+++ K+ +L+ + +G+L + + R K + + +GL ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 505 -QAWRLVHGNLKSSNVLL-GPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASH 562
+ ++H +LK N+ + GP + D L L S + APE
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM--YEE 187
Query: 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
+ DVY+FG+ +LE+ T + P ++ V S + + + + E+
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 623 IACNSASPEQRPTMWQVLK 641
C + ++R ++ +L
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 2e-41
Identities = 52/269 (19%), Positives = 105/269 (39%), Gaps = 22/269 (8%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+++G G G L + V +K L S + +G HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVI 90
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L ++I ++ NGSL S + + + +A G+ Y+
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-------LLYKAPETR 558
VH +L + N+L+ + ++D+ L+ D D + + + APE
Sbjct: 147 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 559 NASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617
+ TS SDV+S+G+++ E+++ G+ P + +++N + D
Sbjct: 206 Q-YRKFTSASDVWSYGIVMWEVMSYGERPYWD--MTNQDVINAIEQDYRLPPPMDC-PSA 261
Query: 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
L ++ + C RP Q++ L ++
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 52/281 (18%), Positives = 101/281 (35%), Gaps = 28/281 (9%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYE--QHMESVGGLRH 441
+ LG G+ G +A D + V VK L S + + + +G H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NH 86
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTR-------------AKPLHWTS 488
N+V L L+I +Y G L + + + + L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 489 CLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD 548
L + VA+G++++ +H +L + N+LL + D+ L +
Sbjct: 147 LLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 549 NLLYKA---PETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAR 605
N + T +SDV+S+G+ L EL + V ++ ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 606 EDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
E + ++ C A P +RPT Q+++++++
Sbjct: 266 RMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-41
Identities = 61/264 (23%), Positives = 97/264 (36%), Gaps = 20/264 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G GS G K + I+ K LD + +M + + L+HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 449 AYFQAKEERLL--IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ- 505
+ L + +Y G L S+I R + L L++ + L H+
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRR 128
Query: 506 ---AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD--SLQDDDPDNLLYKAPETRNA 560
++H +LK +NV L L D+ L + S Y +PE N
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN- 187
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA---REDDGAEDERLGM 617
KSD++S G LL EL PP E+ +R R DE
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREGKFRRIPYRYSDE---- 241
Query: 618 LLEVAIACNSASPEQRPTMWQVLK 641
L E+ + RP++ ++L+
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 51/267 (19%), Positives = 107/267 (40%), Gaps = 19/267 (7%)
Query: 390 ELLGKGSLGTTYKAVLDN-----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
+++G G G YK +L + V +K L A + +G H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF-LGEAGIMGQFSHHNI 71
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ L + ++I +Y NG+L + + + + +A G+ Y+
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD-----DPDNLLYKAPETRN 559
VH +L + N+L+ + ++D+ L+ + D + + + APE +
Sbjct: 128 N-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
+ TS SDV+SFG+++ E++T L +E+M + D +
Sbjct: 187 -YRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLPTPMDC-PSAIY 243
Query: 620 EVAIACNSASPEQRPTMWQVLKMLQEI 646
++ + C +RP ++ +L ++
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 58/264 (21%), Positives = 112/264 (42%), Gaps = 20/264 (7%)
Query: 392 LGKGSLGTTYKAVL---DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ G+ + V ++ V +K L + EM + + + L +P +V L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM-MREAQIMHQLDNPYIVRLI 75
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
Q E +L+ + G L + G + + + ++ ++ V+ G+ Y+ +
Sbjct: 76 GVCQ-AEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK-N 129
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETRNASHQ 563
VH +L + NVLL A ++D+ L+ + L + APE N +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRK 188
Query: 564 ATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
+S+SDV+S+GV + E L+ G+ P + + E+M ++ + + E L +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQGKRME-CPPECPPELYALM 245
Query: 623 IACNSASPEQRPTMWQVLKMLQEI 646
C E RP V + ++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 54/264 (20%), Positives = 103/264 (39%), Gaps = 20/264 (7%)
Query: 392 LGKGSLGTTYKAVLDNR---LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ GT K + V VK L + + L +P +V +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ E +L+ + G L + + + + + +++ V+ G+ Y+ ++
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEES-N 127
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETRNASHQ 563
VH +L + NVLL A ++D+ L+ + + APE N ++
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYK 186
Query: 564 ATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
+SKSDV+SFGVL+ E + G+ P + + +E+ + + ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKGERMGCPAGC-PREMYDLM 243
Query: 623 IACNSASPEQRPTMWQVLKMLQEI 646
C + E RP V L+
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 5e-40
Identities = 54/261 (20%), Positives = 108/261 (41%), Gaps = 14/261 (5%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G G Y+ V L V VK L + E + + + ++HPNLV L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLL 79
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +I ++ G+L + + + L +A ++ + Y+ +
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK-N 135
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD---PDNLLYKAPETRNASHQAT 565
+H +L + N L+G + +AD+ L+ L + + APE+ ++ +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNKFS 194
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625
KSDV++FGVLL E+ T + + +++ + + E + E+ AC
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS-PYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRAC 252
Query: 626 NSASPEQRPTMWQVLKMLQEI 646
+P RP+ ++ + + +
Sbjct: 253 WQWNPSDRPSFAEIHQAFETM 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 7e-40
Identities = 57/260 (21%), Positives = 114/260 (43%), Gaps = 17/260 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG G+ G YKA + ++ K +D + M E ++ + HPN+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE--IDILASCDHPNIVKLL 75
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F + ++ ++ G++ +++ + +PL + + + L+Y+H +
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN-K 130
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPE----TRNASH 562
++H +LK+ N+L D + LAD+ ++A ++Q D + APE +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM-LLEV 621
K+DV+S G+ L+E+ +PP H L P ++ + + A+ R +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 622 AIACNSASPEQRPTMWQVLK 641
C + + R T Q+L+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-39
Identities = 61/273 (22%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 390 ELLGKGSLGTTYKAVLDN---RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLV 445
+++G+G+ G KA + R+ +KR+ + + + +E + L HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGS-----------KSTRAKPLHWTSCLKIAE 494
L + + L +Y P+G+L + S ++ A L L A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 495 DVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD-NLLYK 553
DVA+G+ Y+ Q + +H +L + N+L+G ++ A +AD+ L+ ++ + +
Sbjct: 135 DVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDE 613
A E+ N S T+ SDV+S+GVLL E+++ + R +
Sbjct: 194 AIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK--PLN 250
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ ++ C P +RP+ Q+L L +
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 7e-39
Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 17/271 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
+G GS G Y A + N +V +K++ S + + + + LRHPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
R + + L+ +Y + L KPL + QGL+Y+H
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPE--TRNASHQAT 565
++H ++K+ N+LL L D+ ++ A + + + APE Q
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625
K DV+S G+ +EL KPP + + + +C
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 626 NSASPEQRPTMWQVLK---MLQEIKGAVLME 653
P+ RPT +LK +L+E V+M+
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-39
Identities = 67/254 (26%), Positives = 105/254 (41%), Gaps = 13/254 (5%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
LGKG G Y A ++ I+ +K L ++L + +E LRHPN++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
YF LI +Y P G+++ + + ++A LSY H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK- 125
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
R++H ++K N+LLG E +AD+ + S + L Y PE K
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEK 184
Query: 568 SDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACNS 627
D++S GVL E L GKPP F + R +R + D ++
Sbjct: 185 VDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240
Query: 628 ASPEQRPTMWQVLK 641
+P QRP + +VL+
Sbjct: 241 HNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 55/263 (20%), Positives = 95/263 (36%), Gaps = 25/263 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ LG+G+ G AV V VK +D + E ++ + L H N+V
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFY 69
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + + L +Y G LF I + + + G+ Y+H
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL--------YKAPETRNA 560
+ H ++K N+LL ++D+ L A + ++ + LL Y APE
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGL----ATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE--DERLGML 618
DV+S G++L +L G+ P E +W + + D L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 619 LEVAIACNSASPEQRPTMWQVLK 641
L +P R T+ + K
Sbjct: 240 LH---KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 56/273 (20%), Positives = 113/273 (41%), Gaps = 20/273 (7%)
Query: 390 ELLGKGSLGTTYKAVLDNRL------IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
LG+GS G Y+ V + V +K ++ + + + +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 84
Query: 444 LVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAK-----PLHWTSCLKIAEDVAQ 498
+V L + L+I + G L S + + A P + +++A ++A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKA 554
G++Y++ + VH +L + N ++ DF + D+ +T ++ L + +
Sbjct: 145 GMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDER 614
PE+ T+ SDV+SFGV+L E+ T + L +++ +V D D
Sbjct: 204 PESLK-DGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLD-KPDNC 260
Query: 615 LGMLLEVAIACNSASPEQRPTMWQVLKMLQEIK 647
ML E+ C +P+ RP+ +++ ++E
Sbjct: 261 PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 18/268 (6%)
Query: 390 ELLGKGSLGTTYKAVLD----NRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNL 444
E LG GS G + D + V VK L L+ + + + + + ++ L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ L ++ + + P GSL + + + + A VA+G+ Y+
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE 128
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNL----LYKAPETRNA 560
R +H +L + N+LL + D+ L +
Sbjct: 129 S-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 561 SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
+ + SD + FGV L E+ T G+ P L +++++ + E ++ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKEGERLPRPEDCPQDIY 245
Query: 620 EVAIACNSASPEQRPTMWQVLKMLQEIK 647
V + C + PE RPT + L E +
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 54/285 (18%), Positives = 97/285 (34%), Gaps = 35/285 (12%)
Query: 390 ELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMY--EQHMESVGGLRH 441
++LG G+ G A + V VK L + + + M +G H
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SH 100
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK------------------STRAKP 483
N+V L LI++Y G L + + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 484 LHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543
L + L A VA+G+ ++ VH +L + NVL+ + D+ L
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 544 DDDPDN----LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN 599
N + + APE+ T KSDV+S+G+LL E+ + V
Sbjct: 220 YVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278
Query: 600 WVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644
+++ + D + + +C + +RP+ + L
Sbjct: 279 LIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 50/256 (19%), Positives = 109/256 (42%), Gaps = 16/256 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT Y A+ + V +++++ + E+ + + ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYL 83
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ +E ++ +Y GSL ++ + + + Q L ++H +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALEFLHSN-Q 136
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTA--DSLQDDDPDNLLYKAPETRNASHQATS 566
++H ++KS N+LLG D L D+ A S + + APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGP 195
Query: 567 KSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL-GMLLEVAIAC 625
K D++S G++ +E++ G+PP + P + + + + E+L + + C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 626 NSASPEQRPTMWQVLK 641
E+R + ++L+
Sbjct: 254 LDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV 445
+G+G G ++ + + L V +K E + Q ++ HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIV 71
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L + +I + G L S + R L S + A ++ L+Y+
Sbjct: 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL---YKAPETRNASH 562
R VH ++ + NVL+ + L D+ L+ DS L + APE+ N
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN-FR 184
Query: 563 QATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE---DDGAEDERLGML 618
+ TS SDV+ FGV + E+L G P Q N+++ + + L
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERLPMPPNCPPT----L 238
Query: 619 LEVAIACNSASPEQRPTMWQVLKMLQEI 646
+ C + P +RP ++ L I
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (332), Expect = 2e-34
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 20/260 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG G+ G ++ K + + E + ++++ LRHP LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F+ E ++IY++ G LF + + ++ V +GL ++H+
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHEN-N 144
Query: 509 LVHGNLKSSNVLLGPDF--EACLADYCLTA-LTADSLQDDDPDNLLYKAPETRNASHQAT 565
VH +LK N++ E L D+ LTA L + APE
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-GKPVG 203
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA- 624
+D++S GVL LL+G P F N+ D +D + E
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 625 ---CNSASPEQRPTMWQVLK 641
A P R T+ Q L+
Sbjct: 260 IRKLLLADPNTRMTIHQALE 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 27/280 (9%)
Query: 390 ELLGKGSLGTTYKAVL--------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH 441
+ LG+G+ G A + V VK L + +++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSK-----------STRAKPLHWTSCL 490
N++ L +I +Y G+L + + + L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 491 KIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS---LQDDDP 547
A VA+G+ Y+ + +H +L + NVL+ D +AD+ L + +
Sbjct: 139 SCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSARE 606
+ T +SDV+SFGVLL E+ T G P + + E+ ++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFKLLKEGHR 255
Query: 607 DDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
D + L + C A P QRPT Q+++ L I
Sbjct: 256 MDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 9e-34
Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-------- 440
E+LG+G + + VK +D + S E ++ E+ L+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT--LKEVDILRKV 66
Query: 441 --HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQ 498
HPN++ L+ ++ L++D G LF + L KI + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLE 121
Query: 499 GLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLT-ALTADSLQDDDPDNLLYKAPE- 556
+ +H+ +VH +LK N+LL D L D+ + L + Y APE
Sbjct: 122 VICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 557 ----TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAED 612
+ + D++S GV++ LL G PP H M+ + S G+ +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPE 238
Query: 613 ERL--GMLLEVAIACNSASPEQRPTMWQVLK 641
+ ++ P++R T + L
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 52/268 (19%), Positives = 104/268 (38%), Gaps = 21/268 (7%)
Query: 390 ELLGKGSLGTTYKAVL-----DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL 444
++LG G+ GT YK + ++ V +K L + +N+ + + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHV 73
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
L LI P G L + K + L +A+G++Y+
Sbjct: 74 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE 128
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN----LLYKAPETRNA 560
RLVH +L + NVL+ + D+ L L ++ + + + A E+
Sbjct: 129 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL- 186
Query: 561 SHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
T +SDV+S+GV + EL+T G P + +E+ + + +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGERLP-QPPICTIDVY 243
Query: 620 EVAIACNSASPEQRPTMWQVLKMLQEIK 647
+ + C + RP +++ ++
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 49/258 (18%), Positives = 96/258 (37%), Gaps = 17/258 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
++LG+GS T A L +K L+ + + + + + L HP V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
FQ E+ Y NG L I + T ++ L Y+H
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL----YKAPETRNASHQ 563
++H +LK N+LL D + D+ + + + ++ + Y +PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-EKS 186
Query: 564 ATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623
A SD+++ G ++ +L+ G PP F NE + + + + + ++ ++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242
Query: 624 ACNSASPEQRPTMWQVLK 641
+R ++
Sbjct: 243 KLLVLDATKRLGCEEMEG 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 128 bits (322), Expect = 5e-33
Identities = 48/264 (18%), Positives = 86/264 (32%), Gaps = 16/264 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMY----EQHMESVGGLRHPNL 444
++G+G G Y D + +K LD ++ E + V P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
V + F ++ I D G L + + A ++ GL ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQA 564
+ +V+ +LK +N+LL ++D L + Y APE
Sbjct: 125 NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 183
Query: 565 TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI- 623
S +D +S G +L +LL G P + + R + L +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 624 ACNSASPEQRPTMWQVLKMLQEIK 647
+R + QE+K
Sbjct: 242 GLLQRDVNRRLGCLG--RGAQEVK 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (320), Expect = 9e-33
Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 20/260 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG G+ G ++ V + K ++ + + + L HP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLH 92
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F+ K E +LI ++ G LF I + + +GL ++H+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEH-S 147
Query: 509 LVHGNLKSSNVLL--GPDFEACLADYCL-TALTADSLQDDDPDNLLYKAPETRNASHQAT 565
+VH ++K N++ + D+ L T L D + + APE +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-REPVG 206
Query: 566 SKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA- 624
+D+++ GVL LL+G P F +++ R D +++ + A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 625 ---CNSASPEQRPTMWQVLK 641
P +R T+ L+
Sbjct: 263 IKNLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 51/263 (19%), Positives = 106/263 (40%), Gaps = 27/263 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E LG+G G ++ V ++ K + K+ GT + ++ + + RH N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F++ EE ++I+++ +F I+ T A L+ + V + L ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHS-HN 122
Query: 509 LVHGNLKSSNVLLGPDFEA--CLADYCLTALTADSLQDDDPDNLLYKAPETRNA----SH 562
+ H +++ N++ + + ++ A L+ D LL+ APE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQ----ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 563 QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622
++ +D++S G L+ LL+G P FL + ++E + A
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 623 IA----CNSASPEQRPTMWQVLK 641
+ + R T + L+
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-32
Identities = 53/279 (18%), Positives = 99/279 (35%), Gaps = 25/279 (8%)
Query: 390 ELLGKGSLGTTYKAV------LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPN 443
+ LG+G+ G +A V VK L + + + H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 444 LVPLRAYFQAKEERLLI-YDYQPNGSLFSLIHGSK-----------STRAKPLHWTSCLK 491
+V L L++ ++ G+L + + + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 492 IAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-- 549
+ VA+G+ ++ + +H +L + N+LL + D+ L +
Sbjct: 139 YSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 550 --LLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED 607
L + APET T +SDV+SFGVLL E+ + + E ++
Sbjct: 198 LPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256
Query: 608 DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
A D + + + C P QRPT ++++ L +
Sbjct: 257 R-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (301), Expect = 6e-31
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 21/270 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
E+LG G + + A L V VK L A S + + ++ L HP +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 448 RAYFQAKEERL----LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
+A+ ++ +Y +L ++H P+ +++ D Q L++
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFS 127
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLL-----YKAPETR 558
HQ ++H ++K +N+++ + D+ + ADS + Y +PE
Sbjct: 128 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERL-GM 617
++SDVYS G +L E+LTG+PP V + VR A E L
Sbjct: 187 R-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARHEGLSAD 244
Query: 618 LLEVAIACNSASPEQRP-TMWQVLKMLQEI 646
L V + + +PE R T ++ L +
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 2e-30
Identities = 53/262 (20%), Positives = 94/262 (35%), Gaps = 23/262 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG G+ A + +V +K + L G E + + ++HPN+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALD 73
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+++ LI G LF I ++ V + Y+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHD-LG 127
Query: 509 LVHGNLKSSNVLL---GPDFEACLADYCL-TALTADSLQDDDPDNLLYKAPETRNASHQA 564
+VH +LK N+L D + ++D+ L S+ Y AP A
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP-EVLAQKPY 186
Query: 565 TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-----DERLGMLL 619
+ D +S GV+ LL G PP ++ + A + + + +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 620 EVAIACNSASPEQRPTMWQVLK 641
+ + PE+R T Q L+
Sbjct: 245 RHLMEKD---PEKRFTCEQALQ 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 30/268 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
++LG G G + + +K L A E+ E H + + P++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA--RREV-ELHWRA---SQCPHIVRIV 71
Query: 449 AYFQA----KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
++ ++ L++ + G LFS I + + +I + + + + Y+H
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 505 QAWRLVHGNLKSSNVLL---GPDFEACLADY-CLTALTADSLQDDDPDNLLYKAPETRNA 560
+ H ++K N+L P+ L D+ T+ + Y APE
Sbjct: 129 S-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 186
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP--SQHSFLVPNEMMNWVRSAREDDGAED-----E 613
+ D++S GV++ LL G PP S H + M +R + + + E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641
+ ML+ + P QR T+ + +
Sbjct: 247 EVKMLIRNLLKTE---PTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 4e-29
Identities = 57/258 (22%), Positives = 95/258 (36%), Gaps = 18/258 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESV--GGLRHPNLVP 446
++LGKGS G + A +K L + + + V HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 447 LRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ FQ KE + +Y G L I + A ++ GL ++H
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 507 WRLVHGNLKSSNVLLGPDFEACLADYCLTA--LTADSLQDDDPDNLLYKAPETRNASHQA 564
+V+ +LK N+LL D +AD+ + + D+ + Y APE +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE-ILLGQKY 180
Query: 565 TSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-DERLGMLLEVAI 623
D +SFGVLL E+L G+ P E+ + +R ++ LL
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238
Query: 624 ACNSASPEQRPTMWQVLK 641
PE+R + ++
Sbjct: 239 VRE---PEKRLGVRGDIR 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+++G GS G Y+A L D+ +V +K++ K + ++ + L H N+V LR
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLR 79
Query: 449 AYFQAKEER------LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
+F + E+ L+ DY P H S+ + L + + L+Y
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEAC-LADYCL-TALTADSLQDDDPDNLLYKAPETRNA 560
IH + H ++K N+LL PD L D+ L + Y+APE
Sbjct: 138 IHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPP 586
+ TS DV+S G +L ELL G+P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 2e-28
Identities = 39/275 (14%), Positives = 84/275 (30%), Gaps = 29/275 (10%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G GS G Y + V +K + + ++ +P
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTI 68
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ A+ + ++ SL L + ++ + L +A+ + + YIH
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSK-N 123
Query: 509 LVHGNLKSSNVL---LGPDFEACLADYCLTALTADSLQDDDPDN---------LLYKAPE 556
+H ++K N L + D+ L D+ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 557 TRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616
T + + + D+ S G +L+ G P Q + + R + + E L
Sbjct: 184 THL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLK-AATKRQKYERISEKKMSTPIEVLC 241
Query: 617 -----MLLEVAIACNSASPEQRPTMWQVLKMLQEI 646
C S + +P + ++ + +
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 52/261 (19%), Positives = 101/261 (38%), Gaps = 25/261 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES-VGGLR-----HP 442
LLG G G+ Y + + + L V +K ++ +++ + V L+
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 443 NLVPLRAYFQAKEERLLIYDY-QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
++ L +F+ + +LI + +P LF I L V + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVR 124
Query: 502 YIHQAWRLVHGNLKSSNVLLGPD-FEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA 560
+ H ++H ++K N+L+ + E L D+ AL D++ D +Y PE
Sbjct: 125 HCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620
+ V+S G+LL +++ G P +H E++ R+ +E
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSE------CQH 233
Query: 621 VAIACNSASPEQRPTMWQVLK 641
+ C + P RPT ++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (282), Expect = 3e-28
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 33/279 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRA 449
E +G+G+ G YKA + +K++ K + + + L+H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 450 YFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRL 509
K+ +L++++ L L + + G++Y H R+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDR-RV 121
Query: 510 VHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPETRNASHQATSK 567
+H +LK N+L+ + E +AD+ L ++ L Y+AP+ S + ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 568 SDVYSFGVLLLELLTGKPP-------------SQHSFLVPNEMMNWVRSAREDDGAEDER 614
D++S G + E++ G P + ++ V + D
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 615 LGMLLEVAIACNSAS------------PEQRPTMWQVLK 641
+ E + S P QR T Q L+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 60/283 (21%), Positives = 100/283 (35%), Gaps = 36/283 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESV---GGLRHPNLV 445
+ LG+G T YKA + IV +K++ + + + + + L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 446 PLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ 505
L F K L++D+ + S L + QGL Y+HQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 506 AWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQ 563
W +H +LK +N+LL + LAD+ L + Y+APE +
Sbjct: 119 HWI-LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 564 ATSKSDVYSFGVLLLELLTGKPP--SQHSFLVPNEMMNWVRSAREDDGAEDERLGM---- 617
D+++ G +L ELL P + + + E+ + L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 618 ------------------LLEVAIACNSASPEQRPTMWQVLKM 642
LL++ +P R T Q LKM
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 8e-28
Identities = 36/277 (12%), Positives = 82/277 (29%), Gaps = 31/277 (11%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVP-L 447
+G+GS G ++ L N V +K + L +P +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ Q +L+ D L + + A+ + + IH+
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDL-----CGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 508 RLVHGNLKSSNVLLG-----PDFEACLADYCLTALTADSLQDDDPDN---------LLYK 553
LV+ ++K N L+G + D+ + D + Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 554 APETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN-EMMNWVRSAREDDGAED 612
+ T + + + D+ + G + + L G P Q N + + ++ +
Sbjct: 181 SINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 613 ERLGM---LLEVAIACNSASPEQRPTMWQVLKMLQEI 646
G + + + + P + + ++
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 52/266 (19%), Positives = 99/266 (37%), Gaps = 25/266 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMES----VGGLRHPNL 444
E LG G K L K + + + + + +E + ++HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 445 VPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+ L ++ K + +LI + G LF + + L + + + G+ Y+H
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLH 130
Query: 505 QAWRLVHGNLKSSNVLL----GPDFEACLADYCL-TALTADSLQDDDPDNLLYKAPETRN 559
+ H +LK N++L P + D+ L + + + + APE N
Sbjct: 131 SLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
++D++S GV+ LL+G P FL + + + EDE
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 620 EVAI----ACNSASPEQRPTMWQVLK 641
+A P++R T+ L+
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 46/292 (15%), Positives = 101/292 (34%), Gaps = 38/292 (13%)
Query: 390 ELLGKGSLGTTYKA--VLDNRLIVCVKRLDASKLAGTSNEMYEQH---MESVGGLRHPNL 444
+G+G+ G +KA + + V +KR+ + + + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 445 VPLRAYFQA----KEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
V L +E +L + + L + + + + + + +GL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGL 129
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNA 560
++H R+VH +LK N+L+ + LAD+ L + + + L+
Sbjct: 130 DFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 561 SHQATSKSDVYSFGVLLLELLTGKPPSQHS--FLVPNEMMNWVRSAREDDGAEDERLGML 618
+ D++S G + E+ KP + S ++++ + E+D D L
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 619 LEVAIACNSAS---------------------PEQRPTMWQVLKM--LQEIK 647
+ + P +R + + L Q+++
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 39/200 (19%), Positives = 82/200 (41%), Gaps = 8/200 (4%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ G YKA +V +K++ + + + L HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ + L++++ + ++ + + QGL++ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPD--NLLYKAPETRNASHQATS 566
++H +LK N+L+ + LAD+ L ++ + L Y+APE ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 567 KSDVYSFGVLLLELLTGKPP 586
D++S G + E++T +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-26
Identities = 50/261 (19%), Positives = 99/261 (37%), Gaps = 21/261 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+G+ G A N++ V +K++ + + ++ + RH N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENIIGIN 72
Query: 449 AYFQAKE----ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIH 504
+A + + + + L+ L+ + + L + +GL YIH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 505 QAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAPETRN 559
A ++H +LK SN+LL + + D+ L + Y+APE
Sbjct: 127 SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 560 ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619
S T D++S G +L E+L+ +P + +N + ED + L
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIINL 243
Query: 620 EVAIACNSASPEQRPTMWQVL 640
+ A + P + W L
Sbjct: 244 K-ARNYLLSLPHKNKVPWNRL 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 1e-25
Identities = 57/261 (21%), Positives = 96/261 (36%), Gaps = 18/261 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
LG GS G + N +K L + E + + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
FQ ++ +I DY G LFSL+ S+ A +V L Y+H
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS-K 123
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
+++ +LK N+LL + + D+ A + Y APE + +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFG-FAKYVPDVTYTLCGTPDYIAPEVVS-TKPYNKS 181
Query: 568 SDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-DERLGMLLEVAIACN 626
D +SFG+L+ E+L G P S + + +A +E + LL I +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 627 SASPEQRPTMWQVLKMLQEIK 647
QR Q +++K
Sbjct: 240 ---LSQRLGNLQ--NGTEDVK 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 4e-25
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 4/198 (2%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ +G G+ G AV V +K+L + + + + + +RH N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
F E D+ G K + + L + + +GL YIH A
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKS 568
+H +LK N+ + D E + D+ L A ADS Y+APE + T
Sbjct: 143 -IHRDLKPGNLAVNEDCELKILDFGL-ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 200
Query: 569 DVYSFGVLLLELLTGKPP 586
D++S G ++ E++TGK
Sbjct: 201 DIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 6e-24
Identities = 47/257 (18%), Positives = 83/257 (32%), Gaps = 15/257 (5%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
+ LG GS G ++ +K LD K+ E + + P LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
F+ ++ +Y G +FS + R A + Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSK 567
L++ +LK N+L+ + D+ A APE S
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGF-AKRVKGRTWTLCGTPEALAPE-IILSKGYNKA 218
Query: 568 SDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAE-DERLGMLLEVAIACN 626
D ++ GVL+ E+ G PP P ++ + S + + L LL + +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 627 SAS--PEQRPTMWQVLK 641
+ + +
Sbjct: 277 LTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 2e-23
Identities = 45/281 (16%), Positives = 96/281 (34%), Gaps = 35/281 (12%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
E +G+G+ GT +KA + IV +KR+ + + + L+H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 449 AYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR 508
+ ++ L++++ + + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHS-RN 121
Query: 509 LVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP--DNLLYKAPETRNASHQATS 566
++H +LK N+L+ + E LA++ L ++ L Y+ P+ + ++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 567 KSDVYSFGVLLLELLTGKPP---SQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623
D++S G + EL P + + + E+ +L +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 624 ACNSAS-----------------------PEQRPTMWQVLK 641
+ S P QR + + L+
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 3e-23
Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 19/269 (7%)
Query: 390 ELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKLAGTSN--EMYEQHMESVGGLRH-P 442
++LG G+ G + D + +K L + + + E + + +R P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 443 NLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
LV L FQ + + LI DY G LF+ + + + ++ L +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEH 144
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCL----TALTADSLQDDDPDNLLYKAPETR 558
+H+ +++ ++K N+LL + L D+ L A + D R
Sbjct: 145 LHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 559 NASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618
D +S GVL+ ELLTG P ++ R + + E +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 619 LEVAIACNSASPEQRPTMWQVLKMLQEIK 647
++ P++R + EIK
Sbjct: 264 KDLIQRLLMKDPKKRLGCGP--RDADEIK 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99.1 bits (246), Expect = 3e-23
Identities = 39/202 (19%), Positives = 77/202 (38%), Gaps = 18/202 (8%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
LG+G ++A+ + N V VK L K E+ + +E++ PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI--KILENLR--GGPNIITLA 96
Query: 449 AYFQAKEERL--LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA 506
+ R L++++ N L + L ++ + L Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 507 WRLVHGNLKSSNVLLGPDF-EACLADYCL-TALTADSLQDDDPDNLLYKAPETRNASHQA 564
++H ++K NV++ + + L D+ L + + +K PE
Sbjct: 149 G-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 565 TSKSDVYSFGVLLLELLTGKPP 586
D++S G +L ++ K P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEP 229
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 3e-23
Identities = 40/212 (18%), Positives = 82/212 (38%), Gaps = 21/212 (9%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G+G+ G +KA V +K++ + ++ + L+H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 449 AYFQAKEER--------LLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
+ K L++D+ + L + + ++ + + GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGL 130
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN------LLYKA 554
YIH+ +++H ++K++NVL+ D LAD+ L + + L Y+
Sbjct: 131 YYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 555 PETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
PE D++ G ++ E+ T P
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 4e-23
Identities = 37/200 (18%), Positives = 67/200 (33%), Gaps = 9/200 (4%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSN-EMYEQHMESVGGLRHPNLVPL 447
+LLGKG+ G +K L + + RHP L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 448 RAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW 507
+ FQ + + +Y G LF + R + ++ L Y+H
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS-R 124
Query: 508 RLVHGNLKSSNVLLGPDFEACLADYCL-TALTADSLQDDDPDNLLYKAPETRNASHQATS 566
+V+ ++K N++L D + D+ L +D +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 567 KSDVYSFGVLLLELLTGKPP 586
D + GV++ E++ G+ P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 1e-22
Identities = 44/203 (21%), Positives = 80/203 (39%), Gaps = 14/203 (6%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+G G+ G+ A L V VK+L + + + + + ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 449 AYFQAKE-----ERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYI 503
F + + + L +++ + + L + + +GL YI
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILRGLKYI 137
Query: 504 HQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASHQ 563
H A +H +LK SN+ + D E + D+ L A D Y+APE
Sbjct: 138 HSADI-IHRDLKPSNLAVNEDCELKILDFGL-ARHTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 564 ATSKSDVYSFGVLLLELLTGKPP 586
D++S G ++ ELLTG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 3e-18
Identities = 36/211 (17%), Positives = 75/211 (35%), Gaps = 15/211 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTS--------NEMYEQHMESVGGLR 440
LG G T + A + N V +K + K+ + + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 441 HPNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGL 500
+++ L +F K + +L+ K + + +I++ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 501 SYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDN-----LLYKAP 555
Y+H+ ++H ++K NVL+ A ++ D+ Y++P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 556 ETRNASHQATSKSDVYSFGVLLLELLTGKPP 586
E +D++S L+ EL+TG
Sbjct: 199 EVLL-GAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (203), Expect = 1e-17
Identities = 32/204 (15%), Positives = 68/204 (33%), Gaps = 16/204 (7%)
Query: 390 ELLGKGSLGTTYKAV-LDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR 448
+ +G G+ G A V +K+L T + + + + + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 449 AYFQAK------EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSY 502
F + ++ L+ + + R + + G+ +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS--------YLLYQMLCGIKH 134
Query: 503 IHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDPDNLLYKAPETRNASH 562
+H A +H +LK SN+++ D + D+ L S Y
Sbjct: 135 LHSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 563 QATSKSDVYSFGVLLLELLTGKPP 586
D++S G ++ E++ K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.6 bits (169), Expect = 2e-13
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 5/83 (6%)
Query: 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
L L L L N+++ P +S L L+ LF +N + SL +L + L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 164 LSGPLPKELASQGRLYSLRLDVN 186
+S P LA+ R+ L L+
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 4e-13
Identities = 37/151 (24%), Positives = 57/151 (37%), Gaps = 27/151 (17%)
Query: 87 LQGLDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSF 144
L L L G + +L L L L L NN ++ P LSGL L L L N +
Sbjct: 221 LDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNIS 279
Query: 145 PPSLLS--------------------LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184
P + L+ L L L L +NN+S P ++S +L L
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 185 VNRFNGSIPPL-NQSSLKIFNVSGNNFTGAI 214
N+ + + L N +++ + N +
Sbjct: 338 NNKVSD-VSSLANLTNINWLSAGHNQISDLT 367
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 2e-11
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 5/107 (4%)
Query: 58 HLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGG--IFAPNSLTKLDQLRVLGLQNN 115
L + + L L L I + ++ L +L+ L NN
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANN 339
Query: 116 SLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYN 162
++ L+ L N+ L HN + P L +L R+ L L+
Sbjct: 340 KVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
+ ++ VL ++ S T LDQ+ L + I + L NL + +N
Sbjct: 22 AEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQ 77
Query: 140 FTGSFPPSLLSLHRLKTLDLSYNN 163
T P L +L +L + ++ N
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 125 SGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184
+ L NL+SL +N + P +L L L L+ N L LAS L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTG 212
N+ + P + L + N +
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISN 277
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 12/66 (18%), Positives = 24/66 (36%), Gaps = 3/66 (4%)
Query: 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163
L + L ++T + + L + +L D + L+ L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 77
Query: 164 LSGPLP 169
L+ P
Sbjct: 78 LTDITP 83
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.0 bits (147), Expect = 2e-11
Identities = 21/151 (13%), Positives = 51/151 (33%), Gaps = 18/151 (11%)
Query: 390 ELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHME--------SVGGLRH 441
+L+G+G + + VK + + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 442 PNLVPLRAYFQAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLS 501
L L+ K +Y ++ N L LI + + + ++ + + + ++
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELID---AKELYRVRVENPDEVLDMILEEVA 117
Query: 502 YIHQAWRLVHGNLKSSNVLLGPDFEACLADY 532
+ +VHG+L NVL+ + + D+
Sbjct: 118 KFYHRG-IVHGDLSQYNVLVS-EEGIWIIDF 146
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193
L +N G+ P L L L +L++S+NNL G +P + + R N+ P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 1/83 (1%)
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGL 127
G + + + + L+ + G P LT+L L L + N+L G IP L
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTL-PQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 128 VNLKSLFLDHNFFTGSFPPSLLS 150
+N P +
Sbjct: 291 QRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 5e-09
Identities = 48/183 (26%), Positives = 72/183 (39%), Gaps = 30/183 (16%)
Query: 40 PSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ--WQGVICYQQKVVRVVLQGLDLGGIFA 97
P D Q LL K L S + C W GV+C
Sbjct: 5 PQDKQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLC-------------------- 43
Query: 98 PNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSL----FLDHNFFTGSFPPSLLSLHR 153
++ T+ ++ L L +L P P S L NL L N G PP++ L +
Sbjct: 44 -DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 154 LKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP--LNQSSLKIFNVSGNNFT 211
L L +++ N+SG +P L+ L +L N +G++PP + +L GN +
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 212 GAI 214
GAI
Sbjct: 163 GAI 165
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 21/56 (37%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 183 LDVNRFNGSIPP--LNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCG 236
L NR G++P L NVS NN G I L RF +S++ N LCG
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 4e-09
Identities = 31/118 (26%), Positives = 46/118 (38%), Gaps = 7/118 (5%)
Query: 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGP 167
RVL L + LT + L L+ + L L HN PP+L +L L+ L S N L
Sbjct: 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 168 LPKELASQGRLYSLRLDVNRFNGSIPPL---NQSSLKIFNVSGNNFTGAITVTSTLSR 222
+ + L L NR S + L + N+ GN+ + L+
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 4e-07
Identities = 23/102 (22%), Positives = 34/102 (33%), Gaps = 25/102 (24%)
Query: 90 LDLGG--IFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNL----------------- 130
L L + L +L + L L +N L P L+ L L
Sbjct: 3 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 131 -----KSLFLDHNFFTG-SFPPSLLSLHRLKTLDLSYNNLSG 166
+ L L +N + L+S RL L+L N+L
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 8e-09
Identities = 36/149 (24%), Positives = 54/149 (36%), Gaps = 3/149 (2%)
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPD-LSG 126
G+ + + LQ L + ++ L L L L N ++ G
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALP-DDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 127 LVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVN 186
L +L L L N P + L RL TL L NNLS + LA L LRL+ N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 187 RFNGSIPPLNQSS-LKIFNVSGNNFTGAI 214
+ + L+ F S + ++
Sbjct: 236 PWVCDCRARPLWAWLQKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 6e-06
Identities = 12/61 (19%), Positives = 18/61 (29%), Gaps = 3/61 (4%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165
L+ L L +N L+ + S P L L+ N+L
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282
Query: 166 G 166
G
Sbjct: 283 G 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.003
Identities = 20/78 (25%), Positives = 29/78 (37%), Gaps = 4/78 (5%)
Query: 113 QNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172
NN P L+ L L+ L L+ N + L L+ S + + LP+ L
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRL 268
Query: 173 ASQGRLYSLRLDVNRFNG 190
A + RL N G
Sbjct: 269 AGR---DLKRLAANDLQG 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 15/124 (12%)
Query: 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLV 128
C + V C + V + L P LD LQNN +T D L
Sbjct: 10 CHLRVVQC-SDLGLEKVPKDL-------PPDTALLD------LQNNKITEIKDGDFKNLK 55
Query: 129 NLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188
NL +L L +N + P + L +L+ L LS N L K + L ++ +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 189 NGSI 192
S+
Sbjct: 116 RKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 28/107 (26%), Positives = 39/107 (36%), Gaps = 3/107 (2%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLS 165
LRV+ + L DL + L L +N T +L L TL L N +S
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 166 GPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212
P A +L L L N+ +P +L+ V N T
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.3 bits (85), Expect = 0.004
Identities = 29/181 (16%), Positives = 47/181 (25%), Gaps = 44/181 (24%)
Query: 55 LRNHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQN 114
+ N G +K+ + + ++ I P L L L L
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI--PQGL--PPSLTELHLDG 180
Query: 115 NSLTGPIPD-LSGLVNLKSLFLDHNFFTGSF-----------------------PPSLLS 150
N +T L GL NL L L N + P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 240
Query: 151 LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNF 210
++ + L NN+S + N F ++S ++ N
Sbjct: 241 HKYIQVVYLHNNNISA----------------IGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 211 T 211
Sbjct: 285 Q 285
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 6/83 (7%)
Query: 107 LRVLGLQNNSLT--GPIPDLSGLVNLKSLFLDHNFFTG----SFPPSLLSLHRLKTLDLS 160
++ L +Q L+ L L + + LD T +L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 161 YNNLSGPLPKELASQGRLYSLRL 183
N L + + S ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 7e-07
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 9/82 (10%)
Query: 129 NLKSLFLDHNFFTG----SFPPSLLSLHRLKTLDLSYNNLSGPLPKELAS-----QGRLY 179
L+ L+L + S +LL+ H L+ LDLS N L +L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 180 SLRLDVNRFNGSIPPLNQSSLK 201
L L ++ + Q+ K
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 5/84 (5%)
Query: 128 VNLKSLFLDHNFFTGSFPPSLLS-LHRLKTLDLSYNNLSG----PLPKELASQGRLYSLR 182
++++SL + + + LL L + + + L L+ + L L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 183 LDVNRFNGSIPPLNQSSLKIFNVS 206
L N L+ +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 23/129 (17%), Positives = 40/129 (31%), Gaps = 11/129 (8%)
Query: 57 NHLFFSQNKSLHFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLD-QLRVLGLQNN 115
F+ HF + ++ + D G L + LRVL L +
Sbjct: 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379
Query: 116 SLTGPIPD-----LSGLVNLKSLFLDHNFFTGSFPPSLLSLHR-----LKTLDLSYNNLS 165
++ L +L+ L L +N + L+ R L+ L L S
Sbjct: 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439
Query: 166 GPLPKELAS 174
+ L +
Sbjct: 440 EEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG----PIPD-LSGLVNLKSLFLDHNFFT 141
+Q +L L L Q +V+ L + LT I L L L L N
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 142 GSFPPSLLSLHRLKTLDLSYNNLSG 166
+L + + + +L
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/74 (14%), Positives = 22/74 (29%), Gaps = 11/74 (14%)
Query: 152 HRLKTLDLSYNNLSG----PLPKELASQGRLYSLRLDVNRFNGSIP-------PLNQSSL 200
L+ L L+ ++S L L + L L L N + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 201 KIFNVSGNNFTGAI 214
+ + ++ +
Sbjct: 429 EQLVLYDIYWSEEM 442
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 113 QNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKEL 172
N S +L+ L + +N P RL+ L S+N+L+ +P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE-VPELP 323
Query: 173 ASQGRLYSLRLDVNRFNGSIPPLNQS--SLKIFN 204
+ L L ++ N P + +S L++ +
Sbjct: 324 QN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 12/92 (13%)
Query: 68 HFCQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLD----QLRVLGLQNNSLTGPIPD 123
++ + L+ L++ N L +L +L L N L +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSN----NKLIELPALPPRLERLIASFNHLAE-VPE 321
Query: 124 LSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLK 155
L NLK L +++N FP S+ L+
Sbjct: 322 LPQ--NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 7e-06
Identities = 19/79 (24%), Positives = 26/79 (32%), Gaps = 6/79 (7%)
Query: 134 FLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193
N + L+ L++S N L LP RL L N +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVP 320
Query: 194 PLNQSSLKIFNVSGNNFTG 212
L Q +LK +V N
Sbjct: 321 ELPQ-NLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 4/59 (6%)
Query: 106 QLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNL 164
Q L L N L+ +P+L +L+SL N T P SL L + + L
Sbjct: 39 QAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 6e-06
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 2/120 (1%)
Query: 87 LQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTG--SF 144
Q LDL G+ + L + VL +++ + L SL L +N
Sbjct: 24 QQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDM 83
Query: 145 PPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFN 204
+ LK L+LS N L + +L L LD N + + + I
Sbjct: 84 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 15/60 (25%), Positives = 26/60 (43%), Gaps = 3/60 (5%)
Query: 101 LTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
L L +L L +N ++ I L+ L NL + L +N + L + L + L+
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 4/62 (6%)
Query: 122 PDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSL 181
L+ L L +L D N + L SL L + L N +S P LA+ L+ +
Sbjct: 167 TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 182 RL 183
L
Sbjct: 223 TL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 11/38 (28%), Positives = 18/38 (47%), Gaps = 1/38 (2%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDH 137
L L L + L+NN ++ P L+ NL + L +
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 6e-05
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSG- 166
+ L L +L + + + +F S R++ +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVS 61
Query: 167 PLPKELASQGRLYSLRLDVNRFNGSIPP 194
L L+ +L +L L+ R + I
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 14/64 (21%), Positives = 23/64 (35%), Gaps = 2/64 (3%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159
++K+ + +LT PDL + L L N +L+ RL L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 160 SYNN 163
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 20/85 (23%), Positives = 27/85 (31%), Gaps = 3/85 (3%)
Query: 120 PIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179
PI ++S + + + D T + PP L L LS N L L RL
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 180 SLRLDVNRFNGSIPPLNQSSLKIFN 204
L LD L +
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLD 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 13/40 (32%), Positives = 20/40 (50%), Gaps = 2/40 (5%)
Query: 121 IPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160
I L+GL L++L+L N + +L L L L+L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 12/75 (16%), Positives = 29/75 (38%), Gaps = 4/75 (5%)
Query: 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNF 139
+ ++ L+ + + +L+ + + N+ + + + L N+ LFL+ N
Sbjct: 24 AETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNK 79
Query: 140 FTGSFPPSLLSLHRL 154
T P + L
Sbjct: 80 LTDIKPLANLKNLGW 94
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 10/67 (14%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159
S + L+ S+T + + L ++ + +++ + L + L L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 160 SYNNLSG 166
+ N L+
Sbjct: 76 NGNKLTD 82
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 11/60 (18%), Positives = 16/60 (26%), Gaps = 4/60 (6%)
Query: 137 HNFFTGSFPPSLLS-LHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL 195
N P + LD+S + L + L LR +P L
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKKLPTL 241
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 664 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.66 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.59 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.58 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.48 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.16 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.02 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.28 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.23 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.19 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.11 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.11 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.11 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.06 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.44 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.96 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.57 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.41 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.32 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=424.66 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=205.9
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|++++ .||||+++.........+.|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 4689999999999998654 59999998666555667889999999999999999999998754 56899999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----QD 544 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~~ 544 (664)
|.++++. ....++|..+..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 90 L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~ 164 (276)
T d1uwha_ 90 LYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164 (276)
T ss_dssp HHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence 9999973 234699999999999999999999998 99999999999999999999999999998764322 22
Q ss_pred CCCCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC---chhHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG---AEDERLGMLL 619 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 619 (664)
...||+.|||||++.. ...++.++|||||||++|||+||+.||.... ....+...+........ .....+..+.
T Consensus 165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243 (276)
T ss_dssp -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHHTSCCCCGGGSCTTCCHHHH
T ss_pred ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCCCcchhccccchHHHH
Confidence 3568999999999863 2357999999999999999999999997642 22233333333322221 2233456799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 620 EVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+++.+||+.+|++||||+||++.|+.+....
T Consensus 244 ~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 244 RLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=419.80 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|.+.++..||||+++... ...+.|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 46799999999999999999999999997543 456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.++++. ....++|..+..|+.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++....... ..
T Consensus 87 L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 87 LSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999863 345689999999999999999999998 999999999999999999999999999987654322 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTG-KPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..||+.|+|||++. ...++.|+|||||||++|||+|+ ++|+... ...++...+....... .+...+..+.+++.+
T Consensus 162 ~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 162 TKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY-KPRLASTHVYQIMNH 237 (263)
T ss_dssp ---CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHH
T ss_pred eecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCCC-CccccCHHHHHHHHH
Confidence 45789999999987 67799999999999999999995 5555432 3344544444433222 223344568999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
||+.+|++||||+||++.|++|.+.
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-51 Score=418.19 Aligned_cols=250 Identities=20% Similarity=0.387 Sum_probs=199.5
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.++||+|+||+||+|.++. ...||||.+..... ....+.|.+|+++|++++|||||+++|+|.+.+..++||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 4689999999999999742 23689998864332 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD 544 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 544 (664)
++|+|.++++. ....++|.++..|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 110 ~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 110 ENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999863 345699999999999999999999998 9999999999999999999999999999876543221
Q ss_pred -------CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHH
Q 006031 545 -------DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLG 616 (664)
Q Consensus 545 -------~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (664)
...+|+.|||||.+. ...++.++|||||||++|||+| |+.||.+. ...++...+...... +.+.+.+.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~~~ 260 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVINAIEQDYRL-PPPMDCPS 260 (299)
T ss_dssp -----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred ceeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCccchH
Confidence 134688999999987 6789999999999999999998 89998753 344555555443322 22334556
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 617 MLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 617 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.+.+++.+||+.+|++||||.||++.|+++..
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 78999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=415.22 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=206.4
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 46799999999999999999999999997543 356789999999999999999999998854 56799999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC---CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---QDD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~~ 545 (664)
|.++++. .....++|..+++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+++...... ...
T Consensus 94 L~~~~~~---~~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 94 LVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHHHTTS---HHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9998853 2234599999999999999999999998 99999999999999999999999999998775432 233
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..+|+.|+|||++. ...++.++|||||||++|||+||..|+... ....++...+....... .+...+..+.+++.+|
T Consensus 170 ~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~c 246 (272)
T d1qpca_ 170 AKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRMV-RPDNCPEELYQLMRLC 246 (272)
T ss_dssp CCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHH
T ss_pred cCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCCCC-CcccChHHHHHHHHHH
Confidence 56889999999987 567899999999999999999965554332 23344444444332222 2233455689999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhhc
Q 006031 626 NSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
|+.+|++||||.||++.|+++-.
T Consensus 247 l~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 247 WKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=406.54 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=210.5
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|+|.+++..++||||+++|+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46899999999999999999999999997644 356789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---CC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---DD 545 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~~ 545 (664)
|.+++.. ....+++..+.+|+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 86 l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 86 LLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999863 345689999999999999999999998 999999999999999999999999999986654332 23
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..+|+.|+|||.+. ...++.|+|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+++.+
T Consensus 161 ~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRL-YRPHLASEKVYTIMYS 236 (258)
T ss_dssp SCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHH
T ss_pred cCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCCC-CCcccccHHHHHHHHH
Confidence 45789999999987 6778999999999999999998 89999764 334555444443222 2333445678999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhh
Q 006031 625 CNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
||+.+|++||||.|+++.|.+|
T Consensus 237 cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHCC
T ss_pred HccCCHhHCcCHHHHHHHhhCC
Confidence 9999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=413.02 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred ccccccCceeEEEEEEcC---CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 390 ELLGKGSLGTTYKAVLDN---RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
++||+|+||+||+|.+++ ++.||||+++.........+.|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4689999997654433445789999999999999999999999864 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--- 543 (664)
|+|.++++. ...++|..++.|+.|||.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999963 35699999999999999999999998 999999999999999999999999999987544321
Q ss_pred --CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 544 --DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 544 --~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
....||+.|||||.+. ...++.++|||||||++|||+| |+.||.+. ...++...+...... ..+...+..+.+
T Consensus 166 ~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~~~~ 241 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERM-GCPAGCPREMYD 241 (277)
T ss_dssp C----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHHHH
Confidence 2345889999999987 6678999999999999999998 89999763 334555544433222 223344567899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhh
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIK 647 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~ 647 (664)
++.+||+.||++||||+||++.|+..-
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-50 Score=413.35 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=210.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.+. +++.||||+++... ...+.|.+|+++|++++|||||+++|+|.+.+..++||||+++|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 468999999999999975 58899999987543 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCC---
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQD--- 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 544 (664)
+|.++++.. ....++|..+..|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 99 ~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 99 NLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp BHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred chHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 999999642 345799999999999999999999999 9999999999999999999999999999876554322
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+++.|+|||++. ...++.|+|||||||++|||++|..|+... .....+.+.+...... ..+...+..+.+++.+
T Consensus 175 ~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 175 GAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYELMRA 251 (287)
T ss_dssp TEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHH
T ss_pred cccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCc-chHHHHHHHHhcCCCC-CCCccchHHHHHHHHH
Confidence 234688999999987 677899999999999999999977765432 2334444444433222 2233445668999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
||+.||++||||+||++.|+.+...
T Consensus 252 cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=410.21 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=206.2
Q ss_pred cccccCceeEEEEEEc---CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 391 LLGKGSLGTTYKAVLD---NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 391 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
+||+|+||+||+|.++ ++..||||+++.... ....+.|.+|+++|++++|||||+++|+|.+ +..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 4999999999999864 456899999975432 2345779999999999999999999999864 5689999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-----
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL----- 542 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----- 542 (664)
+|.+++.. ....+++..+..|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 94 PLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp EHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred cHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 99999853 345799999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
.....+|+.|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.++
T Consensus 169 ~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 244 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRM-ECPPECPPELYAL 244 (285)
T ss_dssp CCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 12345789999999987 5678999999999999999998 99999764 233455544433322 2233455678999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 622 AIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
+.+||+.+|++||||.+|++.|+.+....
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999998876544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=407.89 Aligned_cols=243 Identities=21% Similarity=0.365 Sum_probs=201.2
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec----CCceEEEEecC
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA----KEERLLIYDYQ 464 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 464 (664)
++||+|+||+||+|... +++.||+|++..........+.|.+|+++|++++|||||++++++.+ .+..++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999965 58899999997665544455789999999999999999999999865 34579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCeEeC-CCCCeEEeeccccccccCC
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWR--LVHGNLKSSNVLLG-PDFEACLADYCLTALTADS 541 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~ 541 (664)
++|+|.+++.. ...+++..+..|+.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++.....
T Consensus 95 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 95 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999953 35689999999999999999999997 6 99999999999996 5789999999999876665
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHH
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEV 621 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 621 (664)
......||+.|||||.+. ..++.++|||||||++|||+||+.||.... ....+.+.+.....+.........++.++
T Consensus 169 ~~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred ccCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 555668999999999885 468999999999999999999999997532 23344444433322222223334568999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.||++|||++|+++
T Consensus 246 i~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 246 IEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHccCCHhHCcCHHHHhC
Confidence 99999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=406.72 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=199.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|+. .+++.||||++..... ....+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 46899999999999996 4689999999975443 223467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC----CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS----LQ 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 543 (664)
+|.++++ ....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++++||+|||+|+..... ..
T Consensus 89 ~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 89 ELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp EGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999995 345799999999999999999999999 9999999999999999999999999999875432 22
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|||||++.+...++.++|||||||++|||+||+.||............+.... .........+..+.+++.
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHH
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHHHHHHHH
Confidence 3457999999999987444457889999999999999999999976433322333332221 121222334556889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 006031 624 ACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~ev~~ 641 (664)
+||+.||++|||++|+++
T Consensus 242 ~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 242 KILVENPSARITIPDIKK 259 (271)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHcCCChhHCcCHHHHhc
Confidence 999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=408.40 Aligned_cols=252 Identities=20% Similarity=0.375 Sum_probs=202.3
Q ss_pred hccccccCceeEEEEEEcCC-----eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDNR-----LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|+||+||+|.+++. ..||||++..... ....+.|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 46899999999999997642 4799999865432 22345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+.+|++.+++.. ....++|..+.+|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 91 ~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 91 MENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred cccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999998863 345799999999999999999999998 999999999999999999999999999987644321
Q ss_pred -----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 -----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 -----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....||+.|||||++. ...++.++|||||||++|||+||..|+... ....++...+....... .+...+..+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l 242 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMDCPSAI 242 (283)
T ss_dssp --------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCBHHH
T ss_pred cceEeccCCCCccccCHHHHc-cCCCCCcccccccHHHHHHHHhCCCCcccc-CCHHHHHHHHhccCCCC-CchhhHHHH
Confidence 2245789999999987 678999999999999999999976665432 23445555555443332 233445668
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
.+++.+||+.+|++||||.||++.|+++...
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999987653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=404.93 Aligned_cols=243 Identities=27% Similarity=0.406 Sum_probs=205.9
Q ss_pred HhccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 388 SAELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
..+.||+|+||+||+|+.+ +++.||+|++..... .....+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3578999999999999974 688999999865432 22456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDD 545 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 545 (664)
+|+|.+++.. ...+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 163 (263)
T d2j4za1 90 LGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163 (263)
T ss_dssp TCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred CCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence 9999999953 35699999999999999999999999 99999999999999999999999999998776655555
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHc
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIAC 625 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 625 (664)
..||+.|||||.+. +..++.++|||||||++|||+||+.||... ...++...+.... ...+...+..+.+++.+|
T Consensus 164 ~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 164 LCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVE--FTFPDFVTEGARDLISRL 238 (263)
T ss_dssp TTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHH
T ss_pred cCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC--CCCCccCCHHHHHHHHHH
Confidence 67999999999997 567899999999999999999999999753 2333333332222 122333455689999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006031 626 NSASPEQRPTMWQVLK 641 (664)
Q Consensus 626 l~~~P~~RPt~~ev~~ 641 (664)
|+.||++|||++|+++
T Consensus 239 L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 239 LKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred ccCCHhHCcCHHHHHc
Confidence 9999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=406.48 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=206.1
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
..+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++|||||+++|+|. .++.++||||+++|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence 457899999999999999998899999997543 35678999999999999999999999985 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC---C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ---D 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---~ 544 (664)
+|..+++. .....++|.+++.|+.||+.||+|||+. +|+||||||+|||||+++++||+|||+++....... .
T Consensus 97 ~l~~~~~~---~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 97 SLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp BHHHHHSH---HHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred chhhhhhh---cccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 99999863 2234699999999999999999999999 999999999999999999999999999987644322 2
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...+|+.|+|||++. ...++.++|||||||++|||+||..|+.... ...++...+...... +.+...+..+.+++.+
T Consensus 173 ~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 173 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDLMCQ 249 (285)
T ss_dssp ---CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHH
T ss_pred cccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCC-CCCcccCHHHHHHHHH
Confidence 345889999999997 6788999999999999999999766654432 344555555443322 2333445678999999
Q ss_pred cccCCCCCCCCHHHHHHHHHhhhcccc
Q 006031 625 CNSASPEQRPTMWQVLKMLQEIKGAVL 651 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~~L~~i~~~~~ 651 (664)
||+.+|++||||.+|+++|+++.....
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999998776554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=405.66 Aligned_cols=241 Identities=20% Similarity=0.353 Sum_probs=203.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..|+||||+++|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 36799999999999995 5689999999875543 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..... ....
T Consensus 103 ~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 103 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp BHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred cHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99998853 3589999999999999999999999 9999999999999999999999999999876443 2334
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhh-HHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNE-MMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
..||+.|+|||.+. +..++.++|||||||++|||+||+.||... ...+ +.............+...+..+.+++.+
T Consensus 176 ~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 57999999999997 577899999999999999999999999753 2222 2222333222233344456678999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.||++|||+.|+++
T Consensus 253 ~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=405.49 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--CCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--KEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 465 (664)
.+.||+|+||+||+|.. .+|+.||+|.+..........+.+.+|++++++++|||||++++++.+ .+..|+||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46899999999999986 468899999997765544445779999999999999999999999865 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAW----RLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
+|+|.+++.... .....+++..++.|+.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 999999985321 12357999999999999999999999861 3999999999999999999999999999876543
Q ss_pred C--CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 542 L--QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 542 ~--~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
. .....||+.|||||++. ...++.++|||||||++|||+||+.||... ...++...+...... ..+...+.++.
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~s~~l~ 243 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-RIPYRYSDELN 243 (269)
T ss_dssp --------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred CCccccCCCCcccCCHHHHc-CCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHHH
Confidence 2 23467899999999986 677899999999999999999999999753 333444443332222 12233455689
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++.+||+.||++|||+.|+++
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=412.45 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=202.7
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+|+.||+|+++.... ....+.+.+|+++|++++|||||+++++|.+.+..++||||+++|
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 36799999999999996 4689999999875432 344578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++. ...+++..+..++.|++.||+|||++.+|+||||||+|||+++++++||+|||+|+...+.......
T Consensus 90 ~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 164 (322)
T d1s9ja_ 90 SLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 164 (322)
T ss_dssp EHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---C
T ss_pred cHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccccc
Confidence 99999963 3469999999999999999999997438999999999999999999999999999877665555678
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH--------------------------
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV-------------------------- 601 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~-------------------------- 601 (664)
||+.|||||++. +..++.++||||+||++|||+||+.||..............
T Consensus 165 GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 165 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp CSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred CCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 999999999997 67899999999999999999999999976432211111000
Q ss_pred --------------HhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 006031 602 --------------RSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIK 647 (664)
Q Consensus 602 --------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~ 647 (664)
...............++.+++.+||+.||++|||++|+++ .+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000000001112346889999999999999999999987 355543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=405.00 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=202.4
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 46799999999999996 4688999999975432 34567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~~ 545 (664)
+|.+++.. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..... ....
T Consensus 95 ~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 95 AVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99999853 235699999999999999999999999 9999999999999999999999999999765432 2234
Q ss_pred CCCCCcccCccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHH-HHhhccCCCchhHHHHHHHH
Q 006031 546 DPDNLLYKAPETRN----ASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNW-VRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 546 ~~~~~~y~aPE~~~----~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~ 620 (664)
..||+.|+|||++. ....++.++|||||||++|||+||+.||... ...++... ..........+...+..+.+
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--CGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 67999999999874 2455789999999999999999999999764 23333332 22222222333445567899
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 006031 621 VAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
++.+||+.||++|||+.|+++
T Consensus 248 li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=397.68 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~g 467 (664)
.+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|++++++++|||||+++|+|.+ ++..++||||+++|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 467999999999999985 678999999653 345789999999999999999999999865 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDDP 547 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 547 (664)
+|.++++.. ....++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++...... ....
T Consensus 87 ~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-~~~~ 161 (262)
T d1byga_ 87 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGK 161 (262)
T ss_dssp EHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCCC-cccc
Confidence 999999632 223589999999999999999999998 99999999999999999999999999998765433 2346
Q ss_pred CCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 548 DNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 548 ~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
++..|+|||++. +..++.++|||||||++|||+| |++||... ...++...+....... .+...+..+.+++.+||
T Consensus 162 ~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 162 LPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNCW 237 (262)
T ss_dssp CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCCC-CCTTCCHHHHHHHHHHT
T ss_pred ccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHc
Confidence 788999999987 5788999999999999999999 78887653 4456666665433332 23344567899999999
Q ss_pred cCCCCCCCCHHHHHHHHHhhhc
Q 006031 627 SASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 627 ~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
+.||++||||.||+++|++|+.
T Consensus 238 ~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-49 Score=406.02 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=199.9
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCcccc-CCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLA-GTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|+. .+++.||||++...... ....+.+.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 46799999999999985 56899999998754431 12235788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|..++. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 100 g~l~~~~~-----~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--~~~ 171 (309)
T d1u5ra_ 100 SASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSF 171 (309)
T ss_dssp EHHHHHHH-----HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCC
T ss_pred CchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCC--Ccc
Confidence 99987764 235699999999999999999999999 9999999999999999999999999999876543 346
Q ss_pred CCCCcccCcccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 547 PDNLLYKAPETRNA--SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 547 ~~~~~y~aPE~~~~--~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
.||+.|||||++.+ ...++.++|||||||++|||++|+.||... ...+....+.............+..+.+++.+
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 79999999998853 345899999999999999999999999753 22222222222222222223345568999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 006031 625 CNSASPEQRPTMWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt~~ev~~ 641 (664)
||+.||++|||+.|+++
T Consensus 250 ~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HTCSSGGGSCCHHHHTT
T ss_pred HCcCChhHCcCHHHHHh
Confidence 99999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=409.94 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=202.2
Q ss_pred HhccccccCceeEEEEEEcC------CeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDN------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV 460 (664)
..++||+|+||+||+|+... ...||+|.+..... ......+.+|+.++.++ +|||||+++++|.+.+..++|
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 35789999999999998643 23699999865432 23456788999999988 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC
Q 006031 461 YDYQPNGSLFSLIHGSKS------------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG 522 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~ 522 (664)
|||+++|+|.++++..+. .....++|..++.|+.||+.||+|||++ +||||||||+|||++
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVT 198 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCchhccccc
Confidence 999999999999975321 1124589999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhH
Q 006031 523 PDFEACLADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEM 597 (664)
Q Consensus 523 ~~~~~ki~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~ 597 (664)
.++.+||+|||+|+....... ....+|+.|||||++. ...++.++|||||||++|||+| |+.||.+.. ....+
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~-~~~~~ 276 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP-VDANF 276 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-CSHHH
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 999999999999987654332 1234689999999987 6788999999999999999998 899997642 22344
Q ss_pred HHHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006031 598 MNWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQ 644 (664)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 644 (664)
...+...... +.+...+..+.+++.+||+.+|++||||+||++.|.
T Consensus 277 ~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 277 YKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 4444433222 223344566899999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=403.15 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=208.0
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
.+.||+|+||+||+|+++ +++.||||+++.... ....+.|.+|++++++++||||++++++|...+..++|||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 467999999999999864 357899999975432 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC-------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC
Q 006031 463 YQPNGSLFSLIHGSK-------------------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP 523 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~ 523 (664)
|+++|+|.++++... ......++|..++.|+.|++.||+|||+. +||||||||+|||+|.
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE 175 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECG
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeEEcccceEECC
Confidence 999999999996422 11234589999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCChhhHH
Q 006031 524 DFEACLADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK-PPSQHSFLVPNEMM 598 (664)
Q Consensus 524 ~~~~ki~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~-~P~~~~~~~~~~~~ 598 (664)
++++||+|||+++...... .....+++.|+|||.+. ...++.|+|||||||++|||++|. +||... ...++.
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~--~~~e~~ 252 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHEEVI 252 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHH
T ss_pred CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCC--CHHHHH
Confidence 9999999999998654332 12345788999999987 678999999999999999999986 566543 344555
Q ss_pred HHHHhhccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 599 NWVRSAREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
..+....... .+...+..+.+++.+||+.+|++||||.||+++|++|.+
T Consensus 253 ~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 253 YYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 5555443322 233445668999999999999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=399.59 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=207.2
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec-CCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA-KEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~ 463 (664)
.++||+|+||+||+|.+.+ ...||||+++.... ....+.|.+|+++|++++|||||+++|+|.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4679999999999999754 23689999864322 2345779999999999999999999999875 4578999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.++++. ....+++..+++++.|+|+||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999973 345678999999999999999999998 999999999999999999999999999987654321
Q ss_pred ------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 544 ------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 544 ------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
....+|..|+|||.+. ...++.++||||||+++|||+||+.||.... ...++..++....... .+...+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~~-~p~~~~~~ 262 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLL-QPEYCPDP 262 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCC-CCTTCCHH
T ss_pred ccceecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCCC-CcccCcHH
Confidence 1235789999999987 6788999999999999999999888776432 2233444443333222 22334456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhhccccCCC
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEIKGAVLMED 654 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~~~~~ 654 (664)
+.+++.+||+.||++||+|.||++.|+++......+.
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 8999999999999999999999999999988765543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-48 Score=399.68 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=187.0
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+||||+++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 468999999999999965 6889999999765432 23456889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC---CCCCeEEeeccccccccCCC-C
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG---PDFEACLADYCLTALTADSL-Q 543 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~~-~ 543 (664)
+|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++...... .
T Consensus 93 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 93 ELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp BHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred cHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 99999953 35699999999999999999999999 999999999999994 57899999999998765432 2
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|||||.+. +..++.++|||||||++|||+||+.||... ...++...+....... ......+..+.++
T Consensus 167 ~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 167 STACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 3457999999999987 567899999999999999999999999753 2334433333322221 1223445668999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+.+||+.||++|||++|+++
T Consensus 244 i~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=391.85 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=197.3
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.+.||+|+||+||+|.+.. +..||||.++.... ....+.|.+|++++++++|||||+++|++. .+..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 4689999999999998643 45789998864332 233567999999999999999999999995 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL-- 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 542 (664)
++|+|.+++.. ....+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 90 ~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 90 TLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp TTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred cCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 99999998863 345699999999999999999999999 99999999999999999999999999998764432
Q ss_pred -CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHH
Q 006031 543 -QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLE 620 (664)
Q Consensus 543 -~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 620 (664)
.....+|+.|+|||.+. ...++.++|||||||++|||+| |++||... ...++...+...... ..+...+..+.+
T Consensus 165 ~~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL-PMPPNCPPTLYS 240 (273)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred eccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 22345789999999987 6788999999999999999998 89998764 334555544433322 223345567999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 621 VAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 621 l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
++.+||+.||++|||+.||++.|+++.+.
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999988643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=396.52 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=201.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|++++++++|||||++++++.+++..|+||||+++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 47899999999999996 4689999999875432 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC----
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL---- 542 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 542 (664)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 93 g~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 93 GELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp EEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999853 35699999999999999999999999 99999999999999999999999999998765332
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHH
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVA 622 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 622 (664)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||... ...++...+.... ...+......+.+++
T Consensus 167 ~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLE--YDFPEKFFPKARDLV 241 (288)
T ss_dssp ---CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTC--CCCCTTCCHHHHHHH
T ss_pred cccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHHcCC--CCCCccCCHHHHHHH
Confidence 22356999999999987 677899999999999999999999999753 2333333332221 122333455689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||++|+.+
T Consensus 242 ~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcCHHHHcC
Confidence 9999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=393.16 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=195.3
Q ss_pred hccccccCceeEEEEEEcC----CeEEEEEEccCccccCC-cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLDN----RLIVCVKRLDASKLAGT-SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.+.||+|+||.||+|.+.. ...||||+++....... ..+.|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 4679999999999998643 34789999876543222 34689999999999999999999999965 567899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|++.+++.. ....+++..++.++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 92 APLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp CTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred ecCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999998863 335699999999999999999999998 999999999999999999999999999987644322
Q ss_pred -----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHH
Q 006031 544 -----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGM 617 (664)
Q Consensus 544 -----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (664)
....++..|+|||.+. ...++.++|||||||++|||+| |+.||... ...++...+.......+.+...+..
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp EEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred cceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHHhCCCCCCCcccccHH
Confidence 2335788999999987 6778999999999999999998 89998753 3445555554333333333444567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006031 618 LLEVAIACNSASPEQRPTMWQVLKMLQEI 646 (664)
Q Consensus 618 l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i 646 (664)
+.+++.+||+.||++||||.||++.|++.
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=396.74 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=201.7
Q ss_pred hccccccCceeEEEEEEc-CCe----EEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRL----IVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|+||+||+|.+. +|+ .||+|+++.... ....+.|.+|++++++++|||||+++|+|.+ +..++++||
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~ 91 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQL 91 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEe
Confidence 478999999999999864 333 689998865432 3457789999999999999999999999986 467888999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+.+|+|.+++.. ....+++..+++|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 92 MPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp CTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred ccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999998863 346799999999999999999999998 999999999999999999999999999987654322
Q ss_pred ----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHH
Q 006031 544 ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGML 618 (664)
Q Consensus 544 ----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 618 (664)
....||+.|+|||++. ...++.++|||||||++|||+| |++||+.. ...++...+...... ..+...+..+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~i~~~~~~-~~p~~~~~~~ 242 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERL-PQPPICTIDV 242 (317)
T ss_dssp --------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHHHHHTCCC-CCCTTBCHHH
T ss_pred cccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHH
Confidence 2235789999999987 6778999999999999999999 78888753 234555555443322 2223345568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 619 LEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 619 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.+++.+||+.+|++||||.||++.|+.+..
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999988753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=388.97 Aligned_cols=245 Identities=20% Similarity=0.284 Sum_probs=203.2
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEe
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYD 462 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 462 (664)
..+.||+|+||+||+|.. .+|+.||||+++...... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999996 568999999987543322 246789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC----CeEEeeccccccc
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF----EACLADYCLTALT 538 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~ 538 (664)
|+++|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+++..
T Consensus 94 ~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 94 LVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred cCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999953 34699999999999999999999999 999999999999998776 4999999999876
Q ss_pred cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHH
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERL 615 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 615 (664)
... ......+|+.|+|||++. ...++.++|||||||++|||+||+.||.+. ...+....+........ .....+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred CCCccccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCCCCCchhcCCCC
Confidence 543 333467899999999997 567899999999999999999999999753 23333333332222211 112334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 616 GMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
..+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 56889999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-47 Score=399.96 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=203.2
Q ss_pred HhccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 388 SAELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 357899999999999996 5689999999975433 3456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC--CCCCeEEeeccccccccCCCC-
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG--PDFEACLADYCLTALTADSLQ- 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~--~~~~~ki~DfGla~~~~~~~~- 543 (664)
|+|.+++.. ....+++..+..|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||+++.......
T Consensus 108 g~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 108 GELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999952 335699999999999999999999999 999999999999995 467899999999987654332
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--CchhHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD--GAEDERLGMLLEV 621 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 621 (664)
....||+.|||||++. +..++.++|||||||++|||+||+.||.+. ...++...+....... ......+..+.++
T Consensus 183 ~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp EEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred ceecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2357899999999987 677899999999999999999999999753 2333333333222211 1223345568999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006031 622 AIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 622 ~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
+.+||+.||++|||++|+++.
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=392.80 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=205.7
Q ss_pred hccccccCceeEEEEEEcC-Ce--EEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDN-RL--IVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 464 (664)
.++||+|+||+||+|.+++ +. .||||+++.... ....+.|.+|+++|+++ +|||||+++|+|.+.+..++||||+
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 5789999999999999754 43 578888754332 23456799999999998 7999999999999999999999999
Q ss_pred CCCCHHHHhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecc
Q 006031 465 PNGSLFSLIHGSK-----------STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYC 533 (664)
Q Consensus 465 ~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfG 533 (664)
++|+|.++++... ......++|..+++++.|||+||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~kl~DfG 172 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFG 172 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCceEEcccc
Confidence 9999999997431 12346799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC-CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCChhhHHHHHHhhccCCCch
Q 006031 534 LTALTADSLQD-DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKP-PSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 534 la~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~-P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
+++........ ...+|..|+|||.+. ...++.++|||||||++|||++|.. ||... ...++...+...... ..+
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~~~~i~~~~~~-~~~ 248 (309)
T d1fvra_ 173 LSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYRL-EKP 248 (309)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGGTCCC-CCC
T ss_pred ccccccccccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhcCCC-CCC
Confidence 99865543332 345889999999997 6778999999999999999999765 56542 344555555443222 222
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.||++||||+||++.|+++.+..
T Consensus 249 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 249 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 334566899999999999999999999999999987544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=390.21 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=195.7
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC----ceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE----ERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~ 464 (664)
.+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+.+ ..++|||||
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 46799999999999997 577999999864321 2233455666667889999999999998654 578999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQA-------WRLVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
++|+|.++++. ..++|..+.+++.|+|.||+|||+. .+||||||||+||||++++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999963 3599999999999999999999962 4899999999999999999999999999987
Q ss_pred ccCCC------CCCCCCCCcccCccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------------C
Q 006031 538 TADSL------QDDDPDNLLYKAPETRNASH-----QATSKSDVYSFGVLLLELLTGKPPSQHSFL-------------V 593 (664)
Q Consensus 538 ~~~~~------~~~~~~~~~y~aPE~~~~~~-----~~~~ksDVwSfGvvl~elltG~~P~~~~~~-------------~ 593 (664)
..... .....||+.|+|||++.... .++.|+|||||||++|||+||..|+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 64432 22356899999999886322 257789999999999999999988643211 0
Q ss_pred hhhHHHHHHhhccCCC-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 594 PNEMMNWVRSAREDDG-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 594 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+.+.+........ ...+....+.+++.+||+.||++||||.||++.|+++....
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1122222211111111 13345667999999999999999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-47 Score=398.39 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=202.8
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+||||+++|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 47899999999999996 5689999999875433 24567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC--CCCCeEEeeccccccccCCC-CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG--PDFEACLADYCLTALTADSL-QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~--~~~~~ki~DfGla~~~~~~~-~~ 544 (664)
+|.+++.. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++...... ..
T Consensus 112 ~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 112 ELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp BHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred hHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99998852 345699999999999999999999998 999999999999998 67899999999998765443 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--CCchhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED--DGAEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~ 622 (664)
...+|+.|+|||++. ...++.++||||+||++|||+||+.||.+. ...++...+...... .......+..+.+++
T Consensus 187 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 187 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eccCcccccCHHHHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 356899999999987 677899999999999999999999999753 233333333332221 122234456689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||+.|+++
T Consensus 264 ~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=390.81 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecC-CceEEE
Q 006031 389 AELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAK-EERLLI 460 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~~~~lV 460 (664)
.+.||+|+||.||+|... +++.||||+++.... ....+.+.+|+..+.++ +|+|||.+++++.+. +..++|
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 468999999999999864 346899999975432 12345677777777666 789999999998764 468999
Q ss_pred EecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEE
Q 006031 461 YDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACL 529 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki 529 (664)
|||+++|+|.++++.... .....++|.+++.|+.||++||+|||++ +||||||||+|||+++++++||
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~~~~Kl 175 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKI 175 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCCCcEEE
Confidence 999999999999974321 1234689999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCCC----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCChhhHHHHHHhh
Q 006031 530 ADYCLTALTADSL----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK-PPSQHSFLVPNEMMNWVRSA 604 (664)
Q Consensus 530 ~DfGla~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~-~P~~~~~~~~~~~~~~~~~~ 604 (664)
+|||+|+...... .....||+.|+|||.+. ...++.++|||||||++|||+||. +||.... ....+...+...
T Consensus 176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~~~~~~~~~~~ 253 (299)
T d1ywna1 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEG 253 (299)
T ss_dssp CC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CSHHHHHHHHHT
T ss_pred ccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC
Confidence 9999998654332 22346899999999987 677899999999999999999965 5676432 233444444333
Q ss_pred ccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 605 REDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 605 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
... ..++..+..+.+++.+||+.||++||||+||++.|+++.++
T Consensus 254 ~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 254 TRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222 22333455689999999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=388.66 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=203.0
Q ss_pred hccccccCceeEEEEEEcC--------CeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVLDN--------RLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||.||+|+... +..||||+++.... ......+.+|...+.++ +|||||+++++|.+++..++
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 5789999999999998532 35799999975432 22346788888888887 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 460 IYDYQPNGSLFSLIHGSKS-----------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
||||+++|+|.++++.... .....+++.++++++.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEE
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCCCCeE
Confidence 9999999999999975431 1235689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLT-GKPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 603 (664)
|+|||+++....... ....+++.|+|||.+. .+.++.|+|||||||++|||+| |++||... ....+...+..
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--~~~~~~~~i~~ 252 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKE 252 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHT
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCC--CHHHHHHHHHc
Confidence 999999987655432 2345788999999987 6789999999999999999998 78888653 33445455444
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
.... ..+...+..+.+++.+||+.+|++||||.||++.|++|..
T Consensus 253 ~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 253 GHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3222 2233345568999999999999999999999999999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=390.81 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=207.8
Q ss_pred hccccccCceeEEEEEE------cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCC-CCCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL------DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGL-RHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 461 (664)
.++||+|+||.||+|++ ..++.||||+++.... ......|.+|+.+++++ +|||||+++|+|.+.+..++||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 57899999999999986 3467899999975432 23456789999999998 6999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeE
Q 006031 462 DYQPNGSLFSLIHGSKS-------------TRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEAC 528 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~k 528 (664)
||+++|+|.++++.... .....+++..+..|+.||++||+|||++ ++|||||||+||+++.++.+|
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~~~~k 185 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITK 185 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccccccccccccCccc
Confidence 99999999999975331 1234689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCChhhHHHHHHh
Q 006031 529 LADYCLTALTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTG-KPPSQHSFLVPNEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG-~~P~~~~~~~~~~~~~~~~~ 603 (664)
++|||+++....... ....+|+.|+|||++. ...++.++|||||||++|||+|+ ++|+.. ......+.+.+..
T Consensus 186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPG-MPVDSKFYKMIKE 263 (311)
T ss_dssp ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCSSHHHHHHHHH
T ss_pred ccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhc
Confidence 999999987654322 2345789999999987 67889999999999999999995 555543 3333445555544
Q ss_pred hccCCCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 006031 604 AREDDGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGA 649 (664)
Q Consensus 604 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~ 649 (664)
..... .+...+..+.+++.+||+.||++||||.||+++|+++...
T Consensus 264 ~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 264 GFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 43332 2233456689999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.6e-47 Score=385.17 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=198.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC-CcHHHHHHHHHHHcCCCCCCcccceEEEecCCc----eEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG-TSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEE----RLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----~~lV~e 462 (664)
.+.||+|+||+||+|.. .+++.||||+++...... ...+.|.+|++++++++|||||++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46899999999999995 579999999997654322 224578999999999999999999999876543 789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+|||++.++..+++|||.++......
T Consensus 92 ~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 92 YVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp CCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred CCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 9999999999853 35699999999999999999999998 99999999999999999999999999987543322
Q ss_pred -----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHH-HHHHhhccCC-CchhHHH
Q 006031 543 -----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM-NWVRSAREDD-GAEDERL 615 (664)
Q Consensus 543 -----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 615 (664)
.....||+.|+|||.+. +..++.++|||||||++|||+||+.||... ...++. ..+....... ......+
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp -------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccCcccccCHHHHc-CCCCCcceecccchHHHHHHHhCCCCCCCc--CHHHHHHHHHhcCCCCCchhccCCC
Confidence 22346899999999987 667899999999999999999999999753 222222 2222211111 1122344
Q ss_pred HHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhc
Q 006031 616 GMLLEVAIACNSASPEQRP-TMWQVLKMLQEIKG 648 (664)
Q Consensus 616 ~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~i~~ 648 (664)
..+.+++.+||+.||++|| |++++.+.|.+++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 6689999999999999999 89999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=387.87 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=208.5
Q ss_pred HhccccccCceeEEEEEEc------CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEE
Q 006031 388 SAELLGKGSLGTTYKAVLD------NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 461 (664)
..+.||+|+||+||+|.+. +++.||||+++.... ......|.+|++++++++|||||+++|+|...+..++||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 4578999999999999864 367899999975432 234467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 462 DYQPNGSLFSLIHGSK-----STRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
||+++|+|.++++... ......++|..+.+|+.|+|+||.|||+. +|+||||||+|||+|+++++||+|||+++
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecccce
Confidence 9999999999986321 12234579999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC----CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCChhhHHHHHHhhccCCCch
Q 006031 537 LTADSLQ----DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGK-PPSQHSFLVPNEMMNWVRSAREDDGAE 611 (664)
Q Consensus 537 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (664)
....... ....+++.|+|||.+. ...++.++|||||||++|||+||+ +||... ...++...+...... +.+
T Consensus 182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~~~~~~~i~~~~~~-~~p 257 (308)
T d1p4oa_ 182 DIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGGLL-DKP 257 (308)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTTCCC-CCC
T ss_pred eccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhCCCC-CCc
Confidence 7654322 2335789999999987 677899999999999999999985 666542 333444444332222 223
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
...+..+.+++.+||+.+|++||||.||+++|++..+..
T Consensus 258 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 344566999999999999999999999999998875543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-46 Score=385.02 Aligned_cols=241 Identities=21% Similarity=0.240 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+.+..|+||||+++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 46899999999999996 5689999999965432 224567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...+.. ...
T Consensus 89 g~l~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-~~~ 161 (316)
T d1fota_ 89 GELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-YTL 161 (316)
T ss_dssp CBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-CCC
T ss_pred cccccccc-----ccccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEecccc-ccc
Confidence 99999995 345688899999999999999999999 99999999999999999999999999998876543 346
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|||||.+. +..++.++|||||||++|||+||+.||... ...++...+.... ...+...+..+.+++.+||
T Consensus 162 ~Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 162 CGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp CSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHT
T ss_pred cCcccccCHHHHc-CCCCCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 7999999999987 667899999999999999999999999763 2333333332222 1222334456889999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 006031 627 SASPEQRP-----TMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RP-----t~~ev~~ 641 (664)
+.||++|| |++|+++
T Consensus 237 ~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHT
T ss_pred hhCHHhccccchhhHHHHHc
Confidence 99999996 8999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-46 Score=393.76 Aligned_cols=245 Identities=18% Similarity=0.202 Sum_probs=199.5
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCcccc-CCcHHHHH---HHHHHHcCCCCCCcccceEEEecCCceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLA-GTSNEMYE---QHMESVGGLRHPNLVPLRAYFQAKEERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~---~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 463 (664)
.++||+|+||+||+|+.. +|+.||||++...... ......+. +++++++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 468999999999999964 6899999998643321 12233333 447788889999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 89 MNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp CCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred cCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 999999999953 35688999999999999999999999 999999999999999999999999999998776666
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhcc-CCCchhHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARE-DDGAEDERLGMLLEVA 622 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~ 622 (664)
....||+.|+|||++.....++.++|||||||++|||+||+.||...... +.....+.... ....+...+..+.+++
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAVELPDSFSPELRSLL 240 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence 66789999999999875567899999999999999999999999764322 22222222211 1122333455689999
Q ss_pred HHcccCCCCCCCC-----HHHHHH
Q 006031 623 IACNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt-----~~ev~~ 641 (664)
.+||+.||++||| ++|+++
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHcccCHHHhCCCcccCHHHHHc
Confidence 9999999999999 677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=383.88 Aligned_cols=244 Identities=23% Similarity=0.281 Sum_probs=194.1
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCC---cHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGT---SNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
++||+|+||+||+|.. .+|+.||||+++....... ..+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999995 4689999999975443221 12468899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ-- 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 543 (664)
++++..+.. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 84 TDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred chHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 887776663 345689999999999999999999999 999999999999999999999999999987654332
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-ccCC--------------
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA-REDD-------------- 608 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~-------------- 608 (664)
....+|+.|+|||.+.....++.++|||||||++|||+||++||... ...+....+... ....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--CHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 34568999999999875667899999999999999999999999753 222222222111 1000
Q ss_pred ------C-c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 ------G-A----EDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 ------~-~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
. . .......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 0 0112356899999999999999999999976
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-46 Score=379.03 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=202.3
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCc-------HHHHHHHHHHHcCCC-CCCcccceEEEecCCceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTS-------NEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~-------~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~l 459 (664)
.+.||+|+||+||+|+. .+++.||||+++........ .+.+.+|+.++++++ |||||++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 47899999999999996 57899999999765432222 245889999999997 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 vmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 88 VFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999953 34699999999999999999999998 99999999999999999999999999998765
Q ss_pred CC-CCCCCCCCCcccCcccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccC--CCch
Q 006031 540 DS-LQDDDPDNLLYKAPETRNA-----SHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSARED--DGAE 611 (664)
Q Consensus 540 ~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~ 611 (664)
.. ......||..|+|||.+.+ ...++.++||||+||++|||+||+.||... ...+....+...... ....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--CHHHHHHHHHhCCCCCCCccc
Confidence 43 2344678999999998752 345688999999999999999999999864 233333333322221 1222
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 612 DERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 612 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
...+.++.+++.+||+.+|++|||+.||++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 345567999999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=386.60 Aligned_cols=242 Identities=18% Similarity=0.239 Sum_probs=203.0
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+++.||+|++++... .....+.+.+|+++|++++|||||++++++.+.+..|+||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 46899999999999996 5689999999975432 234567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQD 544 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~~ 544 (664)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..... ...
T Consensus 90 g~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 90 GELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp CBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred Cchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 999999953 35689999999999999999999999 9999999999999999999999999999865432 223
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIA 624 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 624 (664)
...||+.|+|||++. +..++.++||||+||++|||++|+.||... ...++...+.... ...+...+.++.+++.+
T Consensus 164 ~~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred cceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence 457899999999987 677899999999999999999999999763 2334433333222 22233445568999999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 006031 625 CNSASPEQRPT-----MWQVLK 641 (664)
Q Consensus 625 Cl~~~P~~RPt-----~~ev~~ 641 (664)
||+.||++||+ +.|+++
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHT
T ss_pred hccCCchhhcccccccHHHHHc
Confidence 99999999995 778876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-45 Score=386.08 Aligned_cols=241 Identities=18% Similarity=0.199 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccc-cCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKL-AGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+++|+.++|||||++++++.+.+..++|+||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46899999999999996 4689999999865432 224567889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQDDD 546 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 546 (664)
|+|.+++.. ...+++..+..|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++...... ...
T Consensus 126 g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-~~~ 198 (350)
T d1rdqe_ 126 GEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-WTL 198 (350)
T ss_dssp CBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-CCC
T ss_pred cchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-ccc
Confidence 999999953 34689999999999999999999999 99999999999999999999999999998775443 346
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHHHcc
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAIACN 626 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 626 (664)
.||+.|||||++. +..++.++|||||||++|||+||+.||... ....+...+..... ..+...+..+.+++.+||
T Consensus 199 ~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 199 CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp EECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHS
T ss_pred cCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHh
Confidence 7899999999987 677899999999999999999999999753 23333333322221 222334456899999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 006031 627 SASPEQRP-----TMWQVLK 641 (664)
Q Consensus 627 ~~~P~~RP-----t~~ev~~ 641 (664)
+.||++|+ |++|+++
T Consensus 274 ~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHT
T ss_pred hhCHHhccccccccHHHHHc
Confidence 99999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=379.46 Aligned_cols=242 Identities=18% Similarity=0.234 Sum_probs=199.4
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|... +++.||||.++.... ....+.+|+++|++++|||||++++++.+.+..|+||||+++|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 468999999999999964 688999999975432 3567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCC--CCeEEeeccccccccCCC-CC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPD--FEACLADYCLTALTADSL-QD 544 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~--~~~ki~DfGla~~~~~~~-~~ 544 (664)
+|.++++. ....+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++...... ..
T Consensus 87 ~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 87 DIFERINT----SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp BHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99999953 234699999999999999999999998 99999999999999854 589999999998764432 22
Q ss_pred CCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCC--chhHHHHHHHHHH
Q 006031 545 DDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDG--AEDERLGMLLEVA 622 (664)
Q Consensus 545 ~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~ 622 (664)
...+++.|+|||... ...++.++||||+||++|||++|+.||... ...++...+.......+ .....+..+.+++
T Consensus 162 ~~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccchhcc-CCCCCchhhcccHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 345789999999886 667899999999999999999999999763 23333333322222111 1112345689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 006031 623 IACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 623 ~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+||+.||++|||+.|+++
T Consensus 239 ~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=374.18 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=197.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNG 467 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 467 (664)
.+.||+|+||+||+|.. .+++.||||+++.........+.+.+|++++++++|||||++++++.+.+..|+||||+.++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence 36799999999999996 56899999999765543344578999999999999999999999999999999999999764
Q ss_pred CHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC--CCC
Q 006031 468 SLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL--QDD 545 (664)
Q Consensus 468 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--~~~ 545 (664)
+.+++.. .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.++...... ...
T Consensus 87 -~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 87 -LKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp -HHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred -hhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 4444432 2345699999999999999999999999 99999999999999999999999999998765433 234
Q ss_pred CCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------------
Q 006031 546 DPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------------- 608 (664)
Q Consensus 546 ~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 608 (664)
..||+.|+|||.+.....++.++|||||||++|||++|+.||..... ...+...........
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 56899999999887566678999999999999999999999975321 112222111111100
Q ss_pred ----C-----chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhh
Q 006031 609 ----G-----AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIK 647 (664)
Q Consensus 609 ----~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~ 647 (664)
. ........+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0 001123568899999999999999999999875 55553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=380.80 Aligned_cols=238 Identities=18% Similarity=0.260 Sum_probs=190.7
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcC-CCCCCcccceEEEec----CCceEEEEec
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGG-LRHPNLVPLRAYFQA----KEERLLIYDY 463 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e~ 463 (664)
++||+|+||+||+|.. .+++.||||+++. ...+.+|++++.+ .+|||||+++++|.+ ....|+||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 5699999999999996 5689999999853 2457788988654 589999999999865 4568999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC---CCCeEEeeccccccccC
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP---DFEACLADYCLTALTAD 540 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 540 (664)
|++|+|.+++... ....+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++....
T Consensus 91 ~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 91 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeeccC
Confidence 9999999999642 235699999999999999999999999 9999999999999985 56799999999987654
Q ss_pred C-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-HhhccCC-----CchhH
Q 006031 541 S-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV-RSAREDD-----GAEDE 613 (664)
Q Consensus 541 ~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~ 613 (664)
. ......||+.|||||++. ...++.++|||||||++|||+||+.||...... ...... ....... .....
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 167 HNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCCCCCSCCCSSCCCCCCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSCCTTHHHH
T ss_pred CCccccccCCcccCCcHHHc-CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHHHhcCCCCCCCccccc
Confidence 3 334467999999999987 667899999999999999999999999753221 111111 1111111 11233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 614 RLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 614 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 4567899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.3e-45 Score=371.90 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=199.0
Q ss_pred hccccccCceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 389 AELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
.++||+|+||+||+|..++++.||||+++.........+.+.+|+.+|++++|||||++++++.+.+..++++||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 36799999999999999999999999997665544556789999999999999999999999999999999999998877
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
+..+.+ ....+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+|++|||.+........ ...
T Consensus 87 ~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 87 KKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp HHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred HHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 777763 346799999999999999999999998 999999999999999999999999999987654322 234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------------ 608 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 608 (664)
.+++.|+|||.+.....++.++|||||||++|||++|+.||..... ...+.+.........
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 5888999999987667789999999999999999999999975321 112222111111100
Q ss_pred --------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122356889999999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=380.24 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=198.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccc-cCCcHHHHHHHHHHHc-CCCCCCcccceEEEecCCceEEEEecCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKL-AGTSNEMYEQHMESVG-GLRHPNLVPLRAYFQAKEERLLIYDYQP 465 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~lV~e~~~ 465 (664)
.+.||+|+||+||+|+.. +++.||||+++.... .....+.+..|+.++. .++|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 468999999999999964 689999999965432 2234556666766654 6899999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC--CC
Q 006031 466 NGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS--LQ 543 (664)
Q Consensus 466 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 543 (664)
+|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++..... ..
T Consensus 87 ~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 87 GGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp TCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 9999999963 34688999999999999999999999 9999999999999999999999999999865432 23
Q ss_pred CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHHHHHH
Q 006031 544 DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLLEVAI 623 (664)
Q Consensus 544 ~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 623 (664)
....||+.|+|||++. +..++.++|||||||++|||+||+.||.+. ...++...+.... ...+...+..+.+++.
T Consensus 161 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDN--PFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred cccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCccCCHHHHHHHH
Confidence 3457899999999997 677899999999999999999999999753 3334444333222 2223334556899999
Q ss_pred HcccCCCCCCCCHH-HHH
Q 006031 624 ACNSASPEQRPTMW-QVL 640 (664)
Q Consensus 624 ~Cl~~~P~~RPt~~-ev~ 640 (664)
+||+.||++|||+. |++
T Consensus 236 ~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHSCSSGGGSBTTBSCGG
T ss_pred HhcccCCCCCcCHHHHHH
Confidence 99999999999985 675
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=376.42 Aligned_cols=237 Identities=20% Similarity=0.329 Sum_probs=194.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccC----CcHHHHHHHHHHHcCCC--CCCcccceEEEecCCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAG----TSNEMYEQHMESVGGLR--HPNLVPLRAYFQAKEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 461 (664)
.+.||+|+||+||+|+. .+++.||||+++...... .....+.+|+.++++++ |||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 46899999999999996 568999999987543321 11234678999999886 899999999999999999999
Q ss_pred ecCCC-CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-CCCeEEeecccccccc
Q 006031 462 DYQPN-GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-DFEACLADYCLTALTA 539 (664)
Q Consensus 462 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~ 539 (664)
||+.+ +++.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 89 e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp ECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceecc
Confidence 99976 688888852 35699999999999999999999999 9999999999999985 4799999999998877
Q ss_pred CCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCCCchhHHHHHHH
Q 006031 540 DSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDDGAEDERLGMLL 619 (664)
Q Consensus 540 ~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 619 (664)
........||+.|+|||++.+...++.++|||||||++|||+||+.||... .++.. . ....+...+.++.
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~i~~---~---~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIR---G---QVFFRQRVSSECQ 232 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHH---C---CCCCSSCCCHHHH
T ss_pred cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hHHhh---c---ccCCCCCCCHHHH
Confidence 666666789999999999874445577899999999999999999999742 22211 1 1111222345589
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006031 620 EVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
+++.+||+.||++|||++|+++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=364.77 Aligned_cols=246 Identities=18% Similarity=0.238 Sum_probs=190.0
Q ss_pred hccccccCceeEEEEEEc--CCeEEEEEEccCccccCCcHHHHHHHHHHHcC---CCCCCcccceEEEec-----CCceE
Q 006031 389 AELLGKGSLGTTYKAVLD--NRLIVCVKRLDASKLAGTSNEMYEQHMESVGG---LRHPNLVPLRAYFQA-----KEERL 458 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~---l~H~niv~l~g~~~~-----~~~~~ 458 (664)
.+.||+|+||+||+|... +++.||||+++...........+.+|+.+++. .+||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 467999999999999963 36789999986544333333445566666555 489999999999853 34679
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccc
Q 006031 459 LIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALT 538 (664)
Q Consensus 459 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 538 (664)
+++||++++++..... .....+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||+++..
T Consensus 92 ~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred EEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 9999999887765554 2345689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCC-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHH-HHHHhhccCC--------
Q 006031 539 ADS-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMM-NWVRSAREDD-------- 608 (664)
Q Consensus 539 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~-------- 608 (664)
... ......||+.|+|||++. ...++.++||||+||++|||+||+.||.... ..+.. ..........
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cccccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCchhcccccc
Confidence 433 234567999999999987 6778999999999999999999999997642 22222 2111111000
Q ss_pred ----------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 609 ----------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 609 ----------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
.........+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011223557899999999999999999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=360.81 Aligned_cols=245 Identities=19% Similarity=0.224 Sum_probs=191.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec--------CCceEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA--------KEERLL 459 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------~~~~~l 459 (664)
.+.||+|+||+||+|+. .+|+.||||++..........+.+.+|+++|++++||||+++++++.. .+..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 46799999999999996 578999999997665555566788999999999999999999999855 346799
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeecccccccc
Q 006031 460 IYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTA 539 (664)
Q Consensus 460 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 539 (664)
||||+.++++..... ....++...+..|+.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 95 v~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 95 VFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp EEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 999998877766552 345688899999999999999999999 99999999999999999999999999997654
Q ss_pred CCC------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----
Q 006031 540 DSL------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----- 608 (664)
Q Consensus 540 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 608 (664)
... .....||+.|+|||.+.....++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcCCCChhhc
Confidence 322 1234689999999998756678999999999999999999999997532 222222111111000
Q ss_pred -------------------Cchh------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 -------------------GAED------ERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 -------------------~~~~------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.... .....+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0001 11235678999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=354.98 Aligned_cols=246 Identities=18% Similarity=0.232 Sum_probs=200.1
Q ss_pred ccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCCceEEEEecCCCCC
Q 006031 390 ELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+.||+|+||+||+|+. .+++.||||+++.........+.+.+|+.+++.++||||++++++|.+.+..++|+||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 6799999999999996 578899999997665544556889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCCC--CCC
Q 006031 469 LFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSLQ--DDD 546 (664)
Q Consensus 469 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~~ 546 (664)
+..+++ ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.++....... ...
T Consensus 88 l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 88 KKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp HHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred cccccc-----cccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 998885 345688999999999999999999999 999999999999999999999999999987654332 234
Q ss_pred CCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC------------------
Q 006031 547 PDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------------ 608 (664)
Q Consensus 547 ~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 608 (664)
.++..|+|||.+.....++.++|||||||++|||++|+.||.........+...........
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 56788999998875566799999999999999999999997543322222221111111000
Q ss_pred --------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
.........+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011222345889999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=363.58 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=192.5
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC------ceEEEE
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE------ERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lV~ 461 (664)
.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||+++++|...+ +.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 36799999999999996 46899999999755443334567889999999999999999999997654 569999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+ +.+|..+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++.....
T Consensus 103 e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp ECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccCCc
Confidence 999 5678887742 4599999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-------------
Q 006031 542 LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD------------- 608 (664)
Q Consensus 542 ~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------- 608 (664)
. ....+|+.|+|||.+.+...++.++||||+||++|||++|+.||..... ...+...........
T Consensus 175 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 175 M-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp C-CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred c-ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 3 3467899999999987556779999999999999999999999976421 111111111111000
Q ss_pred ------------C---chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhh
Q 006031 609 ------------G---AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIK 647 (664)
Q Consensus 609 ------------~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~ 647 (664)
. ........+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 011223457899999999999999999999975 66554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=361.83 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=193.3
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC------CceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK------EERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 461 (664)
.++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||+++++|... ...++||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 367999999999999964 689999999965432 234789999999999999999998543 2478999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTAD 540 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~ 540 (664)
||++++.+..+.+.. .....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999876544443211 2345799999999999999999999998 999999999999999775 899999999987654
Q ss_pred C-CCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC-----------
Q 006031 541 S-LQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD----------- 608 (664)
Q Consensus 541 ~-~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----------- 608 (664)
. ......++..|+|||.+.+...++.++||||+||++|||++|+.||..... ...+...........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhhhccch
Confidence 3 233457899999999887567789999999999999999999999975421 112222111110000
Q ss_pred ---------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhccc
Q 006031 609 ---------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKGAV 650 (664)
Q Consensus 609 ---------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~~~ 650 (664)
.........+.+|+.+||+.||++|||+.|+++. ++++++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 0011234558899999999999999999999863 66665543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=350.89 Aligned_cols=249 Identities=14% Similarity=0.159 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccce-EEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLR-AYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~-g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|+. .+++.||||.+..... .+.+.+|++++++++|+|++..+ ++..+.+..++||||+ +
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 46899999999999986 5689999998865432 23578899999999877766554 4556777889999999 4
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeC---CCCCeEEeeccccccccCCCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLG---PDFEACLADYCLTALTADSLQ 543 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~~~ 543 (664)
+++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+++.......
T Consensus 87 ~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 567666642 345699999999999999999999999 999999999999985 456799999999987654321
Q ss_pred ---------CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHHHhhccCC--Cc
Q 006031 544 ---------DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSAREDD--GA 610 (664)
Q Consensus 544 ---------~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~--~~ 610 (664)
....||+.|||||.+. +..++.++|||||||++|||+||+.||........ .+..+........ ..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred ccceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 2346899999999987 66789999999999999999999999976432221 1212211111111 01
Q ss_pred hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 006031 611 EDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKG 648 (664)
Q Consensus 611 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~ 648 (664)
....+.++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 12234568999999999999999999999999988743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-41 Score=348.37 Aligned_cols=251 Identities=14% Similarity=0.163 Sum_probs=199.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC-CCcccceEEEecCCceEEEEecCCC
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH-PNLVPLRAYFQAKEERLLIYDYQPN 466 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~ 466 (664)
.+.||+|+||+||+|+.. +++.||||.+..... ...+.+|++.++.++| +|++.+++++.+....++||||+ +
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 467999999999999964 689999998865432 2346677888888865 89999999999999999999998 6
Q ss_pred CCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCC-----CCCeEEeeccccccccCC
Q 006031 467 GSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGP-----DFEACLADYCLTALTADS 541 (664)
Q Consensus 467 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~-----~~~~ki~DfGla~~~~~~ 541 (664)
++|.++++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 85 ~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 85 PSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 899999863 234689999999999999999999999 9999999999999974 578999999999876433
Q ss_pred C---------CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCh-hhHHHHHHhhccCCC--
Q 006031 542 L---------QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVP-NEMMNWVRSAREDDG-- 609 (664)
Q Consensus 542 ~---------~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~-- 609 (664)
. .....||+.|||||.+. +..++.++|||||||++|||+||+.||....... ......+........
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 2 12345899999999987 6778999999999999999999999997643322 222222211111111
Q ss_pred -chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 006031 610 -AEDERLGMLLEVAIACNSASPEQRPTMWQVLKMLQEIKGAV 650 (664)
Q Consensus 610 -~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~i~~~~ 650 (664)
.....+.++.+++..|++.+|++||+++.+.+.|+++....
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11123456899999999999999999999999998875544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=359.07 Aligned_cols=246 Identities=20% Similarity=0.286 Sum_probs=196.2
Q ss_pred HhccccccCceeEEEEEE----cCCeEEEEEEccCccc--cCCcHHHHHHHHHHHcCCCC-CCcccceEEEecCCceEEE
Q 006031 388 SAELLGKGSLGTTYKAVL----DNRLIVCVKRLDASKL--AGTSNEMYEQHMESVGGLRH-PNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lV 460 (664)
..+.||+|+||+||+|.. .+|+.||||.++.... .....+.+.+|++++++++| |||+++++++.+.+..++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 357899999999999985 2478999999875432 12345678899999999976 8999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccC
Q 006031 461 YDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTAD 540 (664)
Q Consensus 461 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 540 (664)
+||+.+|+|.+++.. ...+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp ECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999953 34567888899999999999999999 999999999999999999999999999986543
Q ss_pred CC---CCCCCCCCcccCccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCChh--hHHHHHHhhccCCCchhHH
Q 006031 541 SL---QDDDPDNLLYKAPETRNASH-QATSKSDVYSFGVLLLELLTGKPPSQHSFLVPN--EMMNWVRSAREDDGAEDER 614 (664)
Q Consensus 541 ~~---~~~~~~~~~y~aPE~~~~~~-~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 614 (664)
.. .....+++.|+|||.+.... .++.++|||||||+||||+||+.||........ .+.... .......+...
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 259 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 259 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccCCCCCcccC
Confidence 22 22346889999999886433 468899999999999999999999976543222 222211 11122223345
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006031 615 LGMLLEVAIACNSASPEQRP-----TMWQVLK 641 (664)
Q Consensus 615 ~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 641 (664)
+..+.+++.+||+.+|++|| |++|+++
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 56689999999999999999 4788875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=357.05 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecCC----ceEEEEec
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAKE----ERLLIYDY 463 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~ 463 (664)
.+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|+++|++++||||+++++++.... ..+++++|
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 46899999999999985 5799999999965432 123467889999999999999999999986543 23555566
Q ss_pred CCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC-
Q 006031 464 QPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL- 542 (664)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 542 (664)
+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 92 LMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred ecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 779999999952 3589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ----CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhh-ccCC---------
Q 006031 543 ----QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSA-REDD--------- 608 (664)
Q Consensus 543 ----~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~--------- 608 (664)
.....||+.|+|||.+.....++.++||||+||++|||++|+.||.... ..+........ ....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC--HHHHHHHHhhhccCCChhhhhhhhh
Confidence 2335688999999998656678899999999999999999999997542 11111111100 0000
Q ss_pred --------------Cc-----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhhc
Q 006031 609 --------------GA-----EDERLGMLLEVAIACNSASPEQRPTMWQVLKM--LQEIKG 648 (664)
Q Consensus 609 --------------~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~i~~ 648 (664)
.. .......+.+++.+||+.||++|||+.|+++. |++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 01112458899999999999999999999874 544433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-41 Score=351.22 Aligned_cols=239 Identities=17% Similarity=0.241 Sum_probs=191.2
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEec--CCceEEEEecC
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQA--KEERLLIYDYQ 464 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~~ 464 (664)
.++||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++||||+
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 46899999999999996 56899999998642 4567899999999995 9999999999874 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCC-CeEEeeccccccccCC-C
Q 006031 465 PNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDF-EACLADYCLTALTADS-L 542 (664)
Q Consensus 465 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~-~ 542 (664)
.+++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+++..... .
T Consensus 115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999997654 3589999999999999999999999 999999999999998655 5899999999876543 2
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHH------------HHHhhccCC--
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMN------------WVRSAREDD-- 608 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~------------~~~~~~~~~-- 608 (664)
.....+|+.|+|||.+.+...++.++||||+||++|||++|+.||............ +........
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 334568999999999875666899999999999999999999998764322111111 110000000
Q ss_pred --------------------CchhHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006031 609 --------------------GAEDERLGMLLEVAIACNSASPEQRPTMWQVLK 641 (664)
Q Consensus 609 --------------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 641 (664)
........++.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011223356889999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=353.96 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=193.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEecC-----CceEEEEe
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQAK-----EERLLIYD 462 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e 462 (664)
.+.||+|+||+||+|+. .+|+.||||+++.........+.+.+|++++++++|||||++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 46899999999999995 5799999999976544333456788999999999999999999998643 34567778
Q ss_pred cCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCCC
Q 006031 463 YQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADSL 542 (664)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 542 (664)
|+.+|+|.++++. ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.......
T Consensus 103 ~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~ 175 (348)
T d2gfsa1 103 HLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175 (348)
T ss_dssp ECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred eecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCccc
Confidence 8889999999952 3599999999999999999999999 99999999999999999999999999997654433
Q ss_pred CCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHHHhhccCC--------------
Q 006031 543 QDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWVRSAREDD-------------- 608 (664)
Q Consensus 543 ~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 608 (664)
....|+..|+|||.......++.++|||||||++|||++|+.||.+.. .......+.......
T Consensus 176 -~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 176 -TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp -SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred -ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 345688899999987756667899999999999999999999997532 111111111110000
Q ss_pred ----------C-c----hhHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 006031 609 ----------G-A----EDERLGMLLEVAIACNSASPEQRPTMWQVLK--MLQEIK 647 (664)
Q Consensus 609 ----------~-~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~i~ 647 (664)
. . .......+.+|+.+|++.||++|||++|+++ .++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 0 0112345789999999999999999999987 355543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=347.00 Aligned_cols=243 Identities=16% Similarity=0.206 Sum_probs=183.1
Q ss_pred hccccccCceeEEEEEEc-CCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcccceEEEec------CCceEEEE
Q 006031 389 AELLGKGSLGTTYKAVLD-NRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLVPLRAYFQA------KEERLLIY 461 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~~~lV~ 461 (664)
.++||+|+||+||+|... +|+.||||++..........+.+.+|+.++++++|||||+++++|.. ....|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 368999999999999965 69999999997655433344678899999999999999999999864 35789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEeeccccccccCC
Q 006031 462 DYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLADYCLTALTADS 541 (664)
Q Consensus 462 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 541 (664)
||+.++ +.+.++ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 102 Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 102 ELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp ECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccccc
Confidence 999764 555553 3489999999999999999999999 9999999999999999999999999998765543
Q ss_pred CC-CCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCChhhHHHHH-------------------
Q 006031 542 LQ-DDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLVPNEMMNWV------------------- 601 (664)
Q Consensus 542 ~~-~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~~~~~~~~~------------------- 601 (664)
.. ....+|+.|+|||++. +..++.++||||+||++|||++|+.||...... .......
T Consensus 173 ~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp --------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 32 3456899999999987 567899999999999999999999999753210 0111110
Q ss_pred ---HhhccCC---------------C--chhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006031 602 ---RSAREDD---------------G--AEDERLGMLLEVAIACNSASPEQRPTMWQVLKM 642 (664)
Q Consensus 602 ---~~~~~~~---------------~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 642 (664)
....... . ........+.+|+.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 122345678999999999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-35 Score=311.74 Aligned_cols=251 Identities=16% Similarity=0.196 Sum_probs=185.1
Q ss_pred hccccccCceeEEEEEE-cCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-----------CCCcccceEEEecC--
Q 006031 389 AELLGKGSLGTTYKAVL-DNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-----------HPNLVPLRAYFQAK-- 454 (664)
Q Consensus 389 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~~-- 454 (664)
.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 47899999999999996 5799999999975432 3466788888887765 57899999987643
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCC------eE
Q 006031 455 EERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFE------AC 528 (664)
Q Consensus 455 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~------~k 528 (664)
...+++++++..+......... .....+++..+..++.||+.||+|||+..+|+||||||+|||++.++. ++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 4566777766555433332211 344678889999999999999999998439999999999999986653 89
Q ss_pred EeeccccccccCCCCCCCCCCCcccCccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----h-hhHHHHHHh
Q 006031 529 LADYCLTALTADSLQDDDPDNLLYKAPETRNASHQATSKSDVYSFGVLLLELLTGKPPSQHSFLV----P-NEMMNWVRS 603 (664)
Q Consensus 529 i~DfGla~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ksDVwSfGvvl~elltG~~P~~~~~~~----~-~~~~~~~~~ 603 (664)
++|||.+....... ....+|+.|+|||.+. ...++.++||||+||+++||++|+.||...... . ..+...+..
T Consensus 173 l~dfg~s~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 173 IADLGNACWYDEHY-TNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp ECCCTTCEETTBCC-CSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred Eeeccccccccccc-ccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 99999998654432 3467899999999887 667899999999999999999999998753221 0 111111111
Q ss_pred hccC---------------------------------------CCchhHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--
Q 006031 604 ARED---------------------------------------DGAEDERLGMLLEVAIACNSASPEQRPTMWQVLKM-- 642 (664)
Q Consensus 604 ~~~~---------------------------------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~-- 642 (664)
.... ..........+.+|+.+|++.||++|||++|+++.
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 1000 01124556779999999999999999999999874
Q ss_pred HHhh
Q 006031 643 LQEI 646 (664)
Q Consensus 643 L~~i 646 (664)
+++.
T Consensus 331 f~~~ 334 (362)
T d1q8ya_ 331 LKDT 334 (362)
T ss_dssp GTTC
T ss_pred cCCC
Confidence 5544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=6e-33 Score=287.00 Aligned_cols=205 Identities=34% Similarity=0.553 Sum_probs=158.1
Q ss_pred CCChhHHHHHHHHHhccCCCCCCcCcCCCCCCCcc--ccceEecC----CcEEEEEEcCCCCCCcC-CCccccCCCCCCE
Q 006031 37 SLLPSDAQVLLAFKAKADLRNHLFFSQNKSLHFCQ--WQGVICYQ----QKVVRVVLQGLDLGGIF-APNSLTKLDQLRV 109 (664)
Q Consensus 37 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~~~~~~C~--w~gv~C~~----~~v~~l~l~~~~l~g~~-~p~~l~~l~~L~~ 109 (664)
-|.|+|++||++||+++.+++.+ .+|+.++|||. |.||+|+. .||+.|+|+++++.|.. .|+++++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l-~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcC-CCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 38899999999999999876544 34555689995 99999975 37999999999999853 2459999999999
Q ss_pred EEecC-CCCCCCCC-CCCCCCCCCEEeccCCcCCCC------------------------CcccccCCCCCCEEeccCCc
Q 006031 110 LGLQN-NSLTGPIP-DLSGLVNLKSLFLDHNFFTGS------------------------FPPSLLSLHRLKTLDLSYNN 163 (664)
Q Consensus 110 L~L~~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~------------------------~p~~~~~l~~L~~L~l~~N~ 163 (664)
|+|++ |+|+|.+| +|++|++|++|+|++|+|+|. +|..+.++++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999998 699999999999988887654 44555666666666666666
Q ss_pred CcCCCchhhc----------------------------------------------------------------------
Q 006031 164 LSGPLPKELA---------------------------------------------------------------------- 173 (664)
Q Consensus 164 l~g~~p~~~~---------------------------------------------------------------------- 173 (664)
++|.+|..+.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555553221
Q ss_pred -CCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCCccCcCCC
Q 006031 174 -SQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCGEIIHKEC 243 (664)
Q Consensus 174 -~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg~~~~~~c 243 (664)
.+++|+.|+|++|+|+|.+|.. .+++|++|||++|+|+|.+|....++++..+.+.+|+.+||.|++ .|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 1233445555555555555542 457899999999999999998888899999999999999998875 56
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.7e-23 Score=199.26 Aligned_cols=164 Identities=12% Similarity=0.107 Sum_probs=119.2
Q ss_pred HhccccccCceeEEEEEEcCCeEEEEEEccCcccc----------------CCcHHHHHHHHHHHcCCCCCCcccceEEE
Q 006031 388 SAELLGKGSLGTTYKAVLDNRLIVCVKRLDASKLA----------------GTSNEMYEQHMESVGGLRHPNLVPLRAYF 451 (664)
Q Consensus 388 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 451 (664)
.+++||+|+||+||+|...+|+.||||.++..... ........+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 36789999999999999989999999987532110 00123345788889999999999887653
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCeEeCCCCCeEEee
Q 006031 452 QAKEERLLIYDYQPNGSLFSLIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQAWRLVHGNLKSSNVLLGPDFEACLAD 531 (664)
Q Consensus 452 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ivHrDlk~~NILl~~~~~~ki~D 531 (664)
..+++|||+++..+.+ ++......++.|++++|+|||+. +|+||||||+|||++++ .++++|
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEE
Confidence 2479999998755432 34445678999999999999999 99999999999999965 589999
Q ss_pred ccccccccCCCCCCCCCCCcccC------ccccccCCCCCchhhHHHHHHHH
Q 006031 532 YCLTALTADSLQDDDPDNLLYKA------PETRNASHQATSKSDVYSFGVLL 577 (664)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~ksDVwSfGvvl 577 (664)
||.++....... ..|.. .|++ .+.++.++|+||..--+
T Consensus 146 FG~a~~~~~~~~------~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW------REILERDVRNIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH------HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc------HHHHHHHHHHHHHHH--cCCCCCcccHHHHHHHH
Confidence 999876542211 11111 1222 24567889999965433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=6e-19 Score=167.52 Aligned_cols=131 Identities=24% Similarity=0.261 Sum_probs=93.0
Q ss_pred ccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCEEeccCCcCCCCCccc
Q 006031 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLDHNFFTGSFPPS 147 (664)
Q Consensus 70 C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~~p~~ 147 (664)
|.|..|.|+ +++|+. +|+ .+. +++++|+|++|+|++.++ .|.++++|+.|+|++|++++..+..
T Consensus 8 C~~~~v~Cs----------~~~L~~-iP~-~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~ 73 (192)
T d1w8aa_ 8 CEGTTVDCT----------GRGLKE-IPR-DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73 (192)
T ss_dssp EETTEEECT----------TSCCSS-CCS-CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT
T ss_pred EcCCEEEEe----------CCCcCc-cCC-CCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccc
Confidence 667777665 445553 433 342 567778888888876554 4677778888888888887777777
Q ss_pred ccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 148 LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 148 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. .+++|++|+|++|.+.+..
T Consensus 74 ~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 777788888888888887666667777788888888888887666643 5677778888888776654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=7.2e-17 Score=161.18 Aligned_cols=154 Identities=24% Similarity=0.199 Sum_probs=107.6
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.++.|+|++|.+++ +++..|.++++|++|+|++|+|+. +|.++.+++|++|+|++|+++ .+|..+.++++|++|+|+
T Consensus 32 ~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCC-cCHHHhhccccccccccccccccc-ccccccccccccccccccccc-cccccccccccccccccc
Confidence 46677777777776 455567777777777777777763 445566677777777777766 345555555555555555
Q ss_pred CC------------------------cCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccC
Q 006031 161 YN------------------------NLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAI 214 (664)
Q Consensus 161 ~N------------------------~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~ 214 (664)
+| .+++..+..+..+++|+.|++++|+|++.++.. .+++|++|+|++|+|+..+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccC
Confidence 55 444333444566778888888888888766653 6789999999999999544
Q ss_pred CCCCcccccCccccccCCCCCCc
Q 006031 215 TVTSTLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 215 p~~~~l~~~~~~~~~~N~~lcg~ 237 (664)
+....+..+..+.+.+|||.|..
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSG
T ss_pred hhHCCCCCCCEEEecCCCCCCCc
Confidence 44566778888999999999963
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.4e-17 Score=156.27 Aligned_cols=155 Identities=26% Similarity=0.317 Sum_probs=125.6
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..++.|+|++|.|++.+++..+.++++|+.|+|++|++.+.++ .+..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 4688999999999887777788999999999999999998887 588899999999999999976777889999999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCcccccCCCCCcccccCccccccCCCCCC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~~lcg 236 (664)
|++|+|++..|..|..+++|++|+|++|.+....+.. ....|+.+.+..|.++...| ..+..+....+..|..-|.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p--~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP--SKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS--TTTTTSBGGGSCTTTCCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC--hhhcCCEeeecCHhhCcCC
Confidence 9999999777788899999999999999988655432 11235556777888887777 4566666666666665553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=2.5e-16 Score=157.15 Aligned_cols=145 Identities=23% Similarity=0.190 Sum_probs=109.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
.+...++.++++|+. +|+ .+. ++|++|+|++|+|++..+ .|.++++|++|+|++|+|+ .+|. ++.+++|++|+
T Consensus 10 ~~~~~v~C~~~~L~~-iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~ 83 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTA-LPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLD 83 (266)
T ss_dssp TTCCEEECTTSCCSS-CCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEE
T ss_pred CCCeEEEccCCCCCe-eCc-CcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccc
Confidence 345567888889986 544 554 589999999999998776 5899999999999999998 6664 68899999999
Q ss_pred ccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccC
Q 006031 159 LSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFN 231 (664)
Q Consensus 159 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N 231 (664)
|++|+++ .+|..+..+++|+.|++++|++.+..+.. .+.+|+.|++++|.+++..+.. ..+..+..+.+.+|
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence 9999999 46778889999999999999988655542 4556666666666666554432 22334444445444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=2.6e-15 Score=151.17 Aligned_cols=157 Identities=22% Similarity=0.212 Sum_probs=130.2
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+..+....++....+++..+.++++|++|+|++|.+.+..+ .+..+++|+.+++++|+|++..+..|..+++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 344444433332233667789999999999999999987766 5778999999999999999666677889999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCC-CcccccCccccccCCCCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVT-STLSRFGISSFLFNPSLCG 236 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~-~~l~~~~~~~~~~N~~lcg 236 (664)
++|+|++..|..+..+++|+.|++++|++++..|.. .+++|++||+++|++++.+|.. ..+.++..+.+.+|++.|.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999888889999999999999999999888764 7789999999999999887632 4566778888999999886
Q ss_pred c
Q 006031 237 E 237 (664)
Q Consensus 237 ~ 237 (664)
.
T Consensus 241 C 241 (284)
T d1ozna_ 241 C 241 (284)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6.4e-15 Score=148.24 Aligned_cols=150 Identities=23% Similarity=0.201 Sum_probs=102.4
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--------------------------CCCCCCCCCEEe
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--------------------------DLSGLVNLKSLF 134 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--------------------------~~~~l~~L~~L~ 134 (664)
.++.|+|++|+++. +++.++.++++|++|++++|++.+..+ .|.++++|+.|+
T Consensus 33 ~~~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 33 ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECcCCcCCC-CCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 46789999999987 777789999999999999999876544 244566677777
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g 212 (664)
|++|.+.+..+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|++++..|.. .+++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 7777766555556666667777777777776544556666667777777777776555532 56667777777777776
Q ss_pred cCCCC-CcccccCccccccC
Q 006031 213 AITVT-STLSRFGISSFLFN 231 (664)
Q Consensus 213 ~~p~~-~~l~~~~~~~~~~N 231 (664)
..|.. ..+.++..+.+.+|
T Consensus 192 i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSS
T ss_pred cChhHhhhhhhccccccccc
Confidence 66532 22334444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=3.2e-15 Score=130.49 Aligned_cols=102 Identities=32% Similarity=0.416 Sum_probs=70.2
Q ss_pred CEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCc
Q 006031 108 RVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNR 187 (664)
Q Consensus 108 ~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 187 (664)
++|+|++|+|+ .+|.+.++++|++|||++|+|+ .+|+.++.+++|++|+|++|+|+ .+| .+..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 46777777776 4456777777777777777776 66777777777777777777777 445 36777777777777777
Q ss_pred CccCCCC---CCCCCCcEEEccCCccccc
Q 006031 188 FNGSIPP---LNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 188 l~g~~p~---~~~~~L~~l~l~~N~l~g~ 213 (664)
++..... ..+++|+.|++++|.++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 7643321 2556777777777777654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.58 E-value=5e-16 Score=158.76 Aligned_cols=134 Identities=25% Similarity=0.375 Sum_probs=104.4
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCC-CEEEecCCCCCCCCC------------------------CCCCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQL-RVLGLQNNSLTGPIP------------------------DLSGLVNLKSLF 134 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L-~~L~L~~N~l~g~~p------------------------~~~~l~~L~~L~ 134 (664)
..+..+++.+|.+.|.+|. .+..+..| +.+++++|+++|.+| .+..+++|+.|+
T Consensus 149 ~~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeecccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3455666666666665533 45555444 555555555555443 235678889999
Q ss_pred ccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC-CCCCCcEEEccCCc-ccc
Q 006031 135 LDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL-NQSSLKIFNVSGNN-FTG 212 (664)
Q Consensus 135 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~L~~l~l~~N~-l~g 212 (664)
+++|.++|.+| .++.+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|.+|.. .+++|+.+++++|+ ++|
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 99999987765 6888999999999999999999999999999999999999999999976 67899999999998 677
Q ss_pred c-CC
Q 006031 213 A-IT 215 (664)
Q Consensus 213 ~-~p 215 (664)
. +|
T Consensus 307 ~plp 310 (313)
T d1ogqa_ 307 SPLP 310 (313)
T ss_dssp TTSS
T ss_pred CCCC
Confidence 5 45
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.57 E-value=1.2e-14 Score=147.67 Aligned_cols=160 Identities=20% Similarity=0.280 Sum_probs=109.9
Q ss_pred ccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC-CCCCCCCCCEEeccC
Q 006031 70 CQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP-DLSGLVNLKSLFLDH 137 (664)
Q Consensus 70 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~L~~ 137 (664)
|.|++|.|+. ..++.|+|++|.++. +++.+|.++++|++|++++|.+....| .|.++++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCC-cChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 7899999975 357789999999988 666689999999999999999998877 488999999999999
Q ss_pred CcCCCCCcc------------------------------------------------cccCCCCCC--------------
Q 006031 138 NFFTGSFPP------------------------------------------------SLLSLHRLK-------------- 155 (664)
Q Consensus 138 N~l~g~~p~------------------------------------------------~~~~l~~L~-------------- 155 (664)
|+++ .+|. .+..+++|+
T Consensus 89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 9876 2321 122333444
Q ss_pred -------EEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCC--CCCCCcEEEccCCcccccCCCCCcccccCcc
Q 006031 156 -------TLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPL--NQSSLKIFNVSGNNFTGAITVTSTLSRFGIS 226 (664)
Q Consensus 156 -------~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~ 226 (664)
.|++++|.+++..|..+..++.++.|++++|++++..|.. .+++|++|+|++|+|+...+....+.++..+
T Consensus 168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247 (305)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEE
T ss_pred ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEE
Confidence 4444444444444555555566666666666666554432 4566777777777776544344455566666
Q ss_pred ccccC
Q 006031 227 SFLFN 231 (664)
Q Consensus 227 ~~~~N 231 (664)
.+.+|
T Consensus 248 ~Ls~N 252 (305)
T d1xkua_ 248 YLHNN 252 (305)
T ss_dssp ECCSS
T ss_pred ECCCC
Confidence 66665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=4e-14 Score=123.40 Aligned_cols=103 Identities=28% Similarity=0.255 Sum_probs=90.6
Q ss_pred EEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCc
Q 006031 84 RVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNN 163 (664)
Q Consensus 84 ~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 163 (664)
.|+|++|+++. + + .+.+|++|++|+|++|.|+..++.++.+++|+.|++++|+++ .+| .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l-~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-L-C-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-C-C-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-C-c-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 58999999986 4 3 599999999999999999976567999999999999999999 566 49999999999999999
Q ss_pred CcCCC-chhhcCCCCCCeeeCcCCcCccC
Q 006031 164 LSGPL-PKELASQGRLYSLRLDVNRFNGS 191 (664)
Q Consensus 164 l~g~~-p~~~~~l~~L~~L~l~~N~l~g~ 191 (664)
|+..- +..+..+++|+.|++++|+++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 98432 25789999999999999999854
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=8.2e-14 Score=132.24 Aligned_cols=144 Identities=23% Similarity=0.325 Sum_probs=104.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
..++.|++.++++.. + +.+..|++|++|+|++|+|++..| ++++++|++|++++|.+. .+|. +.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l--~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c--cccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-cccccccccccc
Confidence 467778888888775 3 247778888888888888887554 788888888888888877 5553 778888888888
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCccccccCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSFLFNP 232 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~~~N~ 232 (664)
++|.+.. + ..+..+++|+.|++++|++....+-..+++|+.|++++|++++..+ ...+.++..+.+.+|+
T Consensus 114 ~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 114 FNNQITD-I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNK 183 (199)
T ss_dssp CSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred ccccccc-c-cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCCcc-ccCCCCCCEEECCCCC
Confidence 8888764 2 2467788888888888887743223467788888888888876533 4556666777776663
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=6.5e-14 Score=134.16 Aligned_cols=123 Identities=27% Similarity=0.340 Sum_probs=55.1
Q ss_pred EEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC
Q 006031 82 VVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY 161 (664)
Q Consensus 82 v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 161 (664)
++.|++.++.+.. +. .+..+++|++|+|++|.|++. +.++++++|++|+|++|+++ .+| .+.++++|+.|++++
T Consensus 48 L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 48 IDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp CCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred ccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCc-cccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 4444444444443 11 244445555555555555442 22444455555555555554 233 244445555555555
Q ss_pred CcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccc
Q 006031 162 NNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 162 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 212 (664)
|.+. .++ .+..+++|+.+++++|.+++..+...+++|+.+++++|++++
T Consensus 122 ~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 122 NGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp SCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC
T ss_pred cccc-ccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 4443 222 344444444444444444433323334444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.48 E-value=7.6e-14 Score=133.68 Aligned_cols=140 Identities=25% Similarity=0.377 Sum_probs=117.9
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.+++.|+|++|.+++ ++ .+++|++|+.|+|++|+|++ +|.+.++++|+.|++++|.+. .++ .+.++++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~-l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccC-cc--ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 579999999999998 43 48899999999999999986 567999999999999999987 444 6889999999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcccccCcccc
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTLSRFGISSF 228 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l~~~~~~~~ 228 (664)
++|.+++ +..+..+++|+.+++++|++++..|-.++++|+.|+|++|+++. +|....+.++..+.+
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L 207 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLEL 207 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEE
T ss_pred ccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEc
Confidence 9999984 34678899999999999999976555688999999999999985 454455555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=1.3e-13 Score=130.76 Aligned_cols=133 Identities=27% Similarity=0.385 Sum_probs=113.1
Q ss_pred ccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCC
Q 006031 72 WQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSL 151 (664)
Q Consensus 72 w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 151 (664)
+.|+. .-..+..|+|++|.+++. + .+++|++|+.|++++|.+.. +|.+.++++|+.|++++|.+.. + ..+.++
T Consensus 55 l~~l~-~l~nL~~L~Ls~N~l~~~-~--~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~-~-~~~~~l 127 (199)
T d2omxa2 55 IDGVE-YLNNLTQINFSNNQLTDI-T--PLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD-I-DPLKNL 127 (199)
T ss_dssp CTTGG-GCTTCCEEECCSSCCCCC-G--GGTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC-C-GGGTTC
T ss_pred ccccc-cCCCcCcCccccccccCc-c--cccCCccccccccccccccc-cccccccccccccccccccccc-c-cccchh
Confidence 44542 236799999999999983 3 39999999999999999875 4568999999999999999984 3 348899
Q ss_pred CCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCccccc
Q 006031 152 HRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGA 213 (664)
Q Consensus 152 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ 213 (664)
++|+.|++++|+++ .+| .+..+++|+.|++++|++++..+-..+++|+.|++++|+++..
T Consensus 128 ~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 128 TNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp TTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC
T ss_pred hhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCCC
Confidence 99999999999998 455 5889999999999999999765556889999999999999863
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2e-13 Score=124.89 Aligned_cols=111 Identities=20% Similarity=0.083 Sum_probs=60.5
Q ss_pred cccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCC
Q 006031 100 SLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLY 179 (664)
Q Consensus 100 ~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 179 (664)
.+.+...|++|+|++|+|+....-+..+++|+.|||++|+++ .++ .|..+++|++|+|++|+++...+..+..+++|+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 344555566666666666544222344566666666666665 443 355566666666666666633333344566666
Q ss_pred eeeCcCCcCccCC--CC-CCCCCCcEEEccCCcccc
Q 006031 180 SLRLDVNRFNGSI--PP-LNQSSLKIFNVSGNNFTG 212 (664)
Q Consensus 180 ~L~l~~N~l~g~~--p~-~~~~~L~~l~l~~N~l~g 212 (664)
.|+|++|+++... .. ..+++|+.|++++|.++.
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcccc
Confidence 6666666665321 11 145566666666666553
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.7e-13 Score=125.39 Aligned_cols=121 Identities=21% Similarity=0.200 Sum_probs=99.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++..|+|++|+++. + +..+..+++|+.|+|++|+|+. ++.|..+++|+.|+|++|+++...+..+..+++|++|+|
T Consensus 18 ~~lr~L~L~~n~I~~-i-~~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-I-ENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-C-CCGGGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-c-CccccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 367889999999988 4 4456789999999999999985 477999999999999999999444444567999999999
Q ss_pred cCCcCcCCCc--hhhcCCCCCCeeeCcCCcCccCCCC-----CCCCCCcEEE
Q 006031 160 SYNNLSGPLP--KELASQGRLYSLRLDVNRFNGSIPP-----LNQSSLKIFN 204 (664)
Q Consensus 160 ~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~~p~-----~~~~~L~~l~ 204 (664)
++|+|+ .++ ..+..+++|+.|++++|.++..... ..+++|++||
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999998 455 3688999999999999999754320 2567788776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=6.3e-13 Score=138.73 Aligned_cols=143 Identities=24% Similarity=0.346 Sum_probs=80.1
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCc--------------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP-------------- 145 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p-------------- 145 (664)
..+..+++.++.+.. + +.+..+++|+.|++++|.+++..| ++.+++|+.|++++|++++..|
T Consensus 219 ~~L~~L~l~~n~l~~-~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCC-C--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCC-c--chhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 356677777777776 2 257778888888888888876544 7777888888888887774322
Q ss_pred ------ccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCC-CCCCCCcEEEccCCcccccCCCCC
Q 006031 146 ------PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFTGAITVTS 218 (664)
Q Consensus 146 ------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~L~~l~l~~N~l~g~~p~~~ 218 (664)
..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|++++ +|. ..+++|++|++++|+|++.+| ..
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~-l~ 370 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP-LA 370 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG-GT
T ss_pred cccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh-hc
Confidence 1233344455555555555432 2 14445555555555555543 222 244455555555555554443 23
Q ss_pred cccccCcccccc
Q 006031 219 TLSRFGISSFLF 230 (664)
Q Consensus 219 ~l~~~~~~~~~~ 230 (664)
.+.++..+.+.+
T Consensus 371 ~l~~L~~L~L~~ 382 (384)
T d2omza2 371 NLTRITQLGLND 382 (384)
T ss_dssp TCTTCSEEECCC
T ss_pred cCCCCCEeeCCC
Confidence 333444444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.38 E-value=2.9e-12 Score=129.70 Aligned_cols=131 Identities=24% Similarity=0.291 Sum_probs=98.3
Q ss_pred CCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeC
Q 006031 104 LDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRL 183 (664)
Q Consensus 104 l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 183 (664)
+++|+.+++++|+++.... ..+++|+.|++++|..++..|..+.+++.++.|++++|++++..|..+..+++|+.|+|
T Consensus 149 l~~L~~l~l~~n~l~~l~~--~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 149 MKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp CTTCCEEECCSSCCCSCCS--SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccccCccccccCCccccCc--ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 4444445555444442211 22567788888888888888888999999999999999999888899999999999999
Q ss_pred cCCcCccCCCC-C-CCCCCcEEEccCCcccccCCCC-------CcccccCccccccCCCCCCc
Q 006031 184 DVNRFNGSIPP-L-NQSSLKIFNVSGNNFTGAITVT-------STLSRFGISSFLFNPSLCGE 237 (664)
Q Consensus 184 ~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~~p~~-------~~l~~~~~~~~~~N~~lcg~ 237 (664)
++|+|+. +|. . .+++|++|+|++|+|+...... ..+..+..+.+.+|++-+..
T Consensus 227 ~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 227 NNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp CSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred ccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCc
Confidence 9999985 554 3 6899999999999999643211 22345667788899876543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=7.7e-13 Score=120.06 Aligned_cols=106 Identities=25% Similarity=0.221 Sum_probs=69.5
Q ss_pred ccccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCC-CCCCCC-CCCCCCCCCEEeccCCcCCCCCccc
Q 006031 70 CQWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNS-LTGPIP-DLSGLVNLKSLFLDHNFFTGSFPPS 147 (664)
Q Consensus 70 C~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~-l~g~~p-~~~~l~~L~~L~L~~N~l~g~~p~~ 147 (664)
|.+.+|+|.. +++... |..+..+++|+.|+|++|+ |+...+ .|.++++|+.|+|++|+|+..-|..
T Consensus 8 ~~~~~l~c~~----------~~~~~~--p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~ 75 (156)
T d2ifga3 8 HGSSGLRCTR----------DGALDS--LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (156)
T ss_dssp SSSSCEECCS----------SCCCTT--TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred CCCCeEEecC----------CCCccC--cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccc
Confidence 3466666643 334332 3457777788888886654 665544 4777888888888888887555666
Q ss_pred ccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcC
Q 006031 148 LLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRF 188 (664)
Q Consensus 148 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 188 (664)
|..+++|++|+|++|+|+ .+|..+....+|+.|+|++|.+
T Consensus 76 f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp GGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred ccccccccceeccCCCCc-ccChhhhccccccccccCCCcc
Confidence 777788888888888877 5555444444566666666655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=5.6e-12 Score=121.86 Aligned_cols=144 Identities=22% Similarity=0.287 Sum_probs=75.4
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEecc
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLS 160 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 160 (664)
.++.|++.++++.. +. .+.+|++|+.|+|++|++++..| +.++++|++|++++|.++ .++ .+.++++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE--GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECT
T ss_pred CcCEEECCCCCCCc-ch--hHhcCCCCcEeecCCceeecccc-cccccccccccccccccc-ccc-cccccccccccccc
Confidence 34455555555543 21 34555555555555555544332 444555555555555444 332 24444445544444
Q ss_pred CCcCcCCCc--------------------hhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcccccCCCCCcc
Q 006031 161 YNNLSGPLP--------------------KELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVTSTL 220 (664)
Q Consensus 161 ~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~~~l 220 (664)
+|...+..+ ..+..+++|+.|++++|++++..+-..+++|+.|+|++|++++. |....+
T Consensus 116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l 194 (227)
T d1h6ua2 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI-SPLASL 194 (227)
T ss_dssp TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-GGGGGC
T ss_pred cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCCC-hhhcCC
Confidence 444432111 12455666777777777776544444667777777777777653 334455
Q ss_pred cccCccccccC
Q 006031 221 SRFGISSFLFN 231 (664)
Q Consensus 221 ~~~~~~~~~~N 231 (664)
.++..+.+.+|
T Consensus 195 ~~L~~L~Ls~N 205 (227)
T d1h6ua2 195 PNLIEVHLKNN 205 (227)
T ss_dssp TTCCEEECTTS
T ss_pred CCCCEEECcCC
Confidence 55566666555
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=8e-12 Score=120.73 Aligned_cols=150 Identities=23% Similarity=0.340 Sum_probs=116.3
Q ss_pred cccceEecCCcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCc-----
Q 006031 71 QWQGVICYQQKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFP----- 145 (664)
Q Consensus 71 ~w~gv~C~~~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p----- 145 (664)
+..|+. .-..+..|+|++|.+.+. . .+..+++|+.|++++|.++ .++.+.++++|+.|++++|...+..+
T Consensus 55 ~l~~l~-~l~~L~~L~ls~n~i~~~-~--~l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~ 129 (227)
T d1h6ua2 55 TIEGVQ-YLNNLIGLELKDNQITDL-A--PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129 (227)
T ss_dssp CCTTGG-GCTTCCEEECCSSCCCCC-G--GGTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCGGGTTCT
T ss_pred cchhHh-cCCCCcEeecCCceeecc-c--ccccccccccccccccccc-ccccccccccccccccccccccccchhcccc
Confidence 455543 246899999999999883 2 4899999999999999987 56778889999999998888764322
Q ss_pred ---------------ccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCcc
Q 006031 146 ---------------PSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNNF 210 (664)
Q Consensus 146 ---------------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~l 210 (664)
..+.++++|++|++++|++++. + .+.++++|+.|+|++|++++..+-..+++|++|+|++|++
T Consensus 130 ~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207 (227)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred chhhhhchhhhhchhhhhccccccccccccccccccc-h-hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcC
Confidence 2356778899999999999843 3 3889999999999999999744434789999999999999
Q ss_pred cccCCCCCcccccCcccc
Q 006031 211 TGAITVTSTLSRFGISSF 228 (664)
Q Consensus 211 ~g~~p~~~~l~~~~~~~~ 228 (664)
++..| ...+.++..+.+
T Consensus 208 t~i~~-l~~l~~L~~L~l 224 (227)
T d1h6ua2 208 SDVSP-LANTSNLFIVTL 224 (227)
T ss_dssp CBCGG-GTTCTTCCEEEE
T ss_pred CCCcc-cccCCCCCEEEe
Confidence 97654 344555554443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.2e-11 Score=111.90 Aligned_cols=110 Identities=20% Similarity=0.204 Sum_probs=92.0
Q ss_pred cCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCC-cCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCe
Q 006031 102 TKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHN-FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYS 180 (664)
Q Consensus 102 ~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 180 (664)
......+.++.+++++...+..+.++++|+.|+|++| .++..-+..|.++++|+.|+|++|+|+..-|..|..+++|+.
T Consensus 5 C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp SCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 4455667899999999877778889999999999766 488555567999999999999999999777888999999999
Q ss_pred eeCcCCcCccCCCC-CCCCCCcEEEccCCccc
Q 006031 181 LRLDVNRFNGSIPP-LNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 181 L~l~~N~l~g~~p~-~~~~~L~~l~l~~N~l~ 211 (664)
|+|++|+|+...+. +...+|+.|+|++|.|.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhccccccccccCCCccc
Confidence 99999999944443 24457999999999885
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.25 E-value=7.5e-12 Score=130.37 Aligned_cols=123 Identities=23% Similarity=0.295 Sum_probs=101.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC---------------------CCCCCCCCCEEeccCC
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP---------------------DLSGLVNLKSLFLDHN 138 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p---------------------~~~~l~~L~~L~L~~N 138 (664)
..+..+++.++.+++. + .++.+++|+.|++++|.+++..| .+..+++|+.|+|++|
T Consensus 241 ~~L~~L~l~~n~l~~~-~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n 317 (384)
T d2omza2 241 TNLTDLDLANNQISNL-A--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317 (384)
T ss_dssp TTCSEEECCSSCCCCC-G--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred cccchhccccCccCCC-C--cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCC
Confidence 4577788888888873 2 47778888888888888776533 2456789999999999
Q ss_pred cCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCCCCCCCCCcEEEccCCc
Q 006031 139 FFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIPPLNQSSLKIFNVSGNN 209 (664)
Q Consensus 139 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~l~l~~N~ 209 (664)
++++. + .+..+++|++|+|++|+|++ +| .+..+++|++|+|++|++++.+|-.++++|+.|+|++|.
T Consensus 318 ~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 318 NISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384 (384)
T ss_dssp CCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCEE
T ss_pred CCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCCc
Confidence 99964 4 38899999999999999984 55 699999999999999999988876789999999999983
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=3.6e-14 Score=134.49 Aligned_cols=114 Identities=23% Similarity=0.281 Sum_probs=98.3
Q ss_pred ccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCC
Q 006031 99 NSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRL 178 (664)
Q Consensus 99 ~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 178 (664)
.++..|++|++|+|++|+|+. ++.+.+|++|+.|+|++|+++ .+|..+..+++|++|++++|+++. ++ .+..+++|
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L 117 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHS
T ss_pred hHHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccc
Confidence 478899999999999999984 577999999999999999998 788777777899999999999984 44 58889999
Q ss_pred CeeeCcCCcCccCCC--C-CCCCCCcEEEccCCcccccCCC
Q 006031 179 YSLRLDVNRFNGSIP--P-LNQSSLKIFNVSGNNFTGAITV 216 (664)
Q Consensus 179 ~~L~l~~N~l~g~~p--~-~~~~~L~~l~l~~N~l~g~~p~ 216 (664)
+.|+|++|+++.... . ..+++|+.|+|++|.++...+.
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence 999999999985421 2 3788999999999999887664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=5.2e-11 Score=115.85 Aligned_cols=145 Identities=13% Similarity=0.132 Sum_probs=92.5
Q ss_pred ccccceEecC-----------CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCC--CCCCCCCCCEEecc
Q 006031 70 CQWQGVICYQ-----------QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIP--DLSGLVNLKSLFLD 136 (664)
Q Consensus 70 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L~L~ 136 (664)
|.++.|.|.. ..++.|+|++|.+.. +++..|.++++|++|+|++|.+...+| .|.++++++.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 7788888863 246777777777765 555567777888888888887776554 36677777777765
Q ss_pred -CCcCCCCCcccccCCCCCCEEeccCCcCcCCCc-hhhcCCCCCCeeeCcCCcCccCCCCC--C-CCCCcEEEccCCccc
Q 006031 137 -HNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLP-KELASQGRLYSLRLDVNRFNGSIPPL--N-QSSLKIFNVSGNNFT 211 (664)
Q Consensus 137 -~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~--~-~~~L~~l~l~~N~l~ 211 (664)
.|++....|..|.++++|++|++++|+++..-+ ..+..+..|..+..+++++....+.. . ...++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 466766666667777788888888777763222 12333444444455555554332221 1 235667777777777
Q ss_pred ccCC
Q 006031 212 GAIT 215 (664)
Q Consensus 212 g~~p 215 (664)
...+
T Consensus 167 ~i~~ 170 (242)
T d1xwdc1 167 EIHN 170 (242)
T ss_dssp EECT
T ss_pred cccc
Confidence 6544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.02 E-value=1.5e-12 Score=123.13 Aligned_cols=108 Identities=23% Similarity=0.327 Sum_probs=91.2
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCC-CCCCCCCEEeccCCcCCCCCcccccCCCCCCEEe
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDL-SGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLD 158 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 158 (664)
..+..|+|++|.++. ++ .|..|++|+.|+|++|.|+. +|.+ ..+++|+.|+|++|+++ .++ .+.++++|++|+
T Consensus 48 ~~L~~L~Ls~n~I~~-i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEESC-CC--CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred cccceeECcccCCCC-cc--cccCCccccChhhccccccc-cccccccccccccccccccccc-ccc-cccccccccccc
Confidence 578999999999986 43 59999999999999999985 4543 44678999999999999 454 488899999999
Q ss_pred ccCCcCcCCCc--hhhcCCCCCCeeeCcCCcCccCCCC
Q 006031 159 LSYNNLSGPLP--KELASQGRLYSLRLDVNRFNGSIPP 194 (664)
Q Consensus 159 l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~~p~ 194 (664)
|++|+|+ .++ ..+..+++|+.|+|++|++....+.
T Consensus 122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccchhc-cccccccccCCCccceeecCCCccccCccc
Confidence 9999998 444 4689999999999999999866554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.90 E-value=4.7e-09 Score=107.04 Aligned_cols=100 Identities=28% Similarity=0.340 Sum_probs=81.0
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEec
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDL 159 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 159 (664)
.++++|+|++++|+. +|+ . +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++.- .++|++|+|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~-~---~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPE-L---PPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCS-C---CTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCC-C---CCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 467899999999986 543 2 578999999999999 55643 568999999999998 66542 146999999
Q ss_pred cCCcCcCCCchhhcCCCCCCeeeCcCCcCccCCC
Q 006031 160 SYNNLSGPLPKELASQGRLYSLRLDVNRFNGSIP 193 (664)
Q Consensus 160 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 193 (664)
++|+++ .+|. ++.+++|+.|++++|.+++.++
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred cccccc-cccc-hhhhccceeecccccccccccc
Confidence 999998 6775 6789999999999999886554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.83 E-value=8.6e-09 Score=104.99 Aligned_cols=102 Identities=29% Similarity=0.315 Sum_probs=83.9
Q ss_pred CCCCEEEecCCCCCCCCCCCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccCCcCcCCCchhhcCCCCCCeeeCc
Q 006031 105 DQLRVLGLQNNSLTGPIPDLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSYNNLSGPLPKELASQGRLYSLRLD 184 (664)
Q Consensus 105 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 184 (664)
.+|+.|||++|+|+. +|++ +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|+|+
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 468999999999985 6653 679999999999999 899764 57999999999998 55531 2469999999
Q ss_pred CCcCccCCCCCCCCCCcEEEccCCcccccCCCC
Q 006031 185 VNRFNGSIPPLNQSSLKIFNVSGNNFTGAITVT 217 (664)
Q Consensus 185 ~N~l~g~~p~~~~~~L~~l~l~~N~l~g~~p~~ 217 (664)
+|+++...+...++.|+.|++++|.++..++..
T Consensus 107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 107 NNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp SSCCSSCCCCTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccccccccchhhhccceeecccccccccccccc
Confidence 999986544457899999999999998776543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=1.7e-08 Score=97.55 Aligned_cols=144 Identities=16% Similarity=0.159 Sum_probs=84.8
Q ss_pred CcEEEEEEcCCCCCCcCCCccccCCCCCCEEEecC-CCCCCCCCC-CCCCCCCCEEeccCCcCCCC--------------
Q 006031 80 QKVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQN-NSLTGPIPD-LSGLVNLKSLFLDHNFFTGS-------------- 143 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~-N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~-------------- 143 (664)
..+..|+|++|.+...+++..+.+++.+++|++.. |++....+. |.++++|+.|++++|+++..
T Consensus 53 ~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~ 132 (242)
T d1xwdc1 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132 (242)
T ss_dssp TTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEE
T ss_pred chhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccc
Confidence 45677777777776655555666677777766653 555555553 56667777777777666522
Q ss_pred -----------CcccccCC-CCCCEEeccCCcCcCCCchhhcCCCCCCee-eCcCCcCccCCCC--CCCCCCcEEEccCC
Q 006031 144 -----------FPPSLLSL-HRLKTLDLSYNNLSGPLPKELASQGRLYSL-RLDVNRFNGSIPP--LNQSSLKIFNVSGN 208 (664)
Q Consensus 144 -----------~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L-~l~~N~l~g~~p~--~~~~~L~~l~l~~N 208 (664)
-+..+.++ ..++.|++++|+++ .++..+...+++..+ ++++|+++...+. ..+++|++|+|++|
T Consensus 133 ~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred ccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCC
Confidence 11222233 25666777777777 445444455555444 4566777643332 25678888888888
Q ss_pred cccccCCCCCcccccCcc
Q 006031 209 NFTGAITVTSTLSRFGIS 226 (664)
Q Consensus 209 ~l~g~~p~~~~l~~~~~~ 226 (664)
+|+...+ ..+.++..+
T Consensus 212 ~l~~l~~--~~~~~l~~L 227 (242)
T d1xwdc1 212 RIHSLPS--YGLENLKKL 227 (242)
T ss_dssp CCCCCCS--SSCTTCCEE
T ss_pred cCCccCH--HHHcCCccc
Confidence 8875443 334444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=5.4e-08 Score=96.55 Aligned_cols=149 Identities=19% Similarity=0.182 Sum_probs=70.9
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCC-CCCCC-CCC-CCCCCCCCEEeccCC-cCCCC-CcccccC-CCCC
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNN-SLTGP-IPD-LSGLVNLKSLFLDHN-FFTGS-FPPSLLS-LHRL 154 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N-~l~g~-~p~-~~~l~~L~~L~L~~N-~l~g~-~p~~~~~-l~~L 154 (664)
++..|+|.++.+++.. +..++++++|++|+|+++ +++.. +.. ..++++|++|+|+++ .++.. ++..+.. .++|
T Consensus 72 ~L~~L~L~~~~l~~~~-~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 72 KLQNLSLEGLRLSDPI-VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCSEEECTTCBCCHHH-HHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CcccccccccCCCcHH-HHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 3444444444444322 123444555555555542 33210 111 123455555555542 22211 1112222 2455
Q ss_pred CEEeccCC--cCcCC-CchhhcCCCCCCeeeCcCC-cCccCCCC--CCCCCCcEEEccC-CcccccCC-CCCcccccCcc
Q 006031 155 KTLDLSYN--NLSGP-LPKELASQGRLYSLRLDVN-RFNGSIPP--LNQSSLKIFNVSG-NNFTGAIT-VTSTLSRFGIS 226 (664)
Q Consensus 155 ~~L~l~~N--~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~--~~~~~L~~l~l~~-N~l~g~~p-~~~~l~~~~~~ 226 (664)
+.|+|++. .++.. +...+..+++|++|+|++| .+++.... ..+++|++|+|++ ++++.... ....+.++..+
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 55555532 23211 2223456889999999885 46654433 2678899999998 56765422 12233344444
Q ss_pred cccc
Q 006031 227 SFLF 230 (664)
Q Consensus 227 ~~~~ 230 (664)
.+.+
T Consensus 231 ~l~~ 234 (284)
T d2astb2 231 QVFG 234 (284)
T ss_dssp ECTT
T ss_pred eeeC
Confidence 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.4e-08 Score=90.36 Aligned_cols=66 Identities=26% Similarity=0.238 Sum_probs=35.1
Q ss_pred CCCCCCEEeccCCcCCCC--CcccccCCCCCCEEeccCCcCcCCCch-hhcCCCCCCeeeCcCCcCccCC
Q 006031 126 GLVNLKSLFLDHNFFTGS--FPPSLLSLHRLKTLDLSYNNLSGPLPK-ELASQGRLYSLRLDVNRFNGSI 192 (664)
Q Consensus 126 ~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~ 192 (664)
.+++|++|+|++|+++.. ++..+..+++|+.|||++|+++ .++. ......+|+.|+|++|.++...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCc
Confidence 455666666666666532 2233455666666666666665 3332 2223335666666666665443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.19 E-value=7.1e-08 Score=98.39 Aligned_cols=133 Identities=19% Similarity=0.142 Sum_probs=81.4
Q ss_pred CcEEEEEEcCCCCC--C--cC----C----CccccCCCCCCEEEecCCCCCCCCC-----CCCCCCCCCEEeccCCcCCC
Q 006031 80 QKVVRVVLQGLDLG--G--IF----A----PNSLTKLDQLRVLGLQNNSLTGPIP-----DLSGLVNLKSLFLDHNFFTG 142 (664)
Q Consensus 80 ~~v~~l~l~~~~l~--g--~~----~----p~~l~~l~~L~~L~L~~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g 142 (664)
..+..|+|++|.+. | .+ . .......+.|+.|++++|+++-.-- .+..++.|+.|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 56777888877652 1 00 0 0112345677788888777652211 23446678888888887763
Q ss_pred C-----CcccccCCCCCCEEeccCCcCcCC----CchhhcCCCCCCeeeCcCCcCccCC--------CCCCCCCCcEEEc
Q 006031 143 S-----FPPSLLSLHRLKTLDLSYNNLSGP----LPKELASQGRLYSLRLDVNRFNGSI--------PPLNQSSLKIFNV 205 (664)
Q Consensus 143 ~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~--------p~~~~~~L~~l~l 205 (664)
. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.+++.- .......|+.||+
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 2 334456677788888888877532 3445667777888888888776421 1123456778888
Q ss_pred cCCcccc
Q 006031 206 SGNNFTG 212 (664)
Q Consensus 206 ~~N~l~g 212 (664)
++|+++.
T Consensus 281 s~N~i~~ 287 (344)
T d2ca6a1 281 QYNEIEL 287 (344)
T ss_dssp CSSCCBH
T ss_pred CCCcCCh
Confidence 8887753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=1.9e-07 Score=92.42 Aligned_cols=108 Identities=22% Similarity=0.190 Sum_probs=69.6
Q ss_pred ccCCCCCCEEEecCCCCCCCC-C-CCCCCCCCCEEeccCCcCCCCCcccccCCCCCCEEeccC-CcCcCC-CchhhcCCC
Q 006031 101 LTKLDQLRVLGLQNNSLTGPI-P-DLSGLVNLKSLFLDHNFFTGSFPPSLLSLHRLKTLDLSY-NNLSGP-LPKELASQG 176 (664)
Q Consensus 101 l~~l~~L~~L~L~~N~l~g~~-p-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~-~p~~~~~l~ 176 (664)
.....+|++|||++|.++... + -+.++++|++|+|++|.+++..+..++++++|++|+|++ +.++.. +..-+..++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~ 121 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence 345567888888877766432 2 256678888888888888777777788888888888877 455521 222345677
Q ss_pred CCCeeeCcCC-cCccC-CCC---CCCCCCcEEEccCC
Q 006031 177 RLYSLRLDVN-RFNGS-IPP---LNQSSLKIFNVSGN 208 (664)
Q Consensus 177 ~L~~L~l~~N-~l~g~-~p~---~~~~~L~~l~l~~N 208 (664)
+|++|+++++ .++.. +.. ...+.|+.|++++.
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred hccccccccccccccccchhhhcccccccchhhhccc
Confidence 8888888774 44321 111 13457888888753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=2.4e-07 Score=83.51 Aligned_cols=84 Identities=25% Similarity=0.152 Sum_probs=65.1
Q ss_pred cCCCCCCEEEecCCCCCCCCC---CCCCCCCCCEEeccCCcCCCCCcc-cccCCCCCCEEeccCCcCcCCCch-------
Q 006031 102 TKLDQLRVLGLQNNSLTGPIP---DLSGLVNLKSLFLDHNFFTGSFPP-SLLSLHRLKTLDLSYNNLSGPLPK------- 170 (664)
Q Consensus 102 ~~l~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~------- 170 (664)
.++++|++|+|++|+|+..-+ .+..+++|+.|||++|+++ .+++ ...+..+|+.|+|++|.++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 468999999999999986533 2557999999999999999 5554 444556899999999999876553
Q ss_pred hhcCCCCCCeeeCcCCcC
Q 006031 171 ELASQGRLYSLRLDVNRF 188 (664)
Q Consensus 171 ~~~~l~~L~~L~l~~N~l 188 (664)
.+..+++|+.|| ++++
T Consensus 141 i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 141 IRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHTTSTTCCEET--TEEC
T ss_pred HHHHCCCCCEEC--cCCC
Confidence 256688888775 4444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=9.4e-08 Score=100.60 Aligned_cols=38 Identities=26% Similarity=0.233 Sum_probs=16.6
Q ss_pred CCCCCEEeccCCcCCC----CCcccccCCCCCCEEeccCCcC
Q 006031 127 LVNLKSLFLDHNFFTG----SFPPSLLSLHRLKTLDLSYNNL 164 (664)
Q Consensus 127 l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l 164 (664)
+++|+.|+|++|.++. .+...+..+++|++|||++|+|
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i 67 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence 3444444444444431 2233334444455555544444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=1.2e-07 Score=99.82 Aligned_cols=110 Identities=24% Similarity=0.219 Sum_probs=82.1
Q ss_pred cEEEEEEcCCCCCCcCCCccccCCCCCCEEEecCCCCCC----CCC-CCCCCCCCCEEeccCCcCCCC----Cccccc-C
Q 006031 81 KVVRVVLQGLDLGGIFAPNSLTKLDQLRVLGLQNNSLTG----PIP-DLSGLVNLKSLFLDHNFFTGS----FPPSLL-S 150 (664)
Q Consensus 81 ~v~~l~l~~~~l~g~~~p~~l~~l~~L~~L~L~~N~l~g----~~p-~~~~l~~L~~L~L~~N~l~g~----~p~~~~-~ 150 (664)
.+..||++++++++.--..-+..+++|+.|+|++|+|+- .+. .+..+++|+.|||++|+++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 578999999999873112235678999999999999872 122 357889999999999998621 223332 2
Q ss_pred CCCCCEEeccCCcCcCC----CchhhcCCCCCCeeeCcCCcCcc
Q 006031 151 LHRLKTLDLSYNNLSGP----LPKELASQGRLYSLRLDVNRFNG 190 (664)
Q Consensus 151 l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g 190 (664)
..+|++|+|++|+++.. ++..+..+++|++|+|++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999753 55677788889999998888763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.92 E-value=1.4e-06 Score=88.37 Aligned_cols=134 Identities=21% Similarity=0.212 Sum_probs=99.4
Q ss_pred CcEEEEEEcCCCCCCcCC---CccccCCCCCCEEEecCCCCCCC--------CC------CCCCCCCCCEEeccCCcCCC
Q 006031 80 QKVVRVVLQGLDLGGIFA---PNSLTKLDQLRVLGLQNNSLTGP--------IP------DLSGLVNLKSLFLDHNFFTG 142 (664)
Q Consensus 80 ~~v~~l~l~~~~l~g~~~---p~~l~~l~~L~~L~L~~N~l~g~--------~p------~~~~l~~L~~L~L~~N~l~g 142 (664)
.+++.|+|++|.++..-. ...+...++|++|+|++|.|+-. +. .....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 578899999998876310 12456789999999999998531 11 12356789999999999873
Q ss_pred C----CcccccCCCCCCEEeccCCcCcCC-----CchhhcCCCCCCeeeCcCCcCccC----CCC--CCCCCCcEEEccC
Q 006031 143 S----FPPSLLSLHRLKTLDLSYNNLSGP-----LPKELASQGRLYSLRLDVNRFNGS----IPP--LNQSSLKIFNVSG 207 (664)
Q Consensus 143 ~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~--~~~~~L~~l~l~~ 207 (664)
. +...+..++.|++|+|++|+++.. +...+..+++|+.|+|++|+++.. +.. ..++.|+.|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 344466788999999999998732 334567789999999999998642 111 2567899999999
Q ss_pred Cccccc
Q 006031 208 NNFTGA 213 (664)
Q Consensus 208 N~l~g~ 213 (664)
|.+++.
T Consensus 253 n~i~~~ 258 (344)
T d2ca6a1 253 CLLSAR 258 (344)
T ss_dssp CCCCHH
T ss_pred CccCch
Confidence 999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.84 E-value=2.2e-05 Score=75.82 Aligned_cols=130 Identities=17% Similarity=0.091 Sum_probs=82.4
Q ss_pred ccC-ceeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCC-CCCcccceEEEecCCceEEEEecCCCCCHHH
Q 006031 394 KGS-LGTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLR-HPNLVPLRAYFQAKEERLLIYDYQPNGSLFS 471 (664)
Q Consensus 394 ~G~-fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 471 (664)
+|+ .+.||+....++ .+++|+...... .....+.+|...+..+. +--+.+++.+..+.+..++||+++++.++.+
T Consensus 23 ~G~s~~~v~rv~~~~~-~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 23 EGMSPAKVYKLVGENE-NLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCCSSSEEEEEECSSC-EEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCCCcEEEEEeCCC-eEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 344 358998875444 567787654322 22334566777665553 3335667788888888999999999988765
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006031 472 LIHGSKSTRAKPLHWTSCLKIAEDVAQGLSYIHQ---------------------------------------------- 505 (664)
Q Consensus 472 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~---------------------------------------------- 505 (664)
.... ......++.++++.++.||+
T Consensus 100 ~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T d1j7la_ 100 EYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred cccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence 4421 01122334444444444441
Q ss_pred -------c-----CCcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 506 -------A-----WRLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 506 -------~-----~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
. ..++|+|+.|.||+++++..+.|.||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 127899999999999987666799997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.44 E-value=0.00028 Score=67.35 Aligned_cols=73 Identities=12% Similarity=0.120 Sum_probs=50.5
Q ss_pred ccccCc-eeEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCC--CCcccceEEEecCCceEEEEecCCCCC
Q 006031 392 LGKGSL-GTTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRH--PNLVPLRAYFQAKEERLLIYDYQPNGS 468 (664)
Q Consensus 392 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gs 468 (664)
+..|.. +.||+...+++..+++|.-..... ..+..|...++.+.. -.+.+++++..+.+..++||+|++|-+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 445554 579999988888888897654322 235566666655532 335667888888888999999998765
Q ss_pred H
Q 006031 469 L 469 (664)
Q Consensus 469 L 469 (664)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.38 E-value=2.8e-05 Score=69.76 Aligned_cols=108 Identities=14% Similarity=0.137 Sum_probs=63.6
Q ss_pred CCCCCCEEEecCC-CCCCC-C----CCCCCCCCCCEEeccCCcCCCC----CcccccCCCCCCEEeccCCcCcCC----C
Q 006031 103 KLDQLRVLGLQNN-SLTGP-I----PDLSGLVNLKSLFLDHNFFTGS----FPPSLLSLHRLKTLDLSYNNLSGP----L 168 (664)
Q Consensus 103 ~l~~L~~L~L~~N-~l~g~-~----p~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~ 168 (664)
+.++|++|+|+++ .++.. + ..+...++|+.|+|++|.++.. +-..+...+.|++|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567888888764 34321 0 1355667788888888877632 223344567788888888877632 1
Q ss_pred chhhcCCCCCCeeeCcCCcCccCCCC----C-----CCCCCcEEEccCCcc
Q 006031 169 PKELASQGRLYSLRLDVNRFNGSIPP----L-----NQSSLKIFNVSGNNF 210 (664)
Q Consensus 169 p~~~~~l~~L~~L~l~~N~l~g~~p~----~-----~~~~L~~l~l~~N~l 210 (664)
-..+...++|+.|+|++|++...=.. . ..++|+.|+++++..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 22355566778888877765421100 0 345677777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.96 E-value=0.00092 Score=68.28 Aligned_cols=77 Identities=9% Similarity=0.026 Sum_probs=45.0
Q ss_pred ccccccCceeEEEEEEc-CCeEEEEEEccCc-cc----cCCcHHHHHHHHHHHcCC-CC--CCcccceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLD-NRLIVCVKRLDAS-KL----AGTSNEMYEQHMESVGGL-RH--PNLVPLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~----~~~~~~~~~~e~~~l~~l-~H--~niv~l~g~~~~~~~~~lV 460 (664)
+.||.|....||+.... +++.|+||.-... .. .....+....|.+.++.+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999854 4678888864321 10 011222334566666544 22 334455544 45667899
Q ss_pred EecCCCCC
Q 006031 461 YDYQPNGS 468 (664)
Q Consensus 461 ~e~~~~gs 468 (664)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.86 E-value=0.00019 Score=64.12 Aligned_cols=86 Identities=13% Similarity=0.167 Sum_probs=62.3
Q ss_pred CCCCCCEEeccCC-cCCCC----CcccccCCCCCCEEeccCCcCcC----CCchhhcCCCCCCeeeCcCCcCccCCCC--
Q 006031 126 GLVNLKSLFLDHN-FFTGS----FPPSLLSLHRLKTLDLSYNNLSG----PLPKELASQGRLYSLRLDVNRFNGSIPP-- 194 (664)
Q Consensus 126 ~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p~-- 194 (664)
+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.+.. .+-..+...+.|+.|+|++|.++..--.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4688999999974 46532 33346677889999999999873 2334556678999999999988743110
Q ss_pred ----CCCCCCcEEEccCCccc
Q 006031 195 ----LNQSSLKIFNVSGNNFT 211 (664)
Q Consensus 195 ----~~~~~L~~l~l~~N~l~ 211 (664)
...++|+.|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 14578999999988754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.57 E-value=0.0023 Score=63.37 Aligned_cols=134 Identities=9% Similarity=0.065 Sum_probs=76.4
Q ss_pred eEEEEEEcCCeEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCc-----ccce--EEEecCCceEEEEecCCCCCHH-
Q 006031 399 TTYKAVLDNRLIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNL-----VPLR--AYFQAKEERLLIYDYQPNGSLF- 470 (664)
Q Consensus 399 ~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~e~~~~gsL~- 470 (664)
.||+...++|..+++|...... ...+++..|...+..|....+ +..- ......+..+.++++++|..+.
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred eeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 7999999999999999875432 356677778877766543222 1111 1223456678999999764321
Q ss_pred ----H---------Hhc----cCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc------CC
Q 006031 471 ----S---------LIH----GSKSTRAKPLHWTS-------------------CLKIAEDVAQGLSYIHQA------WR 508 (664)
Q Consensus 471 ----~---------~l~----~~~~~~~~~l~~~~-------------------~~~i~~~ia~~L~yLH~~------~~ 508 (664)
. .+| .........+++.. +..+...+.+.++.+... .+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 111 11111112222211 111222233333444321 26
Q ss_pred cccCCCCCCCeEeCCCCCeEEeecccccc
Q 006031 509 LVHGNLKSSNVLLGPDFEACLADYCLTAL 537 (664)
Q Consensus 509 ivHrDlk~~NILl~~~~~~ki~DfGla~~ 537 (664)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 56899987654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.41 E-value=0.00019 Score=63.98 Aligned_cols=109 Identities=19% Similarity=0.218 Sum_probs=62.6
Q ss_pred cCCCCCCEEEecC-CCCCCCC--C---CCCCCCCCCEEeccCCcCCCC----CcccccCCCCCCEEeccCCcCcCC----
Q 006031 102 TKLDQLRVLGLQN-NSLTGPI--P---DLSGLVNLKSLFLDHNFFTGS----FPPSLLSLHRLKTLDLSYNNLSGP---- 167 (664)
Q Consensus 102 ~~l~~L~~L~L~~-N~l~g~~--p---~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~---- 167 (664)
.+.+.|+.|+|++ |.++... + .+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456777777776 4453211 1 345667778888888877643 222344567788888887777532
Q ss_pred CchhhcCCCCCCeeeC--cCCcCccCC----CC--CCCCCCcEEEccCCcc
Q 006031 168 LPKELASQGRLYSLRL--DVNRFNGSI----PP--LNQSSLKIFNVSGNNF 210 (664)
Q Consensus 168 ~p~~~~~l~~L~~L~l--~~N~l~g~~----p~--~~~~~L~~l~l~~N~l 210 (664)
+-..+...++|+.++| ++|.+.... -. ...+.|+.|+++.|+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2234566677776544 455553211 00 0456777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.05 E-value=0.0003 Score=62.66 Aligned_cols=109 Identities=18% Similarity=0.241 Sum_probs=77.7
Q ss_pred CcEEEEEEcCC-CCCCc----CCCccccCCCCCCEEEecCCCCCCCCC-----CCCCCCCCCEEeccCCcCCCC----Cc
Q 006031 80 QKVVRVVLQGL-DLGGI----FAPNSLTKLDQLRVLGLQNNSLTGPIP-----DLSGLVNLKSLFLDHNFFTGS----FP 145 (664)
Q Consensus 80 ~~v~~l~l~~~-~l~g~----~~p~~l~~l~~L~~L~L~~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----~p 145 (664)
..++.|+|+++ .++.. + -..+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l-~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHH-HHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 56788888874 45421 1 1245678999999999998865321 245578999999999998743 34
Q ss_pred ccccCCCCCCEEec--cCCcCcC----CCchhhcCCCCCCeeeCcCCcCc
Q 006031 146 PSLLSLHRLKTLDL--SYNNLSG----PLPKELASQGRLYSLRLDVNRFN 189 (664)
Q Consensus 146 ~~~~~l~~L~~L~l--~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~ 189 (664)
..+...++|+.++| ++|.+.. .+-..+...++|+.|+++.|+..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 56777889997666 5677753 34456678899999999887653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.62 E-value=0.052 Score=54.70 Aligned_cols=72 Identities=14% Similarity=0.078 Sum_probs=45.6
Q ss_pred ccccccCceeEEEEEEcCC--------eEEEEEEccCccccCCcHHHHHHHHHHHcCCCCCCcc-cceEEEecCCceEEE
Q 006031 390 ELLGKGSLGTTYKAVLDNR--------LIVCVKRLDASKLAGTSNEMYEQHMESVGGLRHPNLV-PLRAYFQAKEERLLI 460 (664)
Q Consensus 390 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lV 460 (664)
+.|+.|-.=.+|+....++ ..|.+++... . .......+|..+++.+.-.++. ++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 3577777789999887543 4466665532 1 2334556788887777433444 57777642 689
Q ss_pred EecCCCCCH
Q 006031 461 YDYQPNGSL 469 (664)
Q Consensus 461 ~e~~~~gsL 469 (664)
+||+++..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.32 E-value=0.23 Score=47.77 Aligned_cols=29 Identities=24% Similarity=0.368 Sum_probs=25.9
Q ss_pred CcccCCCCCCCeEeCCCCCeEEeeccccc
Q 006031 508 RLVHGNLKSSNVLLGPDFEACLADYCLTA 536 (664)
Q Consensus 508 ~ivHrDlk~~NILl~~~~~~ki~DfGla~ 536 (664)
++||+|+.+.||+++++...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 69999999999999988777899998764
|